Citrus Sinensis ID: 045452
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LDQ3 | 669 | Putative cysteine-rich re | yes | no | 1.0 | 0.452 | 0.506 | 7e-86 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.891 | 0.317 | 0.553 | 7e-85 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.891 | 0.330 | 0.567 | 7e-84 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.996 | 0.358 | 0.531 | 9e-84 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.996 | 0.451 | 0.506 | 1e-83 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.976 | 0.347 | 0.528 | 2e-83 | |
| Q3E9X6 | 690 | Cysteine-rich receptor-li | no | no | 1.0 | 0.439 | 0.508 | 8e-83 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 1.0 | 0.449 | 0.488 | 5e-82 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.891 | 0.409 | 0.522 | 1e-81 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 1.0 | 0.448 | 0.482 | 1e-81 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function desciption |
|---|
Score = 317 bits (812), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 156/308 (50%), Positives = 216/308 (70%), Gaps = 5/308 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSK+S QG EEFKNE +L +KLQH NL+R+LGFC++ EE++LVYE++
Sbjct: 362 GKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFV 421
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R +II GI +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 422 PNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 481
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + +ANT ++ GT GY+ PEYA +G +S KSDV+SFGVL+L+II
Sbjct: 482 MNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEII 541
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
SGK+ S I+++ S ++ HA+ LW+ G +E VD + + S + RC+ IALLCVQ
Sbjct: 542 SGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQ 601
Query: 240 ENPNDRPSMLEVSSMLKNETTNTNTPKKPAF---SKQVDEIGIELLSTTNLE-KCSAYDV 295
E+P DRP + + ML + TT + P+ P F + +++ G+E +T+ S D
Sbjct: 602 EDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDA 661
Query: 296 SFSEVVAR 303
S +E R
Sbjct: 662 SITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 151/273 (55%), Positives = 207/273 (75%), Gaps = 3/273 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L GE +A+K+LS +S QG EFKNE ML AKLQH NL+++LG C++ +E+ML+YEYM
Sbjct: 544 GRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYM 603
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP+R+++LDWK R I+EGI QGLLYL +YSRL +IHRD+KA NILL ED
Sbjct: 604 PNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDED 663
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF + KANT++V GT GY+ PEY R+G++S KSDVFSFGVL+L+II
Sbjct: 664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 723
Query: 181 SGKRLSMLCGINEN-LSILEHAYELWKGGKGMEFVDSFLDDRN-SSCKLMRCLEIALLCV 238
G++ + +E L+++ H + L+K + E +D L D + +++RC+++ALLCV
Sbjct: 724 CGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCV 783
Query: 239 QENPNDRPSMLEVSSMLKNETTNT-NTPKKPAF 270
Q+N +DRPSML+V SM+ + N + PK+PAF
Sbjct: 784 QQNADDRPSMLDVVSMIYGDGNNALSLPKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 155/273 (56%), Positives = 202/273 (73%), Gaps = 3/273 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L GE +A+K+LS +S QG EFKNE +L AKLQH NL++VLG CI+ +E+ML+YEYM
Sbjct: 513 GKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYM 572
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
NKSLD +LFDP+R+ +LDW R I+EGI QGLLYL +YSRL +IHRD+KASNILL ED
Sbjct: 573 QNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDED 632
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFGLARIF E +ANT++V GT GY+ PEY R+G++S KSDVFSFGVL+L+II
Sbjct: 633 MNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 692
Query: 181 SGKR-LSMLCGINENLSILEHAYELWKGGKGMEFVD-SFLDDRNSSCKLMRCLEIALLCV 238
G++ S + L+++ H + L+K K E +D S D +++RC+++ALLCV
Sbjct: 693 CGRKNNSFHHDLEGPLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCV 752
Query: 239 QENPNDRPSMLEVSSMLKNETTNT-NTPKKPAF 270
QEN DRPSML+V SM+ E N + PK+PAF
Sbjct: 753 QENAEDRPSMLDVVSMIYGEGNNALSLPKEPAF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (794), Expect = 9e-84, Method: Compositional matrix adjust.
Identities = 161/303 (53%), Positives = 207/303 (68%), Gaps = 1/303 (0%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LS+ S QG EE NEV++ +KLQH NL+++LG CI+ EERMLVYEYM
Sbjct: 541 GKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYM 600
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P KSLD YLFDP+++ ILDWK R +I+EGI +GLLYL SRL IIHRDLKASNILL E+
Sbjct: 601 PKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDEN 660
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ PKISDFGLARIF +ANT +VVGT GY+ PEYA +G +S KSDVFS GV+ L+II
Sbjct: 661 LNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEII 720
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SG+R S NL++L +A++LW G+ D + D+ ++ +C+ I LLCVQE
Sbjct: 721 SGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQE 780
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFSEV 300
NDRP++ V ML E + PK+PAF + E S + +K S DVS + V
Sbjct: 781 VANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAE-SSDQSSQKVSINDVSLTAV 839
Query: 301 VAR 303
R
Sbjct: 840 TGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 155/306 (50%), Positives = 207/306 (67%), Gaps = 4/306 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSKSS QG EFKNEV+L AKLQH NL+R+LGFC+D EER+LVYEY+
Sbjct: 365 GTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYV 424
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R II G+ +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 425 PNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDAD 484
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + + NT ++VGT GY+ PEYA G YS KSDV+SFGVL+L+II
Sbjct: 485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEII 544
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK+ S + ++ +A+ LW G+ +E VD + + +++RC+ I LLCVQE
Sbjct: 545 SGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQE 604
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDEIGIELLSTTNLEKC---SAYDVSF 297
+P +RP++ + ML + T P++P Q IG + L T K S D S
Sbjct: 605 DPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQ-SRIGKDPLDTDTTSKSLLGSVDDASI 663
Query: 298 SEVVAR 303
+++ R
Sbjct: 664 TDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 159/301 (52%), Positives = 213/301 (70%), Gaps = 5/301 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P + IAVK+LS+ S QG EEFKNEV+L AKLQH NL+R+LG+C+ EE++L+YEYM
Sbjct: 549 GMFPGDQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYM 608
Query: 61 PNKSLDCYLFDPIRRLI--LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
P+KSLD ++FD R+L LDWK R +II GI +GLLYL + SRL IIHRDLK SNILL
Sbjct: 609 PHKSLDFFIFD--RKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLD 666
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
E+M PKISDFGLARIF ANT +VVGT GY+ PEYA +G++S KSDVFSFGV++++
Sbjct: 667 EEMNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIE 726
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238
ISGKR + ++LS+L HA++LWK +G+E +D L + + ++CL + LLCV
Sbjct: 727 TISGKRNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCV 786
Query: 239 QENPNDRPSMLEVSSML-KNETTNTNTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSF 297
QE+PNDRP+M V ML +E TPK+PAF + + S+T E CS +++
Sbjct: 787 QEDPNDRPTMSNVVFMLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTI 846
Query: 298 S 298
+
Sbjct: 847 T 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E9X6|CRK21_ARATH Cysteine-rich receptor-like protein kinase 21 OS=Arabidopsis thaliana GN=CRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 8e-83, Method: Compositional matrix adjust.
Identities = 158/311 (50%), Positives = 211/311 (67%), Gaps = 8/311 (2%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +A K+LSK S QG EFKNEV+L A+LQH NL+ +LGF ++ EE++LVYE++
Sbjct: 380 GMFPNGTEVAAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFV 439
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDPI+R+ LDW +R +IIEGIT+G+LYL + SRLTIIHRDLKASNILL +
Sbjct: 440 PNKSLDHFLFDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAE 499
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFGLAR F +ANT +VVGT GY+PPEY G +STKSDV+SFGVL+L+II
Sbjct: 500 MNPKIADFGLARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEII 559
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
GK+ S I+ ++S ++ H + L G +E VD + + +++RC+ I LLCVQ
Sbjct: 560 GGKKNSSFHQIDGSVSNLVTHVWRLRNNGSLLELVDPAIGENYDKDEVIRCIHIGLLCVQ 619
Query: 240 ENPNDRPSMLEVSSMLKNETTNTNTPKKPAF----SKQVDEIGIELL---STTNLEKCSA 292
ENP+DRPSM + ML N + P+ P F + + + LL ST+ CS
Sbjct: 620 ENPDDRPSMSTIFRMLTNVSITLPVPQPPGFFFRERSEPNPLAERLLPGPSTSMSFTCSV 679
Query: 293 YDVSFSEVVAR 303
D S + V R
Sbjct: 680 DDASITSVRPR 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 150/307 (48%), Positives = 206/307 (67%), Gaps = 4/307 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G G+ +AVK+LSK+S QG EFK EV++ AKLQH NL+R+LGF + EER+LVYEYM
Sbjct: 368 GTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYM 427
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLDC LFDP +++ LDW +R +II GI +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 428 PNKSLDCLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 487
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ PKI+DFG+ARIF + + NT ++VGT GY+ PEYA G +S KSDV+SFGVL+L+II
Sbjct: 488 INPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEII 547
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SG++ S + +L HA+ LW K ++ VD + + + +++RC+ I LLCVQE
Sbjct: 548 SGRKNSSFGESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQE 607
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQV----DEIGIELLSTTNLEKCSAYDVS 296
+P RP++ V ML + T P++P F Q D + + +TT S D S
Sbjct: 608 DPAKRPAISTVFMMLTSNTVTLPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDES 667
Query: 297 FSEVVAR 303
+++ R
Sbjct: 668 ITDLYPR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (776), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 141/270 (52%), Positives = 192/270 (71%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G G +AVK+LSK+S QG EFKNEV++ A L+H NL+R+LGF I+ EER+LVYEY+
Sbjct: 353 GTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYV 412
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
NKSLD +LFDP ++ L W +R HII GI +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 413 ENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 472
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + + NT ++VGT GY+ PEYA +G +S KSDV+SFGVL+L+II
Sbjct: 473 MNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEII 532
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SG++ + ++ ++ HA+ LW+ G ++ VD F+ D +++RC I LLCVQE
Sbjct: 533 SGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQE 592
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAF 270
+P RP+M +S ML + T P++P F
Sbjct: 593 DPVKRPAMSTISVMLTSNTMALPAPQQPGF 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 149/309 (48%), Positives = 208/309 (67%), Gaps = 6/309 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +AVK+LSK+S QG EF NEV++ AKLQH NL+R+LGFC++ +ER+LVYE++
Sbjct: 368 GIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFV 427
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD ++FD + +LDW +R II GI +G+LYL + SRLTIIHRDLKA NILLG+D
Sbjct: 428 PNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDD 487
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M KI+DFG+ARIF + +ANT ++VGT GY+ PEYA G +S KSDV+SFGVL+L+II
Sbjct: 488 MNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEII 547
Query: 181 SGKRLSMLCGINENLS--ILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238
SGK+ S + ++ + ++ + + LW G +E VD D ++ RC+ IALLCV
Sbjct: 548 SGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCV 607
Query: 239 QENPNDRPSMLEVSSMLKNETTNTNTPKKPAF---SKQVDEIG-IELLSTTNLEKCSAYD 294
QE DRP+M + ML + P++P F S + +++G ++ LS CS D
Sbjct: 608 QEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDD 667
Query: 295 VSFSEVVAR 303
S + V R
Sbjct: 668 ASITNVTPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | ||||||
| 224142425 | 763 | predicted protein [Populus trichocarpa] | 1.0 | 0.397 | 0.702 | 1e-122 | |
| 356558668 | 909 | PREDICTED: uncharacterized protein LOC10 | 0.993 | 0.331 | 0.676 | 1e-117 | |
| 224142427 | 327 | predicted protein [Populus trichocarpa] | 0.910 | 0.844 | 0.684 | 1e-112 | |
| 296088199 | 1130 | unnamed protein product [Vitis vinifera] | 1.0 | 0.268 | 0.643 | 1e-111 | |
| 255565055 | 721 | conserved hypothetical protein [Ricinus | 1.0 | 0.420 | 0.631 | 1e-108 | |
| 224142431 | 332 | predicted protein [Populus trichocarpa] | 0.996 | 0.909 | 0.621 | 1e-108 | |
| 224082290 | 335 | predicted protein [Populus trichocarpa] | 0.996 | 0.901 | 0.621 | 1e-107 | |
| 359484771 | 781 | PREDICTED: G-type lectin S-receptor-like | 0.983 | 0.381 | 0.634 | 1e-105 | |
| 296084604 | 580 | unnamed protein product [Vitis vinifera] | 0.983 | 0.513 | 0.634 | 1e-105 | |
| 359497026 | 738 | PREDICTED: G-type lectin S-receptor-like | 0.910 | 0.373 | 0.673 | 1e-104 |
| >gi|224142425|ref|XP_002324558.1| predicted protein [Populus trichocarpa] gi|222865992|gb|EEF03123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1141), Expect = e-122, Method: Compositional matrix adjust.
Identities = 213/303 (70%), Positives = 248/303 (81%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GVLP G+ IAVKKLSKSS QGF+EFKNEVMLTAKLQHVNL++VLGFC++ EE++L+YEYM
Sbjct: 461 GVLPGGQEIAVKKLSKSSTQGFDEFKNEVMLTAKLQHVNLVKVLGFCVEREEKVLIYEYM 520
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P KSLD YLFDPIRR +LDWK+R IIEGITQGLLYLQEYSRLTIIHRDLKASNILL D
Sbjct: 521 PKKSLDSYLFDPIRRYLLDWKRREEIIEGITQGLLYLQEYSRLTIIHRDLKASNILLDGD 580
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+ARIF K+ +ANT ++VGT GY+PPEY R GVYS KSDV+SFG++LL II
Sbjct: 581 MKPKISDFGMARIFTKDEQEANTSRLVGTYGYVPPEYVRNGVYSIKSDVYSFGIVLLHII 640
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK+ L G +E LS+LE+AYELWK GKGME +D LDD SSCKL++CL+IALLCVQE
Sbjct: 641 SGKKNGSLYGSDETLSLLEYAYELWKDGKGMEIMDPSLDDTLSSCKLIKCLQIALLCVQE 700
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFSEV 300
NP DRPSMLEVSSMLKNET PK+PAFS + DE +++ CS D + S+V
Sbjct: 701 NPIDRPSMLEVSSMLKNETAIVTIPKRPAFSVKTDEDDKNRPDQLHIKICSVDDATISQV 760
Query: 301 VAR 303
V R
Sbjct: 761 VGR 763
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558668|ref|XP_003547625.1| PREDICTED: uncharacterized protein LOC100787480 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-117, Method: Compositional matrix adjust.
Identities = 205/303 (67%), Positives = 252/303 (83%), Gaps = 2/303 (0%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+L + +AVKKLSK+S QGFEEFKNEVMLTA+LQHVNL+R+LGF ID E++MLVYEYM
Sbjct: 450 GILSNRQEVAVKKLSKASTQGFEEFKNEVMLTARLQHVNLVRLLGFYIDGEQQMLVYEYM 509
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDPIRR +LDW+KR++IIEGITQGLLYLQEYSRLTIIHRD+KASNILL +
Sbjct: 510 PNKSLDSYLFDPIRRYLLDWRKRIYIIEGITQGLLYLQEYSRLTIIHRDIKASNILLDNE 569
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+ARIF K+ L+ANT ++VGT GY+ PEYA +G+YSTKSDV+SFGVLLLQI+
Sbjct: 570 MKPKISDFGMARIFRKDELEANTSKIVGTYGYVSPEYAMKGLYSTKSDVYSFGVLLLQIV 629
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SG+R + G +ENL+++E+AYELWK GKGMEF D LDD +S+CKL+RC++IALLCVQE
Sbjct: 630 SGRRTACFYGEHENLNLMEYAYELWKEGKGMEFADPSLDDSHSTCKLLRCMQIALLCVQE 689
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFSEV 300
+ NDRP++ E+SSMLK++T P+KPAFS DE + EKCS D + S+V
Sbjct: 690 DANDRPTVKEISSMLKSDTILI-IPQKPAFSINRDEKKPNKF-IMHEEKCSINDATISQV 747
Query: 301 VAR 303
VAR
Sbjct: 748 VAR 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142427|ref|XP_002324559.1| predicted protein [Populus trichocarpa] gi|222865993|gb|EEF03124.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1053), Expect = e-112, Method: Compositional matrix adjust.
Identities = 189/276 (68%), Positives = 231/276 (83%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LSK+S QG EEFKNEV LT KLQHVN++ VLGFC + EE+ML+YEYM
Sbjct: 28 GKLPNGKEIAVKRLSKTSTQGEEEFKNEVTLTEKLQHVNIVTVLGFCAEREEKMLIYEYM 87
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD Y++DPIRR +LDW+KRV IIEG+TQGLLYLQEYS TIIHRD+K+SN+LL E+
Sbjct: 88 PNKSLDIYIYDPIRRYMLDWRKRVQIIEGLTQGLLYLQEYSNFTIIHRDIKSSNVLLDEE 147
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+AR+F K+ L+ANT ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQII
Sbjct: 148 MNPKISDFGMARLFRKDELEANTSRIVGTYGYVPPEYVRKGIYSMKYDVYSFGVLLLQII 207
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK+ + G +EN ++LE+AYELWK G+G+EF D LDD SSCKL RCL++ALLCVQE
Sbjct: 208 SGKKSTCYYGADENWNLLEYAYELWKDGEGVEFFDPSLDDSFSSCKLTRCLQVALLCVQE 267
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDE 276
NP DRPSML++SSMLKNE TPK+P+FS + DE
Sbjct: 268 NPLDRPSMLKISSMLKNENAPIATPKRPSFSTKRDE 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088199|emb|CBI35714.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 408 bits (1049), Expect = e-111, Method: Compositional matrix adjust.
Identities = 195/303 (64%), Positives = 241/303 (79%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LSK+S QG EEFKNEV LTA LQHVNL+++LGFC EE+ML+YE M
Sbjct: 828 GKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECM 887
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDP +++LDW KR+HIIEGITQGLLYLQEYSRL IIHRDLKASNILL +
Sbjct: 888 PNKSLDFYLFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLDGE 947
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKI+DFG+ARIF K+ +ANT ++VGT GY+ PEY ++G YS KSDV+SFGVLLLQII
Sbjct: 948 MKPKIADFGIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSDVYSFGVLLLQII 1007
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK+ + G+++NL +LE+AYELWK GK MEF+D LDD SSCKL RC+++ALLCVQE
Sbjct: 1008 SGKKNTCFYGLDQNLHLLEYAYELWKDGKSMEFMDPSLDDACSSCKLTRCMQVALLCVQE 1067
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFSEV 300
NP DRPS+LEV SM+KNET TP++PAF+ + DE+ + S + E S + S+V
Sbjct: 1068 NPADRPSVLEVDSMIKNETAAIATPRRPAFAAKRDEVEADGKSASGHEIGSVNVTTISQV 1127
Query: 301 VAR 303
+ R
Sbjct: 1128 LPR 1130
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565055|ref|XP_002523520.1| conserved hypothetical protein [Ricinus communis] gi|223537227|gb|EEF38859.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1020), Expect = e-108, Method: Compositional matrix adjust.
Identities = 192/304 (63%), Positives = 243/304 (79%), Gaps = 1/304 (0%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LSK+S QG +EFKNE+ LTAKLQHVNL+R+LG+C + +E+ML+YEYM
Sbjct: 418 GKLPRGQEIAVKRLSKTSNQGLKEFKNELKLTAKLQHVNLVRLLGYCTERKEKMLIYEYM 477
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFD RRL L+W+KRVHIIEGI QGLLYLQEYS LTIIH+D+K+SNILL +
Sbjct: 478 PNKSLDFYLFDQKRRLELNWEKRVHIIEGIAQGLLYLQEYSNLTIIHKDIKSSNILLDSN 537
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+ARIF KE+ +ANT Q+VGT GY+PPEY ++GVYSTK DV+SFGVLLLQII
Sbjct: 538 MKPKISDFGMARIFQKENHEANTCQIVGTYGYVPPEYVKRGVYSTKYDVYSFGVLLLQII 597
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK+ + G + NL++LE+AYE W+ G G EF+D LDD +S+CKL+RCL++ LLCVQE
Sbjct: 598 SGKKNTCYYGSHVNLNLLEYAYEFWETGNGKEFLDPVLDDSHSTCKLLRCLQVGLLCVQE 657
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFS-KQVDEIGIELLSTTNLEKCSAYDVSFSE 299
+P DRPS+L++ SMLKNE +PK+PAFS DEI + +T+ + S S SE
Sbjct: 658 SPIDRPSILQICSMLKNENDIIVSPKRPAFSVTSNDEIEKNVSKSTSQDVGSVNSASLSE 717
Query: 300 VVAR 303
++ R
Sbjct: 718 LLPR 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142431|ref|XP_002324561.1| predicted protein [Populus trichocarpa] gi|222865995|gb|EEF03126.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1016), Expect = e-108, Method: Compositional matrix adjust.
Identities = 189/304 (62%), Positives = 240/304 (78%), Gaps = 2/304 (0%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G IAVK+LS SS QG EEFKNEV LTA+LQHVNL+R+LGFC + E+ML+YEYM
Sbjct: 30 GKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIYEYM 89
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDPIRR LDW KRV IIEG+TQGLLYLQEYS TIIHRDLK+SNILL ++
Sbjct: 90 PNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILLDDE 149
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+A++F K+ +ANT ++VGT GYIPPEYAR+G+YS K DV+SFGV+LLQ+I
Sbjct: 150 MNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDVYSFGVVLLQMI 209
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK + NE+L++LE+AY+LWK G+GMEF+D FLDD +S CKL+ C+++ALLCVQE
Sbjct: 210 SGKTNTRFYSENEDLNLLEYAYDLWKNGRGMEFIDPFLDDSSSPCKLLTCMQVALLCVQE 269
Query: 241 NPNDRPSMLEVSSMLKNETT-NTNTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFSE 299
NP+ RP+MLE SMLKN+ + TP++P FS++ + +E+ S++ CS D S+
Sbjct: 270 NPDARPTMLEAFSMLKNDDSLAIATPERPGFSEK-KKGDMEIASSSQQVMCSFNDSQVSQ 328
Query: 300 VVAR 303
+ R
Sbjct: 329 LEPR 332
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082290|ref|XP_002335492.1| predicted protein [Populus trichocarpa] gi|222834258|gb|EEE72735.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1015), Expect = e-107, Method: Compositional matrix adjust.
Identities = 189/304 (62%), Positives = 239/304 (78%), Gaps = 2/304 (0%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G IAVK+LS SS QG EEFKNEV LTA+LQHVNL+R+LGFC + E+ML+YEYM
Sbjct: 33 GKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIYEYM 92
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDPIRR LDW KRV IIEG+TQGLLYLQEYS TIIHRDLK+SNILL ++
Sbjct: 93 PNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILLDDE 152
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+A++F K+ +ANT ++VGT GYIPPEYAR+G+YS K DV+SFGV+LLQ+I
Sbjct: 153 MNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDVYSFGVVLLQMI 212
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK + NE+L++LE+AY+LWK G+GMEF+D FLDD +S CKL+ C+++ALLCVQE
Sbjct: 213 SGKTNTRFYSENEDLNLLEYAYDLWKNGRGMEFIDPFLDDSSSPCKLLTCMQVALLCVQE 272
Query: 241 NPNDRPSMLEVSSMLKNETT-NTNTPKKPAFSKQVDEIGIELLSTTNLEKCSAYDVSFSE 299
NP+ RP+MLE SMLKN+ + TP++P FS++ + +E S++ CS D S+
Sbjct: 273 NPDARPTMLEAFSMLKNDDSLAIATPERPGFSEK-KKGDMETASSSQQVMCSFNDSQVSQ 331
Query: 300 VVAR 303
+ R
Sbjct: 332 LEPR 335
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484771|ref|XP_003633158.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 386 bits (992), Expect = e-105, Method: Compositional matrix adjust.
Identities = 191/301 (63%), Positives = 239/301 (79%), Gaps = 3/301 (0%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GE +AVK+LSK+S QG EEFKNEV LTAKLQHVNL+R+ GFC + EE+ML+YEYMPNKSL
Sbjct: 481 GEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSL 540
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D YLFDP RR LDW KR+ IIEGITQGLLYLQEYS TIIHRDLKASNILL +MKPKI
Sbjct: 541 DFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKI 600
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
SDFG+AR F K+ +A+T ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQIIS +R
Sbjct: 601 SDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRN 660
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245
S G+++NL++LE+AYELWK G+GM F+D LDD +SSCKLM C+++ALLC+QENP+ R
Sbjct: 661 SCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQENPDHR 720
Query: 246 PSMLEVSSMLKNETTNTNTPKKPAFS--KQVDEIGIELLSTTNLEKC-SAYDVSFSEVVA 302
P+MLEVSSMLK+ET P +PAFS D++ + +T++ + S D + S++V
Sbjct: 721 PTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVNDATISDLVP 780
Query: 303 R 303
R
Sbjct: 781 R 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084604|emb|CBI25625.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 386 bits (991), Expect = e-105, Method: Compositional matrix adjust.
Identities = 191/301 (63%), Positives = 239/301 (79%), Gaps = 3/301 (0%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GE +AVK+LSK+S QG EEFKNEV LTAKLQHVNL+R+ GFC + EE+ML+YEYMPNKSL
Sbjct: 280 GEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSL 339
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D YLFDP RR LDW KR+ IIEGITQGLLYLQEYS TIIHRDLKASNILL +MKPKI
Sbjct: 340 DFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKI 399
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
SDFG+AR F K+ +A+T ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQIIS +R
Sbjct: 400 SDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRN 459
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245
S G+++NL++LE+AYELWK G+GM F+D LDD +SSCKLM C+++ALLC+QENP+ R
Sbjct: 460 SCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQENPDHR 519
Query: 246 PSMLEVSSMLKNETTNTNTPKKPAFS--KQVDEIGIELLSTTNLEKC-SAYDVSFSEVVA 302
P+MLEVSSMLK+ET P +PAFS D++ + +T++ + S D + S++V
Sbjct: 520 PTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVNDATISDLVP 579
Query: 303 R 303
R
Sbjct: 580 R 580
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497026|ref|XP_003635401.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 383 bits (984), Expect = e-104, Method: Compositional matrix adjust.
Identities = 186/276 (67%), Positives = 226/276 (81%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LSK+S QG EEFKNEV LTA LQHVNL+++LGFC EE+ML+YE M
Sbjct: 450 GKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECM 509
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDP RR LDW KR+ IIEGITQGLLYLQEYS TIIHRDLKASNILL +
Sbjct: 510 PNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSE 569
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+AR F K+ +A+T ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQII
Sbjct: 570 MKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQII 629
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
S +R S G+++NL++LE+AYELWK G+GM F+D LDD +SSCKLM C+++ALLC+QE
Sbjct: 630 SSRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQE 689
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDE 276
NP+ RP+MLEVSSMLK+ET P +PAFS + +E
Sbjct: 690 NPDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNE 725
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.841 | 0.3 | 0.564 | 1.9e-76 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 1.0 | 0.452 | 0.493 | 4.5e-75 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.848 | 0.303 | 0.555 | 2.2e-73 | |
| TAIR|locus:2121706 | 690 | CRK21 "cysteine-rich RLK (RECE | 0.848 | 0.372 | 0.562 | 2.8e-73 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 1.0 | 0.357 | 0.506 | 3.6e-73 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.996 | 0.451 | 0.496 | 1.2e-72 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.996 | 0.446 | 0.480 | 2e-72 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.960 | 0.371 | 0.498 | 1.1e-71 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 1.0 | 0.359 | 0.496 | 1.4e-71 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.986 | 0.463 | 0.482 | 1.4e-71 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 1.9e-76, P = 1.9e-76
Identities = 145/257 (56%), Positives = 198/257 (77%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L GE +A+K+LS +S QG EFKNE ML AKLQH NL+++LG C++ +E+ML+YEYM
Sbjct: 544 GRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYM 603
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP+R+++LDWK R I+EGI QGLLYL +YSRL +IHRD+KA NILL ED
Sbjct: 604 PNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDED 663
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF + KANT++V GT GY+ PEY R+G++S KSDVFSFGVL+L+II
Sbjct: 664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 723
Query: 181 SGKRLSMLCGINEN-LSILEHAYELWKGGKGMEFVDSFLDDRN-SSCKLMRCLEIALLCV 238
G++ + +E L+++ H + L+K + E +D L D + +++RC+++ALLCV
Sbjct: 724 CGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCV 783
Query: 239 QENPNDRPSMLEVSSML 255
Q+N +DRPSML+V SM+
Sbjct: 784 QQNADDRPSMLDVVSMI 800
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 4.5e-75, P = 4.5e-75
Identities = 152/308 (49%), Positives = 210/308 (68%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSK+S QG EEFKNE +L +KLQH NL+R+LGFC++ EE++LVYE++
Sbjct: 362 GKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFV 421
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R +II GI +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 422 PNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 481
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + +ANT ++ GT GY+ PEYA +G +S KSDV+SFGVL+L+II
Sbjct: 482 MNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEII 541
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
SGK+ S I+++ S ++ HA+ LW+ G +E VD + + S + RC+ IALLCVQ
Sbjct: 542 SGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQ 601
Query: 240 ENPNDRPSMLEVSSMLKNEXXXXXXXXXXAF---SKQVDEIGIELLSTTNLE-KCSAYDV 295
E+P DRP + + ML + F + +++ G+E +T+ S D
Sbjct: 602 EDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDA 661
Query: 296 SFSEVVAR 303
S +E R
Sbjct: 662 SITEFYPR 669
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
Identities = 144/259 (55%), Positives = 192/259 (74%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP GE +AVK+L ++S QG EEFKNEV+L AKLQH NL+R+LG CI EE++LVYEYM
Sbjct: 547 GTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYM 606
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LF+P ++ +LDWKKR IIEGI +GLLYL SRL ++HRDLKASNILL D
Sbjct: 607 PNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDAD 666
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+AR+F + + NT +VVGT GY+ PEYA +G++S KSDV+ FGVL+L+II
Sbjct: 667 MKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEII 726
Query: 181 SGKR-LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
+GKR +S C ++L+I +A+ W E +D + S +++RC+ IALLCVQ
Sbjct: 727 TGKRAVSFHCH-EDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQ 785
Query: 240 ENPNDRPSMLEVSSMLKNE 258
++ ++RP + V ML N+
Sbjct: 786 DHADERPDIPTVILMLSND 804
|
|
| TAIR|locus:2121706 CRK21 "cysteine-rich RLK (RECEPTOR-like protein kinase) 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 2.8e-73, P = 2.8e-73
Identities = 145/258 (56%), Positives = 191/258 (74%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +A K+LSK S QG EFKNEV+L A+LQH NL+ +LGF ++ EE++LVYE++
Sbjct: 380 GMFPNGTEVAAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFV 439
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDPI+R+ LDW +R +IIEGIT+G+LYL + SRLTIIHRDLKASNILL +
Sbjct: 440 PNKSLDHFLFDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAE 499
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFGLAR F +ANT +VVGT GY+PPEY G +STKSDV+SFGVL+L+II
Sbjct: 500 MNPKIADFGLARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEII 559
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
GK+ S I+ ++S ++ H + L G +E VD + + +++RC+ I LLCVQ
Sbjct: 560 GGKKNSSFHQIDGSVSNLVTHVWRLRNNGSLLELVDPAIGENYDKDEVIRCIHIGLLCVQ 619
Query: 240 ENPNDRPSMLEVSSMLKN 257
ENP+DRPSM + ML N
Sbjct: 620 ENPDDRPSMSTIFRMLTN 637
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
Identities = 156/308 (50%), Positives = 204/308 (66%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+L G+ IAVK+LSK S+QG +EF NEV L AKLQH+NL+R+LG C+D E+ML+YEY+
Sbjct: 540 GMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 599
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N SLD +LFD R L+W+KR II GI +GLLYL + SR IIHRDLKASN+LL ++
Sbjct: 600 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 659
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF +E +ANT +VVGT GY+ PEYA G++S KSDVFSFGVLLL+II
Sbjct: 660 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 719
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSS----CKLMRCLEIALL 236
SGKR N +L++L + WK GK +E VD D SS +++RC++I LL
Sbjct: 720 SGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLL 779
Query: 237 CVQENPNDRPSMLEVSSMLKNEXXXXXXXXXXAFSKQVDEIGIELLSTTNLE-KCSAYDV 295
CVQE DRP M V ML +E F + ++ S+T + +C+ V
Sbjct: 780 CVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQV 839
Query: 296 SFSEVVAR 303
+ S + AR
Sbjct: 840 TLSVIDAR 847
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
Identities = 152/306 (49%), Positives = 202/306 (66%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSKSS QG EFKNEV+L AKLQH NL+R+LGFC+D EER+LVYEY+
Sbjct: 365 GTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYV 424
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R II G+ +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 425 PNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDAD 484
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + + NT ++VGT GY+ PEYA G YS KSDV+SFGVL+L+II
Sbjct: 485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEII 544
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
SGK+ S + ++ +A+ LW G+ +E VD + + +++RC+ I LLCVQE
Sbjct: 545 SGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQE 604
Query: 241 NPNDRPSMLEVSSMLKNEXXXXXXXXXXAFSKQVDEIGIELLSTTNLEKC---SAYDVSF 297
+P +RP++ + ML + Q IG + L T K S D S
Sbjct: 605 DPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQ-SRIGKDPLDTDTTSKSLLGSVDDASI 663
Query: 298 SEVVAR 303
+++ R
Sbjct: 664 TDIHPR 669
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
Identities = 149/310 (48%), Positives = 207/310 (66%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +AVK+LSK+S QG EF NEV++ AKLQH NL+R+LGFC++ +ER+LVYE++
Sbjct: 368 GIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFV 427
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD ++FD + +LDW +R II GI +G+LYL + SRLTIIHRDLKA NILLG+D
Sbjct: 428 PNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDD 487
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M KI+DFG+ARIF + +ANT ++VGT GY+ PEYA G +S KSDV+SFGVL+L+II
Sbjct: 488 MNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEII 547
Query: 181 SGKRLSMLCGINENLS--ILEHAYELWKGGKGMEFVD-SFLDDRNSSCKLMRCLEIALLC 237
SGK+ S + ++ + ++ + + LW G +E VD SF D+ + ++ RC+ IALLC
Sbjct: 548 SGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRIN-EVSRCIHIALLC 606
Query: 238 VQENPNDRPSMLEVSSMLKNEXXXXXXXXXXAF---SKQVDEIG-IELLSTTNLEKCSAY 293
VQE DRP+M + ML F S + +++G ++ LS CS
Sbjct: 607 VQEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVD 666
Query: 294 DVSFSEVVAR 303
D S + V R
Sbjct: 667 DASITNVTPR 676
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 725 (260.3 bits), Expect = 1.1e-71, P = 1.1e-71
Identities = 151/303 (49%), Positives = 199/303 (65%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L CG+ +AVK+LS++S QG EEFKNE+ L AKLQH NL+++LG+C+D EERML+YEY
Sbjct: 482 GTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQ 541
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD ++FD RR LDW KRV II+GI +G+LYL E SRL IIHRDLKASN+LL D
Sbjct: 542 PNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSD 601
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M KISDFGLAR + +ANT +VVGT GY+ PEY G +S KSDVFSFGVL+L+I+
Sbjct: 602 MNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIV 661
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC----KLMRCLEIALL 236
SG+R L++L HA+ + K E +D + N SC +++R + I LL
Sbjct: 662 SGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAV---NESCTDISEVLRVIHIGLL 718
Query: 237 CVQENPNDRPSMLEVSSMLKNEXXXXXXXXXXAFSKQ----VDEIGIEL-LSTTNLEKCS 291
CVQ++P DRP+M V ML +E F+++ D + I L + + N + S
Sbjct: 719 CVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMS 778
Query: 292 AYD 294
D
Sbjct: 779 VID 781
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 1.4e-71, P = 1.4e-71
Identities = 153/308 (49%), Positives = 202/308 (65%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G+ IAVK+LSK S+QG +EF NEV L AKLQH+NL+R+LG C+D E+ML+YEY+
Sbjct: 536 GRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 595
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N SLD +LFD R L+W+KR II GI +GLLYL + SR IIHRDLKASN+LL ++
Sbjct: 596 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 655
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF +E +ANT +VVGT GY+ PEYA G++S KSDVFSFGVLLL+II
Sbjct: 656 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 715
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSF-LDDRNSSC---KLMRCLEIALL 236
SGKR N +L++L + WK G +E VD +D +S +++RC++I LL
Sbjct: 716 SGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLL 775
Query: 237 CVQENPNDRPSMLEVSSMLKNEXXXXXXXXXXAFSKQVDEIGIELLSTTNLE-KCSAYDV 295
CVQE DRP M V ML +E F + + S+T + +C+ +
Sbjct: 776 CVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQI 835
Query: 296 SFSEVVAR 303
+ S + AR
Sbjct: 836 TLSVIDAR 843
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 1.4e-71, P = 1.4e-71
Identities = 148/307 (48%), Positives = 207/307 (67%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSK+S QG +EF+NEV++ AKLQH NL+++LG+C++ EE++LVYE++
Sbjct: 343 GTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFV 402
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFD ++ LDW +R II GI +G+LYL + SRLTIIHRDLKA NILL +D
Sbjct: 403 PNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDD 462
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + +A T +VVGT GY+ PEYA G +S KSDV+SFGVL+L+II
Sbjct: 463 MNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEII 522
Query: 181 SGKRLSMLCGINENL-SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
SG + S L ++E++ +++ + + LW G E VD D + ++ RC+ IALLCVQ
Sbjct: 523 SGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQ 582
Query: 240 ENPNDRPSMLEVSSMLKNEXXXXXXXXXXAF---SKQVDEIGIELLSTTNLEKCSAYDVS 296
E+ DRP+M + ML F SKQ ++ G + S+T+ CS + S
Sbjct: 583 EDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRSKQ-EQAGPSIDSSTH---CSVDEAS 638
Query: 297 FSEVVAR 303
+ V R
Sbjct: 639 ITRVTPR 645
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 303 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 8e-46
Identities = 80/253 (31%), Positives = 122/253 (48%), Gaps = 26/253 (10%)
Query: 6 GEVIAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+AVK L + +S Q EEF E + KL H N++++LG C + E +V EYM
Sbjct: 28 KVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGD 87
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL + L + I +G+ YL IHRDL A N L+GE++ K
Sbjct: 88 LLSYLRKNRPK--LSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVK 142
Query: 125 ISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
ISDFGL+R ++ + + ++ I ++ PE ++G +++KSDV+SFGVLL +I +
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT-- 198
Query: 184 RLSMLCGI-NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242
L +S E E K G + N +L + L C E+P
Sbjct: 199 ----LGEQPYPGMS-NEEVLEYLKNGYRLPQPP------NCPPELYD---LMLQCWAEDP 244
Query: 243 NDRPSMLEVSSML 255
DRP+ E+ +L
Sbjct: 245 EDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-45
Identities = 81/252 (32%), Positives = 123/252 (48%), Gaps = 25/252 (9%)
Query: 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+AVK L + S Q EEF E + KL H N++++LG C + E M+V EYMP L
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL 88
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL R L + I +G+ YL IHRDL A N L+GE++ KI
Sbjct: 89 LDYLRKN-RPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKI 144
Query: 126 SDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GK 183
SDFGL+R ++ + K ++ I ++ PE ++G +++KSDV+SFGVLL +I + G+
Sbjct: 145 SDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE 202
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243
+S E K G + + + ++ L C E+P
Sbjct: 203 EP------YPGMS-NAEVLEYLKKGYRLPKPPNCPPEL---------YKLMLQCWAEDPE 246
Query: 244 DRPSMLEVSSML 255
DRP+ E+ +L
Sbjct: 247 DRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-44
Identities = 80/257 (31%), Positives = 116/257 (45%), Gaps = 41/257 (15%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L +S + EEF E + KL H N++R+LG C E +V EYMP L +
Sbjct: 32 AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L K + + I +G+ YL +HRDL A N L+ E++ KISDF
Sbjct: 92 L--RKHGEKLTLKDLLQMALQIAKGMEYL---ESKNFVHRDLAARNCLVTENLVVKISDF 146
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GL+R ++ G +P PE + G +++KSDV+SFGVLL +I +
Sbjct: 147 GLSRDIYEDD-----YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIALLCV 238
G++ E EL + G + R +C +LM L C
Sbjct: 202 EQP-YPGMS-----NEEVLELLEDGYRLP--------RPENCPDELYELM------LQCW 241
Query: 239 QENPNDRPSMLEVSSML 255
+P DRP+ E+ L
Sbjct: 242 AYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 7e-44
Identities = 78/250 (31%), Positives = 118/250 (47%), Gaps = 23/250 (9%)
Query: 6 GEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++AVK L K S + + + E+ + +L H N++R++ D + LV EY
Sbjct: 24 GKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGG 83
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L YL R L + I I +GL YL IIHRDLK NILL E+
Sbjct: 84 DLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHRDLKPENILLDENGVV 137
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGLA+ K S T VGT Y+ PE Y K DV+S GV+L ++++G
Sbjct: 138 KIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTG 195
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK-LMRCLEIALLCVQEN 241
K I + L ++ G +EF + + K L++ C+ ++
Sbjct: 196 KPPFSGENILDQLQLIRR-----ILGPPLEFDEPKWSSGSEEAKDLIKK------CLNKD 244
Query: 242 PNDRPSMLEV 251
P+ RP+ E+
Sbjct: 245 PSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 82/256 (32%), Positives = 125/256 (48%), Gaps = 29/256 (11%)
Query: 10 AVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + S + ++F E + KL H N++R+LG C + E LV EYM L Y
Sbjct: 27 AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86
Query: 69 L------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L F + L K + I +G+ YL + +HRDL A N L+GED+
Sbjct: 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLV 143
Query: 123 PKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KISDFGL+R ++ + + T + I ++ PE + G++++KSDV+SFGVLL +I +
Sbjct: 144 VKISDFGLSRDVYDDDYYRKKTGGKL-PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
Query: 182 GKRLSMLCGI-NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
L LS E E + G + + D+ + E+ L C Q
Sbjct: 203 ------LGATPYPGLS-NEEVLEYLRKGYRLPKPEYCPDE-------LY--ELMLSCWQL 246
Query: 241 NPNDRPSMLEVSSMLK 256
+P DRP+ E+ L+
Sbjct: 247 DPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 5e-43
Identities = 65/187 (34%), Positives = 93/187 (49%), Gaps = 10/187 (5%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G+ +A+K + K + EE E+ + KL H N++++ G D LV EY S
Sbjct: 18 GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKP 123
L L + +L D R I+ I +GL YL IIHRDLK NILL D K
Sbjct: 78 LKDLLKENEGKLSEDEILR--ILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKV 132
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISG 182
K++DFGL+++ + T +VGT Y+ PE YS KSD++S GV+L ++
Sbjct: 133 KLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPEL 190
Query: 183 KRLSMLC 189
K L
Sbjct: 191 KDLIRKM 197
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 70/249 (28%), Positives = 107/249 (42%), Gaps = 27/249 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G+++A+K + K + E E+ + KL+H N++R+ D ++ LV EY
Sbjct: 24 GKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGD 83
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L L +R L + + I L YL I+HRDLK NILL ED K
Sbjct: 84 LFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVK 137
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
++DFGLAR K T VGT Y+ PE Y D++S GV+L ++++GK
Sbjct: 138 LADFGLARQL-DPGEKLTT--FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKP 194
Query: 185 LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALLCVQENP 242
G ++ L + + K GK D + K + + L +P
Sbjct: 195 P--FPGDDQLLELFK------KIGKPKPPFPPPEWDISPEAKDLIRKLLVK-------DP 239
Query: 243 NDRPSMLEV 251
R + E
Sbjct: 240 EKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 73/256 (28%), Positives = 111/256 (43%), Gaps = 44/256 (17%)
Query: 6 GEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML-VY-EYMP 61
GE++AVK LS S + E + E+ + + LQH N++R G D E+ L ++ EY+
Sbjct: 25 GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84
Query: 62 NKSLDCYL--FDP-----IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
SL L F IR+ I +GL YL I+HRD+K +N
Sbjct: 85 GGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLAYLHSNG---IVHRDIKGAN 131
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
IL+ D K++DFG A+ T V GT ++ PE R Y +D++S G
Sbjct: 132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC 191
Query: 175 LLLQIISGKR-LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCL 231
++++ +GK S L N L+K G E + + K L +CL
Sbjct: 192 TVIEMATGKPPWSEL----GNPMAA-----LYKIGSSGE-PPEIPEHLSEEAKDFLRKCL 241
Query: 232 EIALLCVQENPNDRPS 247
+P RP+
Sbjct: 242 RR-------DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 64/258 (24%), Positives = 109/258 (42%), Gaps = 54/258 (20%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K + S + E+ NE+ + K +H N+++ G + +E +V E+ SL
Sbjct: 25 GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84
Query: 66 DCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L+ + + ++ + + +GL YL IIHRD+KA+NILL
Sbjct: 85 --------KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTS 133
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D + K+ DFGL+ + + VGT ++ PE Y K+D++S G+ +++
Sbjct: 134 DGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
Query: 180 ISGK---------RLSMLCGINENLSILEHAYELWKGGK-GMEFVDSFLDDRNSSCKLMR 229
GK + N L K EF D FL
Sbjct: 191 AEGKPPYSELPPMKALFKIATN-------GPPGLRNPEKWSDEFKD-FLK---------- 232
Query: 230 CLEIALLCVQENPNDRPS 247
C+Q+NP RP+
Sbjct: 233 ------KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 59/173 (34%), Positives = 98/173 (56%), Gaps = 6/173 (3%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K L ++F+ EV +L+H +LI + C E ++ E M SL +
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L P + +L + + + +G+ YL+E + IHRDL A NIL+GED+ K++DF
Sbjct: 93 LRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADF 148
Query: 129 GLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
GLAR+ KE + ++++ + + PE A G +STKSDV+SFG+LL ++ +
Sbjct: 149 GLARLI-KEDVYLSSDKKI-PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 64/184 (34%), Positives = 100/184 (54%), Gaps = 20/184 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVK L K + + F E + L+H NL+++LG + +V EYM SL
Sbjct: 29 GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87
Query: 66 DCYLFDPIR---RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
YL R R ++ +++ + +G+ YL+E + +HRDL A N+L+ ED+
Sbjct: 88 VDYL----RSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLV 140
Query: 123 PKISDFGLARIFAKESLKANTEQVVGT--IGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
K+SDFGLA+ +A+ Q G + + PE R+ +STKSDV+SFG+LL +I
Sbjct: 141 AKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193
Query: 181 SGKR 184
S R
Sbjct: 194 SFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 79/257 (30%), Positives = 124/257 (48%), Gaps = 31/257 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+AVK L K EEF E + +++H NL+++LG C ++ E+M +L
Sbjct: 31 SLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL + R+ ++ +++ I+ + YL+ + IHRDL A N L+GE+ K+
Sbjct: 90 LDYLRECNRQE-VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKV 145
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+DFGL+R+ ++ A+ I + PE +S KSDV++FGVLL +I + +
Sbjct: 146 ADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGM 203
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIALLCVQE 240
S GI+ L YEL + G ME R C +LMR C Q
Sbjct: 204 SPYPGID-----LSQVYELLEKGYRME--------RPEGCPPKVYELMRA------CWQW 244
Query: 241 NPNDRPSMLEVSSMLKN 257
NP+DRPS E+ +
Sbjct: 245 NPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 73/251 (29%), Positives = 116/251 (46%), Gaps = 30/251 (11%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K + + A ++F E + KL H NL+++ G C +V EYM N L Y
Sbjct: 31 VAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + R+ L + + + + + + YL+ IHRDL A N L+GED K+SDF
Sbjct: 90 LRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDF 144
Query: 129 GLARIFAKESLKANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
GLAR + ++ GT + + PPE +S+KSDV+SFGVL+ ++ S ++
Sbjct: 145 GLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM 200
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSCKLMRCLEIALLCVQENPND 244
YE + + +E V + + R I C E P D
Sbjct: 201 P---------------YERFSNSEVVESVSAGYRLYRPKLAP-TEVYTIMYSCWHEKPED 244
Query: 245 RPSMLEVSSML 255
RP+ ++ S L
Sbjct: 245 RPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 78/255 (30%), Positives = 115/255 (45%), Gaps = 28/255 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNK 63
GEV+AVKKL S+A+ +F+ E+ + LQH N+++ G C + R LV EY+P
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
SL YL R LD +K + I +G+ YL +HRDL NIL+ + +
Sbjct: 93 SLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRV 147
Query: 124 KISDFGLARIFA--KESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII- 180
KI DFGL ++ KE K E I + PE + +S SDV+SFGV+L ++
Sbjct: 148 KIGDFGLTKVLPQDKEYYKV-REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
Query: 181 --------SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232
+ + M+ + I+ H EL K + C
Sbjct: 207 YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP--------APPGCP-AEIYA 257
Query: 233 IALLCVQENPNDRPS 247
I C +P+ RPS
Sbjct: 258 IMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 60/188 (31%), Positives = 103/188 (54%), Gaps = 19/188 (10%)
Query: 9 IAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L ++ + +EF+ E L + LQH N++ +LG C + +++EY+ + L
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 68 YLF-------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L D + LD +HI I G+ YL S +HRDL A N
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARN 154
Query: 115 ILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
L+GE + KISDFGL+R I++ + + ++ ++ + ++PPE G ++T+SD++SFG
Sbjct: 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFG 213
Query: 174 VLLLQIIS 181
V+L +I S
Sbjct: 214 VVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 75/240 (31%), Positives = 113/240 (47%), Gaps = 23/240 (9%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK L K ++F E + KL+H LI++ C E +V E M SL Y
Sbjct: 33 VAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L R L + + + + G+ YL+ + IHRDL A N+L+GE+ K++DF
Sbjct: 92 LQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADF 147
Query: 129 GLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML 188
GLAR+ KE + E I + PE A +S KSDV+SFG+LL +I++ R+
Sbjct: 148 GLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206
Query: 189 CGIN-ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS 247
N E L ++ Y + C +I L C +E+P+DRP+
Sbjct: 207 GMTNAEVLQQVDQGYRM---------------PCPPGCP-KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 33/207 (15%)
Query: 1 GVLPCGE--VIAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
G+LP ++AVK L + +SA +F+ E L A+ H N++++LG C + L++
Sbjct: 28 GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87
Query: 58 EYMPNKSLDCYLFD-------------------PIRRLILDWKKRVHIIEGITQGLLYLQ 98
EYM L+ +L + L L +++ I + + G+ YL
Sbjct: 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147
Query: 99 EYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPE- 156
E +HRDL N L+GE+M KI+DFGL+R I++ + KA+ + I ++PPE
Sbjct: 148 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI-PIRWMPPES 203
Query: 157 --YARQGVYSTKSDVFSFGVLLLQIIS 181
Y R Y+T+SDV+++GV+L +I S
Sbjct: 204 IFYNR---YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 64/179 (35%), Positives = 93/179 (51%), Gaps = 18/179 (10%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK L K E F E + KL+H L+++ C + E +V EYM SL +
Sbjct: 33 VAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + L + V + I +G+ YL+ IHRDL A NIL+GE++ KI+DF
Sbjct: 92 LKSGEGKK-LRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADF 147
Query: 129 GLARIF------AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
GLAR+ A+E K I + PE A G ++ KSDV+SFG+LL +I++
Sbjct: 148 GLARLIEDDEYTAREGAKF-------PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 79/260 (30%), Positives = 117/260 (45%), Gaps = 38/260 (14%)
Query: 6 GEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
GE +AVK L+ S Q +F+ E+ + L H N+++ G C R L+ EY+P+
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL YL R ++ K+ + I +G+ YL IHRDL A NIL+ +
Sbjct: 93 GSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDL 147
Query: 123 PKISDFGLARIFA--KESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVL 175
KISDFGLA++ K+ G P PE R +S+ SDV+SFGV
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEP------GESPIFWYAPECLRTSKFSSASDVWSFGVT 201
Query: 176 LLQIISGKRLS--------MLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227
L ++ + S + GI + I+ EL K G+ + S D+
Sbjct: 202 LYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDE------- 254
Query: 228 MRCLEIALLCVQENPNDRPS 247
++ LC + P DRPS
Sbjct: 255 --VYDLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-26
Identities = 71/285 (24%), Positives = 113/285 (39%), Gaps = 25/285 (8%)
Query: 7 EVIAVKKLSK---SSAQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPN 62
+++A+K L+K S ++ E F E+ + A L H N++++ F D LV EY+
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-M 121
SL+ L R+ L + + I+ I L YL IIHRD+K NILL D
Sbjct: 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGR 139
Query: 122 KPKISDFGLARIFAKESLKANTEQ----VVGTIGYIPPEYARQGV---YSTKSDVFSFGV 174
K+ DFGLA++ ++ VGT GY+ PE S+ SD++S G+
Sbjct: 140 VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199
Query: 175 LLLQIISGKRLSMLC-GINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCL 231
L ++++G + L+ EL S + + + L + L
Sbjct: 200 TLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLL 259
Query: 232 EIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDE 276
+P +R S S K D
Sbjct: 260 AK-------DPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-26
Identities = 79/250 (31%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K L K + E F E L +LQH L+R L + E ++ EYM N SL +
Sbjct: 33 VAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDF 90
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L P + L K + + I +G+ +++ R IHRDL+A+NIL+ E + KI+DF
Sbjct: 91 LKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADF 146
Query: 129 GLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML 188
GLAR+ A E I + PE G ++ KSDV+SFG+LL +I++ R+
Sbjct: 147 GLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205
Query: 189 CGIN-ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS 247
N E + LE Y + R +C E+ LC +E P +RP+
Sbjct: 206 GMTNPEVIQNLERGYRM---------------PRPDNCP-EELYELMRLCWKEKPEERPT 249
Query: 248 MLEVSSMLKN 257
+ S+L++
Sbjct: 250 FEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 26/188 (13%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+ +A+K++S + + E+ L L+H N+++ +G S+ ++ EY N
Sbjct: 25 GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84
Query: 64 SLDCYLFDPIRRLILDWKKRVHI--------IEGITQGLLYLQEYSRLTIIHRDLKASNI 115
SL R++I KK + + QGL YL E +IHRD+KA+NI
Sbjct: 85 SL--------RQII---KKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANI 130
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
L +D K++DFG+A S + VVGT ++ PE ST SD++S G
Sbjct: 131 LTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCT 188
Query: 176 LLQIISGK 183
++++++G
Sbjct: 189 VIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 78/267 (29%), Positives = 113/267 (42%), Gaps = 56/267 (20%)
Query: 9 IAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L + A G +EF E + A+L H ++R++G C E MLV E P L
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLK 84
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQ---GLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
YL RR I + E Q G+ YL+ +HRDL A N+LL + K
Sbjct: 85 YLKK--RREI----PVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAK 135
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIG------YIPPEYARQGVYSTKSDVFSFGVLLLQ 178
ISDFG++R +L A ++ T + PE G +S+KSDV+S+GV L
Sbjct: 136 ISDFGMSR-----ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW- 189
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE------ 232
E S Y KG + + ++ S + + E
Sbjct: 190 --------------EAFSYGAKPYGEMKGAEVIAMLE--------SGERLPRPEECPQEI 227
Query: 233 --IALLCVQENPNDRPSMLEVSSMLKN 257
I L C + P DRP+ E+ S +
Sbjct: 228 YSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 51/182 (28%), Positives = 99/182 (54%), Gaps = 16/182 (8%)
Query: 9 IAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L ++S + +E +E + A + H +++R+LG C+ S + L+ + MP L
Sbjct: 39 VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLD 97
Query: 68 YLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
Y+ + + +L+W + I +G+ YL+E ++HRDL A N+L+
Sbjct: 98 YVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEKR---LVHRDLAARNVLVKTPQHV 148
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
KI+DFGLA++ + + + E I ++ E +Y+ KSDV+S+GV + ++++ G
Sbjct: 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFG 208
Query: 183 KR 184
+
Sbjct: 209 AK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 1e-24
Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 13/182 (7%)
Query: 6 GEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G++ A+K L K + E E + +++ H +++ L + +EE++ LV EY P
Sbjct: 18 GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LHYAFQTEEKLYLVLEYAP 76
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L +L R + + I L YL L II+RDLK NILL D
Sbjct: 77 GGELFSHL-SKEGRFSEERARF--YAAEIVLALEYLH---SLGIIYRDLKPENILLDADG 130
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K++DFGLA+ + E + NT GT Y+ PE Y D +S GVLL ++++
Sbjct: 131 HIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
Query: 182 GK 183
GK
Sbjct: 189 GK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 72/253 (28%), Positives = 114/253 (45%), Gaps = 38/253 (15%)
Query: 9 IAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L +S ++ E F E ++ +K H N++R++G + R ++ E M L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 68 YLFD----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GED 120
+L + P R L K + + +G YL+E IHRD+ A N LL G
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPG 155
Query: 121 MKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
KI+DFG+AR I+ + ++ I ++PPE G++++K+DV+SFGVLL +I
Sbjct: 156 RVAKIADFGMARDIYRASYYRKGGRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
Query: 180 ISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIA 234
S + N+ E GG + D C ++M
Sbjct: 215 FSLGYMPYPGRTNQE------VMEFVTGGGRL--------DPPKGCPGPVYRIMT----- 255
Query: 235 LLCVQENPNDRPS 247
C Q P DRP+
Sbjct: 256 -DCWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 5e-24
Identities = 75/263 (28%), Positives = 122/263 (46%), Gaps = 47/263 (17%)
Query: 7 EVIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+A+K L + SS + +F E + + H N+IR+ G S M++ EYM N SL
Sbjct: 33 IDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL 92
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D +L + + V ++ GI G+ YL S + +HRDL A NIL+ ++ K+
Sbjct: 93 DKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKV 147
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
SDFGL+R E +A T G G IP PE +++ SDV+SFG+++ +++
Sbjct: 148 SDFGLSRR--LEDSEA-TYTTKG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202
Query: 181 S-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL---MRC----LE 232
S G+R Y ++ V +L M C +
Sbjct: 203 SYGER----------------PYWDMSNQDVIKAV-------EDGYRLPPPMDCPSALYQ 239
Query: 233 IALLCVQENPNDRPSMLEVSSML 255
+ L C Q++ N+RP+ ++ S L
Sbjct: 240 LMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-24
Identities = 71/270 (26%), Positives = 126/270 (46%), Gaps = 44/270 (16%)
Query: 7 EVIAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
E++AVK L + +S ++F+ E L QH N+++ G C + + ++V+EYM + L
Sbjct: 36 ELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL 95
Query: 66 DCYL--FDP-IRRLI--------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+ +L P L L + + I I G++YL + +HRDL N
Sbjct: 96 NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRN 152
Query: 115 ILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGT----IGYIPPEYARQGVYSTKSDV 169
L+G D+ KI DFG++R ++ + + V G I ++PPE ++T+SDV
Sbjct: 153 CLVGYDLVVKIGDFGMSRDVYTTDYYR-----VGGHTMLPIRWMPPESIMYRKFTTESDV 207
Query: 170 FSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSCKL 227
+SFGV+L +I + GK+ + E + +E + L R +C
Sbjct: 208 WSFGVVLWEIFTYGKQ-----------PWYGLSNE-----EVIECITQGRLLQRPRTCPS 251
Query: 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
+I L C + +P R ++ ++ L+
Sbjct: 252 EVY-DIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 44/272 (16%)
Query: 9 IAVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L ++++ + +E L ++ H ++I++ G C +L+ EY SL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 68 YL----------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTI 105
+L +P R L + I++G+ YL E + +
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDER-ALTMGDLISFAWQISRGMQYLAE---MKL 148
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165
+HRDL A N+L+ E K KISDFGL+R +E + + ++ E +Y+T
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSIL-EHAYELWKGGKGMEFVDSFLDDRNSS 224
+SDV+SFGVLL +I++ G N I E + L K G ME + N S
Sbjct: 209 QSDVWSFGVLLWEIVT-------LGGNPYPGIAPERLFNLLKTGYRMERPE------NCS 255
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 256
++ + L C ++ P+ RP+ ++S L+
Sbjct: 256 EEMYN---LMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 3e-23
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 28/192 (14%)
Query: 6 GEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERML--VYEY 59
G++ +K+ LS S + E+ NEV + KL H N+I+ +S E+ L V EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK----YYESFEEKGKLCIVMEY 80
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVH------IIEGITQGLLYLQEYSRLTIIHRDLKAS 113
L + I KK I++ Q L L+ I+HRD+K
Sbjct: 81 ADGGDLS--------QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSF 172
NI L + K+ DFG++++ + A T VVGT Y+ PE + Y+ KSD++S
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKP-YNYKSDIWSL 189
Query: 173 GVLLLQIISGKR 184
G +L ++ + K
Sbjct: 190 GCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-23
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 52/270 (19%)
Query: 9 IAVKKLSKSSAQGFE-EFKNE--VMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+A+K ++++++ EF NE VM HV +R+LG + ++V E M L
Sbjct: 39 VAIKTVNENASMRERIEFLNEASVMKEFNCHHV--VRLLGVVSTGQPTLVVMELMAKGDL 96
Query: 66 DCYL------------FDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
YL P + + E I G+ YL +HRDL A
Sbjct: 97 KSYLRSRRPEAENNPGLGPPTLQKFIQM-----AAE-IADGMAYLAA---KKFVHRDLAA 147
Query: 113 SNILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
N ++ ED+ KI DFG+ R I+ + + + ++ + ++ PE + GV++TKSDV+S
Sbjct: 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTTKSDVWS 206
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRN----SSCKL 227
FGV+L ++ ++ E Y+ G E V F+ D
Sbjct: 207 FGVVLWEM---------------ATLAEQPYQ----GLSNEEVLKFVIDGGHLDLPENCP 247
Query: 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
+ LE+ +C Q NP RP+ LE+ S LK+
Sbjct: 248 DKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 4e-23
Identities = 71/242 (29%), Positives = 115/242 (47%), Gaps = 28/242 (11%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K + + A E+F E + KL H L+++ G C + LV+E+M + L Y
Sbjct: 31 VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY 89
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L +R + + + + +G+ YL+ + +IHRDL A N L+GE+ K+SDF
Sbjct: 90 L--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDF 144
Query: 129 GLARIFAKESLKANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
G+ R + ++T GT + + PE YS+KSDV+SFGVL+ ++ S +
Sbjct: 145 GMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245
EN S E + G + R +S + E+ C +E P DR
Sbjct: 201 PY-----ENRSNSEVVETINAGFR-------LYKPRLASQSVY---ELMQHCWKERPEDR 245
Query: 246 PS 247
PS
Sbjct: 246 PS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-23
Identities = 57/191 (29%), Positives = 105/191 (54%), Gaps = 18/191 (9%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++AVK L ++S ++F+ E L LQH +++R G C + ++V+EYM + L+
Sbjct: 37 LVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNR 96
Query: 68 YL--FDPIRRLI----------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+L P +++ L + + I I G++YL + L +HRDL N
Sbjct: 97 FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNC 153
Query: 116 LLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
L+G+ + KI DFG++R I++ + + ++ I ++PPE ++T+SD++SFGV
Sbjct: 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTESDIWSFGV 212
Query: 175 LLLQIIS-GKR 184
+L +I + GK+
Sbjct: 213 VLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 56/266 (21%)
Query: 4 PCGEVIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
P G++ A+KK+ + ++ E+ + +++ G E +V EYM
Sbjct: 24 PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGIT--------QGLLYLQEYSRLTIIHRDLKASN 114
SL L+ KK I E + +GL YL +++ IIHRD+K SN
Sbjct: 84 GSLA--------DLL---KKVGKIPEPVLAYIARQILKGLDYL--HTKRHIIHRDIKPSN 130
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
+L+ + KI+DFG++++ + NT VGT+ Y+ PE + YS +D++S G+
Sbjct: 131 LLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPERIQGESYSYAADIWSLGL 188
Query: 175 LLLQIISGKR----------LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSS 224
LL+ GK ++ I + L EF D F+
Sbjct: 189 TLLECALGKFPFLPPGQPSFFELMQAICD-----GPPPSLPAEEFSPEFRD-FIS----- 237
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLE 250
C+Q++P RPS E
Sbjct: 238 -----------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-23
Identities = 61/184 (33%), Positives = 101/184 (54%), Gaps = 15/184 (8%)
Query: 9 IAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L K ++ Q +EF E L + H N++++LG C+ +E + ++ E M L
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88
Query: 68 YLFDP----IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---- 119
YL D +L K+ + I + +G +YL+ ++ IHRDL A N L+ E
Sbjct: 89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYD 145
Query: 120 -DMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
D KI DFGLAR I+ + + E ++ + ++ PE G ++T+SDV+SFGVL+
Sbjct: 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLL-PVRWMAPESLLDGKFTTQSDVWSFGVLMW 204
Query: 178 QIIS 181
+I++
Sbjct: 205 EILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 7e-23
Identities = 71/262 (27%), Positives = 129/262 (49%), Gaps = 32/262 (12%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++AVK L +S ++F E L LQH ++++ G C++ + ++V+EYM + L+
Sbjct: 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96
Query: 68 YL--FDPIRRLI--------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+L P L+ L + +HI + I G++YL +HRDL N L+
Sbjct: 97 FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLV 153
Query: 118 GEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
GE++ KI DFG++R +++ + + ++ I ++PPE ++T+SDV+S GV+L
Sbjct: 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRWMPPESIMYRKFTTESDVWSLGVVL 212
Query: 177 LQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235
+I + GK+ NE + + L R +C ++ L
Sbjct: 213 WEIFTYGKQPWYQLSNNEVIECITQGRVL---------------QRPRTCP-KEVYDLML 256
Query: 236 LCVQENPNDRPSMLEVSSMLKN 257
C Q P+ R ++ E+ S+L+N
Sbjct: 257 GCWQREPHMRLNIKEIHSLLQN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 8e-23
Identities = 80/272 (29%), Positives = 107/272 (39%), Gaps = 55/272 (20%)
Query: 4 PCGEVI--AVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+VI AVK L ++F E + L H NLIR+ G + M+V E
Sbjct: 19 SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELA 77
Query: 61 PNKSL------DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
P SL D I L D+ I G+ YL E R IHRDL A N
Sbjct: 78 PLGSLLDRLRKDALGHFLISTL-CDYA------VQIANGMRYL-ESKRF--IHRDLAARN 127
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT------IGYIPPEYARQGVYSTKSD 168
ILL D K KI DFGL R +L N + V + PE R +S SD
Sbjct: 128 ILLASDDKVKIGDFGLMR-----ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182
Query: 169 VFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---MEFVDSFLD--DRNS 223
V+ FGV L ++ + + E W G G ++ +D + +R
Sbjct: 183 VWMFGVTLWEMFT------------------YGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSML 255
+C + L C NP DRP+ + L
Sbjct: 225 ACPQ-DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 29/261 (11%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
GVL +AVK + +F E + + H N+++++G C+ + +V E
Sbjct: 14 GVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL 73
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+P SL +L RL + KK + + G+ YL+ S+ IHRDL A N L+GE
Sbjct: 74 VPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLE--SK-NCIHRDLAARNCLVGE 128
Query: 120 DMKPKISDFGLARIFAKE--SLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ KISDFG++R ++ +Q+ I + PE G Y+++SDV+S+G+LL
Sbjct: 129 NNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTSESDVWSYGILLW 186
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM--RCLEIAL 235
+ S + Y + E ++S R + +L + L
Sbjct: 187 ETFSLG---------------DTPYPGMSNQQTRERIES--GYRMPAPQLCPEEIYRLML 229
Query: 236 LCVQENPNDRPSMLEVSSMLK 256
C +P +RPS E+ + L+
Sbjct: 230 QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 73/251 (29%), Positives = 116/251 (46%), Gaps = 25/251 (9%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL-DC 67
+AVK L K + F E L LQH L+R+ E ++ EYM SL D
Sbjct: 33 VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
D +++L K + I +G+ Y++ R IHRDL+A+N+L+ E + KI+D
Sbjct: 92 LKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIAD 146
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A E I + PE G ++ KSDV+SFG+LL +I++ ++
Sbjct: 147 FGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
Query: 188 LCGINEN-LSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRP 246
N + +S L+ Y + R +C +I C +E +RP
Sbjct: 206 PGMSNSDVMSALQRGYRM---------------PRMENCP-DELYDIMKTCWKEKAEERP 249
Query: 247 SMLEVSSMLKN 257
+ + S+L +
Sbjct: 250 TFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 20/192 (10%)
Query: 6 GEVIAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+++A+K L ++ Q + EF+ E L A+L H N++ +LG + +++EY+
Sbjct: 34 AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93
Query: 65 LDCYLF--------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
L +L D + LD +HI I G+ YL + +H+DL
Sbjct: 94 LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDL 150
Query: 111 KASNILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
A NIL+GE + KISD GL+R I++ + + + ++ I ++PPE G +S+ SD+
Sbjct: 151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDI 209
Query: 170 FSFGVLLLQIIS 181
+SFGV+L +I S
Sbjct: 210 WSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 57/192 (29%), Positives = 104/192 (54%), Gaps = 19/192 (9%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++AVK L + ++F+ E L LQH ++++ G C D + ++V+EYM + L+
Sbjct: 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 96
Query: 68 YL--FDPIRRLILDWKKR-----------VHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L P +++D + R +HI I G++YL +HRDL N
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRN 153
Query: 115 ILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
L+G ++ KI DFG++R +++ + + ++ I ++PPE ++T+SDV+SFG
Sbjct: 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRWMPPESIMYRKFTTESDVWSFG 212
Query: 174 VLLLQIIS-GKR 184
V+L +I + GK+
Sbjct: 213 VILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 52/182 (28%), Positives = 96/182 (52%), Gaps = 13/182 (7%)
Query: 8 VIAVKKLSKSSAQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++ VK L K+ + + EF+ E+ + KL H N++R+LG C ++E ++ EY L
Sbjct: 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 67 CYL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+L + ++ L K++V + I G+ +L S +HRDL A N L+
Sbjct: 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQ 153
Query: 121 MKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
+ K+S L++ ++ E K + + ++ PE ++ +STKSDV+SFGVL+ ++
Sbjct: 154 REVKVSLLSLSKDVYNSEYYKLR--NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
Query: 180 IS 181
+
Sbjct: 212 FT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-22
Identities = 68/264 (25%), Positives = 125/264 (47%), Gaps = 31/264 (11%)
Query: 9 IAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L ++ E+F EV + ++L N+ R+LG C ++ EYM N L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 68 YL--------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+L L + +++ I G+ YL+ L +HRDL N L+G+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGK 165
Query: 120 DMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ KI+DFG++R +++ + + + I ++ E G ++TKSDV++FGV L +
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 179 IISGKRLSMLCGIN--ENLS---ILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233
I++ LC E+L+ ++E+A ++ ++ R +C E+
Sbjct: 225 ILT------LCREQPYEHLTDQQVIENAGHFFRDDGRQIYL-----PRPPNCP-KDIYEL 272
Query: 234 ALLCVQENPNDRPSMLEVSSMLKN 257
L C + + DRP+ E+ L+
Sbjct: 273 MLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-21
Identities = 71/251 (28%), Positives = 116/251 (46%), Gaps = 26/251 (10%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL-DC 67
+AVK + K + E F E + LQH L++ L + E ++ E+M SL D
Sbjct: 33 VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDF 90
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
D + L K + I +G+ ++++ + IHRDL+A+NIL+ + KI+D
Sbjct: 91 LKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A E I + PE G ++ KSDV+SFG+LL++I++ R+
Sbjct: 146 FGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
Query: 188 LCGIN-ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRP 246
N E + LE Y + R +C I + C + P +RP
Sbjct: 205 PGMSNPEVIRALERGYRM---------------PRPENCP-EELYNIMMRCWKNRPEERP 248
Query: 247 SMLEVSSMLKN 257
+ + S+L +
Sbjct: 249 TFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-21
Identities = 77/258 (29%), Positives = 126/258 (48%), Gaps = 40/258 (15%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDC 67
+AVK L K E F E + KL+H L+++ + + SEE + +V EYM SL
Sbjct: 33 VAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 89
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L D R L V + + G+ Y++ R+ IHRDL+++NIL+G+ + KI+D
Sbjct: 90 FLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIAD 145
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A + I + PE A G ++ KSDV+SFG+LL ++++ R+
Sbjct: 146 FGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
Query: 188 LCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC--------LEIALLCVQ 239
G+N N +LE ++ M C E+ L C +
Sbjct: 205 -PGMN-NREVLEQVERGYR---------------------MPCPQDCPISLHELMLQCWK 241
Query: 240 ENPNDRPSMLEVSSMLKN 257
++P +RP+ + S L++
Sbjct: 242 KDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-21
Identities = 58/160 (36%), Positives = 83/160 (51%), Gaps = 8/160 (5%)
Query: 26 KNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85
+NE + L H N+I ++ + M+V EY P +L Y+ +LD
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDT--- 102
Query: 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTE 144
I+ Q LL L I+HRDLK NILL + M KI DFG+++I + +S KA T
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYT- 160
Query: 145 QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
VVGT YI PE Y+ KSD+++ G +L ++ S KR
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEF----KNEVMLTAKLQHVNLIRVLGFCIDSEER---MLVYE 58
GE++A+KK+ E F E+ L KL+H N++R+ S+ + +V+E
Sbjct: 24 GELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRLKEIVT-SKGKGSIYMVFE 80
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
YM + L L P + K ++ + +GL YL I+HRD+K SNIL+
Sbjct: 81 YMDH-DLTGLLDSPEVKFTESQIK--CYMKQLLEGLQYLHSNG---ILHRDIKGSNILIN 134
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVL 175
D K++DFGLAR + K + T +V+ T+ Y PPE A + Y + D++S G +
Sbjct: 135 NDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATR--YGPEVDMWSVGCI 191
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYEL 204
L ++ GK + G E L LE +EL
Sbjct: 192 LAELFLGK--PIFQGSTE-LEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-20
Identities = 60/182 (32%), Positives = 100/182 (54%), Gaps = 14/182 (7%)
Query: 6 GEVIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNK 63
G +AVK + + ++AQ F E + +L+H NL+++LG ++ + + +V EYM
Sbjct: 29 GNKVAVKCIKNDATAQAFLA---EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
SL YL R +L + + + + YL+ + +HRDL A N+L+ ED
Sbjct: 86 SLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVA 141
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K+SDFGL + + S +T ++ + + PE R+ +STKSDV+SFG+LL +I S
Sbjct: 142 KVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196
Query: 184 RL 185
R+
Sbjct: 197 RV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 67/262 (25%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 9 IAVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYM 60
+AVK KL + EEF +E H N+++++G C ++ M++ +M
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 61 PNKSLDCYLFDPIRRL-----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+ L +L RL L + + + I G+ YL S IHRDL A N
Sbjct: 90 KHGDLHSFLLY--SRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNC 144
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+L EDM ++DFGL++ + +I E VY++KSDV++FGV
Sbjct: 145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 204
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235
+ +I + + + G+ EN I Y+ + G ++ + LD+ ++
Sbjct: 205 MWEIAT-RGQTPYPGV-ENHEI----YDYLRHGNRLKQPEDCLDE---------LYDLMY 249
Query: 236 LCVQENPNDRPSMLEVSSMLKN 257
C + +P DRP+ ++ +L+N
Sbjct: 250 SCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 73/262 (27%), Positives = 126/262 (48%), Gaps = 34/262 (12%)
Query: 9 IAVKKLSKS-SAQGFEEFKNE--VMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+AVK +++S S + EF NE VM HV +R+LG + ++V E M + L
Sbjct: 39 VAVKTVNESASLRERIEFLNEASVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDL 96
Query: 66 DCYLF-------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
YL + R ++ + + I G+ YL +HRDL A N ++
Sbjct: 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVA 153
Query: 119 EDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
D KI DFG+ R I+ + + + ++ + ++ PE + GV++T SD++SFGV+L
Sbjct: 154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTTSSDMWSFGVVLW 212
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV-DSFLDDRNSSCKLMRCLEIALL 236
+I S+ E Y+ + ++FV D D+ +C R ++ +
Sbjct: 213 EIT---------------SLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP-ERVTDLMRM 256
Query: 237 CVQENPNDRPSMLEVSSMLKNE 258
C Q NP RP+ LE+ ++LK++
Sbjct: 257 CWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-20
Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 10/198 (5%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDC 67
+A+K L K E F E + KL+H L+++ + + SEE + +V EYM SL
Sbjct: 33 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 89
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L + + L + V + I G+ Y++ R+ +HRDL+A+NIL+GE++ K++D
Sbjct: 90 FLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 145
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A + I + PE A G ++ KSDV+SFG+LL ++ + R+
Sbjct: 146 FGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
Query: 188 LCGIN-ENLSILEHAYEL 204
+N E L +E Y +
Sbjct: 205 PGMVNREVLDQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-20
Identities = 76/251 (30%), Positives = 130/251 (51%), Gaps = 26/251 (10%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDC 67
+A+K L K E F E + KL+H L+ + + + SEE + +V E+M SL
Sbjct: 33 VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVSEEPIYIVTEFMGKGSLLD 89
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L + + L + V + I G+ Y++ R+ IHRDL+A+NIL+G+++ KI+D
Sbjct: 90 FLKEGDGKY-LKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIAD 145
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A + I + PE A G ++ KSDV+SFG+LL ++++ R+
Sbjct: 146 FGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
Query: 188 LCGIN-ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRP 246
+N E L +E Y + +G S +LM+ LC +++P++RP
Sbjct: 205 PGMVNREVLEQVERGYRM-PCPQGCP---------ESLHELMK------LCWKKDPDERP 248
Query: 247 SMLEVSSMLKN 257
+ + S L++
Sbjct: 249 TFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-20
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 36/262 (13%)
Query: 9 IAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K ++++ S + EF NE + + +++R+LG + +++ E M L
Sbjct: 39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98
Query: 68 YLFDPIRRLILD-----------WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
YL R L + KK + + I G+ YL +HRDL A N +
Sbjct: 99 YL----RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 151
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ ED KI DFG+ R + + + + ++ PE + GV++T SDV+SFGV+L
Sbjct: 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211
Query: 177 LQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV-DSFLDDRNSSCKLMRCLEIAL 235
+I ++ E Y+ + + FV + L D+ +C M E+
Sbjct: 212 WEIA---------------TLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDM-LFELMR 255
Query: 236 LCVQENPNDRPSMLEVSSMLKN 257
+C Q NP RPS LE+ S +K
Sbjct: 256 MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-20
Identities = 72/272 (26%), Positives = 123/272 (45%), Gaps = 61/272 (22%)
Query: 6 GEVIAVKKLS----KSSAQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G ++AVK+++ SS Q E + E+ L A+L H ++IR+LG + L E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 60 MPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
M S+ L + + ++ ++ E + +GL YL E IIHRD+K +N+L+
Sbjct: 85 MAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHENQ---IIHRDVKGANLLI 136
Query: 118 ---GEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
G+ ++ I+DFG A A + A Q++GTI ++ PE R Y DV+S
Sbjct: 137 DSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194
Query: 173 GVLLLQIISGK----------RLSMLCGI---NENLSILEHAYELWKGGKGMEFVDSFLD 219
G +++++ + K L+++ I SI EH L G +
Sbjct: 195 GCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH---LSPGLR---------- 241
Query: 220 DRNSSCKLMRCLEIALLCVQENPNDRPSMLEV 251
++ L C++ P DRP E+
Sbjct: 242 ------------DVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-20
Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 31/238 (13%)
Query: 24 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83
+F +E + + H N+I + G S+ M+V EYM N SLD +L + + +
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQL 108
Query: 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT 143
V ++ GI G+ YL S + +HRDL A NIL+ ++ K+SDFGL+R+ + A T
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 144 EQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSI 197
G IP PE +++ SDV+S+G+++ +++S G+R + +
Sbjct: 166 T----RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA 221
Query: 198 LEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSML 255
+E Y L + +D + +LM L C Q++ N+RP ++ S+L
Sbjct: 222 IEEGYRL----------PAPMDCPAALHQLM------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-19
Identities = 76/255 (29%), Positives = 119/255 (46%), Gaps = 31/255 (12%)
Query: 6 GEVIAVKKLS-KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G+ +AVK + +AQ F E E + KL H NL+R+LG I +V E M +
Sbjct: 29 GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLG-VILHNGLYIVMELMSKGN 84
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L +L R L+ + + + +G+ YL+ ++HRDL A NIL+ ED K
Sbjct: 85 LVNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAK 140
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GK 183
+SDFGLAR+ S+ + ++ + + PE + +S+KSDV+S+GVLL ++ S G+
Sbjct: 141 VSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243
+ E +E Y ME + D LM C + P
Sbjct: 196 APYPKMSLKEVKECVEKGYR-------MEPPEGCPADVYV---LMTS------CWETEPK 239
Query: 244 DRPSMLEVSSMLKNE 258
RPS ++ L+ E
Sbjct: 240 KRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 68/245 (27%), Positives = 110/245 (44%), Gaps = 26/245 (10%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K + A E+F E + KL H L+++ G C + +V E+M N L Y
Sbjct: 31 VAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L R+ L + + + + +G+ YL+ R + IHRDL A N L+ K+SDF
Sbjct: 90 LRQ--RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDF 144
Query: 129 GLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML 188
G+ R + + ++ + + PPE YS+KSDV+SFGVL+ ++ + ++
Sbjct: 145 GMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF- 202
Query: 189 CGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL--MRCLEIALLCVQENPNDRP 246
E S E + +G R KL M E+ C E P RP
Sbjct: 203 ----EKKSNYEVVEMISRG------------FRLYRPKLASMTVYEVMYSCWHEKPEGRP 246
Query: 247 SMLEV 251
+ E+
Sbjct: 247 TFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 31/197 (15%)
Query: 6 GEVIAVKK--LSKSSAQG-------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLV 56
GE++AVK+ L SA + E+ L +LQH N+++ LG +D++ +
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 57 YEYMPNKS----LDCY--LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
EY+P S L+ Y + + R + + I +GL YL ++R IIHRD+
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKGLNYL--HNR-GIIHRDI 132
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESL----KANTEQVVGTIGYIPPEYARQGVYSTK 166
K +NIL+ KISDFG+++ SL + G++ ++ PE +Q Y+ K
Sbjct: 133 KGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK 192
Query: 167 SDVFSFGVLLLQIISGK 183
+D++S G L++++++GK
Sbjct: 193 ADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 26/186 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+KK+ + Q E NE+++ +H N++ + +E +V EYM SL
Sbjct: 44 GKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102
Query: 66 -DCYLFDPIRRLILDWKKRVHIIEG--------ITQGLLYLQEYSRLTIIHRDLKASNIL 116
D I+ V + E + QGL YL +IHRD+K+ NIL
Sbjct: 103 TD----------IITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNIL 148
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
L +D K++DFG A KE K N+ VVGT ++ PE ++ Y K D++S G++
Sbjct: 149 LSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMC 206
Query: 177 LQIISG 182
+++ G
Sbjct: 207 IEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 58/188 (30%), Positives = 92/188 (48%), Gaps = 13/188 (6%)
Query: 3 LPCGEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
LP E +A+K+ L K +E + EV ++ H N+++ + +E LV Y+
Sbjct: 23 LPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SL + R LD +++ + +GL YL + IHRD+KA NILLGED
Sbjct: 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGED 138
Query: 121 MKPKISDFGLARIFAK----ESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVL 175
KI+DFG++ A T VGT ++ PE Q Y K+D++SFG+
Sbjct: 139 GSVKIADFGVSASLADGGDRTRKVRKT--FVGTPCWMAPEVMEQVHGYDFKADIWSFGIT 196
Query: 176 LLQIISGK 183
+++ +G
Sbjct: 197 AIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 39/271 (14%)
Query: 8 VIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++AVK L ++ +F EV + ++L+ N+IR+LG C+D + ++ EYM N L+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 67 CYL--------------FDPIRR--LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+L P + + +H+ I G+ YL S L +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 111 KASNILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
N L+GE++ KI+DFG++R ++A + + V+ I ++ E G ++T SDV
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDV 223
Query: 170 FSFGVLLLQIISGKRLSMLC-----GINENLSILEHAYELWKGGKGMEFVDSFLDDRNSS 224
++FGV L +I+ MLC G + ++E+A E ++ ++ R
Sbjct: 224 WAFGVTLWEIL------MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYL-----FRPPP 272
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSML 255
C E+ L C + +RPS ++ + L
Sbjct: 273 CP-QGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-19
Identities = 56/189 (29%), Positives = 97/189 (51%), Gaps = 26/189 (13%)
Query: 9 IAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L S + + +F +E + + H N+I + G S M++ E+M N +LD
Sbjct: 35 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94
Query: 68 YL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+L F I + V ++ GI G+ YL E + +HRDL A NIL+ ++
Sbjct: 95 FLRQNDGQFTVI--------QLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNL 143
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
K+SDFGL+R ++ +G G IP PE +++ SDV+S+G+++
Sbjct: 144 VCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201
Query: 177 LQIIS-GKR 184
+++S G+R
Sbjct: 202 WEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-19
Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 28/196 (14%)
Query: 6 GEVIAVKK--LSKSSAQGFEE--------FKNEVMLTAKLQHVNLIRVLGFCIDSEERML 55
GE++AVK+ L + A + ++E+ L H+N+++ LGF E +
Sbjct: 26 GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
EY+P S+ L R + + E + +GL YL I+HRDLKA N+
Sbjct: 86 FLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNL 139
Query: 116 LLGEDMKPKISDFGLAR----IFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSD 168
L+ D KISDFG+++ I+ + + Q G++ ++ PE QG YS K D
Sbjct: 140 LVDADGICKISDFGISKKSDDIYDNDQ--NMSMQ--GSVFWMAPEVIHSYSQG-YSAKVD 194
Query: 169 VFSFGVLLLQIISGKR 184
++S G ++L++ +G+R
Sbjct: 195 IWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 59/189 (31%), Positives = 98/189 (51%), Gaps = 28/189 (14%)
Query: 9 IAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L + + ++F +E + + H N+IR+ G + M++ EYM N +LD
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95
Query: 68 YL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
YL F + V ++ GI G+ YL S + +HRDL A NIL+ ++
Sbjct: 96 YLRDHDGEFSSY--------QLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNL 144
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
+ K+SDFGL+R+ E T G G IP PE +++ SDV+SFG+++
Sbjct: 145 ECKVSDFGLSRVL--EDDPEGTYTTSG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200
Query: 177 LQIIS-GKR 184
+++S G+R
Sbjct: 201 WEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-18
Identities = 61/181 (33%), Positives = 88/181 (48%), Gaps = 10/181 (5%)
Query: 6 GEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
V A+K+ LSK + + EE +E + AKL +IR +D + +V EY N
Sbjct: 25 KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L L R L D R I Q LL L I+HRD+K+ N+ L
Sbjct: 85 DLHKLLKMQRGRPLPEDQVWRFFI-----QILLGLAHLHSKKILHRDIKSLNLFLDAYDN 139
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI D G+A++ + + ANT +VGT Y+ PE Y+ KSDV++ GV+L + +G
Sbjct: 140 VKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
Query: 183 K 183
K
Sbjct: 198 K 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 80/260 (30%), Positives = 114/260 (43%), Gaps = 57/260 (21%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
EV+A+KK+S S Q E++++ EV +L+H N I G + LV EY
Sbjct: 40 NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG 99
Query: 63 KSLDCYLFDPIRRLILD-WKKRVH------IIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+ D IL+ KK + I G QGL YL + R IHRD+KA NI
Sbjct: 100 SASD----------ILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNI 146
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSF 172
LL E K++DFG A SL + VGT ++ PE +G Y K DV+S
Sbjct: 147 LLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGMEFVDSFLDDRNSSCKL 227
G+ +++ +R L +N +S L H + L F + F+D
Sbjct: 201 GITCIEL--AERKPPLFNMNA-MSALYHIAQNDSPTLSSNDWSDYFRN-FVD-------- 248
Query: 228 MRCLEIALLCVQENPNDRPS 247
C+Q+ P DRPS
Sbjct: 249 --------SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-18
Identities = 64/263 (24%), Positives = 122/263 (46%), Gaps = 34/263 (12%)
Query: 1 GVLPCGEVIAVKKLS------KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 54
G+ G++IAVK++ ++ + +E+ + EV L L+HVN+++ LG C+D
Sbjct: 19 GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78
Query: 55 LVYEYMPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+ E++P S+ L F P+ + + I G+ YL ++HRD+K
Sbjct: 79 IFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHNNC---VVHRDIKG 130
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVV----GTIGYIPPEYARQGVYSTKSD 168
+N++L + K+ DFG AR A L ++ GT ++ PE + Y KSD
Sbjct: 131 NNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSD 190
Query: 169 VFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228
++S G + ++ +GK L+ ++ ++ G + L D S+
Sbjct: 191 IWSIGCTVFEMATGK---------PPLASMDRLAAMFYIGAHRGLMPR-LPDSFSA---- 236
Query: 229 RCLEIALLCVQENPNDRPSMLEV 251
++ C+ + ++RPS L++
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 27/194 (13%)
Query: 7 EVIAVKKLSKSSAQGF--EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ +A+K L K A+G EEFK+E M+ ++LQH N++ +LG + +++ Y +
Sbjct: 36 QAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94
Query: 65 LDCYLF-------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
L +L D + L+ VHI+ I G+ +L + ++H+DL
Sbjct: 95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLA 151
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT----IGYIPPEYARQGVYSTKS 167
N+L+ + + KISD GL R E A+ +++G I ++ PE G +S S
Sbjct: 152 TRNVLVFDKLNVKISDLGLFR----EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS 207
Query: 168 DVFSFGVLLLQIIS 181
D++S+GV+L ++ S
Sbjct: 208 DIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-17
Identities = 77/251 (30%), Positives = 116/251 (46%), Gaps = 41/251 (16%)
Query: 7 EVIAVKKLSKSSAQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
EV+A+KK+S S Q E++++ EV KL+H N I+ G + LV EY
Sbjct: 41 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ D + + L + + G QGL YL ++ +IHRD+KA NILL E
Sbjct: 101 ASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 154
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQII 180
K+ DFG A I A AN VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 155 KLGDFGSASIMA----PANX--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL- 207
Query: 181 SGKRLSMLCGINENLSILEHAYE----LWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236
+R L +N +S L H + + G E+ +F+D
Sbjct: 208 -AERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFVDS---------------- 249
Query: 237 CVQENPNDRPS 247
C+Q+ P DRP+
Sbjct: 250 CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 11/183 (6%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN--EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
GE++A+KK+ E+ L +L H N+I++L + LV+E+M
Sbjct: 24 GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM--- 80
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
D Y R+ L + + QGL + + I+HRDLK N+L+ +
Sbjct: 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVL 137
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQIISG 182
K++DFGLAR F + T VV T Y PE YST D++S G + +++S
Sbjct: 138 KLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195
Query: 183 KRL 185
+ L
Sbjct: 196 RPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 84/281 (29%), Positives = 129/281 (45%), Gaps = 54/281 (19%)
Query: 10 AVKKLSKSSAQG-FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K++ + +++ +F E+ + KL H N+I +LG C L EY P+ +L
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 68 YL-------FDPIRRL------ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L DP + L ++ +H + +G+ YL S+ IHRDL A N
Sbjct: 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 154
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP-----EYARQGVYSTKSDV 169
IL+GE+ KI+DFGL+R V T+G +P E VY+T SDV
Sbjct: 155 ILVGENYVAKIADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 206
Query: 170 FSFGVLLLQIISGKRLSMLCGIN--ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227
+S+GVLL +I+S + CG+ E L Y L K L+ + L
Sbjct: 207 WSYGVLLWEIVSLGG-TPYCGMTCAELYEKLPQGYRLEKP----------LNCDDEVYDL 255
Query: 228 MRCLEIALLCVQENPNDRPS----MLEVSSMLKNETTNTNT 264
MR C +E P +RPS ++ ++ ML+ T NT
Sbjct: 256 MR------QCWREKPYERPSFAQILVSLNRMLEERKTYVNT 290
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 27 NEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY-----LFDPIRRLILDWK 81
+EV + +L+H N++R ID + +Y M Y L I++ + +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQ-TLYIVME------YCEGGDLAQLIQKCKKE-R 99
Query: 82 KRV--HIIEGI-TQGLLYLQE-----YSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133
K + I I TQ LL L E T++HRDLK +NI L + K+ DFGLA+I
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 134 FAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+S A T VGT Y+ PE Y KSD++S G L+ ++ +
Sbjct: 160 LGHDSSFAKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 45/128 (35%), Positives = 68/128 (53%), Gaps = 13/128 (10%)
Query: 58 EYMPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
E+M SLD PI IL I + +GL YL Y+ I+HRD+K SNI
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNI 135
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
L+ + K+ DFG++ E + + + VGT Y+ PE + G Y+ KSDV+S G+
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 176 LLQIISGK 183
++++ GK
Sbjct: 192 IIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 12/172 (6%)
Query: 13 KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP 72
K+ K + +EF E + KL H L+++ G C +V EYM N L YL +
Sbjct: 34 KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH 93
Query: 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132
+R + + + + + +G+ YL+ IHRDL A N L+ + K+SDFGL+R
Sbjct: 94 GKRF--QPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 133 IFAKESLKANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ ++ VG+ + + PPE +S+KSDV++FGVL+ ++ S
Sbjct: 149 YVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 19/183 (10%)
Query: 3 LPCGEVIAVKKLS---KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
L G V+A+KK+ A+ ++ E+ L +L H N+I+ L I++ E +V E
Sbjct: 24 LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT------IIHRDLKAS 113
L R+I +KK+ +I T ++Q S L I+HRD+K +
Sbjct: 84 ADAGDL--------SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+ + K+ D GL R F+ ++ A++ +VGT Y+ PE + Y+ KSD++S G
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLG 193
Query: 174 VLL 176
LL
Sbjct: 194 CLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 47/258 (18%)
Query: 7 EVIAVKKLSKSSAQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
EV+A+KK+S S Q E++++ EV +++H N I G + LV EY
Sbjct: 51 EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGS 110
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ D + + L + I G QGL YL + +IHRD+KA NILL E +
Sbjct: 111 ASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 164
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQII 180
K++DFG A S+ + VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 165 KLADFGSA------SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218
Query: 181 SGK-------RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233
K +S L I +N S + E W ++ +F+D
Sbjct: 219 ERKPPLFNMNAMSALYHIAQNESPTLQSNE-WS-----DYFRNFVDS------------- 259
Query: 234 ALLCVQENPNDRPSMLEV 251
C+Q+ P DRP+ E+
Sbjct: 260 ---CLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 3e-17
Identities = 61/187 (32%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-----EVMLTAKLQHVNLIRVLG-FCIDSEERMLVYEY 59
G ++A+KK+ + ++ N E+ L +L+H N+I +L F S LV+E+
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN-LVFEF 83
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M L+ + D L K + +GL YL I+HRDLK +N+L+
Sbjct: 84 MET-DLEKVIKDKSIVLTPADIKS--YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIAS 137
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGV-- 174
D K++DFGLAR F + K T QVV T Y PE AR Y D++S G
Sbjct: 138 DGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAPELLFGARH--YGVGVDMWSVGCIF 193
Query: 175 --LLLQI 179
LLL++
Sbjct: 194 AELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 50/178 (28%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G +AVK + Q E NEV++ QH N++ + + EE ++ E++ +L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + + L+ ++ + E + Q L YL +IHRD+K+ +ILL D + K+
Sbjct: 106 T----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +K+ K + +VGT ++ PE + Y T+ D++S G+++++++ G+
Sbjct: 159 SDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 62/253 (24%), Positives = 112/253 (44%), Gaps = 43/253 (16%)
Query: 5 CGEVIAVKKLS-KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+V+A+K + + + E+ + E+ ++ + + + G + + ++ EY
Sbjct: 25 TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
S D ++ LD I+ + GL YL E + IHRD+KA+NILL E+
Sbjct: 85 SC----LDLLKPGKLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDV 137
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K++DFG++ K NT VGT ++ PE +Q Y K+D++S G+ +++ G+
Sbjct: 138 KLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
Query: 184 ---------RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234
R+ L N S+ + + K K +FV
Sbjct: 196 PPLSDLHPMRVLFLIPKNNPPSLEGNKFS--KPFK--DFVS------------------- 232
Query: 235 LLCVQENPNDRPS 247
LC+ ++P +RPS
Sbjct: 233 -LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-17
Identities = 60/251 (23%), Positives = 109/251 (43%), Gaps = 40/251 (15%)
Query: 14 LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73
L++ S + + NE+++ + LQH N+I +D ++ EY +L +D I
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL----YDKI 90
Query: 74 RR---LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGL 130
R + + + + + I + Y+ + I+HRD+K NI L + K+ DFG+
Sbjct: 91 VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGI 147
Query: 131 ARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR------ 184
++I E A T VVGT Y+ PE + Y+ KSD+++ G +L ++++ KR
Sbjct: 148 SKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
Query: 185 LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244
L + I++ Y E + L+ +Q++P
Sbjct: 206 PLNLV-----VKIVQGNYTPVVSVYSSELI-----------SLVHS------LLQQDPEK 243
Query: 245 RPSMLEVSSML 255
RP+ EV
Sbjct: 244 RPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-17
Identities = 82/270 (30%), Positives = 116/270 (42%), Gaps = 63/270 (23%)
Query: 8 VIAVKKLSKSSA--QGFEEFKNEVMLTAKL--QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L K A + + +E M K+ +H N+I +LG C +V EY +
Sbjct: 44 TVAVKML-KDDATEKDLSDLVSE-MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHG 101
Query: 64 SLDCYL-----------FDPIRRLI--LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+L +L D R L K V + +G+ +L IHRDL
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDL 158
Query: 111 KASNILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYS 164
A N+L+ ED KI+DFGLAR I + + T G +P PE VY+
Sbjct: 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN------GRLPVKWMAPEALFDRVYT 212
Query: 165 TKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRN 222
+SDV+SFGVLL +I + G S GI +E ++L K G ME +
Sbjct: 213 HQSDVWSFGVLLWEIFTLGG---SPYPGIP-----VEELFKLLKEGYRME--------KP 256
Query: 223 SSC-----KLMRCLEIALLCVQENPNDRPS 247
+C LMR C E P+ RP+
Sbjct: 257 QNCTQELYHLMRD------CWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 28/186 (15%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKL-----QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L K +A E + +M K+ H N++ +LG C +++ EY
Sbjct: 68 VAVKML-KPTAHSSE--REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC--- 121
Query: 64 SLDCY--LFDPIRR---LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
CY L + +RR L + + + +G+ +L + IHRDL A N+LL
Sbjct: 122 ---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLT 175
Query: 119 EDMKPKISDFGLARIFAKES---LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
KI DFGLAR +S +K N V ++ PE VY+ +SDV+S+G+L
Sbjct: 176 HGKIVKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIL 232
Query: 176 LLQIIS 181
L +I S
Sbjct: 233 LWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-17
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 4 PCGEVIAVKKLSKSSAQGFEEFKNEVM---LTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
P G+++AVK + + K + + K ++ G ++ + + EYM
Sbjct: 24 PTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81
Query: 61 PNKSLDCYL---FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
SLD L I IL K I + +GL YL + + IIHRD+K SNIL+
Sbjct: 82 DGGSLDKILKEVQGRIPERIL--GK---IAVAVLKGLTYL--HEKHKIIHRDVKPSNILV 134
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K+ DFG++ K VGT Y+ PE + YS KSD++S G+ L+
Sbjct: 135 NSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 178 QIISGK 183
++ +G+
Sbjct: 191 ELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-17
Identities = 69/264 (26%), Positives = 120/264 (45%), Gaps = 33/264 (12%)
Query: 8 VIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++AVK L ++ +F E+ + ++L+ N+IR+L CI S+ ++ EYM N L+
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 67 CYLF------DPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+L + + + + + + I G+ YL S L +HRDL N L+G
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
++ KI+DFG++R + V I ++ E G ++T SDV++FGV L +
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR---CLE--- 232
I++ LC E Y + +E F D+ L + C +
Sbjct: 225 ILT------LCK--------EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY 270
Query: 233 -IALLCVQENPNDRPSMLEVSSML 255
+ L C + N +RPS E+ + L
Sbjct: 271 KLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 76/258 (29%), Positives = 114/258 (44%), Gaps = 47/258 (18%)
Query: 7 EVIAVKKLSKSSAQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
EV+AVKK+S S Q E++++ EV +L+H N I G + LV EY
Sbjct: 47 EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGS 106
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ D + + L + I G QGL YL ++ +IHRD+KA NILL E +
Sbjct: 107 ASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQV 160
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQII 180
K++DFG A S + VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 161 KLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214
Query: 181 SGK-------RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233
K +S L I +N S + E +G FVD
Sbjct: 215 ERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG--FVD------------------ 254
Query: 234 ALLCVQENPNDRPSMLEV 251
C+Q+ P +RP+ E+
Sbjct: 255 --YCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 62/257 (24%), Positives = 112/257 (43%), Gaps = 34/257 (13%)
Query: 8 VIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++AVK L + + +F E+ + ++L++ N+IR+LG C+ + ++ EYM N L+
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 67 CYLFD-PIRRLI--------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+L I + +++ I G+ YL + L +HRDL N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
G KI+DFG++R + V I ++ E G ++T SDV++FGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR-------C 230
++ + LC E Y L + +E F ++ L +
Sbjct: 223 EMFT------LCK--------EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPV 268
Query: 231 LEIALLCVQENPNDRPS 247
++ + C + DRP+
Sbjct: 269 FKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-17
Identities = 55/179 (30%), Positives = 74/179 (41%), Gaps = 28/179 (15%)
Query: 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGL 94
H +I++ D E V EY PN L IR+ LD K I L
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLDEKCTRFYAAEILLAL 115
Query: 95 LYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF------------------AK 136
YL IIHRDLK NILL +DM KI+DFG A++
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 137 ESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195
E + VGT Y+ PE + SD+++ G ++ Q+++GK G NE L
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-17
Identities = 57/188 (30%), Positives = 105/188 (55%), Gaps = 19/188 (10%)
Query: 3 LPCGEVI----AVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
+P GE + A+K L++++ + EF +E ++ A + H +L+R+LG C+ S LV
Sbjct: 29 VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVT 87
Query: 58 EYMPNKSLDCYLF---DPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
+ MP+ L Y+ D I +L+L+W + I +G++YL+E ++HRDL A
Sbjct: 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEERR---LVHRDLAAR 138
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ KI+DFGLAR+ + + N + I ++ E ++ +SDV+S+G
Sbjct: 139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYG 198
Query: 174 VLLLQIIS 181
V + ++++
Sbjct: 199 VTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 52/180 (28%), Positives = 95/180 (52%), Gaps = 19/180 (10%)
Query: 9 IAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K + +S Q F+E + ++ L H ++R+LG C + + LV + P SL
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLD 97
Query: 68 YL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
++ DP + +L+W + I +G+ YL+E+ ++HR+L A NILL D
Sbjct: 98 HVRQHRDSLDP--QRLLNWCVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDS 146
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+I+DFG+A + + K + I ++ E G Y+ +SDV+S+GV + +++S
Sbjct: 147 IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 34/253 (13%)
Query: 6 GEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+ A+K+ L S + E+ NE+ + A + H N+I +D + +V EY P
Sbjct: 25 NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84
Query: 64 SLDCYL--FDPIRRLI---LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
L + R+LI W+ + ++ G LQ I+HRDLK++NILL
Sbjct: 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRG-------LQALHEQKILHRDLKSANILLV 137
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ KI D G++++ K K +GT Y+ PE + YS KSD++S G LL +
Sbjct: 138 ANDLVKIGDLGISKVLKKNMAKT----QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238
+ + ++ + GK + D + + M +
Sbjct: 194 MATFA-------PPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM---------L 237
Query: 239 QENPNDRPSMLEV 251
Q P RP+ ++
Sbjct: 238 QVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K+++ E NE+++ + +H N++ L + +E +V EY+ SL
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 104 T----DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E K +T +VGT ++ PE + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 56/161 (34%), Positives = 86/161 (53%), Gaps = 13/161 (8%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
E+ L +L+H N++++L + LV+EY + L YL L + K I+
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIK--SIM 104
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147
+ +GL Y +S I+HRDLK NIL+ D K++DFGLAR F L+ T +VV
Sbjct: 105 YQLLRGLAYC--HSHR-ILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV 160
Query: 148 GTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
T+ Y PE ++ YST D++S G + ++I+GK L
Sbjct: 161 -TLWYRAPEILLGSKH--YSTAVDIWSVGCIFAEMITGKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 13/149 (8%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I L YL IIHRD+K NILL E I+DF +A ++ T GT
Sbjct: 109 IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR---LSMLCGINENLSILEHAYELWK 206
GY+ PE + YS D +S GV + + GKR ++ + E A L+
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP 222
Query: 207 GG---KGMEFVDSFLDDRNSSCKLMRCLE 232
+ ++ ++ L +R+ +L L+
Sbjct: 223 ATWSTEAIDAINKLL-ERDPQKRLGDNLK 250
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-16
Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 52/263 (19%)
Query: 10 AVKKLSKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A K + + + +EV ++ +L+H N++R ++++ +V + +
Sbjct: 40 AFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGA----- 94
Query: 69 LFDPIRRLILDWKKRVH---------IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
P+ K++ I + L YL + R I+HRDL +NI+LGE
Sbjct: 95 ---PLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGE 149
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D K I+DFGLA+ ++ ++ VVGTI Y PE + Y K+DV++FG +L Q+
Sbjct: 150 DDKVTITDFGLAK---QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
Query: 180 I-------SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232
S LS+ I+E YE G E V + +
Sbjct: 207 CTLQPPFYSTNMLSLA------TKIVEAVYEPLPEGMYSEDV-TDVITS----------- 248
Query: 233 IALLCVQENPNDRPSMLEVSSML 255
C+ + RP +++VS+M+
Sbjct: 249 ----CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 70/268 (26%), Positives = 117/268 (43%), Gaps = 45/268 (16%)
Query: 9 IAVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYM 60
+AVK K++ + E+F +E + + H N++R++G C+ + E +++ +M
Sbjct: 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88
Query: 61 PNKSL----------DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+ L DC + P + L V + I G+ YL S + IHRDL
Sbjct: 89 KHGDLHSFLLYSRLGDCPQYLPTQML-------VKFMTDIASGMEYL---SSKSFIHRDL 138
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
A N +L E+M ++DFGL++ + +I E VY+TKSDV+
Sbjct: 139 AARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVW 198
Query: 171 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230
SFGV + +I + + + G+ EN I Y+ + G ++ LD
Sbjct: 199 SFGVTMWEIAT-RGQTPYPGV-ENSEI----YDYLRQGNRLKQPPDCLD----------G 242
Query: 231 L-EIALLCVQENPNDRPSMLEVSSMLKN 257
L + C NP DRPS + L+
Sbjct: 243 LYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-16
Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 46/266 (17%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K++ + +S +F E+ + KL H N+I +LG C L EY P+ +L
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 68 YL-------FDPI------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L DP L ++ +H + +G+ YL + IHRDL A N
Sbjct: 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 142
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP-----EYARQGVYSTKSDV 169
IL+GE+ KI+DFGL+R V T+G +P E VY+T SDV
Sbjct: 143 ILVGENYVAKIADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 194
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229
+S+GVLL +I+S + CG+ YE G +E N ++
Sbjct: 195 WSYGVLLWEIVSLGG-TPYCGMT-----CAELYEKLPQGYRLE------KPLNCDDEVY- 241
Query: 230 CLEIALLCVQENPNDRPSMLEVSSML 255
++ C +E P +RPS ++ L
Sbjct: 242 --DLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 79/266 (29%), Positives = 118/266 (44%), Gaps = 46/266 (17%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K L + +S +F E+ + KL H N+I +LG C + + EY P +L
Sbjct: 33 AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92
Query: 68 YL-------FDPI------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L DP L ++ + + G+ YL E IHRDL A N
Sbjct: 93 FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARN 149
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP-----EYARQGVYSTKSDV 169
+L+GE++ KI+DFGL+R V T+G +P E VY+TKSDV
Sbjct: 150 VLVGENLASKIADFGLSR--------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDV 201
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229
+SFGVLL +I+S + CG+ YE G ME RN ++
Sbjct: 202 WSFGVLLWEIVSLGG-TPYCGMT-----CAELYEKLPQGYRME------KPRNCDDEVY- 248
Query: 230 CLEIALLCVQENPNDRPSMLEVSSML 255
E+ C ++ P +RP ++S L
Sbjct: 249 --ELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-16
Identities = 59/182 (32%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
GE++AVK L + Q +K E+ + L H N+++ G C + + L+ EY+P
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL--QEYSRLTIIHRDLKASNILLGED 120
SL YL P +L L + + + I +G+ YL Q Y IHRDL A N+LL D
Sbjct: 93 GSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLHSQHY-----IHRDLAARNVLLDND 143
Query: 121 MKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
KI DFGLA+ + E + + E ++ +S SDV+SFGV L ++
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 180 IS 181
++
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-16
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 19/188 (10%)
Query: 6 GEVIAVKKLSKSSAQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G++ A+K + K+ ++ E + ++ Q +++ L + ++ + LV EY+P
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LYYSFQGKKNLYLVMEYLP 76
Query: 62 NKSLDCY-LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
D L + + L D + I I L YL IIHRDLK NIL+ +
Sbjct: 77 GG--DLASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSN 129
Query: 121 MKPKISDFGLA------RIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
K++DFGL+ R + +++VGT YI PE +S D +S G
Sbjct: 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGC 189
Query: 175 LLLQIISG 182
+L + + G
Sbjct: 190 ILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 8/178 (4%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
IA+K++ + ++ + E+ L + L+H N+++ LG ++ + E +P SL
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISD 127
L L + + + + I +GL YL + I+HRD+K N+L+ KISD
Sbjct: 96 LRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISD 152
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQIISGK 183
FG ++ A + TE GT+ Y+ PE +G Y +D++S G ++++ +GK
Sbjct: 153 FGTSKRLA--GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDC 67
AVK L++ + + E+F E ++ H N++ +LG C+ SE ++V YM + L
Sbjct: 27 AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN 86
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
++ + K + + +G+ YL +HRDL A N +L E K++D
Sbjct: 87 FIRSETHNPTV--KDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVAD 141
Query: 128 FGLAR-IFAKESLKA-NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
FGLAR I+ KE N + ++ E + ++TKSDV+SFGVLL ++++
Sbjct: 142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMPNKSLDCYLFDPIRRLILDWKKRV- 84
E+ + + +++ G +D + EY SLD ++ +++ ++V
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL 107
Query: 85 -HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT 143
I E + +GL YL IIHRD+K SNILL + K+ DFG+ + E + +
Sbjct: 108 GKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLA 160
Query: 144 EQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GT Y+ PE + YS SDV+S G+ LL++ +
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-15
Identities = 67/258 (25%), Positives = 124/258 (48%), Gaps = 44/258 (17%)
Query: 6 GEVIAVKKLS-----KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY-EY 59
G+ AVK++S ++ + ++ + E+ L +KLQH N+++ LG E+ + ++ E
Sbjct: 25 GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYIFLEL 83
Query: 60 MPNKSLDCYL--FDPIRR-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+P SL L + +I + ++ I GL YL + R +HRD+K +NIL
Sbjct: 84 VPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYL--HDR-NTVHRDIKGANIL 134
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY-ARQGVYSTKSDVFSFGVL 175
+ + K++DFG+A+ + + + G+ ++ PE A+QG Y +D++S G
Sbjct: 135 VDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGME---FVDSFLDDRNSSCKLMRCLE 232
+L++ +GK S LE ++K G+ E D D+ +
Sbjct: 192 VLEMATGK---------PPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAK---------D 233
Query: 233 IALLCVQENPNDRPSMLE 250
L C+Q +P+ RP+ E
Sbjct: 234 FILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 17/179 (9%)
Query: 9 IAVKKLSKSSAQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK + Q + +F +E + + H N+++++G C + +V E +P
Sbjct: 22 VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L ++ L K+ V G+ YL+ + IHRDL A N L+GE+ KISD
Sbjct: 82 FLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISD 136
Query: 128 FGLAR-----IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
FG++R I++ LK Q+ I + PE G YS++SDV+S+G+LL + S
Sbjct: 137 FGMSRQEDDGIYSSSGLK----QI--PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 47/178 (26%), Positives = 93/178 (52%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G +AVKK+ Q E NEV++ QH N++ + + +E +V E++ +L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ ++ + + + L +L +IHRD+K+ +ILL D + K+
Sbjct: 104 T----DIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKL 156
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +KE + + +VGT ++ PE + Y T+ D++S G+++++++ G+
Sbjct: 157 SDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 51/179 (28%), Positives = 90/179 (50%), Gaps = 12/179 (6%)
Query: 7 EVIAVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS- 64
EV+A+K + A+ E+ + E+ + ++ + R G + + ++ EY+ S
Sbjct: 30 EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
LD P+ + I+ I +GL YL + IHRD+KA+N+LL E K
Sbjct: 90 LDLLKPGPLEETYI-----ATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVK 141
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
++DFG+A +K NT VGT ++ PE +Q Y K+D++S G+ +++ G+
Sbjct: 142 LADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-15
Identities = 48/178 (26%), Positives = 91/178 (51%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K+++ E NE+++ +L++ N++ L + +E +V EY+ SL
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ N+LLG D K+
Sbjct: 104 T----DVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E K +T +VGT ++ PE + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 60/187 (32%), Positives = 102/187 (54%), Gaps = 18/187 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNK 63
GE++A+K++ + +G E+ L +L+H N++R L I +E + MLV+EYM +K
Sbjct: 25 GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVR-LHDVIHTENKLMLVFEYM-DK 82
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L Y+ R LD + +G+ + E ++HRDLK N+L+ + +
Sbjct: 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGEL 139
Query: 124 KISDFGLARIFAKESLKANT--EQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQ 178
K++DFGLAR F + NT +VV T+ Y P+ +R YST D++S G ++ +
Sbjct: 140 KLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLLGSR--TYSTSIDIWSVGCIMAE 193
Query: 179 IISGKRL 185
+I+G+ L
Sbjct: 194 MITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-15
Identities = 48/178 (26%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K+++ E NE+++ + ++ N++ L + +E +V EY+ SL
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 104 T----DVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E K +T +VGT ++ PE + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+V+A+K + +E E+ + + +++ G + + +V EY S+
Sbjct: 28 GQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
+ I L ++ I+ +GL YL IHRD+KA NILL E+ + K+
Sbjct: 86 -SDIMK-ITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKL 140
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG++ K NT V+GT ++ PE ++ Y+ K+D++S G+ +++ GK
Sbjct: 141 ADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 49/178 (27%), Positives = 93/178 (52%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVKK+ Q E NEV++ H N++ + + +E +V E++ +L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ ++ + + + L YL +IHRD+K+ +ILL D + K+
Sbjct: 107 T----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +KE K + +VGT ++ PE + Y T+ D++S G++++++I G+
Sbjct: 160 SDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 18/184 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAK----LQHVNLIRVLGFCIDSEERMLVYEYMP 61
GE +A+KK++ + N+ + K QH ++++L +LV EYMP
Sbjct: 25 GETVALKKVA--LRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ L L D R L K + + +G+ Y+ I+HRDLK +N+L+ D
Sbjct: 83 S-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHA---NGIMHRDLKPANLLISADG 136
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQ 178
KI+DFGLAR+F++E + + Q V T Y PE AR+ Y D+++ G + +
Sbjct: 137 VLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGARK--YDPGVDLWAVGCIFAE 193
Query: 179 IISG 182
+++G
Sbjct: 194 LLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 49/179 (27%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
+ GE++A+K + FE + E+ + + +H N++ G + ++ +V EY
Sbjct: 24 DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83
Query: 62 NKSLD---CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
SL P+ L + ++ +GL YL E + IHRD+K +NILL
Sbjct: 84 GGSLQDIYQVTRGPLSELQI-----AYVCRETLKGLAYLHETGK---IHRDIKGANILLT 135
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA---RQGVYSTKSDVFSFGV 174
ED K++DFG++ K + +GT ++ PE A R+G Y K D+++ G+
Sbjct: 136 EDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 48/178 (26%), Positives = 92/178 (51%), Gaps = 10/178 (5%)
Query: 7 EVIAVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+V+A+K + A+ E+ + E+ + ++ + + G + + ++ EY+ S
Sbjct: 30 QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D +R D + +++ I +GL YL + IHRD+KA+N+LL E K+
Sbjct: 90 ----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 142
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG+A +K NT VGT ++ PE +Q Y +K+D++S G+ +++ G+
Sbjct: 143 ADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 51/188 (27%), Positives = 93/188 (49%), Gaps = 22/188 (11%)
Query: 4 PCGEVIAVKKLS-KSSAQGFEEFKNEVMLTAKLQHV---NLIRVLGFCIDSEERMLVYEY 59
P G V+A+K ++ + + + EV L ++L+ N+ + G + ++ EY
Sbjct: 24 PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83
Query: 60 MPNKSLDCYLFDPIRRLI----LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
S +R L+ + K II + L Y+ ++ +IHRD+KA+NI
Sbjct: 84 AEGGS--------VRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANI 132
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGV 174
L+ K+ DFG+A + + S K +T VGT ++ PE +G Y TK+D++S G+
Sbjct: 133 LVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 175 LLLQIISG 182
+ ++ +G
Sbjct: 191 TIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 2e-14
Identities = 48/179 (26%), Positives = 94/179 (52%), Gaps = 11/179 (6%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+++++ E NE+++ + ++ N++ L + +E +V EY+ SL
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 105 T----DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 126 SDFGL-ARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG A+I ++S ++ +VGT ++ PE + Y K D++S G++ +++I G+
Sbjct: 158 TDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 6 GEVIAVKKLS-KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
GE +AVK L +S + K E+ + L H N+++ G C + L+ E++P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL YL P + ++ K+++ I +G+ YL SR +HRDL A N+L+ + +
Sbjct: 93 GSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG--SR-QYVHRDLAARNVLVESEHQ 147
Query: 123 PKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI DFGL + I + + + + + PE Q + SDV+SFGV L ++++
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 19/189 (10%)
Query: 6 GEVIAVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
GE++AVK ++ + + +E +E+ + L+H NL++ G + E+ + EY
Sbjct: 25 GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84
Query: 64 SLDCYLFDPIRRL--ILDWK-KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+L+ L ILD RV+ ++ + +GL YL + I+HRD+K +NI L +
Sbjct: 85 TLEELL-----EHGRILDEHVIRVYTLQ-LLEGLAYLHSHG---IVHRDIKPANIFLDHN 135
Query: 121 MKPKISDFGLARIFAKESLKANTEQ--VVGTIGYIPPEYARQGVYSTK---SDVFSFGVL 175
K+ DFG A + E + GT Y+ PE G +D++S G +
Sbjct: 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCV 195
Query: 176 LLQIISGKR 184
+L++ +GKR
Sbjct: 196 VLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 46/178 (25%), Positives = 93/178 (52%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+++AVKK+ Q E NEV++ QH N++ + + +E +V E++ +L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ ++ + + + L L +IHRD+K+ +ILL D + K+
Sbjct: 105 T----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +KE + + +VGT ++ PE + Y + D++S G+++++++ G+
Sbjct: 158 SDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-14
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 43/263 (16%)
Query: 7 EVIAVKKLSKSSAQGFEEFKNEVMLTAK-LQHVN---LIRVLGFCIDSEERMLVYEYMPN 62
+ +AVK L + K+E++ A +Q ++ ++R++G C ++E MLV E
Sbjct: 23 KTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAEL 79
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L+ +L + + + K ++ ++ G+ YL+E + +HRDL A N+LL
Sbjct: 80 GPLNKFLQK--NKHVTE-KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHY 133
Query: 123 PKISDFGLARIFAKESLKANTEQVVGT----IGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
KISDFGL++ + N + + + PE +S+KSDV+SFGVL+ +
Sbjct: 134 AKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC----LEIA 234
S + + +KG KG E C RC ++
Sbjct: 191 AFS------------------YGQKPYKGMKGNEVTQMIESGERMECP-QRCPPEMYDLM 231
Query: 235 LLCVQENPNDRPSMLEVSSMLKN 257
LC ++RP V L+N
Sbjct: 232 KLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 24/181 (13%)
Query: 6 GEVIAVKKLSKS-SAQGFEEFK-NEVMLTAKLQ---HVNLIRVLGFC--IDSEERM---L 55
G +A+KK+ S +G E+ L +L+ H N++R+L C ++ + L
Sbjct: 24 GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83
Query: 56 VYEYMPNKSLDCYLFDPIRRLI---LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
V+E++ D L + + L + ++ + +G+ +L + I+HRDLK
Sbjct: 84 VFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKP 135
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
NIL+ D + KI+DFGLARI++ E A T VV T+ Y PE Q Y+T D++S
Sbjct: 136 QNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWYRAPEVLLQSSYATPVDMWSV 192
Query: 173 G 173
G
Sbjct: 193 G 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 31/201 (15%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKN--EVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMP 61
GE++A+KK+ K +EE N EV KL H N++++ +++E V+EYM
Sbjct: 23 TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80
Query: 62 NKSLDCYLFDPIRRLILDWKKRV-------HIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+ L+ L+ D K + II I QGL ++ + HRDLK N
Sbjct: 81 ----EGNLYQ----LMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPEN 129
Query: 115 ILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSF 172
+L+ KI+DFGLAR I S T+ V T Y PE R YS+ D+++
Sbjct: 130 LLVSGPEVVKIADFGLAREI---RSRPPYTD-YVSTRWYRAPEILLRSTSYSSPVDIWAL 185
Query: 173 GVLLLQIISGKRLSMLCGINE 193
G ++ ++ + + L G +E
Sbjct: 186 GCIMAELYTLRPL--FPGSSE 204
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-14
Identities = 48/178 (26%), Positives = 91/178 (51%), Gaps = 10/178 (5%)
Query: 7 EVIAVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+V+A+K + A+ E+ + E+ + ++ + + G + + ++ EY+ S
Sbjct: 30 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + LD + I+ I +GL YL + IHRD+KA+N+LL E + K+
Sbjct: 90 ----LDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKL 142
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG+A +K N VGT ++ PE +Q Y +K+D++S G+ +++ G+
Sbjct: 143 ADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
E+ + + H N+++ + E ++ E+M SL+ I D + +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVA 174
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147
I G+ YL R I+HRD+K SN+L+ KI+DFG++RI A+ N+ V
Sbjct: 175 RQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--V 229
Query: 148 GTIGYIPPEYA----RQGVYSTKS-DVFSFGVLLLQIISGK 183
GTI Y+ PE G Y + D++S GV +L+ G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-14
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 5/158 (3%)
Query: 24 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83
+F E + + H N++R++G C + +V E + +L RL + K+
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV--KEL 96
Query: 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT 143
+ ++E G+ YL+ IHRDL A N L+ E KISDFG++R +
Sbjct: 97 IQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153
Query: 144 EQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ + PE G YS++SDV+SFG+LL + S
Sbjct: 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 48/178 (26%), Positives = 97/178 (54%), Gaps = 15/178 (8%)
Query: 9 IAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K+L + +S + +E +E + A + + ++ R+LG C+ S + L+ + MP L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 97
Query: 68 YLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
Y+ + + +L+W + I +G+ YL+E ++HRDL A N+L+
Sbjct: 98 YVREHKDNIGSQYLLNWCVQ------IAKGMNYLEERR---LVHRDLAARNVLVKTPQHV 148
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI+DFGLA++ + + + E I ++ E +Y+ +SDV+S+GV + ++++
Sbjct: 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I GL +L + I++RDLK N+LL + +ISD GLA + GT
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGT 157
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GY+ PE + VY D F+ G L ++I+G+
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 72/259 (27%), Positives = 112/259 (43%), Gaps = 43/259 (16%)
Query: 9 IAVKKL-SKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+AVK L S ++ + + +E+ M+ +H N+I +LG C ++ EY +L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 67 -------------CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
CY + L +K V + +G+ YL + IHRDL A
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ ED KI+DFGLAR T + ++ PE +Y+ +SDV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229
Query: 174 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK-----LM 228
VLL +I + L G +E ++L K G M D+ S+C +M
Sbjct: 230 VLLWEIFT------LGGSPYPGVPVEELFKLLKEGHRM--------DKPSNCTNELYMMM 275
Query: 229 RCLEIALLCVQENPNDRPS 247
R C P+ RP+
Sbjct: 276 RD------CWHAVPSQRPT 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 20/175 (11%)
Query: 28 EVMLTAKLQ---HVNLIRVLGFC----IDSEERM-LVYEYMPNKSLDCYLFD-PIRRLIL 78
EV L +L+ H N++R++ C D E ++ LV+E++ ++ L YL P L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA 107
Query: 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES 138
+ K ++ +GL +L I+HRDLK NIL+ + K++DFGLARI+ S
Sbjct: 108 ETIK--DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---S 159
Query: 139 LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193
+ VV T+ Y PE Q Y+T D++S G + ++ +R + CG +E
Sbjct: 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 68/239 (28%), Positives = 103/239 (43%), Gaps = 41/239 (17%)
Query: 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL-----------FDPIR--RLILDWKK 82
+H N+I +LG C ++ EY +L +L FD + L +K
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN 142
V + +G+ YL+ SR IHRDL A N+L+ ED KI+DFGLAR
Sbjct: 136 LVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 202
T + ++ PE VY+ +SDV+SFG+L+ +I + L G +E +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT------LGGSPYPGIPVEELF 246
Query: 203 ELWKGGKGMEFVDSFLDDRNSSCK-----LMRCLEIALLCVQENPNDRPSMLEVSSMLK 256
+L + G M D+ S+C LMR C P RP+ ++ L
Sbjct: 247 KLLREGHRM--------DKPSNCTHELYMLMR------ECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-13
Identities = 59/255 (23%), Positives = 112/255 (43%), Gaps = 36/255 (14%)
Query: 9 IAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+ L S + F E + + H N++R+ G M+V EYM N +LD
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L +L+ + + ++ G+ G+ YL E + +H+ L A +L+ D+ KIS
Sbjct: 96 FLRKHEGQLVA--GQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISG 150
Query: 128 FGLARIFAKESLKANTEQVVGTIG------YIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
F + + +E + T+ + PE + +S+ SDV+SFG+++ +++S
Sbjct: 151 FRRLQ-------EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
Query: 182 -GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
G+R + + +E + L RN L + + L C Q+
Sbjct: 204 YGERPYWDMSGQDVIKAVEDGFRLPA-------------PRNCPNLLHQLM---LDCWQK 247
Query: 241 NPNDRPSMLEVSSML 255
+RP ++ S+L
Sbjct: 248 ERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 51/234 (21%), Positives = 110/234 (47%), Gaps = 18/234 (7%)
Query: 34 KLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQG 93
KLQH N+++++G C + L++EY+ K+L L + L W++R I GI +
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153
L +L ++ +L I++ +P + L + ++ + Y+
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYV 845
Query: 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLS-MLCGINENLSILEHAYELWKGGKGME 212
PE + KSD++ FG++L+++++GK + G++ SI+E A +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG--SIVEWARYCYSDCHLDM 903
Query: 213 FVDSFLDDRNSSCK--LMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNT 264
++D + S + ++ + +AL C +P RP +V L++ + ++++
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 71/242 (29%), Positives = 105/242 (43%), Gaps = 31/242 (12%)
Query: 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL-----------FDPIR--RLILDWKK 82
+H N+I +LG C ++ EY +L YL FD + L +K
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN 142
V + +G+ YL + IHRDL A N+L+ ED KI+DFGLAR
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 202
T + ++ PE VY+ +SDV+SFGVLL +I + S GI +E +
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG-SPYPGIP-----VEELF 246
Query: 203 ELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
+L K G M D+ ++C I C P+ RP+ ++ L T T
Sbjct: 247 KLLKEGHRM--------DKPANCT-HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297
Query: 263 NT 264
+T
Sbjct: 298 ST 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165
IHRDL A NILL E+ KI DFGLAR K+ + ++ PE VY+T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSS 224
+SDV+SFGVLL +I S G INE + K G M + N++
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGVQINEEFC------QRLKDGTRMRAPE------NAT 303
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
++ R I L C Q +P +RP+ + +L +
Sbjct: 304 PEIYR---IMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
V P EV V K+ S + F L ++L H +L+++ G C+ E M V EY+
Sbjct: 24 IVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIM-VEEYV 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--- 117
LD +L + L WK + + + + L YL++ ++H ++ NIL+
Sbjct: 83 KFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED---KKLVHGNVCGKNILVARY 137
Query: 118 GEDMKP----KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKS--DVFS 171
G + K+SD G+ E+ V I +I PE R G S D +S
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWS 191
Query: 172 FGVLLLQIISG 182
FG LL+I S
Sbjct: 192 FGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 52/152 (34%), Positives = 69/152 (45%), Gaps = 14/152 (9%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165
IHRDL A NILL E+ KI DFGLAR K+ + ++ PE VY+T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC 225
+SDV+SFGVLL +I S+ + I E K G M + + S
Sbjct: 255 QSDVWSFGVLLWEI-----FSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS-- 307
Query: 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
I L C NP DRP+ E+ +L +
Sbjct: 308 -------IMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-13
Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 13 KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP 72
+L KSS+ E+ + E +L AK++H N++ +V EY L +
Sbjct: 34 RLPKSSSA-VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ 92
Query: 73 IRRL-----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L IL W Q L +Q ++HRD+K+ NI L ++ K K+ D
Sbjct: 93 RGKLFPEDTILQW---------FVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGD 143
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
FG AR+ A T VGT Y+PPE Y+ KSD++S G +L ++ + K
Sbjct: 144 FGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 66/260 (25%), Positives = 116/260 (44%), Gaps = 30/260 (11%)
Query: 6 GEVIAVKKLS---KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G +A+KK+ A+ + E+ L +L H N+I+ I+ E +V E
Sbjct: 27 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86
Query: 63 KSLDCYL--FDPIRRLILD---WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
L + F +RLI + WK V + L+ ++HRD+K +N+ +
Sbjct: 87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA-------LEHMHSRRVMHRDIKPANVFI 139
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
K+ D GL R F+ ++ A++ +VGT Y+ PE + Y+ KSD++S G LL
Sbjct: 140 TATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237
++ + + S G NL Y L K + ++ L + S +L + + +C
Sbjct: 198 EMAALQ--SPFYGDKMNL------YSLCKKIEQCDYPP--LPSDHYSEELRQLVN---MC 244
Query: 238 VQENPNDRPSMLEVSSMLKN 257
+ +P RP + V + K
Sbjct: 245 INPDPEKRPDITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 50/181 (27%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERM-LVYEYMPN 62
G++ A KKL K + K ++ L+ VN I L + +S+ + LV M
Sbjct: 18 GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L ++++ + L+ ++ +H IT G+L+L + I++RD+K N+LL +
Sbjct: 78 GDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGN 133
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
++SD GLA + K+ Q GT GY+ PE ++ YS D F+ G + ++++G
Sbjct: 134 CRLSDLGLA-VELKDG--KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
Query: 183 K 183
+
Sbjct: 191 R 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 54/185 (29%), Positives = 100/185 (54%), Gaps = 14/185 (7%)
Query: 6 GEVIAVKKLS-KSSAQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPN 62
GEV+A+KK+ + +G E+ L +L H N++++L I +E ++ LV+E++ +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFL-H 82
Query: 63 KSLDCYL-FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ L ++ P+ + L K + + QGL + + ++HRDLK N+L+ +
Sbjct: 83 QDLKKFMDASPLSGIPLPLIKSY--LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEG 137
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQII 180
K++DFGLAR F ++ T +VV T+ Y PE YST D++S G + +++
Sbjct: 138 AIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
Query: 181 SGKRL 185
+ + L
Sbjct: 196 TRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 9 IAVKKLS---KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+A+KK+ A+ ++ E+ L +L H N+I+ L I+ E +V E L
Sbjct: 30 VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDL 89
Query: 66 DCYL--FDPIRRLILD---WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+ F +RLI + WK V + + +SR ++HRD+K +N+ +
Sbjct: 90 SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH------MHSR-RVMHRDIKPANVFITAT 142
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
K+ D GL R F+ ++ A++ +VGT Y+ PE + Y+ KSD++S G LL ++
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 20/193 (10%)
Query: 6 GEVIAVKKLS-KSSAQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERM--------- 54
GE++A+KK+ + +GF E+ + +L H N++ + D ++ +
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91
Query: 55 -LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
LV+EYM D L + ++ + + HI + Q L L + +HRD+K S
Sbjct: 92 YLVFEYM-----DHDLMGLLESGLVHFSED-HIKSFMKQLLEGLNYCHKKNFLHRDIKCS 145
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-QGVYSTKSDVFSF 172
NILL + K++DFGLAR++ E + T +V+ T+ Y PPE + Y DV+S
Sbjct: 146 NILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSC 204
Query: 173 GVLLLQIISGKRL 185
G +L ++ + K +
Sbjct: 205 GCILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 45/203 (22%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKL-QHVNLIRVLGFCIDSEERM- 54
EV+A+KK+ F+ F+N E+M +L H N++++L I +E
Sbjct: 32 KEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV-IKAENDKD 83
Query: 55 --LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEY--SRLTIIHRDL 110
LV+EYM + L IR IL + VH + Q LL +Y S +IHRDL
Sbjct: 84 IYLVFEYM-----ETDLHAVIRANIL---EDVHKRYIMYQ-LLKALKYIHSG-NVIHRDL 133
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQ-----VVGTIGYIPPEY---ARQGV 162
K SNILL D + K++DFGLAR + L+ N E V T Y PE + +
Sbjct: 134 KPSNILLNSDCRVKLADFGLARSLS--ELEENPENPVLTDYVATRWYRAPEILLGSTR-- 189
Query: 163 YSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G +L +++ GK L
Sbjct: 190 YTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 31/189 (16%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
VI L+K + E K EV+L AK++H N++ ++ +V EY C
Sbjct: 29 VIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY-------C 81
Query: 68 YLFDPIRRL------------ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
D ++R+ IL W Q L L+ I+HRD+K+ NI
Sbjct: 82 DGGDLMKRINRQRGVLFSEDQILSW---------FVQISLGLKHIHDRKILHRDIKSQNI 132
Query: 116 LLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
L ++ M K+ DFG+AR A T VGT Y+ PE + Y+ K+D++S G
Sbjct: 133 FLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGC 190
Query: 175 LLLQIISGK 183
+L ++ + K
Sbjct: 191 VLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 9 IAVKKLS-KSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+AVK L ++ + + +E+ M+ +H N+I +LG C ++ EY +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 67 CYL-----------FDPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
YL +D R + +K V + +G+ YL + IHRDL A
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ E+ KI+DFGLAR T + ++ PE VY+ +SDV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 174 VLLLQIIS 181
VL+ +I +
Sbjct: 227 VLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 22/191 (11%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVY 57
+ +AVK L S+ EEF E + H N+I+++G + S + M++
Sbjct: 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 58 EYMPNKSLDCYLF------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
+M + L +L +P L + V + I G+ YL S IHRDL
Sbjct: 87 PFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVRFMIDIASGMEYL---SSKNFIHRDLA 140
Query: 112 ASNILLGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
A N +L E+M ++DFGL++ I++ + + + + ++ E VY+T SDV+
Sbjct: 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVKWLALESLADNVYTTHSDVW 199
Query: 171 SFGVLLLQIIS 181
+FGV + +I++
Sbjct: 200 AFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 13/156 (8%)
Query: 35 LQHVNLIRVLGFCI----DSEERM-LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEG 89
+H N++R+ C D E ++ LV+E++ ++ L YL D + + + ++
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQ 118
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
+ +GL +L + ++HRDLK NIL+ + K++DFGLARI+ S + VV T
Sbjct: 119 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 172
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+ Y PE Q Y+T D++S G + ++ K L
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 19/184 (10%)
Query: 9 IAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+ VK+L S+ F EV +L H N+++ LG CI+S +LV E+ P L
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 68 YLFDPIRRLILDWKKRV--HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL + +K V + + GLL+L + IH DL N L D+ KI
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKI 141
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEY----------ARQGVYSTKSDVFSFGVL 175
D+GLA E + + ++ PE Q + KS+++S GV
Sbjct: 142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ---TKKSNIWSLGVT 198
Query: 176 LLQI 179
+ ++
Sbjct: 199 MWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 8/99 (8%)
Query: 93 GLLYLQ-------EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQ 145
GLL++Q +S+ +IHRD+K++NILL + K+ DFG ++++A
Sbjct: 146 GLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 146 VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
GT Y+ PE R+ YS K+D+FS GVLL ++++ KR
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 36/173 (20%)
Query: 6 GEVIAVKKL--SKSSAQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYM 60
G+ A+KK K G + E+ L +L+H N++ ++ ++ ++ L+++Y
Sbjct: 27 GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86
Query: 61 PNKSLDCYLFDPIRRLILDW---KKRVHIIEG--------ITQGLLYLQEYSRLTIIHRD 109
+ I+ + KRV I I G+ YL ++HRD
Sbjct: 87 EHDLWQ----------IIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRD 133
Query: 110 LKASNILL----GEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPPE 156
LK +NIL+ E KI D GLAR+F LK A+ + VV TI Y PE
Sbjct: 134 LKPANILVMGEGPERGVVKIGDLGLARLFNA-PLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 34/79 (43%), Positives = 51/79 (64%), Gaps = 5/79 (6%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-Y 163
+++RDLK +NILL E +ISD GLA F+K+ A+ VGT GY+ PE ++GV Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAY 173
Query: 164 STKSDVFSFGVLLLQIISG 182
+ +D FS G +L +++ G
Sbjct: 174 DSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK--RVH 85
E L +KL H +++ ++ + ++ EY + LDC + L K
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC----KLEELKHTGKTLSENQ 107
Query: 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQ 145
+ E Q LL + + I+HRDLKA NI L ++ KI DFG++R+ A T
Sbjct: 108 VCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-- 164
Query: 146 VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 203
GT Y+ PE + Y +KSD++S G +L + M C L HA+E
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE--------MCC--------LAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 42/126 (33%), Positives = 72/126 (57%), Gaps = 9/126 (7%)
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+M SLD L R+ + ++ I + +GL YL+E + I+HRD+K SNIL+
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K+ DFG++ +S+ AN+ VGT Y+ PE + Y+ +SD++S G+ L+
Sbjct: 134 NSRGEIKLCDFGVSGQLI-DSM-ANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 178 QIISGK 183
++ G+
Sbjct: 190 EMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 53/166 (31%), Positives = 90/166 (54%), Gaps = 22/166 (13%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP---NKSLD-CYLFDPIRRLILDWKK 82
E+ L +L H N++R+L + SE ++ LV+E++ K +D L LI K
Sbjct: 48 EISLLKELNHPNIVRLLDV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KS 103
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN 142
++ + QG+ Y +S ++HRDLK N+L+ + K++DFGLAR F ++
Sbjct: 104 YLY---QLLQGIAYC--HSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTY 156
Query: 143 TEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
T +VV T+ Y PE +RQ YST D++S G + ++++ + L
Sbjct: 157 THEVV-TLWYRAPEILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 14/186 (7%)
Query: 2 VLPCGEVIAVKKLSKSS--AQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
V A+K + K G +E +E + + H ++++ D + ++ E
Sbjct: 14 VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73
Query: 59 YMPNKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
Y L + +R + D I + YL II+RDLK N+LL
Sbjct: 74 YCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLL 126
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K+ DFG A+ K T GT Y+ PE Y D +S G+LL
Sbjct: 127 DSNGYVKLVDFGFAK---KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLY 183
Query: 178 QIISGK 183
++++G+
Sbjct: 184 ELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 35/202 (17%)
Query: 2 VLPC-----GEVIAVKKLSKSSAQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEE 52
VL C GE++A+KK +S + E+ K EV + +L+H N++ +
Sbjct: 17 VLKCRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74
Query: 53 RMLVYEYMPNKSLDCYL--------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
LV+EY+ L+ L D +R I W+ + Q + Y
Sbjct: 75 LYLVFEYVERTLLE-LLEASPGGLPPDAVRSYI--WQ--------LLQAIAYCH---SHN 120
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-Y 163
IIHRD+K NIL+ E K+ DFG AR T+ V T Y PE Y
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNY 179
Query: 164 STKSDVFSFGVLLLQIISGKRL 185
DV++ G ++ +++ G+ L
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
E ML + H ++IR+ + +V +P+ S D Y + R L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147
+ I +GL YL IIHRD+K NI + + + I D G A+ +
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLA 217
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
GT+ PE + Y++K+D++S G++L ++++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 67/261 (25%), Positives = 108/261 (41%), Gaps = 49/261 (18%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
VI +SK S + EE + EV + + ++H N+++ ++ +V +Y L
Sbjct: 29 VIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL-- 86
Query: 68 YLFDPI---------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+ I ILDW Q L L+ I+HRD+K+ NI L
Sbjct: 87 --YKKINAQRGVLFPEDQILDW---------FVQICLALKHVHDRKILHRDIKSQNIFLT 135
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+D K+ DFG+AR+ A T +GT Y+ PE Y+ KSD+++ G +L +
Sbjct: 136 KDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYE 193
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238
+ + L+HA+E G V + ++ L
Sbjct: 194 MCT----------------LKHAFE---AGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 239 Q---ENPNDRPSMLEVSSMLK 256
Q NP DRPS V+S+L+
Sbjct: 235 QLFKRNPRDRPS---VNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN 142
RV+I E + L L +L II+RD+K NILL + ++DFGL++ F E +
Sbjct: 108 RVYIAEIV----LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-R 162
Query: 143 TEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQIISG 182
GTI Y+ PE R G + D +S GVL ++++G
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 6 GEVIAVKK-----LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +AVK+ S + + + E+ L LQH +++ G D E + EYM
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 61 PNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
P S+ L + + + R I +G+ YL I+HRD+K +NIL
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH---SNMIVHRDIKGANILRD 138
Query: 119 EDMKPKISDFGLA-RIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
K+ DFG + R+ S + V GT ++ PE Y K+DV+S G ++
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198
Query: 178 QIISGK 183
++++ K
Sbjct: 199 EMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 47/180 (26%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GE+ A+K + + F + E+++ +H N++ G + ++ + E+ SL
Sbjct: 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93
Query: 66 -DCY-LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
D Y + P+ + + R + QGL YL + +HRD+K +NILL ++
Sbjct: 94 QDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNGHV 145
Query: 124 KISDFGL-ARIFAKESLKANTEQVVGTIGYIPPEYA---RQGVYSTKSDVFSFGVLLLQI 179
K++DFG+ A+I A A + +GT ++ PE A R+G Y+ D+++ G+ +++
Sbjct: 146 KLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GE+ AVK + F + E+ + + +H N++ G + E+ + EY SL
Sbjct: 34 GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93
Query: 66 -DCY-LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
D Y + P+ L + + R + QGL YL ++ HRD+K +NILL ++
Sbjct: 94 QDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM---HRDIKGANILLTDNGDV 145
Query: 124 KISDFGLARIFAK-ESLKANTEQVVGTIGYIPPEYA---RQGVYSTKSDVFSFGVLLLQI 179
K++DFG+A AK + A + +GT ++ PE A + G Y+ D+++ G+ +++
Sbjct: 146 KLADFGVA---AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 28 EVMLTAKLQHVNLIRVLGFCI-DSEERMLVYEYMPNKSLDCYLFDPIRRLI-------LD 79
E L L H N++ +L CI D E ++Y YM +L +L RL L
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC--RLGEANNPQALS 115
Query: 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR-IFAKE- 137
++ VH+ I G+ YL + +IH+D+ A N ++ E+++ KI+D L+R +F +
Sbjct: 116 TQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY 172
Query: 138 -SLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
L N + + ++ E YS+ SDV+SFGVLL ++++
Sbjct: 173 HCLGDNENR---PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 95 LYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVVGTIGY 152
L L L II+RDLK NILL E+ K++DFGL +KES+ + GT+ Y
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCGTVEY 164
Query: 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+ PE + ++ +D +SFGVL+ ++++G
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 9 IAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L + + +E E + +L + ++R++G C ++E MLV E L+
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNK 83
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L ++ + V ++ ++ G+ YL+ + +HRDL A N+LL KISD
Sbjct: 84 FLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISD 138
Query: 128 FGL------------ARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
FGL AR K LK + PE +S++SDV+S+G+
Sbjct: 139 FGLSKALGADDSYYKARSAGKWPLK-----------WYAPECINFRKFSSRSDVWSYGIT 187
Query: 176 LLQIIS 181
+ + S
Sbjct: 188 MWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 36/93 (38%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 91 TQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTI 150
T+ +L L+ +++RDLK +NILL E +ISD GLA F+K+ A+ VGT
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 159
Query: 151 GYIPPEYARQGV-YSTKSDVFSFGVLLLQIISG 182
GY+ PE ++G Y + +D FS G +L +++ G
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 47/136 (34%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVV 147
I GL +L E II+RDLK N+LL + KI+DFG+ KE + T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGM----CKEGILGGVTTSTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL---SILEH--AY 202
GT YI PE Y D ++ GVLL ++++G+ S G +E+ SILE Y
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ--SPFEGDDEDELFQSILEDEVRY 215
Query: 203 ELWKGGKGMEFVDSFL 218
W + + SFL
Sbjct: 216 PRWLSKEAKSILKSFL 231
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 35/76 (46%), Positives = 44/76 (57%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165
IHRDL A NILL E+ KI DFGLAR K+ + ++ PE VY+
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 166 KSDVFSFGVLLLQIIS 181
+SDV+SFGVLL +I S
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 31/194 (15%)
Query: 6 GEVIAVKKLS-KSSAQGFE-EFKNEVMLTAKLQHVNLIR----VLGFCIDSEERMLVYEY 59
GE++A+KKL + +GF E+ + KLQH N++ V+G +D +V EY
Sbjct: 30 GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK--IYMVMEY 87
Query: 60 MPN--KSL-----DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+ + KSL +L ++ L+L + G+ +L + I+HRDLK
Sbjct: 88 VEHDLKSLMETMKQPFLQSEVKCLMLQ----------LLSGVAHLHDNW---ILHRDLKT 134
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFS 171
SN+LL KI DFGLAR + LK T+ VV T+ Y PE YST D++S
Sbjct: 135 SNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWS 192
Query: 172 FGVLLLQIISGKRL 185
G + ++++ K L
Sbjct: 193 VGCIFAELLTKKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 36/200 (18%)
Query: 6 GEVIAVKKLSKSSAQG---FEEFKNEVMLTAKLQHVNLIRVL--GFCIDSEERML-VYEY 59
G +A+K L + + F+ E L A+L H N++ +L G + V+EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP--GLLFAVFEY 60
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT------IIHRDLKAS 113
+P ++L L D + G L LQ L I+HRDLK
Sbjct: 61 VPGRTLR-------EVLAAD-----GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQ 108
Query: 114 NILLGE-DMKP--KISDFGL------ARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164
NI++ + ++P K+ DFG+ R +L TE V+GT Y PE R +
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE-VLGTPTYCAPEQLRGEPVT 167
Query: 165 TKSDVFSFGVLLLQIISGKR 184
SD++++G++ L+ ++G+R
Sbjct: 168 PNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 19/190 (10%)
Query: 11 VKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE--RMLVYEYMPNKSLDCY 68
+ K K+ ++ + +NE++ +L H N++++ EE R YM + D
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI-------EEILRSEANTYMITQKYDFD 248
Query: 69 LFDPIRRLILDWKKRVHIIE--GITQGLLYLQEY--SRLTIIHRDLKASNILLGEDMKPK 124
L+ + DWK R + + I + LL EY + +IHRD+K NI L D K
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIV 307
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+ DFG A F KE +A VGT+ PE Y +D++S G++LL ++S
Sbjct: 308 LGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD- 365
Query: 185 LSMLCGINEN 194
C I +
Sbjct: 366 ---FCPIGDG 372
|
Length = 501 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 10/104 (9%)
Query: 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTE 144
+I+ +GL YL E +IHRD+K NILL ++ + K+ DFG++ + NT
Sbjct: 117 YILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT- 172
Query: 145 QVVGTIGYIPPE-----YARQGVYSTKSDVFSFGVLLLQIISGK 183
+GT ++ PE Y +SDV+S G+ +++ GK
Sbjct: 173 -FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 18/182 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFK---NE--VMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GE++A+K++ KS E + E ++ T K L+++L D E L EY+
Sbjct: 26 GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQDDEYLYLAMEYV 83
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P L + ++ + R ++ E + L IHRDLK N L+
Sbjct: 84 PGGDFRTLLNN--LGVLSEDHARFYMAEMF----EAVDALHELGYIHRDLKPENFLIDAS 137
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
K++DFGL++ AN+ VVG+ Y+ PE R Y D +S G +L + +
Sbjct: 138 GHIKLTDFGLSKGIVT---YANS--VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL 192
Query: 181 SG 182
G
Sbjct: 193 CG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 55/213 (25%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM---------- 54
C + +AVKK+ + Q + E+ + +L H N+++V S +
Sbjct: 29 CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRL------- 103
+V EYM + ++ QG L +E++RL
Sbjct: 89 NSVYIVQEYMETD---------LANVL-------------EQGPL-SEEHARLFMYQLLR 125
Query: 104 --------TIIHRDLKASNILLG-EDMKPKISDFGLARIFAKE-SLKANTEQVVGTIGYI 153
++HRDLK +N+ + ED+ KI DFGLARI S K + + T Y
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 154 PPEYARQGVYSTKS-DVFSFGVLLLQIISGKRL 185
P TK+ D+++ G + ++++GK L
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 44/176 (25%), Positives = 90/176 (51%), Gaps = 14/176 (7%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVL-GFCIDSEERMLVYEYMPNKSLDCY 68
A K + S + E+F E+ + ++ +H N++ + + +++ +L+ E+ +LD
Sbjct: 34 AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDS- 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
+ + R + + + R + + + L +L + +IHRDLKA NILL D K++DF
Sbjct: 92 IMLELERGLTEPQIRY-VCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADF 147
Query: 129 GLARIFAKESLKANTEQVVGTIGYIPPEYA-----RQGVYSTKSDVFSFGVLLLQI 179
G++ K +T +GT ++ PE + Y K+D++S G+ L+++
Sbjct: 148 GVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 49/178 (27%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 9 IAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L + +S + +E +E + A + + R+LG C+ S + LV + MP L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLD 97
Query: 68 YLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
Y+ + R+ +L+W + I +G+ YL+E + ++HRDL A N+L+
Sbjct: 98 YVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHV 148
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI+DFGLAR+ + + + + I ++ E ++ +SDV+S+GV + ++++
Sbjct: 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
EV L L+H N++ + + LV+EY+ +K L Y+ D I+ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFL 110
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147
I +GL Y R ++HRDLK N+L+ E + K++DFGLAR AK V
Sbjct: 111 YQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEV 165
Query: 148 GTIGYIPPEYAR-QGVYSTKSDVFSFGVLLLQIISGKRL 185
T+ Y PP+ YST+ D++ G + ++ SG+ L
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
EV L L+H N++ + + LV+EY+ +K L YL D I ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLF 111
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147
+ + +GL Y R ++HRDLK N+L+ E + K++DFGLAR AK V
Sbjct: 112 Q-LLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEV 165
Query: 148 GTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRL 185
T+ Y PP+ YST+ D++ G + ++ +G+ L
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 51/188 (27%), Positives = 97/188 (51%), Gaps = 23/188 (12%)
Query: 6 GEVIAVKKLS-KSSAQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
E++A+K++ +G E+ L +L+H N++R+ ++ LV+EY ++
Sbjct: 25 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQ 83
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGIT----QGLLYLQEYSRLTIIHRDLKASNILLGE 119
L Y FD I I++ +GL + ++ ++HRDLK N+L+ +
Sbjct: 84 DLKKY-FDSCNGDI-----DPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINK 134
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLL 176
+ + K++DFGLAR F ++ + +VV T+ Y PP+ A+ +YST D++S G +
Sbjct: 135 NGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAK--LYSTSIDMWSAGCIF 190
Query: 177 LQIISGKR 184
++ + R
Sbjct: 191 AELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 56/186 (30%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 6 GEVIAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---EERMLVYEYM 60
GE +A+KKLS+ S + E+ L +QH N+I +L + +E Y M
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P D I L K +++ + GL Y+ IIHRDLK N+ + ED
Sbjct: 100 PYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNED 153
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQI 179
+ KI DFGLAR A V T Y PE ++ ++ D++S G ++ ++
Sbjct: 154 CELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
Query: 180 ISGKRL 185
++GK L
Sbjct: 209 LTGKTL 214
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 89 GITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG 148
I + L YL +L++IHRD+K SN+L+ + + K+ DFG++ +S+ A T G
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSV-AKTID-AG 165
Query: 149 TIGYIPPEY----ARQGVYSTKSDVFSFGVLLLQIISGK 183
Y+ PE Q Y KSDV+S G+ ++++ +G+
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 47/179 (26%), Positives = 90/179 (50%), Gaps = 12/179 (6%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G + A K + S + E++ E+ + A H ++++LG + ++ E+ P ++
Sbjct: 37 GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + + R L + ++ +I Q L LQ + IIHRDLKA N+LL D K+
Sbjct: 97 DAIMLELDRGLT---EPQIQVI--CRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKL 151
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYA-----RQGVYSTKSDVFSFGVLLLQI 179
+DFG++ K + ++ +GT ++ PE + Y K+D++S G+ L+++
Sbjct: 152 ADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 59/218 (27%), Positives = 85/218 (38%), Gaps = 58/218 (26%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIR-VLGFCI------------DSEE 52
G+V A+K L KS +++ ++ HV R +L D E
Sbjct: 26 GQVYAMKVLRKS----------DMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75
Query: 53 RMLVYEYMPNKSLDCYLFDPIRRLILDWK-KRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
LV EYMP L L IR+ + + R +I E + L L +L IHRD+K
Sbjct: 76 LYLVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELV----LALDSVHKLGFIHRDIK 128
Query: 112 ASNILLGEDMKPKISDFGLA---------------------------RIFAKESLKANTE 144
NIL+ D K++DFGL R + +
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 145 QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
VGT YI PE R Y + D +S GV+L +++ G
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 2e-10
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 48/206 (23%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM 54
G +A+KK+S F + E+ L L+H N+I +L S E
Sbjct: 24 TGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLI-----LDWKKRVHIIEGITQGLLYLQEYSRLTI 105
+V E M D + ++I L + + I +GL YL + +
Sbjct: 77 NDVYIVTELME---TDLH------KVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---V 124
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPE----YAR 159
IHRDLK SNIL+ + KI DFGLAR + + TE VV T Y PE +R
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSR 183
Query: 160 QGVYSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G + ++++ K L
Sbjct: 184 ---YTKAIDIWSVGCIFAELLTRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 42/210 (20%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
C +A+KK+ + + K E + A L H ++ V C D + VY M
Sbjct: 26 CSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTM 81
Query: 61 P---NKSLDCYLFDPIRRLILDWKKRVH----------IIEGITQGLLYLQEYSRLTIIH 107
P +L L ++ L K + I I + Y+ +S+ ++H
Sbjct: 82 PYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATIEYV--HSK-GVLH 136
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKE-----SLKANTE-----------QVVGTIG 151
RDLK NILLG + I D+G A E + + ++VGT
Sbjct: 137 RDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPD 196
Query: 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
Y+ PE S +D+++ GV+L Q+++
Sbjct: 197 YMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 41/126 (32%), Positives = 71/126 (56%), Gaps = 9/126 (7%)
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+M SLD L + +R+ + +V I + +GL YL+E + I+HRD+K SNIL+
Sbjct: 83 EHMDGGSLDQVLKEA-KRIPEEILGKVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILV 137
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K+ DFG++ + + + VGT Y+ PE + YS +SD++S G+ L+
Sbjct: 138 NSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 178 QIISGK 183
++ G+
Sbjct: 194 ELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 61/195 (31%), Positives = 89/195 (45%), Gaps = 24/195 (12%)
Query: 3 LPCGEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGF-CIDSEERM----LV 56
P G +A+KK+S Q F + E+ + + +H N+I +L S E +V
Sbjct: 27 KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86
Query: 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHI---IEGITQGLLYLQEYSRLTIIHRDLKAS 113
E M D Y + L D HI + I +GL Y+ + ++HRDLK S
Sbjct: 87 QELMET---DLYKLIKTQHLSND-----HIQYFLYQILRGLKYIHSAN---VLHRDLKPS 135
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPEYA-RQGVYSTKSDVF 170
N+LL + KI DFGLARI E TE V T Y PE Y+ D++
Sbjct: 136 NLLLNTNCDLKICDFGLARIADPEHDHTGFLTE-YVATRWYRAPEIMLNSKGYTKAIDIW 194
Query: 171 SFGVLLLQIISGKRL 185
S G +L +++S + L
Sbjct: 195 SVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 25/190 (13%)
Query: 7 EVIAVKKLS-KSSAQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP-- 61
E IA+KK+ + +G E+ L ++QH N++R L + SE+R+ LV+EY+
Sbjct: 28 ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR-LQDVVHSEKRLYLVFEYLDLD 86
Query: 62 -NKSLD-CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
K +D F RLI + ++ + I +G+ Y + ++HRDLK N+L+
Sbjct: 87 LKKHMDSSPDFAKNPRLI-----KTYLYQ-ILRGIAYCHSHR---VLHRDLKPQNLLIDR 137
Query: 120 DMKP-KISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVL 175
K++DFGLAR F ++ T +VV T+ Y PE +R YST D++S G +
Sbjct: 138 RTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEILLGSRH--YSTPVDIWSVGCI 193
Query: 176 LLQIISGKRL 185
++++ K L
Sbjct: 194 FAEMVNQKPL 203
|
Length = 294 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 13/183 (7%)
Query: 6 GEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYM 60
G++ A+K L K++ A+ E + E + ++ + L + +E ++ L+ +Y+
Sbjct: 28 GKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYV 87
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+ +L+ R + + R + E I L L+ +L I++RD+K NILL +
Sbjct: 88 SGGEMFTHLYQ--RDNFSEDEVRFYSGEII----LALEHLHKLGIVYRDIKLENILLDSE 141
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-QGVYSTKSDVFSFGVLLLQI 179
++DFGL++ F E K T GTI Y+ PE R +G + D +S G+L+ ++
Sbjct: 142 GHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
Query: 180 ISG 182
++G
Sbjct: 201 LTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165
+HRDL A N+LL + KI DFGLAR +S + + ++ PE +Y+T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-YELWKGGKGMEFVDSFLDDRNSS 224
SDV+S+G+LL +I S L G I++ Y K G M D +
Sbjct: 319 LSDVWSYGILLWEIFS------LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQE---- 368
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
+I + C P RPS L +S ++++
Sbjct: 369 -----VYDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 6 GEVIAVKKLSK------SSAQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDS--EERMLV 56
G+ +A+KKLS+ + + + E +M H N+I +L F EE V
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELV--LMKLVN--HKNIIGLLNVFTPQKSLEEFQDV 96
Query: 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
Y M + +D L I+ LD ++ +++ + G+ +L IIHRDLK SNI+
Sbjct: 97 YLVM--ELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 150
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ D KI DFGLAR + T VV T Y PE Y D++S G ++
Sbjct: 151 VKSDCTLKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIM 207
Query: 177 LQIISGKRL 185
++I G L
Sbjct: 208 GEMIRGTVL 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 40/130 (30%), Positives = 59/130 (45%), Gaps = 22/130 (16%)
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGIT----QGLLYLQEYSRLTIIHRDLKAS 113
E+M SLD Y K H++ I +GL YL L I+HRD+K S
Sbjct: 79 EFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPS 124
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ + K+ DFG++ K VGT Y+ PE Y SDV+S G
Sbjct: 125 NMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERISGEQYGIHSDVWSLG 180
Query: 174 VLLLQIISGK 183
+ +++ G+
Sbjct: 181 ISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 66/252 (26%), Positives = 111/252 (44%), Gaps = 45/252 (17%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+ +K L KS E F + ++L H +L+ G C+ +E ++V EY+ SLD Y
Sbjct: 30 VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTY 89
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKP--- 123
L + + WK + + + + L +L++ + H ++ A N+LL ED K
Sbjct: 90 LKKNKNLINISWK--LEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNP 144
Query: 124 ---KISDFGLA-RIFAKESLKANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQ 178
K+SD G++ + KE L + I ++PPE S +D +SFG L +
Sbjct: 145 PFIKLSDPGISITVLPKEIL-------LERIPWVPPECIENPQNLSLAADKWSFGTTLWE 197
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL-- 236
I G ++ LS L+ +L F +DR+ + E+A L
Sbjct: 198 I--------FSGGDKPLSALDSQKKL-----------QFYEDRH-QLPAPKWTELANLIN 237
Query: 237 -CVQENPNDRPS 247
C+ P+ RPS
Sbjct: 238 QCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES---LKANTEQV 146
+ QG+ +L + IHRD+ A N+LL + KI DFGLAR +S +K N
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
V ++ PE VY+ +SDV+S+G+LL +I S
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 55/184 (29%), Positives = 97/184 (52%), Gaps = 11/184 (5%)
Query: 6 GEVIAVKKLS-KSSAQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++A+KK+ +S +G E+ L +LQH N++ + + L++E++ +
Sbjct: 25 GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SM 83
Query: 64 SLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L YL D + + +D + + I QG+L+ +SR ++HRDLK N+L+
Sbjct: 84 DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC--HSR-RVLHRDLKPQNLLIDNKGV 139
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIIS 181
K++DFGLAR F ++ T +VV T+ Y PE YST D++S G + ++ +
Sbjct: 140 IKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
Query: 182 GKRL 185
K L
Sbjct: 198 KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 31/88 (35%), Positives = 52/88 (59%), Gaps = 5/88 (5%)
Query: 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA-RIFAKESLKANTEQVVGTIGYIPP 155
L++ + I++RDLK NILL + +ISD GLA + +++K VGT+GY+ P
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAP 170
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISGK 183
E + Y+ D ++ G LL ++I+G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 35/79 (44%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKES---LKANTEQVVGTIGYIPPEYARQGV 162
IHRDL A NILL KI DFGLAR +S +K N V ++ PE V
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 163 YSTKSDVFSFGVLLLQIIS 181
Y+ +SDV+S+G+LL +I S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
EYM SLD + + I + +GL +L+E IIHRD+K +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLV 136
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG------VYSTKSDVFS 171
+ + K+ DFG++ K N +G Y+ PE + G Y+ +SDV+S
Sbjct: 137 NGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192
Query: 172 FGVLLLQIISGK 183
G+ +L++ G+
Sbjct: 193 LGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 29/190 (15%)
Query: 6 GEVIAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPN 62
G+ +A+KK+ K S+ + E+ L L+H N+I + I E+ V E +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-- 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
D + R L + + + + I +GL Y+ ++HRDLK SNIL+ E+
Sbjct: 93 -GTDLHRLLTSRPLEKQFIQ--YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCD 146
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-------GVYSTKSDVFSFGVL 175
KI DFGLARI Q GY+ Y R Y + D++S G +
Sbjct: 147 LKICDFGLARI-----------QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCI 195
Query: 176 LLQIISGKRL 185
+++ GK L
Sbjct: 196 FAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA-RIFAKESLKANTEQVVG 148
IT GL L R I++RDLK NILL + +ISD GLA I E+++ VG
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VG 163
Query: 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
T+GY+ PE + Y+ D + G L+ ++I GK
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 33/79 (41%), Positives = 47/79 (59%), Gaps = 2/79 (2%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164
II+RDLK N+LL +D KI+DFG+ + KA+T GT YI PE + Y+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQKYN 174
Query: 165 TKSDVFSFGVLLLQIISGK 183
D +SFGVLL +++ G+
Sbjct: 175 ESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 14/176 (7%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
A K + S + E++ E+ + A H N++++L ++ E+ ++D +
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
+ + R + + + RV + + + L YL E IIHRDLKA NIL D K++DFG
Sbjct: 94 LE-LERPLTEPQIRV-VCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFG 148
Query: 130 LARIFAKESLK-ANTEQVVGTIGYIPPEY-----ARQGVYSTKSDVFSFGVLLLQI 179
++ AK + + +GT ++ PE ++ Y K+DV+S G+ L+++
Sbjct: 149 VS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 42/106 (39%), Positives = 56/106 (52%), Gaps = 11/106 (10%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVV 147
I GL +L I++RDLK NILL D KI+DFG+ KE++ A T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGM----CKENMLGDAKTCTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193
GT YI PE Y+T D +SFGVLL +++ G+ S G +E
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 12/184 (6%)
Query: 6 GEVIAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDSEERMLVYEYMPN 62
G +A+KKLS+ SA + E+ L + H N+I +L F S Y+
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ L + ++ L ++ I +GL Y+ IIHRDLK SNI + ED +
Sbjct: 100 HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCE 156
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIIS 181
KI DFGLAR E V T Y PE ++ ++ D++S G ++ ++++
Sbjct: 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 182 GKRL 185
GK L
Sbjct: 212 GKTL 215
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMPNKSLDCYLFDPIRRLILDW 80
+ NE + ++ H +IR+ F + ++R L + EY+P L YL + +
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNS 101
Query: 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK 140
+ E I L YL I++RDLK NILL ++ K++DFG FAK+ L+
Sbjct: 102 TGLFYASE-IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFG----FAKK-LR 152
Query: 141 ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
T + GT Y+ PE + ++ D ++ G+L+ +++ G
Sbjct: 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 14/180 (7%)
Query: 6 GEVIAVKKLSKSS--AQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G+ A+K LSK+ E NE + ++H L+ + G D LV EY+P
Sbjct: 26 GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L R R + + + L YL L I++RDLK N+LL D
Sbjct: 86 GEL-FSHLRKSGRFPEPVA-RFYAAQ-VVLALEYLH---SLDIVYRDLKPENLLLDSDGY 139
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFG FAK +K T + GT Y+ PE Y D ++ G+L+ ++++G
Sbjct: 140 IKITDFG----FAKR-VKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 9/172 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
EV L L+H N++ + LV+EY+ + L YL D L+ ++ +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMF 110
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147
+ + +GL Y + I+HRDLK N+L+ E + K++DFGLAR AK V
Sbjct: 111 Q-LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEV 164
Query: 148 GTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 198
T+ Y PP+ YST D++ G +L ++ +G+ + + E L ++
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 30/76 (39%), Positives = 45/76 (59%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165
+HRDL A N+L+ E KI DFGLAR ++S + + ++ PE +Y+T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 166 KSDVFSFGVLLLQIIS 181
SDV+SFG+LL +I +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 48/187 (25%), Positives = 83/187 (44%), Gaps = 16/187 (8%)
Query: 6 GEVIAVKKL-----SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYE 58
G +AVK++ S +++ + E+ L L H +++ G D ER L E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 59 YMPNKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+MP S+ D ++ L I +G+ YL I+HRD+K +NIL
Sbjct: 87 HMPGGSIK----DQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILR 139
Query: 118 GEDMKPKISDFGLARIFAKESLKAN-TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFG ++ L + V GT ++ PE Y K+D++S G +
Sbjct: 140 DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199
Query: 177 LQIISGK 183
+++++ K
Sbjct: 200 VEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVV 147
I GL +L II+RDLK N++L + KI+DFG+ KE++ T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM----CKENIFGGKTTRTFC 162
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN---LSILEH 200
GT YI PE Y D ++FGVLL ++++G+ G +E+ SI+EH
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--PPFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 19/187 (10%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G++ A KKL+K +G+E E + AK+ H I L + ++ + LV M
Sbjct: 18 GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMN 76
Query: 62 NKSLDCYLFD-----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
L ++++ P + I GL +L + II+RDLK N+L
Sbjct: 77 GGDLRYHIYNVDEENPG----FPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVL 129
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
L D +ISD GLA K T+ GT G++ PE + Y D F+ GV L
Sbjct: 130 LDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTL 187
Query: 177 LQIISGK 183
++I+ +
Sbjct: 188 YEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 89 GITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG 148
+ +GL YL+E + I+HRD+K SNIL+ + K+ DFG++ + + + VG
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
T Y+ PE + YS +SD++S G+ L+++ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 32/88 (36%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA-RIFAKESLKANTEQVVGTIGYIPP 155
L++ R ++RDLK NILL + +ISD GLA +I ES++ VGT+GY+ P
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAP 170
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISGK 183
E Y+ D + G L+ ++I G+
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 22/189 (11%)
Query: 2 VLPCGEVIAVK-KLSKSSAQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
+ P E IAV K K+ E+F E + + H ++++++G + +V E
Sbjct: 28 MSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86
Query: 59 YMPNKSLDCYLFD-----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
P L YL + LIL ++ L YL+ +HRD+ A
Sbjct: 87 LAPLGELRSYLQVNKYSLDLASLIL-------YSYQLSTALAYLES---KRFVHRDIAAR 136
Query: 114 NILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
N+L+ K+ DFGL+R ES KA+ ++ I ++ PE +++ SDV+ F
Sbjct: 137 NVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRRFTSASDVWMF 194
Query: 173 GVLLLQIIS 181
GV + +I+
Sbjct: 195 GVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 44/207 (21%)
Query: 6 GEVIAVKK-LSKSSAQGFE-EFKNEVMLTAKLQHVNLIRVLGFCID-----SEERMLVYE 58
G V+A+KK L + GF E+ + KL+H N++ ++ ++ +R VY
Sbjct: 33 GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92
Query: 59 YMP--NKSLDCYLFDPIRRLILDWKKRVH--------IIEGITQGLLYLQEYSRLTIIHR 108
P + L L +P V + + +G+ YL E I+HR
Sbjct: 93 VTPYMDHDLSGLLENP----------SVKLTESQIKCYMLQLLEGINYLHENH---ILHR 139
Query: 109 DLKASNILLGEDMKPKISDFGLARIFAKES---------LKANTEQVVGTIGYIPPEY-- 157
D+KA+NIL+ KI+DFGLAR + +V T Y PPE
Sbjct: 140 DIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199
Query: 158 -ARQGVYSTKSDVFSFGVLLLQIISGK 183
R+ Y+T D++ G + ++ + +
Sbjct: 200 GERR--YTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I +GL YL I+HRD+K N+L+ + KI DFGLAR+ + K T++VV T
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 150 IGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
Y PE +R Y++ D++S G + +++ + L
Sbjct: 168 QYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRRIL 204
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 35/192 (18%)
Query: 9 IAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+ VK+L +S Q +F E LQH NL++ LG C + +LV E+ P L
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 68 YLF----------DP--IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
YL DP ++R+ + I GLL+L + IH DL N
Sbjct: 85 YLRSCRKAELMTPDPTTLQRMACE----------IALGLLHLH---KNNFIHSDLALRNC 131
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY--------STKS 167
LL D+ KI D+GL+ KE +Q+ + +I PE + V+ + +S
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE-VHGNLLVVDQTKES 190
Query: 168 DVFSFGVLLLQI 179
+V+S GV + ++
Sbjct: 191 NVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 40/116 (34%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVV 147
I GL +L II+RDLK N++L + KI+DFG+ KE++ T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFC 162
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN---LSILEH 200
GT YI PE Y D ++FGVLL ++++G+ + G +E+ SI+EH
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 15 SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLV--YEYMPNKS----LDCY 68
S +++ + E+ L LQH +++ G D E+ L EYMP S L Y
Sbjct: 41 SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY 100
Query: 69 --LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
L + + R K I+EG++ YL I+HRD+K +NIL K+
Sbjct: 101 GALTESVTR-----KYTRQILEGMS----YLHSN---MIVHRDIKGANILRDSAGNVKLG 148
Query: 127 DFGLARIFAKESLKAN-TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
DFG ++ + V GT ++ PE Y K+DV+S G ++++++ K
Sbjct: 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 31/195 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN------EVMLTAKLQHVNLIRVLGFCIDSEERM----- 54
E +A+KK++ + F+ + E+ L L H N+I + + R
Sbjct: 30 NEKVAIKKIANA----FDNRIDAKRTLREIKLLRHLDHENVIAIKD-IMPPPHREAFNDV 84
Query: 55 -LVYEYMPNKSLDCYLFDPIRR---LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+VYE M D L IR L D + + + + +GL Y+ + ++HRDL
Sbjct: 85 YIVYELM-----DTDLHQIIRSSQTLSDDHCQ--YFLYQLLRGLKYIHSAN---VLHRDL 134
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
K SN+LL + KI DFGLAR E TE VV P Y+T DV+
Sbjct: 135 KPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVW 193
Query: 171 SFGVLLLQIISGKRL 185
S G + +++ K L
Sbjct: 194 SVGCIFAELLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 28/191 (14%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHV-------NLIRVLGFCIDSEERMLVYE 58
G V+AVK++ ++ + EE K +M L V +++ G+ I + + E
Sbjct: 40 GHVMAVKQMRRTGNK--EENKRILM---DLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94
Query: 59 YMPN--KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
M L + PI IL + I + L YL+E + +IHRD+K SNIL
Sbjct: 95 LMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE--KHGVIHRDVKPSNIL 147
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY----ARQGVYSTKSDVFSF 172
L K+ DFG++ +S KA T G Y+ PE Y ++DV+S
Sbjct: 148 LDASGNVKLCDFGISG-RLVDS-KAKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSL 204
Query: 173 GVLLLQIISGK 183
G+ L+++ +G+
Sbjct: 205 GISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 21/158 (13%)
Query: 31 LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGI 90
L +++ H++L V G C+ E ++V E++ + LD L R+ + WK + + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126
Query: 91 TQGLLYLQEYSRLTIIHRDLKASNIL-----LGEDMKP--KISDFGLARIFAKESLKA-N 142
L YL++ + ++H ++ A NIL L E P K+SD G+ S A +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV-------SFTALS 176
Query: 143 TEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQI 179
E+ V I +I PE G ST +D +SFG LL+I
Sbjct: 177 REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 47/184 (25%), Positives = 93/184 (50%), Gaps = 14/184 (7%)
Query: 6 GEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYM 60
G++ A+K L K++ A+ E + E + ++ + L + ++ ++ L+ +Y+
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L +L R ++ V I G + +L L+ +L II+RD+K NILL +
Sbjct: 88 NGGELFTHLSQRERFK----EQEVQIYSG--EIVLALEHLHKLGIIYRDIKLENILLDSN 141
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQ 178
++DFGL++ F ++ ++ GTI Y+ P+ R G + D +S GVL+ +
Sbjct: 142 GHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 179 IISG 182
+++G
Sbjct: 201 LLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 4 PCGEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
P ++AVKK L S + + + E++ + +LQH N++ + I E +V M
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 62 NKS----LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
S L + + + L + I++ + L Y+ IHR +KAS+ILL
Sbjct: 83 YGSCEDLLKTHFPEGLPELAI-----AFILKDVLNALDYIH---SKGFIHRSVKASHILL 134
Query: 118 GEDMKPKISDFGLARIFAKESLKAN-----TEQVVGTIGYIPPEYARQGV--YSTKSDVF 170
D K +S + K + + V + ++ PE +Q + Y+ KSD++
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194
Query: 171 SFGV 174
S G+
Sbjct: 195 SVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 32/67 (47%), Positives = 44/67 (65%), Gaps = 7/67 (10%)
Query: 93 GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF-AKESLKAN--TEQVVGT 149
GL Y+ R I+HRD+KA+NIL+ +D K++DFGLAR F ++ K N T +VV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 150 IGYIPPE 156
+ Y PPE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 7e-09
Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 47 CIDSEERML-VYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
C +E R+ V EY+ L +F R R + + R + E I+ L YL E
Sbjct: 64 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG--- 116
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA--NTEQVVGTIGYIPPEYARQGV 162
II+RDLK N+LL + K++D+G+ KE L+ T GT YI PE R
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMC----KEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 194
Y D ++ GVL+ ++++G+ + G ++N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA-RIFAKESLKANTEQVVGTIGYIPP 155
L++ R I++RDLK NILL + +ISD GLA +I E+++ VGT+GY+ P
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAP 170
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISGK 183
E Y+ D + G L+ ++I G+
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 47 CIDSEERM-LVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
C +E R+ V E++ L +F R R + + R + E I+ L +L E
Sbjct: 64 CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG--- 116
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPEYARQGV 162
II+RDLK N+LL + K++D+G+ KE ++ T GT YI PE R
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGM----CKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 194
Y D ++ GVL+ ++++G+ + G+++N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 29/151 (19%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVV 147
IT L++L + II+RDLK N+LL + K++DFG+ KE + T
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM----CKEGIFNGKTTSTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG------INEN---LSIL 198
GT YI PE ++ +Y D ++ GVLL + MLCG NE+ +IL
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYE--------MLCGHAPFEAENEDDLFEAIL 209
Query: 199 --EHAYELWKGGKGMEFVDSFLDDRNSSCKL 227
E Y W ++ + +F+ +N + +L
Sbjct: 210 NDEVVYPTWLSQDAVDILKAFM-TKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 6 GEVIAVKKLSKSSAQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++A+K +S + +G F + E L L+H N++ + E V+EYM +
Sbjct: 30 GQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HT 87
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L Y+ L + R+ + + + +GL Y+ I+HRDLK N+L+ +
Sbjct: 88 DLAQYMIQHPGGL-HPYNVRLFMFQ-LLRGLAYIH---GQHILHRDLKPQNLLISYLGEL 142
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISG 182
K++DFGLAR + S ++E V T+ Y PP+ YS+ D++ G + ++++ G
Sbjct: 143 KLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
Query: 183 KRLSMLCGINENLSILEHAYELW 205
+ G++ + E ++W
Sbjct: 201 QPA--FPGVS---DVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 43/200 (21%)
Query: 6 GEVIAVKK---------LSKSSAQGFEEFKNEVMLTAKLQHVNLIR----VLGFCIDSEE 52
GE++A+KK + SS + E+ L L+H N++ V+G +DS
Sbjct: 32 GEIVALKKVRMDNERDGIPISSLR-------EITLLLNLRHPNIVELKEVVVGKHLDS-- 82
Query: 53 RMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI--IEGITQ----GLLYLQEYSRLTII 106
LV EY + L+ + ++ + GL YL E II
Sbjct: 83 IFLVMEYCEQD---------LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FII 130
Query: 107 HRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA-RQGVYST 165
HRDLK SN+LL + KI+DFGLAR + + K T +VV T+ Y PE Y+T
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVV-TLWYRAPELLLGCTTYTT 188
Query: 166 KSDVFSFGVLLLQIISGKRL 185
D+++ G +L ++++ K L
Sbjct: 189 AIDMWAVGCILAELLAHKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 16/187 (8%)
Query: 6 GEVIAVKKL-----SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYE 58
G +AVK++ S+ +++ + E+ L L+H +++ G D EE+ L E
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 59 YMPNKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
YMP S+ D ++ L I QG+ YL I+HRD+K +NIL
Sbjct: 87 YMPGGSIK----DQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILR 139
Query: 118 GEDMKPKISDFGLA-RIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFG + RI + V GT ++ PE Y K+DV+S +
Sbjct: 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199
Query: 177 LQIISGK 183
+++++ K
Sbjct: 200 VEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT--EQVV 147
+ +GL Y+ + +IHRDLK SN+L+ ED + +I DFG+AR + + + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 148 GTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISGKRL 185
T Y PE Y+T D++S G + +++ ++L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 47 CIDSEERM-LVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
C + R+ LV EY+ L +F R R + + R + E I L +L E
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA--NTEQVVGTIGYIPPEYARQGV 162
II+RDLK N+LL D K++D+G+ KE L T GT YI PE R
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGM----CKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 204
Y D ++ GVL+ ++++G+ + N +++ ++ +++
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 40/195 (20%)
Query: 9 IAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL- 65
+AVKKLS+ S + E+ L ++H N+I +L + P +SL
Sbjct: 45 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLE 92
Query: 66 ---DCYLFDPI-----------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
D YL + ++L D + +I I +GL Y+ IIHRDLK
Sbjct: 93 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIHSAD---IIHRDLK 147
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVF 170
SN+ + ED + KI DFGLAR E V T Y PE + Y+ D++
Sbjct: 148 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIW 202
Query: 171 SFGVLLLQIISGKRL 185
S G ++ ++++G+ L
Sbjct: 203 SVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 14/181 (7%)
Query: 6 GEVIAVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++A+K +L + F + E L L+H N++ + E LV+EY+
Sbjct: 30 GKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTD 88
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-QEYSRLTIIHRDLKASNILLGEDMK 122
C D + ++ + + + +GL Y+ Q Y I+HRDLK N+L+ + +
Sbjct: 89 L--CQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY----ILHRDLKPQNLLISDTGE 141
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIIS 181
K++DFGLAR + S + E V T+ Y PP+ YST D++ G + +++I
Sbjct: 142 LKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 182 G 182
G
Sbjct: 200 G 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN----LIRVLGFCIDSEERM-LVYEYM 60
G+ A+K L KS + N V + + + L + S++ + LV EY+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79
Query: 61 PNKSLDC-YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
DC L + L DW K+ I + +L +++ + IIHRD+K N+L+ +
Sbjct: 80 NGG--DCASLIKTLGGLPEDWAKQY-----IAEVVLGVEDLHQRGIIHRDIKPENLLIDQ 132
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK-SDVFSFGVLLLQ 178
K++DFGL+R + ++ VGT Y+ PE GV K SD +S G ++ +
Sbjct: 133 TGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPE-TILGVGDDKMSDWWSLGCVIFE 185
Query: 179 IISGKR 184
+ G
Sbjct: 186 FLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 33/190 (17%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIR--------------VLGFCIDSEER 53
VI L +S + + + E L ++L+H N++ V+GFC E
Sbjct: 29 VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC----EG 84
Query: 54 MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
+Y + + +++W + I L YL E I+HRDLK
Sbjct: 85 GDLYHKLKEQKGKLLP----ENQVVEWFVQ------IAMALQYLHEKH---ILHRDLKTQ 131
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+ L K+ D G+AR+ + A+T ++GT Y+ PE Y+ KSDV++ G
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALG 189
Query: 174 VLLLQIISGK 183
+ ++ + K
Sbjct: 190 CCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 40/107 (37%), Positives = 53/107 (49%), Gaps = 18/107 (16%)
Query: 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG----LARIFAKESLK 140
I + L YL+E L IIHRD+K SNILL + K+ DFG L AK
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---- 164
Query: 141 ANTEQVVGTIGYIPPE----YARQGVYSTKSDVFSFGVLLLQIISGK 183
+ G Y+ PE AR G Y +SDV+S G+ L ++ +GK
Sbjct: 165 ---TRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 16/178 (8%)
Query: 12 KKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEYMPNKSLDC 67
KK K + +NE+ ++ N++++ GF ID + + L+ EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
L + L +K ++ + +GL L +Y+ +++L + + L+ E+ K KI
Sbjct: 112 VLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIIC 166
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGK 183
GL +I + K V + Y + Y+ K D++S GV+L +I +GK
Sbjct: 167 HGLEKILSSPPFKN-----VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 31/79 (39%), Positives = 46/79 (58%), Gaps = 2/79 (2%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164
II+RDLK N++L D KI+DFG+ + +A+T GT YI PE + Y+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYT 174
Query: 165 TKSDVFSFGVLLLQIISGK 183
D +SFGVLL +++ G+
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I+ GL +L II+RDLK N++L + KI+DFG+ + + + T GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGT 164
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
YI PE Y D +++GVLL ++++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVV 147
+T L++L + +I+RDLK NILL + K++DFG+ KE + T
Sbjct: 105 VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGM----CKEGILNGVTTTTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GT YI PE ++ Y D ++ GVL+ ++++G+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 21/186 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-----EVMLTA-KLQHVNLIRVLGFCIDSEERM-LVYE 58
GE+ A+K L K +E ++ + TA +H L+ + C +E+ + V E
Sbjct: 24 GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFA-CFQTEDHVCFVME 82
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
Y L + I + + V + GL YL E I++RDLK N+LL
Sbjct: 83 YAAGGDLMMH----IHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLD 135
Query: 119 EDMKPKISDFGLARIFAKESL--KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ KI+DFGL KE + T GT ++ PE + Y+ D + GVL+
Sbjct: 136 TEGFVKIADFGL----CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI 191
Query: 177 LQIISG 182
+++ G
Sbjct: 192 YEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 105 IIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQ 160
++HRDLK N+L+ + KI+D GL R F+ +K+ T ++V T+ Y PE +
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAPEVLLGSTH 188
Query: 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 204
YST D++S G + ++ + L G +E L L H ++L
Sbjct: 189 --YSTPVDIWSVGCIFAEMSRKQPL--FPGDSE-LQQLLHIFKL 227
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 31/86 (36%), Positives = 46/86 (53%), Gaps = 11/86 (12%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV---VGTIGYIPPE----Y 157
++HRDLK N+L+ D + KI DFGLAR F+ E+ N + V T Y PE +
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFS-ENPGENAGFMTEYVATRWYRAPEIMLSF 184
Query: 158 ARQGVYSTKSDVFSFGVLLLQIISGK 183
Y+ DV+S G +L +++ K
Sbjct: 185 QS---YTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
+ L L+ + +I+RDLK NILL + DFGL ++ K+ K NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
Y+ PE Y+ D ++ GVLL ++++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-08
Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDS------EERMLVYE 58
G++ A+K + + + EE K E+ ML H N+ G I ++ LV E
Sbjct: 31 GQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+ S+ L + L + +I I +GL +L ++ +IHRD+K N+LL
Sbjct: 90 FCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT 145
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-----QGVYSTKSDVFSFG 173
E+ + K+ DFG++ + + NT +GT ++ PE Y KSD++S G
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 174 VLLLQIISG 182
+ +++ G
Sbjct: 204 ITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 50/162 (30%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86
E L L+H N++ L I +++ + LV+EY+ + L Y+ D L
Sbjct: 53 EASLLKDLKHANIV-TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGG--GLSMHNVRLF 108
Query: 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT--E 144
+ + +GL Y + ++HRDLK N+L+ E + K++DFGLAR AK S+ + T
Sbjct: 109 LFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR--AK-SVPSKTYSN 162
Query: 145 QVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRL 185
+VV T+ Y PP+ YST D++ G + ++ +G+ L
Sbjct: 163 EVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 18/103 (17%)
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI-------------FAKESLK 140
L YL Y I+HRDLK N+L+ K++DFGL++I K++ +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 141 ANTEQVVGTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISG 182
+QV GT YI PE RQG Y D ++ G++L + + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 55/179 (30%), Positives = 85/179 (47%), Gaps = 14/179 (7%)
Query: 9 IAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---EERMLVYEYMPNK 63
+AVKKLS+ + + E++L + H N+I +L EE VY M +
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM--E 106
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+D L I + LD ++ +++ + G+ +L IIHRDLK SNI++ D
Sbjct: 107 LMDANLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI DFGLAR + T VV T Y PE Y D++S G ++ +++ G
Sbjct: 163 KILDFGLARTACTNFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 30/93 (32%), Positives = 50/93 (53%)
Query: 92 QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151
Q +L L E ++HRDLK++NI L K+ DFG ++ ++ GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
Y+ PE + YS K+D++S GV+L ++++ R
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIG 151
L L+ + II+RDLK NILL K++DFGL KES+ T GTI
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL----CKESIHEGTVTHTFCGTIE 165
Query: 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
Y+ PE + + D +S G L+ +++G
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 15/185 (8%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
G+++A+KK +S + K E+ + +L+H NL+ ++ + LV+E++
Sbjct: 26 GQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ LD P LD + + I +G+ + ++ IIHRD+K NIL+ +
Sbjct: 84 HTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSG 137
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQII 180
K+ DFG AR A + T+ V T Y PE Y D+++ G L+ +++
Sbjct: 138 VVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195
Query: 181 SGKRL 185
+G+ L
Sbjct: 196 TGEPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 7 EVIAVKKLSKSSAQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
E++A+KK S + EE K E+ + L+ N++ + + LV+EY+
Sbjct: 27 EIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L+ L + + + K R +I + I + + I+HRD+K N+L+ +
Sbjct: 85 NMLE--LLEEMPNGVPPEKVRSYIYQLIKA----IHWCHKNDIVHRDIKPENLLISHNDV 138
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
K+ DFG AR + E AN + V T Y PE Y D++S G +L ++ G
Sbjct: 139 LKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197
Query: 183 KRL 185
+ L
Sbjct: 198 QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 9 IAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---EERMLVYEYMPNK 63
+A+KKLS+ + + E++L + H N+I +L EE VY M +
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM--E 109
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+D L I+ + LD ++ +++ + G+ +L IIHRDLK SNI++ D
Sbjct: 110 LMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI DFGLAR A S V T Y PE Y D++S G ++ ++I G
Sbjct: 166 KILDFGLART-AGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
Query: 184 RL 185
L
Sbjct: 223 VL 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 22/189 (11%)
Query: 6 GEVIAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDS--EERMLVYEYM 60
G +A+KKL + S + E+ L ++H N+I +L F D + Y M
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVH-IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
P D +L D R+ ++ + +GL Y+ IIHRDLK N+ + E
Sbjct: 100 PFMGTDLGKLMKHEKLSED---RIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNE 153
Query: 120 DMKPKISDFGLARIFAKESLKANTEQV--VGTIGYIPPEYARQGVYSTKS-DVFSFGVLL 176
D + KI DFGLAR + ++E V T Y PE ++ T++ D++S G ++
Sbjct: 154 DCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206
Query: 177 LQIISGKRL 185
++++GK L
Sbjct: 207 AEMLTGKPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I + +L L+ + I++RDLK NILL + DFGL++ A + T GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGT 159
Query: 150 IGYIPPE-YARQGVYSTKSDVFSFGVLLLQIISG 182
Y+ PE + Y+ D +S GVL+ ++ G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARI-FAKESLKANTEQVVGTIGYIPPEYARQ--G 161
+ HRDLK NIL D K KI DFGLAR+ F V T Y PE
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 183
Query: 162 VYSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G + ++++GK L
Sbjct: 184 KYTPAIDIWSIGCIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85
E+ L +L+H N+I + + +R L+++Y + D + R KK V
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQ 104
Query: 86 IIEGITQGLLY-----LQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAK 136
+ G+ + LLY + ++HRDLK +NIL+ E + KI+D G AR+F
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-N 163
Query: 137 ESLK--ANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIISGK 183
LK A+ + VV T Y PE + TK+ D+++ G + ++++ +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 21/190 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCI------DSEERMLVYE 58
G++ A+K + + + EE K E+ ML H N+ G I ++ LV E
Sbjct: 41 GQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99
Query: 59 YMPNKSL-DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ S+ D L DW +I I +GL +L + +IHRD+K N+LL
Sbjct: 100 FCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGLAHLHAHK---VIHRDIKGQNVLL 154
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-----QGVYSTKSDVFSF 172
E+ + K+ DFG++ + + NT +GT ++ PE Y +SD++S
Sbjct: 155 TENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212
Query: 173 GVLLLQIISG 182
G+ +++ G
Sbjct: 213 GITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQ 145
+I + +GL Y+ IIHRDLK SN+ + ED + +I DFGLAR +A+ E
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-------QADDEM 172
Query: 146 V--VGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRL 185
V T Y PE + Y+ D++S G ++ +++ GK L
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVV 147
I L YL +S +++RDLK N++L +D KI+DFGL KE +K A +
Sbjct: 104 IVSALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGL----CKEGIKDGATMKTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GT Y+ PE Y D + GV++ +++ G+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 53/185 (28%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVM-----LTAKLQHVNLIRVLGFCIDSEERM-LVYEY 59
G+ AVK L K + +E K+ +M L ++H L+ L + + +++ V +Y
Sbjct: 20 GKFYAVKVLQKKAILKKKEQKH-IMAERNVLLKNVKHPFLVG-LHYSFQTADKLYFVLDY 77
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L +L R + + R + E I L YL L II+RDLK NILL
Sbjct: 78 VNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---LNIIYRDLKPENILLDS 131
Query: 120 DMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
++DFGL KE ++ + T GT Y+ PE R+ Y D + G +L
Sbjct: 132 QGHVVLTDFGL----CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 178 QIISG 182
+++ G
Sbjct: 188 EMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 96 YLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155
YL II+RDLK N+LL K++DFG FAK+ + T + GT Y+ P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG----FAKK-VPDRTFTLCGTPEYLAP 184
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISG 182
E + + D ++ GVLL + I+G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 24/144 (16%)
Query: 92 QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151
Q +L + L I++RDLK N+LL +D K++DFG A++ + T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG---INENLSILEHAYELWKGG 208
YI PE + +D ++ G+ + +I+ G C NE L I + E
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVG------CPPFYANEPLLIYQKILE----- 242
Query: 209 KGMEFVDSFLDDRNSSCK-LMRCL 231
G+ + FLD ++CK LM+ L
Sbjct: 243 -GIIYFPKFLD---NNCKHLMKKL 262
|
Length = 340 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 9 IAVKKLSK--SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---EERMLVYEYMPNK 63
+A+KKLS+ + + E++L + H N+I +L EE VY M +
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM--E 102
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+D L I+ + LD ++ +++ + G+ +L IIHRDLK SNI++ D
Sbjct: 103 LMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI DFGLAR + T VV T Y PE Y D++S G ++ +++ K
Sbjct: 159 KILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
Query: 184 RL 185
L
Sbjct: 216 IL 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 93 GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152
LL LQ IIHRD+K +NILL + K+ DFG++ L+ NT VGT +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194
Query: 153 IPPEY-----ARQGVYSTKSDVFSFGVLLLQIISG 182
+ PE Y + DV+S G+ +++ G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 18/145 (12%)
Query: 46 FCIDSEERML--VYEYMPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYS 101
FC +++ L V EYMP L + +D + W K + +L L
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIH 159
Query: 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ- 160
+ +IHRD+K N+LL + K++DFG + E+ + VGT YI PE +
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 161 ---GVYSTKSDVFSFGVLLLQIISG 182
G Y + D +S GV L +++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVV 147
I L YL +++RDLK N++L +D KI+DFGL KE + A +
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFC 156
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GT Y+ PE Y D + GV++ +++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153
+L L + IHRD+K N+LL + K++DFG KE + + VGT YI
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYI 210
Query: 154 PPEYARQ----GVYSTKSDVFSFGVLLLQIISG 182
PE + G Y + D +S GV L +++ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVM-----LTAKLQHVNLIRVLGFCIDSEERM-LVYEY 59
G AVK L K + +E +N +M L L+H L+ L + + E++ V +Y
Sbjct: 20 GSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG-LHYSFQTAEKLYFVLDY 77
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L +L R L+ + R + E + + YL L II+RDLK NILL
Sbjct: 78 VNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---LNIIYRDLKPENILLDS 131
Query: 120 DMKPKISDFGLARIFAKESL--KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
++DFGL KE + + T GT Y+ PE R+ Y D + G +L
Sbjct: 132 QGHVVLTDFGL----CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLY 187
Query: 178 QIISG 182
+++ G
Sbjct: 188 EMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
E+ + +++H N++ ++ ++ + LV + M S + D RL K I+
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVDRKIRLTESQVK--CIL 125
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA----------KE 137
I GL L ++ +HRDL +NI + KI+DFGLAR + E
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 138 SLKAN---TEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193
+++ T +VV T+ Y PE Y D++S G + ++++GK L G NE
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL--FPGENE 239
|
Length = 335 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 28 EVMLTAKLQHVNLIRVLG-FCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86
E + + H ++I++ G F + +++ Y + L CYL I D + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI---LAI 187
Query: 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV 146
+ + + YL E IIHRD+KA NI + + DFG A F +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GTI PE + Y D++S G++L ++ +
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF 134
R L+ + R + E I L YL L I++RDLK NILL ++DFGL
Sbjct: 91 RCFLEPRARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL---- 142
Query: 135 AKESLKAN--TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KE+++ N T GT Y+ PE + Y D + G +L +++ G
Sbjct: 143 CKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 15/183 (8%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERM-LVYEYMPN 62
G A+K L K +E + V + LQ+ + L + + +R+ V EY
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L +L R+ + + R + E I L YL +SR +++RD+K N++L +D
Sbjct: 80 GELFFHL--SRERVFTEERARFYGAE-IVSALEYL--HSR-DVVYRDIKLENLMLDKDGH 133
Query: 123 PKISDFGLARIFAKESL--KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
KI+DFGL KE + A + GT Y+ PE Y D + GV++ +++
Sbjct: 134 IKITDFGL----CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 181 SGK 183
G+
Sbjct: 190 CGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 45/171 (26%), Positives = 69/171 (40%), Gaps = 44/171 (25%)
Query: 49 DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK-RVHIIEGITQGLLYLQEYSRLTIIH 107
D L+ EY+P + L +++ ++ R +I E I L + +L IH
Sbjct: 72 DENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETI----LAIDSIHKLGYIH 124
Query: 108 RDLKASNILLGEDMKPKISDFGL------------ARIFAK------------------- 136
RD+K N+LL K+SDFGL RI +
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 137 -ESLKANTEQ----VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
E+ K N VGT YI PE Q Y+ + D +S GV++ +++ G
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 11/181 (6%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERM-LVYEYMPN 62
G+ A+K L K +E + + + L++ + L + +++R+ V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L +L R+ + + R + E I L YL I++RDLK N++L +D
Sbjct: 80 GELFFHL--SRERVFSEDRTRFYGAE-IVSALDYLHSGK---IVYRDLKLENLMLDKDGH 133
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGL + ++ A + GT Y+ PE Y D + GV++ +++ G
Sbjct: 134 IKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
Query: 183 K 183
+
Sbjct: 192 R 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 53/189 (28%)
Query: 81 KKRVHIIEGIT-QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL 139
K+ +++I+G+ Q L L++ R+ I+HRD+K N+L+ D + KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA---VDMCT 361
Query: 140 KANTEQVVGTIG--YIPPE--------------------------YARQGVYSTKSDVFS 171
N + G + Y PPE Y R ++ D ++
Sbjct: 362 GINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF----DSYT 417
Query: 172 FGVLLLQI-------ISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNS- 223
GVLL+Q+ ++ RL N L ++ W+ KG ++ S LD
Sbjct: 418 AGVLLMQMCVPELRPVANIRL-----FNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEA 472
Query: 224 ----SCKLM 228
+CKL+
Sbjct: 473 GWDLACKLI 481
|
Length = 507 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 36/126 (28%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAK------------- 136
I + +L + +L IHRD+K N+LL K+SDFGL K
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 137 ----------------ESLKANTEQV----VGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
E+ K N Q+ VGT YI PE Q Y+ D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 177 LQIISG 182
+++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 38/125 (30%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 67 CYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
C LF + R L ++ + I + + L YL IIHRD+K NI L E +
Sbjct: 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVL 226
Query: 126 SDFGLARIFAKESLKANTEQV---VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
DFG A K +T Q GT+ PE Y K+D++S G++L + +S
Sbjct: 227 GDFGAA---CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSV 282
Query: 183 KRLSM 187
K +++
Sbjct: 283 KNVTL 287
|
Length = 392 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85
E+ L +L+H N+I + + +R L+++Y + D + R KK +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQ 104
Query: 86 IIEGITQGLLY-----LQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAK 136
+ + + LLY + ++HRDLK +NIL+ E + KI+D G AR+F
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-N 163
Query: 137 ESLK--ANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIISGK 183
LK A+ + VV T Y PE + TK+ D+++ G + ++++ +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 29/100 (29%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG-LARIFAKESLKANTEQVVG 148
+ + +L + +L +HRD+K N+LL ++ +++DFG R+ A ++++N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 149 TIGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGK 183
T YI PE + +G Y + D +S GV + +++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 36/126 (28%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAK------------- 136
I + +L + +L IHRD+K N+LL K+SDFGL K
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 137 ----------------ESLKANTEQV----VGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
E+ K N Q+ VGT YI PE Q Y+ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 177 LQIISG 182
+++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 23/185 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN--EVMLTAKLQ-HVNLIRVLGFCIDSEER--MLVYEYM 60
G+ A+K + K + E+ N E+ +L H N++R++ D + LV+E M
Sbjct: 24 GKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82
Query: 61 PNKSLDCYLFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
D L++ I R+ L K+ + + + L ++ R I HRD+K NIL+
Sbjct: 83 -----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIK 134
Query: 119 EDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLL 176
+D+ K++DFG R I++K TE + T Y PE G Y K D+++ G +
Sbjct: 135 DDIL-KLADFGSCRGIYSKPPY---TE-YISTRWYRAPECLLTDGYYGPKMDIWAVGCVF 189
Query: 177 LQIIS 181
+I+S
Sbjct: 190 FEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 92 QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151
+ L+ LQ IHRD+K +NILL + K+ DFG++ L+ NT VGT
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPF 189
Query: 152 YIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISG 182
++ PE Y + DV+S G+ +++ G
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 50/191 (26%), Positives = 78/191 (40%), Gaps = 47/191 (24%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMPNKSLD-----CY-LFDPIRRLILD 79
EV + +L+H N++R + ++ + L + E+ L CY +F I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE---- 117
Query: 80 WKKRVHIIEGITQGLLYLQEYSR--------LTIIHRDLKASNILLGEDMK--------- 122
H I IT+ LL+ Y ++HRDLK NI L ++
Sbjct: 118 -----HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 123 --------PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSF 172
KI DFGL++ ES+ VGT Y PE Y KSD+++
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 173 GVLLLQIISGK 183
G ++ ++ SGK
Sbjct: 230 GCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR----QG 161
IHRD+K N+LL + K++DFG + + VGT YI PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 162 VYSTKSDVFSFGVLLLQIISG 182
Y + D +S GV L +++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 23/159 (14%)
Query: 35 LQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR-VHIIE----- 88
LQH N+++ LG C+++ +LV+EY L YL W +R ++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMA 105
Query: 89 -GITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147
I G+ ++ + +H DL N L D+ K+ D+G+ KE +
Sbjct: 106 CEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162
Query: 148 GTIGYIPPEY--ARQG----VYSTK-SDVFSFGVLLLQI 179
+ ++ PE G TK S+V++ GV L ++
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 10/104 (9%)
Query: 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE--S 138
+ R + E I L YL + I++RDLK NILL ++DFGL KE +
Sbjct: 97 RARFYAAE-IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGL----CKEGIA 148
Query: 139 LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
T GT Y+ PE R+ Y D + G +L +++ G
Sbjct: 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 29/192 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-------EVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
G+++A+KK +S E+ E+ + +L+H NL+ ++ + LV+E
Sbjct: 26 GQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKR---VHIIEGIT-QGLLYLQEYSRLTIIHRDLKASN 114
Y + L+ L+ R H+I+ I Q L + + IHRD+K N
Sbjct: 81 YCDHTVLN----------ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPEN 130
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY-ARQGVYSTKSDVFSFG 173
IL+ + + K+ DFG ARI + V T Y PE Y DV++ G
Sbjct: 131 ILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG 188
Query: 174 VLLLQIISGKRL 185
+ ++++G+ L
Sbjct: 189 CVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G++ A+K + KS E F+ E + + + ++ D + LV EY P
Sbjct: 26 GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-------RLTIIHRDLKASNI 115
L L L + E + Q YL E ++ +HRD+K N+
Sbjct: 86 GDL----------LSLLNRYEDQFDEDMAQ--FYLAELVLAIHSVHQMGYVHRDIKPENV 133
Query: 116 LLGEDMKPKISDFG-LARIFAKESLKANTEQVVGTIGYIPPEY------ARQGVYSTKSD 168
L+ K++DFG AR+ A + N++ VGT YI PE +G Y + D
Sbjct: 134 LIDRTGHIKLADFGSAARLTANK--MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 169 VFSFGVLLLQIISGK 183
+S GV+ ++I G+
Sbjct: 192 WWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-05
Identities = 26/130 (20%), Positives = 47/130 (36%), Gaps = 14/130 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLI--RVLGFCIDSEERMLVYEYMPNK 63
E +K + + EV + L L +VL L+ E++ +
Sbjct: 21 DEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+LD + +++ I E + + L L + L + H DL NIL+ +
Sbjct: 79 TLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL 128
Query: 124 KISDFGLARI 133
I D+ A
Sbjct: 129 GIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I + +L + +L +HRD+K N+LL + +++DFG ++ + VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGT 166
Query: 150 IGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGK 183
YI PE + G Y + D +S GV + +++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 45/138 (32%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE------------ 137
+ + +L ++ +L IHRD+K NIL+ K+SDFGL+ F K+
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 138 ------SLKANTEQV---------------------------VGTIGYIPPEYARQGVYS 164
N+ V VGT YI PE Q Y
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 165 TKSDVFSFGVLLLQIISG 182
+ D +S G ++ + + G
Sbjct: 227 QECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
+ + ++ + +L +HRD+K NIL+ + +++DFG + + E + VGT
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGT 166
Query: 150 IGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGK 183
YI PE + +G Y + D +S GV + +++ G+
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 25/194 (12%)
Query: 4 PCGEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM- 60
P GE + V++ L + + + E+ ++ H N++ I E +V +M
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 61 --PNKSLDCYLF-DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
K L C F D + L + +I++G+ + L Y+ + +HR +KAS+IL+
Sbjct: 83 YGSAKDLICTHFMDGMSELAI-----AYILQGVLKALDYIHH---MGYVHRSVKASHILI 134
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQV-------VGTIGYIPPEYARQGV--YSTKSD 168
D K +S GL + + V V + ++ PE +Q + Y KSD
Sbjct: 135 SVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192
Query: 169 VFSFGVLLLQIISG 182
++S G+ ++ +G
Sbjct: 193 IYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 31/198 (15%)
Query: 4 PCGEVIAVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
P G ++ V+ L + + + +NEV+L+ +H N++ ++ +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 62 ----NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
N L Y + + ++ +I+ G +GL YL + IHR++KAS+IL+
Sbjct: 83 YGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHILI 134
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQV----------VGTIGYIPPEYARQGV--YST 165
D +S GL+ ++ SL N ++ + ++ PE RQ + Y+
Sbjct: 135 SGDGLVSLS--GLSHLY---SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV 189
Query: 166 KSDVFSFGVLLLQIISGK 183
KSD++S G+ ++ +G+
Sbjct: 190 KSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 52/243 (21%), Positives = 89/243 (36%), Gaps = 67/243 (27%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEF-KNEVMLTAKLQHVN-------------LIRVLGF 46
G+ GEV +K+ + + K +V+L ++ HV ++R+
Sbjct: 10 GIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYS 69
Query: 47 CIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK-KRVHIIEGITQGLLYLQEYSRLTI 105
D + V +Y+P + L IR I R +I E ++ ++
Sbjct: 70 FQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCA----VESVHKMGF 122
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIF------------------------------- 134
IHRD+K NIL+ D K++DFGL F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 135 --------------AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
A++ + +VGT YI PE + Y+ D +S GV+L +++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 181 SGK 183
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 31/124 (25%), Positives = 48/124 (38%), Gaps = 43/124 (34%)
Query: 102 RLTIIHRDLKASNILLGEDMKPKISDFGLA------------------------------ 131
++ IHRD+K NIL+ D K++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 132 -----------RIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQI 179
R ++ + +VGT YI PE R G Y+ D +S GV+L ++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM 237
Query: 180 ISGK 183
+ G+
Sbjct: 238 LVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 6e-04
Identities = 32/118 (27%), Positives = 53/118 (44%), Gaps = 13/118 (11%)
Query: 69 LFDPIRR-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP-KIS 126
LFD +++ L + II + + L L ++ IIH D+K N+L +
Sbjct: 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152
Query: 127 DFGLARIFAKESLKANTEQVV-GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
D+GL +I T GT+ Y PE + Y D ++ GVL ++++GK
Sbjct: 153 DYGLCKI-------IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 18/44 (40%), Positives = 28/44 (63%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133
I++ L L R IIHRDLK N+L+ + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 32/139 (23%), Positives = 52/139 (37%), Gaps = 45/139 (32%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF--------------- 134
I + L ++ ++ IHRD+K NIL+ D K++DFGL F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 135 ------------------------------AKESLKANTEQVVGTIGYIPPEYARQGVYS 164
K+ + +VGT YI PE + Y+
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 165 TKSDVFSFGVLLLQIISGK 183
D +S GV+L +++ G+
Sbjct: 227 QLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 31/120 (25%), Positives = 45/120 (37%), Gaps = 30/120 (25%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA------------------ 131
+ L YL L I++RDLK NILL E +SDF L+
Sbjct: 112 VLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 132 ---------RIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
E + VGT YI PE + + D ++ G+LL +++ G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.42 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.41 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.36 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.32 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.32 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.17 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.65 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.37 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.84 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.82 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.54 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.02 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.01 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.89 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.85 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.65 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.4 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.15 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 94.11 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=324.63 Aligned_cols=229 Identities=25% Similarity=0.337 Sum_probs=191.5
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe-eeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++++.+|+|.+... ++...+++.+|+++++..+||+||++|+.|++... .+|+||||++|||.+++.. .+.+++.
T Consensus 102 ~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~---~g~i~E~ 178 (364)
T KOG0581|consen 102 PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR---VGRIPEP 178 (364)
T ss_pred CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh---cCCCCHH
Confidence 57999999999654 45667899999999999999999999999999994 9999999999999999843 3669999
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.+-+++.+|++||.|||+ .+ |+||||||+|||++..|.|||||||.+..+.+. ....+.||..|||||.+.+
T Consensus 179 ~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 179 VLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISG 251 (364)
T ss_pred HHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcC
Confidence 999999999999999996 66 999999999999999999999999999877654 4566889999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCC--CccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGI--NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
..|+.++||||||+.++|+++|+.||..... ....+.+... -.+..+.+... ..+.++.++|..||
T Consensus 252 ~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I----v~~ppP~lP~~--------~fS~ef~~FV~~CL 319 (364)
T KOG0581|consen 252 ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI----VDEPPPRLPEG--------EFSPEFRSFVSCCL 319 (364)
T ss_pred CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH----hcCCCCCCCcc--------cCCHHHHHHHHHHh
Confidence 9999999999999999999999999976511 1222222221 11122221111 24558999999999
Q ss_pred cCCCCCCCCHHHHHHh
Q 045452 239 QENPNDRPSMLEVSSM 254 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~ 254 (303)
++||.+|||+.++++.
T Consensus 320 ~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 320 RKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCcccCCCHHHHhcC
Confidence 9999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=333.25 Aligned_cols=232 Identities=30% Similarity=0.417 Sum_probs=195.8
Q ss_pred CCCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
+.+|+.||+|++... .....+.+.+||++.++|+|||||+++++|+++++.|||.|+|..++|..+++ .++.++
T Consensus 40 ~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K---rrk~lt 116 (592)
T KOG0575|consen 40 LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK---RRKPLT 116 (592)
T ss_pred cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH---hcCCCC
Confidence 478999999999653 45577889999999999999999999999999999999999999999999884 567899
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||.|||+.+ |+|||||..|+|++++.+|||+|||+|..+... ..+..+.+||+.|.|||++.
T Consensus 117 EpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--~Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 117 EPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--GERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred cHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc--ccccceecCCCcccChhHhc
Confidence 9999999999999999999999 999999999999999999999999999877532 45667789999999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
....+..+||||+|||||-|+.|++||......+.+..+. ... ...|...+.+..+||.++|+
T Consensus 192 k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------~~~----------Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 192 KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------LNE----------YSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-------hcC----------cccccccCHHHHHHHHHHhc
Confidence 9999999999999999999999999996544333322222 111 11111223467899999999
Q ss_pred CCCCCCCCHHHHH--HhhccCC
Q 045452 240 ENPNDRPSMLEVS--SMLKNET 259 (303)
Q Consensus 240 ~dp~~Rps~~~l~--~~L~~~~ 259 (303)
+||.+|||+++|+ .++..-.
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCC
Confidence 9999999999998 4463333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=319.76 Aligned_cols=231 Identities=26% Similarity=0.333 Sum_probs=184.0
Q ss_pred CCCCCEEEEEEccCCC-------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 3 LPCGEVIAVKKLSKSS-------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
-.+|+.||||+++... ........+|+++|++|+|||||+++++|+.....|+||||+.||.|.+++. .+
T Consensus 194 ~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv---~n 270 (475)
T KOG0615|consen 194 KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV---AN 270 (475)
T ss_pred cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH---hc
Confidence 3689999999996431 1123346799999999999999999999999999999999999999999984 56
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEecccccccccccccccccceeeccccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
+.+.++.-+.++.|++.|+.|||++| |+||||||+|||+..+ -.+||.|||++...+. .....+++||+.|
T Consensus 271 k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsY 344 (475)
T KOG0615|consen 271 KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSY 344 (475)
T ss_pred cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcccc---ceehhhhcCCccc
Confidence 67888899999999999999999999 9999999999999876 6799999999987653 3445668999999
Q ss_pred cCchhcccCC---CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 153 IPPEYARQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 153 ~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|||++.+.. +..+.|+|||||++|-+++|.+||......... +++...+..... ...-...+.+
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl------~eQI~~G~y~f~------p~~w~~Isee 412 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL------KEQILKGRYAFG------PLQWDRISEE 412 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH------HHHHhcCccccc------ChhhhhhhHH
Confidence 9999997765 334789999999999999999999644433211 111111111110 0111223457
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..+||.+||..||++|||+.|+++.
T Consensus 413 a~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 413 ALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHHHhhEeCcccCcCHHHHhcC
Confidence 8899999999999999999999854
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=317.67 Aligned_cols=241 Identities=31% Similarity=0.467 Sum_probs=195.1
Q ss_pred CCCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-eeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
|.....||+|++.... ....+.|.+|+.+|++++|||||+++|++.... .+++||||+++|+|.+++... .+..++
T Consensus 62 ~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~ 140 (362)
T KOG0192|consen 62 WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLP 140 (362)
T ss_pred eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCC
Confidence 4433349999997553 223679999999999999999999999999887 799999999999999999654 467799
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccccccceeeccccccCchhc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
+..++.|+.+|+.|+.|||+++. |+||||||+|||++.++ ++||+|||+++...... .......||..|||||++
T Consensus 141 ~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~ 216 (362)
T KOG0192|consen 141 LKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVL 216 (362)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhh
Confidence 99999999999999999998774 89999999999999997 99999999998765432 112225689999999999
Q ss_pred c--cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 159 R--QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 159 ~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
. ...++.++||||||+++|||+||..||..... ..........+....+... ....+..++..
T Consensus 217 ~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~~---------~~~~l~~l~~~ 281 (362)
T KOG0192|consen 217 RGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPKE---------CPPHLSSLMER 281 (362)
T ss_pred cCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCcc---------CCHHHHHHHHH
Confidence 9 56899999999999999999999999954332 2223333333333332222 33478899999
Q ss_pred cccCCCCCCCCHHHHHHhhccCCCCCC
Q 045452 237 CVQENPNDRPSMLEVSSMLKNETTNTN 263 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~~~~~~~~ 263 (303)
||..||+.||++.+++..|+.......
T Consensus 282 CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred hCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 999999999999999999998765443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=302.01 Aligned_cols=238 Identities=22% Similarity=0.325 Sum_probs=192.4
Q ss_pred CCCCCEEEEEEcc--CCChhhHHHHHHHHHHHhcCCCCcceeEEE-EEEeCC-eeeEEEeeCCCCChhhhhcCc-CcccC
Q 045452 3 LPCGEVIAVKKLS--KSSAQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDSE-ERMLVYEYMPNKSLDCYLFDP-IRRLI 77 (303)
Q Consensus 3 l~~g~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~-~~~lv~e~~~~~sL~~~l~~~-~~~~~ 77 (303)
+.+|+.||.|.+. ..+....+.+..|+.+|++|+|||||++++ .+..++ .++||||||.+|+|.+.++.. ..+..
T Consensus 41 ~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ 120 (375)
T KOG0591|consen 41 LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRL 120 (375)
T ss_pred ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhcccc
Confidence 5789999999986 335567788999999999999999999998 444444 489999999999999998652 34667
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcC-CCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~-~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+++..+|+++.|++.||.++|..- ++-|+||||||.|||++.+|.|||+|||+++.+.+.. ......+||+.||+||
T Consensus 121 ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE 198 (375)
T KOG0591|consen 121 IPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPE 198 (375)
T ss_pred CchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHH
Confidence 999999999999999999999832 2349999999999999999999999999999887653 3334478999999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
++.+..|+.++||||+||++|||+..+.||... +......++..+.. + .-....++..+.+||..
T Consensus 199 ~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~-~--------~~p~~~YS~~l~~li~~ 263 (375)
T KOG0591|consen 199 RIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDY-P--------PLPDEHYSTDLRELINM 263 (375)
T ss_pred HHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCC-C--------CCcHHHhhhHHHHHHHH
Confidence 999999999999999999999999999999533 33333333333321 1 11124566789999999
Q ss_pred cccCCCCCCCCHHHHHHhhcc
Q 045452 237 CVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~~ 257 (303)
|+..||+.||+...+++.++.
T Consensus 264 ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 264 CIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HccCCcccCCCcchHHHHHHH
Confidence 999999999986666555554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=304.94 Aligned_cols=226 Identities=31% Similarity=0.410 Sum_probs=184.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++|..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++.+|+|||||.||+|.+|++ +++.+++.
T Consensus 33 ~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~---~~~~l~e~ 109 (429)
T KOG0595|consen 33 KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR---RRGRLPEA 109 (429)
T ss_pred cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH---HcCCCCHH
Confidence 56799999999766 56778889999999999999999999999999999999999999999999995 45579999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC------CcEEEecccccccccccccccccceeeccccccCc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED------MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~------~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
.+..++.||+.||++||+++ |+||||||+|||++.. ..+||+|||+++.+.+ .....+.+|++.||||
T Consensus 110 t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~---~~~a~tlcGSplYMAP 183 (429)
T KOG0595|consen 110 TARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP---GSMAETLCGSPLYMAP 183 (429)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc---hhHHHHhhCCccccCH
Confidence 99999999999999999999 9999999999999865 5689999999998874 3444557899999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|++....|+.|+|+||+|+|+|++++|..||......+... ..-.+........... ...+++++.
T Consensus 184 EV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~------~~~k~~~~~~~~~~~~--------s~~~~~Ll~ 249 (429)
T KOG0595|consen 184 EVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL------YIKKGNEIVPVLPAEL--------SNPLRELLI 249 (429)
T ss_pred HHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhccccccCchhhhc--------cCchhhhhh
Confidence 99999999999999999999999999999996554433222 2122222222222211 224456777
Q ss_pred hcccCCCCCCCCHHHHH
Q 045452 236 LCVQENPNDRPSMLEVS 252 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~ 252 (303)
..+..+|.+|-+..+..
T Consensus 250 ~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 250 SLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHHhcCccccCchHHhh
Confidence 77777777777666543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=313.86 Aligned_cols=257 Identities=43% Similarity=0.709 Sum_probs=216.1
Q ss_pred CcCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-eeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 1 g~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
|++++|+.||||.+.........+|.+|+.++.+++|||+|+++|||.+.+ +.+||+||+++|+|.++|+..... .++
T Consensus 94 G~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~ 172 (361)
T KOG1187|consen 94 GVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLD 172 (361)
T ss_pred EEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCC
Confidence 678999999999886654331455999999999999999999999999988 599999999999999999764333 899
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccccee-eccccccCchhc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV-VGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~ 158 (303)
|..+++|+.++|.||+|||+.....|+|||||++|||+|.+.+.||+|||++...... ....... .||..|+|||+.
T Consensus 173 W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 173 WETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYA 250 (361)
T ss_pred HHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhh
Confidence 9999999999999999999977667999999999999999999999999999544321 1111112 689999999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccccccc-CCCCh-HHHHHHHHHHHh
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLD-DRNSS-CKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~ 236 (303)
..+..+.++||||||+++.||++|+.+..............+....+......+++++.+. ..... .....+..+..+
T Consensus 251 ~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~ 330 (361)
T KOG1187|consen 251 STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALR 330 (361)
T ss_pred ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHH
Confidence 8888999999999999999999999887655544445577777788888888889998876 44443 566779999999
Q ss_pred cccCCCCCCCCHHHHHHhhccCCC
Q 045452 237 CVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
|++.+|.+||++.++++.|+....
T Consensus 331 C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 331 CLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999999999999965543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=318.54 Aligned_cols=241 Identities=34% Similarity=0.486 Sum_probs=198.5
Q ss_pred CcCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 g~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
|.|.....||+|.++... ...+.|.+|+.+|++|+|++||+++++|...+.++|||||++.|+|.++|+. ..+..+..
T Consensus 225 g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~ 302 (468)
T KOG0197|consen 225 GKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNL 302 (468)
T ss_pred EEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cCCCccch
Confidence 567777899999997653 3446788999999999999999999999998899999999999999999976 34667899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
...+.++.||++|++||++++ +|||||..+||||+.+..+||+|||+++......+..... ..-...|.|||.+..
T Consensus 303 ~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~kfPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 303 PQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GKFPIKWTAPEALNY 378 (468)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CCCCceecCHHHHhh
Confidence 999999999999999999999 9999999999999999999999999999665544433322 223679999999999
Q ss_pred CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..++.+|||||||+++|||+| |+.|+..-...+..+.++ .+. +-..|...+.++++|+..||+
T Consensus 379 ~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~Gy---------Rlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 379 GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RGY---------RLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------ccC---------cCCCCCCCCHHHHHHHHHHhh
Confidence 999999999999999999998 777765433333222222 222 222333445589999999999
Q ss_pred CCCCCCCCHHHHHHhhccCCCCCC
Q 045452 240 ENPNDRPSMLEVSSMLKNETTNTN 263 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~~~~~~ 263 (303)
.+|++|||++.+...|++..+...
T Consensus 443 ~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 443 EDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCcccCCCHHHHHHHHHHhhhccc
Confidence 999999999999999998876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=298.50 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=190.7
Q ss_pred CCCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 3 LPCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+.+++||||+++-... ...+.+.+|+..++.++||||++++..|..+..+|+||+||.+||+.+.+...-.. .+++.
T Consensus 48 ~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~-Gl~E~ 126 (516)
T KOG0582|consen 48 IPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPD-GLEEA 126 (516)
T ss_pred cccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccc-cccHH
Confidence 46789999999975543 34689999999999999999999999999999999999999999999999764443 39999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc-ccccc-ceeeccccccCchhcc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES-LKANT-EQVVGTIGYIPPEYAR 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~-~~~~~-~~~~~~~~y~aPE~~~ 159 (303)
.+..+++++++||.|||++| .+|||||+.|||++.+|.|||+|||.+..+.... ..... .++.|+++|+|||++.
T Consensus 127 ~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 127 SIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred HHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhh
Confidence 99999999999999999999 9999999999999999999999999886554322 12222 5678999999999853
Q ss_pred --cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
...|+.|+||||||+...||.+|..||... ..+........+..... .-..............++++|..|
T Consensus 204 q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~------pPmkvLl~tLqn~pp~~-~t~~~~~d~~k~~~ksf~e~i~~C 276 (516)
T KOG0582|consen 204 QQLHGYDFKADIWSFGITACELAHGHAPFSKY------PPMKVLLLTLQNDPPTL-LTSGLDKDEDKKFSKSFREMIALC 276 (516)
T ss_pred hcccCccchhhhhhhhHHHHHHhcCCCCcccC------ChHHHHHHHhcCCCCCc-ccccCChHHhhhhcHHHHHHHHHH
Confidence 346999999999999999999999999532 22222222222222111 122223333334455789999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 045452 238 VQENPNDRPSMLEVSS 253 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~ 253 (303)
|.+||.+|||+++++.
T Consensus 277 L~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 277 LVKDPSKRPTASKLLK 292 (516)
T ss_pred hhcCcccCCCHHHHhc
Confidence 9999999999999963
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=309.82 Aligned_cols=229 Identities=25% Similarity=0.373 Sum_probs=194.9
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
..+++.||||.+........+.+.+|+.+|+..+|+|||.+++.|..++.+|+||||++||+|.+.+ .+..+++.+
T Consensus 295 ~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV----t~~~~~E~q 370 (550)
T KOG0578|consen 295 ISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV----TKTRMTEGQ 370 (550)
T ss_pred ccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh----hcccccHHH
Confidence 3578889999997666666678899999999999999999999999999999999999999999998 556699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++++++.||+|||..| |+|||||.+|||++.+|.+||+|||++..+..... .....+||+.|||||+.....
T Consensus 371 IA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 371 IAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred HHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcc
Confidence 9999999999999999999 99999999999999999999999999987765432 455678999999999999999
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
|..+.||||||++++||+-|++||... ..+...+.+...+.. ....+...+..+.+++.+||..|+
T Consensus 446 YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLIa~ng~P--------~lk~~~klS~~~kdFL~~cL~~dv 511 (550)
T KOG0578|consen 446 YGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLIATNGTP--------KLKNPEKLSPELKDFLDRCLVVDV 511 (550)
T ss_pred cCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHHhhcCCC--------CcCCccccCHHHHHHHHHHhhcch
Confidence 999999999999999999999999642 223333333332211 122334445589999999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
.+||++.+||+.
T Consensus 512 ~~RasA~eLL~H 523 (550)
T KOG0578|consen 512 EQRASAKELLEH 523 (550)
T ss_pred hcCCCHHHHhcC
Confidence 999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=295.84 Aligned_cols=231 Identities=26% Similarity=0.377 Sum_probs=183.5
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--eeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+|+..|||..........+.+.+|+.++++++|||||+++|.....+ .++++|||+++|+|.+++.... + .+++..
T Consensus 41 ~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g-~-~l~E~~ 118 (313)
T KOG0198|consen 41 TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYG-G-KLPEPL 118 (313)
T ss_pred CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcC-C-CCCHHH
Confidence 48899999986654333678999999999999999999999855544 6899999999999999996532 1 699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccc-cccccccceeeccccccCchhccc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAK-ESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
+..+..||+.||+|||++| ++||||||+|||++. ++.+||+|||++..... ...........||+.|+|||++.+
T Consensus 119 v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 119 VRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC
Confidence 9999999999999999998 999999999999999 79999999999877654 222233344679999999999985
Q ss_pred C-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 G-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
. ....++|||||||++.||+||..||... ................+.+.. ..+.+..+++.+|+.
T Consensus 196 g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip~---------~ls~~a~~Fl~~C~~ 261 (313)
T KOG0198|consen 196 GEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIPD---------SLSDEAKDFLRKCFK 261 (313)
T ss_pred CCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCCc---------ccCHHHHHHHHHHhh
Confidence 3 3335999999999999999999999643 222233333333332222221 123478899999999
Q ss_pred CCCCCCCCHHHHHHh
Q 045452 240 ENPNDRPSMLEVSSM 254 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~ 254 (303)
.||+.|||++++++.
T Consensus 262 ~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 262 RDPEKRPTAEELLEH 276 (313)
T ss_pred cCcccCcCHHHHhhC
Confidence 999999999999976
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=287.18 Aligned_cols=241 Identities=21% Similarity=0.277 Sum_probs=183.7
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++|+.||||++... ++...+-.++|++++++|+|+|+|.++.+|.....+++|+|||+..-| +-|... -..++..
T Consensus 25 ~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL-~eLe~~--p~G~~~~ 101 (396)
T KOG0593|consen 25 DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL-HELERY--PNGVPSE 101 (396)
T ss_pred CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH-HHHHhc--cCCCCHH
Confidence 68999999999654 345567788999999999999999999999999999999999976544 444332 3348889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 160 (303)
.+..++.|++.|+.|+|.++ ++||||||+|||++.+|.+||||||+++.+... ...-..-+.|.+|+|||.+.+
T Consensus 102 ~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~YTDYVATRWYRaPELLvGD 176 (396)
T KOG0593|consen 102 LVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNYTDYVATRWYRAPELLVGD 176 (396)
T ss_pred HHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--cchhhhhhhhhhccChhhhccc
Confidence 99999999999999999988 999999999999999999999999999987632 122222467999999998877
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHH--------HHHHHhhCC------CccccccccccCCCChHH
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE--------HAYELWKGG------KGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 226 (303)
..|....|||++||++.||++|++.|...+..+.+..+. .....+... ..++..+...-....+..
T Consensus 177 tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~ 256 (396)
T KOG0593|consen 177 TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKI 256 (396)
T ss_pred CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccc
Confidence 679999999999999999999999987655444332222 111222211 111111111111111122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHH
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~ 252 (303)
+.-+.+++.+||+.||.+|++-++++
T Consensus 257 s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 257 SNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred hHHHHHHHHHHhcCCccccccHHHHh
Confidence 33678999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=291.33 Aligned_cols=219 Identities=25% Similarity=0.327 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
++|+.+|+|++++.. ....+..+.|..++..++||+||+++-.|.+.+.+|+|++|+.||.|.-.|+ +.+.+++
T Consensus 48 dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~---~eg~F~E 124 (357)
T KOG0598|consen 48 DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ---REGRFSE 124 (357)
T ss_pred ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH---hcCCcch
Confidence 689999999997542 3456778899999999999999999999999999999999999999998884 4667999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+.-++.+|+.||.|||+.| |+||||||+|||++.+|+++|+|||++...... .....+++||+.|+|||++.+
T Consensus 125 ~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 125 DRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred hHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCccccChHHHhc
Confidence 999999999999999999999 999999999999999999999999999754322 333445899999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++..+|+||||+++|+|++|.+||...+..... ....... ....+...+.+.++++.++|+.
T Consensus 200 ~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------~~I~~~k----------~~~~p~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 200 KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------DKILKGK----------LPLPPGYLSEEARDLLKKLLKR 263 (357)
T ss_pred CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH------HHHhcCc----------CCCCCccCCHHHHHHHHHHhcc
Confidence 99999999999999999999999999654432211 1111111 0111112334788999999999
Q ss_pred CCCCCC
Q 045452 241 NPNDRP 246 (303)
Q Consensus 241 dp~~Rp 246 (303)
||++|.
T Consensus 264 dp~~RL 269 (357)
T KOG0598|consen 264 DPRQRL 269 (357)
T ss_pred CHHHhc
Confidence 999995
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=302.04 Aligned_cols=229 Identities=24% Similarity=0.302 Sum_probs=189.1
Q ss_pred CCCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 3 LPCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 l~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
..+++.+|||++... ...-.+.+..|-..|.+| +||+|+++|-.|.+...+|+|+||+++|.|.++|. +-+.+
T Consensus 95 ~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~---K~Gsf 171 (604)
T KOG0592|consen 95 KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK---KYGSF 171 (604)
T ss_pred cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH---HhCcc
Confidence 368899999998543 223345677899999999 99999999999999999999999999999999994 45679
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc---------cc--cceee
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK---------AN--TEQVV 147 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~---------~~--~~~~~ 147 (303)
++.-...++.+|+.||+|||.+| ||||||||+|||++++|+++|.|||.+..+...... .. ...++
T Consensus 172 de~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFV 248 (604)
T KOG0592|consen 172 DETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFV 248 (604)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccccee
Confidence 99999999999999999999999 999999999999999999999999999887543211 11 24589
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
||..|++||++.....+..+|+|+||||+|+|+.|++||...+.-...+.+...... .+...+
T Consensus 249 GTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~-----------------fp~~fp 311 (604)
T KOG0592|consen 249 GTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE-----------------FPEGFP 311 (604)
T ss_pred eeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-----------------CCCCCC
Confidence 999999999999999999999999999999999999999755543333322222111 122222
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..+.+||.+.|..||++|+|+.+|.+.
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhC
Confidence 467899999999999999999999754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=295.84 Aligned_cols=224 Identities=25% Similarity=0.352 Sum_probs=183.5
Q ss_pred CCCCEEEEEEccCC----Ch-hhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKS----SA-QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.. .. ...+.+.+|+.+++.++ ||||+++++++......++||||+.||.|.+++. ..+.
T Consensus 40 ~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~---~~g~ 116 (370)
T KOG0583|consen 40 LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV---NKGR 116 (370)
T ss_pred cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH---HcCC
Confidence 46799999987653 12 23557778999999998 9999999999999999999999999999999994 3567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+.+.....++.|++.|++|||+.| |+||||||+||+++.+ +++||+|||++.... .......+.+|++.|+|||
T Consensus 117 l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPE 191 (370)
T KOG0583|consen 117 LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPE 191 (370)
T ss_pred CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHH
Confidence 889999999999999999999999 9999999999999999 999999999998763 2234455678999999999
Q ss_pred hcccCC-CC-CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH-HHHHHHH
Q 045452 157 YARQGV-YS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK-LMRCLEI 233 (303)
Q Consensus 157 ~~~~~~-~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l 233 (303)
++.+.. |+ .++||||+|+++|.|++|..||... ........+..+.. . .+... +.++..|
T Consensus 192 vl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~~~~--~---------~p~~~~S~~~~~L 254 (370)
T KOG0583|consen 192 VLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRKGEF--K---------IPSYLLSPEARSL 254 (370)
T ss_pred HhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhcCCc--c---------CCCCcCCHHHHHH
Confidence 999877 76 6899999999999999999999642 11121222222111 0 11111 3478899
Q ss_pred HHhcccCCCCCCCCHHHHH
Q 045452 234 ALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~ 252 (303)
+.+||..||.+|+|+.+++
T Consensus 255 i~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 255 IEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHcCCCcccCCCHHHHh
Confidence 9999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=301.82 Aligned_cols=225 Identities=27% Similarity=0.380 Sum_probs=186.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.+|||++... .......+.+|+-+|+.+.|||++++|+++++..++|+|.||++||-|.+++ ..++++++
T Consensus 35 ~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdyl---v~kG~l~e 111 (786)
T KOG0588|consen 35 ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYL---VRKGPLPE 111 (786)
T ss_pred cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHH---HhhCCCCC
Confidence 68999999999654 2334567889999999999999999999999999999999999999999998 46778999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
....++++||+.|+.|+|..+ |||||+||+|+|++..+++||+|||+|..-.. .....+.||+++|.|||++.+
T Consensus 112 ~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---gklLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 112 REAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP---GKLLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred HHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC---CccccccCCCcccCCchhhcC
Confidence 999999999999999999999 99999999999999999999999999865333 334455789999999999999
Q ss_pred CCCC-CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
.+|+ .++||||+|+|+|.|++|..||...+....+ . +...+.. ..|...+.++.+||.+||.
T Consensus 186 ~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL---l---KV~~G~f-----------~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 186 RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL---L---KVQRGVF-----------EMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH---H---HHHcCcc-----------cCCCcCCHHHHHHHHHHhc
Confidence 9875 5899999999999999999999633222111 1 1111111 1112223478899999999
Q ss_pred CCCCCCCCHHHHHHh
Q 045452 240 ENPNDRPSMLEVSSM 254 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~ 254 (303)
.||++|.|+++|++.
T Consensus 249 VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 249 VDPSTRITTEEILKH 263 (786)
T ss_pred cCccccccHHHHhhC
Confidence 999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=312.84 Aligned_cols=238 Identities=32% Similarity=0.478 Sum_probs=200.7
Q ss_pred CCCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-------c-
Q 045452 4 PCGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------R- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~- 74 (303)
++...||||.++..... ..++|++|++++..|+|||||+++|+|..++..|+|+|||..|+|..+|.... .
T Consensus 514 ~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g 593 (774)
T KOG1026|consen 514 QDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASG 593 (774)
T ss_pred ccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCC
Confidence 45678999999877655 78899999999999999999999999999999999999999999999996521 1
Q ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccc
Q 045452 75 ---RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 75 ---~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
..+++..+.+.++.|||.|+.||-+++ ++||||-.+|+||.++-.|||+|||+++.+.+.++........-..+
T Consensus 594 ~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIR 670 (774)
T KOG1026|consen 594 QDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIR 670 (774)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeee
Confidence 223889999999999999999999998 99999999999999999999999999999887777666644555889
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|||||.+..+.|+.++||||+|+++||+++ |..||......+. .+....+.. -..|...+.++
T Consensus 671 WMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------Ie~i~~g~l---------L~~Pe~CP~~v 734 (774)
T KOG1026|consen 671 WMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------IECIRAGQL---------LSCPENCPTEV 734 (774)
T ss_pred cCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------HHHHHcCCc---------ccCCCCCCHHH
Confidence 999999999999999999999999999997 7788754433322 222222222 23344445689
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 231 LEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
++|+..||+.+|.+||+++||-.+|+....
T Consensus 735 Y~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 735 YSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999988553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=295.82 Aligned_cols=242 Identities=25% Similarity=0.275 Sum_probs=186.9
Q ss_pred CCCCCEEEEEEccCCChhhHHH-HHHHHHHHhcCC-CCcceeEEEEEEeCC-eeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQ-HVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~-~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
..+|+.||||.++.......+. =.+|+..|++|+ ||||+++.+++.+.+ .+++||||| ..+|.++++++ +..++
T Consensus 32 ~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R--~r~fs 108 (538)
T KOG0661|consen 32 KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR--NRLFS 108 (538)
T ss_pred cCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc--CCcCC
Confidence 4688999999997764432221 237999999997 999999999998887 999999999 56899999763 77899
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc-
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA- 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~- 158 (303)
+..+..|+.||+.||+|+|.+| +.|||+||+|||+.++..+||+|||+|+.+.+..... .-+.|.+|+|||++
T Consensus 109 e~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT---eYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 109 ESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT---EYVSTRWYRAPEVLL 182 (538)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCCcc---hhhhcccccchHHhh
Confidence 9999999999999999999999 9999999999999999999999999999886553222 23569999999976
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC--------------CccccccccccCCCCh
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG--------------KGMEFVDSFLDDRNSS 224 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~ 224 (303)
+...|+.+.|+|++|||++|+.+.++.|...+..+....+-......... ..+......+.. ..+
T Consensus 183 rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~-L~p 261 (538)
T KOG0661|consen 183 RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKD-LLP 261 (538)
T ss_pred hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHH-hCc
Confidence 55679999999999999999999999987655444333322221111100 011111111111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..+.++.++|.+||..||.+|||+.+.++.
T Consensus 262 ~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 262 NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 144578899999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.06 Aligned_cols=229 Identities=21% Similarity=0.281 Sum_probs=182.4
Q ss_pred CCCEEEEEEccCCChh---hHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 5 CGEVIAVKKLSKSSAQ---GFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
+|+.||||.++..... ..+.+.+|+.++++++||||+++++++.+ ....+++|||+++|+|.+++.. ...
T Consensus 42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~ 118 (283)
T PHA02988 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKD 118 (283)
T ss_pred CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCC
Confidence 6889999999755332 35778899999999999999999999876 3467999999999999999853 456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+++.....++.+++.||.+||.. + ++||||||+||+++.++.+||+|||++..+.... ....++..|+|||
T Consensus 119 ~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE 190 (283)
T PHA02988 119 LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYK 190 (283)
T ss_pred CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHH
Confidence 88899999999999999999984 6 8899999999999999999999999987654321 1235688999999
Q ss_pred hccc--CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 157 YARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 157 ~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+.+ ..++.++|||||||++|+|++|..||....... .. ........... .+...+..+.+++
T Consensus 191 ~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~---~~i~~~~~~~~---------~~~~~~~~l~~li 255 (283)
T PHA02988 191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IY---DLIINKNNSLK---------LPLDCPLEIKCIV 255 (283)
T ss_pred HhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHhcCCCCC---------CCCcCcHHHHHHH
Confidence 9876 678999999999999999999999996432111 11 11111111111 1112244788999
Q ss_pred HhcccCCCCCCCCHHHHHHhhccCC
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.+||+.||++|||+.++++.|++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999999999998765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=265.25 Aligned_cols=244 Identities=24% Similarity=0.274 Sum_probs=184.8
Q ss_pred CCCCCEEEEEEccCCChh--hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKSSAQ--GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.++|+.||||+++..... .-....+|+..++.++|+||+.++++|.+...+.+|+||++ .+|...+++ +...++.
T Consensus 24 ~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd--~~i~l~p 100 (318)
T KOG0659|consen 24 TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD--KNIILSP 100 (318)
T ss_pred cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc--cccccCH
Confidence 478999999999755322 23456789999999999999999999999999999999995 589888865 4667899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.|+.+++.|++|||... |+||||||.|+|++.+|.+||+|||+++.+......... .+-|.+|+|||.+-+
T Consensus 101 a~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~--~V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 101 ADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH--QVVTRWYRAPELLFG 175 (318)
T ss_pred HHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccccc--ceeeeeccChHHhcc
Confidence 999999999999999999999 999999999999999999999999999988754332222 266999999997755
Q ss_pred C-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccc-----------cccccccCCCChHHHH
Q 045452 161 G-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGME-----------FVDSFLDDRNSSCKLM 228 (303)
Q Consensus 161 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~ 228 (303)
. .|+...|+||.|||+.||+-|.+-|...+..+....+-...........++ ...........+..+.
T Consensus 176 sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~ 255 (318)
T KOG0659|consen 176 SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASS 255 (318)
T ss_pred chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccH
Confidence 4 699999999999999999998877654433332222221111111111000 0000011112222334
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
++.+|+.+||..||.+|+|+.++++.
T Consensus 256 d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 256 DALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHHHhhhccCchhcccHHHHhcc
Confidence 66899999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.09 Aligned_cols=231 Identities=23% Similarity=0.293 Sum_probs=189.0
Q ss_pred CCCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
-.+|+++|+|+++... ....+.++.|-.+|....+++||++|-.|.+.+.+||||||++||++..+| .+...++
T Consensus 163 k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL---~~~~~L~ 239 (550)
T KOG0605|consen 163 KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL---MRKDTLT 239 (550)
T ss_pred ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHH---HhcCcCc
Confidence 3689999999998664 345677888999999999999999999999999999999999999999998 4677899
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccc----------------------c
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAK----------------------E 137 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~----------------------~ 137 (303)
+..+..++.+.+.|+..||+.| ++||||||+|+|||..|++||.|||++.-+.. .
T Consensus 240 e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (550)
T KOG0605|consen 240 EDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPS 316 (550)
T ss_pred hHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCc
Confidence 9999999999999999999999 99999999999999999999999999843211 0
Q ss_pred cccc----c-------------------cceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCcc
Q 045452 138 SLKA----N-------------------TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 194 (303)
Q Consensus 138 ~~~~----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 194 (303)
.... . ....+||+.|+|||++.+..|+..+|+||||||||||+.|-+||-.....+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 317 DFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET 396 (550)
T ss_pred cccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0000 0 1123699999999999999999999999999999999999999976666555
Q ss_pred ccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 045452 195 LSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS---MLEVSS 253 (303)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~l~~ 253 (303)
...+......+........ +.+..+||.+||. ||++|.- ++||.+
T Consensus 397 ~rkI~nwr~~l~fP~~~~~-------------s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 397 YRKIVNWRETLKFPEEVDL-------------SDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHhhhccCCCcCcc-------------cHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 5555544444432221111 1478899999999 9999985 556543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=280.79 Aligned_cols=224 Identities=24% Similarity=0.367 Sum_probs=187.4
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..|+.||||.++.+ +......+++|+++|..|+||||+.+|.+|++.+...|||||..+|.|.+|+. ..+.+++
T Consensus 76 ~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS---er~~LsE 152 (668)
T KOG0611|consen 76 KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS---ERGSLSE 152 (668)
T ss_pred cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH---HhccccH
Confidence 57999999999765 34556678899999999999999999999999999999999999999999994 4667999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.....+++||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+.. .....+++|++.|.+||++.+
T Consensus 153 rEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 153 REARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred HHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc---ccHHHHhcCCcccCCccccCC
Confidence 999999999999999999988 99999999999999999999999999987654 334456899999999999999
Q ss_pred CCCC-CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
.+|. +..|.||||+++|-|+.|..||...... ....+...+...+... +....-||++||.
T Consensus 227 ~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP~~-----------PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 227 TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREPET-----------PSDASGLIRWMLM 288 (668)
T ss_pred CCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCCCC-----------CchHHHHHHHHHh
Confidence 9875 5799999999999999999999543321 1222233332222111 1134579999999
Q ss_pred CCCCCCCCHHHHHHh
Q 045452 240 ENPNDRPSMLEVSSM 254 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~ 254 (303)
.||+.|.|+++|...
T Consensus 289 VNP~RRATieDiAsH 303 (668)
T KOG0611|consen 289 VNPERRATIEDIASH 303 (668)
T ss_pred cCcccchhHHHHhhh
Confidence 999999999999754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=288.82 Aligned_cols=239 Identities=29% Similarity=0.431 Sum_probs=183.2
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC-eeeEEEeeCCCCChhhhhcCcCc------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~------ 74 (303)
.+++.||+|+++... ......+.+|+.+++.+ +||||+++++++...+ ..+++|||+++|+|.+++.....
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~ 114 (338)
T cd05102 35 SSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYR 114 (338)
T ss_pred ccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhccccc
Confidence 346789999997543 33456789999999999 8999999999887644 58899999999999988864211
Q ss_pred -----------------------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcC
Q 045452 75 -----------------------------------------------------RLILDWKKRVHIIEGITQGLLYLQEYS 101 (303)
Q Consensus 75 -----------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~ 101 (303)
...+++..+..++.||+.||+|||+.|
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 194 (338)
T cd05102 115 EKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK 194 (338)
T ss_pred ccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 134778889999999999999999998
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHh
Q 045452 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181 (303)
Q Consensus 102 ~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 181 (303)
++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 195 ---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 195 ---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred ---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 99999999999999999999999999876533221112222335678999999988889999999999999999997
Q ss_pred -CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 182 -GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 182 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
|..||........ . ......+.... .+...+.++.+|+.+||..||.+|||+.++++.|+....
T Consensus 272 ~g~~pf~~~~~~~~---~---~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 272 LGASPYPGVQINEE---F---CQRLKDGTRMR---------APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCCCCccHH---H---HHHHhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999854322111 1 11111111111 111223478899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=284.49 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=183.5
Q ss_pred CCCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 3 LPCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
+.+|+.||+|+++.+. ........+||.+|++|+||||+++.++.... ..+|+|+|||+. +|..++.. ....+
T Consensus 139 ~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~--p~vkf 215 (560)
T KOG0600|consen 139 LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS--PGVKF 215 (560)
T ss_pred cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC--CCccc
Confidence 5789999999997554 34455667899999999999999999999876 689999999965 67777643 34569
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++.+++-++.||+.||.|||..| |+|||||.+||||+.+|.+||+|||+++++....... ....+-|.+|+|||.+
T Consensus 216 t~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 216 TEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELL 291 (560)
T ss_pred ChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHh
Confidence 99999999999999999999999 9999999999999999999999999999876544332 2235679999999988
Q ss_pred ccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC-------ccccccccccCCC-C------
Q 045452 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-------GMEFVDSFLDDRN-S------ 223 (303)
Q Consensus 159 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~-~------ 223 (303)
.+. .|+.+.|+||+|||+.||++|++.|......+. ++...+...... .......+..... .
T Consensus 292 LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~ 368 (560)
T KOG0600|consen 292 LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET 368 (560)
T ss_pred cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH
Confidence 766 599999999999999999999998864443332 222222211110 0000011111000 0
Q ss_pred -hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 224 -SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 224 -~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...+....+|+..+|..||.+|.|+.++++
T Consensus 369 ~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 369 FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111235679999999999999999998874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=289.19 Aligned_cols=230 Identities=26% Similarity=0.353 Sum_probs=192.2
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||+|++.-. .....+.+++|+.++.+++++||.++|+.+..+..++++||||.||++.+.+. .+..+++..
T Consensus 36 ~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~---~~~~~~E~~ 112 (467)
T KOG0201|consen 36 KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK---SGNILDEFE 112 (467)
T ss_pred cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc---cCCCCccce
Confidence 57899999999755 34567889999999999999999999999999999999999999999999984 344458889
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+.-++++++.|+.|||..+ .+|||||+.||++..+|.+||+|||.+..+.... .+..+++||+.|||||++.+..
T Consensus 113 i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~ 187 (467)
T KOG0201|consen 113 IAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSG 187 (467)
T ss_pred eeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhcccc
Confidence 9999999999999999999 9999999999999999999999999998776543 3337789999999999999989
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
|+.++||||||++.+||++|.+|+......... -++....+.......+..+.+++..||.+||
T Consensus 188 Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 188 YDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSAPPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred ccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 999999999999999999999998543332211 1222222222223344568899999999999
Q ss_pred CCCCCHHHHHH--hhcc
Q 045452 243 NDRPSMLEVSS--MLKN 257 (303)
Q Consensus 243 ~~Rps~~~l~~--~L~~ 257 (303)
+.||+|.++++ +++.
T Consensus 252 ~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 252 EFRPSAKELLKHKFIKR 268 (467)
T ss_pred ccCcCHHHHhhhHHHHh
Confidence 99999999974 4555
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=288.63 Aligned_cols=228 Identities=26% Similarity=0.344 Sum_probs=191.0
Q ss_pred CCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe-eeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 5 CGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+++.+|+|+++... ........+|+.++++++|||||.+.+.|..++. .+|||+||+||++.+.+... ++..+++.
T Consensus 28 ~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~-k~~~f~E~ 106 (426)
T KOG0589|consen 28 DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ-KGVLFPEE 106 (426)
T ss_pred CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH-hhccccHH
Confidence 56789999987553 3344567889999999999999999999999988 99999999999999998763 36779999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..|+.|++.|+.|||+.+ |+|||||+.|||++.++.|+|+|||++..+.... .....-.||+.|++||++.+.
T Consensus 107 ~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~ 181 (426)
T KOG0589|consen 107 RILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDI 181 (426)
T ss_pred HHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCC
Confidence 99999999999999999888 9999999999999999999999999999887543 234456899999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
+|..++|||||||++|||++.+++|...+... -..+...+. ....+..++.++..+|..||..+
T Consensus 182 pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~~----------~~Plp~~ys~el~~lv~~~l~~~ 245 (426)
T KOG0589|consen 182 PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRGL----------YSPLPSMYSSELRSLVKSMLRKN 245 (426)
T ss_pred CCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhcc----------CCCCCccccHHHHHHHHHHhhcC
Confidence 99999999999999999999999985443222 112222211 22334455668999999999999
Q ss_pred CCCCCCHHHHHHh
Q 045452 242 PNDRPSMLEVSSM 254 (303)
Q Consensus 242 p~~Rps~~~l~~~ 254 (303)
|..||++.+++..
T Consensus 246 P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 246 PEHRPSALELLRR 258 (426)
T ss_pred CccCCCHHHHhhC
Confidence 9999999999755
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.09 Aligned_cols=241 Identities=26% Similarity=0.418 Sum_probs=182.1
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 73 (303)
++..||+|.++.. .......+.+|+.++.+++||||+++++++.+....+++|||+.+++|.+++....
T Consensus 45 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (304)
T cd05096 45 RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124 (304)
T ss_pred cceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccc
Confidence 3457999998754 34456789999999999999999999999999999999999999999998875421
Q ss_pred ------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee
Q 045452 74 ------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 74 ------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+.............
T Consensus 125 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~ 201 (304)
T cd05096 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAV 201 (304)
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCC
Confidence 1134677889999999999999999998 9999999999999999999999999987654332222222334
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHh--CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC 225 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
++..|+|||.+.+..++.++||||||+++|+|++ +..||....... .............. ... ...+..
T Consensus 202 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~-~~~-----~~~~~~ 272 (304)
T cd05096 202 LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQGR-QVY-----LFRPPP 272 (304)
T ss_pred CCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhccc-ccc-----ccCCCC
Confidence 5778999999988889999999999999999987 455664332211 11111111111100 000 011112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
.+..+.+|+.+||..||++|||+.+|.+.|++
T Consensus 273 ~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 273 CPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 23478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=262.91 Aligned_cols=241 Identities=26% Similarity=0.287 Sum_probs=190.5
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhcCc-Cccc
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDP-IRRL 76 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~-~~~~ 76 (303)
+.+++.+|+|++.....+..+..++|++..++++|||+++++++...+. ..|++++|...|||.+.+... .++.
T Consensus 43 ~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~ 122 (302)
T KOG2345|consen 43 LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN 122 (302)
T ss_pred cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCC
Confidence 4678999999999888888899999999999999999999998875443 489999999999999988763 3455
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-------cccceeecc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-------ANTEQVVGT 149 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-------~~~~~~~~~ 149 (303)
.+++.++++|+.+|.+||++||+... +++||||||.||++++.+.+++.|||.+....-.... .......++
T Consensus 123 ~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct 201 (302)
T KOG2345|consen 123 FVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCT 201 (302)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCC
Confidence 89999999999999999999998763 6999999999999999999999999998764321100 011123468
Q ss_pred ccccCchhcccC---CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc-cccccCCCChH
Q 045452 150 IGYIPPEYARQG---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV-DSFLDDRNSSC 225 (303)
Q Consensus 150 ~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 225 (303)
..|+|||.+.-+ ..+.++|||||||++|.|+.|.-||..... .++...--+ ...........
T Consensus 202 ~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------------~GgSlaLAv~n~q~s~P~~~~ 267 (302)
T KOG2345|consen 202 IPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------------QGGSLALAVQNAQISIPNSSR 267 (302)
T ss_pred CcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------------cCCeEEEeeeccccccCCCCC
Confidence 999999998655 467899999999999999999999842211 222211111 11122222233
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
.++.+.++|.+||+.||.+||++.+++..+.++
T Consensus 268 yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 268 YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 567899999999999999999999999988764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=265.43 Aligned_cols=214 Identities=25% Similarity=0.322 Sum_probs=181.8
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|..+|+|+++... ....+...+|..+|+.+.||+++++++.+.+...+++||||.+||.|..+++ +.+.+++
T Consensus 67 ~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr---k~~rF~e 143 (355)
T KOG0616|consen 67 HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR---KSGRFSE 143 (355)
T ss_pred cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH---hcCCCCc
Confidence 578899999997552 3456778889999999999999999999999999999999999999999994 4556999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
....-++.||+.||+|||.++ |++|||||+|||+|.+|.+||.|||++..... +..+.+||+.|+|||++..
T Consensus 144 ~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----rT~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 144 PHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred hhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-----cEEEecCCccccChHHhhc
Confidence 999999999999999999999 99999999999999999999999999987643 3566889999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
+.+..++|.|+||+++|||+.|.+||...+.. .--.++..+. ...|...+.++.+|+.+.|+.
T Consensus 216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~-----------v~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGK-----------VKFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCc-----------ccCCcccCHHHHHHHHHHHhh
Confidence 99999999999999999999999999655431 1111222221 123333345788999999999
Q ss_pred CCCCC
Q 045452 241 NPNDR 245 (303)
Q Consensus 241 dp~~R 245 (303)
|-.+|
T Consensus 279 D~t~R 283 (355)
T KOG0616|consen 279 DLTKR 283 (355)
T ss_pred hhHhh
Confidence 99999
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=283.09 Aligned_cols=236 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 5 CGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+|+.||||++.... .-....+.+|++-|+.++|||||++|.+......+|+|+|+-.+|+|.+||-++ ...+.++.
T Consensus 42 TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH--e~Gl~E~L 119 (864)
T KOG4717|consen 42 TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH--EEGLNEDL 119 (864)
T ss_pred ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh--hccccHHH
Confidence 69999999996553 345568899999999999999999999999999999999999999999999653 45589999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
..++++||+.|+.|+|+.+ ++||||||+|+.+.+ -|-|||.|||++..+.. .....+.+|+..|.|||++.+.
T Consensus 120 a~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G~kL~TsCGSLAYSAPEILLGD 193 (864)
T KOG4717|consen 120 AKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---GKKLTTSCGSLAYSAPEILLGD 193 (864)
T ss_pred HHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC---cchhhcccchhhccCchhhhcC
Confidence 9999999999999999999 999999999987764 58899999999877654 3445567899999999999999
Q ss_pred CCCC-cccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYST-KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~-~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.|+. +.||||||+|+|.|+.|++||..++..+.+..+..... .-|.-.+.++++||..||..
T Consensus 194 sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-----------------tvPshvS~eCrdLI~sMLvR 256 (864)
T KOG4717|consen 194 SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-----------------TVPSHVSKECRDLIQSMLVR 256 (864)
T ss_pred ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-----------------cCchhhhHHHHHHHHHHHhc
Confidence 8875 78999999999999999999987776665554443322 22334456899999999999
Q ss_pred CCCCCCCHHHHH--HhhccCCCCCCCC
Q 045452 241 NPNDRPSMLEVS--SMLKNETTNTNTP 265 (303)
Q Consensus 241 dp~~Rps~~~l~--~~L~~~~~~~~~~ 265 (303)
||.+|.++++|. .+|+......++.
T Consensus 257 dPkkRAslEeI~s~~Wlq~~D~~~sT~ 283 (864)
T KOG4717|consen 257 DPKKRASLEEIVSTSWLQAGDRGLSTA 283 (864)
T ss_pred CchhhccHHHHhccccccCCCCCcccc
Confidence 999999999997 5677777666663
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=280.36 Aligned_cols=230 Identities=20% Similarity=0.245 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.++.. .......+..|+.++++++||||+++++++...+..++||||+++++|.+++.. ...+++
T Consensus 16 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~ 92 (312)
T cd05585 16 DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR---EGRFDL 92 (312)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh---cCCCCH
Confidence 46889999998643 234456788899999999999999999999999999999999999999998843 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+
T Consensus 93 ~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 167 (312)
T cd05585 93 SRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLG 167 (312)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcC
Confidence 999999999999999999998 9999999999999999999999999986532211 12233568999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||...... .......... . ..+...+.++.++|.+||..
T Consensus 168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~--~---------~~~~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP--L---------RFPDGFDRDAKDLLIGLLSR 230 (312)
T ss_pred CCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC--C---------CCCCcCCHHHHHHHHHHcCC
Confidence 89999999999999999999999999533211 1111111110 0 11122334788999999999
Q ss_pred CCCCCCCHHHHHHhhccC
Q 045452 241 NPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~ 258 (303)
||.+||++..+.+.|...
T Consensus 231 dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 231 DPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CHHHcCCCCCHHHHHcCC
Confidence 999998765555555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=290.71 Aligned_cols=238 Identities=28% Similarity=0.409 Sum_probs=184.1
Q ss_pred CCCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-------
Q 045452 3 LPCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------- 73 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------- 73 (303)
..+++.||+|.++... ....+.+.+|+.+++.+ +|+||+++++.+......++||||+.+|+|.+++....
T Consensus 65 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~ 144 (374)
T cd05106 65 EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFV 144 (374)
T ss_pred ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccc
Confidence 3456789999997543 34456788999999999 89999999999999999999999999999998875311
Q ss_pred ------------------------------------------------------------cccCCCHHHHHHHHHHHHHH
Q 045452 74 ------------------------------------------------------------RRLILDWKKRVHIIEGITQG 93 (303)
Q Consensus 74 ------------------------------------------------------------~~~~~~~~~~~~~~~~i~~~ 93 (303)
....+++..+++++.||+.|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 224 (374)
T cd05106 145 MALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQG 224 (374)
T ss_pred ccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHH
Confidence 11247788899999999999
Q ss_pred HHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhH
Q 045452 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173 (303)
Q Consensus 94 l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 173 (303)
|+|||+.| ++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||
T Consensus 225 L~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 301 (374)
T cd05106 225 MDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 301 (374)
T ss_pred HHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHH
Confidence 99999998 999999999999999999999999998765432211111222345679999999888899999999999
Q ss_pred HHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 045452 174 VLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 174 ~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~ 252 (303)
|++|+|++ |..||....... ............ ..+...+.++.+++.+||+.||.+|||+.+++
T Consensus 302 vil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 302 ILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQM---------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred HHHHHHHhCCCCCCccccccH------HHHHHHHcccCc---------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999997 999985432211 011111111100 01111234788999999999999999999999
Q ss_pred HhhccC
Q 045452 253 SMLKNE 258 (303)
Q Consensus 253 ~~L~~~ 258 (303)
+.|++.
T Consensus 367 ~~l~~~ 372 (374)
T cd05106 367 QLIQRQ 372 (374)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=284.89 Aligned_cols=225 Identities=20% Similarity=0.240 Sum_probs=180.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ......+.+|+.++++++||||+++++++......++||||+.+++|.+++. ....+++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 94 (323)
T cd05571 18 ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSE 94 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH---HcCCCCH
Confidence 578999999996532 2344677889999999999999999999999999999999999999988884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... ........|+..|+|||++.+
T Consensus 95 ~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05571 95 DRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecCccccChhhhcC
Confidence 999999999999999999998 999999999999999999999999998643221 112233568999999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||...... .......... . ..+...+.++.++|.+||..
T Consensus 170 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~--~---------~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE--I---------RFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC--C---------CCCCCCCHHHHHHHHHHccC
Confidence 89999999999999999999999999533211 1011111111 0 11122344788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||++|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 233 DPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHcCCCCCCCHHHHHc
Confidence 999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=292.84 Aligned_cols=229 Identities=19% Similarity=0.212 Sum_probs=184.1
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-CcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~ 84 (303)
++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++... .....+++..+.
T Consensus 93 ~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~ 172 (478)
T PTZ00267 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172 (478)
T ss_pred CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence 6789999886666666677889999999999999999999999999999999999999999887542 234568899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.............|+..|+|||++.+..++
T Consensus 173 ~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred HHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence 99999999999999998 999999999999999999999999999876543322223345689999999999988899
Q ss_pred CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
.++|||||||++|+|++|..||..... .........+.. .. .+...+.++.++|.+||..||++
T Consensus 250 ~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~-~~---------~~~~~s~~~~~li~~~L~~dP~~ 313 (478)
T PTZ00267 250 KKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKY-DP---------FPCPVSSGMKALLDPLLSKNPAL 313 (478)
T ss_pred cHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-CC---------CCccCCHHHHHHHHHHhccChhh
Confidence 999999999999999999999853221 111111111111 00 11122346889999999999999
Q ss_pred CCCHHHHHH
Q 045452 245 RPSMLEVSS 253 (303)
Q Consensus 245 Rps~~~l~~ 253 (303)
||++++++.
T Consensus 314 Rps~~~~l~ 322 (478)
T PTZ00267 314 RPTTQQLLH 322 (478)
T ss_pred CcCHHHHHh
Confidence 999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=278.82 Aligned_cols=239 Identities=28% Similarity=0.446 Sum_probs=190.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 73 (303)
.++..|++|.++.......+.+.+|+..+++++|+||+++++++......++||||+++++|.+++....
T Consensus 33 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (291)
T cd05094 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112 (291)
T ss_pred CcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccc
Confidence 4566799999977766667789999999999999999999999999999999999999999999985421
Q ss_pred ---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccc
Q 045452 74 ---RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTI 150 (303)
Q Consensus 74 ---~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 150 (303)
....+++..++.++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++................++.
T Consensus 113 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~ 189 (291)
T cd05094 113 PRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189 (291)
T ss_pred cccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcce
Confidence 1234789999999999999999999998 9999999999999999999999999987654332222222344578
Q ss_pred cccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++||||||+++|+|++ |..||....... ............. +...+..
T Consensus 190 ~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~ 253 (291)
T cd05094 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECITQGRVLER---------PRVCPKE 253 (291)
T ss_pred eecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhCCCCCCC---------CccCCHH
Confidence 8999999988889999999999999999998 999875432211 1111111111111 1112346
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
+.+++.+||..+|++|||+.++++.|++....
T Consensus 254 ~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 254 VYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 88999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=284.35 Aligned_cols=224 Identities=24% Similarity=0.317 Sum_probs=185.7
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++.||+|.+.+. .......+.+|+++++.++||||+.+++.|+++.++|+|+|||.| +|..++. ....++++
T Consensus 25 ~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~---~d~~lpEe 100 (808)
T KOG0597|consen 25 YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE---QDGKLPEE 100 (808)
T ss_pred cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH---hccCCCHH
Confidence 47889999998543 234567899999999999999999999999999999999999966 9999984 45679999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.+++.||.|||+.+ |+|||+||+||++.++|.+|+||||+++.++..+. ......||+.|||||...+.
T Consensus 101 ~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~ 175 (808)
T KOG0597|consen 101 QVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQ 175 (808)
T ss_pred HHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCce--eeeeccCcccccCHHHHcCC
Confidence 99999999999999999998 99999999999999999999999999998765432 23335799999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.|+..+|+||||||+||+++|++||.... +....+....... ..+...+..+.+++...|.+|
T Consensus 176 pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~v----------~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 176 PYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDPV----------KPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred CccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCCC----------CCcccccHHHHHHHHHHhhcC
Confidence 99999999999999999999999994322 1111122221111 112233457889999999999
Q ss_pred CCCCCCHHHHHH
Q 045452 242 PNDRPSMLEVSS 253 (303)
Q Consensus 242 p~~Rps~~~l~~ 253 (303)
|.+|.|+.+++.
T Consensus 239 P~~RltW~~Ll~ 250 (808)
T KOG0597|consen 239 PAQRLTWTDLLG 250 (808)
T ss_pred hhhcccHHHHhc
Confidence 999999999964
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=283.93 Aligned_cols=237 Identities=27% Similarity=0.421 Sum_probs=183.6
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 74 (303)
.++..||||+++... ....+.+.+|+.+++.+ +||||+++++++......++||||+++|+|.+++.....
T Consensus 63 ~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~ 142 (375)
T cd05104 63 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKH 142 (375)
T ss_pred ccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccc
Confidence 456789999997543 34456788999999999 899999999999999999999999999999988854210
Q ss_pred -----------------------------------------------------------------ccCCCHHHHHHHHHH
Q 045452 75 -----------------------------------------------------------------RLILDWKKRVHIIEG 89 (303)
Q Consensus 75 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 89 (303)
...+++..+..++.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 222 (375)
T cd05104 143 EDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQ 222 (375)
T ss_pred cchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHH
Confidence 124778899999999
Q ss_pred HHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccc
Q 045452 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169 (303)
Q Consensus 90 i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 169 (303)
|+.||+|||+.+ ++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||
T Consensus 223 i~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi 299 (375)
T cd05104 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 299 (375)
T ss_pred HHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH
Confidence 999999999998 99999999999999999999999999876543322111222234567999999998899999999
Q ss_pred hhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 045452 170 FSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSM 248 (303)
Q Consensus 170 wslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 248 (303)
|||||++|+|++ |..||....... ........+.... .+...+.++.+|+.+||..||++|||+
T Consensus 300 ~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 300 WSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML---------SPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC---------CCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999998 888875332111 1111111111110 111123478899999999999999999
Q ss_pred HHHHHhhccC
Q 045452 249 LEVSSMLKNE 258 (303)
Q Consensus 249 ~~l~~~L~~~ 258 (303)
.++++.|++.
T Consensus 365 ~eil~~l~~~ 374 (375)
T cd05104 365 KQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHhh
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.40 Aligned_cols=225 Identities=24% Similarity=0.299 Sum_probs=178.9
Q ss_pred CCCCEEEEEEccCCC----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++... ......+.+|+.+++.++||||+++++.+..++..++||||+.+++|.+++. ....+.
T Consensus 22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~ 98 (323)
T cd05584 22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFM 98 (323)
T ss_pred CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH---HcCCCC
Confidence 478999999986431 2334567889999999999999999999999999999999999999998884 345678
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.
T Consensus 99 ~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 99 EDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhcc
Confidence 8899999999999999999998 9999999999999999999999999986432221 1122346899999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||...... ........+.. ..+...+..+.++|.+||.
T Consensus 174 ~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL-----------NLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred CCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHcc
Confidence 888999999999999999999999999543211 11111111110 1111223468899999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 045452 240 ENPNDRP-----SMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rp-----s~~~l~~ 253 (303)
.||++|| ++.++++
T Consensus 237 ~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred cCHhHcCCCCCCCHHHHhc
Confidence 9999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=275.98 Aligned_cols=234 Identities=28% Similarity=0.480 Sum_probs=185.6
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc---------
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--------- 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 74 (303)
+++.||+|.++... ......+.+|+..++.++||||+++++++......+++|||+++++|.+++.....
T Consensus 34 ~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05048 34 SATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113 (283)
T ss_pred ceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccc
Confidence 34679999997543 34556789999999999999999999999998899999999999999998854211
Q ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccc
Q 045452 75 ----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTI 150 (303)
Q Consensus 75 ----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 150 (303)
...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++................++.
T Consensus 114 ~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~ 190 (283)
T cd05048 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190 (283)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccc
Confidence 145788999999999999999999998 9999999999999999999999999987654332222223345678
Q ss_pred cccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++|+|||||++|+|++ |..||...... ............. .+...+.+
T Consensus 191 ~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~~~~~i~~~~~~~---------~~~~~~~~ 254 (283)
T cd05048 191 RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------EVIEMIRSRQLLP---------CPEDCPAR 254 (283)
T ss_pred cccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCC---------CcccCCHH
Confidence 8999999988889999999999999999998 98888533221 1111122111111 12223457
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+.+|+.+||..||++||++.+|++.|+.
T Consensus 255 ~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 255 VYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=273.92 Aligned_cols=230 Identities=23% Similarity=0.277 Sum_probs=180.1
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..+++|||+++|+|..++... ....+++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~ 101 (285)
T cd05631 23 ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDE 101 (285)
T ss_pred cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh-CCCCCCH
Confidence 579999999986432 223346788999999999999999999999999999999999999998877432 2345889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 102 QRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcC
Confidence 999999999999999999998 9999999999999999999999999987653221 1123467999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|+.||............. ..... ... ..+...+.++.+|+.+||..
T Consensus 176 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~-~~~---------~~~~~~s~~~~~li~~~l~~ 242 (285)
T cd05631 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKE-DQE---------EYSEKFSEDAKSICRMLLTK 242 (285)
T ss_pred CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhc-ccc---------cCCccCCHHHHHHHHHHhhc
Confidence 899999999999999999999999996443222111111 11110 000 11112234688999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 045452 241 NPNDRPS-----MLEVSS 253 (303)
Q Consensus 241 dp~~Rps-----~~~l~~ 253 (303)
||.+||+ ++++++
T Consensus 243 ~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 243 NPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CHHHhcCCCCCCHHHHhc
Confidence 9999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=271.04 Aligned_cols=232 Identities=25% Similarity=0.353 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.+.... ......+.+|++++++++|+||+++++++......++||||+.+++|.+++.. ....+++..
T Consensus 18 ~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~ 95 (252)
T cd05084 18 ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKE 95 (252)
T ss_pred cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh--CCCCCCHHH
Confidence 478999999886543 44567789999999999999999999999999999999999999999998853 234588999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.................+..|+|||.+.+..
T Consensus 96 ~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 172 (252)
T cd05084 96 LIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172 (252)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC
Confidence 9999999999999999998 9999999999999999999999999987544322111111122345799999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|+|++ |..||...... ............ ..+...+..+.+++.+||..+
T Consensus 173 ~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVRL---------PCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCC---------CCcccCCHHHHHHHHHHcCCC
Confidence 9999999999999999997 88887432111 111111111111 111222347889999999999
Q ss_pred CCCCCCHHHHHHhhc
Q 045452 242 PNDRPSMLEVSSMLK 256 (303)
Q Consensus 242 p~~Rps~~~l~~~L~ 256 (303)
|++|||+.++.+.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=274.32 Aligned_cols=234 Identities=27% Similarity=0.461 Sum_probs=185.2
Q ss_pred CCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------
Q 045452 5 CGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 73 (303)
+++.||+|.++..... ..+.+.+|+.+++.++|+||+++++++......+++|||+++++|.+++....
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (280)
T cd05049 34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113 (280)
T ss_pred CcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccc
Confidence 4678999999765443 56789999999999999999999999999999999999999999999986421
Q ss_pred -cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
....+++..+..++.+++.++++||+.| ++|+||+|+||+++.++.++|+|||.+................++..|
T Consensus 114 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05049 114 SPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190 (280)
T ss_pred cccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCccccee
Confidence 1345788899999999999999999998 999999999999999999999999998754332222222223456789
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++||||||+++|+|++ |..||....... . ......+.... .+...+..+.
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~ 254 (280)
T cd05049 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---V----IECITQGRLLQ---------RPRTCPSEVY 254 (280)
T ss_pred cChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCCcCC---------CCCCCCHHHH
Confidence 99999999999999999999999999998 999985432211 1 11111111111 1112234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+++.+||..||++||++.++++.|++
T Consensus 255 ~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 255 DIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=293.89 Aligned_cols=238 Identities=21% Similarity=0.266 Sum_probs=189.1
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEE-EEeC------CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGF-CIDS------EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.|..||+|++-..++...+.+++||.+|++| .|+|||.+++. .... -.++|+||||.||+|.+++.......
T Consensus 61 ~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~ 140 (738)
T KOG1989|consen 61 GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR 140 (738)
T ss_pred CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc
Confidence 3489999998888888899999999999999 59999999993 3221 25789999999999999997654444
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccc----c--ceeecc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KAN----T--EQVVGT 149 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~----~--~~~~~~ 149 (303)
+++..+++|+.++++|+++||.+. .+++|||||-+|||++.+|+.||||||.+........ ... . =....|
T Consensus 141 -lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TT 218 (738)
T KOG1989|consen 141 -LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTT 218 (738)
T ss_pred -CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCC
Confidence 999999999999999999999986 5699999999999999999999999999864322110 000 0 012358
Q ss_pred ccccCchhc---ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH
Q 045452 150 IGYIPPEYA---RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 150 ~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.|+|||.+ .+...+.|+|||+|||++|-||....||...+. ..++...+.....+.+
T Consensus 219 p~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------------laIlng~Y~~P~~p~y 279 (738)
T KOG1989|consen 219 PQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------------LAILNGNYSFPPFPNY 279 (738)
T ss_pred ccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------------eeEEeccccCCCCccH
Confidence 999999966 567799999999999999999999999963321 1222223333333566
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCC
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTN 263 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~ 263 (303)
+..+.+||..||+.||.+||++-+++..+-.+.....
T Consensus 280 s~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 280 SDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred HHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 7789999999999999999999999988777654443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=268.90 Aligned_cols=250 Identities=20% Similarity=0.218 Sum_probs=198.1
Q ss_pred CCCEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 5 CGEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++..+|+|++..... ....+...|-++|+.++||.++.+|+.|+.+...|++||||+||+|..++++ +.+..+++.
T Consensus 101 t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~ 179 (459)
T KOG0610|consen 101 TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK-QPGKRFSES 179 (459)
T ss_pred CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh-CCCCccchh
Confidence 458899999975533 3345677899999999999999999999999999999999999999888765 456779999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccc------------------------
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE------------------------ 137 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~------------------------ 137 (303)
.+.-++.+++.||+|||.+| |++|||||+||||-++|++-|.||+++..+...
T Consensus 180 ~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s 256 (459)
T KOG0610|consen 180 AARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPS 256 (459)
T ss_pred hHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccccccc
Confidence 99999999999999999999 999999999999999999999999998654210
Q ss_pred ----------c--------------------cccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCcc
Q 045452 138 ----------S--------------------LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187 (303)
Q Consensus 138 ----------~--------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 187 (303)
. ...+...++||-.|.|||++.+..-+.++|+|+||+++|||+.|..||.
T Consensus 257 ~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 257 CFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred ccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC
Confidence 0 0011223578999999999999999999999999999999999999997
Q ss_pred ccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCC----HHHHHH--hhccCCCC
Q 045452 188 LCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS----MLEVSS--MLKNETTN 261 (303)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~l~~--~L~~~~~~ 261 (303)
..+..+....+-.. . +.....+..+..+.+||++.|.+||++|.- +.||.+ ++++..++
T Consensus 337 G~~~~~Tl~NIv~~--------~-------l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 337 GSNNKETLRNIVGQ--------P-------LKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred CCCchhhHHHHhcC--------C-------CcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 66655433221110 0 111111133457889999999999999998 888864 47777776
Q ss_pred CCCCCCCCcccc
Q 045452 262 TNTPKKPAFSKQ 273 (303)
Q Consensus 262 ~~~~~~~~~~~~ 273 (303)
+-....|++...
T Consensus 402 Lir~~~PP~iP~ 413 (459)
T KOG0610|consen 402 LIRCARPPEIPK 413 (459)
T ss_pred heeccCCCcCCC
Confidence 655555655444
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=280.19 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=182.5
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|..||+|.++.. .....+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.. ...+++..
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~ 104 (331)
T cd06649 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEI 104 (331)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH---cCCCCHHH
Confidence 46889999998754 334567899999999999999999999999999999999999999999999843 34588999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||.|||+.+ +++||||||+||+++.++.++|+|||++....... .....++..|+|||.+.+..
T Consensus 105 ~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~ 178 (331)
T cd06649 105 LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTH 178 (331)
T ss_pred HHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCC
Confidence 9999999999999999853 39999999999999999999999999987553321 22345789999999999888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC--c---------------------------cc-
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK--G---------------------------ME- 212 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---------------------------~~- 212 (303)
++.++|||||||++|+|++|+.||......+....... ....... . ..
T Consensus 179 ~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T cd06649 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFEL 256 (331)
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcccccccccccccccccccchhHHHH
Confidence 99999999999999999999999954322110000000 0000000 0 00
Q ss_pred ---cccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 213 ---FVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 213 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..............+.++.+||.+||..||++|||++++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 257 LDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred HHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000001111234578999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=278.96 Aligned_cols=225 Identities=20% Similarity=0.237 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.++.. .......+.+|+.+++.++||||+++++.+......++||||+++++|..++. ....+++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~~~~ 94 (323)
T cd05595 18 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTE 94 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH---HcCCCCH
Confidence 57899999999653 23345667789999999999999999999999999999999999999988874 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.+
T Consensus 95 ~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05595 95 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCCcccccC
Confidence 999999999999999999998 9999999999999999999999999886432211 11223468999999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||....... .......... ..+...+.++.++|.+||..
T Consensus 170 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~~-----------~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEI-----------RFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCC-----------CCCCCCCHHHHHHHHHHccC
Confidence 889999999999999999999999985432211 1111111110 01112234788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||.+|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 233 DPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHhCCCCCCCHHHHHc
Confidence 999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=275.83 Aligned_cols=238 Identities=29% Similarity=0.469 Sum_probs=188.0
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------c
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----------R 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~ 74 (303)
++..+|+|.+........+.+.+|+.++++++|+||+++++++......+++|||+++++|.+++.... .
T Consensus 34 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (288)
T cd05093 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113 (288)
T ss_pred cceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCC
Confidence 456789999977666667789999999999999999999999999999999999999999999885321 1
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..++.++.|++.+|+|||+.| ++||||||+||+++.++.++|+|||++..+.............++..|+|
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence 234899999999999999999999998 99999999999999999999999999876543222222222335678999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+..++.++|+|||||++|+|++ |..||....... .......+..... +...+.++.+|
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~i~~~~~~~~---------~~~~~~~l~~l 254 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECITQGRVLQR---------PRTCPKEVYDL 254 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCcCCC---------CCCCCHHHHHH
Confidence 999988889999999999999999998 888874332111 1111111111110 11123468899
Q ss_pred HHhcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
+.+||+.||.+|||+.++.+.|++....
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=285.38 Aligned_cols=226 Identities=27% Similarity=0.404 Sum_probs=182.9
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
++.||||+++.-. ..+|.-|++|+|+||+.+.|+|.....+|||||||..|.|...|+ .+..+....+..
T Consensus 147 netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~ 216 (904)
T KOG4721|consen 147 NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVD 216 (904)
T ss_pred CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh---ccCccCHHHHHH
Confidence 6789999985432 257888999999999999999999999999999999999999994 456788899999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 165 (303)
|..+||.|+.|||... |+|||||.=||||+.+..|||+|||-++...... ..-.+.||..|||||++.+.+++.
T Consensus 217 Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsE 290 (904)
T KOG4721|consen 217 WSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSE 290 (904)
T ss_pred HHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCccc
Confidence 9999999999999988 9999999999999999999999999987665431 112267999999999999999999
Q ss_pred cccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 166 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
++||||||+|+|||+||..||....... -+|.-+. ..+...++..++. -+.-|+++||...|..|
T Consensus 291 KVDIwSfGVVLWEmLT~EiPYkdVdssA---------IIwGVGs--NsL~LpvPstcP~----GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 291 KVDIWSFGVVLWEMLTGEIPYKDVDSSA---------IIWGVGS--NSLHLPVPSTCPD----GFKLLLKQCWNSKPRNR 355 (904)
T ss_pred ccceehhHHHHHHHHhcCCCccccchhe---------eEEeccC--CcccccCcccCch----HHHHHHHHHHhcCCCCC
Confidence 9999999999999999999985332211 1222111 1112122223332 45568999999999999
Q ss_pred CCHHHHHHhhccCCCCC
Q 045452 246 PSMLEVSSMLKNETTNT 262 (303)
Q Consensus 246 ps~~~l~~~L~~~~~~~ 262 (303)
|++.+++..|.-.....
T Consensus 356 PSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 356 PSFRQILLHLDIASPEL 372 (904)
T ss_pred ccHHHHHHHHhhcCHHH
Confidence 99999999987655443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=300.12 Aligned_cols=239 Identities=30% Similarity=0.474 Sum_probs=195.3
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----cccCCCHH
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----RRLILDWK 81 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~ 81 (303)
-.||||.+++. +......|.+|..+|+.++|||||+++|++.+....+|++|||.+|+|..+|++.. ....++..
T Consensus 723 ~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~ 802 (1025)
T KOG1095|consen 723 IQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMR 802 (1025)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHH
Confidence 35899999766 45677899999999999999999999999999999999999999999999997731 24568899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+||+|+.||++++ ++||||..+|+|++....|||+|||+++.+....+........-...|||||.+...
T Consensus 803 dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 803 DLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG 879 (1025)
T ss_pred HHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc
Confidence 99999999999999999999 999999999999999999999999999976655555444433345799999999999
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++||+++ |..||...+..+. +. ....++ + -..|...+..+++++.+||+.
T Consensus 880 iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v---~~---~~~~gg-R---------L~~P~~CP~~ly~lM~~CW~~ 943 (1025)
T KOG1095|consen 880 IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV---LL---DVLEGG-R---------LDPPSYCPEKLYQLMLQCWKH 943 (1025)
T ss_pred ccccccchhhhHHHHHHHHhCCCCCCCCcchHHH---HH---HHHhCC-c---------cCCCCCCChHHHHHHHHHccC
Confidence 99999999999999999998 6777753332211 11 111222 2 223333445789999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~~~~ 264 (303)
+|++||++..|++.+.++.....+
T Consensus 944 ~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 944 DPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ChhhCccHHHHHhhhhhhhhhhcc
Confidence 999999999999988877655444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=282.32 Aligned_cols=231 Identities=22% Similarity=0.292 Sum_probs=182.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ......+..|+.++..++||||+++++++......++||||+++++|.+++. ....+++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~ 100 (333)
T cd05600 24 DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSE 100 (333)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH---HcCCCCH
Confidence 468999999996432 2345678889999999999999999999999999999999999999999984 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..... ......|+..|+|||.+.+
T Consensus 101 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 101 DHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcC
Confidence 999999999999999999998 99999999999999999999999999875433 2233568999999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||......+.... ...+...... ... .......+.++.++|.+||..
T Consensus 173 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~~~----~~~-~~~~~~~s~~~~~li~~~l~~ 243 (333)
T cd05600 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN----LKYWKETLQR----PVY-DDPRFNLSDEAWDLITKLIND 243 (333)
T ss_pred CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH----HHhccccccC----CCC-CccccccCHHHHHHHHHHhhC
Confidence 8999999999999999999999999964332111111 1111110000 000 000012234788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|.+||++.+++..
T Consensus 244 ~~~rr~s~~~ll~h 257 (333)
T cd05600 244 PSRRFGSLEDIKNH 257 (333)
T ss_pred hhhhcCCHHHHHhC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=279.29 Aligned_cols=222 Identities=21% Similarity=0.248 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++... ....+.+.+|+.++++++||||+++++++...+..+++|||+.+++|.+++.. ...+++
T Consensus 41 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 117 (329)
T PTZ00263 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK---AGRFPN 117 (329)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH---cCCCCH
Confidence 468999999986432 23456788999999999999999999999999999999999999999998843 456888
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... ....|++.|+|||++.+
T Consensus 118 ~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 118 DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQS 189 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcC
Confidence 999999999999999999998 9999999999999999999999999987654322 23468999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||..... .........+. .. .+...+.++.+||.+||..
T Consensus 190 ~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~--~~---------~p~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAGR--LK---------FPNWFDGRARDLVKGLLQT 252 (329)
T ss_pred CCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCC--cC---------CCCCCCHHHHHHHHHHhhc
Confidence 8899999999999999999999999853221 11111111111 11 1111234678999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 045452 241 NPNDRPS-----MLEVSS 253 (303)
Q Consensus 241 dp~~Rps-----~~~l~~ 253 (303)
||.+||+ +++++.
T Consensus 253 dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 9999997 566653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=271.06 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=187.8
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-----CCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||++... .....++-.+|+.+++.++|+||+.+++++.. -+..|+|+|+| +.+|.+.++ .+.
T Consensus 45 ~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik---~~~ 120 (359)
T KOG0660|consen 45 RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIK---SQQ 120 (359)
T ss_pred CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHH---cCc
Confidence 57899999999633 34456788899999999999999999999865 24689999999 678888884 344
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.++...+..++.||+.||+|+|+.+ ++||||||.|++++.+..+||+|||+++.............-+.|.+|+|||
T Consensus 121 ~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPE 197 (359)
T KOG0660|consen 121 DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPE 197 (359)
T ss_pred cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHH
Confidence 5999999999999999999999998 9999999999999999999999999999875432223334456799999999
Q ss_pred hcc-cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH--------HHhhCCCcccccc-------ccccC
Q 045452 157 YAR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY--------ELWKGGKGMEFVD-------SFLDD 220 (303)
Q Consensus 157 ~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~ 220 (303)
++. ...|+.+.||||+|||+.||++|++.|...........+.... ...........+. ..+..
T Consensus 198 lll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~ 277 (359)
T KOG0660|consen 198 LLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSS 277 (359)
T ss_pred HHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHH
Confidence 764 5579999999999999999999999986544333322211110 0000000000000 00011
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCCCCCCCC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNETTNTNTP 265 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~~~~~~~ 265 (303)
.++. ......+|+.+||..||.+|+|+++.++. |.....+...|
T Consensus 278 ~fp~-a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 278 IFPN-ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HcCC-CCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 1111 12356799999999999999999999864 55555544444
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.63 Aligned_cols=235 Identities=30% Similarity=0.465 Sum_probs=188.3
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
...+++.||+|.++.......+.+.+|+.+++.++|+||+++++++......+++|||+++++|.+++... ....+++.
T Consensus 26 ~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 104 (261)
T cd05148 26 LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVA 104 (261)
T ss_pred EecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC-CCCCCCHH
Confidence 34568899999998776656778999999999999999999999999999999999999999999999653 24568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+|+.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........... ...++..|+|||.+.+.
T Consensus 105 ~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~--~~~~~~~~~~PE~~~~~ 179 (261)
T cd05148 105 SLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS--DKKIPYKWTAPEAASHG 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc--CCCCceEecCHHHHccC
Confidence 99999999999999999988 99999999999999999999999999876543221111 22346689999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|+|++ |..||......+ ... ... ..... ..+...+..+.+++.+||..
T Consensus 180 ~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~-~~~~~---------~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05148 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYD---QIT-AGYRM---------PCPAKCPQEIYKIMLECWAA 243 (261)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HHH-hCCcC---------CCCCCCCHHHHHHHHHHcCC
Confidence 89999999999999999998 888885332111 111 111 11110 11122234688999999999
Q ss_pred CCCCCCCHHHHHHhhccC
Q 045452 241 NPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~ 258 (303)
||.+|||+.++++.|++.
T Consensus 244 ~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 244 EPEDRPSFKALREELDNI 261 (261)
T ss_pred CchhCcCHHHHHHHHhcC
Confidence 999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=262.10 Aligned_cols=228 Identities=25% Similarity=0.368 Sum_probs=180.8
Q ss_pred CCCCEEEEEEccCC----C----hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc
Q 045452 4 PCGEVIAVKKLSKS----S----AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~----~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
++|+..|+|++.-. . ....+.-..|+.+++++ .||+|+++.++++.+...++|++.|+.|.|.++| ..
T Consensus 40 ~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL---ts 116 (411)
T KOG0599|consen 40 ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL---TS 116 (411)
T ss_pred ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh---hh
Confidence 57888999988422 1 12334456799999998 8999999999999999999999999999999999 34
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++....++++|+.+|+.|||..+ |+||||||+|||++++.+++|.|||+++.+.. +......+||+.|.|
T Consensus 117 ~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~---GekLrelCGTPgYLA 190 (411)
T KOG0599|consen 117 KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEP---GEKLRELCGTPGYLA 190 (411)
T ss_pred heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCC---chhHHHhcCCCcccC
Confidence 667999999999999999999999998 99999999999999999999999999987754 334445789999999
Q ss_pred chhcccC------CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 155 PEYARQG------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 155 PE~~~~~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
||.+.+. .|+...|+|++|+|||.|+.|-+||..-....-+..+......+. .+++ ...+.
T Consensus 191 PEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~---speW----------adis~ 257 (411)
T KOG0599|consen 191 PETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR---SPEW----------ADISA 257 (411)
T ss_pred hhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC---Ccch----------hhccc
Confidence 9988643 578899999999999999999999964322211111111111111 1111 11233
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...+||.+||+.||.+|.|+++.++
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhc
Confidence 5679999999999999999999874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=271.17 Aligned_cols=232 Identities=36% Similarity=0.526 Sum_probs=177.5
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
..+..|+||.++.. .....+.+.+|++.+++++||||+++++++...+..++||||+++|+|.+++... ....+++..
T Consensus 26 ~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~ 104 (259)
T PF07714_consen 26 DKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK-NKEPLSEQQ 104 (259)
T ss_dssp SSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT-CTTTSBHHH
T ss_pred CCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 35678999999654 3445789999999999999999999999999888899999999999999999653 235689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.|+.||+.||+|||+.+ ++|++|+++||+++.++.+||+|||++....................|+|||.+.+..
T Consensus 105 ~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 105 RLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred ccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999988 9999999999999999999999999997763332223333345678999999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||||+++||+++ |+.||.... ... ............. +...+..+.+++.+||..|
T Consensus 182 ~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~-~~~~~~~~~~~~~---------~~~~~~~~~~li~~C~~~~ 245 (259)
T PF07714_consen 182 YTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEE-IIEKLKQGQRLPI---------PDNCPKDIYSLIQQCWSHD 245 (259)
T ss_dssp ESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHH-HHHHHHTTEETTS---------BTTSBHHHHHHHHHHT-SS
T ss_pred ccccccccccccccccccccccccccccc------ccc-cccccccccccee---------ccchhHHHHHHHHHHcCCC
Confidence 9999999999999999999 678863221 111 1111122211111 1112346889999999999
Q ss_pred CCCCCCHHHHHHhh
Q 045452 242 PNDRPSMLEVSSML 255 (303)
Q Consensus 242 p~~Rps~~~l~~~L 255 (303)
|++|||+.++++.|
T Consensus 246 p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 246 PEKRPSFQEILQEL 259 (259)
T ss_dssp GGGS--HHHHHHHH
T ss_pred hhhCcCHHHHHhcC
Confidence 99999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=274.26 Aligned_cols=243 Identities=21% Similarity=0.248 Sum_probs=180.2
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++..+...++||||+.++++..+.. ....+++.
T Consensus 24 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 100 (287)
T cd07848 24 ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE---MPNGVPPE 100 (287)
T ss_pred CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh---cCCCCCHH
Confidence 468899999986542 2345678899999999999999999999999999999999999877755442 23458899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+.
T Consensus 101 ~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 176 (287)
T cd07848 101 KVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGA 176 (287)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCC
Confidence 99999999999999999998 99999999999999999999999999876543221 112234578999999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhhCCCcc-ccccccc------cCCCChHH
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGKGM-EFVDSFL------DDRNSSCK 226 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~------~~~~~~~~ 226 (303)
.++.++|+|||||++|+|++|+.||......+....... ....+...... ....... ........
T Consensus 177 ~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07848 177 PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGIL 256 (287)
T ss_pred CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhccc
Confidence 899999999999999999999999965432211111110 00000000000 0000000 00011113
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
+.++.+||.+||+.||++|||++++++
T Consensus 257 s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 257 SGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=279.17 Aligned_cols=226 Identities=21% Similarity=0.240 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++.. .......+.+|+.+++.++||||+++++++...+..++||||+++++|..++. ....+++
T Consensus 18 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~~~~l~~ 94 (328)
T cd05593 18 ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS---RERVFSE 94 (328)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH---hcCCCCH
Confidence 57899999999654 23345678889999999999999999999999999999999999999988874 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ........|+..|+|||.+.+
T Consensus 95 ~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 169 (328)
T cd05593 95 DRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLED 169 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhcC
Confidence 999999999999999999998 999999999999999999999999998653221 111223468999999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||....... ......... . ..+...+.++.++|.+||..
T Consensus 170 ~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~~--~---------~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMED--I---------KFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccCC--c---------cCCCCCCHHHHHHHHHHcCC
Confidence 889999999999999999999999995432111 111111110 0 11112234788999999999
Q ss_pred CCCCCC-----CHHHHHHh
Q 045452 241 NPNDRP-----SMLEVSSM 254 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~~ 254 (303)
||++|| ++.++++.
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=278.43 Aligned_cols=223 Identities=21% Similarity=0.255 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++.. ...+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~ 100 (291)
T cd05612 24 ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSN 100 (291)
T ss_pred CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH---cCCCCH
Confidence 468999999986432 23456788999999999999999999999999999999999999999999843 456889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++...... .....|+..|+|||.+.+
T Consensus 101 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 101 STGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcC
Confidence 999999999999999999998 999999999999999999999999998765332 123457899999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||....... .. ....... .. .+......+.++|.+||..
T Consensus 173 ~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~---~~i~~~~--~~---------~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IY---EKILAGK--LE---------FPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCC--cC---------CCccCCHHHHHHHHHHcCC
Confidence 889999999999999999999999985432111 11 1111111 01 1111234688999999999
Q ss_pred CCCCCCC-----HHHHHHh
Q 045452 241 NPNDRPS-----MLEVSSM 254 (303)
Q Consensus 241 dp~~Rps-----~~~l~~~ 254 (303)
||.+||+ ++++++.
T Consensus 236 dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CHHHccCCccCCHHHHhcC
Confidence 9999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=270.52 Aligned_cols=234 Identities=27% Similarity=0.436 Sum_probs=184.3
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc----------
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR---------- 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 74 (303)
++..+|+|.++.......+.+.+|+++++.++|+||+++++++......+++|||+.+++|.+++.....
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (280)
T cd05092 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113 (280)
T ss_pred CceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccccc
Confidence 5678999998777666778899999999999999999999999999999999999999999998854211
Q ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 75 --RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 75 --~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
...+++..++.++.|++.|++|||+.| ++|+||||+||++++++.++|+|||++................++..|
T Consensus 114 ~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05092 114 VAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190 (280)
T ss_pred CCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccc
Confidence 134788999999999999999999998 999999999999999999999999998755432221112223346789
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++|+|||||++|+|++ |..||....... .......+ .... .+...+..+.
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~-~~~~---------~~~~~~~~~~ 254 (280)
T cd05092 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIECITQG-RELE---------RPRTCPPEVY 254 (280)
T ss_pred cCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHHHHHcC-ccCC---------CCCCCCHHHH
Confidence 99999988889999999999999999998 888885332111 11111111 1111 0111234688
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+++.+||+.||.+||++.+|++.|++
T Consensus 255 ~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 255 AIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=277.98 Aligned_cols=226 Identities=23% Similarity=0.338 Sum_probs=174.7
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++.... ......+.+|+.+++.++|+||+++++++......++||||+.+++|.+.. ...+..
T Consensus 97 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~ 169 (353)
T PLN00034 97 PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQF 169 (353)
T ss_pred CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHH
Confidence 478999999986543 344577899999999999999999999999999999999999999985432 245678
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc--
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-- 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 160 (303)
+..++.||+.||+|||+.| ++||||||+|||++.++.+||+|||++..+..... ......|+..|+|||.+..
T Consensus 170 ~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 244 (353)
T PLN00034 170 LADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDL 244 (353)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCcccccccc
Confidence 8899999999999999998 99999999999999999999999999876543211 1123468999999998743
Q ss_pred ---CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 161 ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 161 ---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
...+.++|||||||++|+|++|+.||......+....... ...... ...+...+.++.+||.+|
T Consensus 245 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~l~~li~~~ 311 (353)
T PLN00034 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----ICMSQP---------PEAPATASREFRHFISCC 311 (353)
T ss_pred ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----HhccCC---------CCCCCccCHHHHHHHHHH
Confidence 2345689999999999999999999973332221111110 000000 111122334788999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|..||++|||+.++++.
T Consensus 312 l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 312 LQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.65 Aligned_cols=234 Identities=30% Similarity=0.418 Sum_probs=184.2
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+..+++.||+|.++... ...+.+.+|+.++++++|+||+++++++...+..+++|||+.+++|.+++.... ...+++.
T Consensus 26 ~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 103 (261)
T cd05068 26 LWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLP 103 (261)
T ss_pred EecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CCCCCHH
Confidence 34567889999986543 235678899999999999999999999999999999999999999999985432 3468999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.+++.|+.+||+.| ++|+||+|+||+++.++.++|+|||++.......... ......+..|+|||.+.+.
T Consensus 104 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05068 104 QLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYN 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccCccccccC
Confidence 99999999999999999998 9999999999999999999999999987765322111 1111224579999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|+|++ |+.||...... ............ ..+...+..+.+++.+||..
T Consensus 180 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~ 243 (261)
T cd05068 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGYRM---------PCPPGCPKELYDIMLDCWKE 243 (261)
T ss_pred CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC---------CCCCcCCHHHHHHHHHHhhc
Confidence 89999999999999999999 88888532211 111111111110 01112234788999999999
Q ss_pred CCCCCCCHHHHHHhhcc
Q 045452 241 NPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~ 257 (303)
+|++||++.++++.|++
T Consensus 244 ~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 244 DPDDRPTFETLQWKLED 260 (261)
T ss_pred CcccCCCHHHHHHHHhc
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.37 Aligned_cols=228 Identities=21% Similarity=0.274 Sum_probs=179.7
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|+++... ......+..|+.++++++||||+++++++......|+||||+.+++|.+++. +...+++.
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~ 98 (318)
T cd05582 22 DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEE 98 (318)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHH
Confidence 478999999996532 2234567789999999999999999999999999999999999999998884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.+.
T Consensus 99 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~ 173 (318)
T cd05582 99 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRR 173 (318)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCC
Confidence 99999999999999999998 9999999999999999999999999987543321 112234688999999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|..||...... ........... ..+...+..+.++|.+||+.|
T Consensus 174 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~~-----------~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAKL-----------GMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred CCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhhcC
Confidence 8899999999999999999999998543211 11111111110 011122346889999999999
Q ss_pred CCCCCCHHH--HHHhhc
Q 045452 242 PNDRPSMLE--VSSMLK 256 (303)
Q Consensus 242 p~~Rps~~~--l~~~L~ 256 (303)
|++||++.+ +.+.+.
T Consensus 237 P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 237 PANRLGAGPDGVEEIKR 253 (318)
T ss_pred HhHcCCCCCCCHHHHhC
Confidence 999999655 444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.81 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=177.8
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.++... ......+.+|+.++++++||||+++++++......++||||+.+ +|.+++.. ....+++..
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~ 104 (288)
T cd07871 28 LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN--CGNLMSMHN 104 (288)
T ss_pred CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh--cCCCCCHHH
Confidence 478999999986443 22345678899999999999999999999998999999999975 88887743 234578899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-C
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 161 (303)
+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......++..|+|||.+.+ .
T Consensus 105 ~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (288)
T cd07871 105 VKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGST 179 (288)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCc
Confidence 9999999999999999998 9999999999999999999999999986543221 11222457889999998765 5
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH-----HHhhCCCcc-ccccccccC-------CCChHHHH
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGM-EFVDSFLDD-------RNSSCKLM 228 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~-------~~~~~~~~ 228 (303)
.++.++||||+||++|+|++|+.||......+......... ..|...... ++....... ........
T Consensus 180 ~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T cd07871 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDT 259 (288)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCH
Confidence 68899999999999999999999996543322211111100 011110000 000000000 00111234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
++.++|.+||..||.+|||++++++
T Consensus 260 ~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 260 DGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhc
Confidence 6789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=267.36 Aligned_cols=233 Identities=30% Similarity=0.456 Sum_probs=184.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.||+|.+... ......+.+|+.+++.++|+||+++++++......+++|||+++++|.+++... ....+++..+
T Consensus 29 ~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~ 106 (263)
T cd05052 29 KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVL 106 (263)
T ss_pred cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC-CCCCCCHHHH
Confidence 45889999998654 334567889999999999999999999999999999999999999999988542 2345889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.+|++||+.+ ++|+||||+||+++.++.+||+|||++.......... ......+..|+|||.+.+..+
T Consensus 107 ~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 182 (263)
T cd05052 107 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKF 182 (263)
T ss_pred HHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCC
Confidence 999999999999999988 9999999999999999999999999987654432211 111223567999999988889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|||||||++|+|++ |..||...... ............ ..+...+.++.+++.+||..||
T Consensus 183 ~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p 246 (263)
T cd05052 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGYRM---------ERPEGCPPKVYELMRACWQWNP 246 (263)
T ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCCC---------CCCCCCCHHHHHHHHHHccCCc
Confidence 999999999999999998 88887532211 111111111111 1112223578899999999999
Q ss_pred CCCCCHHHHHHhhccC
Q 045452 243 NDRPSMLEVSSMLKNE 258 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~ 258 (303)
++|||+.++++.|++.
T Consensus 247 ~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 247 SDRPSFAEIHQAFETM 262 (263)
T ss_pred ccCCCHHHHHHHHHhh
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.29 Aligned_cols=232 Identities=23% Similarity=0.348 Sum_probs=181.7
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+..||+|.++... ......+.+|+..+++++||||+++++++..+...++||||+++++|.+++... ...+++..+
T Consensus 32 ~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~ 109 (266)
T cd05064 32 RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQL 109 (266)
T ss_pred ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC--CCCCCHHHH
Confidence 46789999997653 334567889999999999999999999999999999999999999999988542 346889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+......... ......++..|+|||.+.+..+
T Consensus 110 ~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 185 (266)
T cd05064 110 MGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHF 185 (266)
T ss_pred HHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCc
Confidence 999999999999999998 999999999999999999999999987543222111 1111234568999999988899
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|||||||++|++++ |..||....... ........... ..+...+..+.+++.+||+.+|
T Consensus 186 ~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li~~c~~~~p 249 (266)
T cd05064 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRL---------PAPRNCPNLLHQLMLDCWQKER 249 (266)
T ss_pred cchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CCCCCCCHHHHHHHHHHcCCCc
Confidence 999999999999999775 999985432111 11111111111 1112233468899999999999
Q ss_pred CCCCCHHHHHHhhccC
Q 045452 243 NDRPSMLEVSSMLKNE 258 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~ 258 (303)
.+||++++|.+.|.+.
T Consensus 250 ~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 250 GERPRFSQIHSILSKM 265 (266)
T ss_pred hhCCCHHHHHHHHHhh
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=269.91 Aligned_cols=247 Identities=25% Similarity=0.334 Sum_probs=182.8
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|.++... ......+.+|+.+++.++||||+++++++... ...+++|||+.+++|.+++. ...+++
T Consensus 31 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~l~~ 106 (283)
T cd05080 31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP----KHKLNL 106 (283)
T ss_pred CCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHH----HcCCCH
Confidence 578899999997543 34557788999999999999999999988653 35789999999999999884 335899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc-ccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA-NTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~ 159 (303)
..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.
T Consensus 107 ~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 107 AQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 999999999999999999998 9999999999999999999999999987654322111 111123456799999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++||||||+++|+|++|..||........ ...........................+...+.++.+++.+||.
T Consensus 184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 262 (283)
T cd05080 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWE 262 (283)
T ss_pred ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence 88899999999999999999999999754321100 00000000000000000000011111122234578999999999
Q ss_pred CCCCCCCCHHHHHHhhccC
Q 045452 240 ENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~ 258 (303)
.+|++|||++++++.|++.
T Consensus 263 ~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 263 TEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cChhhCCCHHHHHHHHHHh
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.65 Aligned_cols=234 Identities=28% Similarity=0.410 Sum_probs=184.5
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
...+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+++|||+.+++|.+++... ....+++.
T Consensus 26 ~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 103 (261)
T cd05072 26 YYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLP 103 (261)
T ss_pred EecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh-cCCCCCHH
Confidence 346778899999865432 3578899999999999999999999999999999999999999999988542 34458889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+.
T Consensus 104 ~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05072 104 KLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFG 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccC
Confidence 99999999999999999988 999999999999999999999999999765432211 11122346689999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|+|++ |..||....... ............ .....+.++.+++.+||..
T Consensus 180 ~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~ 243 (261)
T cd05072 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRMP---------RMENCPDELYDIMKTCWKE 243 (261)
T ss_pred CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHccC
Confidence 89999999999999999998 899985322111 111111111110 1111234688999999999
Q ss_pred CCCCCCCHHHHHHhhcc
Q 045452 241 NPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~ 257 (303)
+|++||+++++++.|++
T Consensus 244 ~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 244 KAEERPTFDYLQSVLDD 260 (261)
T ss_pred CcccCcCHHHHHHHHhc
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=266.75 Aligned_cols=232 Identities=27% Similarity=0.417 Sum_probs=181.3
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+.++..+|+|.++... .....+.+|+.+++.++||||+++++++......+++|||+++++|.+++... ...+++.
T Consensus 24 ~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~ 100 (256)
T cd05114 24 KWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR--QGKLSKD 100 (256)
T ss_pred EeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC--ccCCCHH
Confidence 45567789999986443 23467888999999999999999999999999999999999999999988542 2358899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+.......... .....++..|+|||.+.+.
T Consensus 101 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd05114 101 MLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFS 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec-cCCCCCchhhCChhhcccC
Confidence 99999999999999999998 9999999999999999999999999987653322111 1112345689999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|+|++ |+.||..... ......... ..... .+...+..+.+++.+||..
T Consensus 177 ~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~-~~~~~---------~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISR-GFRLY---------RPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHC-CCCCC---------CCCCCCHHHHHHHHHHccC
Confidence 89999999999999999999 8888843321 111111111 11110 1111234688999999999
Q ss_pred CCCCCCCHHHHHHhhc
Q 045452 241 NPNDRPSMLEVSSMLK 256 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~ 256 (303)
+|.+||++.++++.|.
T Consensus 241 ~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 241 KPEGRPTFAELLRAIT 256 (256)
T ss_pred CcccCcCHHHHHHhhC
Confidence 9999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=274.01 Aligned_cols=177 Identities=25% Similarity=0.341 Sum_probs=152.7
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.+|+|.++.. .....+.+.+|+.++++++|+||+++++++..++..++||||+.+++|.+++.. ...+++..
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~ 104 (333)
T cd06650 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQI 104 (333)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH---cCCCCHHH
Confidence 46889999998654 334557789999999999999999999999999999999999999999999843 44588999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.||.|||+.+ +++|+||||+||+++.++.+||+|||++..+.... .....++..|+|||.+.+..
T Consensus 105 ~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 178 (333)
T cd06650 105 LGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTH 178 (333)
T ss_pred HHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCC
Confidence 9999999999999999742 29999999999999999999999999986543221 12245788999999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCcccc
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLC 189 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~ 189 (303)
++.++|+|||||++|+|++|..||...
T Consensus 179 ~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 179 YSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=269.75 Aligned_cols=234 Identities=26% Similarity=0.407 Sum_probs=180.6
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------cc
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------RL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~ 76 (303)
+++.||+|+++... ......+.+|+.+++.++|+||+++++++......++||||+++++|.+++..... ..
T Consensus 35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 114 (277)
T cd05062 35 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114 (277)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 46789999986432 33456788999999999999999999999988999999999999999998854211 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+.............++..|+|||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 115 PPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 4577889999999999999999988 9999999999999999999999999987654332222222234467899999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|+||||+++|+|++ |..||...... .............. +...+..+.+++.
T Consensus 192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li~ 255 (277)
T cd05062 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRFVMEGGLLDK---------PDNCPDMLFELMR 255 (277)
T ss_pred HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCCC---------CCCCCHHHHHHHH
Confidence 9988889999999999999999999 67787432211 11111111111111 1112346889999
Q ss_pred hcccCCCCCCCCHHHHHHhhcc
Q 045452 236 LCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+||+.||++|||+.++++.|+.
T Consensus 256 ~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 256 MCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCChhhCcCHHHHHHHhhC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=266.92 Aligned_cols=233 Identities=27% Similarity=0.389 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++++.||+|+++... ....+.+.+|+.+++.++|+||+++++++. ....+++|||+++++|.+++. ....+++.
T Consensus 20 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~ 95 (257)
T cd05116 20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ---KNKHVTEK 95 (257)
T ss_pred CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH---hcCCCCHH
Confidence 578999999986443 345678899999999999999999999875 457799999999999999884 33468999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc-ccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA-NTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 160 (303)
.+..++.|++.||++||+.| ++|+||||.||+++.++.++|+|||++.......... ......++..|+|||.+..
T Consensus 96 ~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 172 (257)
T cd05116 96 NITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172 (257)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc
Confidence 99999999999999999998 9999999999999999999999999987654332111 1111223578999999988
Q ss_pred CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..++.++|+|||||++|+|++ |..||....... ............ .+...+.++.++|.+||.
T Consensus 173 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~~---------~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERME---------CPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC---------CCCCCCHHHHHHHHHHhc
Confidence 888999999999999999998 899985332111 111111111111 111233478899999999
Q ss_pred CCCCCCCCHHHHHHhhccCC
Q 045452 240 ENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~~ 259 (303)
.||++||++.+|.+.|++.+
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 237 YGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred cCchhCcCHHHHHHHHhccc
Confidence 99999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=261.72 Aligned_cols=246 Identities=23% Similarity=0.286 Sum_probs=184.2
Q ss_pred CCCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcC
Q 045452 3 LPCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
..+|+.||+|+++-... .......+|+.+++.|+|+| |+.+++++...+ .+++|+||+ ..+|..++....
T Consensus 33 ~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~ 111 (323)
T KOG0594|consen 33 KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLP 111 (323)
T ss_pred ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhcc
Confidence 46789999999976543 23456689999999999999 999999999877 789999999 568888886533
Q ss_pred cc-cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 74 RR-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 74 ~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
.. ..++...++.++.||+.||+|||+.+ |+||||||+||+++.+|.+||+|||+++.+.-.... ....+.|.+|
T Consensus 112 ~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWY 186 (323)
T KOG0594|consen 112 KKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWY 186 (323)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeec
Confidence 21 45777899999999999999999999 999999999999999999999999999865432211 2335679999
Q ss_pred cCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH-----HhhCCCccccccccccCCC-ChH
Q 045452 153 IPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGMEFVDSFLDDRN-SSC 225 (303)
Q Consensus 153 ~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~ 225 (303)
+|||++.+. .|+...||||+|||+.||+++++.|......+....+-.... .|++.....-......... +..
T Consensus 187 RaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~ 266 (323)
T KOG0594|consen 187 RAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKD 266 (323)
T ss_pred cCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccc
Confidence 999998777 699999999999999999999988865544222222222111 1222111111111111111 111
Q ss_pred HH-------HHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 226 KL-------MRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 226 ~~-------~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.. ....+++.+||+.+|.+|.|++..+..
T Consensus 267 l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 267 LSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred hHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11 367899999999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=274.74 Aligned_cols=230 Identities=23% Similarity=0.294 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccCC----ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKS----SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||+|+++.. .....+.+..|+.+++.+ +|+||+++++++......++||||+.+|+|.+++. .+..+
T Consensus 26 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~ 102 (332)
T cd05614 26 DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNF 102 (332)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH---HcCCC
Confidence 57899999998643 223446678899999999 59999999999999999999999999999999884 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..+..++.||+.||+|||+.| ++||||||+|||++.++.+||+|||++..+..... .......|+..|+|||.+
T Consensus 103 ~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 103 SEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEII 178 (332)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHh
Confidence 99999999999999999999998 99999999999999999999999999876533221 112234689999999998
Q ss_pred ccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 159 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
.+. .++.++|||||||++|+|++|..||.............. ...... ...+...+..+.+++.+|
T Consensus 179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~~~~~~li~~~ 245 (332)
T cd05614 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RILKCD-----------PPFPSFIGPEAQDLLHKL 245 (332)
T ss_pred cCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHhcCC-----------CCCCCCCCHHHHHHHHHH
Confidence 765 478899999999999999999999964433222211111 111100 011112234688999999
Q ss_pred ccCCCCCCC-----CHHHHHH
Q 045452 238 VQENPNDRP-----SMLEVSS 253 (303)
Q Consensus 238 l~~dp~~Rp-----s~~~l~~ 253 (303)
|..||++|| +++++++
T Consensus 246 l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 246 LRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred cCCCHHHcCCCCCCCHHHHHc
Confidence 999999999 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=267.37 Aligned_cols=232 Identities=22% Similarity=0.249 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-CcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~ 79 (303)
.+|+.||+|++.... ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|..++... .....++
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~ 95 (280)
T cd05608 16 ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP 95 (280)
T ss_pred cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCC
Confidence 478999999986432 223456788999999999999999999999999999999999999998877432 2345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++..+..... ......|+..|+|||.+.
T Consensus 96 ~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~ 170 (280)
T cd05608 96 EPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQ 170 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhc
Confidence 9999999999999999999998 99999999999999999999999999876543221 122345789999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||||+++|+|++|+.||.......... ......... . ...+...+..+.+++.+||+
T Consensus 171 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~-~---------~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRILND-S---------VTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhhccc-C---------CCCcccCCHHHHHHHHHHhc
Confidence 9999999999999999999999999996433221111 111110000 0 01112234478899999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 045452 240 ENPNDRP-----SMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rp-----s~~~l~~ 253 (303)
.||++|| ++++++.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.65 Aligned_cols=226 Identities=21% Similarity=0.241 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++.. .......+..|+.+++.++||||+++++++......++||||+++++|..++. ....+++
T Consensus 18 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~l~~ 94 (325)
T cd05594 18 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSE 94 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 57899999999653 22345667889999999999999999999999999999999999999988874 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
..+..++.||+.||+|||+ .| ++||||||+||+++.++.+||+|||++....... .......|+..|+|||++.
T Consensus 95 ~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05594 95 DRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLE 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHc
Confidence 9999999999999999997 67 9999999999999999999999999986432211 1122345899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||....... ......... . ..+...+.++.++|.+||.
T Consensus 170 ~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~~~~--~---------~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE--I---------RFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHhcCC--C---------CCCCCCCHHHHHHHHHHhh
Confidence 8889999999999999999999999995432111 011111110 0 1111223478899999999
Q ss_pred CCCCCCC-----CHHHHHHh
Q 045452 240 ENPNDRP-----SMLEVSSM 254 (303)
Q Consensus 240 ~dp~~Rp-----s~~~l~~~ 254 (303)
.||++|+ ++.++++.
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999996 89988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=279.09 Aligned_cols=234 Identities=30% Similarity=0.397 Sum_probs=188.7
Q ss_pred EEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 9 IAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 9 vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
||+|..+.. ......++++|+++|++++|||||++||+......+++|||+|.||+|.++|... ...++..+...
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~ 266 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLR 266 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHH
Confidence 899998753 4667889999999999999999999999999999999999999999999999653 22599999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 165 (303)
++.+.+.||+|||+++ ++||||-.+|+|++.++.+||+|||+++.-. .+........-...|+|||.+....++.
T Consensus 267 ~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 267 FCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred HHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCcccc
Confidence 9999999999999999 9999999999999999999999999987543 1111111123467999999999999999
Q ss_pred cccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
++||||||+++||+++ |..||.... ...-.......+... ..+...+.++..++.+||..+|++
T Consensus 342 kTDV~sfGV~~~Eif~~g~~Py~g~~------~~~v~~kI~~~~~r~---------~~~~~~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 342 KTDVWSFGVLLWEIFENGAEPYPGMK------NYEVKAKIVKNGYRM---------PIPSKTPKELAKVMKQCWKKDPED 406 (474)
T ss_pred ccchhheeeeEEeeeccCCCCCCCCC------HHHHHHHHHhcCccC---------CCCCCCHHHHHHHHHHhccCChhh
Confidence 9999999999999998 777874322 112112221222222 222244557889999999999999
Q ss_pred CCCHHHHHHhhccCCCCCCC
Q 045452 245 RPSMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 245 Rps~~~l~~~L~~~~~~~~~ 264 (303)
|||+.++.+.|+........
T Consensus 407 R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 407 RPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCHHHHHHHHHHHHhcccc
Confidence 99999999999887765553
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=273.97 Aligned_cols=231 Identities=19% Similarity=0.309 Sum_probs=179.4
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|+++.. .......+..|..+++.+ +||||+++++++......++||||+++++|..++. ....++
T Consensus 18 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~---~~~~l~ 94 (329)
T cd05588 18 KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ---RQRKLP 94 (329)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH---HcCCCC
Confidence 47899999999753 233456688899999988 79999999999999999999999999999988874 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05588 95 EEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccCCccccCHHHHc
Confidence 9999999999999999999998 999999999999999999999999998642211 11223356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCc--cccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE--NLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+..++.++|+|||||++|+|++|..||....... ................ .. .+...+.++.++|.+|
T Consensus 170 ~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~---------~p~~~~~~~~~li~~~ 239 (329)
T cd05588 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IR---------IPRSLSVKASSVLKGF 239 (329)
T ss_pred CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CC---------CCCCCCHHHHHHHHHH
Confidence 9889999999999999999999999996433222 1111111111111111 01 1112234688999999
Q ss_pred ccCCCCCCCC------HHHHH
Q 045452 238 VQENPNDRPS------MLEVS 252 (303)
Q Consensus 238 l~~dp~~Rps------~~~l~ 252 (303)
|..||.+||+ +++++
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHh
Confidence 9999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.61 Aligned_cols=236 Identities=27% Similarity=0.396 Sum_probs=183.0
Q ss_pred CCEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc---------
Q 045452 6 GEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--------- 74 (303)
Q Consensus 6 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 74 (303)
+..||||+++... ....+.+.+|+.+++++. ||||+++++++......++||||+++|+|.+++.....
T Consensus 67 ~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~ 146 (400)
T cd05105 67 VMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146 (400)
T ss_pred ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccc
Confidence 4579999997543 345578999999999995 99999999999999999999999999999888753210
Q ss_pred --------------------------------------------------------------------------------
Q 045452 75 -------------------------------------------------------------------------------- 74 (303)
Q Consensus 75 -------------------------------------------------------------------------------- 74 (303)
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 226 (400)
T cd05105 147 PKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLL 226 (400)
T ss_pred ccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHH
Confidence
Q ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccc
Q 045452 75 ----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTI 150 (303)
Q Consensus 75 ----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 150 (303)
...+++..+..++.||+.||+|||..+ ++|+||||+||+++.++.+||+|||++................++.
T Consensus 227 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 303 (400)
T cd05105 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303 (400)
T ss_pred HhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCc
Confidence 124778888999999999999999988 9999999999999999999999999987654322222222234567
Q ss_pred cccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++|||||||++|+|++ |..||....... ............. .+...+.+
T Consensus 304 ~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~ 368 (400)
T cd05105 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYNKIKSGYRMA---------KPDHATQE 368 (400)
T ss_pred ceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHHHHhcCCCCC---------CCccCCHH
Confidence 8999999988889999999999999999997 888885322111 1111111111111 11122347
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
+.+++.+||..||++|||+.+|.+.|++..
T Consensus 369 l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 369 VYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=274.00 Aligned_cols=221 Identities=22% Similarity=0.251 Sum_probs=171.8
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+.+++|..++. ....++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~ 94 (323)
T cd05575 18 ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFP 94 (323)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH---hcCCCC
Confidence 478999999986432 222344455544 5678899999999999999999999999999999988884 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (323)
T cd05575 95 EPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLR 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChhhcChhhhc
Confidence 9999999999999999999998 999999999999999999999999998643221 11222346899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||....... ......... . ..+...+..+.++|.+||+
T Consensus 170 ~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~--~---------~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNKP--L---------RLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred CCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC--C---------CCCCCCCHHHHHHHHHHhh
Confidence 8899999999999999999999999985432111 111111110 0 0111123478899999999
Q ss_pred CCCCCCCCHH
Q 045452 240 ENPNDRPSML 249 (303)
Q Consensus 240 ~dp~~Rps~~ 249 (303)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (323)
T cd05575 233 KDRTKRLGAK 242 (323)
T ss_pred cCHHhCCCCC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=261.07 Aligned_cols=233 Identities=33% Similarity=0.486 Sum_probs=187.0
Q ss_pred CCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc------ccC
Q 045452 5 CGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------RLI 77 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~ 77 (303)
.+..|++|.++..... ..+.+.+|+..++.++|+||+++++++......+++|||+++++|.+++..... ...
T Consensus 22 ~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 101 (262)
T cd00192 22 KTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKST 101 (262)
T ss_pred CCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhcccccccccccc
Confidence 3889999999765443 367899999999999999999999999999999999999999999999865311 367
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+..+.............++..|+|||.
T Consensus 102 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (262)
T cd00192 102 LSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHH
Confidence 899999999999999999999988 99999999999999999999999999987654332222333456789999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+....++.++|+||||+++|+|++ |..||...... . ........... ..+...+.++.+++.+
T Consensus 179 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~ 242 (262)
T cd00192 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------E-VLEYLRKGYRL---------PKPEYCPDELYELMLS 242 (262)
T ss_pred hccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCC---------CCCccCChHHHHHHHH
Confidence 988889999999999999999999 58888544211 1 11111111111 1112224578899999
Q ss_pred cccCCCCCCCCHHHHHHhhc
Q 045452 237 CVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~ 256 (303)
||..+|.+|||+.+++..|+
T Consensus 243 ~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 243 CWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HccCCcccCcCHHHHHHhhC
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=269.47 Aligned_cols=235 Identities=29% Similarity=0.459 Sum_probs=183.5
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 73 (303)
.+++.||+|.++... ......+.+|+.+++.++|+||+++++++......+++|||+.+++|.+++....
T Consensus 32 ~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 111 (283)
T cd05090 32 DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS 111 (283)
T ss_pred CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccc
Confidence 356889999997543 3445678899999999999999999999999999999999999999999884311
Q ss_pred -----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeec
Q 045452 74 -----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG 148 (303)
Q Consensus 74 -----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 148 (303)
....+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++................+
T Consensus 112 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 188 (283)
T cd05090 112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188 (283)
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCc
Confidence 1234788899999999999999999998 99999999999999999999999999876543322222233345
Q ss_pred cccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .............. .+...+
T Consensus 189 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~ 252 (283)
T cd05090 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QEVIEMVRKRQLLP---------CSEDCP 252 (283)
T ss_pred cceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCcCC---------CCCCCC
Confidence 678999999988889999999999999999998 8888743221 11111111111111 111123
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
.++.+++.+||+.||.+||++.+|.+.|..
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 253 PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=274.85 Aligned_cols=221 Identities=21% Similarity=0.239 Sum_probs=178.4
Q ss_pred CCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 6 g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+..||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++. ....+++..
T Consensus 56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~ 132 (340)
T PTZ00426 56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDV 132 (340)
T ss_pred CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHH
Confidence 468999998543 23345678899999999999999999999999999999999999999999984 345689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||.|||+.| ++||||||+|||++.++.+||+|||++..+... .....|++.|+|||++.+..
T Consensus 133 ~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 204 (340)
T PTZ00426 133 GCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVG 204 (340)
T ss_pred HHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCC
Confidence 9999999999999999999 999999999999999999999999998765322 22356899999999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|+|||||++|+|++|..||..... .........+.. . .+...+..+.++|.+||..||
T Consensus 205 ~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~~~~--~---------~p~~~~~~~~~li~~~l~~dp 267 (340)
T PTZ00426 205 HGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKILEGII--Y---------FPKFLDNNCKHLMKKLLSHDL 267 (340)
T ss_pred CCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHhcCCC--C---------CCCCCCHHHHHHHHHHcccCH
Confidence 99999999999999999999999964321 111111111110 0 111123467899999999999
Q ss_pred CCCC-----CHHHHHHh
Q 045452 243 NDRP-----SMLEVSSM 254 (303)
Q Consensus 243 ~~Rp-----s~~~l~~~ 254 (303)
.+|+ +++++++.
T Consensus 268 ~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 268 TKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHcCCCCCCCHHHHHcC
Confidence 9995 88888754
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=264.06 Aligned_cols=233 Identities=27% Similarity=0.372 Sum_probs=183.0
Q ss_pred CCCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.+...... ....+.+|+.++++++|+||+++++++......+++|||+.+++|.+++... ...+++..
T Consensus 17 ~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~ 94 (251)
T cd05041 17 KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKK 94 (251)
T ss_pred eCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc--CCCCCHHH
Confidence 44899999998765443 5678999999999999999999999999999999999999999999988542 33578899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.+|++||+.+ ++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..
T Consensus 95 ~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 171 (251)
T cd05041 95 LLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171 (251)
T ss_pred HHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCC
Confidence 9999999999999999988 9999999999999999999999999987654222221111122356799999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|+|++ |..||....... .......... ...+...+.++.+++.+||..+
T Consensus 172 ~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 235 (251)
T cd05041 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGYR---------MPAPQLCPEEIYRLMLQCWAYD 235 (251)
T ss_pred CCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCCC---------CCCCccCCHHHHHHHHHHhccC
Confidence 9999999999999999998 778874332111 1111111110 0111223347889999999999
Q ss_pred CCCCCCHHHHHHhhcc
Q 045452 242 PNDRPSMLEVSSMLKN 257 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~ 257 (303)
|.+|||+.++++.|+.
T Consensus 236 p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 236 PENRPSFSEIYNELQI 251 (251)
T ss_pred hhhCcCHHHHHHHhhC
Confidence 9999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=282.60 Aligned_cols=219 Identities=23% Similarity=0.305 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.+|||.+++.. ....+..+.|.+++... +||.++.++..|.+.+++|+||||+.||++.... ....++
T Consensus 391 ~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~----~~~~F~ 466 (694)
T KOG0694|consen 391 GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI----HTDVFS 466 (694)
T ss_pred CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE----eccccc
Confidence 478899999998763 45678888999888887 6999999999999999999999999999854443 456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+.-++..|+.||+|||++| |+|||||.+|||+|.+|.+||+|||++..-- .......+++||+.|+|||++.
T Consensus 467 e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~ 541 (694)
T KOG0694|consen 467 EPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLT 541 (694)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC--CCCCccccccCChhhcChhhhc
Confidence 9999999999999999999999 9999999999999999999999999997532 2345667799999999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..|+.+.|.|+||++||+|+.|+.||...+..+....+- .. + ...|.-.+.+..+|++++|.
T Consensus 542 e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~d-------~----~~yP~~ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 542 EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------ND-------E----VRYPRFLSKEAIAIMRRLLR 604 (694)
T ss_pred cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------cC-------C----CCCCCcccHHHHHHHHHHhc
Confidence 9999999999999999999999999996544333221111 10 0 11222234477899999999
Q ss_pred CCCCCCCCH
Q 045452 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rps~ 248 (303)
+||++|.-.
T Consensus 605 k~p~kRLG~ 613 (694)
T KOG0694|consen 605 KNPEKRLGS 613 (694)
T ss_pred cCcccccCC
Confidence 999999854
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=278.08 Aligned_cols=232 Identities=20% Similarity=0.277 Sum_probs=177.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.+++.++|+||+++++++.+....++||||+++|+|.+++.. ...+++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~e 100 (381)
T cd05626 24 DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR---MEVFPE 100 (381)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh---cCCCCH
Confidence 578999999996532 33456788999999999999999999999999999999999999999998843 456889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc---------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--------------------- 139 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~--------------------- 139 (303)
..+..++.||+.||.|||..| |+||||||+||+++.++.+||+|||++..+.....
T Consensus 101 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (381)
T cd05626 101 VLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177 (381)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccc
Confidence 999999999999999999998 99999999999999999999999998754311000
Q ss_pred ------------------------ccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc
Q 045452 140 ------------------------KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 140 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 195 (303)
........|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-- 255 (381)
T cd05626 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE-- 255 (381)
T ss_pred ccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH--
Confidence 000112468999999999988889999999999999999999999996433211
Q ss_pred cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh--cccCCCCCCCCHHHHHHh
Q 045452 196 SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL--CVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~Rps~~~l~~~ 254 (303)
............... .....+.++.++|.+ |+..+|..||++.+++..
T Consensus 256 ----~~~~i~~~~~~~~~~-------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 256 ----TQLKVINWENTLHIP-------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ----HHHHHHccccccCCC-------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111111111001100 001123467789988 556677779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=271.24 Aligned_cols=225 Identities=24% Similarity=0.281 Sum_probs=174.9
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++... ....+.+..|..++..+ +||||+++++++......++||||+++++|..++.. ...++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~---~~~~~ 94 (316)
T cd05592 18 GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS---SGRFD 94 (316)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH---cCCCC
Confidence 468899999986532 23344556677777654 899999999999999999999999999999988843 44689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05592 95 EARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILK 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHc
Confidence 9999999999999999999998 9999999999999999999999999987543221 2223356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||....... ........ . ...+...+.++.+++.+||.
T Consensus 170 ~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~-~---------~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILND-R---------PHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC-C---------CCCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999999999996432111 11111111 0 01111223467899999999
Q ss_pred CCCCCCCCHH-HHHH
Q 045452 240 ENPNDRPSML-EVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~-~l~~ 253 (303)
.||.+||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05592 233 RDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=280.24 Aligned_cols=231 Identities=21% Similarity=0.282 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++.... ......+.+|+.++++++|+||+++++.+.+++.+++||||+++|+|.+++.. ...+++
T Consensus 24 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~---~~~~~~ 100 (376)
T cd05598 24 DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR---LGIFEE 100 (376)
T ss_pred CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh---cCCCCH
Confidence 568999999986432 23456788999999999999999999999999999999999999999999843 456888
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc----------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES---------------------- 138 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~---------------------- 138 (303)
..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++..+....
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (376)
T cd05598 101 DLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177 (376)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence 999999999999999999998 9999999999999999999999999975321000
Q ss_pred -------------------cccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHH
Q 045452 139 -------------------LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 199 (303)
Q Consensus 139 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 199 (303)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||......+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----- 252 (376)
T cd05598 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET----- 252 (376)
T ss_pred cccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHH-----
Confidence 00001124689999999999998999999999999999999999999964432111
Q ss_pred HHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCC---CHHHHHHh
Q 045452 200 HAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRP---SMLEVSSM 254 (303)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~l~~~ 254 (303)
............. ......+.++.++|.+|+ .+|.+|+ ++.++++.
T Consensus 253 -~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 253 -QLKVINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred -HHHHhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 1111111100000 001112346778898876 5999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=270.51 Aligned_cols=235 Identities=28% Similarity=0.405 Sum_probs=183.7
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc----------
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP---------- 72 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------- 72 (303)
+...||+|.++.. .......+.+|+.+++++ +|+||+++++++..+...+++|||+.+++|..++...
T Consensus 41 ~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~ 120 (293)
T cd05053 41 ETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120 (293)
T ss_pred CceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccc
Confidence 4578999998754 334456788999999999 8999999999999999999999999999999988542
Q ss_pred ---CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecc
Q 045452 73 ---IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149 (303)
Q Consensus 73 ---~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 149 (303)
.....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+.............++
T Consensus 121 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 197 (293)
T cd05053 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197 (293)
T ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCC
Confidence 12456889999999999999999999988 999999999999999999999999998765433222212222345
Q ss_pred ccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++|||||||++|+|++ |..||...... ............. .+...+.
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~ 261 (293)
T cd05053 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-------ELFKLLKEGYRME---------KPQNCTQ 261 (293)
T ss_pred ccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCcCC---------CCCCCCH
Confidence 67999999988889999999999999999997 88887532211 1111111111111 1112234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
.+.+|+.+||..||++|||+.++++.|++.
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=272.44 Aligned_cols=227 Identities=21% Similarity=0.312 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|+++.. .......+..|+.++.++ +||||+++++++......++||||+++++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~---~~~~l~ 94 (329)
T cd05618 18 KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 94 (329)
T ss_pred CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH---HcCCCC
Confidence 46889999999754 233456678899888877 89999999999999999999999999999988874 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05618 95 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccccccCCccccCHHHHc
Confidence 9999999999999999999998 999999999999999999999999998643211 11122356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCcc--ccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--LSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+..++.++|+|||||++|+|++|..||........ ............... .. .+...+.++.++|.+|
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~---------~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR---------IPRSLSVKAASVLKSF 239 (329)
T ss_pred CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-CC---------CCCCCCHHHHHHHHHH
Confidence 99999999999999999999999999954322211 111111122111111 01 1112234678999999
Q ss_pred ccCCCCCCCCH
Q 045452 238 VQENPNDRPSM 248 (303)
Q Consensus 238 l~~dp~~Rps~ 248 (303)
|..||++||++
T Consensus 240 L~~dP~~R~~~ 250 (329)
T cd05618 240 LNKDPKERLGC 250 (329)
T ss_pred hcCCHHHcCCC
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.71 Aligned_cols=241 Identities=25% Similarity=0.423 Sum_probs=182.2
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc--------c
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--------R 75 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~ 75 (303)
++..||+|.++.. .....+.+.+|+.+++.++|+||+++++++......+++|||+.+++|.+++..... .
T Consensus 45 ~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05095 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124 (296)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence 4557999999755 344567899999999999999999999999999999999999999999998854211 1
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++..+.............++..|++|
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 24677889999999999999999998 999999999999999999999999998765433222212222345789999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHh--CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|...+..++.++|+|||||++|+|++ |..||......... ................ ..+...+..+.++
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l 272 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI---ENTGEFFRDQGRQVYL------PKPALCPDSLYKL 272 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH---HHHHHHHhhccccccC------CCCCCCCHHHHHH
Confidence 98888889999999999999999998 66777533222211 1111111111000000 0111123478899
Q ss_pred HHhcccCCCCCCCCHHHHHHhhcc
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+.+||+.||++||++.+|++.|++
T Consensus 273 i~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 273 MLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHcCCCcccCCCHHHHHHHHhC
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.14 Aligned_cols=240 Identities=23% Similarity=0.255 Sum_probs=175.1
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|+++.... .....+.+|+.+++.++||||+++++++.+....++||||+. ++|.+++.. ....++...
T Consensus 28 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~ 104 (303)
T cd07869 28 VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK--HPGGLHPEN 104 (303)
T ss_pred CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh--CCCCCCHHH
Confidence 3789999999865432 233467789999999999999999999999999999999995 577777643 234588899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-C
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 161 (303)
+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+ .
T Consensus 105 ~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (303)
T cd07869 105 VKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGST 179 (303)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCC
Confidence 9999999999999999998 9999999999999999999999999986543221 11222457889999998865 4
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC--------c-cccccccccCCCC---------
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK--------G-MEFVDSFLDDRNS--------- 223 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~~~~~~~--------- 223 (303)
.++.++|||||||++|+|++|..||..... ....+........... . ............+
T Consensus 180 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (303)
T cd07869 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNK 257 (303)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhc
Confidence 578899999999999999999999964321 1111111111110000 0 0000000000000
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
......+.+++.+||+.||++|||++++++
T Consensus 258 ~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 258 LSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 001235779999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=271.16 Aligned_cols=238 Identities=31% Similarity=0.443 Sum_probs=183.3
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCc------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~------ 74 (303)
.+++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... ...+++|||+.+++|.+++.....
T Consensus 35 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~ 114 (337)
T cd05054 35 ASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYR 114 (337)
T ss_pred cccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccc
Confidence 456899999997543 33456788899999999 899999999988654 568899999999999988753211
Q ss_pred ----------------------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 045452 75 ----------------------------------------------------RLILDWKKRVHIIEGITQGLLYLQEYSR 102 (303)
Q Consensus 75 ----------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 102 (303)
...+++..+..++.||+.||+|||+.+
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~- 193 (337)
T cd05054 115 NKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK- 193 (337)
T ss_pred cccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 136789999999999999999999988
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS- 181 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~- 181 (303)
|+||||||.||+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 194 --ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~ 271 (337)
T cd05054 194 --CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271 (337)
T ss_pred --eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHc
Confidence 99999999999999999999999999976543222222222345678999999999999999999999999999998
Q ss_pred CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 182 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
|..||......+ . ........... ..+...+.++.+++.+||+.+|++||++.++++.|++..
T Consensus 272 g~~p~~~~~~~~---~---~~~~~~~~~~~---------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 272 GASPYPGVQIDE---E---FCRRLKEGTRM---------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred CCCCCCCCCccH---H---HHHHHhccCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999985322111 0 11111111111 111223347889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=263.81 Aligned_cols=231 Identities=26% Similarity=0.407 Sum_probs=179.9
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+.++..||+|.++... ...+.+.+|+.++++++||||+++++++......+++|||+.+++|.+++... ...+++..
T Consensus 25 ~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~ 101 (256)
T cd05113 25 WRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQ 101 (256)
T ss_pred ecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc--CCCCCHHH
Confidence 3455679999986543 23467899999999999999999999999888899999999999999988542 23689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||+.+ ++|+||+|.||+++.++.+||+|||.+......... ......++..|+|||.+.+..
T Consensus 102 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~ 177 (256)
T cd05113 102 LLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSK 177 (256)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCc
Confidence 9999999999999999998 999999999999999999999999998765432211 111123456899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|+|++ |..||....... ....... .... ..+...+..+.+++.+||..+
T Consensus 178 ~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~-~~~~---------~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQ-GLRL---------YRPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhc-CCCC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 8999999999999999998 888885332111 1111111 1110 001112357889999999999
Q ss_pred CCCCCCHHHHHHhhc
Q 045452 242 PNDRPSMLEVSSMLK 256 (303)
Q Consensus 242 p~~Rps~~~l~~~L~ 256 (303)
|.+||++.+|+..|+
T Consensus 242 p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 242 AEERPTFQQLLSSIE 256 (256)
T ss_pred cccCCCHHHHHHhhC
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.48 Aligned_cols=241 Identities=25% Similarity=0.411 Sum_probs=184.4
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC--------cc
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------RR 75 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~ 75 (303)
.+..||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...+++||++.+++|.+++.... ..
T Consensus 45 ~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05051 45 APVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124 (296)
T ss_pred CceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccC
Confidence 45678999987553 4456789999999999999999999999999999999999999999999985422 11
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+||
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 125 KSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 25899999999999999999999988 999999999999999999999999998765433222222233456789999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHh--CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|.+.+..++.++|||||||++|+|++ +..||..... ..........+........ ...+...+.++.++
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~l 272 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD---QQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYEL 272 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---HHHHHHHHhcccccccccc------CCCccCCCHHHHHH
Confidence 99988889999999999999999998 6667643221 1111211111111110000 01112223578999
Q ss_pred HHhcccCCCCCCCCHHHHHHhhcc
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+.+||+.||.+|||+.+|++.|++
T Consensus 273 i~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 273 MLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHhccChhcCCCHHHHHHHhcC
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=263.54 Aligned_cols=233 Identities=23% Similarity=0.342 Sum_probs=181.0
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
++..||+|.+.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++|.+++.. ....+++..+
T Consensus 21 ~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 97 (257)
T cd05115 21 KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG--KKDEITVSNV 97 (257)
T ss_pred CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHh--CCCCCCHHHH
Confidence 45679999987553 334567899999999999999999999875 4578999999999999998853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc-cceeeccccccCchhcccCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN-TEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 162 (303)
+.++.|++.||++||+.| ++|+||||+||+++.++.+||+|||++........... .....++..|+|||.+.+..
T Consensus 98 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 98 VELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred HHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC
Confidence 999999999999999998 99999999999999999999999999875433211111 11112356899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|++++ |..||....... .......+... ..+...+.++.+++.+||..+
T Consensus 175 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------DCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 8999999999999999996 999985332111 11111111111 111222357889999999999
Q ss_pred CCCCCCHHHHHHhhccCC
Q 045452 242 PNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~ 259 (303)
|++||++.++.+.|+..+
T Consensus 239 ~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 239 WEDRPNFAKVEERMRTYY 256 (257)
T ss_pred hhhCcCHHHHHHHHhhhc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=267.14 Aligned_cols=234 Identities=25% Similarity=0.406 Sum_probs=182.1
Q ss_pred CCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-----------
Q 045452 5 CGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP----------- 72 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------- 72 (303)
+++.||||+++.... ...+.+.+|+.++..++||||+++++++......+++++|+.+++|.+++...
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05091 34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113 (283)
T ss_pred ceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccc
Confidence 467899999975533 34567889999999999999999999999999999999999999999887421
Q ss_pred --CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccc
Q 045452 73 --IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTI 150 (303)
Q Consensus 73 --~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 150 (303)
.....+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++................++.
T Consensus 114 ~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 190 (283)
T cd05091 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190 (283)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCc
Confidence 11235788889999999999999999998 9999999999999999999999999987654322222222334567
Q ss_pred cccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++|||||||++|+|++ |..||...... ............. .+...+..
T Consensus 191 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~i~~~~~~~---------~~~~~~~~ 254 (283)
T cd05091 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DVIEMIRNRQVLP---------CPDDCPAW 254 (283)
T ss_pred cccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCC---------CCCCCCHH
Confidence 8999999988889999999999999999998 77777432211 1111111111111 11123346
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 255 ~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 255 VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=277.63 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=175.3
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||.++.. .......+.+|+.+++.++||||+++++++.... ..++||||+. ++|.+++. ...
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~---~~~ 98 (338)
T cd07859 23 HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK---AND 98 (338)
T ss_pred CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH---hcc
Confidence 57899999998643 2234457889999999999999999999886432 4799999994 68888874 344
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aP 155 (303)
.+++..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++........ ........++..|+||
T Consensus 99 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aP 175 (338)
T cd07859 99 DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175 (338)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCH
Confidence 6899999999999999999999998 99999999999999999999999999875432211 1112234689999999
Q ss_pred hhccc--CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH--------HHHhhCCCcccccccc-------c
Q 045452 156 EYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGMEFVDSF-------L 218 (303)
Q Consensus 156 E~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-------~ 218 (303)
|++.+ ..++.++|||||||++|+|++|+.||...........+... ................ .
T Consensus 176 E~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 255 (338)
T cd07859 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF 255 (338)
T ss_pred HHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCch
Confidence 98865 56889999999999999999999998543321111100000 0000000000000000 0
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.... ......+.+++.+||..||++|||++++++.
T Consensus 256 ~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 256 SQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0123467899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=273.71 Aligned_cols=226 Identities=22% Similarity=0.269 Sum_probs=178.2
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|+++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~~~ 94 (321)
T cd05591 18 GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ---RSRKFD 94 (321)
T ss_pred CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 46889999998653 233455677888888866 89999999999999999999999999999988884 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05591 95 EPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQ 169 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHc
Confidence 9999999999999999999998 9999999999999999999999999986532221 1122346899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|+.||....... .......... ..+...+.++.+++.+||.
T Consensus 170 ~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~~-----------~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDDV-----------LYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred CCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhc
Confidence 8889999999999999999999999996432111 1111111110 0111123478899999999
Q ss_pred CCCCCCC-------CHHHHHHh
Q 045452 240 ENPNDRP-------SMLEVSSM 254 (303)
Q Consensus 240 ~dp~~Rp-------s~~~l~~~ 254 (303)
.||++|| ++.++++.
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=274.18 Aligned_cols=220 Identities=23% Similarity=0.295 Sum_probs=174.6
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++++|..++.. ...++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~---~~~l~ 94 (320)
T cd05590 18 ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFD 94 (320)
T ss_pred CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH---cCCCC
Confidence 46899999998643 223456677888888876 799999999999999999999999999999988843 45689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........|+..|+|||.+.
T Consensus 95 ~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (320)
T cd05590 95 EARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQ 169 (320)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcccccccCccccCHHHHc
Confidence 9999999999999999999998 999999999999999999999999998653221 11223346899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|+.||....... .......... ..+...+.++.+++.+||+
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999999999996432111 1111111110 0111123468899999999
Q ss_pred CCCCCCCCH
Q 045452 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rps~ 248 (303)
.||.+||++
T Consensus 233 ~dP~~R~~~ 241 (320)
T cd05590 233 KNPTMRLGS 241 (320)
T ss_pred cCHHHCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=263.58 Aligned_cols=232 Identities=28% Similarity=0.423 Sum_probs=182.9
Q ss_pred CCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
...||+|.++... ......+.+|+..+++++|+||+++++++......+++|||+++++|.+++... ...+++..++
T Consensus 32 ~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~ 109 (266)
T cd05033 32 EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLV 109 (266)
T ss_pred cceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhc--cCCCCHHHHH
Confidence 4689999987543 345567889999999999999999999999999999999999999999998542 2368899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.+++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++..+.............++..|+|||.+.+..++
T Consensus 110 ~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 186 (266)
T cd05033 110 GMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186 (266)
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCc
Confidence 99999999999999988 999999999999999999999999999876422211111122345789999999888899
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++|+||||+++|+|++ |..||....... ............ .+...+..+.+++.+||+.+|+
T Consensus 187 ~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 187 SASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRLP---------PPMDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred cccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcc
Confidence 99999999999999997 888884322111 111111111100 1112234688999999999999
Q ss_pred CCCCHHHHHHhhccC
Q 045452 244 DRPSMLEVSSMLKNE 258 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~ 258 (303)
+||+++++++.|.+.
T Consensus 251 ~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 251 ERPTFSQIVSTLDKM 265 (266)
T ss_pred cCcCHHHHHHHHHhh
Confidence 999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=275.01 Aligned_cols=230 Identities=22% Similarity=0.280 Sum_probs=178.4
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ......+.+|+.+++.++|+||+++++.+.++...++||||+.+|+|.+++. ....+++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~l~~ 100 (364)
T cd05599 24 DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTE 100 (364)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH---HcCCCCH
Confidence 478999999996432 2344667889999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc-------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA------------------- 141 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~------------------- 141 (303)
..+..++.||+.||+|||+.| ++||||||+|||++.++.++|+|||++..+.......
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (364)
T cd05599 101 EETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177 (364)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence 999999999999999999998 9999999999999999999999999986543211000
Q ss_pred -----------------ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHH
Q 045452 142 -----------------NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 204 (303)
Q Consensus 142 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 204 (303)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~------~~~~~i 251 (364)
T cd05599 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ------ETYRKI 251 (364)
T ss_pred cccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH------HHHHHH
Confidence 011235899999999998888999999999999999999999999543211 111111
Q ss_pred hhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 045452 205 WKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS---MLEVSS 253 (303)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~l~~ 253 (303)
........... ....+.++.++|.+|+. +|.+|++ +.++++
T Consensus 252 ~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 252 INWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 11111111110 00123467899999996 9999998 777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=273.18 Aligned_cols=224 Identities=23% Similarity=0.294 Sum_probs=174.2
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHH---hcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLT---AKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++... ....+.+.+|+.++ +.++||||+++++++.+.+..|+||||+.+++|..++. ...
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~----~~~ 97 (324)
T cd05589 22 KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDV 97 (324)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh----cCC
Confidence 478999999996442 23345666676555 56689999999999999999999999999999988773 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........|+..|+|||.
T Consensus 98 l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~ 172 (324)
T cd05589 98 FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--GDRTSTFCGTPEFLAPEV 172 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC--CCcccccccCccccCHhH
Confidence 899999999999999999999998 999999999999999999999999987643221 122233568999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+.+..++.++|||||||++|+|++|..||....... .......... ..+...+..+.++|.+|
T Consensus 173 ~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~~-----------~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDEV-----------RYPRFLSREAISIMRRL 235 (324)
T ss_pred hcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-----------CCCCCCCHHHHHHHHHH
Confidence 998889999999999999999999999985432111 1111111110 01112234678999999
Q ss_pred ccCCCCCCC-----CHHHHHH
Q 045452 238 VQENPNDRP-----SMLEVSS 253 (303)
Q Consensus 238 l~~dp~~Rp-----s~~~l~~ 253 (303)
|..||.+|| ++.++++
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhh
Confidence 999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=266.93 Aligned_cols=234 Identities=27% Similarity=0.428 Sum_probs=183.7
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-------ccc
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------RRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~ 76 (303)
+++.||+|.+.... ......+.+|+.+++.++|+||+++++++......+++|||+++++|.+++.... ...
T Consensus 35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (277)
T cd05032 35 PETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114 (277)
T ss_pred cceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCC
Confidence 45789999986543 3445678899999999999999999999999999999999999999999985422 123
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.............++..|+|||
T Consensus 115 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05032 115 PPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHH
Confidence 4688899999999999999999988 9999999999999999999999999987654433222223344577899999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|||||||++|++++ |..||....... ............. +...+.++.+++.
T Consensus 192 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~li~ 255 (277)
T cd05032 192 SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVIDGGHLDL---------PENCPDKLLELMR 255 (277)
T ss_pred HHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHhcCCCCCC---------CCCCCHHHHHHHH
Confidence 9988889999999999999999998 888884322111 1111111111111 1112457889999
Q ss_pred hcccCCCCCCCCHHHHHHhhcc
Q 045452 236 LCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+||..+|++|||+.++++.|++
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHcCCChhhCCCHHHHHHHhcC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=276.78 Aligned_cols=230 Identities=20% Similarity=0.264 Sum_probs=179.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.++... ....+.+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++... ...+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~ 101 (330)
T cd05601 24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY--EDQFDE 101 (330)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh--cCCCCH
Confidence 478999999997542 234567889999999999999999999999999999999999999999998542 246899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..+...... ......|+..|+|||++.
T Consensus 102 ~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 102 DMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcc
Confidence 999999999999999999998 999999999999999999999999999765433211 222346789999999886
Q ss_pred -----cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 160 -----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 160 -----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
...++.++|||||||++|+|++|..||...... ............... ......+.++.+||
T Consensus 178 ~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-------~~~~~~~~~~~~li 244 (330)
T cd05601 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF-------PEDPKVSSDFLDLI 244 (330)
T ss_pred ccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC-------CCCCCCCHHHHHHH
Confidence 455778999999999999999999999543221 111111111111110 01112234688999
Q ss_pred HhcccCCCCCCCCHHHHHH
Q 045452 235 LLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~ 253 (303)
.+||. +|.+|||+++++.
T Consensus 245 ~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 245 QSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHcc-ChhhCCCHHHHhC
Confidence 99998 9999999999974
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=270.12 Aligned_cols=229 Identities=24% Similarity=0.323 Sum_probs=174.7
Q ss_pred CCCCEEEEEEccCCC--------------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhh
Q 045452 4 PCGEVIAVKKLSKSS--------------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDC 67 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~ 67 (303)
.+|+.||||++.+.. -...+...+||.+|+++.|||||+++.+..+. +.+|||+|||..|.+..
T Consensus 120 ~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w 199 (576)
T KOG0585|consen 120 VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW 199 (576)
T ss_pred CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc
Confidence 478999999995431 12335788999999999999999999999765 57999999999888732
Q ss_pred hhcCcCcccC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc---cccc
Q 045452 68 YLFDPIRRLI-LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL---KANT 143 (303)
Q Consensus 68 ~l~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~---~~~~ 143 (303)
. ..... +++.+.++++++++.||.|||.+| |+||||||+|+|++.+|+|||+|||.+..+..... ....
T Consensus 200 ~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L 272 (576)
T KOG0585|consen 200 C----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQL 272 (576)
T ss_pred C----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHH
Confidence 2 23333 899999999999999999999999 99999999999999999999999999987632211 1112
Q ss_pred ceeeccccccCchhcccCC----CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccccccc
Q 045452 144 EQVVGTIGYIPPEYARQGV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLD 219 (303)
Q Consensus 144 ~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (303)
..-.||+.|+|||...+.. ...+.||||+|+++|-|+.|+.||......+ ...++... . +.
T Consensus 273 ~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~------l~~KIvn~--p-------L~ 337 (576)
T KOG0585|consen 273 SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE------LFDKIVND--P-------LE 337 (576)
T ss_pred hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH------HHHHHhcC--c-------cc
Confidence 2257999999999886632 3558899999999999999999995332211 11111111 0 11
Q ss_pred CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 220 DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
....+....++.+||.+||.+||++|.++.+|...
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 11111233478899999999999999999999654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=264.02 Aligned_cols=232 Identities=23% Similarity=0.289 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+.... ......+..|++++++++||||+++++++..+...+++|||+.+++|..++... ....+++
T Consensus 16 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~ 94 (277)
T cd05607 16 NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV-GERGLEM 94 (277)
T ss_pred cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-cccCCCH
Confidence 468999999986432 122345567999999999999999999999999999999999999998887542 2345889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+
T Consensus 95 ~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 168 (277)
T cd05607 95 ERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKE 168 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHcc
Confidence 999999999999999999998 9999999999999999999999999987654322 1122457889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+|||||++|+|++|..||......... ........... ... .....+.++.+++.+||..
T Consensus 169 ~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~--~~~--------~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDE--VKF--------EHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhccc--ccc--------ccccCCHHHHHHHHHHhcc
Confidence 88999999999999999999999998643221111 11111111110 000 0011234688999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
||.+||+++++++.
T Consensus 237 ~P~~R~~~~~~~~~ 250 (277)
T cd05607 237 KPEDRLGSREKNDD 250 (277)
T ss_pred CHhhCCCCccchhh
Confidence 99999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=267.94 Aligned_cols=241 Identities=31% Similarity=0.441 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.++.......+.+.+|+.++++++||||+++++++... ...++||||+++++|.+++... ...+++.
T Consensus 31 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~ 108 (284)
T cd05081 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH--RERLDHR 108 (284)
T ss_pred CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc--CcCCCHH
Confidence 46889999999877666778899999999999999999999987543 4689999999999999998532 3458899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 160 (303)
.++.++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++..+...... .......++..|+|||.+.+
T Consensus 109 ~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 109 KLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc
Confidence 99999999999999999998 999999999999999999999999998765432211 11111123456999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCc--------c-ccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE--------N-LSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
..++.++|+||||+++|+|++|..++....... . ............... ....+...+.++.
T Consensus 186 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 256 (284)
T cd05081 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG---------RLPAPPGCPAEIY 256 (284)
T ss_pred CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC---------cCCCCCCCCHHHH
Confidence 889999999999999999999876653221100 0 000000001111110 0011122234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+|+.+||..+|++|||+.+|++.|+..
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 257 AIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=259.89 Aligned_cols=230 Identities=23% Similarity=0.300 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSS-----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||+|.++... ....+.+.+|+.++++++||||+++++++......++++||+++++|.+++. ....+
T Consensus 25 ~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~ 101 (263)
T cd06625 25 DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK---AYGAL 101 (263)
T ss_pred CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH---HhCCC
Confidence 578999999986432 1234578889999999999999999999999999999999999999998884 34558
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc-cceeeccccccCchh
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN-TEQVVGTIGYIPPEY 157 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~ 157 (303)
++..+..++.+++.||++||+.| ++|+||+|+||+++.++.++|+|||.+........... .....++..|+|||.
T Consensus 102 ~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (263)
T cd06625 102 TETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178 (263)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcce
Confidence 88999999999999999999998 99999999999999999999999999875533211111 122346789999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+.+..++.++|+||||+++|+|++|+.||..... .............. ..+......+.++|.+|
T Consensus 179 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~ 243 (263)
T cd06625 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNP---------QLPSHVSPDARNFLRRT 243 (263)
T ss_pred eccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCCC---------CCCccCCHHHHHHHHHH
Confidence 9888899999999999999999999999853211 11111111111111 11122334688999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|..+|.+|||+.++++.
T Consensus 244 l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 244 FVENAKKRPSAEELLRH 260 (263)
T ss_pred hhcCcccCCCHHHHhhC
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=278.99 Aligned_cols=231 Identities=25% Similarity=0.350 Sum_probs=182.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ......+..|+.++..++|+||+++++++.++...++||||+.+++|.+++.. ...+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~ 100 (350)
T cd05573 24 DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR---KDVFPE 100 (350)
T ss_pred CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH---cCCCCH
Confidence 368999999996542 23456788999999999999999999999999999999999999999999853 356899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc----------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES---------------------- 138 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~---------------------- 138 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (350)
T cd05573 101 ETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177 (350)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence 999999999999999999988 9999999999999999999999999987654322
Q ss_pred -----cccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc
Q 045452 139 -----LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF 213 (303)
Q Consensus 139 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (303)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||...... ...............
T Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~ 251 (350)
T cd05573 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ------ETYNKIINWKESLRF 251 (350)
T ss_pred cccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH------HHHHHHhccCCcccC
Confidence 001122346899999999999999999999999999999999999999644311 111111110000000
Q ss_pred ccccccCCCChHHHHHHHHHHHhcccCCCCCCCC-HHHHHHh
Q 045452 214 VDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS-MLEVSSM 254 (303)
Q Consensus 214 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~l~~~ 254 (303)
. .....+.++.++|.+||. ||.+||+ ++++++.
T Consensus 252 p-------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 252 P-------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred C-------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0 000124578899999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=263.72 Aligned_cols=231 Identities=30% Similarity=0.445 Sum_probs=180.1
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++..+|+|++..... ....+.+|+.++++++|+||+++++++......+++|||+++++|.+++... ...+++..
T Consensus 25 ~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~ 101 (256)
T cd05059 25 WRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER--KGKLGTEW 101 (256)
T ss_pred ecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccCCCHHH
Confidence 45667899999864432 3356888999999999999999999999989999999999999999988542 23688999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.++++||+.+ ++|+||+|+||+++.++.+||+|||.+.......... .....++..|+|||.+.+..
T Consensus 102 ~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~ 177 (256)
T cd05059 102 LLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSR 177 (256)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-cCCCCCCccccCHHHhccCC
Confidence 9999999999999999998 9999999999999999999999999987654322111 11112345799999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|+|++ |..||......+ .. ........ ...+...+.++.+++.+||..+
T Consensus 178 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGYR---------LYRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred CCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCCc---------CCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999999999999998 788885332111 11 11111110 1111223457889999999999
Q ss_pred CCCCCCHHHHHHhhc
Q 045452 242 PNDRPSMLEVSSMLK 256 (303)
Q Consensus 242 p~~Rps~~~l~~~L~ 256 (303)
|++|||+.++++.|.
T Consensus 242 p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 242 PEDRPAFKKLLSQLT 256 (256)
T ss_pred hhhCcCHHHHHHHhC
Confidence 999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=264.83 Aligned_cols=235 Identities=26% Similarity=0.400 Sum_probs=183.9
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
++..||+|.++... ....+.+.+|+.+++++ +|+||+++++++...+..+++|||+.+++|.+++... ....+++..
T Consensus 64 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~ 142 (302)
T cd05055 64 AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLED 142 (302)
T ss_pred ceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHH
Confidence 45689999987553 34557889999999999 8999999999999999999999999999999998542 223489999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.||+|||+.+ ++|+||||+||+++.++.++++|||++................++..|+|||.+.+..
T Consensus 143 ~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 143 LLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred HHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 9999999999999999998 9999999999999999999999999987654322111122233567899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||+||++|+|++ |..||....... ............ ..+...+.++.+++.+||..+
T Consensus 220 ~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~ 284 (302)
T cd05055 220 YTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRM---------AQPEHAPAEIYDIMKTCWDAD 284 (302)
T ss_pred CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 898885432211 111111111110 011112347889999999999
Q ss_pred CCCCCCHHHHHHhhccC
Q 045452 242 PNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~ 258 (303)
|++|||+.++++.|++.
T Consensus 285 p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 285 PLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred chhCcCHHHHHHHHHhh
Confidence 99999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=269.91 Aligned_cols=227 Identities=21% Similarity=0.285 Sum_probs=178.2
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.||+|+++... ....+.+..|+.++.++ +|++|+++++++......++||||+++++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~ 94 (327)
T cd05617 18 KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLP 94 (327)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 578899999997542 23456788899999888 79999999999999999999999999999988874 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... ........|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (327)
T cd05617 95 EEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILR 169 (327)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccCCcccCCHHHHC
Confidence 9999999999999999999998 999999999999999999999999998643211 11223356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|..||....................... . ..+...+..+.+++.+||.
T Consensus 170 ~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~---------~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-I---------RIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-C---------CCCCCCCHHHHHHHHHHhc
Confidence 99999999999999999999999999964433322222222222222111 0 1111123467899999999
Q ss_pred CCCCCCCCH
Q 045452 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rps~ 248 (303)
.||.+|+++
T Consensus 240 ~dP~~R~~~ 248 (327)
T cd05617 240 KDPKERLGC 248 (327)
T ss_pred cCHHHcCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=277.97 Aligned_cols=231 Identities=22% Similarity=0.268 Sum_probs=176.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++... .....+.+.+|+.++++++||||+++++++.+....|+||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~ 100 (377)
T cd05629 24 DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI---KYDTFSE 100 (377)
T ss_pred CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 57899999998543 22345678899999999999999999999999999999999999999999884 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc------------cc-------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------------KA------- 141 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~------------~~------- 141 (303)
..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++..+..... ..
T Consensus 101 ~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (377)
T cd05629 101 DVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177 (377)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999 99999999999999999999999999863321000 00
Q ss_pred --------------------------ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc
Q 045452 142 --------------------------NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 142 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 195 (303)
......|+..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--- 254 (377)
T cd05629 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH--- 254 (377)
T ss_pred ccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHH---
Confidence 001135899999999999888999999999999999999999999533211
Q ss_pred cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC---CCHHHHHHh
Q 045452 196 SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR---PSMLEVSSM 254 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~~l~~~ 254 (303)
..............+.. ....+.++.++|.+||. +|.+| +++.+++..
T Consensus 255 ---~~~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 255 ---ETYRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ---HHHHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 11111111111111110 01123467899999997 77775 588888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=260.47 Aligned_cols=237 Identities=21% Similarity=0.296 Sum_probs=186.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~ 79 (303)
.+|+.||||.++.. .......+.+|+.+++.++||||+++++++...+..++++||+++++|.+++.... ....++
T Consensus 25 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 104 (267)
T cd08228 25 LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP 104 (267)
T ss_pred CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCC
Confidence 47899999987542 33445678899999999999999999999999999999999999999988875322 234578
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~ 179 (267)
T cd08228 105 ERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIH 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhc
Confidence 8999999999999999999988 99999999999999999999999999876543221 112245788999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||+|+++|+|++|..||...... ....... ....... .......+..+.+++.+||.
T Consensus 180 ~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~~~~~~--------~~~~~~~~~~~~~li~~cl~ 246 (267)
T cd08228 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IEQCDYP--------PLPTEHYSEKLRELVSMCIY 246 (267)
T ss_pred cCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-HhcCCCC--------CCChhhcCHHHHHHHHHHCC
Confidence 888899999999999999999999998533211 1111111 1111111 11112234578899999999
Q ss_pred CCCCCCCCHHHHHHhhccC
Q 045452 240 ENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~ 258 (303)
.+|++||+++++++.|++.
T Consensus 247 ~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 247 PDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCcccCcCHHHHHHHHHHh
Confidence 9999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=265.11 Aligned_cols=231 Identities=25% Similarity=0.279 Sum_probs=180.2
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|++..... .....+.+|+.+++.++|+||+++++.+......++||||+.+++|.+++... ....+++
T Consensus 23 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~ 101 (285)
T cd05605 23 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM-GNPGFDE 101 (285)
T ss_pred CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc-CcCCCCH
Confidence 4689999999865422 23355778999999999999999999999999999999999999998887532 2345899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 102 ERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcC
Confidence 999999999999999999998 9999999999999999999999999987653221 1122467899999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||+|+++|+|++|..||...........+. ....... ...+...+..+.+||.+||..
T Consensus 176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05605 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKEDQ----------EEYSEKFSEAARSICRQLLTK 242 (285)
T ss_pred CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhhcc----------cccCcccCHHHHHHHHHHccC
Confidence 889999999999999999999999996432211111111 1111100 111122344688999999999
Q ss_pred CCCCCC-----CHHHHHHh
Q 045452 241 NPNDRP-----SMLEVSSM 254 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~~ 254 (303)
||.+|| ++++++..
T Consensus 243 ~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 243 DPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CHHHhcCCCCCCHHHHhcC
Confidence 999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=259.76 Aligned_cols=233 Identities=26% Similarity=0.349 Sum_probs=182.8
Q ss_pred cCCCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 2 VLPCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
...+++.||+|.++... ......+.+|+.+++.++|+||+++++++......++||||+++++|.+++... ...+++
T Consensus 15 ~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~ 92 (250)
T cd05085 15 TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKT 92 (250)
T ss_pred EecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc--CCCCCH
Confidence 35678899999987653 334557889999999999999999999999999999999999999999988542 345789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.+++.+|.++|+.| ++|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+
T Consensus 93 ~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 168 (250)
T cd05085 93 KQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNY 168 (250)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhcc
Confidence 999999999999999999988 999999999999999999999999998654332211 1111233567999999988
Q ss_pred CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..++.++|+||||+++|++++ |..||...... ..... ........ .+...+..+.+++.+||.
T Consensus 169 ~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~~-~~~~~~~~---------~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QAREQ-VEKGYRMS---------CPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHH-HHcCCCCC---------CCCCCCHHHHHHHHHHcc
Confidence 889999999999999999998 88888533211 11111 11111111 111123478899999999
Q ss_pred CCCCCCCCHHHHHHhhc
Q 045452 240 ENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~ 256 (303)
.+|++||++.++++.|.
T Consensus 233 ~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 233 YKPENRPKFSELQKELA 249 (250)
T ss_pred cCcccCCCHHHHHHHhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=272.71 Aligned_cols=222 Identities=22% Similarity=0.247 Sum_probs=172.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+.+++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~ 94 (325)
T cd05604 18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFP 94 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH---HcCCCC
Confidence 578999999986432 223344555554 4677899999999999999999999999999999988874 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... ........|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05604 95 EPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIR 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHHc
Confidence 9999999999999999999998 999999999999999999999999998643211 11222356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||....... ......... .. ..+..+..+.+++.+||.
T Consensus 170 ~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~~--~~---------~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHKP--LV---------LRPGASLTAWSILEELLE 232 (325)
T ss_pred CCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcCC--cc---------CCCCCCHHHHHHHHHHhc
Confidence 9899999999999999999999999995432111 111111110 00 011123467899999999
Q ss_pred CCCCCCCCHHH
Q 045452 240 ENPNDRPSMLE 250 (303)
Q Consensus 240 ~dp~~Rps~~~ 250 (303)
.+|.+||++.+
T Consensus 233 ~~p~~R~~~~~ 243 (325)
T cd05604 233 KDRQRRLGAKE 243 (325)
T ss_pred cCHHhcCCCCC
Confidence 99999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=267.56 Aligned_cols=228 Identities=21% Similarity=0.262 Sum_probs=173.8
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++++|...+. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~ 94 (321)
T cd05603 18 SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFL 94 (321)
T ss_pred CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH---HcCCCC
Confidence 478999999986432 223344555554 5778899999999999999999999999999999988774 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ........|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05603 95 EPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLR 169 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhc
Confidence 8999999999999999999988 999999999999999999999999998643221 11223346899999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||...... .......... . ..+......+.++|.+||+
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~--~---------~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHKP--L---------QLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred CCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcCC--C---------CCCCCCCHHHHHHHHHHcc
Confidence 888999999999999999999999999543211 1111111110 0 1111223467899999999
Q ss_pred CCCCCCCCHH-HHHHhhc
Q 045452 240 ENPNDRPSML-EVSSMLK 256 (303)
Q Consensus 240 ~dp~~Rps~~-~l~~~L~ 256 (303)
.||.+||++. ++.+.++
T Consensus 233 ~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 233 KDQRRRLGAKADFLEIKN 250 (321)
T ss_pred CCHhhcCCCCCCHHHHhC
Confidence 9999999764 3444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=268.64 Aligned_cols=224 Identities=24% Similarity=0.282 Sum_probs=175.0
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+.+++|..++.. ...++
T Consensus 18 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~---~~~~~ 94 (316)
T cd05620 18 GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD---KGRFD 94 (316)
T ss_pred CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH---cCCCC
Confidence 478999999996532 23345566788787754 999999999999999999999999999999888843 45688
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05620 95 LYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQ 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceeccCCCcCccCHHHHc
Confidence 9999999999999999999998 999999999999999999999999988643211 11223356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||...... .......... . ..+...+.++.++|.+||.
T Consensus 170 ~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~-~---------~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDT-P---------HYPRWITKESKDILEKLFE 232 (316)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-C---------CCCCCCCHHHHHHHHHHcc
Confidence 989999999999999999999999999533211 1111111110 0 0111123478899999999
Q ss_pred CCCCCCCCHH-HHH
Q 045452 240 ENPNDRPSML-EVS 252 (303)
Q Consensus 240 ~dp~~Rps~~-~l~ 252 (303)
.||++||++. +++
T Consensus 233 ~dP~~R~~~~~~~~ 246 (316)
T cd05620 233 RDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHcCCChHHHH
Confidence 9999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=275.35 Aligned_cols=235 Identities=18% Similarity=0.168 Sum_probs=173.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.||+|... ...+.+|+.++++++||||+++++++......+++++++. ++|..++.. ...+++..+
T Consensus 115 ~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~l~~~~~ 184 (391)
T PHA03212 115 KTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA---KRNIAICDI 184 (391)
T ss_pred CCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh---cCCCCHHHH
Confidence 578899999753 2346789999999999999999999999999999999984 678777743 345889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++....... ........|+..|+|||++.+..+
T Consensus 185 ~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 260 (391)
T PHA03212 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPY 260 (391)
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCC
Confidence 999999999999999998 9999999999999999999999999986432211 112223568999999999998889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCc----cccHHHHHHHHhh----------------------CCCcccccccc
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINE----NLSILEHAYELWK----------------------GGKGMEFVDSF 217 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~----------------------~~~~~~~~~~~ 217 (303)
+.++|||||||++|+|++|..||....... ....+........ ...... ....
T Consensus 261 ~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 339 (391)
T PHA03212 261 GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRK-PGSR 339 (391)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCC-CCCC
Confidence 999999999999999999998864322110 0001111100000 000000 0000
Q ss_pred ccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 218 LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.........+.++.+||.+||..||++|||++++++
T Consensus 340 ~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 340 PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000001122457889999999999999999999984
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=253.94 Aligned_cols=227 Identities=25% Similarity=0.340 Sum_probs=181.6
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++|+.+|+|+++-. .....+.+.+|+++-+.|+||||+++.+.+......|+|+|++.|+.|..-|. .+..+++.
T Consensus 34 ~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV---~R~~ySEa 110 (355)
T KOG0033|consen 34 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEA 110 (355)
T ss_pred cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH---HHHHHHHH
Confidence 67888889988643 44578899999999999999999999999998889999999999999865552 44668899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
..-.++.||+++|.|+|.++ |+|||+||.|+++... .-+||+|||++..++. ......+.|++.|+|||++
T Consensus 111 ~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvv 184 (355)
T KOG0033|consen 111 DASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVL 184 (355)
T ss_pred HHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC---ccccccccCCCcccCHHHh
Confidence 99999999999999999998 9999999999999543 3499999999988763 3334457899999999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
...+++..+|||+.|+|+|-|+.|.+||.........+.+ ..+.. .+. ...-+-.+++..+|+++||
T Consensus 185 rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I-------~~g~y-d~~-----~~~w~~is~~Ak~LvrrML 251 (355)
T KOG0033|consen 185 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI-------KAGAY-DYP-----SPEWDTVTPEAKSLIRRML 251 (355)
T ss_pred hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH-------hcccc-CCC-----CcccCcCCHHHHHHHHHHh
Confidence 9999999999999999999999999999753332222211 11110 000 1111112236789999999
Q ss_pred cCCCCCCCCHHHHH
Q 045452 239 QENPNDRPSMLEVS 252 (303)
Q Consensus 239 ~~dp~~Rps~~~l~ 252 (303)
..||.+|.|+.|.+
T Consensus 252 ~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 252 TVNPKKRITADEAL 265 (355)
T ss_pred ccChhhhccHHHHh
Confidence 99999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=275.21 Aligned_cols=237 Identities=28% Similarity=0.422 Sum_probs=186.7
Q ss_pred EEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 8 VIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 8 ~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
.||||+++... ++..+.|++|+..+++-+|.||+-+.|+|..... .||+-+|+|.+|..+|+- .+..+++...+.
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv--~etkfdm~~~id 492 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV--QETKFDMNTTID 492 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc--hhhhhhHHHHHH
Confidence 69999998663 4578899999999999999999999999987776 999999999999999864 356689999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc---cCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---QGV 162 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~ 162 (303)
|+.||+.|+.|||.++ |+|+|||..|||+.+++.|||+|||++..-..-.........-|...|+|||++. ..+
T Consensus 493 IAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nP 569 (678)
T KOG0193|consen 493 IAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNP 569 (678)
T ss_pred HHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCC
Confidence 9999999999999999 9999999999999999999999999985422111111222345788999999875 346
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
|+..+||||||||+|||++|..||... ..+ .-+|--+......+..... ...++++.+|+..||.+++
T Consensus 570 fS~qSDVYaFGiV~YELltg~lPysi~-~~d--------qIifmVGrG~l~pd~s~~~---s~~pk~mk~Ll~~C~~~~~ 637 (678)
T KOG0193|consen 570 FSFQSDVYAFGIVWYELLTGELPYSIQ-NRD--------QIIFMVGRGYLMPDLSKIR---SNCPKAMKRLLSDCWKFDR 637 (678)
T ss_pred CCcccchhhhhHHHHHHHhCcCCcCCC-Chh--------heEEEecccccCccchhhh---ccCHHHHHHHHHHHHhcCc
Confidence 899999999999999999999999622 111 1112222221112211111 1123478899999999999
Q ss_pred CCCCCHHHHHHhhccCCCCC
Q 045452 243 NDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~~~~ 262 (303)
++||.+.+|+..|+......
T Consensus 638 ~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 638 EERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccCccHHHHHHHHHHhhhcc
Confidence 99999999999998877643
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.55 Aligned_cols=237 Identities=27% Similarity=0.420 Sum_probs=184.5
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 73 (303)
.+..|++|.+.... ......+.+|+.+++.++||||+++++.+......++++||+.+++|.+++....
T Consensus 29 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 108 (290)
T cd05045 29 GYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108 (290)
T ss_pred cceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccc
Confidence 44678999886543 3445778999999999999999999999999999999999999999999875321
Q ss_pred -----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc
Q 045452 74 -----------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN 142 (303)
Q Consensus 74 -----------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 142 (303)
....+++..++.++.|++.+|+|||+.+ ++||||+|+||+++.++.++|+|||++...........
T Consensus 109 ~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~ 185 (290)
T cd05045 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185 (290)
T ss_pred cccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhc
Confidence 1235788899999999999999999988 99999999999999999999999999876533222111
Q ss_pred cceeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCC
Q 045452 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDR 221 (303)
Q Consensus 143 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ............ ..
T Consensus 186 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~---------~~ 249 (290)
T cd05045 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-------ERLFNLLKTGYR---------ME 249 (290)
T ss_pred ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCC---------CC
Confidence 222344678999999888889999999999999999998 8888843221 111111111111 11
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
.+...+.++.+++.+||+.+|++||++.++++.|++...
T Consensus 250 ~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 250 RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 112233578899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.56 Aligned_cols=234 Identities=25% Similarity=0.429 Sum_probs=181.3
Q ss_pred CCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe------eeEEEeeCCCCChhhhhcCcC---c
Q 045452 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RMLVYEYMPNKSLDCYLFDPI---R 74 (303)
Q Consensus 6 g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~---~ 74 (303)
+..||+|.++.. .......+.+|+..++.++|+||+++++++..... .+++|||+++++|..++.... .
T Consensus 27 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~ 106 (273)
T cd05035 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106 (273)
T ss_pred cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC
Confidence 478999998754 33455688999999999999999999999876554 799999999999988875421 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+.............++..|+|
T Consensus 107 ~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (273)
T cd05035 107 PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183 (273)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccC
Confidence 246889999999999999999999988 99999999999999999999999999876643322222222234568999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+..++.++|||||||++|+|++ |..||...... . .......+..... +...+..+.++
T Consensus 184 pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~~~~~~---------~~~~~~~~~~l 247 (273)
T cd05035 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---E----IYDYLRHGNRLKQ---------PEDCLDELYDL 247 (273)
T ss_pred HhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCCC---------CcCCCHHHHHH
Confidence 999988889999999999999999999 88887432211 1 1111111111111 11223478899
Q ss_pred HHhcccCCCCCCCCHHHHHHhhccC
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+.+||..||++|||+.+++..|++.
T Consensus 248 i~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 248 MYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.94 Aligned_cols=236 Identities=22% Similarity=0.307 Sum_probs=186.6
Q ss_pred CCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCCH
Q 045452 5 CGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~ 80 (303)
+|+.||+|.++.. .....+.+.+|+.++++++|+|++++++.+...+..+++|||+++++|..++.... ....+++
T Consensus 26 ~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 105 (267)
T cd08224 26 DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE 105 (267)
T ss_pred CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCH
Confidence 7899999988632 23346788999999999999999999999999999999999999999998885422 2455889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.+++.+|++||+.| ++|+||+|+||+++.++.++|+|||++..+...... .....++..|.|||.+.+
T Consensus 106 ~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~ 180 (267)
T cd08224 106 RTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHE 180 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhcc
Confidence 999999999999999999998 999999999999999999999999998765433211 122457888999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||...... . .............. ......+..+.++|.+||..
T Consensus 181 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~-~~~~~~~~~~~~~~--------~~~~~~~~~~~~~i~~cl~~ 247 (267)
T cd08224 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----L-YSLCKKIEKCDYPP--------LPADHYSEELRDLVSRCINP 247 (267)
T ss_pred CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----H-HHHHhhhhcCCCCC--------CChhhcCHHHHHHHHHHcCC
Confidence 88999999999999999999999998533211 1 11111111111111 11112334788999999999
Q ss_pred CCCCCCCHHHHHHhhccC
Q 045452 241 NPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~ 258 (303)
+|++|||+.+|++.|++.
T Consensus 248 ~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 248 DPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CcccCCCHHHHHHHHHHh
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=264.02 Aligned_cols=239 Identities=23% Similarity=0.416 Sum_probs=180.1
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---------ccc
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------RRL 76 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~ 76 (303)
..||+|.++.. .....+.+.+|++++++++|+|++++++++......++||||+.+++|.+++.... ...
T Consensus 45 ~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 35899998754 34455679999999999999999999999999999999999999999999885421 112
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.............++..|+|||
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 4678899999999999999999998 9999999999999999999999999987653322222222233467899999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh--CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+.+..++.++|+||||+++|+|++ +..||....... ........+........ ...+...+..+.+|+
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li 272 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLM 272 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHH
Confidence 9988889999999999999999998 556664322111 11111111111110000 011112234788999
Q ss_pred HhcccCCCCCCCCHHHHHHhhcc
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
.+||..||++|||+.++++.|++
T Consensus 273 ~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 273 MRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHcCCCchhCcCHHHHHHHHhC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=271.28 Aligned_cols=225 Identities=24% Similarity=0.282 Sum_probs=177.9
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.||||.++.. .......+..|+.+++.+ +||||+++++++...+..++||||+.+++|..++.. ...++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~l~ 94 (318)
T cd05570 18 GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFD 94 (318)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH---cCCCC
Confidence 46889999999753 233456677888888887 799999999999999999999999999999888843 44689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~ 169 (318)
T cd05570 95 EPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILS 169 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhc
Confidence 9999999999999999999998 9999999999999999999999999886422111 1122346889999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|..||...... .......... . ..+...+..+.++|.+||.
T Consensus 170 ~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~--~---------~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDE--V---------RYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC--C---------CCCCcCCHHHHHHHHHHcc
Confidence 999999999999999999999999999533211 1111111111 0 0111223478899999999
Q ss_pred CCCCCCCCH-----HHHHH
Q 045452 240 ENPNDRPSM-----LEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~-----~~l~~ 253 (303)
.||++||++ .++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHcCCCCCCCHHHHhc
Confidence 999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=256.97 Aligned_cols=229 Identities=30% Similarity=0.411 Sum_probs=182.0
Q ss_pred EEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||||.+..... ...+.+.+|+..+++++|+||+++++++.. ...+++|||+++++|.+++..... ..+++..++.+
T Consensus 25 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~ 102 (257)
T cd05040 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDY 102 (257)
T ss_pred EEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHH
Confidence 689999977655 567789999999999999999999999988 889999999999999999865322 46899999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcccCCCCC
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~ 165 (303)
+.|++.||++||+.+ ++|+||+|+||+++.++.+||+|||++..+...... .......++..|+|||.+.+..++.
T Consensus 103 ~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (257)
T cd05040 103 AVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179 (257)
T ss_pred HHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCc
Confidence 999999999999998 999999999999999999999999998776432111 1111234567899999998888999
Q ss_pred cccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
++|+|||||++|+|++ |..||......+ ... .......... .+...+..+.+++.+||..+|++
T Consensus 180 ~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd05040 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---KIDKEGERLE---------RPEACPQDIYNVMLQCWAHNPAD 244 (257)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHhcCCcCC---------CCccCCHHHHHHHHHHCCCCccc
Confidence 9999999999999998 999984322111 111 1111111110 11122347889999999999999
Q ss_pred CCCHHHHHHhhc
Q 045452 245 RPSMLEVSSMLK 256 (303)
Q Consensus 245 Rps~~~l~~~L~ 256 (303)
|||+.++++.|.
T Consensus 245 Rps~~~~~~~l~ 256 (257)
T cd05040 245 RPTFAALREFLP 256 (257)
T ss_pred CCCHHHHHHHhc
Confidence 999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=253.46 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=183.3
Q ss_pred CCCCEEEEEEccCCChh-hH-HHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSAQ-GF-EEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.||+|+++..... .. -.-.+||.++.+.+|||||.+-.+..-+ +..|+|||||+. +|..++.. -..++.
T Consensus 99 ~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~--m~q~F~ 175 (419)
T KOG0663|consen 99 KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET--MKQPFL 175 (419)
T ss_pred CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh--ccCCCc
Confidence 57899999999866421 11 2456899999999999999999988754 479999999964 67777643 135788
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
..+++-++.|++.|++|||... |+||||||+|+|++..|.+||+|||+++.+++.... ....+-|.+|+|||.+.
T Consensus 176 ~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLL 250 (419)
T KOG0663|consen 176 PGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLL 250 (419)
T ss_pred hHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhc
Confidence 9999999999999999999998 999999999999999999999999999988765222 12245699999999887
Q ss_pred cC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH-----HHhhCCCccc---------cccccccCCCCh
Q 045452 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGME---------FVDSFLDDRNSS 224 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~~ 224 (303)
+. .|+.+.|+||+|||+.||+++.+.|...+..+....+.... ..|.+..... .....+...+..
T Consensus 251 G~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~ 330 (419)
T KOG0663|consen 251 GAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA 330 (419)
T ss_pred CCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccc
Confidence 66 58999999999999999999999987655544444333222 1222221111 111112222222
Q ss_pred H-HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 225 C-KLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 225 ~-~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
. .+..-++|+..+|..||.+|.|+++.++.
T Consensus 331 ~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 331 LSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 2 23456799999999999999999998753
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=261.21 Aligned_cols=231 Identities=29% Similarity=0.430 Sum_probs=180.6
Q ss_pred CCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+..||+|.+..... ...+.+.+|+.+++.+.|+||+++++++. ....+++|+|+.+++|.+++.. ...+++..++
T Consensus 23 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~ 98 (257)
T cd05060 23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK---RREIPVSDLK 98 (257)
T ss_pred cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh---CCCCCHHHHH
Confidence 37899999975543 35567889999999999999999999875 5578999999999999999853 3368999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc-cceeeccccccCchhcccCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN-TEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 163 (303)
.++.|++.+|++||..+ ++|+||+|+||+++.++.++|+|||.+..+........ .....++..|+|||.+.+..+
T Consensus 99 ~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 99 ELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred HHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCC
Confidence 99999999999999998 99999999999999999999999999876543221111 111123457999999988889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|+||||+++|+|++ |..||...... . ............ .+...+..+.++|.+||..+|
T Consensus 176 ~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~----~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---E----VIAMLESGERLP---------RPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred CccchHHHHHHHHHHHHcCCCCCcccCCHH---H----HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhcCCh
Confidence 999999999999999998 89998533211 1 111111111111 111223478899999999999
Q ss_pred CCCCCHHHHHHhhccCC
Q 045452 243 NDRPSMLEVSSMLKNET 259 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~ 259 (303)
++||++.++++.|++..
T Consensus 240 ~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 240 EDRPTFSELESTFRRDP 256 (257)
T ss_pred hhCcCHHHHHHHHHhcc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.55 Aligned_cols=237 Identities=27% Similarity=0.396 Sum_probs=184.8
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---------
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 73 (303)
++..||+|.++... ......+.+|+.+++.+ +||||+++++++......+++|||+.+++|.+++....
T Consensus 46 ~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 125 (304)
T cd05101 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125 (304)
T ss_pred cceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 45689999986542 34567889999999999 89999999999999999999999999999999986421
Q ss_pred ----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecc
Q 045452 74 ----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149 (303)
Q Consensus 74 ----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 149 (303)
....+++..+..++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||++..+.............++
T Consensus 126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05101 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202 (304)
T ss_pred cccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCC
Confidence 1235788899999999999999999998 999999999999999999999999999776543222222223346
Q ss_pred ccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++||||||+++|+|++ |..||..... .............. .+...+.
T Consensus 203 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~ 266 (304)
T cd05101 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-------EELFKLLKEGHRMD---------KPANCTN 266 (304)
T ss_pred ceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCcCC---------CCCCCCH
Confidence 78999999988889999999999999999998 7777642211 11111111111111 1112235
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
++.+++.+||..+|.+|||+.++++.|++...
T Consensus 267 ~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 267 ELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 78899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.14 Aligned_cols=230 Identities=21% Similarity=0.258 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+....++||||+++|+|.+++. ...+++
T Consensus 66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~----~~~l~~ 141 (370)
T cd05596 66 SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS----NYDIPE 141 (370)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH----hcCCCH
Confidence 47899999998643 22334567889999999999999999999999999999999999999999883 335788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| ++||||||+|||++.++.+||+|||++........ .......|++.|+|||++.+
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 217 (370)
T cd05596 142 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhcc
Confidence 899999999999999999998 99999999999999999999999999876543221 12233568999999998865
Q ss_pred C----CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 161 G----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 161 ~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
. .++.++|+|||||++|+|++|..||...... ..............+. .....+.++.++|.+
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~ 284 (370)
T cd05596 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLTFP-------DDIEISKQAKDLICA 284 (370)
T ss_pred CCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCCCC-------CcCCCCHHHHHHHHH
Confidence 3 3788999999999999999999999643321 1111111111111111 111124578899999
Q ss_pred cccCCCCC--CCCHHHHHHh
Q 045452 237 CVQENPND--RPSMLEVSSM 254 (303)
Q Consensus 237 cl~~dp~~--Rps~~~l~~~ 254 (303)
||..+|.+ |+|+++++..
T Consensus 285 ~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 285 FLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HccChhhccCCCCHHHHhcC
Confidence 99999987 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=264.70 Aligned_cols=234 Identities=29% Similarity=0.437 Sum_probs=181.3
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc----ccCCC
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR----RLILD 79 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~ 79 (303)
++..||+|.++... ......+..|+.+++.++|+||+++++++......+++|||+.+++|.+++..... ...++
T Consensus 35 ~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~ 114 (277)
T cd05036 35 VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114 (277)
T ss_pred CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCC
Confidence 56789999986543 33456788999999999999999999999998899999999999999998854221 23588
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEecccccccccccccccccceeeccccccCch
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~---~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+..+..++.||+.+|+|||+.+ ++|+||+|+||+++.++ .+||+|||++..+..............+..|+|||
T Consensus 115 ~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05036 115 MKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHH
Confidence 9999999999999999999998 99999999999998764 59999999987664332222222223356899999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|||||||++|+|++ |..||....... ............ .+...+..+.+++.
T Consensus 192 ~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~i~ 255 (277)
T cd05036 192 AFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEFVTGGGRLD---------PPKGCPGPVYRIMT 255 (277)
T ss_pred HHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCC---------CCCCCCHHHHHHHH
Confidence 9988889999999999999999997 888885332211 111121111111 11122347889999
Q ss_pred hcccCCCCCCCCHHHHHHhhcc
Q 045452 236 LCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+||+.+|++|||+.++++.|+.
T Consensus 256 ~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 256 DCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCCCcccCcCHHHHHHHhhC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.80 Aligned_cols=239 Identities=29% Similarity=0.414 Sum_probs=185.3
Q ss_pred CEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-----------
Q 045452 7 EVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----------- 73 (303)
Q Consensus 7 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------- 73 (303)
..||+|.++... ....+.+.+|+.+++++ +|+||+++++++......+++|||+++++|.+++....
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (334)
T cd05100 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124 (334)
T ss_pred eeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 478999987543 34567889999999999 89999999999999889999999999999999985421
Q ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccc
Q 045452 74 --RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 74 --~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
....+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++................++..
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 201 (334)
T cd05100 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201 (334)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCce
Confidence 2234788899999999999999999988 99999999999999999999999999876543222211222233567
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||.+.+..++.++||||||+++|+|++ |..||..... .............. .+...+.++
T Consensus 202 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~l 265 (334)
T cd05100 202 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------EELFKLLKEGHRMD---------KPANCTHEL 265 (334)
T ss_pred EcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCC---------CCCCCCHHH
Confidence 999999988889999999999999999998 7788743221 11111111111111 111223478
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCC
Q 045452 231 LEIALLCVQENPNDRPSMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~ 264 (303)
.+++.+||+.+|++|||+.++++.|+...+....
T Consensus 266 ~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 8999999999999999999999999988755443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=271.09 Aligned_cols=233 Identities=22% Similarity=0.381 Sum_probs=180.7
Q ss_pred EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||+|.++... ....+.+.+|+.+++.++|+||+++++++... ..+++++|+.+|+|.+++... ...++...++.+
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~ 114 (316)
T cd05108 38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNW 114 (316)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhc--cccCCHHHHHHH
Confidence 48999987543 34567888999999999999999999999764 578999999999999998642 345788899999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..+.............++..|+|||.+.+..++.+
T Consensus 115 ~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 191 (316)
T cd05108 115 CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191 (316)
T ss_pred HHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCch
Confidence 999999999999998 99999999999999999999999999987653322211122234568999999998899999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+||||||+++|+|++ |..||...... ............. .+.....++.+++.+||..+|.+|
T Consensus 192 ~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~R 255 (316)
T cd05108 192 SDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERLP---------QPPICTIDVYMIMVKCWMIDADSR 255 (316)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCCCCCC---------CCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999997 89888532111 1111111111110 111123468899999999999999
Q ss_pred CCHHHHHHhhccCCCCC
Q 045452 246 PSMLEVSSMLKNETTNT 262 (303)
Q Consensus 246 ps~~~l~~~L~~~~~~~ 262 (303)
|++.+++..|.......
T Consensus 256 ps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 256 PKFRELIIEFSKMARDP 272 (316)
T ss_pred cCHHHHHHHHHHHHcCC
Confidence 99999999988766443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=269.56 Aligned_cols=225 Identities=24% Similarity=0.282 Sum_probs=175.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhc-CCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAK-LQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||.++... ......+..|..++.. ++||||+++++++.+....++||||+++|+|..++.. ...++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~ 94 (316)
T cd05619 18 GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS---CHKFD 94 (316)
T ss_pred CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH---cCCCC
Confidence 468899999986542 2334556677777776 4999999999999999999999999999999988843 34588
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05619 95 LPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILL 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHc
Confidence 9999999999999999999998 9999999999999999999999999986432111 1122346899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||+||++|+|++|..||....... ......... .. .+...+.++.++|.+||.
T Consensus 170 ~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~-~~---------~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDN-PC---------YPRWLTREAKDILVKLFV 232 (316)
T ss_pred CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC-CC---------CCccCCHHHHHHHHHHhc
Confidence 8889999999999999999999999985432111 111111110 00 111123467899999999
Q ss_pred CCCCCCCCHH-HHHH
Q 045452 240 ENPNDRPSML-EVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~-~l~~ 253 (303)
.||.+||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05619 233 REPERRLGVKGDIRQ 247 (316)
T ss_pred cCHhhcCCChHHHHc
Confidence 9999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=265.35 Aligned_cols=234 Identities=29% Similarity=0.480 Sum_probs=181.7
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 73 (303)
+++.||+|.+.... ......+.+|+.++++++||||+++++++......+++|||+.+++|.+++....
T Consensus 34 ~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (288)
T cd05050 34 PFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113 (288)
T ss_pred cceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 57899999987553 3445678899999999999999999999999999999999999999999985321
Q ss_pred ---------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccc
Q 045452 74 ---------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTE 144 (303)
Q Consensus 74 ---------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 144 (303)
....+++..++.++.|++.||++||+.+ ++||||+|+||+++.++.++|+|||++.............
T Consensus 114 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 190 (288)
T cd05050 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190 (288)
T ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccC
Confidence 1124678889999999999999999988 9999999999999999999999999987553322221122
Q ss_pred eeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCC
Q 045452 145 QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNS 223 (303)
Q Consensus 145 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...... . ............ .+
T Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------~-~~~~~~~~~~~~---------~~ 254 (288)
T cd05050 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------E-VIYYVRDGNVLS---------CP 254 (288)
T ss_pred CCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHhcCCCCC---------CC
Confidence 2234567999999988889999999999999999997 77787422111 1 111111111110 11
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
...+.++.+++.+||+.+|.+|||+.++++.|++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 255 DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1223478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.94 Aligned_cols=229 Identities=21% Similarity=0.300 Sum_probs=178.8
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||+|.+... .....+.+.+|+.++++++||||+++++++...+..+++|||+++++|..+. .+++..
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~ 96 (279)
T cd06619 24 LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-------KIPEHV 96 (279)
T ss_pred CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-------cCCHHH
Confidence 57899999998654 3445567889999999999999999999999999999999999999985442 367888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++..+.... .....++..|+|||.+.+..
T Consensus 97 ~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 169 (279)
T cd06619 97 LGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQ 169 (279)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCC
Confidence 9999999999999999998 9999999999999999999999999987653321 22246788999999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|+||||+++|+|++|+.||........................... .....+.++.+++.+||+.+|
T Consensus 170 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--------PVGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--------CCCcCCHHHHHHHHHHhhCCh
Confidence 999999999999999999999998643322111111111111111111110 011123468899999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
++||+++++++.
T Consensus 242 ~~Rp~~~eil~~ 253 (279)
T cd06619 242 KERPAPENLMDH 253 (279)
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.35 Aligned_cols=228 Identities=23% Similarity=0.352 Sum_probs=182.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+.+++.++|+|++++++.+......++||||+++++|.+++. ...+++..+
T Consensus 43 ~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 118 (296)
T cd06654 43 ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQI 118 (296)
T ss_pred CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH----hcCCCHHHH
Confidence 5788999999876655556788999999999999999999999999999999999999999999883 345788999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||+|||..| ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..+
T Consensus 119 ~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 119 AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCC
Confidence 999999999999999998 9999999999999999999999999887543221 11122357889999999988888
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+|||||++|+|++|..||...... ........... .. ...+......+.+++.+||..+|+
T Consensus 194 ~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~~-------~~~~~~~~~~l~~li~~~l~~~p~ 259 (296)
T cd06654 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT-PE-------LQNPEKLSAIFRDFLNRCLDMDVE 259 (296)
T ss_pred CccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCCC-CC-------CCCccccCHHHHHHHHHHCcCCcc
Confidence 99999999999999999999999543211 11111111110 00 011122334688999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+|||+.++++.
T Consensus 260 ~Rpt~~eil~~ 270 (296)
T cd06654 260 KRGSAKELLQH 270 (296)
T ss_pred cCcCHHHHhhC
Confidence 99999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=267.63 Aligned_cols=239 Identities=26% Similarity=0.400 Sum_probs=184.4
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---------
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 73 (303)
++..||+|.++... ......+..|+.+++++ +||||+++++++......+++|||+.+++|.+++....
T Consensus 43 ~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~ 122 (314)
T cd05099 43 QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122 (314)
T ss_pred cceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccccc
Confidence 35579999987543 34566788999999999 69999999999998889999999999999999985421
Q ss_pred ----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecc
Q 045452 74 ----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149 (303)
Q Consensus 74 ----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 149 (303)
....+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||.+................++
T Consensus 123 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 199 (314)
T cd05099 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199 (314)
T ss_pred ccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCC
Confidence 1245888999999999999999999988 999999999999999999999999999765432221111112234
Q ss_pred ccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ............. .+...+.
T Consensus 200 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~ 263 (314)
T cd05099 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-------ELFKLLREGHRMD---------KPSNCTH 263 (314)
T ss_pred ccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCCCCCH
Confidence 67999999988889999999999999999998 78887432211 1111111111111 1112234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
++.+++.+||..+|++|||+.++++.|.+.....
T Consensus 264 ~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 264 ELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 6889999999999999999999999998876433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=260.87 Aligned_cols=233 Identities=29% Similarity=0.442 Sum_probs=181.0
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
..+++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||+.+++|.+++... ....+++.
T Consensus 26 ~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 102 (260)
T cd05070 26 TWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG-EGRALKLP 102 (260)
T ss_pred EecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc-CCCCCCHH
Confidence 346778899999865433 3467899999999999999999999875 45689999999999999988542 23457899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+..+...... ......++..|+|||.+.+.
T Consensus 103 ~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 178 (260)
T cd05070 103 NLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcC
Confidence 99999999999999999998 999999999999999999999999998765432211 11112345679999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|+|++ |..||...... ... ......... ..+...+..+.+++.+||.+
T Consensus 179 ~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05070 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVL-EQVERGYRM---------PCPQDCPISLHELMLQCWKK 242 (260)
T ss_pred CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCCCC---------CCCCcCCHHHHHHHHHHccc
Confidence 88999999999999999999 88888532211 111 111111111 11122334788999999999
Q ss_pred CCCCCCCHHHHHHhhcc
Q 045452 241 NPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~ 257 (303)
+|.+|||+.++.++|++
T Consensus 243 ~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 243 DPEERPTFEYLQSFLED 259 (260)
T ss_pred CcccCcCHHHHHHHHhc
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.34 Aligned_cols=229 Identities=25% Similarity=0.308 Sum_probs=183.4
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.|++|.+... .......+.+|+.+++.++||||+++++++......+++|||+++++|.+++... ....+++.
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 101 (256)
T cd08529 23 ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPED 101 (256)
T ss_pred CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh-cCCCCCHH
Confidence 47899999998643 3445678889999999999999999999999999999999999999999998653 24568899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||++..+...... .....++..|+|||.+.+.
T Consensus 102 ~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08529 102 QVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDK 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCC
Confidence 99999999999999999988 999999999999999999999999998765433211 1234578899999999988
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+||||+++|+|++|..||..... ......... ..... .+.....++.+++.+||+.+
T Consensus 177 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~---------~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIR-GVFPP---------VSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-CCCCC---------CccccCHHHHHHHHHHccCC
Confidence 899999999999999999999999854331 111111111 11111 11122347889999999999
Q ss_pred CCCCCCHHHHHHh
Q 045452 242 PNDRPSMLEVSSM 254 (303)
Q Consensus 242 p~~Rps~~~l~~~ 254 (303)
|++||++.++++.
T Consensus 241 p~~Rp~~~~ll~~ 253 (256)
T cd08529 241 YRQRPDTFQLLRN 253 (256)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=268.86 Aligned_cols=224 Identities=20% Similarity=0.215 Sum_probs=172.2
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHH-HHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.||+|++.... ......+..|. .+++.++|+||+++++++...+..++||||+.+++|..++.. ...+.
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~ 94 (325)
T cd05602 18 AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFL 94 (325)
T ss_pred CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh---cCCCC
Confidence 467899999986432 12223444444 456788999999999999999999999999999999988843 45578
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05602 95 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLH 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccccCCccccCHHHHc
Confidence 8899999999999999999998 999999999999999999999999998653221 11223356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||....... ......... . ......+..+.++|.+||+
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~--~---------~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKP--L---------QLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred CCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC--c---------CCCCCCCHHHHHHHHHHcc
Confidence 9899999999999999999999999995332111 111111110 0 0111223467899999999
Q ss_pred CCCCCCCCHHHHH
Q 045452 240 ENPNDRPSMLEVS 252 (303)
Q Consensus 240 ~dp~~Rps~~~l~ 252 (303)
.||.+||++.+..
T Consensus 233 ~~p~~R~~~~~~~ 245 (325)
T cd05602 233 KDRTKRLGAKDDF 245 (325)
T ss_pred cCHHHCCCCCCCH
Confidence 9999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.91 Aligned_cols=231 Identities=20% Similarity=0.306 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..+++|||+++++|.+++. ....+++..+
T Consensus 32 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~ 108 (267)
T cd06645 32 NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH---VTGPLSESQI 108 (267)
T ss_pred CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH---hcCCCCHHHH
Confidence 5789999999976655556678899999999999999999999999999999999999999999884 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc---c
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---Q 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~ 160 (303)
+.++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||.+..+.... .......|+..|+|||.+. .
T Consensus 109 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 183 (267)
T cd06645 109 AYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERK 183 (267)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccC
Confidence 999999999999999998 9999999999999999999999999987654321 1122346788999999874 4
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+|||||++|+|++|..||........ ............... . ....+..+.++|.+||..
T Consensus 184 ~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~~~----~--~~~~~~~~~~li~~~l~~ 251 (267)
T cd06645 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNFQPPKLK----D--KMKWSNSFHHFVKMALTK 251 (267)
T ss_pred CCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCCCCCccc----c--cCCCCHHHHHHHHHHccC
Confidence 4578899999999999999999999854321110 011111110000000 0 001223678999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|++||+++++++.
T Consensus 252 ~P~~R~~~~~ll~~ 265 (267)
T cd06645 252 NPKKRPTAEKLLQH 265 (267)
T ss_pred CchhCcCHHHHhcC
Confidence 99999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=280.39 Aligned_cols=233 Identities=23% Similarity=0.272 Sum_probs=182.5
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--------eeeEEEeeCCCCChhhhhcCc
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--------ERMLVYEYMPNKSLDCYLFDP 72 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~ 72 (303)
..+|+.||||.+... .......+.+|+..+..++|+||++++..+.... ..++||||+++|+|.+++...
T Consensus 54 ~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~ 133 (496)
T PTZ00283 54 VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSR 133 (496)
T ss_pred cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHh
Confidence 457999999998644 3445667889999999999999999988775432 368999999999999988643
Q ss_pred C-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccc
Q 045452 73 I-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 73 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.............|+..
T Consensus 134 ~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~ 210 (496)
T PTZ00283 134 AKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210 (496)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcc
Confidence 2 2456899999999999999999999998 99999999999999999999999999876543322223334568999
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|+|||.+.+..++.++|||||||++|+|++|..||...... ........ +.... .+...+.++.
T Consensus 211 Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~~-~~~~~---------~~~~~~~~l~ 274 (496)
T PTZ00283 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTLA-GRYDP---------LPPSISPEMQ 274 (496)
T ss_pred eeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhc-CCCCC---------CCCCCCHHHH
Confidence 99999999989999999999999999999999998532211 11111111 11111 1122334788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHh
Q 045452 232 EIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+++.+||..||.+||++.+++..
T Consensus 275 ~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 275 EIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHcccChhhCcCHHHHHhC
Confidence 99999999999999999999753
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.58 Aligned_cols=230 Identities=21% Similarity=0.304 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.++..+++|.+........+.+.+|+.+++.++|+|++++++++......+++|||+.+++|..++.. ....+++..+
T Consensus 28 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~l~~~~~ 105 (282)
T cd06643 28 ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQI 105 (282)
T ss_pred CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh--cCCCCCHHHH
Confidence 35788999999766666677889999999999999999999999999999999999999999887743 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc----
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---- 159 (303)
..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 106 ~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 180 (282)
T cd06643 106 RVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETS 180 (282)
T ss_pred HHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCC
Confidence 999999999999999998 9999999999999999999999999986543221 1222345788999999873
Q ss_pred -cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
+..++.++|+||+||++|+|++|+.||..... ........... .... ..+...+.++.++|.+||
T Consensus 181 ~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~-------~~~~~~~~~~~~li~~~l 246 (282)
T cd06643 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPTL-------AQPSRWSSEFKDFLKKCL 246 (282)
T ss_pred CCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcC-CCCC-------CCccccCHHHHHHHHHHc
Confidence 44577899999999999999999999853221 11111111111 0000 111223357889999999
Q ss_pred cCCCCCCCCHHHHHHh
Q 045452 239 QENPNDRPSMLEVSSM 254 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~ 254 (303)
..||.+||++.++++.
T Consensus 247 ~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 247 EKNVDARWTTTQLLQH 262 (282)
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=261.41 Aligned_cols=232 Identities=22% Similarity=0.334 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|.+++. ....+++..+
T Consensus 32 ~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~ 108 (267)
T cd06646 32 HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH---VTGPLSELQI 108 (267)
T ss_pred CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHH
Confidence 5788999999976555555678899999999999999999999999999999999999999998884 3456889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc---c
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---Q 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~ 160 (303)
..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.... .......++..|+|||.+. .
T Consensus 109 ~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~ 183 (267)
T cd06646 109 AYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKN 183 (267)
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccC
Confidence 999999999999999988 9999999999999999999999999987654221 1122245788999999874 3
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||+||++|+|++|+.||......... ......... .... ......+..+.++|.+||..
T Consensus 184 ~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~----~~~~--~~~~~~~~~~~~li~~~l~~ 251 (267)
T cd06646 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMSKSNFQ----PPKL--KDKTKWSSTFHNFVKISLTK 251 (267)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------eeeecCCCC----CCCC--ccccccCHHHHHHHHHHhhC
Confidence 44778999999999999999999998432211100 000000000 0000 01112335788999999999
Q ss_pred CCCCCCCHHHHHHhh
Q 045452 241 NPNDRPSMLEVSSML 255 (303)
Q Consensus 241 dp~~Rps~~~l~~~L 255 (303)
+|++|||++++++.|
T Consensus 252 ~P~~Rp~~~~il~~l 266 (267)
T cd06646 252 NPKKRPTAERLLTHL 266 (267)
T ss_pred ChhhCcCHHHHhcCC
Confidence 999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.06 Aligned_cols=232 Identities=26% Similarity=0.423 Sum_probs=178.4
Q ss_pred EEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCc---Cccc
Q 045452 8 VIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDP---IRRL 76 (303)
Q Consensus 8 ~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~---~~~~ 76 (303)
.||+|.++.. .....+.+.+|+..++.++|+||+++++++... ...+++|+|+.+++|.+++... ....
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 6899998654 344567889999999999999999999987542 2468999999999998876321 1234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..+.............++..|++||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence 5789999999999999999999988 9999999999999999999999999988764332211122234567899999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
...+..++.++|+||||+++|+|++ |..||..... . ........+..... +...+..+.++|.
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~----~~~~~~~~~~~~~~---------~~~~~~~~~~li~ 248 (272)
T cd05075 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---S----EIYDYLRQGNRLKQ---------PPDCLDGLYSLMS 248 (272)
T ss_pred HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHHHHHcCCCCCC---------CCCCCHHHHHHHH
Confidence 9988889999999999999999999 7888853211 1 11122222211111 1112346889999
Q ss_pred hcccCCCCCCCCHHHHHHhhccC
Q 045452 236 LCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+||+.||.+|||+.++++.|++.
T Consensus 249 ~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 249 SCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=272.92 Aligned_cols=241 Identities=21% Similarity=0.273 Sum_probs=182.6
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CC-----cceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HV-----NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.++|+.||||+++.. +.-..+-..|+.+|..|+ |. |+|+++++|...++.|||+|.+ +.+|.++++.+ +-.
T Consensus 208 ~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n-~f~ 284 (586)
T KOG0667|consen 208 HKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNN-KFR 284 (586)
T ss_pred cCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhc-CCC
Confidence 468999999999554 444455677999999995 43 8999999999999999999999 67999999764 344
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC--CcEEEecccccccccccccccccceeeccccccC
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED--MKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~--~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
.++...+..++.||+.+|.+||+.+ |||+||||+|||+... ..|||+|||.++......+ .-+.+..|+|
T Consensus 285 Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRA 356 (586)
T KOG0667|consen 285 GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRA 356 (586)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeecccccc
Confidence 5999999999999999999999998 9999999999999754 3599999999987654332 3456889999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH---------------HHhhC-CCccc------
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY---------------ELWKG-GKGME------ 212 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---------------~~~~~-~~~~~------ 212 (303)
||++.+.+|+.+.|+||||||+.||++|.+.|...+..+....+.... +++.. .....
T Consensus 357 PEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~ 436 (586)
T KOG0667|consen 357 PEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETS 436 (586)
T ss_pred chhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeec
Confidence 999999999999999999999999999988876554433332222111 00001 00000
Q ss_pred ----------------------cc--cccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 213 ----------------------FV--DSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 213 ----------------------~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.. ...+...........+.+++.+||..||.+|+|+.+.+..
T Consensus 437 ~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 437 APRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred ccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0001111111334567999999999999999999998753
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=260.81 Aligned_cols=234 Identities=27% Similarity=0.411 Sum_probs=180.9
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++..||+|+++.... ..+.+.+|+.+++.++|+||+++++++. ....+++|||+++++|.+++... ....+++..
T Consensus 27 ~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~ 103 (262)
T cd05071 27 WNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQ 103 (262)
T ss_pred ecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc-cccCCCHHH
Confidence 44556799999965332 3467889999999999999999999874 45679999999999999998542 234578999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+..+...... ......++..|+|||...+..
T Consensus 104 ~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~ 179 (262)
T cd05071 104 LVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR 179 (262)
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCC
Confidence 9999999999999999998 999999999999999999999999998765433211 111233567899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|+|++ |..||....... .. ..... .... ..+...+..+.+++.+||+.+
T Consensus 180 ~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~---~~~~~-~~~~---------~~~~~~~~~l~~li~~~l~~~ 243 (262)
T cd05071 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL---DQVER-GYRM---------PCPPECPESLHDLMCQCWRKE 243 (262)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH---HHHhc-CCCC---------CCccccCHHHHHHHHHHccCC
Confidence 9999999999999999999 777875332111 01 11111 1100 011123347889999999999
Q ss_pred CCCCCCHHHHHHhhccCC
Q 045452 242 PNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~ 259 (303)
|++||++.+++++|++.+
T Consensus 244 p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 244 PEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCCCHHHHHHHHHHhc
Confidence 999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=273.26 Aligned_cols=232 Identities=21% Similarity=0.269 Sum_probs=175.4
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ......+.+|+.++.+++|+||+++++.+.+....++||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~ 100 (363)
T cd05628 24 DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTE 100 (363)
T ss_pred CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH---hcCCCCH
Confidence 468999999996432 2344678889999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-------------------- 140 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-------------------- 140 (303)
..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||++..+......
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (363)
T cd05628 101 EETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177 (363)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence 999999999999999999998 999999999999999999999999998754321100
Q ss_pred -------------cccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhC
Q 045452 141 -------------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 207 (303)
Q Consensus 141 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 207 (303)
......+|+..|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~~ 251 (363)
T cd05628 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE------TYKKVMNW 251 (363)
T ss_pred cccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC
Confidence 00123468999999999998899999999999999999999999995432111 11111111
Q ss_pred CCccccccccccCCCChHHHHHHHHHHHhccc--CCCCCCCCHHHHHHh
Q 045452 208 GKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ--ENPNDRPSMLEVSSM 254 (303)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~~l~~~ 254 (303)
.....+.. . ...+.++.++|.+++. .++..||++++|++.
T Consensus 252 ~~~~~~p~-----~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 252 KETLIFPP-----E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred cCcccCCC-----c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 11111110 0 0112356678877554 234456899999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=276.42 Aligned_cols=230 Identities=22% Similarity=0.295 Sum_probs=175.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|++.... ......+.+|+.++++++|+||+++++.+.++...++||||+++|+|.+++.. ...+++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~e 100 (382)
T cd05625 24 DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR---MGIFPE 100 (382)
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh---cCCCCH
Confidence 578999999986532 23456788999999999999999999999999999999999999999998843 346889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc---------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--------------------- 139 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~--------------------- 139 (303)
..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (382)
T cd05625 101 DLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177 (382)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccc
Confidence 999999999999999999998 99999999999999999999999999753210000
Q ss_pred ------------------------ccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc
Q 045452 140 ------------------------KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 140 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 195 (303)
........|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---- 253 (382)
T cd05625 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP---- 253 (382)
T ss_pred cccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH----
Confidence 0001123688999999999988999999999999999999999999954321
Q ss_pred cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 045452 196 SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS---MLEVSS 253 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~~l~~ 253 (303)
................. .....+.++.++|.+|+ .+|.+|++ +.+++.
T Consensus 254 --~~~~~~i~~~~~~~~~p-------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 254 --LETQMKVINWQTSLHIP-------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred --HHHHHHHHccCCCcCCC-------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 11111111111111110 01112346778888876 49999997 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.33 Aligned_cols=233 Identities=29% Similarity=0.463 Sum_probs=182.0
Q ss_pred CCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----cccCCCH
Q 045452 6 GEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----RRLILDW 80 (303)
Q Consensus 6 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~ 80 (303)
++.||+|.+.... ......+.+|+..++.++||||+++++++......+++|||+++++|.+++.... ....+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred ceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 4679999886543 3456788899999999999999999999999899999999999999999986421 2234788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-----cEEEecccccccccccccccccceeeccccccCc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-----KPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-----~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..++.++.+++.+|+|||+.+ ++|+||+|+||+++.++ .++++|||++..+.............++..|+||
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence 999999999999999999988 99999999999999887 8999999998765433222222223456789999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
|.+.+..++.++||||||+++|+|++ |..||..... ......... .... ..+...+..+.++|
T Consensus 183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~-~~~~---------~~~~~~~~~~~~li 246 (269)
T cd05044 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQHVTA-GGRL---------QKPENCPDKIYQLM 246 (269)
T ss_pred HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHHHhc-CCcc---------CCcccchHHHHHHH
Confidence 99988889999999999999999998 9998853221 111111111 1000 11122345788999
Q ss_pred HhcccCCCCCCCCHHHHHHhhcc
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
.+||..+|.+||++.++++.|++
T Consensus 247 ~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 247 TNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHcCCCcccCCCHHHHHHHHhC
Confidence 99999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=264.95 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=172.4
Q ss_pred CCCEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCcceeEEEEEEe-----CCeeeEEEeeCCCCChhhhhcCcCc
Q 045452 5 CGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKL---QHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
+|+.||+|.++... ......+.+|+.+++.+ +||||+++++++.. ....+++|||+. ++|.+++... .
T Consensus 26 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~ 103 (290)
T cd07862 26 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV-P 103 (290)
T ss_pred CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC-C
Confidence 57889999986432 22234556677776665 79999999999853 346899999996 6888887542 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..++.++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++...... .......++..|+|
T Consensus 104 ~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~a 177 (290)
T cd07862 104 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRA 177 (290)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccC
Confidence 345889999999999999999999998 999999999999999999999999998765432 12233457899999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH-----HhhCCC-c-cccccccccC---CCCh
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGK-G-MEFVDSFLDD---RNSS 224 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~-~-~~~~~~~~~~---~~~~ 224 (303)
||.+.+..++.++|||||||++|+|++|.+||......+....+..... .+.... . .......... ...+
T Consensus 178 PE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T cd07862 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 257 (290)
T ss_pred hHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHcc
Confidence 9999888899999999999999999999999965433221111110000 000000 0 0000000000 0001
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
..+..+.+++.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 258 DIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 12346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.71 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=196.3
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.++..||+|+++.... ..+..|..|+.+|.+|+||||++++++|..++.+|+++||++.|+|.+++.++.... +....
T Consensus 560 eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~ 638 (807)
T KOG1094|consen 560 EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAP 638 (807)
T ss_pred cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccch
Confidence 4568999999987754 456899999999999999999999999999999999999999999999997643222 45567
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
..+++.||+.|++||.+.+ ++||||.+.|||+++++++||+|||+++-+....+.......+-..+|+|||.+..+.
T Consensus 639 ~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk 715 (807)
T KOG1094|consen 639 GVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK 715 (807)
T ss_pred hHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc
Confidence 7889999999999999998 9999999999999999999999999998776666665555566688999999999999
Q ss_pred CCCcccchhhHHHHHHHHh--CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 163 YSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
++.++|+|+||+.+||+++ ...||..... .+.++..-.......... ....|...+..+++++..||..
T Consensus 716 FttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~------~l~~P~~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 716 FTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQV------VLSRPPACPQGLYELMLRCWRR 786 (807)
T ss_pred ccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcce------eccCCCcCcHHHHHHHHHHhch
Confidence 9999999999999999865 6777743321 122222223333222111 1233445556899999999999
Q ss_pred CCCCCCCHHHHHHhhccCC
Q 045452 241 NPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~ 259 (303)
|-++||+++++-..|++..
T Consensus 787 es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 787 ESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hhhcCCCHHHHHHHHHHhc
Confidence 9999999999998887653
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=273.81 Aligned_cols=235 Identities=19% Similarity=0.214 Sum_probs=179.3
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+++.||+|.+... ....+|+.++++++|+||+++++++......+++|+++. ++|..++. ....+++..++
T Consensus 118 ~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~l~~~~~~ 188 (392)
T PHA03207 118 QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD---RSGPLPLEQAI 188 (392)
T ss_pred cceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH---hcCCCCHHHHH
Confidence 4678899988543 234579999999999999999999999999999999985 67878773 34568999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++................|+..|+|||++.+..++
T Consensus 189 ~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 265 (392)
T PHA03207 189 TIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265 (392)
T ss_pred HHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCC
Confidence 99999999999999998 999999999999999999999999998766543333333345689999999999988999
Q ss_pred CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC----------------------cccc-ccccccCC
Q 045452 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK----------------------GMEF-VDSFLDDR 221 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~-~~~~~~~~ 221 (303)
.++|||||||++|+|++|+.||...........+........... .... ......
T Consensus 266 ~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 343 (392)
T PHA03207 266 AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIR-- 343 (392)
T ss_pred chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhh--
Confidence 999999999999999999999865543322222222111111000 0000 000000
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
......++.++|.+||..||++|||+.+++..
T Consensus 344 -~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 344 -KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred -ccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01123467899999999999999999999876
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.24 Aligned_cols=231 Identities=23% Similarity=0.330 Sum_probs=183.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.+++|.+........+.+.+|+.++++++||||+++++++.....++++|||+.+++|.+++.. ....+++..+
T Consensus 26 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~--~~~~l~~~~~ 103 (262)
T cd06613 26 ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSELQI 103 (262)
T ss_pred CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh--hccCCCHHHH
Confidence 46788999999776666678899999999999999999999999999999999999999999998854 2256889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC--
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG-- 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-- 161 (303)
..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+..+.... .......++..|+|||.+.+.
T Consensus 104 ~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~ 178 (262)
T cd06613 104 AYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERK 178 (262)
T ss_pred HHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhccccc
Confidence 999999999999999988 9999999999999999999999999987654321 112224567889999998776
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|+|++|..||...... .............. ........+.++.+++.+||..
T Consensus 179 ~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~ 246 (262)
T cd06613 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPM------RALFLISKSNFPPP------KLKDKEKWSPVFHDFIKKCLTK 246 (262)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCCc------cccchhhhhHHHHHHHHHHcCC
Confidence 7889999999999999999999998533211 11111111100000 0112233455788999999999
Q ss_pred CCCCCCCHHHHHH
Q 045452 241 NPNDRPSMLEVSS 253 (303)
Q Consensus 241 dp~~Rps~~~l~~ 253 (303)
+|.+|||+.+++.
T Consensus 247 ~p~~Rpt~~~il~ 259 (262)
T cd06613 247 DPKKRPTATKLLQ 259 (262)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=264.99 Aligned_cols=181 Identities=20% Similarity=0.293 Sum_probs=149.1
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++|+.||+|.++... ....+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.... ...+++.
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~ 101 (327)
T cd08227 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMSEL 101 (327)
T ss_pred ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc-cCCCCHH
Confidence 578999999996542 3345677889999999999999999999999999999999999999999985422 2348899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-----ccccceeeccccccCch
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-----KANTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE 156 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.+++.||+.......... ........++..|+|||
T Consensus 102 ~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (327)
T cd08227 102 AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPE 178 (327)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChH
Confidence 99999999999999999998 99999999999999999999999986543321110 00111234567899999
Q ss_pred hccc--CCCCCcccchhhHHHHHHHHhCCCCccc
Q 045452 157 YARQ--GVYSTKSDVFSFGVLLLQIISGKRLSML 188 (303)
Q Consensus 157 ~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~ 188 (303)
.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 179 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 179 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred HhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9875 4588999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=258.64 Aligned_cols=241 Identities=23% Similarity=0.366 Sum_probs=182.8
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|.++... ......+.+|+.+++.++|+|++++++++... ...+++|||+++++|.+++... ...+++
T Consensus 31 ~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~ 108 (284)
T cd05079 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN--KNKINL 108 (284)
T ss_pred CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc--cCCCCH
Confidence 468899999987553 44557899999999999999999999998775 5689999999999999988532 235899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~ 159 (303)
..+..++.+++.+|+|||+.| ++||||||+||+++.++.++|+|||++..+..... ........++..|+|||.+.
T Consensus 109 ~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 109 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence 999999999999999999998 99999999999999999999999999876543221 11122234567899999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCC--------ccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++||||||+++|+|+++..|....... ................... ..+...+.++.
T Consensus 186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 256 (284)
T cd05079 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL---------PRPPNCPEEVY 256 (284)
T ss_pred cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC---------CCCCCCCHHHH
Confidence 888999999999999999999987664321100 0000011111111111110 11112345789
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+|+.+||+.+|.+|||+.++++.|++.
T Consensus 257 ~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 257 QLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=258.73 Aligned_cols=237 Identities=22% Similarity=0.297 Sum_probs=186.0
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-CcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~ 79 (303)
.+|+.||||.+... .......+.+|+.+++.++|+||+++++++..+...+++|||+++++|.+++... .....++
T Consensus 25 ~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 104 (267)
T cd08229 25 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 104 (267)
T ss_pred CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCC
Confidence 57899999987543 2334567889999999999999999999999999999999999999999887532 2245689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.+|+.+|.|||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.+.
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 105 EKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIH 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhc
Confidence 9999999999999999999998 999999999999999999999999998765432211 12245788999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||||+++|+|++|..||...... ... .......... ........+.++.+++.+||.
T Consensus 180 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~ 246 (267)
T cd08229 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEQCDY--------PPLPSDHYSEELRQLVNMCIN 246 (267)
T ss_pred CCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHH-HhhhhhcCCC--------CCCCcccccHHHHHHHHHhcC
Confidence 888899999999999999999999998532211 000 0010100000 011112234578899999999
Q ss_pred CCCCCCCCHHHHHHhhccC
Q 045452 240 ENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~ 258 (303)
.||++|||+.+|.+.+++.
T Consensus 247 ~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 247 PDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcccCCCHHHHHHHHhhh
Confidence 9999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=262.28 Aligned_cols=231 Identities=26% Similarity=0.385 Sum_probs=177.7
Q ss_pred EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.|++|.+.... ......+..|+..+++++||||+++++++. +...+++++|+++|+|.+++.. ....+++..+..+
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i 114 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNW 114 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh--cccCCCHHHHHHH
Confidence 47888875432 234567788888999999999999999875 4567899999999999999854 2346899999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.+................++..|+|||.+.+..++.+
T Consensus 115 ~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~ 191 (279)
T cd05111 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191 (279)
T ss_pred HHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCch
Confidence 999999999999998 99999999999999999999999999976543222222223345678999999988889999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+||||||+++|++++ |..||...... ........+..... +......+.+++.+||..||++|
T Consensus 192 ~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li~~c~~~~p~~R 255 (279)
T cd05111 192 SDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLAQ---------PQICTIDVYMVMVKCWMIDENVR 255 (279)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCCC---------CCCCCHHHHHHHHHHcCCCcccC
Confidence 999999999999998 99888432211 11111121111110 11122367889999999999999
Q ss_pred CCHHHHHHhhccCCC
Q 045452 246 PSMLEVSSMLKNETT 260 (303)
Q Consensus 246 ps~~~l~~~L~~~~~ 260 (303)
||+.++++.|.....
T Consensus 256 ps~~el~~~l~~~~~ 270 (279)
T cd05111 256 PTFKELANEFTRMAR 270 (279)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999887554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=272.54 Aligned_cols=230 Identities=20% Similarity=0.253 Sum_probs=176.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+... .......+.+|+.+++.++||||+++++++.++...++||||+++|+|.+++. ...+++
T Consensus 66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~----~~~~~~ 141 (370)
T cd05621 66 SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS----NYDVPE 141 (370)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH----hcCCCH
Confidence 46889999998542 22334567889999999999999999999999999999999999999999884 335788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ........|+..|+|||++.+
T Consensus 142 ~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 142 KWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhc
Confidence 999999999999999999998 9999999999999999999999999987654322 112234568999999999865
Q ss_pred CC----CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 161 GV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 161 ~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.. ++.++|+|||||++|+|++|..||...... ..............+.. ....+..+.+++.+
T Consensus 218 ~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~p~-------~~~~s~~~~~li~~ 284 (370)
T cd05621 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLNFPE-------DVEISKHAKNLICA 284 (370)
T ss_pred cCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccCCCC-------cccCCHHHHHHHHH
Confidence 43 778999999999999999999999643221 11111111111111111 11123467799999
Q ss_pred cccCCCC--CCCCHHHHHHh
Q 045452 237 CVQENPN--DRPSMLEVSSM 254 (303)
Q Consensus 237 cl~~dp~--~Rps~~~l~~~ 254 (303)
||..++. .|+++.++++.
T Consensus 285 ~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 285 FLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HccCchhccCCCCHHHHhcC
Confidence 9985554 38899998765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=259.41 Aligned_cols=227 Identities=30% Similarity=0.444 Sum_probs=182.5
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
.|+.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+....+++|||+++++|.+++... ....+++..+.
T Consensus 28 ~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~ 105 (256)
T cd05039 28 RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQL 105 (256)
T ss_pred cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc-CCCCCCHHHHH
Confidence 478999999976644 5678899999999999999999999999888999999999999999998542 22368999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ....+..|.|||.+....++
T Consensus 106 ~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~ 177 (256)
T cd05039 106 GFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFS 177 (256)
T ss_pred HHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCC
Confidence 99999999999999998 99999999999999999999999999876532211 12235679999999888889
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++|+||||+++|++++ |..||...... .............. +...+..+.++|.+||..+|+
T Consensus 178 ~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05039 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRMEA---------PEGCPPEVYKVMKDCWELDPA 241 (256)
T ss_pred cHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCCCC---------ccCCCHHHHHHHHHHhccChh
Confidence 99999999999999997 88888533211 11111111111111 111234788999999999999
Q ss_pred CCCCHHHHHHhhcc
Q 045452 244 DRPSMLEVSSMLKN 257 (303)
Q Consensus 244 ~Rps~~~l~~~L~~ 257 (303)
+|||++++++.|++
T Consensus 242 ~Rp~~~~l~~~l~~ 255 (256)
T cd05039 242 KRPTFKQLREQLAL 255 (256)
T ss_pred hCcCHHHHHHHHhc
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=260.71 Aligned_cols=228 Identities=23% Similarity=0.360 Sum_probs=182.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+..++.++|+||+++++++......++|+||+.+++|..++. ...+++..+
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~l~~~~~ 117 (296)
T cd06655 42 ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT----ETCMDEAQI 117 (296)
T ss_pred CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH----hcCCCHHHH
Confidence 5789999999876555556788899999999999999999999999999999999999999998883 345899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.+++.++++||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 118 ~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 118 AAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCC
Confidence 999999999999999998 99999999999999999999999998875433221 1122357889999999988889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+|||||++|+|++|..||...... ........... .. ...+...+..+.++|.+||..||.
T Consensus 193 ~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~~-~~-------~~~~~~~~~~~~~li~~~l~~dp~ 258 (296)
T cd06655 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT-PE-------LQNPEKLSPIFRDFLNRCLEMDVE 258 (296)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC-cc-------cCCcccCCHHHHHHHHHHhhcChh
Confidence 99999999999999999999998543321 11111111110 00 001112234688999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+|||+.++++.
T Consensus 259 ~Rpt~~~il~~ 269 (296)
T cd06655 259 KRGSAKELLQH 269 (296)
T ss_pred hCCCHHHHhhC
Confidence 99999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.87 Aligned_cols=222 Identities=20% Similarity=0.330 Sum_probs=173.3
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
...|++|.+..........+.+|+.+++.++||||+++++++......+++|||+++++|..++.. ....+++..++.
T Consensus 32 ~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~ 109 (262)
T cd05077 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFK 109 (262)
T ss_pred ceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHH
Confidence 346899998766555566788999999999999999999999998899999999999999888743 234589999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-------EEEecccccccccccccccccceeeccccccCchhc
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-------PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~-------~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++.||+.||+|||+.+ ++||||||+||+++.++. ++++|||++...... ....++..|+|||.+
T Consensus 110 i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~ 180 (262)
T cd05077 110 VAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECV 180 (262)
T ss_pred HHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhh
Confidence 9999999999999998 999999999999987664 899999988654221 123467889999987
Q ss_pred c-cCCCCCcccchhhHHHHHHHH-hCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 159 R-QGVYSTKSDVFSFGVLLLQII-SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 159 ~-~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
. +..++.++||||||+++|+|+ .|..||...... .......... .. ......++.+||.+
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~--~~---------~~~~~~~~~~li~~ 242 (262)
T cd05077 181 EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EKERFYEGQC--ML---------VTPSCKELADLMTH 242 (262)
T ss_pred cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HHHHHHhcCc--cC---------CCCChHHHHHHHHH
Confidence 6 466889999999999999998 577776432211 1111111110 00 00112468899999
Q ss_pred cccCCCCCCCCHHHHHHhhc
Q 045452 237 CVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~ 256 (303)
||+.||.+||++.+|++.|+
T Consensus 243 cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 243 CMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HcCCChhhCcCHHHHHHhcC
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=257.78 Aligned_cols=233 Identities=31% Similarity=0.463 Sum_probs=182.1
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. ....+++|||+.+++|.+++... .+..+++.
T Consensus 26 ~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~ 102 (260)
T cd05067 26 YYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-EGIKLTIN 102 (260)
T ss_pred ecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc-CCCCCCHH
Confidence 456789999999865433 3467889999999999999999999874 55789999999999999988542 24468899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.+++.+|+|||+.| ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+...
T Consensus 103 ~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~ 178 (260)
T cd05067 103 KLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 178 (260)
T ss_pred HHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccC
Confidence 99999999999999999988 999999999999999999999999998765422211 11122346789999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|++++ |..||....... ............ .+...+.++.+++.+||..
T Consensus 179 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05067 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYRMP---------RPDNCPEELYELMRLCWKE 242 (260)
T ss_pred CcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHccC
Confidence 89999999999999999998 999985332111 111111111111 1111234788999999999
Q ss_pred CCCCCCCHHHHHHhhcc
Q 045452 241 NPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~ 257 (303)
+|++|||+++++..|++
T Consensus 243 ~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 243 KPEERPTFEYLRSVLED 259 (260)
T ss_pred ChhhCCCHHHHHHHhhc
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=263.36 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=183.7
Q ss_pred CCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhhcCcCcc-----cCC
Q 045452 6 GEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRR-----LIL 78 (303)
Q Consensus 6 g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~ 78 (303)
+..|++|.++.. .....+.+.+|+.+++.++|+||+++++++.. ....+++++|+.+++|.+++...... ..+
T Consensus 35 ~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l 114 (280)
T cd05043 35 EEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114 (280)
T ss_pred eeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCC
Confidence 788999998754 34456778899999999999999999998876 46789999999999999988543221 568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.............++..|+|||.+
T Consensus 115 ~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 115 STQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 89999999999999999999988 999999999999999999999999998765432222111223346789999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
.+..++.++||||||+++|++++ |..||..... .. ............ .....+.++.+++.+|
T Consensus 192 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~ 255 (280)
T cd05043 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FE-MAAYLKDGYRLA---------QPINCPDELFAVMACC 255 (280)
T ss_pred hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HH-HHHHHHcCCCCC---------CCCcCCHHHHHHHHHH
Confidence 88889999999999999999998 9999853221 11 111111111100 0111234688999999
Q ss_pred ccCCCCCCCCHHHHHHhhccCCC
Q 045452 238 VQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
|..||++|||+.++++.|+...+
T Consensus 256 l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 256 WALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=269.87 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=183.2
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC--------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------- 73 (303)
.+++.||+|+++... ....+.+.+|+.++.++. ||||+++++++......++||||+.+|+|.+++....
T Consensus 65 ~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~ 144 (401)
T cd05107 65 QSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYL 144 (401)
T ss_pred CCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhc
Confidence 356789999997653 334567889999999996 9999999999999899999999999999999885421
Q ss_pred --------------------------------------------------------------------------------
Q 045452 74 -------------------------------------------------------------------------------- 73 (303)
Q Consensus 74 -------------------------------------------------------------------------------- 73 (303)
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (401)
T cd05107 145 DKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERT 224 (401)
T ss_pred ccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCc
Confidence
Q ss_pred -------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccccee
Q 045452 74 -------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV 146 (303)
Q Consensus 74 -------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 146 (303)
....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++...............
T Consensus 225 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 301 (401)
T cd05107 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301 (401)
T ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCc
Confidence 0123567788999999999999999988 999999999999999999999999998764322211111223
Q ss_pred eccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChH
Q 045452 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC 225 (303)
Q Consensus 147 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+ ........+.... .+..
T Consensus 302 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~~~~~~~~~~~~---------~p~~ 366 (401)
T cd05107 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QFYNAIKRGYRMA---------KPAH 366 (401)
T ss_pred CCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HHHHHHHcCCCCC---------CCCC
Confidence 45778999999988889999999999999999998 888874332111 1111111111111 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.+.++.+|+.+||..+|.+||++.+|+..|++..
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=258.68 Aligned_cols=234 Identities=32% Similarity=0.486 Sum_probs=183.4
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++++.||||.+.... ...+.+.+|+..+++++|+||+++++++......+++|||+++++|.+++... ....+++.
T Consensus 26 ~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~~~~~ 103 (261)
T cd05034 26 TWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLP 103 (261)
T ss_pred EEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc-ccCCCCHH
Confidence 34667889999986543 34567899999999999999999999999888999999999999999998552 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.+++.|+++||+.+ ++|+||+|+||+++.++.++|+|||.+..+....... ......+..|+|||.+.+.
T Consensus 104 ~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~ 179 (261)
T cd05034 104 QLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYG 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhh-hhccCCCccccCHHHhccC
Confidence 99999999999999999998 9999999999999999999999999987654321111 1112235689999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|++++ |+.||...... .... .. ...... ..+...+.++.+++.+||..
T Consensus 180 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~~-~~~~~~---------~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05034 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE---QV-ERGYRM---------PRPPNCPEELYDLMLQCWDK 243 (261)
T ss_pred CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HH-HcCCCC---------CCCCCCCHHHHHHHHHHccc
Confidence 89999999999999999998 89988432211 1111 11 111000 00111134788999999999
Q ss_pred CCCCCCCHHHHHHhhcc
Q 045452 241 NPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~ 257 (303)
+|.+||+++++.+.|++
T Consensus 244 ~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 244 DPEERPTFEYLQSFLED 260 (261)
T ss_pred CcccCCCHHHHHHHHhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=262.15 Aligned_cols=237 Identities=28% Similarity=0.399 Sum_probs=183.4
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc--------
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------- 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 74 (303)
++..||+|.++... ......+.+|+.+++.+ +|+||+++++++......++||||+.+++|.+++.....
T Consensus 49 ~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 128 (307)
T cd05098 49 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128 (307)
T ss_pred ccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 34579999997543 34556788999999999 899999999999999999999999999999999865321
Q ss_pred -----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecc
Q 045452 75 -----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149 (303)
Q Consensus 75 -----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 149 (303)
...+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||.+................++
T Consensus 129 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~ 205 (307)
T cd05098 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205 (307)
T ss_pred cccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCc
Confidence 235788999999999999999999988 999999999999999999999999998765432211111112234
Q ss_pred ccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++|+|||||++|+|++ |..||.... ..............+ .+...+.
T Consensus 206 ~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~ 269 (307)
T cd05098 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VEELFKLLKEGHRMD---------KPSNCTN 269 (307)
T ss_pred cceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHHcCCCCC---------CCCcCCH
Confidence 68999999988889999999999999999998 778874221 111111111111111 1112234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
++.+++.+||..+|.+|||+.++++.|++...
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 78899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.63 Aligned_cols=241 Identities=22% Similarity=0.291 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|..||+|.++... ......+.+|++++++++||||+++++++..++..+++|||+++++|.+++.. ...+++..
T Consensus 24 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~---~~~~~~~~ 100 (308)
T cd06615 24 PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPENI 100 (308)
T ss_pred CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh---cCCCCHHH
Confidence 468889999987543 33456788999999999999999999999999999999999999999999853 35688999
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+.
T Consensus 101 ~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~ 173 (308)
T cd06615 101 LGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 173 (308)
T ss_pred HHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCC
Confidence 99999999999999997 46 999999999999999999999999988654322 12234678899999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc-----------------cccc----ccccC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM-----------------EFVD----SFLDD 220 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~----~~~~~ 220 (303)
.++.++|+||||+++|+|++|..||......................... +..+ .....
T Consensus 174 ~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T cd06615 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK 253 (308)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCcc
Confidence 88999999999999999999999985332111100000000000000000 0000 00000
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
......+.++.+++.+||..+|++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 254 LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011134468899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=259.22 Aligned_cols=231 Identities=25% Similarity=0.424 Sum_probs=180.0
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
..||||.++.. .....+.|..|+..++.++||||+++++++..+...+++|||+.+++|.+++... ...+++..++.
T Consensus 33 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~ 110 (269)
T cd05065 33 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVG 110 (269)
T ss_pred eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC--CCCCCHHHHHH
Confidence 46999998755 3445678999999999999999999999999999999999999999999988542 34588999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee---ccccccCchhcccCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV---GTIGYIPPEYARQGV 162 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~---~~~~y~aPE~~~~~~ 162 (303)
++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++................ .+..|+|||.+.+..
T Consensus 111 i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (269)
T cd05065 111 MLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187 (269)
T ss_pred HHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc
Confidence 9999999999999998 9999999999999999999999999987654322111111111 135799999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|||||||++|++++ |..||....... ... ......... .+...+..+.+++.+||..+
T Consensus 188 ~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~----~i~~~~~~~---------~~~~~~~~~~~li~~~l~~~ 251 (269)
T cd05065 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN----AIEQDYRLP---------PPMDCPTALHQLMLDCWQKD 251 (269)
T ss_pred ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH----HHHcCCcCC---------CcccCCHHHHHHHHHHcCCC
Confidence 9999999999999999886 999985332111 111 111111000 01112346789999999999
Q ss_pred CCCCCCHHHHHHhhccC
Q 045452 242 PNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~ 258 (303)
|.+||++.+++..|++.
T Consensus 252 p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 252 RNARPKFGQIVSTLDKM 268 (269)
T ss_pred hhhCcCHHHHHHHHHhh
Confidence 99999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=268.30 Aligned_cols=228 Identities=23% Similarity=0.321 Sum_probs=188.5
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.+|+|.++.... ...+.+.+|+.+|+++. ||||+.+++++++...+++|||+|.||.|.+.+... .++
T Consensus 58 ~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~s 133 (382)
T KOG0032|consen 58 STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYS 133 (382)
T ss_pred CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCC
Confidence 4599999999965533 24578999999999997 999999999999999999999999999999998653 399
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC----CcEEEecccccccccccccccccceeeccccccCc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~----~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
+.....++.|++.+++|||..| ++||||||+|+|+... +.+|++|||++..... .......+|++.|+||
T Consensus 134 E~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 134 ERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAP 207 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCc
Confidence 9999999999999999999999 9999999999999643 4799999999987655 4455667899999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|++....++..+|+||+|+++|.|++|..||.......... ....+.. . .....-+..+..+.++|+
T Consensus 208 Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~--~-----f~~~~w~~is~~akd~i~ 274 (382)
T KOG0032|consen 208 EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF--D-----FTSEPWDDISESAKDFIR 274 (382)
T ss_pred hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC--C-----CCCCCccccCHHHHHHHH
Confidence 99999999999999999999999999999996554332221 2222211 1 111222223457889999
Q ss_pred hcccCCCCCCCCHHHHHHh
Q 045452 236 LCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~ 254 (303)
.|+..||.+|+|+.++++.
T Consensus 275 ~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 275 KLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HhcccCcccCCCHHHHhcC
Confidence 9999999999999999983
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=258.64 Aligned_cols=232 Identities=29% Similarity=0.428 Sum_probs=179.6
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
++++..||+|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+++|||+.+++|.+++... ....+++..
T Consensus 27 ~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~ 103 (260)
T cd05069 27 WNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQ 103 (260)
T ss_pred EcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC-CCCCCCHHH
Confidence 4556679999986543 23467889999999999999999999875 45689999999999999998542 234578999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||...+..
T Consensus 104 ~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~ 179 (260)
T cd05069 104 LVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCC
Confidence 9999999999999999998 999999999999999999999999998765432211 111223467899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|+|++ |..||...... . ........... ..+...+..+.+++.+||..|
T Consensus 180 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05069 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNR------E-VLEQVERGYRM---------PCPQGCPESLHELMKLCWKKD 243 (260)
T ss_pred cChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCC---------CCCcccCHHHHHHHHHHccCC
Confidence 9999999999999999999 88888532211 1 11111111111 111122347889999999999
Q ss_pred CCCCCCHHHHHHhhcc
Q 045452 242 PNDRPSMLEVSSMLKN 257 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~ 257 (303)
|++||++++++++|++
T Consensus 244 p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 244 PDERPTFEYIQSFLED 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=255.72 Aligned_cols=237 Identities=24% Similarity=0.331 Sum_probs=174.3
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc--ccCCCHH
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--RLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~ 81 (303)
....+|+|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|+|.+++..... ....++.
T Consensus 21 ~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05042 21 SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD 100 (269)
T ss_pred CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHH
Confidence 34578889876443 33456788999999999999999999999999999999999999999999865322 2335677
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 160 (303)
.+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++................++..|+|||++..
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05042 101 VLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhc
Confidence 88999999999999999998 99999999999999999999999999865332221111222345677999998643
Q ss_pred ------CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 161 ------GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 161 ------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
..++.++|||||||++|+|++ |..||...... ......... .......... +...+..+.++
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~ 246 (269)
T cd05042 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVRE-QDIKLPKPQL----DLKYSDRWYEV 246 (269)
T ss_pred cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhc-cCccCCCCcc----cccCCHHHHHH
Confidence 346789999999999999998 77777433211 111111111 1111111111 11233466789
Q ss_pred HHhcccCCCCCCCCHHHHHHhhc
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~ 256 (303)
+..|| .||++|||+++|++.|.
T Consensus 247 ~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 247 MQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHh-cCcccccCHHHHHHHhc
Confidence 99998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=265.32 Aligned_cols=220 Identities=23% Similarity=0.245 Sum_probs=172.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCC-cceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.||||+++.. .....+.+..|+.++..++|+ +|+++++++...+..++||||+++++|..++. ....++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~ 99 (324)
T cd05587 23 GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGKFK 99 (324)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCC
Confidence 46789999998643 233456778899999999664 68889999999999999999999999998884 344588
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+|||++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 100 ~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 100 EPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC--CCceeeecCCccccChhhhc
Confidence 9999999999999999999998 999999999999999999999999998643211 11222356899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||+||++|+|++|+.||...... .......... ...+...+.++.+++.+||.
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN-----------VSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-----------CCCCCCCCHHHHHHHHHHhh
Confidence 988999999999999999999999998533211 1111111110 01111223468899999999
Q ss_pred CCCCCCCCH
Q 045452 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rps~ 248 (303)
.||.+|++.
T Consensus 238 ~~P~~R~~~ 246 (324)
T cd05587 238 KHPAKRLGC 246 (324)
T ss_pred cCHHHcCCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=262.04 Aligned_cols=238 Identities=26% Similarity=0.414 Sum_probs=183.0
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------cc
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------RL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~ 76 (303)
.+..||+|.++... ......+.+|+..++.++|+||+++++++......+++|||+.+|+|.+++..... ..
T Consensus 35 ~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 114 (288)
T cd05061 35 AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114 (288)
T ss_pred cceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCC
Confidence 35689999986543 33445688899999999999999999999988999999999999999999854211 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.++...+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE 191 (288)
T cd05061 115 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (288)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHH
Confidence 3566788999999999999999998 9999999999999999999999999987654322222222234467899999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|+|||||++|+|++ |..||...... .............. +...+..+.+++.
T Consensus 192 ~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~li~ 255 (288)
T cd05061 192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLKFVMDGGYLDQ---------PDNCPERVTDLMR 255 (288)
T ss_pred HhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC---------CCCCCHHHHHHHH
Confidence 9988889999999999999999998 67787532211 11111111111110 1111347889999
Q ss_pred hcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 236 LCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
+||+.||++|||+.++++.|++...+
T Consensus 256 ~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 256 MCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 99999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.54 Aligned_cols=231 Identities=26% Similarity=0.447 Sum_probs=181.2
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
..+|+|+++.. .....+.+..|+.++++++|+||+++++++...+..+++|||+++++|.+++.. ....+++..+..
T Consensus 34 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~ 111 (268)
T cd05063 34 VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVG 111 (268)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHH
Confidence 37999998755 344567889999999999999999999999999999999999999999998854 234688999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccc-ceeeccccccCchhcccCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT-EQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~ 164 (303)
++.+++.|+++||+.+ ++|+||||+||+++.++.++++|||++............ .....+..|+|||.+.+..++
T Consensus 112 ~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (268)
T cd05063 112 MLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188 (268)
T ss_pred HHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC
Confidence 9999999999999998 999999999999999999999999998765432211111 111224579999999888889
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++|+|||||++|+|++ |..||...... ............. .+...+.++.+++.+||..+|+
T Consensus 189 ~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~~~~~---------~~~~~~~~~~~li~~c~~~~p~ 252 (268)
T cd05063 189 SASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDGFRLP---------APMDCPSAVYQLMLQCWQQDRA 252 (268)
T ss_pred hHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCcc
Confidence 99999999999999997 99998533211 1111111111000 0111234688999999999999
Q ss_pred CCCCHHHHHHhhccC
Q 045452 244 DRPSMLEVSSMLKNE 258 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~ 258 (303)
+||++.++++.|++.
T Consensus 253 ~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 253 RRPRFVDIVNLLDKL 267 (268)
T ss_pred cCcCHHHHHHHHHhh
Confidence 999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.55 Aligned_cols=241 Identities=30% Similarity=0.425 Sum_probs=184.6
Q ss_pred CCCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
++++.||+|.++..... ..+.+.+|+..++.++|+||+++++++.. ....+++|||+++++|.+++... ...+++
T Consensus 31 ~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~ 108 (284)
T cd05038 31 NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH--RDQINL 108 (284)
T ss_pred CCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC--ccccCH
Confidence 45889999999765443 56789999999999999999999999877 55789999999999999998542 235899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 159 (303)
..+..++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+......... .......++..|++||.+.
T Consensus 109 ~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 109 KRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence 999999999999999999988 999999999999999999999999999776522111 1111123456799999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc--------cHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--------SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++|+||||+++|+|++|..|+......... ............... ...+...+.++.
T Consensus 186 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 256 (284)
T cd05038 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER---------LPRPPSCPDEVY 256 (284)
T ss_pred cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc---------CCCCccCCHHHH
Confidence 888899999999999999999999887533211100 001111111111110 111112235788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+++.+||..+|.+|||+.+++++|++.
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 257 DLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=254.77 Aligned_cols=237 Identities=27% Similarity=0.357 Sum_probs=176.1
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC--cccCCCHH
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--RRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~ 81 (303)
++..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++++|.+++.... .....++.
T Consensus 21 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05087 21 TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100 (269)
T ss_pred CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHH
Confidence 34678999987553 2344578889999999999999999999998889999999999999999885422 12345677
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||.+................++..|+|||++.+.
T Consensus 101 ~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05087 101 TLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence 88899999999999999998 999999999999999999999999998654333222222234567789999988543
Q ss_pred -------CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 162 -------VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 162 -------~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
.++.++|+||||+++|+|++ |..||....... ... .... ............. .....+.++
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~-~~~~~~~~~~~~~----~~~~~~~~l 246 (269)
T cd05087 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLT---YTVR-EQQLKLPKPRLKL----PLSDRWYEV 246 (269)
T ss_pred cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHH---HHhh-cccCCCCCCccCC----CCChHHHHH
Confidence 35789999999999999996 999985432211 111 1111 1111111111111 123357789
Q ss_pred HHhcccCCCCCCCCHHHHHHhhc
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~ 256 (303)
+..|| .+|++|||+++|...|+
T Consensus 247 ~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 247 MQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHh-cCcccCCCHHHHHHHhc
Confidence 99999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=257.41 Aligned_cols=229 Identities=23% Similarity=0.333 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|..++.. ....+++..+
T Consensus 35 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~ 112 (292)
T cd06644 35 ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQI 112 (292)
T ss_pred CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh--hcCCCCHHHH
Confidence 46899999999877777778899999999999999999999999999999999999999999887643 2345899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc----
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---- 159 (303)
..++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||.+...... ........++..|+|||.+.
T Consensus 113 ~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 187 (292)
T cd06644 113 QVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETM 187 (292)
T ss_pred HHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccc
Confidence 999999999999999988 999999999999999999999999988654322 11223345788999999874
Q ss_pred -cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
...++.++|+|||||++|+|++|..||..... ......... ..... ...+...+.++.++|.+||
T Consensus 188 ~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~li~~~l 253 (292)
T cd06644 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-SEPPT-------LSQPSKWSMEFRDFLKTAL 253 (292)
T ss_pred cCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhc-CCCcc-------CCCCcccCHHHHHHHHHHh
Confidence 34467899999999999999999999853321 111111111 11100 0111222346889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
..||++||+++++++
T Consensus 254 ~~~p~~Rp~~~~il~ 268 (292)
T cd06644 254 DKHPETRPSAAQLLE 268 (292)
T ss_pred cCCcccCcCHHHHhc
Confidence 999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=255.87 Aligned_cols=226 Identities=22% Similarity=0.328 Sum_probs=181.3
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+++.|++|.++.... .+.+.+|++.+++++|+||+++++.+......++++||+.+++|.+++.. ....+++..+.
T Consensus 27 ~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~--~~~~l~~~~~~ 102 (256)
T cd06612 27 TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI--TNKTLTEEEIA 102 (256)
T ss_pred CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh--CccCCCHHHHH
Confidence 478999999865433 67899999999999999999999999999999999999999999998853 24568999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++
T Consensus 103 ~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~ 177 (256)
T cd06612 103 AILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYN 177 (256)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCC
Confidence 99999999999999998 99999999999999999999999999876543321 22234468899999999888899
Q ss_pred CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
.++|+||||+++|+|++|..||........ . ........ .....+.....++.++|.+||+.||++
T Consensus 178 ~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~~P~~ 243 (256)
T cd06612 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRA------I-FMIPNKPP-------PTLSDPEKWSPEFNDFVKKCLVKDPEE 243 (256)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCcchhhh------h-hhhccCCC-------CCCCchhhcCHHHHHHHHHHHhcChhh
Confidence 999999999999999999999853321110 0 00000000 001112223457889999999999999
Q ss_pred CCCHHHHHH
Q 045452 245 RPSMLEVSS 253 (303)
Q Consensus 245 Rps~~~l~~ 253 (303)
|||+.++++
T Consensus 244 Rps~~~il~ 252 (256)
T cd06612 244 RPSAIQLLQ 252 (256)
T ss_pred CcCHHHHhc
Confidence 999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=254.13 Aligned_cols=229 Identities=24% Similarity=0.310 Sum_probs=182.2
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.++.. .....+.+.+|+.+++.++|+||+++++.+..+...+++|||+++++|.+++... ....+++..
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~ 101 (255)
T cd08219 23 NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDT 101 (255)
T ss_pred CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc-cCCCCCHHH
Confidence 46889999998643 3445678889999999999999999999999999999999999999998887532 344578999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||.+||+.| ++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+..
T Consensus 102 ~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~ 176 (255)
T cd08219 102 ILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPYYVPPEIWENMP 176 (255)
T ss_pred HHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--cccccccCCccccCHHHHccCC
Confidence 9999999999999999998 9999999999999999999999999987654321 1112245788999999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|+||||+++|+|++|..||..... ......... +.... .+...+..+.++|.+||..||
T Consensus 177 ~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~---------~~~~~~~~~~~li~~~l~~~P 240 (255)
T cd08219 177 YNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQ-GSYKP---------LPSHYSYELRSLIKQMFKRNP 240 (255)
T ss_pred cCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhc-CCCCC---------CCcccCHHHHHHHHHHHhCCc
Confidence 99999999999999999999999853221 111111111 11111 111223468899999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
++|||+.+++..
T Consensus 241 ~~Rp~~~~il~~ 252 (255)
T cd08219 241 RSRPSATTILSR 252 (255)
T ss_pred ccCCCHHHHhhc
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=257.65 Aligned_cols=231 Identities=29% Similarity=0.454 Sum_probs=180.2
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+.+++.+|+|.+..... ....+.+|+.++++++|||++++++++......+++|||+.+++|.+++.. ....+++..
T Consensus 25 ~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~ 101 (256)
T cd05112 25 WLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQET 101 (256)
T ss_pred EeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh--CccCCCHHH
Confidence 34578899999864432 345788999999999999999999999998999999999999999988853 234578899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+.......... .....++..|+|||.+.+..
T Consensus 102 ~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~ 177 (256)
T cd05112 102 LLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSK 177 (256)
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-cCCCccchhhcCHhHhccCC
Confidence 9999999999999999998 9999999999999999999999999987654322111 11123456899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|+|++ |..||....... .. .....+... ..+...+..+.+|+.+||..+
T Consensus 178 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VV----ETINAGFRL---------YKPRLASQSVYELMQHCWKER 241 (256)
T ss_pred cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HH----HHHhCCCCC---------CCCCCCCHHHHHHHHHHcccC
Confidence 9999999999999999998 888885322111 11 111111000 001112357889999999999
Q ss_pred CCCCCCHHHHHHhhc
Q 045452 242 PNDRPSMLEVSSMLK 256 (303)
Q Consensus 242 p~~Rps~~~l~~~L~ 256 (303)
|++|||+.++++.|.
T Consensus 242 p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 242 PEDRPSFSLLLHQLA 256 (256)
T ss_pred hhhCCCHHHHHHhhC
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=276.97 Aligned_cols=234 Identities=27% Similarity=0.426 Sum_probs=192.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC--CHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL--DWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~--~~~ 81 (303)
.+.-.+|||.+........+-+.+||.+-++|+|.|||++.|.+..+++.-|+||-.+||||..+++. +.+++ .+.
T Consensus 598 ~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs--kWGPlKDNEs 675 (1226)
T KOG4279|consen 598 DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS--KWGPLKDNES 675 (1226)
T ss_pred cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh--ccCCCccchh
Confidence 45667899999877777778899999999999999999999999999999999999999999999975 56777 788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.+-.+..||++||.|||++. |+|||||-+|+||+. .|.+||+|||-+.++..- .....++.||..|||||++..
T Consensus 676 tm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 676 TMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQ 750 (1226)
T ss_pred HHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhcc
Confidence 99999999999999999999 999999999999975 588999999999876532 445566789999999999976
Q ss_pred C--CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 161 G--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 161 ~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
+ .|..++|||||||.+.||.||++||-..+... . ..+.-+- . .....-|...+.+...+|.+|+
T Consensus 751 G~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---A-----AMFkVGm----y--KvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 751 GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---A-----AMFKVGM----Y--KVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred CCcCCCchhhhhhccceeEeeccCCCCeeecCChh---H-----hhhhhcc----e--ecCCCCcHHHHHHHHHHHHHHc
Confidence 6 48899999999999999999999995332211 0 1111110 0 1123345556678899999999
Q ss_pred cCCCCCCCCHHHHHH--hhccC
Q 045452 239 QENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~--~L~~~ 258 (303)
.+||.+||++.++++ +|+.-
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHhccCcccccC
Confidence 999999999999985 35443
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=252.50 Aligned_cols=230 Identities=23% Similarity=0.347 Sum_probs=184.2
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.|++|.+... .......+.+|+.++++++|+||+++++++.+....+++|||+++++|.+++... ....+++.
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~-~~~~~~~~ 101 (256)
T cd08221 23 EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ-KGQLFEEE 101 (256)
T ss_pred CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc-cccCCCHH
Confidence 56899999987643 3455677889999999999999999999999999999999999999999988542 23468999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.|++.+|++||+.+ ++|+||+|+||+++.++.+||+|||.+........ ......++..|.|||.+.+.
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~ 176 (256)
T cd08221 102 MVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGV 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCC
Confidence 99999999999999999988 99999999999999999999999999876543321 22334578999999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+||||+++|+|++|..||..... .........+. .... +...+.++.+++.+||..+
T Consensus 177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~-~~~~---------~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 177 KYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQGN-YTPV---------VSVYSSELISLVHSLLQQD 240 (256)
T ss_pred CCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCC-CCCC---------ccccCHHHHHHHHHHcccC
Confidence 889999999999999999999999853221 11111111111 1110 1222346889999999999
Q ss_pred CCCCCCHHHHHHhh
Q 045452 242 PNDRPSMLEVSSML 255 (303)
Q Consensus 242 p~~Rps~~~l~~~L 255 (303)
|.+||+++++++.+
T Consensus 241 p~~R~s~~~ll~~~ 254 (256)
T cd08221 241 PEKRPTADEVLDQP 254 (256)
T ss_pred cccCCCHHHHhhCc
Confidence 99999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=258.68 Aligned_cols=239 Identities=24% Similarity=0.260 Sum_probs=174.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhcCc-CcccC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDP-IRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~-~~~~~ 77 (303)
.+++.||||+.-.+... --+|+.+|+.++|||||++.-+|.... ...+||||++. +|.++++.. ..+..
T Consensus 47 e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~ 121 (364)
T KOG0658|consen 47 ETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQR 121 (364)
T ss_pred CCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCC
Confidence 45799999998655331 126999999999999999998887532 34689999964 788887542 22566
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
++.-.++-+..||.+||+|||..| ||||||||+|+|+|.+ |.+||||||.|..+...... ..-.++..|+|||
T Consensus 122 mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPE 195 (364)
T KOG0658|consen 122 MPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPE 195 (364)
T ss_pred CceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHH
Confidence 888899999999999999999988 9999999999999976 99999999999876543222 2234689999999
Q ss_pred hccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH--------HhhCC----CccccccccccCCCC
Q 045452 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE--------LWKGG----KGMEFVDSFLDDRNS 223 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~----~~~~~~~~~~~~~~~ 223 (303)
.+.+ ..|+.+.||||.|||+.||+.|++.|...+..+.+..+-.... .+... ..+.+..........
T Consensus 196 Lifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~ 275 (364)
T KOG0658|consen 196 LIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFF 275 (364)
T ss_pred HHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecc
Confidence 7654 5699999999999999999999999876443332222111110 00000 001111111111122
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...+.++.+|+.++|+++|.+|.++.+++.
T Consensus 276 ~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 276 KRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 333457889999999999999999999974
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=256.05 Aligned_cols=230 Identities=21% Similarity=0.308 Sum_probs=182.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.||+|.+........+.+..|+.++++++|+||+++++++......++||||+++++|.+++.. ....+++..+
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~l~~~~~ 105 (280)
T cd06611 28 ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE--LERGLTEPQI 105 (280)
T ss_pred CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH--hcCCCCHHHH
Confidence 46899999999877766778899999999999999999999999999999999999999999998854 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc----
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---- 159 (303)
..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ........++..|+|||.+.
T Consensus 106 ~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~ 180 (280)
T cd06611 106 RYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETF 180 (280)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--ccccceeecchhhcCHHHHhhccc
Confidence 999999999999999998 999999999999999999999999987654322 11223346788999999874
Q ss_pred -cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
...++.++|+||||+++|+|++|..||...... ........ ..... ...+...+.++.++|.+||
T Consensus 181 ~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~-------~~~~~~~~~~~~~li~~~l 246 (280)
T cd06611 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILK-SEPPT-------LDQPSKWSSSFNDFLKSCL 246 (280)
T ss_pred CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhc-CCCCC-------cCCcccCCHHHHHHHHHHh
Confidence 344678999999999999999999998533211 11111111 11000 0111223347889999999
Q ss_pred cCCCCCCCCHHHHHHh
Q 045452 239 QENPNDRPSMLEVSSM 254 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~ 254 (303)
..+|.+||+++++++.
T Consensus 247 ~~~p~~Rps~~~il~~ 262 (280)
T cd06611 247 VKDPDDRPTAAELLKH 262 (280)
T ss_pred ccChhhCcCHHHHhcC
Confidence 9999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=266.14 Aligned_cols=239 Identities=24% Similarity=0.279 Sum_probs=173.8
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||+|++... .......+.+|+.+++.++||||+++++++.... ..++||||+.+ +|...+.
T Consensus 44 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 117 (359)
T cd07876 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----- 117 (359)
T ss_pred CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh-----
Confidence 46899999998643 2344567889999999999999999999986543 47999999965 5655552
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..++...+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++....... ......++..|+||
T Consensus 118 ~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aP 191 (359)
T cd07876 118 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAP 191 (359)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCc
Confidence 23788899999999999999999998 9999999999999999999999999986543221 11224578899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHH---------------HH-HHHHhhCCCc------ccc
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL---------------EH-AYELWKGGKG------MEF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~---------------~~-~~~~~~~~~~------~~~ 213 (303)
|.+.+..++.++|||||||++|+|++|..||............ .. .......... .+.
T Consensus 192 E~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (359)
T cd07876 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEEL 271 (359)
T ss_pred hhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhh
Confidence 9999989999999999999999999999999644321111000 00 0000000000 000
Q ss_pred cccccc---CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 VDSFLD---DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
...... ..........+.+||.+||..||++|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 272 FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred ccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 00111123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=268.58 Aligned_cols=230 Identities=21% Similarity=0.262 Sum_probs=175.2
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|++... .......+.+|+.+++.++||||+++++.+......++||||+++|+|.+++. ...+++
T Consensus 66 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~----~~~~~~ 141 (371)
T cd05622 66 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPE 141 (371)
T ss_pred CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH----hcCCCH
Confidence 47889999998542 22334567889999999999999999999999999999999999999999884 334788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .......|++.|+|||++.+
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 142 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhc
Confidence 899999999999999999999 99999999999999999999999999876543221 12233568999999999865
Q ss_pred CC----CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 161 GV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 161 ~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.. ++.++|||||||++|+|++|..||..... ...............+. .....+..+.++|.+
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~ 284 (371)
T cd05622 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLTFP-------DDNDISKEAKNLICA 284 (371)
T ss_pred cCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCcccCC-------CcCCCCHHHHHHHHH
Confidence 43 78899999999999999999999964321 11111221111111111 111234467899999
Q ss_pred cccCCCCC--CCCHHHHHHh
Q 045452 237 CVQENPND--RPSMLEVSSM 254 (303)
Q Consensus 237 cl~~dp~~--Rps~~~l~~~ 254 (303)
||..++.. |+++++++..
T Consensus 285 ~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 285 FLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCChhhhcCCCCHHHHhcC
Confidence 99843332 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=256.58 Aligned_cols=226 Identities=28% Similarity=0.418 Sum_probs=177.3
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEE-eCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.|+.||+|.++... ..+.+.+|+.++++++|+|++++++++. .++..+++|||+++++|.+++... ....+++..+
T Consensus 28 ~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~ 104 (256)
T cd05082 28 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 104 (256)
T ss_pred cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc-CCCCCCHHHH
Confidence 47789999986443 3467889999999999999999999765 446789999999999999998542 2335889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.+++.+|++||+.| ++|+||+|+||+++.++.+||+|||++....... ....++..|+|||.+.+..+
T Consensus 105 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 105 LKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred HHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCC
Confidence 999999999999999998 9999999999999999999999999986543221 11223567999999988889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|||||||++|+|++ |..||...... ............ ..+...+..+.+++.+||..+|
T Consensus 177 ~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p 240 (256)
T cd05082 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKM---------DAPDGCPPVVYDVMKQCWHLDA 240 (256)
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhcCCh
Confidence 999999999999999997 88888532211 111111111111 1111223478899999999999
Q ss_pred CCCCCHHHHHHhhcc
Q 045452 243 NDRPSMLEVSSMLKN 257 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~ 257 (303)
++|||+.++++.|++
T Consensus 241 ~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 241 ATRPSFLQLREQLEH 255 (256)
T ss_pred hhCcCHHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=270.81 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=177.0
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||++... .....+.+.+|+.+++.++|+||+++++++.... ..++||||+. ++|..++. ...
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~ 98 (372)
T cd07853 23 RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIV---SPQ 98 (372)
T ss_pred CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHh---cCC
Confidence 57899999998643 2334567889999999999999999999998766 7899999996 57777763 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++........ .......++..|+|||
T Consensus 99 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE 174 (372)
T cd07853 99 PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPE 174 (372)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHH
Confidence 6899999999999999999999998 99999999999999999999999999875432211 1112235688999999
Q ss_pred hcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH----------------HHHHhh-CCCccccccccc
Q 045452 157 YARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELWK-GGKGMEFVDSFL 218 (303)
Q Consensus 157 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~-~~~~~~~~~~~~ 218 (303)
.+.+. .++.++||||+||++|+|++|+.||...........+.. ...... ............
T Consensus 175 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (372)
T cd07853 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY 254 (372)
T ss_pred HHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc
Confidence 88764 478899999999999999999999964432211111000 000000 000000000000
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
......+.++.+||.+||..||++|||+.+++..
T Consensus 255 --~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 255 --TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred --ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0111124478899999999999999999999853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.86 Aligned_cols=231 Identities=23% Similarity=0.359 Sum_probs=178.9
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||+|.++.. .......+.+|+.+++.++|+||+++++++.. ...+++++|+++|+|.+++... ...+++..++.+
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~ 114 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNW 114 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHH
Confidence 4899998654 34456778899999999999999999999865 4578999999999999988542 345889999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+.............++..|+|||...+..++.+
T Consensus 115 ~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (279)
T cd05109 115 CVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191 (279)
T ss_pred HHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCch
Confidence 999999999999998 99999999999999999999999999876643222111111234568999999988889999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+|||||||++|+|++ |..||...... ............. .+...+.++.+++.+||..||++|
T Consensus 192 ~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~R 255 (279)
T cd05109 192 SDVWSYGVTVWELMTFGAKPYDGIPAR-------EIPDLLEKGERLP---------QPPICTIDVYMIMVKCWMIDSECR 255 (279)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC---------CCccCCHHHHHHHHHHcCCChhhC
Confidence 999999999999998 88887432211 1111111111111 111223468899999999999999
Q ss_pred CCHHHHHHhhccCCC
Q 045452 246 PSMLEVSSMLKNETT 260 (303)
Q Consensus 246 ps~~~l~~~L~~~~~ 260 (303)
|++.++++.|+....
T Consensus 256 p~~~~l~~~l~~~~~ 270 (279)
T cd05109 256 PRFRELVDEFSRMAR 270 (279)
T ss_pred cCHHHHHHHHHHhhc
Confidence 999999999877653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=253.57 Aligned_cols=234 Identities=25% Similarity=0.372 Sum_probs=176.7
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. +...+++|||+.+++|.+++... ....++..
T Consensus 22 ~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~ 99 (262)
T cd05058 22 QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE--THNPTVKD 99 (262)
T ss_pred ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc--CCCCCHHH
Confidence 3467999998543 34456788899999999999999999998764 45678999999999999998542 23467778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc--ccceeeccccccCchhccc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA--NTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 160 (303)
+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+....... ......++..|+|||.+.+
T Consensus 100 ~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 100 LIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence 8999999999999999988 9999999999999999999999999987553221111 1112234668999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCC-CCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..++.++||||||+++|+|++|. +||.... ..........+.. .. .+...+..+.+++.+||.
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~-~~---------~~~~~~~~~~~li~~cl~ 240 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRR-LL---------QPEYCPDPLYEVMLSCWH 240 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCC-CC---------CCCcCCHHHHHHHHHHcC
Confidence 88999999999999999999965 4553211 1111111111111 00 011123468899999999
Q ss_pred CCCCCCCCHHHHHHhhccCC
Q 045452 240 ENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~~ 259 (303)
.+|++||++.++++.|++..
T Consensus 241 ~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 241 PKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CChhhCCCHHHHHHHHHHHh
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=245.40 Aligned_cols=226 Identities=26% Similarity=0.362 Sum_probs=186.9
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+++-.||+|++.... .....++.+|+++...|+||||+++|++|.++...|+++||...|++...|.+. ....+++
T Consensus 45 ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~-~~~~f~e 123 (281)
T KOG0580|consen 45 KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEG-RMKRFDE 123 (281)
T ss_pred cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhc-ccccccc
Confidence 567789999985442 223457889999999999999999999999999999999999999999998652 4556899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.....+..|++.|+.|+|..+ |+||||||+|+|++..+.+|++|||-+..-. .....+.+||..|.+||...+
T Consensus 124 ~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 124 QRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred cchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCC
Confidence 999999999999999999998 9999999999999999999999999876432 344566889999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
...+...|+|++|++.||++.|.+||......+....+..... ..+.-.+....++|.+|+..
T Consensus 197 ~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-----------------~~p~~is~~a~dlI~~ll~~ 259 (281)
T KOG0580|consen 197 RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-----------------KFPSTISGGAADLISRLLVK 259 (281)
T ss_pred CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-----------------cCCcccChhHHHHHHHHhcc
Confidence 9999999999999999999999999975543332222221111 11122234678999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|.+|.+..++++.
T Consensus 260 ~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 260 NPIERLALTEVMDH 273 (281)
T ss_pred CccccccHHHHhhh
Confidence 99999999998753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=258.49 Aligned_cols=228 Identities=27% Similarity=0.459 Sum_probs=179.5
Q ss_pred CCCCEEEEEEccCCCh---------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc
Q 045452 4 PCGEVIAVKKLSKSSA---------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
.+++.||+|.+..... ...+.+.+|+.++++++||||+++++++......+++|||+++++|.+++..
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 99 (267)
T cd06628 23 SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--- 99 (267)
T ss_pred CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh---
Confidence 4678999998854322 1235688899999999999999999999999999999999999999999843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc----ccccceeeccc
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL----KANTEQVVGTI 150 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~----~~~~~~~~~~~ 150 (303)
...+++..+..++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+........ ........++.
T Consensus 100 ~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (267)
T cd06628 100 YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176 (267)
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCc
Confidence 356888999999999999999999988 99999999999999999999999999876642211 11112234778
Q ss_pred cccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......... ... ...+...+..+
T Consensus 177 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~---------~~~~~~~~~~~ 240 (267)
T cd06628 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIGE-NAS---------PEIPSNISSEA 240 (267)
T ss_pred CccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHhc-cCC---------CcCCcccCHHH
Confidence 99999999888889999999999999999999999854321 111111111 100 11112233578
Q ss_pred HHHHHhcccCCCCCCCCHHHHHH
Q 045452 231 LEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.++|.+||+.||.+||++.++++
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhh
Confidence 89999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=258.05 Aligned_cols=230 Identities=23% Similarity=0.286 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+.... ......+.+|+.++++++|++++.+++.+...+..+++|||+.+++|.+++... ....+++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~l~~ 101 (285)
T cd05630 23 ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GEAGFEE 101 (285)
T ss_pred CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh-cccCCCH
Confidence 478899999986442 223345778999999999999999999999999999999999999998887432 2345889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 102 GRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcC
Confidence 999999999999999999988 9999999999999999999999999986543221 1122457899999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||+|+++|+|++|..||.................... ...+...+.++.+|+.+||+.
T Consensus 176 ~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05630 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------EEYSEKFSPDARSLCKMLLCK 242 (285)
T ss_pred CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-------------hhcCccCCHHHHHHHHHHhhc
Confidence 8899999999999999999999999964322111111111100000 001111234678999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 045452 241 NPNDRPS-----MLEVSS 253 (303)
Q Consensus 241 dp~~Rps-----~~~l~~ 253 (303)
||++||| ++++++
T Consensus 243 ~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 243 DPKERLGCQGGGAREVKE 260 (285)
T ss_pred CHHHccCCCCCchHHHHc
Confidence 9999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=256.79 Aligned_cols=226 Identities=22% Similarity=0.316 Sum_probs=181.5
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||+|.++... ....+.+.+|+.+++.++|+||+++++++.++...++||||+++++|.+++. ...+++..
T Consensus 27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~----~~~l~~~~ 102 (277)
T cd06640 27 RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQ 102 (277)
T ss_pred cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh----cCCCCHHH
Confidence 368899999986543 3456788899999999999999999999999999999999999999999884 34588899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.+|++||+.+ ++|+||+|+||+++.++.++++|||++..+..... ......++..|.|||.+.+..
T Consensus 103 ~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~ 177 (277)
T cd06640 103 IATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCC
Confidence 9999999999999999988 99999999999999999999999999876543221 112235678899999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|+||||+++|+|++|..||........ . ...... .........+..+.+++.+||..+|
T Consensus 178 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~-~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRV------L-FLIPKN---------NPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------h-hhhhcC---------CCCCCchhhhHHHHHHHHHHcccCc
Confidence 99999999999999999999999853221110 0 000001 0112223345678899999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
++||++.+++..
T Consensus 242 ~~Rp~~~~il~~ 253 (277)
T cd06640 242 SFRPTAKELLKH 253 (277)
T ss_pred ccCcCHHHHHhC
Confidence 999999999755
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=254.41 Aligned_cols=231 Identities=25% Similarity=0.386 Sum_probs=180.2
Q ss_pred CCCCCEEEEEEccCCC------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 3 LPCGEVIAVKKLSKSS------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
..+|+.+|+|.++... ......+.+|++.+++++|+||+++++++......+++|||+++++|.+++.. ..
T Consensus 21 ~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~ 97 (265)
T cd06631 21 TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR---FG 97 (265)
T ss_pred EcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh---cC
Confidence 4578999999886432 22345688999999999999999999999999999999999999999999843 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc----cccccceeeccccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES----LKANTEQVVGTIGY 152 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~----~~~~~~~~~~~~~y 152 (303)
.+++..+..++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||.+....... .........++..|
T Consensus 98 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (265)
T cd06631 98 PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccc
Confidence 5789999999999999999999988 9999999999999999999999999987643211 11111223578899
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||.+.+..++.++|+||||+++|+|++|..||...... ............. ...+...+.++.+
T Consensus 175 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 240 (265)
T cd06631 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMFYIGAHRGLM--------PRLPDSFSAAAID 240 (265)
T ss_pred cChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHHHhhhccCCC--------CCCCCCCCHHHHH
Confidence 9999998888899999999999999999999998533211 1111111110000 0111223457889
Q ss_pred HHHhcccCCCCCCCCHHHHHH
Q 045452 233 IALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~ 253 (303)
+|.+||..+|.+||++.++++
T Consensus 241 ~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 241 FVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=256.37 Aligned_cols=232 Identities=27% Similarity=0.437 Sum_probs=181.2
Q ss_pred CCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++... ...+++..++
T Consensus 32 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~ 109 (267)
T cd05066 32 EIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH--DGQFTVIQLV 109 (267)
T ss_pred ceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhc--CCCCCHHHHH
Confidence 3479999987543 344578899999999999999999999999999999999999999999998542 3457899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc-cceeeccccccCchhcccCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN-TEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 163 (303)
.++.|++.||++||+.+ ++|+||||+||+++.++.++++|||++..+........ .....++..|+|||.+.+..+
T Consensus 110 ~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 186 (267)
T cd05066 110 GMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186 (267)
T ss_pred HHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCcc
Confidence 99999999999999998 99999999999999999999999999876643221111 111223468999999988889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|+||||+++|++++ |..||......+ .. .......... .+...+..+.+++.+||..+|
T Consensus 187 ~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p 250 (267)
T cd05066 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEEGYRLP---------APMDCPAALHQLMLDCWQKDR 250 (267)
T ss_pred CchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCc
Confidence 999999999999999886 999985432211 11 1111111000 011123467899999999999
Q ss_pred CCCCCHHHHHHhhccC
Q 045452 243 NDRPSMLEVSSMLKNE 258 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~ 258 (303)
.+||++.++++.|++.
T Consensus 251 ~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 251 NERPKFEQIVSILDKL 266 (267)
T ss_pred hhCCCHHHHHHHHHhh
Confidence 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=259.72 Aligned_cols=228 Identities=23% Similarity=0.337 Sum_probs=181.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||.+........+.+.+|+..++.++|+||+++++.+...+..+++|||+++++|.+++. ...+++..+
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~l~~~~~ 120 (292)
T cd06658 45 HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 120 (292)
T ss_pred CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh----cCCCCHHHH
Confidence 4688999999866555566778899999999999999999999999999999999999999988873 345889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.||+.+|.|||+.+ ++||||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..+
T Consensus 121 ~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 195 (292)
T cd06658 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPY 195 (292)
T ss_pred HHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCC
Confidence 999999999999999998 9999999999999999999999999986543221 11223457889999999988889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||||+++|+|++|..||...... .... . ........ .. .....+..+.+++.+||..||+
T Consensus 196 ~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~---~-~~~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~ 261 (292)
T cd06658 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMR---R-IRDNLPPR-----VK--DSHKVSSVLRGFLDLMLVREPS 261 (292)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhcCCCc-----cc--cccccCHHHHHHHHHHccCChh
Confidence 99999999999999999999998532211 1111 1 11000000 00 0111233678999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+|||++++++.
T Consensus 262 ~Rpt~~~il~~ 272 (292)
T cd06658 262 QRATAQELLQH 272 (292)
T ss_pred HCcCHHHHhhC
Confidence 99999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=260.57 Aligned_cols=228 Identities=23% Similarity=0.341 Sum_probs=182.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+++++|.+++. ...+++..+
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 117 (297)
T cd06656 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQI 117 (297)
T ss_pred CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH----hCCCCHHHH
Confidence 5799999999976655556778899999999999999999999999999999999999999999883 345788999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..+
T Consensus 118 ~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 118 AAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCC
Confidence 999999999999999998 99999999999999999999999999865433221 1122457889999999988889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||||+++|+|++|..||.......... ....... . ....+...+..+.+++.+||..+|+
T Consensus 193 ~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~-~-------~~~~~~~~~~~~~~li~~~l~~~p~ 258 (297)
T cd06656 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT-P-------ELQNPERLSAVFRDFLNRCLEMDVD 258 (297)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCC-C-------CCCCccccCHHHHHHHHHHccCChh
Confidence 999999999999999999999995433211100 0011000 0 0011222334678999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+||+++++++.
T Consensus 259 ~Rps~~~il~~ 269 (297)
T cd06656 259 RRGSAKELLQH 269 (297)
T ss_pred hCcCHHHHhcC
Confidence 99999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=255.43 Aligned_cols=232 Identities=27% Similarity=0.412 Sum_probs=181.1
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+.++..+|+|.++.. ....+.+.+|+.+++.++|+||+++++++.. ...+++|||+++++|.+++... ....+++..
T Consensus 27 ~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~ 103 (260)
T cd05073 27 YNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPK 103 (260)
T ss_pred ecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC-CccccCHHH
Confidence 456778999988644 3345678899999999999999999999877 7789999999999999998642 234578889
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.||.+||+.| ++|+||+|+||+++.++.++|+|||.+..+...... ......++..|+|||.+....
T Consensus 104 ~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~ 179 (260)
T cd05073 104 LIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGS 179 (260)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCC
Confidence 9999999999999999988 999999999999999999999999998765432211 111123456799999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|+||||+++|++++ |..||....... ............ .+...+.++.+++.+||+.+
T Consensus 180 ~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~~ 243 (260)
T cd05073 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMP---------RPENCPEELYNIMMRCWKNR 243 (260)
T ss_pred cCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCCC---------CcccCCHHHHHHHHHHcccC
Confidence 9999999999999999998 888885322111 111111111111 11122347889999999999
Q ss_pred CCCCCCHHHHHHhhcc
Q 045452 242 PNDRPSMLEVSSMLKN 257 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~ 257 (303)
|++||++.++.+.|++
T Consensus 244 p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 244 PEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=272.06 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=177.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .......+.+|+.++..++|+||+++++.+.+....++||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~ 100 (360)
T cd05627 24 DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSE 100 (360)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH---hcCCCCH
Confidence 47899999999643 23345678889999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-------------------- 140 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-------------------- 140 (303)
..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++..+......
T Consensus 101 ~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (360)
T cd05627 101 EATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177 (360)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence 999999999999999999998 999999999999999999999999998654221000
Q ss_pred -------------cccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhC
Q 045452 141 -------------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 207 (303)
Q Consensus 141 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 207 (303)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~------~~~~i~~~ 251 (360)
T cd05627 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE------TYRKVMNW 251 (360)
T ss_pred cccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHH------HHHHHHcC
Confidence 00112468999999999999999999999999999999999999995432211 11111111
Q ss_pred CCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 208 GKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
.....+.. . ...+.++.++|.+|+. ||.+|++...+.+.+...
T Consensus 252 ~~~~~~p~-----~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 252 KETLVFPP-----E--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCceecCC-----C--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 11111100 0 0123467789998775 999999754444444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=259.22 Aligned_cols=228 Identities=23% Similarity=0.362 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+..++.++||||+++++++..++..+++|||+++++|..++ ....+++..+
T Consensus 44 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~----~~~~~~~~~~ 119 (297)
T cd06659 44 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQI 119 (297)
T ss_pred CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHH----hhcCCCHHHH
Confidence 468999999986554445677889999999999999999999999999999999999999998877 3345889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++..+.... .......++..|+|||.+.+..+
T Consensus 120 ~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 120 ATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPY 194 (297)
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCC
Confidence 999999999999999998 9999999999999999999999999986543322 11223457889999999988889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||||+++|+|++|..||....... .. .......... . .........+.++|.+||..+|.
T Consensus 195 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~----~~~~~~~~~~-~------~~~~~~~~~l~~~i~~~l~~~P~ 260 (297)
T cd06659 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM----KRLRDSPPPK-L------KNAHKISPVLRDFLERMLTREPQ 260 (297)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhccCCCC-c------cccCCCCHHHHHHHHHHhcCCcc
Confidence 999999999999999999999986332111 11 1111110000 0 00111234678999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+||+++++++.
T Consensus 261 ~Rps~~~ll~~ 271 (297)
T cd06659 261 ERATAQELLDH 271 (297)
T ss_pred cCcCHHHHhhC
Confidence 99999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=258.89 Aligned_cols=225 Identities=24% Similarity=0.322 Sum_probs=180.1
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.++... ....+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|.+++. ...+++..
T Consensus 27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~ 102 (277)
T cd06642 27 RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK----PGPLEETY 102 (277)
T ss_pred CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh----cCCCCHHH
Confidence 467899999986443 3455678999999999999999999999999999999999999999988873 34588999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++..+.... .......++..|+|||.+.+..
T Consensus 103 ~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06642 103 IATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCC
Confidence 9999999999999999988 9999999999999999999999999987654322 1122245788999999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|+||||+++|+|++|..||........ . ........ .......+.++.++|.+||..+|
T Consensus 178 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~-~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRV------L-FLIPKNSP---------PTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred CchhhhHHHHHHHHHHHHhCCCCCcccchhhH------H-hhhhcCCC---------CCCCcccCHHHHHHHHHHccCCc
Confidence 99999999999999999999999753221110 0 00111100 01111233468899999999999
Q ss_pred CCCCCHHHHHH
Q 045452 243 NDRPSMLEVSS 253 (303)
Q Consensus 243 ~~Rps~~~l~~ 253 (303)
++||++.+++.
T Consensus 242 ~~Rp~~~~il~ 252 (277)
T cd06642 242 RFRPTAKELLK 252 (277)
T ss_pred ccCcCHHHHHH
Confidence 99999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=257.60 Aligned_cols=230 Identities=30% Similarity=0.429 Sum_probs=177.6
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC------------
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------------ 73 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------ 73 (303)
.+++|.++.. .....+.+.+|+.+++++ +||||+++++++......+++|||+++++|.+++....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 103 (270)
T cd05047 24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103 (270)
T ss_pred EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 4688888643 345567888999999999 89999999999999999999999999999999985421
Q ss_pred -cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+|++|||++...... ........+..|
T Consensus 104 ~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y 177 (270)
T cd05047 104 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRW 177 (270)
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCcccc
Confidence 1234788999999999999999999988 999999999999999999999999987532211 111112235679
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++|+||||+++|+|++ |..||....... ...........+ .+...+.++.
T Consensus 178 ~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~ 241 (270)
T cd05047 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRLE---------KPLNCDDEVY 241 (270)
T ss_pred CChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCCCCCC---------CCCcCCHHHH
Confidence 99999988889999999999999999997 999984322111 111111111111 1111234688
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
+++.+||..||.+|||+.++++.|++..
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 242 DLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.68 Aligned_cols=242 Identities=24% Similarity=0.352 Sum_probs=176.7
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||+|.++... ......+.+|+.++++++|+||+++++++..+...++||||+.+ +|.+++.. .+..+++..
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~ 105 (309)
T cd07872 29 LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD--CGNIMSMHN 105 (309)
T ss_pred CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh--cCCCCCHHH
Confidence 468899999986443 22344677899999999999999999999999999999999965 77777643 234578899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-C
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 161 (303)
+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++........ ......++..|+|||.+.+ .
T Consensus 106 ~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 180 (309)
T cd07872 106 VKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSS 180 (309)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCC
Confidence 9999999999999999998 99999999999999999999999999865432211 1122356889999998765 4
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH-----HHhhCCCcc-ccccccccC-------CCChHHHH
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGM-EFVDSFLDD-------RNSSCKLM 228 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~-------~~~~~~~~ 228 (303)
.++.++|||||||++|+|++|+.||......+......... ..|...... ......... ......+.
T Consensus 181 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T cd07872 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDT 260 (309)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCH
Confidence 57889999999999999999999996544332221111100 001000000 000000000 00011234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
++.++|.+||..||.+|||+.++++
T Consensus 261 ~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 261 EGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHHHHhccCChhhCCCHHHHhc
Confidence 6789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=264.95 Aligned_cols=230 Identities=23% Similarity=0.339 Sum_probs=177.6
Q ss_pred CCCEEEEEEcc--CCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 5 CGEVIAVKKLS--KSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+.+.+|+|++. ..+.....-|.+|+..|.+| +|.+|+++|+|-..++.+|+||||- ..+|...|... ...+...
T Consensus 384 ~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~--~~~~~~~ 460 (677)
T KOG0596|consen 384 DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK--KSIDPDW 460 (677)
T ss_pred CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc--cCCCchH
Confidence 34667777654 33566778899999999999 6899999999999999999999986 56888888542 2334434
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.+..|++.++.++|+.| |||.||||.|+|+.. |.+||+|||++..+...+.......-+||..||+||.+...
T Consensus 461 ~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~ 536 (677)
T KOG0596|consen 461 FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM 536 (677)
T ss_pred HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence 88999999999999999999 999999999999864 68999999999998877777777778899999999988544
Q ss_pred C-----------CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 162 V-----------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 162 ~-----------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
. ...++||||||||+|+|+.|+.||... .+.......+...+...++.+ . +.. .++
T Consensus 537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~aI~~P~~~Iefp~--~----~~~--~~l 603 (677)
T KOG0596|consen 537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLHAITDPNHEIEFPD--I----PEN--DEL 603 (677)
T ss_pred cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHHhhcCCCccccccC--C----CCc--hHH
Confidence 3 456899999999999999999998521 111222222222211112111 1 100 138
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHh
Q 045452 231 LEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+++..||+.||++|||+.+|++.
T Consensus 604 i~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 604 IDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHHhcCcccCCCcHHHhcC
Confidence 899999999999999999999875
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=259.08 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=177.7
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.++... ......+.+|+.++++++||||+++++++..+...++||||+. ++|.+++.....+..+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~ 101 (285)
T cd07861 23 KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAE 101 (285)
T ss_pred CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHH
Confidence 478999999986442 2334678899999999999999999999999999999999996 6888887554344678999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 102 ~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 102 LVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCC
Confidence 99999999999999999998 9999999999999999999999999987553221 111223467899999987654
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH-----HHHhhCCCcc--------ccccccccCCCChHHH
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----YELWKGGKGM--------EFVDSFLDDRNSSCKL 227 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 227 (303)
.++.++|+|||||++|+|++|+.||............... ...|...... ........ ......+
T Consensus 177 ~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 255 (285)
T cd07861 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR-SAVKNLD 255 (285)
T ss_pred CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH-HhcCCCC
Confidence 4788999999999999999999998533211100000000 0000000000 00000000 0011123
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.++.++|.+||..||++|||+.+++..
T Consensus 256 ~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 256 EDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 467899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=262.54 Aligned_cols=220 Identities=22% Similarity=0.273 Sum_probs=172.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.||+|+++... ....+.+..|..++..+ +|++|+++++++...+..++||||+++|+|..++. ....++
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~ 99 (323)
T cd05616 23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ---QVGRFK 99 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH---HcCCCC
Confidence 467899999986542 22344567788888877 68899999999999999999999999999988884 345588
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+|||++.++.+||+|||++....... .......|++.|+|||++.
T Consensus 100 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 100 EPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhc
Confidence 9999999999999999999998 9999999999999999999999999986432211 1122346899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|..||...... .... ....... ..+...+.++.+++.+||+
T Consensus 175 ~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~---~i~~~~~-----------~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIMEHNV-----------AYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred CCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC-----------CCCCcCCHHHHHHHHHHcc
Confidence 999999999999999999999999999533211 1111 1111110 1111223478899999999
Q ss_pred CCCCCCCCH
Q 045452 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rps~ 248 (303)
.||.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05616 238 KHPGKRLGC 246 (323)
T ss_pred cCHHhcCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=258.92 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=181.5
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++.. .......+.+|+..++.++|+||+++++++...+..+++|||+.+++|.+++... ....+++.
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~ 101 (314)
T cd08216 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPEL 101 (314)
T ss_pred CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh-cccCCCHH
Confidence 37999999998654 3456678999999999999999999999999999999999999999999998643 23458899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-----ccccceeeccccccCch
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-----KANTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE 156 (303)
.+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++||+.+........ ........++..|+|||
T Consensus 102 ~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (314)
T cd08216 102 AIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178 (314)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence 99999999999999999998 99999999999999999999999998865432211 11112234567899999
Q ss_pred hcccC--CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhh----CC-------Ccc--------cccc
Q 045452 157 YARQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK----GG-------KGM--------EFVD 215 (303)
Q Consensus 157 ~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----~~-------~~~--------~~~~ 215 (303)
.+.+. .++.++|+||+||++|+|++|..||....... ........... .. ... ....
T Consensus 179 ~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
T cd08216 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNR 256 (314)
T ss_pred HhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchh
Confidence 98663 57889999999999999999999996432111 00110000000 00 000 0000
Q ss_pred ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 216 SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.............++.+++.+||..||++|||++++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 257 DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 001111222334578899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=257.29 Aligned_cols=227 Identities=23% Similarity=0.342 Sum_probs=182.2
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++++||+.+++|.+++.. ..+++..
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~ 99 (274)
T cd06609 24 RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETY 99 (274)
T ss_pred CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh----cCCCHHH
Confidence 478999999986543 34556788999999999999999999999999999999999999999999843 2689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+..+.... .......++..|+|||.+.+..
T Consensus 100 ~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 100 IAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCC
Confidence 9999999999999999998 9999999999999999999999999987765432 1223345788899999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|+||||+++|+|++|..||...... ........ ........ . ..+.++.+++.+||..+|
T Consensus 175 ~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~-~~~~~~~~-----~---~~~~~~~~~l~~~l~~~p 239 (274)
T cd06609 175 YDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIPK-NNPPSLEG-----N---KFSKPFKDFVSLCLNKDP 239 (274)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhhh-cCCCCCcc-----c---ccCHHHHHHHHHHhhCCh
Confidence 999999999999999999999998543211 11111111 11111110 0 023468899999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
++|||++++++.
T Consensus 240 ~~Rpt~~~il~~ 251 (274)
T cd06609 240 KERPSAKELLKH 251 (274)
T ss_pred hhCcCHHHHhhC
Confidence 999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=263.31 Aligned_cols=240 Identities=28% Similarity=0.402 Sum_probs=181.4
Q ss_pred CCCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCc-----
Q 045452 3 LPCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR----- 74 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----- 74 (303)
..+++.||||.++... ......+.+|+.++.++ +|+||+++++++... ...+++|||+++|+|.+++.....
T Consensus 34 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~ 113 (343)
T cd05103 34 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPY 113 (343)
T ss_pred cccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccc
Confidence 3568899999997543 33456788999999999 789999999988654 467899999999999988753210
Q ss_pred -----------------------------------------------------------ccCCCHHHHHHHHHHHHHHHH
Q 045452 75 -----------------------------------------------------------RLILDWKKRVHIIEGITQGLL 95 (303)
Q Consensus 75 -----------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~ 95 (303)
...+++..+..++.||+.||+
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 193 (343)
T cd05103 114 KTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGME 193 (343)
T ss_pred cccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHH
Confidence 123677888999999999999
Q ss_pred HHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHH
Q 045452 96 YLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175 (303)
Q Consensus 96 ~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 175 (303)
|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||++
T Consensus 194 ~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 270 (343)
T cd05103 194 FLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 270 (343)
T ss_pred HHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHH
Confidence 999998 99999999999999999999999999876532211111222234567999999988889999999999999
Q ss_pred HHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 176 LLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 176 l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+|+|++ |..||....... .. ......+..... +...+.++.+++..||+.||.+|||+.+|++.
T Consensus 271 l~el~~~g~~p~~~~~~~~---~~---~~~~~~~~~~~~---------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 271 LWEIFSLGASPYPGVKIDE---EF---CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHCCCCCCCCccccH---HH---HHHHhccCCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999997 888885332111 11 111111111111 11122468899999999999999999999999
Q ss_pred hccCCC
Q 045452 255 LKNETT 260 (303)
Q Consensus 255 L~~~~~ 260 (303)
|+....
T Consensus 336 l~~~~~ 341 (343)
T cd05103 336 LGNLLQ 341 (343)
T ss_pred HHHHHh
Confidence 987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=257.63 Aligned_cols=231 Identities=22% Similarity=0.336 Sum_probs=179.6
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.++.. .......+.+|+.++++++|+||+++++.+...+..+++|||+++++|..++........+++..
T Consensus 24 ~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~ 103 (286)
T cd06622 24 PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV 103 (286)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHH
Confidence 37899999988654 33445788899999999999999999999999999999999999999988885432344789999
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||.+..+.... .....++..|+|||.+.+.
T Consensus 104 ~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 104 LRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred HHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCC
Confidence 99999999999999996 46 9999999999999999999999999986553221 1223467889999988544
Q ss_pred C------CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 162 V------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 162 ~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
. ++.++|+|||||++|+|++|..||........ ......... ... ...+...+.++.++|.
T Consensus 177 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~-~~~---------~~~~~~~~~~~~~li~ 243 (286)
T cd06622 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAIVD-GDP---------PTLPSGYSDDAQDFVA 243 (286)
T ss_pred CCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHHhh-cCC---------CCCCcccCHHHHHHHH
Confidence 3 47899999999999999999999854321111 111111111 111 1112223457889999
Q ss_pred hcccCCCCCCCCHHHHHHh
Q 045452 236 LCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~ 254 (303)
+||..+|.+||++.+++..
T Consensus 244 ~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 244 KCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHcccCcccCCCHHHHhcC
Confidence 9999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=256.35 Aligned_cols=221 Identities=24% Similarity=0.343 Sum_probs=171.7
Q ss_pred CEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 7 EVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 7 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
..||+|.+..........+.+|+.+++.++||||+++++++......++||||+++++|..++.. ....+++..+..+
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i 122 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITV 122 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHH
Confidence 46899998765555556788899999999999999999999999999999999999999888853 2346889999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-------cEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-------KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-------~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+.||+.||+|||+.+ ++||||||+||+++..+ .++++|||.+...... ....++..|+|||.+.
T Consensus 123 ~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 123 AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhc
Confidence 999999999999988 99999999999997644 3899999987543211 1234577899999886
Q ss_pred c-CCCCCcccchhhHHHHHHHH-hCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 Q-GVYSTKSDVFSFGVLLLQII-SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+ ..++.++|+||||+++|+|+ +|..||........ .. ...... . ... .....+.++|.+|
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~---~~~~~~--~-----~~~----~~~~~~~~li~~c 255 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK----ER---FYEKKH--R-----LPE----PSCKELATLISQC 255 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH----HH---HHHhcc--C-----CCC----CCChHHHHHHHHH
Confidence 5 56789999999999999985 68888853322111 11 111000 0 000 0123678999999
Q ss_pred ccCCCCCCCCHHHHHHhhc
Q 045452 238 VQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L~ 256 (303)
|..+|.+|||+.++++.|.
T Consensus 256 l~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 256 LTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred cccChhhCcCHHHHHHhhC
Confidence 9999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=256.99 Aligned_cols=232 Identities=30% Similarity=0.421 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccCCChhhH--HHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSAQGF--EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++.||+|.+........ .....|+..+++++|+||+++++++.+....+++|+++.+++|.+++. ....++..
T Consensus 22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~---~~~~~~~~ 98 (260)
T PF00069_consen 22 KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ---KNKPLSEE 98 (260)
T ss_dssp TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH---HHSSBBHH
T ss_pred CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc---cccccccc
Confidence 4677999999977654332 344569999999999999999999999999999999999999999985 45678999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-c
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-Q 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~ 160 (303)
.++.++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||.+..... .........++..|.|||.+. +
T Consensus 99 ~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~ 173 (260)
T PF00069_consen 99 EILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQG 173 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTT
T ss_pred cccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence 99999999999999999998 99999999999999999999999999875411 122233355788999999998 7
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||.................... ..... ........+.++|.+||+.
T Consensus 174 ~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~l~~li~~~l~~ 243 (260)
T PF00069_consen 174 KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL-------PSSSQ---QSREKSEELRDLIKKMLSK 243 (260)
T ss_dssp SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-------HHHTT---SHTTSHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccc-------ccccc---ccchhHHHHHHHHHHHccC
Confidence 8889999999999999999999999865411111111111111000 00000 0000015789999999999
Q ss_pred CCCCCCCHHHHHH
Q 045452 241 NPNDRPSMLEVSS 253 (303)
Q Consensus 241 dp~~Rps~~~l~~ 253 (303)
||++|||+.++++
T Consensus 244 ~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 244 DPEQRPSAEELLK 256 (260)
T ss_dssp SGGGSTTHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=256.47 Aligned_cols=222 Identities=23% Similarity=0.370 Sum_probs=172.9
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
...||+|.+........+.+.+|+.+++.++|||++++++++..+...++||||+.+|+|..++... +..+++..++.
T Consensus 27 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~ 104 (258)
T cd05078 27 KTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN--KNLINISWKLE 104 (258)
T ss_pred cchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC--CCCCCHHHHHH
Confidence 3458888886555556678889999999999999999999999989999999999999999998542 33588999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--------EEEecccccccccccccccccceeeccccccCchh
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--------PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~--------~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
++.||+.||+|||+.+ ++||||||+||+++.++. ++++|||.+...... ....++..|+|||.
T Consensus 105 ~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~ 175 (258)
T cd05078 105 VAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPEC 175 (258)
T ss_pred HHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchh
Confidence 9999999999999998 999999999999987765 699999987654321 22346788999998
Q ss_pred cccC-CCCCcccchhhHHHHHHHHhCC-CCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 158 ARQG-VYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+.+. .++.++|+||||+++|+|++|. .|+..... .... ...... .. .+.....++.+++.
T Consensus 176 ~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~~~-~~~~~~--~~---------~~~~~~~~~~~li~ 237 (258)
T cd05078 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QKKL-QFYEDR--HQ---------LPAPKWTELANLIN 237 (258)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HHHH-HHHHcc--cc---------CCCCCcHHHHHHHH
Confidence 8764 5788999999999999999985 45432111 1111 111110 01 11112246889999
Q ss_pred hcccCCCCCCCCHHHHHHhhc
Q 045452 236 LCVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~ 256 (303)
+||+.||++|||++++++.|+
T Consensus 238 ~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 238 QCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHhccChhhCCCHHHHHHhcC
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.17 Aligned_cols=236 Identities=30% Similarity=0.420 Sum_probs=180.5
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC------------
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------------ 73 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------ 73 (303)
.+|+|.++.. .......+.+|+.++.++ +|+||+++++++..++..+++|||+++++|.+++....
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (303)
T cd05088 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115 (303)
T ss_pred eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 4578877643 334556788999999999 89999999999999999999999999999999885421
Q ss_pred -cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++..... .........+..|
T Consensus 116 ~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y 189 (303)
T cd05088 116 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRW 189 (303)
T ss_pred cccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccch---hhhcccCCCcccc
Confidence 1235789999999999999999999988 99999999999999999999999999853211 1111112235679
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++||||||+++|+|++ |..||......+ ............ .+...+..+.
T Consensus 190 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~ 253 (303)
T cd05088 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRLE---------KPLNCDDEVY 253 (303)
T ss_pred cCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCcCC---------CCCCCCHHHH
Confidence 99999988889999999999999999998 999984322111 111111111110 1111234678
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNETTNTNTP 265 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~ 265 (303)
+|+.+||+.+|++||++.++++.|.+......+.
T Consensus 254 ~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 254 DLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 9999999999999999999999988766554443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=254.01 Aligned_cols=229 Identities=34% Similarity=0.509 Sum_probs=180.5
Q ss_pred CCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+..||+|.++..... ..+.+..|+..++.++|+||+++++++.+.+..+++|||+++++|.+++.... ...+++..++
T Consensus 28 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~ 106 (258)
T smart00219 28 EVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR-PKELSLSDLL 106 (258)
T ss_pred CceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh-hccCCHHHHH
Confidence 588999999765433 56789999999999999999999999999999999999999999999985421 1128999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++............ ...++..|+|||.+.+..++
T Consensus 107 ~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~ 182 (258)
T smart00219 107 SFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFT 182 (258)
T ss_pred HHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCC
Confidence 99999999999999998 999999999999999999999999998766543222111 12256889999999888899
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++|+||||+++++|++ |..||..... ..... .. ....... .+...+.++.+++.+||..||+
T Consensus 183 ~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~---~~-~~~~~~~---------~~~~~~~~~~~~i~~~l~~~p~ 246 (258)
T smart00219 183 SKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE---YL-KKGYRLP---------KPENCPPEIYKLMLQCWAEDPE 246 (258)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HH-hcCCCCC---------CCCcCCHHHHHHHHHHCcCChh
Confidence 99999999999999998 7777643111 11111 11 1111111 1111345788999999999999
Q ss_pred CCCCHHHHHHhh
Q 045452 244 DRPSMLEVSSML 255 (303)
Q Consensus 244 ~Rps~~~l~~~L 255 (303)
+|||+.++++.|
T Consensus 247 ~Rpt~~~ll~~l 258 (258)
T smart00219 247 DRPTFSELVEIL 258 (258)
T ss_pred hCcCHHHHHhhC
Confidence 999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=266.69 Aligned_cols=226 Identities=21% Similarity=0.255 Sum_probs=170.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC---CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|++.... ......+..|..++..+ +||||+++++.+......++||||+.+++|..++. ....
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~ 92 (330)
T cd05586 16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGR 92 (330)
T ss_pred CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH---hcCC
Confidence 578999999985432 12233445566666654 79999999999999999999999999999988884 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.
T Consensus 93 ~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~ 167 (330)
T cd05586 93 FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEV 167 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHH
Confidence 899999999999999999999998 9999999999999999999999999986532211 11233568999999998
Q ss_pred cccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 ARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+. .++.++|||||||++|+|++|..||...... ........+.. .+.. ...+.++.++|.+
T Consensus 168 ~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~--~~~~--------~~~~~~~~~li~~ 231 (330)
T cd05586 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKV--RFPK--------NVLSDEGRQFVKG 231 (330)
T ss_pred HcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCC--CCCC--------ccCCHHHHHHHHH
Confidence 8654 4789999999999999999999998543211 11111111110 1110 1123467899999
Q ss_pred cccCCCCCCC----CHHHHHH
Q 045452 237 CVQENPNDRP----SMLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rp----s~~~l~~ 253 (303)
||..||.+|| ++.++++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhc
Confidence 9999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=270.29 Aligned_cols=238 Identities=17% Similarity=0.160 Sum_probs=173.3
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+++.||||... ...+.+|+.++++++|+||+++++++..+...+++|+++. ++|..++.. ....+++..++
T Consensus 193 ~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~l~~~~~~ 263 (461)
T PHA03211 193 YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA--RLRPLGLAQVT 263 (461)
T ss_pred CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh--cCCCCCHHHHH
Confidence 56788998642 2345689999999999999999999999999999999994 678777743 23468999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||.|||..| |+||||||+|||++.++.++|+|||++..+.............|+..|+|||++.+..++
T Consensus 264 ~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 264 AVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred HHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCC
Confidence 99999999999999998 999999999999999999999999998765433222222235689999999999998999
Q ss_pred CcccchhhHHHHHHHHhCCCCccccCCCccc----cHHHHHHHHhhC--CCccc-----cccc--------cccCCC---
Q 045452 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENL----SILEHAYELWKG--GKGME-----FVDS--------FLDDRN--- 222 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~~~-----~~~~--------~~~~~~--- 222 (303)
.++|||||||++|+|++|..++......... ..+......... ..... +... ......
T Consensus 341 ~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 420 (461)
T PHA03211 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPA 420 (461)
T ss_pred chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcc
Confidence 9999999999999999988765433221111 111111110000 00000 0000 000000
Q ss_pred ---ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 223 ---SSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 223 ---~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.......+.+||.+||..||++|||+.|+++.
T Consensus 421 ~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 421 WTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00112367899999999999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=261.05 Aligned_cols=180 Identities=23% Similarity=0.335 Sum_probs=143.8
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCc------Ccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDP------IRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~------~~~ 75 (303)
.+++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+. ++|..++... ...
T Consensus 26 ~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 102 (317)
T cd07868 26 KDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKP 102 (317)
T ss_pred CCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCc
Confidence 367889999986542 22456789999999999999999999864 456899999985 5777766421 112
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEecccccccccccccc-cccceeeccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLK-ANTEQVVGTI 150 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~----~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~ 150 (303)
..+++..+..++.||+.||+|||+.| ++||||||+|||+ +.++.+||+|||++..+...... .......++.
T Consensus 103 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~ 179 (317)
T cd07868 103 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179 (317)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccc
Confidence 35889999999999999999999998 9999999999999 45678999999999766433211 1223356789
Q ss_pred cccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCcccc
Q 045452 151 GYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLC 189 (303)
Q Consensus 151 ~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~ 189 (303)
.|+|||++.+ ..++.++|+||+||++|+|++|+.||...
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999998876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=266.78 Aligned_cols=239 Identities=23% Similarity=0.255 Sum_probs=174.0
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++||||+.+ +|.+.+.
T Consensus 47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 120 (364)
T cd07875 47 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----- 120 (364)
T ss_pred CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH-----
Confidence 46889999998653 234456788999999999999999999987543 357999999964 6766663
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..++...+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++....... ......++..|+||
T Consensus 121 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aP 194 (364)
T cd07875 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 194 (364)
T ss_pred hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCH
Confidence 23788899999999999999999998 9999999999999999999999999997654321 11224578999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH---------------HH-HHhhCCC-cc-----cc
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH---------------AY-ELWKGGK-GM-----EF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---------------~~-~~~~~~~-~~-----~~ 213 (303)
|++.+..++.++|||||||++|+|++|+.||...........+.. .. ....... .. ..
T Consensus 195 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T cd07875 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 274 (364)
T ss_pred HHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhh
Confidence 999999999999999999999999999999964332111111000 00 0000000 00 00
Q ss_pred ccccc---cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 VDSFL---DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..... ..........++.++|.+||..||.+|||+.++++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=255.48 Aligned_cols=230 Identities=23% Similarity=0.356 Sum_probs=180.0
Q ss_pred CEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 7 EVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
..||||...... ....+.+.+|+.+++.++|+||+++++++.+ ...+++|||+++++|.+++... ...+++..++.
T Consensus 35 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~ 111 (270)
T cd05056 35 IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN--KYSLDLASLIL 111 (270)
T ss_pred cceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhC--CCCCCHHHHHH
Confidence 468999886554 4566789999999999999999999999865 5678999999999999998542 33589999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 165 (303)
++.+++.||++||+.+ ++|+||+|+||+++.++.++|+|||++.......... .....++..|+|||.+....++.
T Consensus 112 ~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ 187 (270)
T cd05056 112 YSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTS 187 (270)
T ss_pred HHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCc
Confidence 9999999999999988 9999999999999999999999999987654332111 11222356799999998888999
Q ss_pred cccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
++|+||||+++|++++ |..||....... .. ..... ..... .+...+..+.+++.+||..+|.+
T Consensus 188 ~~Di~slG~il~el~~~g~~pf~~~~~~~---~~---~~~~~-~~~~~---------~~~~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 188 ASDVWMFGVCMWEILMLGVKPFQGVKNND---VI---GRIEN-GERLP---------MPPNCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred hhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HH---HHHHc-CCcCC---------CCCCCCHHHHHHHHHHcCCChhh
Confidence 9999999999999986 999985433211 11 11111 11111 11122347889999999999999
Q ss_pred CCCHHHHHHhhccCC
Q 045452 245 RPSMLEVSSMLKNET 259 (303)
Q Consensus 245 Rps~~~l~~~L~~~~ 259 (303)
|||+.++++.|++..
T Consensus 252 Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 252 RPRFTELKAQLSDIL 266 (270)
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=253.50 Aligned_cols=227 Identities=23% Similarity=0.341 Sum_probs=181.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.|++|.++.......+.+.+|+.+++.++|+|++++++++...+..++++||+.+++|.+++.. ..++...+
T Consensus 42 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~ 117 (285)
T cd06648 42 STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQI 117 (285)
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh----CCCCHHHH
Confidence 57889999998765555567788999999999999999999999999999999999999999998843 45889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.|++.+|++||+.| ++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..+
T Consensus 118 ~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (285)
T cd06648 118 ATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPY 192 (285)
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCC
Confidence 999999999999999998 99999999999999999999999998765433221 1122457889999999988889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||||+++|+|++|..||..... .......... ..... . .....+..+.+++.+||..+|+
T Consensus 193 ~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~~~~~-----~--~~~~~~~~l~~li~~~l~~~p~ 258 (285)
T cd06648 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-LPPKL-----K--NLHKVSPRLRSFLDRMLVRDPA 258 (285)
T ss_pred CCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-CCCCC-----c--ccccCCHHHHHHHHHHcccChh
Confidence 9999999999999999999999853221 1111111111 10000 0 0111234788999999999999
Q ss_pred CCCCHHHHHH
Q 045452 244 DRPSMLEVSS 253 (303)
Q Consensus 244 ~Rps~~~l~~ 253 (303)
+|||+.++++
T Consensus 259 ~Rpt~~~il~ 268 (285)
T cd06648 259 QRATAAELLN 268 (285)
T ss_pred hCcCHHHHcc
Confidence 9999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=260.94 Aligned_cols=220 Identities=22% Similarity=0.274 Sum_probs=172.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|+++... ....+.+..|+.+++.+. |++|+++++++...+..++||||+++|+|..++. ....++
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~l~ 99 (323)
T cd05615 23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ---QVGKFK 99 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH---HcCCCC
Confidence 578999999986532 234456778888888884 5788899999999999999999999999998884 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 100 ~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05615 100 EPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIA 174 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHc
Confidence 9999999999999999999998 9999999999999999999999999986532221 1122345899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||+||++|+|++|..||...... ... ........ ..+...+.++.+++.+||.
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~~~~~-----------~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELF---QSIMEHNV-----------SYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCC-----------CCCccCCHHHHHHHHHHcc
Confidence 888999999999999999999999998543211 111 11111110 0111123467899999999
Q ss_pred CCCCCCCCH
Q 045452 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rps~ 248 (303)
.+|.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05615 238 KHPSKRLGC 246 (323)
T ss_pred cCHhhCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=257.04 Aligned_cols=231 Identities=23% Similarity=0.387 Sum_probs=180.8
Q ss_pred EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||+|.++... ......+.+|+..+++++|+||+++++++.. ...+++|||+.+++|.+++.. ....+++..+..+
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~ 114 (279)
T cd05057 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNW 114 (279)
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHH
Confidence 58999886554 3455788899999999999999999999987 788999999999999999854 2345899999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+..+.............++..|+|||.+....++.+
T Consensus 115 ~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (279)
T cd05057 115 CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK 191 (279)
T ss_pred HHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCch
Confidence 999999999999988 99999999999999999999999999976643222111111223568999999988889999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+|+||||+++|++++ |..||......+ .......... ...+......+.+++.+||..+|++|
T Consensus 192 ~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~p~~R 255 (279)
T cd05057 192 SDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGER---------LPQPPICTIDVYMVLVKCWMIDAESR 255 (279)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCC---------CCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999999999998 999985332111 1111111111 01111122467899999999999999
Q ss_pred CCHHHHHHhhccCCC
Q 045452 246 PSMLEVSSMLKNETT 260 (303)
Q Consensus 246 ps~~~l~~~L~~~~~ 260 (303)
|++.++++.|.....
T Consensus 256 p~~~~l~~~l~~~~~ 270 (279)
T cd05057 256 PTFKELINEFSKMAR 270 (279)
T ss_pred CCHHHHHHHHHHHHh
Confidence 999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=253.23 Aligned_cols=232 Identities=26% Similarity=0.401 Sum_probs=182.2
Q ss_pred CCCCEEEEEEccCCC------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|.++... ....+.+.+|+..+++++|+||+++++++.+.+..++||||+.+++|.+++.. ...
T Consensus 23 ~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~ 99 (268)
T cd06630 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK---YGA 99 (268)
T ss_pred CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH---hCC
Confidence 678999999986432 22456789999999999999999999999999999999999999999998843 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccc--cccceeeccccccC
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLK--ANTEQVVGTIGYIP 154 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~a 154 (303)
+++..+..++.|++.||.+||+.| ++|+||+|+||+++.++ .++|+|||.+......... .......++..|+|
T Consensus 100 ~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (268)
T cd06630 100 FKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeC
Confidence 889999999999999999999998 99999999999998776 5999999998766433111 11223457889999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|+||+|+++++|++|..||......... .......... .....+.....++.+++
T Consensus 177 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~~~~~~~~~~i 244 (268)
T cd06630 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASAT---------TAPSIPEHLSPGLRDVT 244 (268)
T ss_pred HhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccC---------CCCCCchhhCHHHHHHH
Confidence 99998888899999999999999999999998543322111 1111111111 11122233445788999
Q ss_pred HhcccCCCCCCCCHHHHHH
Q 045452 235 LLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~ 253 (303)
.+||..+|.+|||+.+++.
T Consensus 245 ~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 245 LRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHcCCCcccCcCHHHHhc
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=255.61 Aligned_cols=230 Identities=22% Similarity=0.241 Sum_probs=178.0
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+.... ......+.+|+.+++.++|+||+++++.+..++..+++|||+.+++|.+++... ....+++
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~ 101 (285)
T cd05632 23 ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEE 101 (285)
T ss_pred CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh-cCCCCCH
Confidence 578999999986442 223455778999999999999999999999999999999999999998887542 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 102 ERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcC
Confidence 999999999999999999998 9999999999999999999999999886543221 1122457899999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||........... ......... . ..+...+..+.+|+.+||..
T Consensus 176 ~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~-~---------~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05632 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE-E---------VYSAKFSEEAKSICKMLLTK 242 (285)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc-c---------ccCccCCHHHHHHHHHHccC
Confidence 8899999999999999999999999964322111111 111111100 0 01111233678999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 045452 241 NPNDRPS-----MLEVSS 253 (303)
Q Consensus 241 dp~~Rps-----~~~l~~ 253 (303)
||++||+ +.+++.
T Consensus 243 ~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 243 DPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CHhHcCCCcccChHHHHc
Confidence 9999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=274.29 Aligned_cols=236 Identities=19% Similarity=0.236 Sum_probs=169.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--------CeeeEEEeeCCCCChhhhhcCc-Cc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--------EERMLVYEYMPNKSLDCYLFDP-IR 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~-~~ 74 (303)
.+|+.||||++.... ....+|+.+++.++|+||+++++++... ..+++||||+++ +|.+++... ..
T Consensus 89 ~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~ 163 (440)
T PTZ00036 89 DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN 163 (440)
T ss_pred CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhc
Confidence 578999999885432 2334799999999999999999887532 246799999975 676665431 23
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccccccceeecccccc
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++..+.... ......|++.|+
T Consensus 164 ~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~ 237 (440)
T PTZ00036 164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYR 237 (440)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCcc
Confidence 456899999999999999999999998 99999999999999665 69999999997654321 112245789999
Q ss_pred CchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC---------------cccccccc
Q 045452 154 PPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---------------GMEFVDSF 217 (303)
Q Consensus 154 aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~ 217 (303)
|||++.+. .++.++|||||||++|+|++|.+||......+... .......... ........
T Consensus 238 aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~---~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 314 (440)
T PTZ00036 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV---RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKD 314 (440)
T ss_pred CHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhchhhhcccCCccCchh
Confidence 99987654 68999999999999999999999996433221111 1111000000 00000000
Q ss_pred ccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 218 LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
+....+...+.++.+||.+||.+||.+|||+.++++
T Consensus 315 l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 315 LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111112223457889999999999999999999973
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=250.89 Aligned_cols=230 Identities=24% Similarity=0.368 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC--CHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL--DWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~--~~~ 81 (303)
.++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++... ...+ +..
T Consensus 31 ~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~ 108 (268)
T cd06624 31 STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK--WGPLKDNEQ 108 (268)
T ss_pred CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh--cccCCCcHH
Confidence 467889999997776667788999999999999999999999999999999999999999999998542 2234 788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.++|+|||.+........ ......++..|+|||.+.+
T Consensus 109 ~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 109 TIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhcc
Confidence 88999999999999999988 999999999999976 67899999999876533221 1112346889999998865
Q ss_pred CC--CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 161 GV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 161 ~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.. ++.++|+||+|+++|+|++|..||....... ........... ....+.....++.+++.+||
T Consensus 184 ~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l 249 (268)
T cd06624 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFKVGMFKI---------HPEIPESLSAEAKNFILRCF 249 (268)
T ss_pred ccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhhhhhhcc---------CCCCCcccCHHHHHHHHHHc
Confidence 43 7889999999999999999999985322110 00000000000 01111223346889999999
Q ss_pred cCCCCCCCCHHHHHHh
Q 045452 239 QENPNDRPSMLEVSSM 254 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~ 254 (303)
..+|.+|||+.++++.
T Consensus 250 ~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 250 EPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCchhCCCHHHHHhC
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=253.58 Aligned_cols=218 Identities=24% Similarity=0.408 Sum_probs=171.4
Q ss_pred EEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHH
Q 045452 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87 (303)
Q Consensus 8 ~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 87 (303)
.|++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++||||+.+++|.+++... ...+++..+..++
T Consensus 32 ~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ 107 (259)
T cd05037 32 SVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVA 107 (259)
T ss_pred eeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHH
Confidence 5788887655433 6788899999999999999999999988 7789999999999999998542 2268899999999
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-------cEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-------KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 88 ~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-------~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.||+.||+|||+.+ ++|+||||+||+++.++ .++|+|||++..... .....+...|+|||.+.+
T Consensus 108 ~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 108 KQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRN 178 (259)
T ss_pred HHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcC
Confidence 99999999999988 99999999999999887 799999999876433 122345678999999877
Q ss_pred C--CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 161 G--VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 161 ~--~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
. .++.++|+||||+++|+|++ |..||........ . ..+......... ....+.+++.+|
T Consensus 179 ~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~----~---~~~~~~~~~~~~-----------~~~~~~~li~~~ 240 (259)
T cd05037 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK----E---RFYQDQHRLPMP-----------DCAELANLINQC 240 (259)
T ss_pred CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH----H---HHHhcCCCCCCC-----------CchHHHHHHHHH
Confidence 6 78899999999999999999 4666643321110 0 111111000000 014788999999
Q ss_pred ccCCCCCCCCHHHHHHhhc
Q 045452 238 VQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L~ 256 (303)
|..+|.+|||+.++++.|+
T Consensus 241 l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 241 WTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hccChhhCCCHHHHHHhcC
Confidence 9999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=258.80 Aligned_cols=233 Identities=30% Similarity=0.429 Sum_probs=179.0
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC------------
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------------ 73 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------ 73 (303)
.+++|.++.. .....+.+.+|+.+++++ +||||+++++++......+++|||+++++|.+++....
T Consensus 31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (297)
T cd05089 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110 (297)
T ss_pred eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence 4788888643 334557789999999999 79999999999999889999999999999999985421
Q ss_pred -cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
....+++..+..++.|++.||++||+.| ++||||||+||+++.++.+||+|||++...... ........+..|
T Consensus 111 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y 184 (297)
T cd05089 111 GTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRW 184 (297)
T ss_pred CccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccc
Confidence 1135888999999999999999999988 999999999999999999999999987532211 011111224579
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++|||||||++|+|++ |..||....... ............ .+...+..+.
T Consensus 185 ~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~ 248 (297)
T cd05089 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRME---------KPRNCDDEVY 248 (297)
T ss_pred cCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhcCCCCC---------CCCCCCHHHH
Confidence 99999988889999999999999999997 999985332111 111111111111 1112234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
+|+.+||..+|.+|||++++++.|.+.....
T Consensus 249 ~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 249 ELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999988766443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=250.64 Aligned_cols=230 Identities=26% Similarity=0.377 Sum_probs=185.4
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|++..... .....+.+|+..+++++|+|++++++++......+++|||+++++|.+++.. ...+++..
T Consensus 24 ~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~ 100 (264)
T cd06623 24 PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK---VGKIPEPV 100 (264)
T ss_pred CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH---cCCCCHHH
Confidence 3689999999876544 4567899999999999999999999999999999999999999999999843 36689999
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
++.++.|++.++++||+ .+ ++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+.
T Consensus 101 ~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 101 LAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGE 175 (264)
T ss_pred HHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccCHhhhCCC
Confidence 99999999999999999 88 9999999999999999999999999987664332221 234578899999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChH-HHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-KLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~ 240 (303)
.++.++|+||||+++|+|++|..||............. ... ....... +.. .+..+.++|.+||..
T Consensus 176 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~-~~~~~~~---------~~~~~~~~l~~li~~~l~~ 242 (264)
T cd06623 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AIC-DGPPPSL---------PAEEFSPEFRDFISACLQK 242 (264)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHh-cCCCCCC---------CcccCCHHHHHHHHHHccC
Confidence 88999999999999999999999986554311111111 111 1111111 111 334788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|++||++.++++.
T Consensus 243 ~p~~R~~~~~ll~~ 256 (264)
T cd06623 243 DPKKRPSAAELLQH 256 (264)
T ss_pred ChhhCCCHHHHHhC
Confidence 99999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=251.82 Aligned_cols=228 Identities=23% Similarity=0.350 Sum_probs=190.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
++|+.||||.+.-. ...+++..|+.++++++.+++|++||.+.....+|+|||||..|++.+.++. ++.+++++.+
T Consensus 56 EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~--R~K~L~E~EI 131 (502)
T KOG0574|consen 56 ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA--RRKPLSEQEI 131 (502)
T ss_pred ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH--hcCCccHHHH
Confidence 58999999998543 3567889999999999999999999999999999999999999999999864 5778999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++...+.||+|||... -+|||||..|||++.+|+.||+|||.+..+... -...++..||+.|+|||++..-.|
T Consensus 132 s~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY 206 (502)
T KOG0574|consen 132 SAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGY 206 (502)
T ss_pred HHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccHHHHHHhcc
Confidence 999999999999999998 899999999999999999999999999766432 233455789999999999999999
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++||||||+...||..|++||...-....... .. ..+-.....+...+.++-+++++||.++|+
T Consensus 207 ~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--------IP------T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE 272 (502)
T KOG0574|consen 207 DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--------IP------TKPPPTFKKPEEWSSEFNDFIRSCLIKKPE 272 (502)
T ss_pred chhhhHhhhcchhhhhhcCCCCcccccccceeEe--------cc------CCCCCCCCChHhhhhHHHHHHHHHhcCCHH
Confidence 9999999999999999999999843221111100 00 011122345666777889999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+|.|+..+++.
T Consensus 273 ~R~TA~~L~~H 283 (502)
T KOG0574|consen 273 ERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHhhh
Confidence 99999998764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=266.95 Aligned_cols=229 Identities=23% Similarity=0.360 Sum_probs=190.0
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
-||||.-+.+ .+...+.|+.|..+|+.++||||++++|+|. .+..|||||.++-|-|..||+. .+..++...+..+
T Consensus 420 aVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly 496 (974)
T KOG4257|consen 420 AVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLY 496 (974)
T ss_pred eeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEecccchhHHHHHHh--ccccchHHHHHHH
Confidence 4789988763 5667899999999999999999999999995 4578999999999999999975 4566889999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.||..+|+|||+.. ++||||..+|||+.....|||+|||+++.+....+.... ...-...|+|||.+....++.+
T Consensus 497 ~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtA 572 (974)
T KOG4257|consen 497 CYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTA 572 (974)
T ss_pred HHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccch
Confidence 999999999999988 999999999999999999999999999998776655443 2233679999999999999999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+|||.||++|||+++ |..||......+..-.+ +...+...|+..+..|+.|+.+||+++|.+|
T Consensus 573 SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----------------EnGeRlP~P~nCPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 573 SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred hhHHHHHHHHHHHHHhcCCccccccccceEEEe----------------cCCCCCCCCCCCChHHHHHHHHHhccCcccC
Confidence 999999999999986 88888654444333222 2222233445555689999999999999999
Q ss_pred CCHHHHHHhhccCC
Q 045452 246 PSMLEVSSMLKNET 259 (303)
Q Consensus 246 ps~~~l~~~L~~~~ 259 (303)
|++.+|...|.+..
T Consensus 637 Prftei~~~lsdv~ 650 (974)
T KOG4257|consen 637 PRFTEIKAILSDVL 650 (974)
T ss_pred CcHHHHHHHHHHHH
Confidence 99999977666543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=251.57 Aligned_cols=226 Identities=29% Similarity=0.449 Sum_probs=177.8
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.++... ..+.+.+|+.+++.++|+|++++++++... ..+++|||+.+++|.+++... ....+++..+
T Consensus 27 ~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~ 102 (254)
T cd05083 27 YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR-GRALVSVIQL 102 (254)
T ss_pred cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc-CcCCCCHHHH
Confidence 367889999986543 336788999999999999999999998654 579999999999999998543 2345789999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||.+||+.| ++||||+|+||+++.++.++|+|||++....... .....+..|+|||.+.+..+
T Consensus 103 ~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~ 174 (254)
T cd05083 103 LQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKF 174 (254)
T ss_pred HHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCc
Confidence 999999999999999988 9999999999999999999999999986533211 11223567999999988889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|+||||+++|+|++ |..||....... ............ .+...+..+.+++.+||..+|
T Consensus 175 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p 238 (254)
T cd05083 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRME---------PPEGCPADVYVLMTSCWETEP 238 (254)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCC---------CCCcCCHHHHHHHHHHcCCCh
Confidence 999999999999999997 888885332211 111111111111 112223578899999999999
Q ss_pred CCCCCHHHHHHhhcc
Q 045452 243 NDRPSMLEVSSMLKN 257 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~ 257 (303)
++||++.++++.|++
T Consensus 239 ~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 239 KKRPSFHKLREKLEK 253 (254)
T ss_pred hhCcCHHHHHHHHcc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=296.75 Aligned_cols=231 Identities=25% Similarity=0.341 Sum_probs=187.2
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+++|+..|+|.++-. .....+.+.+|..++..++|||+|++||+-.+.+..+|.||||.+|+|.+.+. .+...++
T Consensus 1257 ~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~---~gri~dE 1333 (1509)
T KOG4645|consen 1257 LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE---HGRIEDE 1333 (1509)
T ss_pred CCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH---hcchhhh
Confidence 678999999988744 23456778899999999999999999999999999999999999999999983 4556788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc--cccccceeeccccccCchhc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES--LKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~ 158 (303)
.....+..|++.|++|||+.| ||||||||.||+++.+|.+|++|||.+..+.+.. .........||+.|||||++
T Consensus 1334 ~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1334 MVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred hHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhh
Confidence 888899999999999999999 9999999999999999999999999999887653 23333446799999999999
Q ss_pred ccCC---CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 159 RQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 159 ~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.. -..+.||||||||+.||+||+.||...+. .+. +. .....+. ....|...+.+-+++|.
T Consensus 1411 t~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~a-IM---y~V~~gh---------~Pq~P~~ls~~g~dFle 1475 (1509)
T KOG4645|consen 1411 TGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWA-IM---YHVAAGH---------KPQIPERLSSEGRDFLE 1475 (1509)
T ss_pred cccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhH-HH---hHHhccC---------CCCCchhhhHhHHHHHH
Confidence 7654 45689999999999999999999843221 111 11 1111121 22233335567889999
Q ss_pred hcccCCCCCCCCHHHHHHh
Q 045452 236 LCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~ 254 (303)
.||..||++|.++.+|++.
T Consensus 1476 ~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHhcCchhhhHHHHHHHh
Confidence 9999999999999988775
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=249.61 Aligned_cols=226 Identities=24% Similarity=0.349 Sum_probs=179.9
Q ss_pred CCCEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 5 CGEVIAVKKLSKSS-----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
+|+.|++|.+.... ....+.+.+|+.+++.++|+||+++++++......++++||+++++|.+++.. ...++
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~ 100 (258)
T cd06632 24 DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK---YGSFP 100 (258)
T ss_pred CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh---cCCCC
Confidence 78999999885432 23556788999999999999999999999999999999999999999999843 34588
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.|++.+|++||+.| ++|+||+|+||+++.++.+||+|||.+....... ......++..|++||.+.
T Consensus 101 ~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~ 174 (258)
T cd06632 101 EPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIA 174 (258)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhc
Confidence 9999999999999999999998 9999999999999999999999999987654322 122345788999999887
Q ss_pred cCC-CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 QGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 ~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
... ++.++|+||||+++|+|++|+.||..... .............. ..+......+.+++.+||
T Consensus 175 ~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP---------PIPDHLSDEAKDFILKCL 239 (258)
T ss_pred CCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCC---------CcCCCcCHHHHHHHHHHh
Confidence 766 88999999999999999999999854321 11111111101111 111122346889999999
Q ss_pred cCCCCCCCCHHHHHHh
Q 045452 239 QENPNDRPSMLEVSSM 254 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~ 254 (303)
..+|.+||++.+++..
T Consensus 240 ~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 240 QRDPSLRPTAAELLEH 255 (258)
T ss_pred hcCcccCcCHHHHhcC
Confidence 9999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=250.28 Aligned_cols=233 Identities=27% Similarity=0.403 Sum_probs=180.8
Q ss_pred CCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcc------cC
Q 045452 5 CGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR------LI 77 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~ 77 (303)
+.+.|++|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.+++...... ..
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (275)
T cd05046 34 GETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113 (275)
T ss_pred CcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccC
Confidence 4578999988654433 5678999999999999999999999998888999999999999999998653321 25
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.++++|||++........ .......++..|+|||.
T Consensus 114 l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~ 189 (275)
T cd05046 114 LSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEA 189 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhh
Confidence 899999999999999999999998 99999999999999999999999999865432211 11222345678999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+..++.++||||||+++|+|++ |..||...... .... ......... ..+...+..+.+++.+
T Consensus 190 ~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~---~~~~~~~~~---------~~~~~~~~~l~~~i~~ 254 (275)
T cd05046 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN---RLQAGKLEL---------PVPEGCPSRLYKLMTR 254 (275)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH---HHHcCCcCC---------CCCCCCCHHHHHHHHH
Confidence 888888899999999999999998 77787432211 1111 111011000 0111223478899999
Q ss_pred cccCCCCCCCCHHHHHHhhc
Q 045452 237 CVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~ 256 (303)
||..+|.+|||+.++++.|.
T Consensus 255 ~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 255 CWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCCcccCCCHHHHHHHhc
Confidence 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.72 Aligned_cols=228 Identities=22% Similarity=0.290 Sum_probs=181.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++.++...+++|||+++++|.+++.. ...++.
T Consensus 16 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~ 92 (262)
T cd05572 16 SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDE 92 (262)
T ss_pred CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh---cCCCCH
Confidence 358999999986432 23457789999999999999999999999999999999999999999999843 345889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||++||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+
T Consensus 93 ~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~ 166 (262)
T cd05572 93 YTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166 (262)
T ss_pred HHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcC
Confidence 999999999999999999988 9999999999999999999999999987664432 1222457889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||+|+++|+|++|..||...... ..........+..... .+...+.++.++|.+||..
T Consensus 167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGKLE---------FPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCCCC---------CCcccCHHHHHHHHHHccC
Confidence 88899999999999999999999999654321 1111111111111111 1111144788999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 045452 241 NPNDRPS-----MLEVSS 253 (303)
Q Consensus 241 dp~~Rps-----~~~l~~ 253 (303)
+|++||+ ++++++
T Consensus 234 ~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 234 NPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ChhhCcCCcccCHHHHhc
Confidence 9999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=259.10 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=176.0
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||+|.++... ......+.+|+.+++.++|+||+++++++......++||||+. ++|..++.. ....+++..
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~ 105 (301)
T cd07873 29 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD--CGNSINMHN 105 (301)
T ss_pred CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh--cCCCCCHHH
Confidence 468899999986442 2334567789999999999999999999999999999999996 588887754 234588999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC-
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 161 (303)
+..++.||+.||.+||+.+ ++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+.
T Consensus 106 ~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 180 (301)
T cd07873 106 VKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGST 180 (301)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCC
Confidence 9999999999999999998 99999999999999999999999999865432211 11223468899999987654
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH-----HHhhCCCcc-ccccccccC-------CCChHHHH
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGM-EFVDSFLDD-------RNSSCKLM 228 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~-------~~~~~~~~ 228 (303)
.++.++||||||+++|+|++|..||......+......... ..|...... ......... ......+.
T Consensus 181 ~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (301)
T cd07873 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDS 260 (301)
T ss_pred CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCH
Confidence 47889999999999999999999986443221111100000 000000000 000000000 00111234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.+.+||.+||..||.+|||+.++++
T Consensus 261 ~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 261 DGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 6789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=256.43 Aligned_cols=239 Identities=25% Similarity=0.321 Sum_probs=171.3
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||+|.++... ......+.+|+.+++.+ +||||+++++++... ...+++|||+. ++|..++...
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~- 100 (288)
T cd07863 23 HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKV- 100 (288)
T ss_pred CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhc-
Confidence 578999999986432 22233455677666655 799999999988642 35799999997 4787877542
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
....+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++........ .....++..|+
T Consensus 101 ~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~ 174 (288)
T cd07863 101 PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYR 174 (288)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCcccccccc
Confidence 2345899999999999999999999998 99999999999999999999999999876543211 12235688999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc------cccccccc-------C
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM------EFVDSFLD-------D 220 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------~ 220 (303)
|||.+.+..++.++|||||||++|+|++|.+||........ .............. ........ .
T Consensus 175 aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
T cd07863 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQ 251 (288)
T ss_pred CchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChhhCcccccccccccCCCCCCchH
Confidence 99999888899999999999999999999999854322111 11111110000000 00000000 0
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...+....++.++|.+||..||++|||+.+++.
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 252 SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=253.01 Aligned_cols=232 Identities=24% Similarity=0.372 Sum_probs=181.8
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
++|+.||+|++.... ....+.+.+|+++++.++|+||+++++++.....+++||||+++++|.+++.. ...+++..
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~ 104 (284)
T cd06620 28 PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK---GGPIPVEI 104 (284)
T ss_pred CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh---ccCCCHHH
Confidence 568999999886543 34567889999999999999999999999999999999999999999888743 45689999
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+.
T Consensus 105 ~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 105 LGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred HHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccC
Confidence 99999999999999997 46 9999999999999999999999999876543221 1234678999999998888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccc-----cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL-----SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.++.++|+|||||++|+|++|..||......... ............. ...+ .....+.++.+++.+
T Consensus 178 ~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~li~~ 248 (284)
T cd06620 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRL--------PSSDFPEDLRDFVDA 248 (284)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCC--------CchhcCHHHHHHHHH
Confidence 8899999999999999999999999654332110 0011111111110 0000 011123468899999
Q ss_pred cccCCCCCCCCHHHHHHh
Q 045452 237 CVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~ 254 (303)
||..||.+|||+.++++.
T Consensus 249 ~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 249 CLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HhcCCcccCcCHHHHhcC
Confidence 999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.09 Aligned_cols=235 Identities=29% Similarity=0.444 Sum_probs=194.1
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
.-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|.....+|||+|||..|+|.+||++. .+..++...++.
T Consensus 292 slTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLly 369 (1157)
T KOG4278|consen 292 SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLY 369 (1157)
T ss_pred ceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHh-chhhcchhHHHH
Confidence 346899999655 446688999999999999999999999999999999999999999999999774 345578888999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 165 (303)
++.||..|+.||...+ ++||||..+|+|+.++..||++|||+++.+...++..... ..-...|.|||-+....++.
T Consensus 370 MAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSi 445 (1157)
T KOG4278|consen 370 MATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSI 445 (1157)
T ss_pred HHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCccccccccccc
Confidence 9999999999999998 9999999999999999999999999999998766554332 12267899999999999999
Q ss_pred cccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
++|||+||+++||+.| |.-||.... +...+.....+..++ .+...+..+++|+++||+.+|.+
T Consensus 446 KSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LLEkgyRM~---------~PeGCPpkVYeLMraCW~WsPsD 509 (1157)
T KOG4278|consen 446 KSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLLEKGYRMD---------GPEGCPPKVYELMRACWNWSPSD 509 (1157)
T ss_pred chhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHhcccccc---------CCCCCCHHHHHHHHHHhcCCccc
Confidence 9999999999999987 777774332 223344444333333 23333447899999999999999
Q ss_pred CCCHHHHHHhhccCCCCC
Q 045452 245 RPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 245 Rps~~~l~~~L~~~~~~~ 262 (303)
||++.|+-+.|+..+...
T Consensus 510 RPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 510 RPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred CccHHHHHHHHHHHhccc
Confidence 999999999888766443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=266.65 Aligned_cols=239 Identities=25% Similarity=0.283 Sum_probs=174.5
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+++.||+|++... .......+.+|+.+++.++|+||+++++++... ...+++|||+.+ ++.+.+.
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 113 (355)
T cd07874 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----- 113 (355)
T ss_pred CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh-----
Confidence 46889999998654 234456788899999999999999999988643 357999999965 5666652
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..++...+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++....... ......++..|+||
T Consensus 114 ~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP 187 (355)
T cd07874 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 187 (355)
T ss_pred hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCH
Confidence 23788899999999999999999998 9999999999999999999999999997654321 12234678999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH----------------HHHHhhCCC---c---ccc
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELWKGGK---G---MEF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~---~---~~~ 213 (303)
|.+.+..++.++|||||||++|+|++|+.||.............. ......... . ...
T Consensus 188 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (355)
T cd07874 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267 (355)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhh
Confidence 999988899999999999999999999999964332111100000 000000000 0 000
Q ss_pred c-cccc--cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 V-DSFL--DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~-~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
. +... ..........++.+||.+||..||++|||+.++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred ccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0000 000111223467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=248.56 Aligned_cols=235 Identities=22% Similarity=0.315 Sum_probs=171.8
Q ss_pred CEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCCHHHHH
Q 045452 7 EVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDWKKRV 84 (303)
Q Consensus 7 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~ 84 (303)
..+++|.++... ....+.+.+|+..++.++||||+++++.+......+++|||+++++|.+++.... .....+...++
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (268)
T cd05086 23 ARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ 102 (268)
T ss_pred ceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHH
Confidence 346677765443 3456788999999999999999999999999999999999999999999886422 12346777888
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc----
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ---- 160 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---- 160 (303)
.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||++..
T Consensus 103 ~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (268)
T cd05086 103 RMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179 (268)
T ss_pred HHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCc
Confidence 99999999999999988 99999999999999999999999998754322211122223456889999998743
Q ss_pred ---CCCCCcccchhhHHHHHHHHhC-CCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 161 ---GVYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 161 ---~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
..++.++||||||+++|+|+++ ..||..... ........... .....++.. .......+.+++..
T Consensus 180 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~l~~~ 248 (268)
T cd05086 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQ-QVKLFKPQL----ELPYSERWYEVLQF 248 (268)
T ss_pred cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhc-ccccCCCcc----CCCCcHHHHHHHHH
Confidence 2357789999999999999974 566643221 11111111111 111111111 11133467889999
Q ss_pred cccCCCCCCCCHHHHHHhhc
Q 045452 237 CVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~ 256 (303)
|| .+|.+||++.++++.|.
T Consensus 249 c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 249 CW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Hh-hCcccCCCHHHHHHHhc
Confidence 99 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=255.72 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=177.7
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.+.... ....+.+.+|+.++++++|+|++++++++..+...+++|||+++++|..++. ....+++.
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~ 100 (286)
T cd07847 24 ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK---NPRGVPEH 100 (286)
T ss_pred CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh---CCCCCCHH
Confidence 368999999886432 2234567899999999999999999999999999999999999988877763 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 160 (303)
.++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 101 ~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~ 175 (286)
T cd07847 101 LIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCC
Confidence 99999999999999999988 99999999999999999999999999876543321 1122346788999998765
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH--------HHHhhCCCcc-ccccccccCCC-----ChHH
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGM-EFVDSFLDDRN-----SSCK 226 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~-----~~~~ 226 (303)
..++.++|+||||+++|+|++|..||......+........ ...+...... ........... ....
T Consensus 176 ~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (286)
T cd07847 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNI 255 (286)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccC
Confidence 45788999999999999999999998643322111111000 0000000000 00000000000 0112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+..+.+++.+||..+|++|||+.+++..
T Consensus 256 ~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 256 SSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 3568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=249.04 Aligned_cols=237 Identities=26% Similarity=0.363 Sum_probs=183.9
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|..+|+|++.... ....+.+.+|+..++.++|+|++++++.+...+..+++||++.+++|.+++........+++..
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~ 103 (267)
T cd06610 24 PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI 103 (267)
T ss_pred CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHH
Confidence 478899999986443 3356788999999999999999999999999999999999999999999986533335689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeeccccccCchhccc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 160 (303)
+..++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+..
T Consensus 104 ~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~ 180 (267)
T cd06610 104 IATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180 (267)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc
Confidence 9999999999999999998 999999999999999999999999998765433222 12233457889999998876
Q ss_pred C-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 G-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
. .++.++|+||||+++|+|++|..||....... ......... .... .........+..+.+++.+||.
T Consensus 181 ~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~li~~~l~ 249 (267)
T cd06610 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND-PPSL----ETGADYKKYSKSFRKMISLCLQ 249 (267)
T ss_pred ccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC-CCCc----CCccccccccHHHHHHHHHHcC
Confidence 6 78899999999999999999999985332211 111111111 0000 0001111233568899999999
Q ss_pred CCCCCCCCHHHHHHh
Q 045452 240 ENPNDRPSMLEVSSM 254 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~ 254 (303)
.||++|||++++++.
T Consensus 250 ~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 250 KDPSKRPTAEELLKH 264 (267)
T ss_pred CChhhCcCHHHHhhC
Confidence 999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=251.04 Aligned_cols=232 Identities=26% Similarity=0.338 Sum_probs=182.3
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||+|.+.... ......+.+|+..+++++||||+++++.+......++++||+.+++|.+++... ...+++..
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~ 101 (265)
T cd06605 24 PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV--QGRIPERI 101 (265)
T ss_pred CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc--cCCCCHHH
Confidence 368999999986553 345567889999999999999999999999999999999999999999998542 25688999
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..++.|++.++++||. .+ ++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+.
T Consensus 102 ~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~ 174 (265)
T cd06605 102 LGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGN 174 (265)
T ss_pred HHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCC
Confidence 99999999999999999 77 99999999999999999999999999865532211 115578899999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+||||+++|+|++|..||....... ......... .......... ....+.++.++|.+||..|
T Consensus 175 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~ 244 (265)
T cd06605 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQY-IVNEPPPRLP--------SGKFSPDFQDFVNLCLIKD 244 (265)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHH-HhcCCCCCCC--------hhhcCHHHHHHHHHHcCCC
Confidence 89999999999999999999999986443211 111111111 1111111110 0013446889999999999
Q ss_pred CCCCCCHHHHHHh
Q 045452 242 PNDRPSMLEVSSM 254 (303)
Q Consensus 242 p~~Rps~~~l~~~ 254 (303)
|.+|||+.+++..
T Consensus 245 p~~Rpt~~~ll~~ 257 (265)
T cd06605 245 PRERPSYKELLEH 257 (265)
T ss_pred chhCcCHHHHhhC
Confidence 9999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=258.05 Aligned_cols=233 Identities=18% Similarity=0.222 Sum_probs=175.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++.. .....+.+.+|+.++..++|+||+++++++.+....++||||+.+++|.+++.. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~ 101 (331)
T cd05597 24 NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPE 101 (331)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH--hcCCCCH
Confidence 46899999998642 223456688899999999999999999999999999999999999999999853 2345889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..+..... .......|+..|+|||++..
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 102 DMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhh
Confidence 999999999999999999999 99999999999999999999999999876543221 11222458999999999863
Q ss_pred -----CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 161 -----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 161 -----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
..++.++|||||||++|+|++|+.||...... ..............+.. .....+..+.++|.
T Consensus 178 ~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~~------~~~~~~~~~~~li~ 245 (331)
T cd05597 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQFPP------DVTDVSEEAKDLIR 245 (331)
T ss_pred ccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccCCC------ccCCCCHHHHHHHH
Confidence 45788999999999999999999998533211 11111111111111110 01113346789999
Q ss_pred hcccCC--CCCCCCHHHHHHh
Q 045452 236 LCVQEN--PNDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~d--p~~Rps~~~l~~~ 254 (303)
+||..+ +..||++.+++..
T Consensus 246 ~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 246 RLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHccCcccccCCCCHHHHhcC
Confidence 988643 3347788888755
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=249.99 Aligned_cols=234 Identities=26% Similarity=0.382 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccCCC----------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSS----------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||+|.++... ....+.+..|+.+++.++|+|++++++++...+..++||||+.+++|.+++..
T Consensus 24 ~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 101 (272)
T cd06629 24 TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-- 101 (272)
T ss_pred CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh--
Confidence 478999999885321 11234678899999999999999999999999999999999999999999854
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
...+++..+..++.||+.+|.+||+.+ ++|+||+|+||+++.++.++++|||.+................++..|+
T Consensus 102 -~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~ 177 (272)
T cd06629 102 -YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177 (272)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCcccc
Confidence 356889999999999999999999988 9999999999999999999999999987654322122222345788999
Q ss_pred CchhcccCC--CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 154 PPEYARQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 154 aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|||.+.... ++.++|+||||+++|++++|..||..... .................. ......+.++.
T Consensus 178 ~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 246 (272)
T cd06629 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRSAPPIPP-----DVSMNLSPVAL 246 (272)
T ss_pred CHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccccCCcCCc-----cccccCCHHHH
Confidence 999887654 78899999999999999999999842211 111111111111111111 11112235788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHh
Q 045452 232 EIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+++.+||..+|.+|||++++++.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 247 DFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHHhcCChhhCCCHHHHhhC
Confidence 99999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=265.64 Aligned_cols=215 Identities=26% Similarity=0.398 Sum_probs=174.2
Q ss_pred hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe--eeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHH
Q 045452 19 AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE--RMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLY 96 (303)
Q Consensus 19 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 96 (303)
+...++|..|+.+|+.|+|+||+++|++|.+... ..+|+|.+..|+|..|+.+ ...++...++.|++||+.||.|
T Consensus 82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~y 158 (632)
T KOG0584|consen 82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVY 158 (632)
T ss_pred hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhh
Confidence 4455889999999999999999999999987665 7889999999999999954 4558889999999999999999
Q ss_pred HHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHH
Q 045452 97 LQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175 (303)
Q Consensus 97 lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 175 (303)
||.+. .+|+|||||.+||||+++ |.|||+|+|+|......... ..+||+.|||||... ..|+...||||||++
T Consensus 159 LHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMC 232 (632)
T KOG0584|consen 159 LHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMC 232 (632)
T ss_pred hhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHH
Confidence 99976 579999999999999876 88999999999876543222 257999999999887 778999999999999
Q ss_pred HHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--
Q 045452 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS-- 253 (303)
Q Consensus 176 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~-- 253 (303)
|+||+|+..||.-+... ...|+....+..+.-+. .....++++||.+||.. .++|||+.|++.
T Consensus 233 mLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~--------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 233 MLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALS--------KVKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred HHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhh--------ccCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 99999999999655432 23344444333222111 11123788999999999 999999999984
Q ss_pred hhcc
Q 045452 254 MLKN 257 (303)
Q Consensus 254 ~L~~ 257 (303)
+|..
T Consensus 298 Ff~~ 301 (632)
T KOG0584|consen 298 FFDE 301 (632)
T ss_pred hhcc
Confidence 3444
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=247.40 Aligned_cols=229 Identities=23% Similarity=0.296 Sum_probs=179.6
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|++.... ....+.+.+|+.++++++|+|++++++.+... ...+++|||+++++|.+++... ....+++
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~l~~ 101 (257)
T cd08223 23 TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPE 101 (257)
T ss_pred CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh-cCCCCCH
Confidence 467899999986432 34556788999999999999999999987643 4679999999999999888542 2345899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.+++.++++||+.| ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 102 ~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 102 NQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcC
Confidence 999999999999999999998 9999999999999999999999999987654322 12223457889999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++++|++|+.||.... ..........+ ... ..+...+..+.+++.+||..
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~-~~~---------~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG-KLP---------PMPKDYSPELGELIATMLSK 240 (257)
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc-CCC---------CCccccCHHHHHHHHHHhcc
Confidence 889999999999999999999999985322 11111111111 110 11122334788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
||++|||+.+++..
T Consensus 241 ~p~~Rp~~~~~l~~ 254 (257)
T cd08223 241 RPEKRPSVKSILRQ 254 (257)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.95 Aligned_cols=222 Identities=30% Similarity=0.399 Sum_probs=183.0
Q ss_pred CCCCEEEEEEccC---CChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSK---SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+.++||||++.= ...+-++.+..|+..+++++|||++.+.|+|......|+||||| -||-.|++. ..+.++.+
T Consensus 49 ~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlle--VhkKplqE 125 (948)
T KOG0577|consen 49 RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQE 125 (948)
T ss_pred CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHH--HHhccchH
Confidence 4788999999852 24456788999999999999999999999999999999999999 457777764 24677999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.+.+.||+|||+.+ .+|||||..|||+++.|.|||+|||.+.... ..+.++||+.|||||++.
T Consensus 126 vEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILA 196 (948)
T KOG0577|consen 126 VEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILA 196 (948)
T ss_pred HHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHhee
Confidence 999999999999999999998 9999999999999999999999999886543 345588999999999874
Q ss_pred --cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
.+.|+-++||||||++..+|.-.++|... .+.+...|.+.......- ....++..+.+++..|
T Consensus 197 MDEGqYdgkvDvWSLGITCIELAERkPPlFn------MNAMSALYHIAQNesPtL---------qs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 197 MDEGQYDGKVDVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNESPTL---------QSNEWSDYFRNFVDSC 261 (948)
T ss_pred ccccccCCccceeeccchhhhhhhcCCCccC------chHHHHHHHHHhcCCCCC---------CCchhHHHHHHHHHHH
Confidence 55799999999999999999999999753 233334444433322111 1334556788999999
Q ss_pred ccCCCCCCCCHHHHH
Q 045452 238 VQENPNDRPSMLEVS 252 (303)
Q Consensus 238 l~~dp~~Rps~~~l~ 252 (303)
|++-|.+|||.++++
T Consensus 262 LqKipqeRptse~ll 276 (948)
T KOG0577|consen 262 LQKIPQERPTSEELL 276 (948)
T ss_pred HhhCcccCCcHHHHh
Confidence 999999999999885
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=247.64 Aligned_cols=229 Identities=23% Similarity=0.331 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.++.. .....+.+.+|+.++++++|+||+++++++...+..++||||+.+++|.+++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~ 101 (256)
T cd08218 23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPED 101 (256)
T ss_pred CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHH
Confidence 47899999998643 2344567889999999999999999999999999999999999999999888542 23357889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+.
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~ 176 (256)
T cd08218 102 QILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENR 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCC
Confidence 99999999999999999988 99999999999999999999999999876543211 11224567889999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+||||+++++|++|..||..... ......... +.... .+.....++.++|.+||+.+
T Consensus 177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~~---------~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSYPP---------VSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred CCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCCCC---------CcccCCHHHHHHHHHHhhCC
Confidence 899999999999999999999999853321 111111111 11111 11122346889999999999
Q ss_pred CCCCCCHHHHHHh
Q 045452 242 PNDRPSMLEVSSM 254 (303)
Q Consensus 242 p~~Rps~~~l~~~ 254 (303)
|.+||++.++++.
T Consensus 241 p~~Rp~~~~vl~~ 253 (256)
T cd08218 241 PRDRPSVNSILEK 253 (256)
T ss_pred hhhCcCHHHHhhC
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=266.84 Aligned_cols=234 Identities=26% Similarity=0.298 Sum_probs=172.5
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+++.||+|++..... .....+.+|+.++++++|+||+++++++... ...+++++++ +++|.+++. .
T Consensus 38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~----~ 112 (343)
T cd07878 38 RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK----C 112 (343)
T ss_pred CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh----c
Confidence 5788999999865422 2345677899999999999999999987543 3568999988 788887773 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++...... .....++..|+||
T Consensus 113 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aP 184 (343)
T cd07878 113 QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAP 184 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCc
Confidence 45899999999999999999999998 999999999999999999999999998765432 1234578999999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccc-----------cccCCCC
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-----------FLDDRNS 223 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 223 (303)
|.+.+ ..++.++|||||||++|+|++|..||....... .+....... +....+.... .......
T Consensus 185 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (343)
T cd07878 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVV-GTPSPEVLKKISSEHARKYIQSLPHMPQ 260 (343)
T ss_pred hHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHh-CCCCHHHHHhcchhhHHHHhhccccccc
Confidence 99876 468899999999999999999999985432211 111111100 0000000000 0000000
Q ss_pred -------hHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 224 -------SCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 224 -------~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
......+.+||.+||..||++|||+.++++.
T Consensus 261 ~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 261 QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0112357799999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=254.69 Aligned_cols=231 Identities=23% Similarity=0.252 Sum_probs=180.6
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+..... ...+.+..|+..++.++|+||+++++.+.+....+++|||+.+++|.+++... ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~ 102 (316)
T cd05574 24 GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ-PGKCLSE 102 (316)
T ss_pred CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhC-CCCccCH
Confidence 3689999999865432 24567889999999999999999999999999999999999999999988532 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--------------------
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-------------------- 140 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-------------------- 140 (303)
..+..++.|++.+|+|||..| ++|+||||+||+++.++.++|+|||++.........
T Consensus 103 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (316)
T cd05574 103 EVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchh
Confidence 999999999999999999988 999999999999999999999999998654321110
Q ss_pred -------cccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc
Q 045452 141 -------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF 213 (303)
Q Consensus 141 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (303)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... .......... ..
T Consensus 180 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~------~~~~~~~~~~--~~ 251 (316)
T cd05574 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE------TFSNILKKEV--TF 251 (316)
T ss_pred hhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH------HHHHHhcCCc--cC
Confidence 01112357888999999988889999999999999999999999985433211 1111111110 00
Q ss_pred ccccccCCCChHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 045452 214 VDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS----MLEVSS 253 (303)
Q Consensus 214 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~l~~ 253 (303)
......+..+.++|.+||..||++||| +++++.
T Consensus 252 -------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 252 -------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 001113457899999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=254.24 Aligned_cols=236 Identities=19% Similarity=0.218 Sum_probs=180.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|.++... ....+.+.+|+.+++.++||||+++++.+..+...+++|||+++++|.+++.. ...+++
T Consensus 24 ~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~ 100 (305)
T cd05609 24 ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN---IGALPV 100 (305)
T ss_pred CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH---cCCCCH
Confidence 467899999986543 23456788999999999999999999999999999999999999999999843 346899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-------------ccccceee
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-------------KANTEQVV 147 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-------------~~~~~~~~ 147 (303)
..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ........
T Consensus 101 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (305)
T cd05609 101 DMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177 (305)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence 999999999999999999988 99999999999999999999999998763110000 00111234
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .... .......... ......+
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~---~~~~~~~~~~--------~~~~~~~ 243 (305)
T cd05609 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFG---QVISDDIEWP--------EGDEALP 243 (305)
T ss_pred cCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhcccCCC--------CccccCC
Confidence 677899999998888999999999999999999999998532111 1111 1111110000 0011223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.++.++|.+||+.||++||+...+.+.|+...
T Consensus 244 ~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred HHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 46889999999999999999877777777754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=280.35 Aligned_cols=240 Identities=22% Similarity=0.257 Sum_probs=181.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-------
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------- 73 (303)
.+|+.||+|+++... ....+++.+|+.++++++||||+++++++.+++..+++|||++|++|.+++....
T Consensus 25 ~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e 104 (932)
T PRK13184 25 VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK 104 (932)
T ss_pred CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccch
Confidence 468999999986532 3345678999999999999999999999999999999999999999999885311
Q ss_pred -cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-------------
Q 045452 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------------- 139 (303)
Q Consensus 74 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~------------- 139 (303)
.....+...++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 105 ~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~ 181 (932)
T PRK13184 105 ELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181 (932)
T ss_pred hhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccc
Confidence 1234566788999999999999999998 99999999999999999999999999976521100
Q ss_pred ---ccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccc
Q 045452 140 ---KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS 216 (303)
Q Consensus 140 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (303)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||....... .... .... .....
T Consensus 182 ~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k----i~~~-~~i~--~P~~~--- 251 (932)
T PRK13184 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK----ISYR-DVIL--SPIEV--- 251 (932)
T ss_pred ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh----hhhh-hhcc--Chhhc---
Confidence 001122468999999999999999999999999999999999999985422110 0000 0000 00000
Q ss_pred cccCCCChHHHHHHHHHHHhcccCCCCCCC-CHHHHHHhhccCCC
Q 045452 217 FLDDRNSSCKLMRCLEIALLCVQENPNDRP-SMLEVSSMLKNETT 260 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~~l~~~L~~~~~ 260 (303)
......+..+.+++.+||..||++|| +++++++.|+....
T Consensus 252 ----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 252 ----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00011234678999999999999996 66777777766543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=248.10 Aligned_cols=235 Identities=26% Similarity=0.395 Sum_probs=179.0
Q ss_pred CCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcC---
Q 045452 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPI--- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~--- 73 (303)
+|+.||||.++.. .....+.+.+|+..++.++||||+++++++.... ..+++++|+.+++|.+++....
T Consensus 26 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 105 (273)
T cd05074 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105 (273)
T ss_pred CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC
Confidence 5789999998654 3345677889999999999999999999886542 2478899999999988764311
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
....++...++.++.|++.||+|||+.+ ++|+||||+||+++.++.+|++|||.+................++..|+
T Consensus 106 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 182 (273)
T cd05074 106 EPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182 (273)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhc
Confidence 1234788999999999999999999988 9999999999999999999999999987654322221222233467899
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+||.+.+..++.++|||||||++|+|++ |..||..... ............... +...+..+.+
T Consensus 183 ~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~~ 246 (273)
T cd05074 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYNYLIKGNRLKQ---------PPDCLEDVYE 246 (273)
T ss_pred CHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHHHHHcCCcCCC---------CCCCCHHHHH
Confidence 9999988888999999999999999999 7788742211 111111111111110 1112347889
Q ss_pred HHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 233 IALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
++.+||..+|.+|||+.++++.|++.
T Consensus 247 l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 247 LMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=254.71 Aligned_cols=245 Identities=24% Similarity=0.276 Sum_probs=179.7
Q ss_pred CCCCEEEEEEccCCCh-----hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSSA-----QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||+|.++.... .....+.+|+..+++++|+||+++++++.+....++||||+ +++|.+++... ...+
T Consensus 23 ~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~--~~~~ 99 (298)
T cd07841 23 ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK--SIVL 99 (298)
T ss_pred CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhcc--CCCC
Confidence 4689999999975532 23456778999999999999999999999999999999999 89999998542 2368
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..++.++.||+.||+|||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+
T Consensus 100 ~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 100 TPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELL 174 (298)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHH
Confidence 99999999999999999999998 99999999999999999999999999876643321 11223457789999987
Q ss_pred cc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHh--------hCC-CccccccccccCC-----CC
Q 045452 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW--------KGG-KGMEFVDSFLDDR-----NS 223 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~-----~~ 223 (303)
.+ ..++.++|+|||||++|+|++|.+||....... ......... ... ............. ..
T Consensus 175 ~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T cd07841 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIF 251 (298)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhc
Confidence 54 457889999999999999999977664322211 111111100 000 0000000000000 01
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
...+.++.++|.+||..||++|||+.+++.. +++..
T Consensus 252 ~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 252 PAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 1224578899999999999999999999975 44433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=256.43 Aligned_cols=178 Identities=24% Similarity=0.349 Sum_probs=142.7
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCc------Cccc
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDP------IRRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~------~~~~ 76 (303)
+++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +...+++|||+. ++|.+++... ....
T Consensus 27 ~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07867 27 DEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPM 103 (317)
T ss_pred ccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCc
Confidence 56789999986543 22457789999999999999999999854 457899999986 4676665321 1223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEecccccccccccccc-cccceeecccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIG 151 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~----~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~ 151 (303)
.+++..+..++.||+.||.|||+.+ ++||||||+||++ +.++.+||+|||++..+...... .......++..
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07867 104 QLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccc
Confidence 5788999999999999999999998 9999999999999 56678999999999876433211 12233467899
Q ss_pred ccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccc
Q 045452 152 YIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSML 188 (303)
Q Consensus 152 y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~ 188 (303)
|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 999998876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=248.85 Aligned_cols=228 Identities=22% Similarity=0.338 Sum_probs=175.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+++.||+|.+.... .....+..|+.+++++ +|+||+++++++... ...+++|||+.+++|.+++... ...
T Consensus 29 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~ 106 (272)
T cd06637 29 KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGN 106 (272)
T ss_pred CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc-cCC
Confidence 468899999986543 3446788899999998 799999999998753 3579999999999999988542 234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||
T Consensus 107 ~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE 181 (272)
T cd06637 107 TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPE 181 (272)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHh
Confidence 6889999999999999999999998 9999999999999999999999999987543221 1223356788999999
Q ss_pred hcc-----cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 157 YAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 157 ~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+. +..++.++|+||+||++|+|++|..||..... ........... .... .....+.++.
T Consensus 182 ~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~--------~~~~~~~~~~ 246 (272)
T cd06637 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIPRNP-APRL--------KSKKWSKKFQ 246 (272)
T ss_pred HhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHHhcCC-CCCC--------CCCCcCHHHH
Confidence 875 33578899999999999999999999853221 11111111111 0000 1111234688
Q ss_pred HHHHhcccCCCCCCCCHHHHHH
Q 045452 232 EIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~ 253 (303)
+|+.+||..+|.+|||+.+++.
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 247 SFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHcCCChhhCCCHHHHhh
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=247.93 Aligned_cols=228 Identities=22% Similarity=0.321 Sum_probs=174.4
Q ss_pred CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSS-----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||+|.++... ......+.+|+.++++++|+||+++++++... ...++++||+++++|.+++.. ..
T Consensus 25 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~ 101 (266)
T cd06651 25 DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA---YG 101 (266)
T ss_pred CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH---cC
Confidence 468999999885432 23446788999999999999999999998753 567899999999999998843 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aP 155 (303)
.+++..++.++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++........ ........++..|+||
T Consensus 102 ~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (266)
T cd06651 102 ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178 (266)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCH
Confidence 5889999999999999999999988 99999999999999999999999999876532111 1111223468899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++|+||+||++|+|++|+.||.... .............. ...+......+.+++
T Consensus 179 E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li- 242 (266)
T cd06651 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE------AMAAIFKIATQPTN---------PQLPSHISEHARDFL- 242 (266)
T ss_pred HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcCCCC---------CCCchhcCHHHHHHH-
Confidence 99988889999999999999999999999985321 11111111111111 111222234567787
Q ss_pred hcccCCCCCCCCHHHHHH
Q 045452 236 LCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~ 253 (303)
+||..+|++||++++++.
T Consensus 243 ~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 243 GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHhcCChhhCcCHHHHhc
Confidence 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=259.19 Aligned_cols=231 Identities=24% Similarity=0.427 Sum_probs=178.0
Q ss_pred EEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||+|.+.... ......+.+|+.+++.++|+||+++++++... ..+++++|+++|+|.+++.. ....+++..++.+
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~ 114 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNW 114 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh--cccCCCHHHHHHH
Confidence 57999886543 33345788999999999999999999998654 56799999999999998854 2335788999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.............++..|+|||.+.+..++.+
T Consensus 115 ~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (303)
T cd05110 115 CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191 (303)
T ss_pred HHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChH
Confidence 999999999999998 99999999999999999999999999976543222212222334678999999988889999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+||||||+++|+|++ |..||..... .............. .+...+..+.+++.+||..+|++|
T Consensus 192 ~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~c~~~~p~~R 255 (303)
T cd05110 192 SDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERLP---------QPPICTIDVYMVMVKCWMIDADSR 255 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCCC---------CCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999999999997 8888743211 11111111111110 111123468899999999999999
Q ss_pred CCHHHHHHhhccCCC
Q 045452 246 PSMLEVSSMLKNETT 260 (303)
Q Consensus 246 ps~~~l~~~L~~~~~ 260 (303)
|++.++++.|+....
T Consensus 256 p~~~~l~~~l~~~~~ 270 (303)
T cd05110 256 PKFKELAAEFSRMAR 270 (303)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=251.38 Aligned_cols=230 Identities=23% Similarity=0.252 Sum_probs=178.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+.... ......+.+|+.++++++||||+++++.+...+..|+||||+++++|.+++.... ...+++
T Consensus 16 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 94 (277)
T cd05577 16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPE 94 (277)
T ss_pred CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC-cCCCCH
Confidence 478999999986432 2234566789999999999999999999999999999999999999998885422 236899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 95 ~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~ 168 (277)
T cd05577 95 ARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG 168 (277)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcC
Confidence 999999999999999999998 9999999999999999999999999987654311 1122356789999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|+.||...........+. .... .. ....+...+..+.++|.+||+.
T Consensus 169 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~-~~---------~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTL-EM---------AVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hccc-cc---------cccCCccCCHHHHHHHHHHccC
Confidence 889999999999999999999999985443321111111 0000 00 0011122244788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||.+|| ++.+++.
T Consensus 236 ~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 236 DPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ChhHccCCCcccHHHHHh
Confidence 999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=276.75 Aligned_cols=240 Identities=28% Similarity=0.434 Sum_probs=198.1
Q ss_pred CCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
...||||.++.. ....+..|+.|+.+|-+++||||+++-|+........||+|||++|+|+.+|+.+. +.+..-++.
T Consensus 657 e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLV 734 (996)
T KOG0196|consen 657 EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLV 734 (996)
T ss_pred ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHH
Confidence 467999999866 45577889999999999999999999999999999999999999999999997643 448888999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc-cccccceeeccccccCchhcccCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES-LKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
.+++.|+.|++||.+++ ++||||..+||||+.+-.+|++|||+++.+.+.. .........-..+|.|||.+....+
T Consensus 735 gMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 735 GMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred HHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhccc
Confidence 99999999999999999 9999999999999999999999999999775443 1111111223579999999999999
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++||||+|++|||.++ |..||+.-...+....++..+. -..|.+.+..|.+|+..||++|-
T Consensus 812 TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR----------------LPpPmDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 812 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR----------------LPPPMDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC----------------CCCCCCCcHHHHHHHHHHHHHHh
Confidence 999999999999999775 9999876655554444443322 23334445689999999999999
Q ss_pred CCCCCHHHHHHhhccCCCCCCCCC
Q 045452 243 NDRPSMLEVSSMLKNETTNTNTPK 266 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~~~~~~~~ 266 (303)
+.||.+.+|...|.+.-.+...-+
T Consensus 876 ~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 876 NRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred hcCCCHHHHHHHHHHHhcCchhhc
Confidence 999999999999888665554433
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=252.19 Aligned_cols=222 Identities=24% Similarity=0.312 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|.++... ....+.+.+|+.++++++||||+++++++.++...+++|||+++++|.+++.. ...++.
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~l~~ 100 (290)
T cd05580 24 GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---SGRFPE 100 (290)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH---cCCCCH
Confidence 468999999986432 23456788999999999999999999999999999999999999999999843 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+
T Consensus 101 ~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 101 PVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILS 172 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcC
Confidence 999999999999999999988 999999999999999999999999998765433 223457889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||..... .........+. ..+ +...+..+.++|.+||..
T Consensus 173 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--~~~---------~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGK--VRF---------PSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC--ccC---------CccCCHHHHHHHHHHccC
Confidence 8889999999999999999999999854331 11111111111 111 111234788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||.+|+ ++++++.
T Consensus 236 ~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CHHHccCcccCCHHHHHc
Confidence 999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=249.41 Aligned_cols=238 Identities=24% Similarity=0.311 Sum_probs=180.6
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCc-CcccCCC
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDP-IRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~ 79 (303)
.+++.+|+|.+..... .....+.+|++++++++|+||+++++++... ..++++|||+++++|.+++... .....++
T Consensus 24 ~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 103 (287)
T cd06621 24 NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG 103 (287)
T ss_pred CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCC
Confidence 4689999999875432 4557789999999999999999999988653 3689999999999998876432 1345588
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
...+..++.||+.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....++..|+|||.+.
T Consensus 104 ~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~ 176 (287)
T cd06621 104 EKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQ 176 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhc
Confidence 8999999999999999999998 99999999999999999999999999865432211 1234678999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||||+++|+|++|..||...... .....+.. ..........+... . ......+..+.+++.+||.
T Consensus 177 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~ 251 (287)
T cd06621 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELL-SYIVNMPNPELKDE-P--GNGIKWSEEFKDFIKQCLE 251 (287)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHH-HHHhcCCchhhccC-C--CCCCchHHHHHHHHHHHcC
Confidence 888999999999999999999999998755331 11111111 11111111111100 0 0011234578899999999
Q ss_pred CCCCCCCCHHHHHH
Q 045452 240 ENPNDRPSMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~~l~~ 253 (303)
.+|++|||+.++++
T Consensus 252 ~~p~~Rpt~~eil~ 265 (287)
T cd06621 252 KDPTRRPTPWDMLE 265 (287)
T ss_pred CCcccCCCHHHHHh
Confidence 99999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=270.48 Aligned_cols=228 Identities=29% Similarity=0.414 Sum_probs=188.5
Q ss_pred CCCCE--EEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEV--IAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~--vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+. ||||+++..... ....|.+|+..|.+|+|+|++++||+..+ ....+|||+++.|||.+.|.+ .....+-.
T Consensus 134 psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk-a~~~~llv 211 (1039)
T KOG0199|consen 134 PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK-AKKAILLV 211 (1039)
T ss_pred CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh-ccccceeH
Confidence 45555 599999876554 77899999999999999999999999987 678899999999999999977 45667888
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccc-ccccccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE-SLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
..+..++.||+.|+.||..++ +|||||..+|+++.....|||+|||+.+.++.. .+........-...|+|||.+.
T Consensus 212 ~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr 288 (1039)
T KOG0199|consen 212 SRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR 288 (1039)
T ss_pred HHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc
Confidence 899999999999999999999 999999999999999999999999999887643 3333333444567899999999
Q ss_pred cCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
...++.++|+|++|+.+|||++ |+.||..+.....+ +.++....-..+...++++++++..||
T Consensus 289 h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD~~erLpRPk~csedIY~imk~cW 352 (1039)
T KOG0199|consen 289 HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNIDAGERLPRPKYCSEDIYQIMKNCW 352 (1039)
T ss_pred cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------HhccccccCCCCCCChHHHHHHHHHhc
Confidence 9999999999999999999997 67887544322111 112222233345556678999999999
Q ss_pred cCCCCCCCCHHHHH
Q 045452 239 QENPNDRPSMLEVS 252 (303)
Q Consensus 239 ~~dp~~Rps~~~l~ 252 (303)
..+|.+|||+..|.
T Consensus 353 ah~paDRptFsair 366 (1039)
T KOG0199|consen 353 AHNPADRPTFSAIR 366 (1039)
T ss_pred cCCccccccHHHHH
Confidence 99999999999996
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=255.22 Aligned_cols=240 Identities=22% Similarity=0.265 Sum_probs=175.4
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.++... ......+.+|+.++++++|+||+++++++.+....++++||+. ++|.+++.. ....+++.
T Consensus 23 ~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~ 99 (284)
T cd07839 23 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS--CNGDIDPE 99 (284)
T ss_pred CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh--cCCCCCHH
Confidence 478999999986432 2233567789999999999999999999999999999999996 577777643 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 100 ~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 174 (284)
T cd07839 100 IVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA 174 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCC
Confidence 99999999999999999998 9999999999999999999999999987553221 111223467899999987664
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhC-----------CCccccccccc---c-CCCChH
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-----------GKGMEFVDSFL---D-DRNSSC 225 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~---~-~~~~~~ 225 (303)
.++.++|||||||++|+|++|..|+....... ............ ........... . ......
T Consensus 175 ~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd07839 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPK 252 (284)
T ss_pred cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhccc
Confidence 47889999999999999999998865433211 111111110000 00000000000 0 001112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.+.++.++|.+||..||.+|||+++++.
T Consensus 253 ~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 253 LNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 3457889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=255.19 Aligned_cols=241 Identities=23% Similarity=0.288 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++++.||+|.++.. .....+.+.+|+.++++++|+||+++++++..++..+++|||+.++.+..+.. ....+++.
T Consensus 24 ~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~---~~~~~~~~ 100 (288)
T cd07833 24 ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA---SPGGLPPD 100 (288)
T ss_pred CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh---cCCCCCHH
Confidence 46889999998653 23345788999999999999999999999999999999999998877665552 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+|+.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+.
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 101 AVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCC
Confidence 99999999999999999998 99999999999999999999999999876544322 111224567889999998877
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhC-----------CCcc---ccccc----cccCCC
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-----------GKGM---EFVDS----FLDDRN 222 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~---~~~~~----~~~~~~ 222 (303)
.++.++|+||||+++|+|++|..||......+ .+......+.. .... ..... ......
T Consensus 177 ~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T cd07833 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRY 253 (288)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhc
Confidence 78899999999999999999999986432211 11111110000 0000 00000 000111
Q ss_pred ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 223 SSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 223 ~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+...+.++.++|.+||..+|++|||+++++..
T Consensus 254 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 254 PGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 22225678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=276.28 Aligned_cols=237 Identities=23% Similarity=0.299 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcC-cccCC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPI-RRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-~~~~~ 78 (303)
.+++.||+|.+... .......+..|+.++++|+||||++++++|... ..+||||||+.+++|.++|.... ....+
T Consensus 36 ~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L 115 (1021)
T PTZ00266 36 RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115 (1021)
T ss_pred CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCC
Confidence 46788999998643 334567789999999999999999999988654 46899999999999999885422 23568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCcEEECC-----------------CCcEEEeccccccccccc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSR----LTIIHRDLKASNILLGE-----------------DMKPKISDFGLARIFAKE 137 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~----~~i~H~dl~p~nil~~~-----------------~~~~kl~df~~~~~~~~~ 137 (303)
++..++.|+.||+.||+|||..+. .+|+|+||||+|||++. .+.+||+|||++..+...
T Consensus 116 ~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~ 195 (1021)
T PTZ00266 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195 (1021)
T ss_pred CHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc
Confidence 999999999999999999998542 34999999999999964 345899999998765432
Q ss_pred ccccccceeeccccccCchhccc--CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccc
Q 045452 138 SLKANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVD 215 (303)
Q Consensus 138 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (303)
.. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..............
T Consensus 196 s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~------~qli~~lk~~p~lp--- 263 (1021)
T PTZ00266 196 SM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF------SQLISELKRGPDLP--- 263 (1021)
T ss_pred cc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH------HHHHHHHhcCCCCC---
Confidence 21 223468999999998854 45788999999999999999999999533211 11111111111000
Q ss_pred ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH--HhhccCC
Q 045452 216 SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVS--SMLKNET 259 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~--~~L~~~~ 259 (303)
....+.++.+||..||..+|.+||++.+++ .++....
T Consensus 264 -------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 264 -------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred -------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 011234788999999999999999999998 4565443
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=247.59 Aligned_cols=228 Identities=26% Similarity=0.396 Sum_probs=180.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++.+|+|.+... .....+.+.+|+.+++.++|+|++++++.+...+..++||||+++++|.+++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 101 (256)
T cd08220 23 ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDED 101 (256)
T ss_pred CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh-cccCCCHH
Confidence 47889999998644 2345678889999999999999999999999999999999999999999998542 23458899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.++.++.+++.++++||+++ ++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+
T Consensus 102 ~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 102 TILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccC
Confidence 99999999999999999998 9999999999999865 458999999987654322 1122457889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||....... .. ..... ..... .+...+..+.+++.+||..
T Consensus 176 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~---~~~~~-~~~~~---------~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LV---LKIMS-GTFAP---------ISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HH---HHHHh-cCCCC---------CCCCcCHHHHHHHHHHccC
Confidence 888999999999999999999999985432211 11 11111 11111 1111234688999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|.+|||+.++++.
T Consensus 240 ~p~~Rpt~~~ll~~ 253 (256)
T cd08220 240 DPSKRPQLSQIMAQ 253 (256)
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=252.61 Aligned_cols=228 Identities=23% Similarity=0.348 Sum_probs=181.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+++++|.+++. ...+++..+
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~l~~~~~ 117 (293)
T cd06647 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQI 117 (293)
T ss_pred CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh----hcCCCHHHH
Confidence 4688999999876555556778899999999999999999999999999999999999999999884 334788899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.+++.+|.+||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 118 ~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~ 192 (293)
T cd06647 118 AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (293)
T ss_pred HHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCC
Confidence 999999999999999998 99999999999999999999999998865443221 1222357788999999988888
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||||+++|++++|..||.......... ....... . ....+......+.++|.+||..+|.
T Consensus 193 ~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~-~-------~~~~~~~~~~~l~~li~~~l~~~p~ 258 (293)
T cd06647 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT-P-------ELQNPEKLSAIFRDFLNRCLEMDVE 258 (293)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC-C-------CCCCccccCHHHHHHHHHHccCChh
Confidence 999999999999999999999996433221111 0000000 0 0111222334688999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+||++.+++..
T Consensus 259 ~Rp~~~~il~h 269 (293)
T cd06647 259 KRGSAKELLQH 269 (293)
T ss_pred hCcCHHHHhcC
Confidence 99999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=253.49 Aligned_cols=232 Identities=17% Similarity=0.215 Sum_probs=175.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|.++.. .......+.+|+.++..++|++|+++++++...+..|+||||+.+|+|.+++.. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~l~~ 101 (331)
T cd05624 24 HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK--FEDRLPE 101 (331)
T ss_pred CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--hcCCCCH
Confidence 47889999998642 223345678899999999999999999999999999999999999999999854 1346889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+..... .......|+..|+|||++.+
T Consensus 102 ~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 102 DMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhc
Confidence 999999999999999999998 99999999999999999999999999876543221 11223468999999998865
Q ss_pred -----CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 161 -----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 161 -----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
..++.++|+||||+++|+|++|..||..... ...............+.. .....+.++.++|.
T Consensus 178 ~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~p~------~~~~~~~~~~~li~ 245 (331)
T cd05624 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQFPS------HITDVSEEAKDLIQ 245 (331)
T ss_pred cccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcccCCC------ccccCCHHHHHHHH
Confidence 4578899999999999999999999953321 111112211111111111 00112347889999
Q ss_pred hcccCCCCC--CCCHHHHHH
Q 045452 236 LCVQENPND--RPSMLEVSS 253 (303)
Q Consensus 236 ~cl~~dp~~--Rps~~~l~~ 253 (303)
+||..+++. |++++++++
T Consensus 246 ~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 246 RLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHccCchhhcCCCCHHHHhc
Confidence 999865543 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=244.39 Aligned_cols=230 Identities=27% Similarity=0.389 Sum_probs=184.9
Q ss_pred CCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+|+.|++|.+.... ....+.+.+|+..+++++|+||+++++.+... ...++++||+.+++|.+++.. ...+++
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~ 100 (260)
T cd06606 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPE 100 (260)
T ss_pred CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH---cCCCCH
Confidence 68999999986554 24567889999999999999999999999988 889999999999999999853 337899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.+++.+|++||+.+ ++|+||+|+||+++.++.++|+|||.+................++..|.|||.+.+
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 101 PVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence 999999999999999999988 99999999999999999999999999877654432111233457889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
...+.++|+||||+++++|++|..||.... ................ ..+...+..+.++|.+||..
T Consensus 178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~~i~~~l~~ 243 (260)
T cd06606 178 EEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP---------EIPEHLSEEAKDFLRKCLRR 243 (260)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc---------CCCcccCHHHHHHHHHhCcC
Confidence 889999999999999999999999986443 1111111111111111 11122245788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|++||++.+++..
T Consensus 244 ~p~~Rp~~~~ll~~ 257 (260)
T cd06606 244 DPKKRPTADELLQH 257 (260)
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=242.24 Aligned_cols=229 Identities=25% Similarity=0.369 Sum_probs=184.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.|++|+++.......+.+.+|+..++.++|+|++++++++..+...++++||+++++|.+++... ...+++..+
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~--~~~~~~~~~ 100 (253)
T cd05122 23 RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST--NQTLTESQI 100 (253)
T ss_pred CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc--CCCCCHHHH
Confidence 368999999997766556678999999999999999999999999999999999999999999988542 246899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.+++.+|++||..| ++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..+
T Consensus 101 ~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~ 174 (253)
T cd05122 101 AYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPY 174 (253)
T ss_pred HHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCC
Confidence 999999999999999988 99999999999999999999999999876654321 233567889999999988888
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||||+++|+|++|..||....... ....... ........ ....+..+.++|.+||..||+
T Consensus 175 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~ 240 (253)
T cd05122 175 DYKADIWSLGITAIELAEGKPPYSELPPMK------ALFKIAT-NGPPGLRN-------PEKWSDEFKDFLKKCLQKNPE 240 (253)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHh-cCCCCcCc-------ccccCHHHHHHHHHHccCChh
Confidence 999999999999999999999985432111 1111111 11111110 111134688999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+|||+.++++.
T Consensus 241 ~R~t~~~~l~~ 251 (253)
T cd05122 241 KRPTAEQLLKH 251 (253)
T ss_pred hCCCHHHHhcC
Confidence 99999998763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=253.26 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=179.5
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||+ +++|.+++... ...+++.
T Consensus 23 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~--~~~~~~~ 99 (286)
T cd07832 23 ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPLPEA 99 (286)
T ss_pred CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc--CCCCCHH
Confidence 478999999986543 334567889999999999999999999999999999999999 99999988542 3568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+.
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 100 QVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeecc
Confidence 99999999999999999998 99999999999999999999999999876543221 112234578899999987654
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHH--------hhCCCcc-ccccccccC-------CCCh
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL--------WKGGKGM-EFVDSFLDD-------RNSS 224 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~-------~~~~ 224 (303)
.++.++||||+|+++|+|++|.+||....... ........ |...... ....-.... ....
T Consensus 176 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07832 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFP 252 (286)
T ss_pred ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCC
Confidence 46889999999999999999977774332211 11111110 0000000 000000000 0001
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.....+.++|.+||..+|++|||+++++..
T Consensus 253 ~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 253 DASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=250.19 Aligned_cols=226 Identities=25% Similarity=0.387 Sum_probs=178.1
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++.. .....+.+.+|+.++++++ |+|++++++++..+...+++|||+.+++|.+++.. ..++
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~ 99 (277)
T cd06917 24 PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA----GPIA 99 (277)
T ss_pred CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc----cCCC
Confidence 57899999998654 3345567888999999986 99999999999999999999999999999998843 3688
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.+++.+|.+||+.| ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus 100 ~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 100 EKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVIT 174 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhc
Confidence 9999999999999999999998 9999999999999999999999999987664432 1122345788999999876
Q ss_pred c-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
+ ..++.++|+||||+++|+|++|..||...... ... .......... ... ...+.++.+++.+||
T Consensus 175 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~-~~~~~~~~~~-----~~~---~~~~~~~~~~i~~~l 239 (277)
T cd06917 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAM-MLIPKSKPPR-----LED---NGYSKLLREFVAACL 239 (277)
T ss_pred cCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhh-hccccCCCCC-----CCc---ccCCHHHHHHHHHHc
Confidence 4 45688999999999999999999998533211 111 0000110000 111 012347889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
..||.+||++.+++.
T Consensus 240 ~~~p~~R~~~~~il~ 254 (277)
T cd06917 240 DEEPKERLSAEELLK 254 (277)
T ss_pred CCCcccCcCHHHHhh
Confidence 999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=259.39 Aligned_cols=168 Identities=25% Similarity=0.335 Sum_probs=141.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+++.||+|+.... ....|+.++++++|+||+++++++......++||+++. ++|.+++.. ....+++..+
T Consensus 89 ~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~ 159 (357)
T PHA03209 89 GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK--RSRPLPIDQA 159 (357)
T ss_pred CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh--ccCCCCHHHH
Confidence 35678999986433 23468999999999999999999999999999999995 577777743 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++...... .......|+..|+|||.+.+..+
T Consensus 160 ~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 233 (357)
T PHA03209 160 LIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKY 233 (357)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCC
Confidence 999999999999999998 999999999999999999999999998643221 11123457899999999998899
Q ss_pred CCcccchhhHHHHHHHHhCCCCc
Q 045452 164 STKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~ 186 (303)
+.++|||||||++|+|+++..++
T Consensus 234 ~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 234 NSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CchhhHHHHHHHHHHHHHcCCcc
Confidence 99999999999999999866554
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.32 Aligned_cols=227 Identities=22% Similarity=0.315 Sum_probs=179.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|++..........+.+|+..++.++|+|++++++.+...+..+++|||+++++|.+++. ...+++..+
T Consensus 43 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 118 (292)
T cd06657 43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 118 (292)
T ss_pred CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh----cCCCCHHHH
Confidence 5789999999865555556778899999999999999999999999999999999999999988773 335789999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.|++.++++||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 119 ~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~ 193 (292)
T cd06657 119 AAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPY 193 (292)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCC
Confidence 999999999999999998 99999999999999999999999998865543211 1122457889999999988888
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||+|+++|+|++|..||...... ........... .. .. .....+..+.+++.+||..+|.
T Consensus 194 ~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~----~~-~~------~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP----PK-LK------NLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhCC----cc-cC------CcccCCHHHHHHHHHHHhCCcc
Confidence 99999999999999999999998532211 11111111000 00 00 0111233678999999999999
Q ss_pred CCCCHHHHHH
Q 045452 244 DRPSMLEVSS 253 (303)
Q Consensus 244 ~Rps~~~l~~ 253 (303)
+||++.+++.
T Consensus 260 ~R~~~~~ll~ 269 (292)
T cd06657 260 QRATAAELLK 269 (292)
T ss_pred cCcCHHHHhc
Confidence 9999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=246.09 Aligned_cols=232 Identities=24% Similarity=0.382 Sum_probs=179.6
Q ss_pred CCCEEEEEEccCC----------ChhhHHHHHHHHHHHhc-CCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-
Q 045452 5 CGEVIAVKKLSKS----------SAQGFEEFKNEVMLTAK-LQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP- 72 (303)
Q Consensus 5 ~g~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~- 72 (303)
+++.+|+|.+... .......+..|+.++.+ ++|+||+++++++..+...+++|||+++++|.+++...
T Consensus 25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~ 104 (269)
T cd08528 25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK 104 (269)
T ss_pred CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH
Confidence 4788999987532 22344567788888875 69999999999999999999999999999998887431
Q ss_pred CcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccc
Q 045452 73 IRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 73 ~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
.....+++..++.++.|++.+|.+||+ .+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~ 178 (269)
T cd08528 105 EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTIL 178 (269)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCccc
Confidence 234568899999999999999999996 56 9999999999999999999999999987654332 2233457889
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|+|||.+.+..++.++|+||||+++|+|++|..||....... .. ........... .....+..+.
T Consensus 179 ~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~~--------~~~~~~~~l~ 243 (269)
T cd08528 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA----TKIVEAVYEPL--------PEGMYSEDVT 243 (269)
T ss_pred CcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH----HHHhhccCCcC--------CcccCCHHHH
Confidence 999999988889999999999999999999999985322111 11 11111111000 0111234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
++|.+||..||++||++.++.++|.+
T Consensus 244 ~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 244 DVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 99999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=249.36 Aligned_cols=231 Identities=21% Similarity=0.267 Sum_probs=175.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEE-----eCCeeeEEEeeCCCCChhhhhcCc-Cccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCI-----DSEERMLVYEYMPNKSLDCYLFDP-IRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~-~~~~ 76 (303)
.+|+.+|+|++.... .....+..|+.+++.+ +|+||+++++++. .+...+++|||+++++|.+++... ....
T Consensus 41 ~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 119 (286)
T cd06638 41 KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119 (286)
T ss_pred CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCc
Confidence 468899999885432 2335677899999999 7999999999884 345689999999999999887532 2345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ ......++..|+|||
T Consensus 120 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 194 (286)
T cd06638 120 RMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPE 194 (286)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChh
Confidence 6889999999999999999999988 99999999999999999999999999876543221 122245788999999
Q ss_pred hccc-----CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 157 YARQ-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 157 ~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+.. ..++.++|+||+||++|+|++|..||....... ..... ........ ..+.....++.
T Consensus 195 ~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~~~~-~~~~~~~~-------~~~~~~~~~~~ 260 (286)
T cd06638 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ALFKI-PRNPPPTL-------HQPELWSNEFN 260 (286)
T ss_pred hhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HHhhc-cccCCCcc-------cCCCCcCHHHH
Confidence 8753 447889999999999999999999985332111 11110 00100000 01111234688
Q ss_pred HHHHhcccCCCCCCCCHHHHHHh
Q 045452 232 EIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
++|.+||..||.+|||+.++++.
T Consensus 261 ~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 261 DFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHHHccCCcccCCCHHHHhhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=245.43 Aligned_cols=229 Identities=21% Similarity=0.285 Sum_probs=176.0
Q ss_pred CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSS-----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||.+.... ....+.+.+|+.++++++|+||+++++++.+. ..++++|||+++++|.+++.. ..
T Consensus 25 ~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~ 101 (265)
T cd06652 25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS---YG 101 (265)
T ss_pred CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH---cC
Confidence 568999999875321 23456788999999999999999999998764 467899999999999998843 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aP 155 (303)
.+++..+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+......... .......++..|+||
T Consensus 102 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (265)
T cd06652 102 ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccCh
Confidence 5788899999999999999999998 999999999999999999999999998765322111 111223478899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++|+||||+++|+|++|+.||.... ............. ....+......+.++|.
T Consensus 179 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~ 243 (265)
T cd06652 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE------AMAAIFKIATQPT---------NPVLPPHVSDHCRDFLK 243 (265)
T ss_pred hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc------hHHHHHHHhcCCC---------CCCCchhhCHHHHHHHH
Confidence 99988888999999999999999999999985321 1111111111110 11122333456789999
Q ss_pred hcccCCCCCCCCHHHHHHh
Q 045452 236 LCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~ 254 (303)
+||. +|++||+++++++.
T Consensus 244 ~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 244 RIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHhc-ChhhCCCHHHHhcC
Confidence 9995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=247.48 Aligned_cols=227 Identities=25% Similarity=0.387 Sum_probs=179.9
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+++.|++|.++.... ..+.+.+|++.++.++|+|++++++.+......++++||+++++|.+++.... ..+++..+.
T Consensus 43 ~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~ 119 (286)
T cd06614 43 TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIA 119 (286)
T ss_pred CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHH
Confidence 588999999976544 56778899999999999999999999999999999999999999999985421 368999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.+++.+|++||+.| ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++
T Consensus 120 ~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~ 194 (286)
T cd06614 120 YVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYG 194 (286)
T ss_pred HHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCC
Confidence 99999999999999988 9999999999999999999999999876543221 111223467889999999888899
Q ss_pred CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
.++|+||||+++|+|++|..||...... ........ ...... ......+..+.++|.+||+.+|.+
T Consensus 195 ~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~ 260 (286)
T cd06614 195 PKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITT-KGIPPL-------KNPEKWSPEFKDFLNKCLVKDPEK 260 (286)
T ss_pred CccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCCCC-------cchhhCCHHHHHHHHHHhccChhh
Confidence 9999999999999999999998532211 11111111 111000 011112347889999999999999
Q ss_pred CCCHHHHHH
Q 045452 245 RPSMLEVSS 253 (303)
Q Consensus 245 Rps~~~l~~ 253 (303)
|||+.+++.
T Consensus 261 Rpt~~~il~ 269 (286)
T cd06614 261 RPSAEELLQ 269 (286)
T ss_pred CcCHHHHhh
Confidence 999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=244.36 Aligned_cols=231 Identities=25% Similarity=0.386 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++.||+|.++.... ...+.+.+|+.+++.++|+||+++++++...+..++++||+.+++|.+++.. +..+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~ 99 (264)
T cd06626 23 DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH---GRILDEH 99 (264)
T ss_pred CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh---cCCCChH
Confidence 4789999999875544 3677899999999999999999999999999999999999999999999843 3457889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc--cceeeccccccCchhcc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~ 159 (303)
.+..++.+++.|+.+||+.| ++|+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.
T Consensus 100 ~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 176 (264)
T cd06626 100 VIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176 (264)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhcc
Confidence 99999999999999999998 99999999999999999999999999876643322111 11245678999999987
Q ss_pred cCC---CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 160 QGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 160 ~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.. .+.++|+||||+++|++++|+.||..... .......... ........ .......+.++|.+
T Consensus 177 ~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~li~~ 243 (264)
T cd06626 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVGA-GHKPPIPD-------SLQLSPEGKDFLDR 243 (264)
T ss_pred CCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHhc-CCCCCCCc-------ccccCHHHHHHHHH
Confidence 766 78899999999999999999999853321 1111111111 11111100 01113467899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 045452 237 CVQENPNDRPSMLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~ 253 (303)
||+.+|.+|||+.+++.
T Consensus 244 ~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 244 CLESDPKKRPTASELLQ 260 (264)
T ss_pred HccCCcccCCCHHHHhc
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.66 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=177.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..+...+++|||+.+++|.+++.... ...+++.
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~ 101 (328)
T cd08226 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF-PEGMSEA 101 (328)
T ss_pred CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc-ccCCCHH
Confidence 57999999998643 23455788999999999999999999999999999999999999999999885432 2358899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-----cccceeeccccccCch
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-----ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE 156 (303)
.+..++.|++.||+|||+.| ++||||||+||+++.++.++++||+.+......... .......++..|+|||
T Consensus 102 ~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (328)
T cd08226 102 LIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178 (328)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChh
Confidence 99999999999999999988 999999999999999999999999765432211100 0011122456799999
Q ss_pred hcccC--CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCc------------------------
Q 045452 157 YARQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG------------------------ 210 (303)
Q Consensus 157 ~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------ 210 (303)
.+.+. .++.++|+|||||++|+|++|..||........ ..........
T Consensus 179 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (328)
T cd08226 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS 252 (328)
T ss_pred hhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccccccchhhhhhccchhhhhc
Confidence 98764 478899999999999999999999854321110 0000000000
Q ss_pred ------------cccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 211 ------------MEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 211 ------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...................+.+|+.+||..||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000001111112234567899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=247.15 Aligned_cols=230 Identities=23% Similarity=0.315 Sum_probs=177.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcC-cc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPI-RR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~-~~ 75 (303)
.+++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++.... ..+++|||+.+++|.+++.... ..
T Consensus 29 ~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 107 (275)
T cd06608 29 KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG 107 (275)
T ss_pred CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcC
Confidence 3678999999865543 346789999999999 7999999999997644 4899999999999998885422 24
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+||
T Consensus 108 ~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aP 182 (275)
T cd06608 108 KRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAP 182 (275)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCH
Confidence 56899999999999999999999988 9999999999999999999999999987654322 122234578899999
Q ss_pred hhccc-----CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 156 EYARQ-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 156 E~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|.+.. ..++.++|+||||+++|+|++|..||...... ......... .... ...+.....++
T Consensus 183 E~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~-------~~~~~~~~~~~ 248 (275)
T cd06608 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPRN-PPPT-------LKSPENWSKKF 248 (275)
T ss_pred hHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhcc-CCCC-------CCchhhcCHHH
Confidence 98753 34677899999999999999999998532211 111111111 1101 01112234578
Q ss_pred HHHHHhcccCCCCCCCCHHHHHH
Q 045452 231 LEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.++|.+||..||++|||+.++++
T Consensus 249 ~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 249 NDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHHHhhcChhhCcCHHHHhc
Confidence 89999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=251.93 Aligned_cols=243 Identities=23% Similarity=0.267 Sum_probs=177.1
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++.... .....+.+|+.++++++||||+++++++... ...+++|||+. ++|.+++... ...++
T Consensus 28 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~l~ 104 (293)
T cd07843 28 KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETM--KQPFL 104 (293)
T ss_pred CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhc--cCCCC
Confidence 3688999999975432 2334567899999999999999999999877 78999999996 4888887542 23589
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.... .......++..|+|||.+.
T Consensus 105 ~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~ 179 (293)
T cd07843 105 QSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLL 179 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhc
Confidence 9999999999999999999998 9999999999999999999999999987665432 1112234678899999886
Q ss_pred cC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhhC------CCccccccccccCCCCh
Q 045452 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKG------GKGMEFVDSFLDDRNSS 224 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~------~~~~~~~~~~~~~~~~~ 224 (303)
+. .++.++|+||||+++|+|++|..||...........+.. .+..+.. ...............+.
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (293)
T cd07843 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA 259 (293)
T ss_pred CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc
Confidence 54 468899999999999999999999864332211111100 0000000 00000000111111111
Q ss_pred H-HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 225 C-KLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 225 ~-~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
. ....+.++|.+||+.||++|||+.+++..
T Consensus 260 ~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 260 LSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 24568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=248.04 Aligned_cols=230 Identities=19% Similarity=0.200 Sum_probs=174.4
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHHHHH-hcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEVMLT-AKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++.... .....+..|...+ ...+|+|++++++++..++..++++||+++++|.+++.. ...++
T Consensus 19 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~ 95 (260)
T cd05611 19 STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT---LGGLP 95 (260)
T ss_pred CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH---cCCCC
Confidence 4688999999865432 1223344454444 455999999999999999999999999999999999843 34689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 96 ~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~ 166 (260)
T cd05611 96 EDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETIL 166 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhc
Confidence 9999999999999999999988 99999999999999999999999998865332 12235678999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+||||+++|+|++|..||........ . ......... .........+..+.+++.+||.
T Consensus 167 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---F---DNILSRRIN-------WPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---H---HHHHhcccC-------CCCcccccCCHHHHHHHHHHcc
Confidence 88889999999999999999999999853322111 1 111111000 0001111223478899999999
Q ss_pred CCCCCCCCHHHHHHhhccC
Q 045452 240 ENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~ 258 (303)
.+|++||++..+.+.|...
T Consensus 234 ~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 234 MDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred CCHHHccCCCcHHHHHcCh
Confidence 9999999887777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=241.09 Aligned_cols=231 Identities=20% Similarity=0.328 Sum_probs=179.3
Q ss_pred CCCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..+|..+|||-+.+. ..+..+++...+.++... .+|+||+.+|+|..+...++.||.| +.++..++.. -.+++++
T Consensus 114 rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr--ik~piPE 190 (391)
T KOG0983|consen 114 RSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR--IKGPIPE 190 (391)
T ss_pred cccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH--hcCCchH
Confidence 357899999998766 445677888888888876 5999999999999999999999998 4456666543 3556899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+-++...++.||.||.+.+ +|+|||+||+|||+|..|++|+||||++.++..+... ....|-+.|||||.+.-
T Consensus 191 ~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp 265 (391)
T KOG0983|consen 191 RILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDP 265 (391)
T ss_pred HhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc---ccccCCccccCccccCC
Confidence 999999999999999999877 5999999999999999999999999999776543322 22357789999998854
Q ss_pred C---CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 161 G---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 161 ~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
. .|+-.+||||||+.++||.||+.||..+...- + ...+...... +.+.... ..+..+.+++..|
T Consensus 266 ~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e---~ltkvln~eP------P~L~~~~--gFSp~F~~fv~~C 332 (391)
T KOG0983|consen 266 PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--E---VLTKVLNEEP------PLLPGHM--GFSPDFQSFVKDC 332 (391)
T ss_pred CCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--H---HHHHHHhcCC------CCCCccc--CcCHHHHHHHHHH
Confidence 3 58889999999999999999999997665431 1 1112222111 1111111 0234678999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|.+|+.+||...++++.
T Consensus 333 L~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 333 LTKDHRKRPKYNKLLEH 349 (391)
T ss_pred hhcCcccCcchHHHhcC
Confidence 99999999999999865
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=249.41 Aligned_cols=226 Identities=23% Similarity=0.329 Sum_probs=180.0
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||||.+.... ......+.+|+..+++++|+||+++++++..+...++||||+.+++|..++. ...+++..
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~----~~~~~~~~ 102 (277)
T cd06641 27 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQ 102 (277)
T ss_pred CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh----cCCCCHHH
Confidence 468899999986432 3445678899999999999999999999999999999999999999998883 34588999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++++|||++..+..... ......++..|+|||.+.+..
T Consensus 103 ~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 177 (277)
T cd06641 103 IATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCC
Confidence 9999999999999999988 99999999999999999999999999876543221 122245688899999998888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|+||||+++|+|++|..||...... ... ......... ......+.++.+++.+||..+|
T Consensus 178 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 178 YDSKADIWSLGITAIELAKGEPPHSELHPM------KVL-FLIPKNNPP---------TLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCccchH------HHH-HHHhcCCCC---------CCCcccCHHHHHHHHHHccCCh
Confidence 899999999999999999999998532111 111 111111110 1111223468899999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
.+||++.+++..
T Consensus 242 ~~Rp~~~~~l~~ 253 (277)
T cd06641 242 SFRPTAKELLKH 253 (277)
T ss_pred hhCcCHHHHHhC
Confidence 999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=255.33 Aligned_cols=246 Identities=21% Similarity=0.263 Sum_probs=176.8
Q ss_pred CCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcC--cccC
Q 045452 5 CGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPI--RRLI 77 (303)
Q Consensus 5 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--~~~~ 77 (303)
+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...++||||+.+ +|.+++.... ....
T Consensus 26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 104 (316)
T cd07842 26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVS 104 (316)
T ss_pred CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcC
Confidence 68999999997633 33456778899999999999999999999988 789999999965 6666654322 1236
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC----CCcEEEeccccccccccccc-ccccceeeccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE----DMKPKISDFGLARIFAKESL-KANTEQVVGTIGY 152 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~----~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y 152 (303)
+++..++.++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++..+..... ........++..|
T Consensus 105 ~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 181 (316)
T cd07842 105 IPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccc
Confidence 889999999999999999999998 999999999999999 89999999999876543322 1122234568889
Q ss_pred cCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccc------cHHHHHHHHhhC------------------
Q 045452 153 IPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL------SILEHAYELWKG------------------ 207 (303)
Q Consensus 153 ~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~------~~~~~~~~~~~~------------------ 207 (303)
+|||.+.+. .++.++|+||||+++++|++|+.||......... ..+.........
T Consensus 182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (316)
T cd07842 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL 261 (316)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh
Confidence 999987654 5788999999999999999999998644332200 000000000000
Q ss_pred ---CCccccccccccCCCC--hHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 208 ---GKGMEFVDSFLDDRNS--SCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 208 ---~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
................ .....++.+++.+||..||++|||+.++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred hhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000000000 0223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.52 Aligned_cols=226 Identities=23% Similarity=0.267 Sum_probs=180.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+.... ....+.+.+|+..+++++||||+++++++..+...++++||+.+++|.+++.. ...+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~ 99 (258)
T cd05578 23 DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSE 99 (258)
T ss_pred cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh---cCCcCH
Confidence 468999999996542 24567889999999999999999999999999999999999999999999843 357899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 100 ~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 100 EQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcc
Confidence 999999999999999999998 9999999999999999999999999987654332 1223457889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||....... .......... .. ...+...+..+.++|.+||..
T Consensus 174 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~---------~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-AD---------VLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-cc---------ccCcccCcHHHHHHHHHHccC
Confidence 889999999999999999999999986544321 1111111110 00 111112235788999999999
Q ss_pred CCCCCCCH--HHHH
Q 045452 241 NPNDRPSM--LEVS 252 (303)
Q Consensus 241 dp~~Rps~--~~l~ 252 (303)
||.+||++ .+++
T Consensus 240 ~p~~R~~~~~~~l~ 253 (258)
T cd05578 240 DPQKRLGDNLKDLK 253 (258)
T ss_pred ChhHcCCccHHHHh
Confidence 99999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.93 Aligned_cols=233 Identities=23% Similarity=0.314 Sum_probs=182.5
Q ss_pred CCCEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 5 CGEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+|+.||+|.+..... ...+.+.+|++++++++|+||+++++.+......+++|||+.+++|.+++.. ...+++.
T Consensus 17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 93 (265)
T cd05579 17 TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDED 93 (265)
T ss_pred CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH---cCCCCHH
Confidence 589999999865433 4567788999999999999999999999999999999999999999998853 2368999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc------ccccceeeccccccCc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------KANTEQVVGTIGYIPP 155 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~------~~~~~~~~~~~~y~aP 155 (303)
.++.++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++........ ........++..|++|
T Consensus 94 ~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 170 (265)
T cd05579 94 VARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170 (265)
T ss_pred HHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCH
Confidence 99999999999999999998 99999999999999999999999999865432211 1122234567899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.......+.++|+||||+++|++++|..||....... . ........ ..... . ...+..+.+++.
T Consensus 171 e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~-~~~~~~~~-~~~~~-----~--~~~~~~~~~~i~ 235 (265)
T cd05579 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------I-FQNILNGK-IEWPE-----D--VEVSDEAIDLIS 235 (265)
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHhcCC-cCCCc-----c--ccCCHHHHHHHH
Confidence 99988888999999999999999999999985332111 1 11111110 00000 0 002347889999
Q ss_pred hcccCCCCCCCCHHHHHHhhccC
Q 045452 236 LCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+||..+|.+|||+..+.+.|+..
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhcCc
Confidence 99999999999997777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=253.37 Aligned_cols=233 Identities=17% Similarity=0.216 Sum_probs=174.6
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|++... .......+.+|+.++..++|++|+++++.+.+....++||||+.+|+|.+++.. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~l~~ 101 (332)
T cd05623 24 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPE 101 (332)
T ss_pred CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH--hcCCCCH
Confidence 45788999998542 122344578899999999999999999999999999999999999999999853 2345889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ........|+..|+|||++.
T Consensus 102 ~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~ 177 (332)
T cd05623 102 DMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQA 177 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhc
Confidence 999999999999999999998 9999999999999999999999999986543221 11122346899999999885
Q ss_pred ----cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 160 ----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 160 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
...++.++|||||||++|+|++|..||..... ...............+. ......+.++.+++.
T Consensus 178 ~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~p------~~~~~~s~~~~~li~ 245 (332)
T cd05623 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQFP------AQVTDVSEDAKDLIR 245 (332)
T ss_pred cccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccccCC------CccccCCHHHHHHHH
Confidence 34578899999999999999999999953321 11111221111111111 011122447889999
Q ss_pred hcccCCC--CCCCCHHHHHHh
Q 045452 236 LCVQENP--NDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~dp--~~Rps~~~l~~~ 254 (303)
+|+..++ ..|++++++++.
T Consensus 246 ~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 246 RLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHccChhhhcCCCCHHHHhCC
Confidence 9886544 346888888755
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=253.18 Aligned_cols=240 Identities=24% Similarity=0.300 Sum_probs=176.6
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.+.... ....+.+.+|+++++.++|+||+++++++......+++|||+.+++|..+.. ....+++.
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 100 (286)
T cd07846 24 ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK---YPNGLDES 100 (286)
T ss_pred CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh---ccCCCCHH
Confidence 368999999985432 2245678899999999999999999999999999999999999988877663 23348999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 160 (303)
.++.++.||+.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07846 101 RVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccc
Confidence 99999999999999999998 99999999999999999999999999876543221 1122356889999998765
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhh-----------------CCCccccccccccCCCC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK-----------------GGKGMEFVDSFLDDRNS 223 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~ 223 (303)
..++.++||||||+++|+|++|..||......+ .......... .................
T Consensus 176 ~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07846 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRF 252 (286)
T ss_pred cccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhC
Confidence 346789999999999999999998885332111 1111000000 00000000000000001
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+..+..+.+++.+||..+|++||++.++++.
T Consensus 253 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 253 PKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 1223568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=250.30 Aligned_cols=228 Identities=22% Similarity=0.313 Sum_probs=174.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEe------CCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+++.||+|.+.... .....+..|+.+++++ +|+||+++++++.. ....+++|||+.+++|.+++... ...
T Consensus 39 ~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~ 116 (282)
T cd06636 39 KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGN 116 (282)
T ss_pred CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCC
Confidence 578899999985543 3446688899999998 79999999999853 45789999999999999988542 234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..++.++.||+.|++|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||
T Consensus 117 ~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 191 (282)
T cd06636 117 ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPE 191 (282)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHh
Confidence 5788889999999999999999998 9999999999999999999999999987543221 1122345788999999
Q ss_pred hcc-----cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 157 YAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 157 ~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+. ...++.++|+||||+++|+|++|..||...... ......... ... .......+..+.
T Consensus 192 ~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~~~~~~~~-~~~--------~~~~~~~~~~~~ 256 (282)
T cd06636 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRN-PPP--------KLKSKKWSKKFI 256 (282)
T ss_pred hcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------hhhhhHhhC-CCC--------CCcccccCHHHH
Confidence 875 345778999999999999999999998533211 111111110 000 001112234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHH
Q 045452 232 EIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~ 253 (303)
++|.+||..||.+|||+.+|++
T Consensus 257 ~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 257 DFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHhCCChhhCcCHHHHhc
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=246.94 Aligned_cols=231 Identities=24% Similarity=0.286 Sum_probs=175.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCc-Cccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDP-IRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~-~~~~ 76 (303)
.+|+.+|+|.+.... .....+.+|+.+++++ +|+|++++++++... ...++||||+++++|.+++... ....
T Consensus 45 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~ 123 (291)
T cd06639 45 KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123 (291)
T ss_pred CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCC
Confidence 578999999985432 2345677899999998 899999999998754 3589999999999999887532 1345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||
T Consensus 124 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 198 (291)
T cd06639 124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPE 198 (291)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChh
Confidence 6899999999999999999999998 99999999999999999999999999876543221 112245788999999
Q ss_pred hcccC-----CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 157 YARQG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 157 ~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+... .++.++|+||||+++|+|++|+.||..... ......... ...... ..+......+.
T Consensus 199 ~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~-------~~~~~~~~~l~ 264 (291)
T cd06639 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------VKTLFKIPR-NPPPTL-------LHPEKWCRSFN 264 (291)
T ss_pred hhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------HHHHHHHhc-CCCCCC-------CcccccCHHHH
Confidence 87543 267899999999999999999999853221 111111111 111111 11122234688
Q ss_pred HHHHhcccCCCCCCCCHHHHHHh
Q 045452 232 EIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
++|.+||..+|++||++.++++.
T Consensus 265 ~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 265 HFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHhhcChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=250.10 Aligned_cols=240 Identities=25% Similarity=0.306 Sum_probs=173.7
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||.+..... .....+.+|+.++++++|+||+++++++..+...++||||+.+ +|.+++... ...+++..
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~ 104 (291)
T cd07844 28 LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDC--GGGLSMHN 104 (291)
T ss_pred CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhC--CCCCCHHH
Confidence 3689999999865432 2234567899999999999999999999999999999999974 888887542 33688999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-C
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 161 (303)
++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ .
T Consensus 105 ~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 179 (291)
T cd07844 105 VRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGST 179 (291)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCc
Confidence 9999999999999999998 99999999999999999999999999865432111 1112245788999998865 4
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc---------cccc--------ccccCC-CC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM---------EFVD--------SFLDDR-NS 223 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~--------~~~~~~-~~ 223 (303)
.++.++||||+|+++|+|++|..||..... .................. .... ...... ..
T Consensus 180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07844 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPR 257 (291)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcC
Confidence 578899999999999999999999854331 111111111111000000 0000 000000 00
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
......+.+++.+||..+|++|||+.++++
T Consensus 258 ~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 258 LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 001146789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=247.08 Aligned_cols=233 Identities=25% Similarity=0.320 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCcC-cccCC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI-RRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~ 78 (303)
.+|+.||+|.++.. .....+.+.+|+..++.++|+||+++++++.. ....+++|||+++++|.+++.... ....+
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l 102 (265)
T cd08217 23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102 (265)
T ss_pred CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCC
Confidence 47889999998643 34456778899999999999999999998764 346799999999999999885421 24568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~--~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
++..++.++.+|+.||.+||..+ +.+++|+||+|+||+++.++.++|+|||++......... .....++..|+|||
T Consensus 103 ~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE 180 (265)
T cd08217 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPE 180 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChh
Confidence 99999999999999999999332 333999999999999999999999999998766543211 12245788999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.+..++.++|+||||+++|+|++|..||..... ............. ..+...+..+.+++.+
T Consensus 181 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~~ 244 (265)
T cd08217 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKFR---------RIPYRYSSELNEVIKS 244 (265)
T ss_pred hhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCCC---------CCccccCHHHHHHHHH
Confidence 99888889999999999999999999999864331 1111111111111 1122233578899999
Q ss_pred cccCCCCCCCCHHHHHHh
Q 045452 237 CVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~ 254 (303)
||..+|++||++.+|++.
T Consensus 245 ~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 245 MLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HccCCcccCCCHHHHhhC
Confidence 999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=250.90 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=176.2
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||.++... ......+.+|++++++++||||+++++++.+....+++|||+. ++|..++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~-~~~~l~~~ 100 (284)
T cd07860 23 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS-PLSGIPLP 100 (284)
T ss_pred CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC-CCCCCCHH
Confidence 478999999986443 2334678899999999999999999999999999999999995 5788877542 24568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.+++.||+|||..+ ++|+||+|+||+++.++.++|+|||++..+.... .......++..|+|||.+.+.
T Consensus 101 ~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 175 (284)
T cd07860 101 LIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGC 175 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecC
Confidence 99999999999999999998 9999999999999999999999999987553221 111223457889999987654
Q ss_pred C-CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC----------------ccccccccccCCCCh
Q 045452 162 V-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK----------------GMEFVDSFLDDRNSS 224 (303)
Q Consensus 162 ~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~ 224 (303)
. ++.++|+||||+++|+|++|..||........ ............ ........... ...
T Consensus 176 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 251 (284)
T cd07860 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVP 251 (284)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-Hcc
Confidence 4 58889999999999999999999864332111 111100000000 00000000000 001
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
....++.++|.+||+.||.+|||+++++..
T Consensus 252 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 252 PLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 123467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=249.04 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||.++... ......+.+|+.++++++|+||+++++++...+..++||||+.+ +|.+++........+++..
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~ 101 (284)
T cd07836 23 TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNT 101 (284)
T ss_pred CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHH
Confidence 468999999987543 23456677899999999999999999999999999999999975 7888875544445689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC-
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 161 (303)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+.
T Consensus 102 ~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 176 (284)
T cd07836 102 VKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSR 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCC
Confidence 9999999999999999998 99999999999999999999999999875533211 11223457889999987654
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC---------Ccccccccccc------CCCChHH
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG---------KGMEFVDSFLD------DRNSSCK 226 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~------~~~~~~~ 226 (303)
.++.++|+||||+++|+|++|..||........ ........... ........... ....+..
T Consensus 177 ~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07836 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHA 253 (284)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhc
Confidence 568899999999999999999999864432211 11111111000 00000000000 0001112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+..+.+++.+||+.||.+||++.++++.
T Consensus 254 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 254 DPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=267.94 Aligned_cols=241 Identities=17% Similarity=0.219 Sum_probs=168.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC------CCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ------HVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+++.||||+++... .....+..|+.+++.++ |.+++++++++... .++|+||+++ +++|.+++. ...
T Consensus 152 ~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~---~~~ 226 (467)
T PTZ00284 152 KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM---KHG 226 (467)
T ss_pred CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH---HcC
Confidence 468899999996432 22334555666666654 44688899988764 4789999988 778888874 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCC----------------cEEEeccccccccccccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDM----------------KPKISDFGLARIFAKESL 139 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~----------------~~kl~df~~~~~~~~~~~ 139 (303)
.+++..+..++.||+.||.|||. .| |+||||||+|||++.++ .+||+|||.+.....
T Consensus 227 ~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--- 300 (467)
T PTZ00284 227 PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--- 300 (467)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc---
Confidence 68999999999999999999997 57 99999999999998765 499999998753221
Q ss_pred ccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH-----------------
Q 045452 140 KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY----------------- 202 (303)
Q Consensus 140 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~----------------- 202 (303)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+....
T Consensus 301 --~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~ 378 (467)
T PTZ00284 301 --SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEAR 378 (467)
T ss_pred --ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHH
Confidence 1223568999999999999999999999999999999999999996543222111111100
Q ss_pred HHhhCCCcc-cccc-----ccccC--CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhcc
Q 045452 203 ELWKGGKGM-EFVD-----SFLDD--RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 203 ~~~~~~~~~-~~~~-----~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~ 257 (303)
..+...... .... ..... .........+.+||.+||..||++|||++++++ +|.+
T Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 379 LLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred HHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 000000000 0000 00000 000011245779999999999999999999986 4544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=240.68 Aligned_cols=216 Identities=21% Similarity=0.274 Sum_probs=165.1
Q ss_pred HHHHHHHHHHhcC-CCCcceeEEEEEEeC----CeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHH
Q 045452 23 EEFKNEVMLTAKL-QHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL 97 (303)
Q Consensus 23 ~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l 97 (303)
+..++|+++--.. .|||||.+++++++. ..+.+|||+++||.|...++++ ....+++.+...++.||..|+.||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHH
Confidence 3456788776655 899999999998764 3578999999999999999764 345699999999999999999999
Q ss_pred HhcCCCCeeecCCCCCcEEECCC---CcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHH
Q 045452 98 QEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174 (303)
Q Consensus 98 h~~~~~~i~H~dl~p~nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 174 (303)
|..+ |.||||||+|+|.+.. ..+||+|||++..... .....+.+.|+.|.|||++....|+..+|+||+|+
T Consensus 178 H~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgV 251 (400)
T KOG0604|consen 178 HSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_pred Hhcc---hhhccCChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhH
Confidence 9999 9999999999999754 4599999999976432 22334456799999999999999999999999999
Q ss_pred HHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 175 LLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 175 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+||-|+.|-+||-...-. ....-.. .++ .....++ +...=.+.++...++|+.+|+.+|.+|.|+++++..
T Consensus 252 imYIlLCGyPPFYS~hg~-aispgMk-~rI--~~gqy~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 252 IMYILLCGYPPFYSNHGL-AISPGMK-RRI--RTGQYEF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHHHhhcCCCcccccCCc-cCChhHH-hHh--hccCccC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 999999999998532211 1111000 000 0011111 111223455678899999999999999999999754
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=255.18 Aligned_cols=245 Identities=23% Similarity=0.254 Sum_probs=178.0
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||.+... .......+.+|+.+++.++|+||+++++++... ...++||||+. ++|.+.+..
T Consensus 39 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---- 113 (353)
T cd07850 39 VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---- 113 (353)
T ss_pred CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----
Confidence 57899999998643 234456778899999999999999999988643 35799999995 578777732
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
.++...+..++.|++.||++||..| ++||||||+||+++.++.+||+|||++........ .....++..|+||
T Consensus 114 -~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aP 186 (353)
T cd07850 114 -DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAP 186 (353)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCH
Confidence 2888899999999999999999998 99999999999999999999999999976543221 2223568899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHH---------------HHHHHhh-CCC------cccc
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE---------------HAYELWK-GGK------GMEF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~---------------~~~~~~~-~~~------~~~~ 213 (303)
|.+.+..++.++|||||||++|+|++|+.||...........+. ....... ... ..+.
T Consensus 187 E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (353)
T cd07850 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL 266 (353)
T ss_pred HHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhh
Confidence 99999999999999999999999999999986433211110000 0000000 000 0000
Q ss_pred cccc----ccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCCC
Q 045452 214 VDSF----LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNETT 260 (303)
Q Consensus 214 ~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~~ 260 (303)
.... ............+.++|.+||..||++|||+.+++.. |+.-.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 267 FPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred CcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0000 0000122334568899999999999999999999854 554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=239.25 Aligned_cols=230 Identities=23% Similarity=0.306 Sum_probs=184.7
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCCH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~ 80 (303)
.+++.||+|.+.... ....+.+.+|++.++.++|+|++++++.+......++++|++++++|.+++.... ....+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 102 (258)
T cd08215 23 SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE 102 (258)
T ss_pred CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCH
Confidence 368999999987553 3566788999999999999999999999999999999999999999999886521 2467899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.+++.||.+||+.| ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||...+
T Consensus 103 ~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~ 177 (258)
T cd08215 103 EQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQN 177 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhcc
Confidence 999999999999999999998 9999999999999999999999999987654432 12233467889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||+|+++++|++|..||...... . ............ .+......+.+++.+||..
T Consensus 178 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~ 241 (258)
T cd08215 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------E-LALKILKGQYPP---------IPSQYSSELRNLVSSLLQK 241 (258)
T ss_pred CCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------H-HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCC
Confidence 88999999999999999999999998543211 1 111111111111 1112334788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|.+|||+.++++.
T Consensus 242 ~p~~Rp~~~~ll~~ 255 (258)
T cd08215 242 DPEERPSIAQILQS 255 (258)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.33 Aligned_cols=236 Identities=22% Similarity=0.291 Sum_probs=182.6
Q ss_pred CCCCEEEEEEccCCC----hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+++.||||.++... ....+.+.+|+.++.++ +|+||+++++.+..+...++||||+.+++|.+++. ....+
T Consensus 26 ~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~ 102 (288)
T cd05583 26 DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHF 102 (288)
T ss_pred cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh---hcCCc
Confidence 467899999986432 23345678899999999 69999999999999999999999999999998884 33458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..+..++.|++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++..+.... ........++..|+|||.+
T Consensus 103 ~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 103 TESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccc-ccccccccCCccccCHHHh
Confidence 89999999999999999999988 9999999999999999999999999987654322 1112224578899999988
Q ss_pred ccCC--CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 159 RQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.. .+.++|+||||+++|+|++|..||............ ........ ...+......+.+++.+
T Consensus 179 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~-----------~~~~~~~~~~l~~li~~ 245 (288)
T cd05583 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSK-----------PPFPKTMSAEARDFIQK 245 (288)
T ss_pred cCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HHHHHccC-----------CCCCcccCHHHHHHHHH
Confidence 7654 678999999999999999999998643222111111 11111110 01111123468899999
Q ss_pred cccCCCCCCCCHHHHHHhhccCC
Q 045452 237 CVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
||..||++|||+.++.+.|+..+
T Consensus 246 ~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 246 LLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred HhcCCHhhccCcchHHHHhcCcc
Confidence 99999999999999988888754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=246.11 Aligned_cols=224 Identities=30% Similarity=0.384 Sum_probs=174.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++||||+. |++.+++.. ....+++
T Consensus 38 ~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~--~~~~l~~ 114 (307)
T cd06607 38 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV--HKKPLQE 114 (307)
T ss_pred CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH--cccCCCH
Confidence 46899999998643 23345678899999999999999999999999999999999996 566666632 2345899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ....++..|+|||.+.
T Consensus 115 ~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 115 VEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILA 185 (307)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeec
Confidence 999999999999999999998 999999999999999999999999988654321 1235678999999874
Q ss_pred --cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
...++.++||||||+++|+|++|..||..... .......... ... .......+..+.++|.+|
T Consensus 186 ~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~-~~~--------~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DSP--------TLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcC-CCC--------CCCchhhCHHHHHHHHHH
Confidence 45678899999999999999999999853221 1111111111 000 011122345788999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|..+|++||++.+++..
T Consensus 251 l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 251 LQKIPQDRPSSEELLKH 267 (307)
T ss_pred hcCChhhCcCHHHHhcC
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=244.62 Aligned_cols=229 Identities=21% Similarity=0.320 Sum_probs=171.7
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHH-HhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-CcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVML-TAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~ 80 (303)
.+|+.||||.++... ......+..|+.. ++.++|+||+++++++..+...+++|||++ ++|.+++... .....+++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~ 102 (283)
T cd06617 24 PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPE 102 (283)
T ss_pred CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCH
Confidence 469999999986543 2233455556665 556799999999999999999999999996 6787776542 23456899
Q ss_pred HHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
..++.++.||+.||+|||+. + ++||||||+||+++.++.+||+|||.+..+.... ......++..|+|||.+.
T Consensus 103 ~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 103 DILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERIN 176 (283)
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcC
Confidence 99999999999999999986 7 9999999999999999999999999987653321 112235678899999886
Q ss_pred c----CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 160 Q----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 160 ~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+ ..++.++|+|||||++|+|++|+.||..... ........... ...... ....+.++.++|.
T Consensus 177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~~~~~~--------~~~~~~~l~~li~ 242 (283)
T cd06617 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVVEE-PSPQLP--------AEKFSPEFQDFVN 242 (283)
T ss_pred CcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHHhc-CCCCCC--------ccccCHHHHHHHH
Confidence 5 3468899999999999999999999853211 11111111111 111111 1112347889999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 045452 236 LCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~ 253 (303)
+||..+|.+||++.++++
T Consensus 243 ~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 243 KCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHccCChhhCcCHHHHhc
Confidence 999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=249.01 Aligned_cols=240 Identities=25% Similarity=0.289 Sum_probs=179.3
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.+++|.++.... .....+.+|+.++++++|+||+++++++..+...++++||+.+ +|..++.. ....+++.
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~--~~~~~~~~ 98 (283)
T cd05118 22 LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPES 98 (283)
T ss_pred CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh--hcccCCHH
Confidence 4789999999865432 3456788899999999999999999999999999999999965 78777743 23568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 99 LIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcC
Confidence 99999999999999999998 9999999999999999999999999987664432 111123467789999988776
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC---cccccc-------cc------ccCCCCh
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---GMEFVD-------SF------LDDRNSS 224 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------~~------~~~~~~~ 224 (303)
.++.++|+||||+++|+|++|+.||...+..+ ............. ...... .+ .......
T Consensus 174 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd05118 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP 250 (283)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhh
Confidence 78899999999999999999999985433211 1111111100000 000000 00 0000112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..+.++.++|.+||.+||.+||++.+++..
T Consensus 251 ~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 251 NASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 234578999999999999999999999753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=241.17 Aligned_cols=226 Identities=25% Similarity=0.368 Sum_probs=182.4
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..+++|+|+++++|.+++.. ...+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~l~~~ 99 (254)
T cd06627 23 ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK---FGPFPES 99 (254)
T ss_pred CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh---ccCCCHH
Confidence 4678999999976543 4567899999999999999999999999999999999999999999998843 3568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.+++.+|.+||+.| ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+.
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 100 LVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred HHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCC
Confidence 99999999999999999988 999999999999999999999999999776543221 2234578899999998887
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+|++|+++|+|++|..||..... ......... .... ..+...+..+.+++.+||..+
T Consensus 175 ~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~---------~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 175 GASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQ-DDHP---------PLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-cCCC---------CCCCCCCHHHHHHHHHHHhCC
Confidence 788999999999999999999999853321 111111111 1111 111122347889999999999
Q ss_pred CCCCCCHHHHHH
Q 045452 242 PNDRPSMLEVSS 253 (303)
Q Consensus 242 p~~Rps~~~l~~ 253 (303)
|++|||+.+++.
T Consensus 239 p~~R~~~~~~l~ 250 (254)
T cd06627 239 PNLRPTAKQLLK 250 (254)
T ss_pred hhhCcCHHHHhc
Confidence 999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=257.76 Aligned_cols=225 Identities=25% Similarity=0.346 Sum_probs=185.1
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|..||||++.+.. ....+.+.+|+.+|..++|||||+++.+......+|+||||+.+|.+.+++. +.+.+.+.
T Consensus 79 ~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~---~~gr~~e~ 155 (596)
T KOG0586|consen 79 LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV---KHGRMKEK 155 (596)
T ss_pred CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH---hcccchhh
Confidence 578999999997653 3455668899999999999999999999999999999999999999999995 45557778
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
....++.|+..+++|||+.+ |+|||||.+|+|++.+.++||+|||++..+.. .......+|++.|.|||++.+.
T Consensus 156 ~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 156 EARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY---GLMLQTFCGSPPYAAPELFNGK 229 (596)
T ss_pred hhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc---cccccccCCCCCccChHhhcCc
Confidence 99999999999999999999 99999999999999999999999999988763 4445567899999999999888
Q ss_pred CC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.+ .+.+|+||+|+++|-|+.|..||...........+- .+. ..-+...+.++.++|+++|..
T Consensus 230 ~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl------~gk-----------~rIp~~ms~dce~lLrk~lvl 292 (596)
T KOG0586|consen 230 KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL------RGK-----------YRIPFYMSCDCEDLLRKFLVL 292 (596)
T ss_pred ccCCcceehhhhhhhheeeeecccccCCcccccccchhe------eee-----------ecccceeechhHHHHHHhhcc
Confidence 75 568999999999999999999996444332211111 000 011111223677999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|.+|++++++.+.
T Consensus 293 ~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 293 NPSKRGPCDQIMKD 306 (596)
T ss_pred CccccCCHHHhhhh
Confidence 99999999999643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=244.19 Aligned_cols=229 Identities=23% Similarity=0.324 Sum_probs=179.3
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++++||+++++|.+++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 101 (257)
T cd08225 23 SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSED 101 (257)
T ss_pred CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHH
Confidence 367889999986432 234567889999999999999999999999999999999999999999988542 23357899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-EEEecccccccccccccccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~-~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.+..++.+++.+|.|||+.+ ++|+||+|+||+++.++. ++++|||.+........ ......++..|+|||.+.+
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~ 176 (257)
T cd08225 102 QILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcC
Confidence 99999999999999999988 999999999999998864 69999999876543221 1122357889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||..... ......... ..... .....+.++.++|.+||..
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~---------~~~~~~~~~~~~i~~~l~~ 240 (257)
T cd08225 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFAP---------ISPNFSRDLRSLISQLFKV 240 (257)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCCC---------CCCCCCHHHHHHHHHHhcc
Confidence 8899999999999999999999999853321 111111111 11111 1112234688999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|++|||+.+++..
T Consensus 241 ~p~~Rpt~~~ll~~ 254 (257)
T cd08225 241 SPRDRPSITSILKR 254 (257)
T ss_pred ChhhCcCHHHHhhC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=244.06 Aligned_cols=227 Identities=22% Similarity=0.261 Sum_probs=171.1
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHHHHH---hcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEVMLT---AKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|.+..... .....+.+|..++ ...+|+||+.+++.+...+..++||||+.+++|..++. ....
T Consensus 17 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~---~~~~ 93 (279)
T cd05633 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGV 93 (279)
T ss_pred CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH---hcCC
Confidence 5689999998864321 1222334444333 34479999999999999899999999999999998884 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....++..|+|||.
T Consensus 94 l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~ 166 (279)
T cd05633 94 FSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 166 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHH
Confidence 899999999999999999999998 9999999999999999999999999986543221 122357899999998
Q ss_pred cc-cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 AR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+. +..++.++|+||+||++|+|++|..||........ .... .... .. ....+...+.++.++|.+
T Consensus 167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~---~~~~-~~---------~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEID---RMTL-TV---------NVELPDSFSPELKSLLEG 232 (279)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHH---HHhh-cC---------CcCCccccCHHHHHHHHH
Confidence 86 45678999999999999999999999964332211 1111 1100 00 011122234578899999
Q ss_pred cccCCCCCCC-----CHHHHHHh
Q 045452 237 CVQENPNDRP-----SMLEVSSM 254 (303)
Q Consensus 237 cl~~dp~~Rp-----s~~~l~~~ 254 (303)
||..||.+|| |+.++++.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.09 Aligned_cols=241 Identities=23% Similarity=0.292 Sum_probs=176.1
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|++.... ......+.+|+..++.++|+|++++++++.+....+++|||+. ++|.+++... ....+++.
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~-~~~~~~~~ 99 (283)
T cd07835 22 LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS-PLTGLDPP 99 (283)
T ss_pred CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC-CCCCCCHH
Confidence 479999999986543 2334678889999999999999999999999999999999994 6888887542 12358999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+.
T Consensus 100 ~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 100 LIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecC
Confidence 99999999999999999988 999999999999999999999999998755322111 1122457889999987654
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhh--------CC-Cccccccccc------cCCCChH
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK--------GG-KGMEFVDSFL------DDRNSSC 225 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~------~~~~~~~ 225 (303)
.++.++|+||||+++|+|++|..||........ ......... .. ...+...... .......
T Consensus 175 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (283)
T cd07835 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPN 251 (283)
T ss_pred cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCC
Confidence 568899999999999999999999854322110 000000000 00 0000000000 0001112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+..+.++|.+||+.+|.+|||++++++.
T Consensus 252 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 252 LDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 23478899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=280.67 Aligned_cols=241 Identities=22% Similarity=0.403 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.++..... ...|+..+++++||||+++++++.+....++||||+++|+|.+++. .+++..+
T Consensus 713 ~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~ 782 (968)
T PLN00113 713 KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERR 782 (968)
T ss_pred CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHH
Confidence 57899999998644321 1346888999999999999999999999999999999999999983 2788999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.+++.|++|||.....+++||||||+||+++.++..++. |+....... .....++..|+|||++.+..+
T Consensus 783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~ 855 (968)
T PLN00113 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDI 855 (968)
T ss_pred HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCC
Confidence 9999999999999996544459999999999999998887775 554332211 111256889999999998899
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccC--CCChHHHHHHHHHHHhcccCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDD--RNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~d 241 (303)
+.++|||||||++|||++|+.||..... .......+..............+..... ........++.+++.+||+.|
T Consensus 856 ~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~ 934 (968)
T PLN00113 856 TEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD 934 (968)
T ss_pred CcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC
Confidence 9999999999999999999999843221 1222233322222222222222222221 223344557889999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~ 262 (303)
|++|||+.++++.|++.....
T Consensus 935 P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 935 PTARPCANDVLKTLESASRSS 955 (968)
T ss_pred chhCcCHHHHHHHHHHhhccc
Confidence 999999999999999876533
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=249.75 Aligned_cols=240 Identities=25% Similarity=0.315 Sum_probs=173.3
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++.... .....+.+|+.++++++|+||+++++++... +..++||||+. ++|.+++... ...++
T Consensus 30 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~l~ 106 (309)
T cd07845 30 TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM--PTPFS 106 (309)
T ss_pred CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhc--ccCCC
Confidence 4689999999864432 2234566899999999999999999998755 46899999996 4787777432 35689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.
T Consensus 107 ~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 181 (309)
T cd07845 107 ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLL 181 (309)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhc
Confidence 9999999999999999999999 99999999999999999999999999876543221 111223477899999876
Q ss_pred c-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhC--------CCccccccccc-cC-------CC
Q 045452 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG--------GKGMEFVDSFL-DD-------RN 222 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~-------~~ 222 (303)
+ ..++.++|+||||+++|+|++|..||........ .......... ........... .. ..
T Consensus 182 ~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T cd07845 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK 258 (309)
T ss_pred CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHh
Confidence 5 4578999999999999999999999864332211 1111111000 00000000000 00 00
Q ss_pred ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 223 SSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 223 ~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
....+.++.++|.+||..||++|||+++++..
T Consensus 259 ~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01124467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=244.39 Aligned_cols=228 Identities=25% Similarity=0.305 Sum_probs=182.6
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCCH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~ 80 (303)
.+|+.+|+|.+... .......+.+|+.+++.++|+||+++++++......+++|||+++++|..++.... ....+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (256)
T cd08530 23 SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE 102 (256)
T ss_pred CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCH
Confidence 47889999998654 23445677889999999999999999999999999999999999999998885421 2356889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.+++.||++||+.| ++|+||+|.||+++.++.++|+|||++...... ......++..|+|||.+.+
T Consensus 103 ~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 103 QEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCC
Confidence 999999999999999999998 999999999999999999999999998765443 1122346889999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+||||+++|+|++|..||...... ............ ..+.....++.+++.+||..
T Consensus 176 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKVQRGKYP---------PIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCC---------CCchhhCHHHHHHHHHHcCC
Confidence 88999999999999999999999998543211 111111111111 11223445789999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
+|++||++.++++.
T Consensus 240 ~p~~Rp~~~~~l~~ 253 (256)
T cd08530 240 KPKLRPNCDKILAS 253 (256)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=243.79 Aligned_cols=229 Identities=29% Similarity=0.377 Sum_probs=176.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+... .....+.+.+|+..++.++|+|++++++++..+...++||||+.+ +|.+.+.. ....+++
T Consensus 48 ~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~--~~~~l~~ 124 (317)
T cd06635 48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEV--HKKPLQE 124 (317)
T ss_pred CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHH--hcCCCCH
Confidence 47889999998643 233456788999999999999999999999999999999999964 77666643 2455899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 125 ~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~ 195 (317)
T cd06635 125 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILA 195 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhc
Confidence 999999999999999999998 99999999999999999999999998764332 12235678999999873
Q ss_pred --cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
...++.++|+||||+++|+|++|..||..... ............ . .......+..+.+++.+|
T Consensus 196 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~-~--------~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-P--------TLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhccC-C--------CCCCccccHHHHHHHHHH
Confidence 45678899999999999999999999853211 111111111111 0 011112334688999999
Q ss_pred ccCCCCCCCCHHHHHHhhccCC
Q 045452 238 VQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L~~~~ 259 (303)
|+.+|.+||++.+++..+--..
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhc
Confidence 9999999999999997654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=244.45 Aligned_cols=233 Identities=23% Similarity=0.352 Sum_probs=174.7
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcC--cCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFD--PIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~ 79 (303)
.+|+.||+|.+.... ......+.+|+..+.++. |+||+++++++......+++|||+. +++.++... ......++
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~ 105 (288)
T cd06616 27 PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIP 105 (288)
T ss_pred CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCC
Confidence 468999999986543 345567889999999995 9999999999999889999999985 455443321 11235689
Q ss_pred HHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 80 WKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
+..+..++.+++.||+|||+. + ++||||+|+||+++.++.++|+|||++......... ....++..|+|||.+
T Consensus 106 ~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~ 179 (288)
T cd06616 106 EEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERI 179 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---ccccCccCccCHHHh
Confidence 999999999999999999974 6 999999999999999999999999998765432111 123467889999998
Q ss_pred ccC---CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 159 RQG---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 159 ~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+. .++.++||||+|+++|+|++|+.||.... ........... ..... .........+.++.+|+.
T Consensus 180 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~l~~li~ 248 (288)
T cd06616 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDPPI-----LSNSEEREFSPSFVNFIN 248 (288)
T ss_pred ccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCCCc-----CCCcCCCccCHHHHHHHH
Confidence 766 68899999999999999999999985432 11111111111 11111 111111223457889999
Q ss_pred hcccCCCCCCCCHHHHHHh
Q 045452 236 LCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~ 254 (303)
+||..+|++|||+++++..
T Consensus 249 ~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 249 LCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=245.76 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=178.0
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|.++... ......+.+|+.+++.++|+|++++++++... ...++||+|+++ +|..++... ...++
T Consensus 22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~ 98 (287)
T cd07840 22 KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSP--EVKFT 98 (287)
T ss_pred CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhcc--CCCCC
Confidence 468999999997653 33456788999999999999999999999888 789999999964 787777432 24689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||++||+.+ ++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.
T Consensus 99 ~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 99 ESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLL 174 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeE
Confidence 9999999999999999999998 99999999999999999999999999876644321 1112234577899999765
Q ss_pred c-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc-----------------ccccccccCC
Q 045452 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM-----------------EFVDSFLDDR 221 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~ 221 (303)
+ ..++.++||||||+++|+|++|..||....... ............... ..........
T Consensus 175 ~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07840 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREF 251 (287)
T ss_pred ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHH
Confidence 4 457889999999999999999999986443211 111111111100000 0000000000
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.....+.++.+++.+||..+|.+||+++++++.
T Consensus 252 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 252 FKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111124578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=241.55 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=184.1
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+.+|..+|||++.+.....+.++.+|++++.+. .|+||++++++|+++...|+|||.+.||+|...|. ++..+++.
T Consensus 100 i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~---~~~~F~E~ 176 (463)
T KOG0607|consen 100 IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQ---KRKHFNER 176 (463)
T ss_pred eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHH---HhhhccHH
Confidence 578999999999877777889999999999999 79999999999999999999999999999999884 46669999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEeccccccccccc-----ccccccceeecccccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKE-----SLKANTEQVVGTIGYI 153 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~---~kl~df~~~~~~~~~-----~~~~~~~~~~~~~~y~ 153 (303)
...++..+|+.||.+||..| |.|||+||+|||...... ||||||++..-+... .......+++|+..||
T Consensus 177 EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfM 253 (463)
T KOG0607|consen 177 EASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFM 253 (463)
T ss_pred HHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhc
Confidence 99999999999999999999 999999999999976655 799999887443211 1122233467899999
Q ss_pred Cchhcc-----cCCCCCcccchhhHHHHHHHHhCCCCccc-cCCCccccHHH---HHHHHhh---CCCccccccccccCC
Q 045452 154 PPEYAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSML-CGINENLSILE---HAYELWK---GGKGMEFVDSFLDDR 221 (303)
Q Consensus 154 aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~-~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~ 221 (303)
|||+.. ...|+.++|.||||+|+|-|++|.+||.. ++....++.-+ ....... .....++.+...
T Consensus 254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW--- 330 (463)
T KOG0607|consen 254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDW--- 330 (463)
T ss_pred chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhh---
Confidence 999652 33589999999999999999999999953 33333332211 1111100 011111211111
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.-.+.+..++|...|..++.+|.++..++.
T Consensus 331 --ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 331 --AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred --HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 112345678999999999999999998875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=246.70 Aligned_cols=242 Identities=21% Similarity=0.235 Sum_probs=173.4
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCe-----eeEEEeeCCCCChhhhhcCcCc-
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEE-----RMLVYEYMPNKSLDCYLFDPIR- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~- 74 (303)
.+|+.||||.++... ......+.+|+.+++.+ +|+||+++++++..... .+++|||+.+ +|.+++.....
T Consensus 24 ~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~ 102 (295)
T cd07837 24 NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG 102 (295)
T ss_pred CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc
Confidence 478999999986442 22345778899999999 56999999999987665 8999999975 78887754221
Q ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccc
Q 045452 75 -RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 75 -~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
...+++..++.++.||+.||.|||..+ ++||||+|+||+++. ++.++|+|||++..+...... .....++..|
T Consensus 103 ~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~ 177 (295)
T cd07837 103 PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWY 177 (295)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCC
Confidence 346899999999999999999999998 999999999999998 889999999998755322111 1112457889
Q ss_pred cCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccc------cc-----ccc---
Q 045452 153 IPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGME------FV-----DSF--- 217 (303)
Q Consensus 153 ~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-----~~~--- 217 (303)
+|||.+.+ ..++.++|+||||+++|+|++|..||........ ............... .. ...
T Consensus 178 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T cd07837 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQ 254 (295)
T ss_pred CChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCCChhhCcchhhccchhhcCcccch
Confidence 99998754 4578899999999999999999999864322111 111111100000000 00 000
Q ss_pred ccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 218 LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
......+..+.++.++|.+||.+||.+||++.+++..
T Consensus 255 ~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 255 DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000011234568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=245.17 Aligned_cols=240 Identities=23% Similarity=0.269 Sum_probs=172.4
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|.+..... .....+.+|+..++.++|+||+++++++......+++|||+. +++.+++.. ....+.+..
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~ 104 (291)
T cd07870 28 INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ--HPGGLHPYN 104 (291)
T ss_pred CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh--CCCCCCHHH
Confidence 4688999999864432 233467789999999999999999999999999999999995 677666533 224577888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC-
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 161 (303)
+..++.|++.||+|||..+ ++|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 105 ~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (291)
T cd07870 105 VRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGAT 179 (291)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCCCCccccccccCCceeecCC
Confidence 8999999999999999998 9999999999999999999999999986543221 111223468899999988654
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC---------CccccccccccCC---------CC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG---------KGMEFVDSFLDDR---------NS 223 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~---------~~ 223 (303)
.++.++|+||||+++|+|++|..||..... ....+.......... ............. ..
T Consensus 180 ~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07870 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257 (291)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccc
Confidence 478899999999999999999999853321 111111111100000 0000000000000 00
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
......+.+++.+|+..||++|||+.+++.
T Consensus 258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 258 LSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 011346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=247.61 Aligned_cols=245 Identities=21% Similarity=0.335 Sum_probs=172.1
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--------eeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--------ERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||||.+.... ......+.+|+.++++++||||+++++++.... ..++||||+. ++|.+++..
T Consensus 35 ~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-- 111 (310)
T cd07865 35 KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN-- 111 (310)
T ss_pred CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh--
Confidence 478999999886432 222345678999999999999999999987654 3599999995 477777643
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeecccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~ 151 (303)
....+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+...... .......++..
T Consensus 112 ~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 188 (310)
T cd07865 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188 (310)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcc
Confidence 2346899999999999999999999998 999999999999999999999999998765432211 11123456788
Q ss_pred ccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH-----HhhCCCcccccccc-ccC----
Q 045452 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGMEFVDSF-LDD---- 220 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~---- 220 (303)
|+|||.+.+. .++.++|+||||+++|+|++|..||...........+..... .++........... ...
T Consensus 189 y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (310)
T cd07865 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKR 268 (310)
T ss_pred ccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccch
Confidence 9999987654 468899999999999999999998854332111111111000 00000000000000 000
Q ss_pred -----CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 221 -----RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 221 -----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.........+.++|.+||..||.+|||++++++.
T Consensus 269 ~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 269 KVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0011112356799999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=257.43 Aligned_cols=226 Identities=21% Similarity=0.335 Sum_probs=183.2
Q ss_pred EEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHH
Q 045452 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87 (303)
Q Consensus 8 ~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 87 (303)
..|-|++........+.|+-||++|..++||+||++++.|+..+.+||+.|||.||-+...+.. -+..+.+.++..++
T Consensus 59 lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE--L~r~LtE~QIqvvc 136 (1187)
T KOG0579|consen 59 LAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE--LGRVLTEDQIQVVC 136 (1187)
T ss_pred hhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH--hccccchHHHHHHH
Confidence 3456777666677788899999999999999999999999999999999999999998877643 25679999999999
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc-----ccCC
Q 045452 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA-----RQGV 162 (303)
Q Consensus 88 ~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~ 162 (303)
++++.||.|||++. |+|||||..|||++-+|.++|+|||.+.... ........++||+.|||||+. ...+
T Consensus 137 ~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~P 211 (1187)
T KOG0579|consen 137 YQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQP 211 (1187)
T ss_pred HHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCcccccchheeeccccCCC
Confidence 99999999999998 9999999999999999999999999986432 223445568999999999976 4557
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
|+.++||||||+.+.+|..+.+|-. ..+.+.-..+........- -.|..++..+.+++.+||.+||
T Consensus 212 YDykaDiWSlGITLIEMAqiEPPHh------elnpMRVllKiaKSePPTL--------lqPS~Ws~~F~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 212 YDYKADIWSLGITLIEMAQIEPPHH------ELNPMRVLLKIAKSEPPTL--------LQPSHWSRSFSDFLKRCLVKNP 277 (1187)
T ss_pred chhhhhHHhhhhHHHHHhccCCCcc------ccchHHHHHHHhhcCCCcc--------cCcchhhhHHHHHHHHHHhcCC
Confidence 9999999999999999999998842 2233333333333222111 2334455578899999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
..||++.+|++.
T Consensus 278 ~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 278 RNRPPAAQLLKH 289 (1187)
T ss_pred ccCCCHHHHhhC
Confidence 999999999753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=243.95 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=172.1
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+++.||+|.++.... .......+|+..++++ +|+|++++++++.+. +..++||||+. ++|.+.+.. ....++
T Consensus 22 ~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~ 98 (282)
T cd07831 22 KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG--RKRPLP 98 (282)
T ss_pred CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh--ccCCCC
Confidence 4789999999865422 2223345788888888 599999999999987 88999999996 577777643 234689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.|++.||++||+.+ ++|+||+|+||+++. +.++|+|||.+......... ....++..|+|||.+.
T Consensus 99 ~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 99 EKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLL 171 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhh
Confidence 9999999999999999999998 999999999999999 99999999998765432211 1234688999999764
Q ss_pred -cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhhCCCcccccc-cccc---CCCChHH
Q 045452 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGKGMEFVD-SFLD---DRNSSCK 226 (303)
Q Consensus 160 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~---~~~~~~~ 226 (303)
+..++.++|+|||||++|+|++|..||......+....... ............... .... .......
T Consensus 172 ~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (282)
T cd07831 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNA 251 (282)
T ss_pred cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccc
Confidence 45578899999999999999999999854332111111000 000000000000000 0000 0001123
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+..+.++|.+||.++|++|||++++++.
T Consensus 252 ~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 252 SAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 4678999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=237.00 Aligned_cols=228 Identities=21% Similarity=0.290 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS-----SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||+|.+... .......+.+|+.++++++|+||+++++++.+. ..+++++||+++++|.+++.. ..
T Consensus 25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~ 101 (264)
T cd06653 25 DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA---YG 101 (264)
T ss_pred CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH---cC
Confidence 57899999987432 233456788999999999999999999998764 468899999999999998843 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aP 155 (303)
.+++..+..++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+||
T Consensus 102 ~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (264)
T cd06653 102 ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178 (264)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCH
Confidence 5889999999999999999999998 999999999999999999999999998765322111 111224578899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++|+||||+++|+|++|+.||.... .............. ...+......+.+++.
T Consensus 179 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~---------~~~p~~~~~~~~~~i~ 243 (264)
T cd06653 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE------AMAAIFKIATQPTK---------PMLPDGVSDACRDFLK 243 (264)
T ss_pred hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC------HHHHHHHHHcCCCC---------CCCCcccCHHHHHHHH
Confidence 99988888999999999999999999999985321 11111111111111 1122233357889999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 045452 236 LCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~ 253 (303)
+||. +|..||++.+++.
T Consensus 244 ~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 244 QIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHhc-CcccCccHHHHhc
Confidence 9999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=239.67 Aligned_cols=208 Identities=17% Similarity=0.157 Sum_probs=163.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.++.... +..|...+....||||+++++++......+++|||+++++|.+++.. ...+++..+
T Consensus 16 ~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~ 87 (237)
T cd05576 16 RTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK---FLNIPEECV 87 (237)
T ss_pred cCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH---hcCCCHHHH
Confidence 5789999999965432 23344555556799999999999999999999999999999998843 345899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+..+.... ....++..|+|||...+..+
T Consensus 88 ~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 159 (237)
T cd05576 88 KRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEE 159 (237)
T ss_pred HHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCC
Confidence 999999999999999998 9999999999999999999999999876554321 11234667999999988888
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+||+|+++|+|++|..|+...... ..... ....+...+..+.++|.+||+.||+
T Consensus 160 ~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 160 TEACDWWSLGAILFELLTGKTLVECHPSG------------INTHT---------TLNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred CchhhHHHHHHHHHHHHHCcchhhcCchh------------ccccc---------ccCCcccCCHHHHHHHHHHccCCHH
Confidence 99999999999999999999876422110 00000 0011112234688999999999999
Q ss_pred CCCCH
Q 045452 244 DRPSM 248 (303)
Q Consensus 244 ~Rps~ 248 (303)
+||++
T Consensus 219 ~R~~~ 223 (237)
T cd05576 219 ERLGA 223 (237)
T ss_pred HhcCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=252.83 Aligned_cols=247 Identities=24% Similarity=0.300 Sum_probs=177.2
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|.++.. .......+.+|+.++++++|+||+++++++... ...++++||+. ++|.+++ ....
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~ 102 (336)
T cd07849 28 PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLI----KTQH 102 (336)
T ss_pred CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHH----hcCC
Confidence 57899999998643 233456788899999999999999999987644 35799999995 4777776 3346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE 156 (303)
+++..++.++.|++.||++||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||
T Consensus 103 l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (336)
T cd07849 103 LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179 (336)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChH
Confidence 899999999999999999999998 999999999999999999999999998765432211 1112245788999999
Q ss_pred hccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC-----------Ccccccccccc-CC--
Q 045452 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG-----------KGMEFVDSFLD-DR-- 221 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~-- 221 (303)
.+.+ ..++.++||||+|+++|+|++|+.||........ ........... ........... ..
T Consensus 180 ~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T cd07849 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVP 256 (336)
T ss_pred HhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCccc
Confidence 8654 5688999999999999999999999854321110 00000000000 00000000000 00
Q ss_pred ---CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCCCC
Q 045452 222 ---NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNETTN 261 (303)
Q Consensus 222 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~~~ 261 (303)
.....+.++.+++.+||..+|++|||+.++++. ++....+
T Consensus 257 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 257 WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 001123468899999999999999999999876 6665544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=257.42 Aligned_cols=238 Identities=27% Similarity=0.322 Sum_probs=184.5
Q ss_pred CCCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCcc
Q 045452 3 LPCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 l~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
-++|+.||||.++.. .....+...+|++++++|+|+|||+++++-+... ...+|||||.||+|...+.+....
T Consensus 35 ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~ 114 (732)
T KOG4250|consen 35 KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA 114 (732)
T ss_pred cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc
Confidence 478999999999764 3456788899999999999999999999876544 568999999999999999987778
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC----CcEEEecccccccccccccccccceeecccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~----~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
..+++..++.++..++.||.|||++| |+||||||.||++... ...||+|||.++.+.... .....+||..
T Consensus 115 ~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~ 188 (732)
T KOG4250|consen 115 YGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEE 188 (732)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchh
Confidence 88999999999999999999999998 9999999999999533 347999999999876544 3344789999
Q ss_pred ccCchhcc-cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC-----------ccccccccc-
Q 045452 152 YIPPEYAR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-----------GMEFVDSFL- 218 (303)
Q Consensus 152 y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~- 218 (303)
|.+||... .+.|+..+|.|||||++|+.+||..||...........+.+......... ..+....+.
T Consensus 189 YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~ 268 (732)
T KOG4250|consen 189 YLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ 268 (732)
T ss_pred hcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC
Confidence 99999998 48899999999999999999999999987665543322332222111110 111111111
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCC
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRP 246 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp 246 (303)
+..........+-..+..+|..+|++|.
T Consensus 269 p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 269 PNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1122333334566788888888999987
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=251.38 Aligned_cols=244 Identities=20% Similarity=0.280 Sum_probs=175.5
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|++.... ......+.+|+.++++++|+||+++++++.. ....++||||+. ++|.+++.. ...
T Consensus 28 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~ 103 (334)
T cd07855 28 RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS---DQP 103 (334)
T ss_pred CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc---CCC
Confidence 579999999986542 2345677889999999999999999998763 346899999995 688888743 445
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeeccccccCc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPP 155 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~aP 155 (303)
+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++......... .......++..|+||
T Consensus 104 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~P 180 (334)
T cd07855 104 LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccCh
Confidence 899999999999999999999988 999999999999999999999999998765432211 111234678899999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhhCCCccccccccccC-C----
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGKGMEFVDSFLDD-R---- 221 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-~---- 221 (303)
|.+.+ ..++.++|+||||+++|+|++|+.||.............. .................... .
T Consensus 181 E~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (334)
T cd07855 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWS 260 (334)
T ss_pred HHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHH
Confidence 98755 4578899999999999999999999954322111000000 00000000000000000000 0
Q ss_pred -CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 222 -NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 222 -~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.....+.++.++|.+||+.+|.+|||+.+++..
T Consensus 261 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 261 KIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001124578999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=247.94 Aligned_cols=243 Identities=28% Similarity=0.339 Sum_probs=173.9
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||+|++... .......+.+|+.+++++ +|+||+++++++... ...++||||+. ++|..++.. ..+
T Consensus 30 ~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~ 104 (337)
T cd07852 30 RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA----NIL 104 (337)
T ss_pred CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc----CCC
Confidence 46889999988542 233445677899999999 999999999998643 36899999996 588888743 267
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc---cccceeeccccccCc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK---ANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~---~~~~~~~~~~~y~aP 155 (303)
++..++.++.||+.||+|||+.| ++|+||+|+||+++.++.++|+|||++......... .......++..|+||
T Consensus 105 ~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 105 EDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence 88899999999999999999988 999999999999999999999999998765432211 122234578899999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH--------HHhhCCCcccccccc------ccC
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY--------ELWKGGKGMEFVDSF------LDD 220 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~------~~~ 220 (303)
|.+.+ ..++.++|+||||+++|+|++|+.||................ ..+.......+.... ...
T Consensus 182 E~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (337)
T cd07852 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD 261 (337)
T ss_pred eeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchh
Confidence 97754 457889999999999999999999985433221111000000 000000000000000 000
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
......+.++.++|.+||+.||++|||+.+++..
T Consensus 262 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 262 ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0001124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=240.47 Aligned_cols=226 Identities=23% Similarity=0.267 Sum_probs=170.9
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHH---HHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEV---MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|.+..... .....+..|. ..++...||+|+++++.+......++||||+.+++|..++. ....
T Consensus 17 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~---~~~~ 93 (278)
T cd05606 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGV 93 (278)
T ss_pred cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH---hcCC
Confidence 4689999999864321 1112233343 34445689999999999999999999999999999988884 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.... .....|+..|+|||.
T Consensus 94 l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~ 166 (278)
T cd05606 94 FSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 166 (278)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHH
Confidence 899999999999999999999988 9999999999999999999999999986553221 123467899999999
Q ss_pred cccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 ARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+. .++.++|+||+|+++|+|++|..||......... ........ ... ..+...+.++.+++.+
T Consensus 167 ~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~---------~~~~~~s~~~~~li~~ 232 (278)
T cd05606 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT-MAV---------ELPDSFSPELRSLLEG 232 (278)
T ss_pred hcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----HHHHHhhc-cCC---------CCCCcCCHHHHHHHHH
Confidence 8644 5889999999999999999999998644222111 11111110 000 1111224578899999
Q ss_pred cccCCCCCCC-----CHHHHHH
Q 045452 237 CVQENPNDRP-----SMLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rp-----s~~~l~~ 253 (303)
||..+|.+|| ++.++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHh
Confidence 9999999999 8999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=245.37 Aligned_cols=240 Identities=25% Similarity=0.299 Sum_probs=174.4
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----------eeeEEEeeCCCCChhhhhcC
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----------ERMLVYEYMPNKSLDCYLFD 71 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~~~sL~~~l~~ 71 (303)
.+|+.||+|.++... ......+.+|+.+++.++|||++++++++.... ..++++||+++ ++..++..
T Consensus 30 ~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~ 108 (302)
T cd07864 30 DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES 108 (302)
T ss_pred CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc
Confidence 468999999996543 234456778999999999999999999987654 78999999975 66666643
Q ss_pred cCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccc
Q 045452 72 PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+........ .......++..
T Consensus 109 ~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~ 182 (302)
T cd07864 109 G--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLW 182 (302)
T ss_pred C--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccC
Confidence 2 346899999999999999999999998 99999999999999999999999999876543221 11111245778
Q ss_pred ccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCc---ccccc------------
Q 045452 152 YIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---MEFVD------------ 215 (303)
Q Consensus 152 y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------------ 215 (303)
|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..+............ .....
T Consensus 183 y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T cd07864 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259 (302)
T ss_pred ccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhcccccccccccccccccc
Confidence 999998754 35788999999999999999999998643321 112222121111100 00000
Q ss_pred --ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 216 --SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 216 --~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.... ......+..+.+++.+||..||.+|||+++++..
T Consensus 260 ~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 260 YRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0011124578899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=237.07 Aligned_cols=235 Identities=23% Similarity=0.304 Sum_probs=179.2
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcC--cCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFD--PIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~ 79 (303)
++|+.+|||.++.... ...+++..|.+...+- ++||||++||.+...+..|+.||+| ..||..+... ......++
T Consensus 87 ~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ip 165 (361)
T KOG1006|consen 87 PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIP 165 (361)
T ss_pred ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCc
Confidence 6899999999986644 5677888898877765 8999999999999999999999999 4577544322 12355688
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+.-+-.+....+.||.||.... .|+|||+||+|||++..|.+||||||++..+.++..... ..|-..|+|||.+.
T Consensus 166 E~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~---daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 166 ENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV---DAGCRPYMAPERID 240 (361)
T ss_pred HhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh---ccCCccccChhccC
Confidence 8888999999999999998754 499999999999999999999999999876654322222 35678999999885
Q ss_pred cC--CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 QG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
.. .|+-++|+||||+++||+.||..|+... ..+.....+...+..+.+..+ ......+..+..+|..|
T Consensus 241 p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w------~svfeql~~Vv~gdpp~l~~~----~~~~~~s~~~~~fintC 310 (361)
T KOG1006|consen 241 PSDKGYDIRSDVWSLGITLYEVATGNFPYRKW------DSVFEQLCQVVIGDPPILLFD----KECVHYSFSMVRFINTC 310 (361)
T ss_pred CccCCcchhhhhhhhcceEeeeecCCCCcchH------HHHHHHHHHHHcCCCCeecCc----ccccccCHHHHHHHHHH
Confidence 43 4889999999999999999999998532 222222233332322222211 11122344788999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|.+|-++||...++..+
T Consensus 311 l~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 311 LIKDRSDRPKYDDLKKF 327 (361)
T ss_pred hhcccccCcchhhhhcC
Confidence 99999999999999765
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=238.45 Aligned_cols=220 Identities=21% Similarity=0.250 Sum_probs=167.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.+|+|.+........ |+.....+ +|+||+++++.+...+..++||||+++++|.+++.. ...+++..
T Consensus 39 ~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~l~~~~ 110 (267)
T PHA03390 39 PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAE 110 (267)
T ss_pred CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh---cCCCCHHH
Confidence 4678899999864322111 22222222 799999999999999999999999999999999843 33789999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..++.|++.||.+||+.| ++|+||+|+||+++.++ .++|+|||.+....... ...++..|+|||.+.+.
T Consensus 111 ~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~ 181 (267)
T PHA03390 111 VKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGH 181 (267)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCC
Confidence 9999999999999999998 99999999999999998 99999999987654221 23468899999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+||+|+++|+|++|..||....... .......... . .. .......+..+.++|.+||+.+
T Consensus 182 ~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~--~~---------~~~~~~~~~~~~~li~~~l~~~ 248 (267)
T PHA03390 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q--KK---------LPFIKNVSKNANDFVQSMLKYN 248 (267)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c--cc---------CCcccccCHHHHHHHHHHhccC
Confidence 89999999999999999999999996332211 1111111110 0 00 0111123447889999999999
Q ss_pred CCCCCC-HHHHHH
Q 045452 242 PNDRPS-MLEVSS 253 (303)
Q Consensus 242 p~~Rps-~~~l~~ 253 (303)
|.+||+ ++++++
T Consensus 249 p~~R~~~~~~~l~ 261 (267)
T PHA03390 249 INYRLTNYNEIIK 261 (267)
T ss_pred hhhCCchHHHHhc
Confidence 999996 588874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=262.61 Aligned_cols=226 Identities=20% Similarity=0.247 Sum_probs=161.6
Q ss_pred hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-c-ccCCCHHHHHHHHHHHHHHHHHHH
Q 045452 21 GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-R-RLILDWKKRVHIIEGITQGLLYLQ 98 (303)
Q Consensus 21 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~-~~~~~~~~~~~~~~~i~~~l~~lh 98 (303)
....+.+|+.++++++|+||+++++++...+..+++++++. ++|..++.... . ........+..++.||+.||+|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999984 56666654311 1 222345677889999999999999
Q ss_pred hcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHH
Q 045452 99 EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178 (303)
Q Consensus 99 ~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 178 (303)
+.| |+||||||+|||++.++.+||+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+
T Consensus 285 ~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 360 (501)
T PHA03210 285 DKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360 (501)
T ss_pred hCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence 998 99999999999999999999999999976643221 12223568999999999999999999999999999999
Q ss_pred HHhCCCCccccCCCccccHHHHHHHHhh------------------CCC---ccccccccccCCCChHHHHHHHHHHHhc
Q 045452 179 IISGKRLSMLCGINENLSILEHAYELWK------------------GGK---GMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 179 ll~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
|++|..++...........+........ ... ............ .....+.++|.+|
T Consensus 361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~km 437 (501)
T PHA03210 361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKM 437 (501)
T ss_pred HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHH
Confidence 9998865432222111111111111000 000 000000000000 0123567889999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|..||++|||+.++++.
T Consensus 438 L~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 438 LTFDWHLRPGAAELLAL 454 (501)
T ss_pred hccCcccCcCHHHHhhC
Confidence 99999999999999863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=243.83 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=173.0
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.+..... .....+.+|+.++++++|+||+++++++..+...++||||+. ++|.+++... .....++.
T Consensus 25 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~ 102 (294)
T PLN00009 25 VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS-PDFAKNPR 102 (294)
T ss_pred CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC-CCCCcCHH
Confidence 4789999999864422 234678899999999999999999999999999999999995 5777776432 22346788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......... .....++..|+|||.+.+
T Consensus 103 ~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 103 LIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLG 177 (294)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCHHHHhC
Confidence 88999999999999999998 999999999999985 457999999998765332111 112345789999998765
Q ss_pred -CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHH--------hhCCCcc-ccccccc--cC----CCCh
Q 045452 161 -GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL--------WKGGKGM-EFVDSFL--DD----RNSS 224 (303)
Q Consensus 161 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~--~~----~~~~ 224 (303)
..++.++|+||+|+++|+|++|..||......+. ....... |...... ....... .. ....
T Consensus 178 ~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (294)
T PLN00009 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVP 254 (294)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCc
Confidence 4578899999999999999999999864322111 1111000 0000000 0000000 00 0011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..+.++.+++.+||+.+|++||++.++++.
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 255 TLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123467899999999999999999999863
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=246.06 Aligned_cols=227 Identities=27% Similarity=0.320 Sum_probs=180.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|++... .......+.+|+.++++++ |+||+++++++..+...+++||++.+++|.+++.. ...++
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~ 100 (280)
T cd05581 24 ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLD 100 (280)
T ss_pred CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH---cCCCC
Confidence 37899999998653 2334567888999999998 99999999999999999999999999999999843 34699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc------------------c
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK------------------A 141 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~------------------~ 141 (303)
+..++.++.|++.+|.+||+.| ++|+||+|+||+++.++.++++|||++......... .
T Consensus 101 ~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (280)
T cd05581 101 EKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccc
Confidence 9999999999999999999998 999999999999999999999999998765433221 2
Q ss_pred ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCC
Q 045452 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDR 221 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
......++..|+|||......++.++|+||||++++++++|+.||...... .......... ..
T Consensus 178 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-----------~~ 240 (280)
T cd05581 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------LTFQKILKLE-----------YS 240 (280)
T ss_pred ccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhcC-----------CC
Confidence 223345688999999988888899999999999999999999998644311 1111111110 01
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSM----LEVSS 253 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~----~~l~~ 253 (303)
.+...+..+.++|.+||..+|.+||++ ++++.
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111224468899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=241.07 Aligned_cols=230 Identities=22% Similarity=0.291 Sum_probs=175.9
Q ss_pred CCCCEEEEEEccCCC----hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||+|.++... ....+.+.+|+.+++++ +|+||+++++.+..+...++||||+++++|.+++.. ...+
T Consensus 26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l 102 (290)
T cd05613 26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ---RERF 102 (290)
T ss_pred CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH---cCCC
Confidence 578999999986532 23346778899999999 699999999999998899999999999999998843 4568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..+..++.|++.||.+||+.| ++||||+|+||+++.++.++|+|||++........ .......++..|+|||.+
T Consensus 103 ~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 103 KEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIV 178 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhc
Confidence 89999999999999999999988 99999999999999999999999999876533221 112234578899999988
Q ss_pred ccC--CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 159 RQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+. .++.++|+||||+++|+|++|..||............ ........ .. .+......+.+++.+
T Consensus 179 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~--~~---------~~~~~~~~~~~ll~~ 245 (290)
T cd05613 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE--PP---------YPQEMSALAKDIIQR 245 (290)
T ss_pred cCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH--HHHhhccC--CC---------CCccCCHHHHHHHHH
Confidence 653 4678999999999999999999998643322111111 11111111 00 111123467899999
Q ss_pred cccCCCCCCC-----CHHHHHH
Q 045452 237 CVQENPNDRP-----SMLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rp-----s~~~l~~ 253 (303)
||..||.+|| ++++++.
T Consensus 246 ~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 246 LLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HhcCCHHHhcCCCCCCHHHHHc
Confidence 9999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=241.38 Aligned_cols=224 Identities=29% Similarity=0.387 Sum_probs=173.4
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.|++|.+... .....+.+.+|+.+++.++|+|++++++++.+....+++|||+. +++.+++.. ....+++
T Consensus 44 ~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~l~~ 120 (313)
T cd06633 44 HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV--HKKPLQE 120 (313)
T ss_pred CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh--cCCCCCH
Confidence 46889999998643 23345678899999999999999999999999999999999995 567666643 2346889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.||+.++.|||+.| ++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 121 ~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 121 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILA 191 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccc
Confidence 999999999999999999998 99999999999999999999999998754221 12345788999999874
Q ss_pred --cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
...++.++|+||||+++|+|++|..||..... ............ .. ......+..+.+++.+|
T Consensus 192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~-~~--------~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNDS-PT--------LQSNEWTDSFRGFVDYC 256 (313)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC-CC--------CCccccCHHHHHHHHHH
Confidence 45678899999999999999999999854321 111111111111 11 01111223678999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|+.+|.+||++.+++..
T Consensus 257 l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 257 LQKIPQERPASAELLRH 273 (313)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=252.10 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=182.2
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||++.... ....+.+.+|+..++.++|+||+++++++.... ..+++|+|+. ++|.+++.. ..
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~ 98 (330)
T cd07834 23 RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS---PQ 98 (330)
T ss_pred CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC---CC
Confidence 458999999987643 445578899999999999999999999988765 7899999996 578888743 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aP 155 (303)
.+++..++.++.+++.||++||+.| ++|+||||.||+++.++.++|+|||++......... .......++..|+||
T Consensus 99 ~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 175 (330)
T cd07834 99 PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175 (330)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCc
Confidence 7899999999999999999999998 999999999999999999999999999766543210 112234568899999
Q ss_pred hhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHH--------hhCCCccccccccccC------
Q 045452 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL--------WKGGKGMEFVDSFLDD------ 220 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~------ 220 (303)
|.+.+. .++.++|+||||+++|+|++|..||.................. ................
T Consensus 176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
T cd07834 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255 (330)
T ss_pred eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH
Confidence 998877 7899999999999999999999998644322111110000000 0000000000000000
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
......+..+.++|.+||..+|++|||+++++.. +++..
T Consensus 256 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 256 KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0011124568899999999999999999999864 55533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=240.41 Aligned_cols=224 Identities=30% Similarity=0.392 Sum_probs=173.7
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+... .....+.+.+|+.+++.++|+|++++++++......++||||+. +++.+.+.. ....+++
T Consensus 38 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~l~~ 114 (308)
T cd06634 38 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQE 114 (308)
T ss_pred CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH--cCCCCCH
Confidence 46889999988532 23445678899999999999999999999999999999999996 577776643 2345889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++...... ....++..|+|||.+.
T Consensus 115 ~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~ 185 (308)
T cd06634 115 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILA 185 (308)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhh
Confidence 999999999999999999988 999999999999999999999999988654321 1234678999999874
Q ss_pred --cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
...++.++||||||+++|+|++|..||..... ......... .... .......+..+.++|.+|
T Consensus 186 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~~~--------~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESP--------ALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred cccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhh-cCCC--------CcCcccccHHHHHHHHHH
Confidence 34578899999999999999999999743211 111111111 1110 111122344688999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|..+|++||++.+++..
T Consensus 251 l~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 251 LQKIPQDRPTSEVLLKH 267 (308)
T ss_pred hhCCcccCCCHHHHhhC
Confidence 99999999999999866
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=251.17 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=176.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||.++.. .......+.+|+.+++.++|+||+++++++... ...++++||+. ++|.+++. ...
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~ 103 (337)
T cd07858 28 ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR---SSQ 103 (337)
T ss_pred CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh---cCC
Confidence 57899999998653 233455677899999999999999999987644 35799999995 68888874 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.+||+|||++....... .......++..|+|||
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 178 (337)
T cd07858 104 TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPE 178 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChH
Confidence 6899999999999999999999998 9999999999999999999999999987654321 1122345688999999
Q ss_pred hccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC-----------Cccccc-------ccc
Q 045452 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG-----------KGMEFV-------DSF 217 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-------~~~ 217 (303)
.+.. ..++.++|+|||||++|+|++|..||........ ........... ...... ...
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (337)
T cd07858 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQS 255 (337)
T ss_pred HHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccC
Confidence 8754 4688999999999999999999999853321110 00000000000 000000 000
Q ss_pred ccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccC
Q 045452 218 LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 258 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~ 258 (303)
.. ......+.++.++|.+||..+|++|||++++++. +...
T Consensus 256 ~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 256 FA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0011223568899999999999999999999866 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=236.69 Aligned_cols=229 Identities=20% Similarity=0.239 Sum_probs=183.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.+|||+++... ......-..|-++++..+||.+..+.-.|...+++|+||||++||.|.-.|. +...+++
T Consensus 191 at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs---rer~FsE 267 (516)
T KOG0690|consen 191 ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS---RERVFSE 267 (516)
T ss_pred ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh---hhhcccc
Confidence 478999999998663 3445556678899999999999999999999999999999999999977773 4567899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
+...-+-..|+.||.|||+.+ |++||+|.+|+++|.+|++||.|||++..- -.......+++||+.|.|||++..
T Consensus 268 ~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 268 DRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred hhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--ccccceeccccCChhhcCchhhcc
Confidence 999999999999999999988 999999999999999999999999998642 234555667899999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..|..+.|.|.+|++||||+.|+.||..-.......++.... -.+|...+.+...|+...|.+
T Consensus 343 nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-----------------~kFPr~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 343 NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-----------------LKFPRTLSPEAKTLLSGLLKK 405 (516)
T ss_pred ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-----------------ccCCccCCHHHHHHHHHHhhc
Confidence 999999999999999999999999996444332222211110 112222233677999999999
Q ss_pred CCCCCC--CHHHHHHhhcc
Q 045452 241 NPNDRP--SMLEVSSMLKN 257 (303)
Q Consensus 241 dp~~Rp--s~~~l~~~L~~ 257 (303)
||.+|. -.+++.+.++.
T Consensus 406 dP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ChHhhcCCCchhHHHHHhh
Confidence 999996 33444444443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.58 Aligned_cols=240 Identities=22% Similarity=0.297 Sum_probs=175.3
Q ss_pred CCCCEEEEEEccCCChhh--------------HHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhh
Q 045452 4 PCGEVIAVKKLSKSSAQG--------------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l 69 (303)
.+|+.||||+++...... ...+.+|+.+++.++|+||+++++++...+..+++|||+. ++|.+++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l 110 (335)
T PTZ00024 32 LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV 110 (335)
T ss_pred CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHH
Confidence 478999999986442211 1246789999999999999999999999999999999996 5888887
Q ss_pred cCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc----------
Q 045452 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL---------- 139 (303)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~---------- 139 (303)
. ....+++..+..++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+........
T Consensus 111 ~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 184 (335)
T PTZ00024 111 D---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184 (335)
T ss_pred H---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeecccccccccccccccc
Confidence 4 3455899999999999999999999998 99999999999999999999999999876542111
Q ss_pred --ccccceeeccccccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc--
Q 045452 140 --KANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV-- 214 (303)
Q Consensus 140 --~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 214 (303)
........++..|+|||.+.+. .++.++|+|||||++|+|++|..||......+ .+..............+.
T Consensus 185 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 261 (335)
T PTZ00024 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRIFELLGTPNEDNWPQA 261 (335)
T ss_pred cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCchhhCcch
Confidence 0111123457789999988654 46889999999999999999999986443221 111111111110000000
Q ss_pred ------cccc---cC---CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 215 ------DSFL---DD---RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 215 ------~~~~---~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.... .. ......+.++.++|.+||..+|++|||+++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 262 KKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred hhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 0000 00 000112346889999999999999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=234.67 Aligned_cols=221 Identities=27% Similarity=0.311 Sum_probs=176.8
Q ss_pred CCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 5 CGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+|+.||+|.++... ......+..|+.++++++|+||+++++.+..+...+++|||+.+++|.+++.. ...+++.
T Consensus 17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~l~~~ 93 (250)
T cd05123 17 TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSEE 93 (250)
T ss_pred CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh---cCCCCHH
Confidence 58999999986543 23556888999999999999999999999999999999999999999999843 3358999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|++||...+.
T Consensus 94 ~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~ 168 (250)
T cd05123 94 RARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGK 168 (250)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCC
Confidence 99999999999999999988 9999999999999999999999999987654322 112234568899999999888
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+||||+++|++++|..||..... ......... .. ...+...+.++.+++.+||..|
T Consensus 169 ~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~--~~---------~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK--DP---------LRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc--CC---------CCCCCCCCHHHHHHHHHHhcCC
Confidence 889999999999999999999999853322 111111111 00 0111112347889999999999
Q ss_pred CCCCCCHHH
Q 045452 242 PNDRPSMLE 250 (303)
Q Consensus 242 p~~Rps~~~ 250 (303)
|++||++.+
T Consensus 232 p~~R~~~~~ 240 (250)
T cd05123 232 PTKRLGSGG 240 (250)
T ss_pred HhhCCCccc
Confidence 999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=239.05 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=187.3
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
++.||||+++.. ..+.|++|-++++. |+|+||+++++.-.... .++||++|.+.|||.++| +...++
T Consensus 233 ~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL----~~ntis 305 (534)
T KOG3653|consen 233 NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL----KANTIS 305 (534)
T ss_pred CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH----Hhcccc
Confidence 599999999654 45677788877775 59999999999876554 899999999999999999 556799
Q ss_pred HHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 80 WKKRVHIIEGITQGLLYLQEY------SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~------~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
|....+++..+++||+|||+- ...+|+|||||..||||..+++..|+|||++..+............+||.+||
T Consensus 306 w~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYM 385 (534)
T KOG3653|consen 306 WNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYM 385 (534)
T ss_pred HHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhc
Confidence 999999999999999999963 34569999999999999999999999999999887655555555578999999
Q ss_pred CchhcccCC-CC-----CcccchhhHHHHHHHHhCCCCccccCCCccc-----------cHHHHHHHHhhCCCccccccc
Q 045452 154 PPEYARQGV-YS-----TKSDVFSFGVLLLQIISGKRLSMLCGINENL-----------SILEHAYELWKGGKGMEFVDS 216 (303)
Q Consensus 154 aPE~~~~~~-~~-----~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 216 (303)
|||++.+.- +. .+.||||+|+|+|||+++-..+......+.. ..-+..........++.+.+.
T Consensus 386 APEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~ 465 (534)
T KOG3653|consen 386 APEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDA 465 (534)
T ss_pred CHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhh
Confidence 999997653 22 3689999999999999854333211111111 111111112222333333333
Q ss_pred cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCC
Q 045452 217 FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~ 264 (303)
+... ....-+.+.+..||..|++.|.|+.=+.+++.+.....+.
T Consensus 466 W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 466 WRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 3322 2234578999999999999999999999999887765543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=251.15 Aligned_cols=242 Identities=23% Similarity=0.272 Sum_probs=171.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--------------CeeeEEEeeCCCCChhhhh
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--------------EERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~l 69 (303)
.+|+.||+|.+........+.+.+|+.+++.++||||+++++++... ...+++|||+. ++|.+++
T Consensus 28 ~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 106 (342)
T cd07854 28 DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL 106 (342)
T ss_pred CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHH
Confidence 57899999998766656667888999999999999999999876543 35789999996 5887777
Q ss_pred cCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccc-cccceee
Q 045452 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLK-ANTEQVV 147 (303)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~-~~~~~~~ 147 (303)
. ...+++..++.++.||+.||.|||+.| ++||||||+||+++. ++.++++|||.+......... .......
T Consensus 107 ~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (342)
T cd07854 107 E----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179 (342)
T ss_pred H----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccc
Confidence 3 345889999999999999999999998 999999999999974 557899999998765322111 1112234
Q ss_pred ccccccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhhCCCccccccccc
Q 045452 148 GTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGKGMEFVDSFL 218 (303)
Q Consensus 148 ~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 218 (303)
++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............. ..................
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (342)
T cd07854 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259 (342)
T ss_pred ccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccc
Confidence 6788999997644 5578899999999999999999999953322111000000 000000000000000000
Q ss_pred cCC-----CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 219 DDR-----NSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 219 ~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
... .......++.+++.+||..||.+|||+.+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 260 EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 00112346889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=238.09 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=172.8
Q ss_pred CCCEEEEEEccCCCh--hhHHHHHHHHHHHhcC---CCCcceeEEEEEEeCCe-----eeEEEeeCCCCChhhhhcCcCc
Q 045452 5 CGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEE-----RMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
+|+.||+|.++.... .....+.+|+.+++++ +|+|++++++++..... .+++|||+. ++|.+++... .
T Consensus 23 ~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~-~ 100 (287)
T cd07838 23 TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKC-P 100 (287)
T ss_pred CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHc-c
Confidence 589999999974422 2234566677766655 69999999999988776 899999996 4788877442 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|+|
T Consensus 101 ~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~ 174 (287)
T cd07838 101 KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRA 174 (287)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccC
Confidence 235899999999999999999999998 99999999999999999999999999876543221 112346788999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCc----------ccccccccc---CC
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG----------MEFVDSFLD---DR 221 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~ 221 (303)
||.+.+..++.++|+|||||++|+|++|..||......+. ............. ......... ..
T Consensus 175 PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07838 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS 251 (287)
T ss_pred hHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcCCCcccchhhcccccccchhh
Confidence 9999988899999999999999999999988854332211 1111111000000 000000000 00
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
........+.++|.+||..||.+||++.+++.
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 11122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=240.66 Aligned_cols=242 Identities=28% Similarity=0.319 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|.++... ....+.+..|+..++.++|+|++++++++......+++|||+. ++|.+++... ...+++.
T Consensus 22 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~--~~~~~~~ 98 (282)
T cd07829 22 KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR--PGPLSPN 98 (282)
T ss_pred CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh--ccCCCHH
Confidence 368999999997653 3345678889999999999999999999999999999999997 5898888542 1468999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.+++.+|++||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+.
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 99 LIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCC
Confidence 99999999999999999998 99999999999999999999999999876543221 11123356789999988766
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH-----HHHhhCCC--------ccccccccccCCCChHHH
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----YELWKGGK--------GMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 227 (303)
.++.++|+||||+++|+|++|..||............... ...|.... ............. +...
T Consensus 174 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 252 (282)
T cd07829 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLD 252 (282)
T ss_pred cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-cccc
Confidence 7889999999999999999999998544322111111000 00000000 0000000000000 1114
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..+.++|.+||..||++||++++++..
T Consensus 253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 253 PEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 578999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=238.37 Aligned_cols=228 Identities=22% Similarity=0.352 Sum_probs=170.1
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+|+.||||.++... ......+..|+..+.+. .|+||+++++++..+...+++|||+. +++.+++.. ....+++..
T Consensus 39 ~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~--~~~~l~~~~ 115 (296)
T cd06618 39 TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR--IQGPIPEDI 115 (296)
T ss_pred CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH--hcCCCCHHH
Confidence 48999999997543 23445566777767666 59999999999999999999999984 567666533 134688999
Q ss_pred HHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..++.+++.+++|||+ .+ ++|+||+|+||+++.++.++|+|||++..+...... ....++..|+|||.+.+.
T Consensus 116 ~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 116 LGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPP 189 (296)
T ss_pred HHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCC
Confidence 99999999999999997 46 999999999999999999999999998765432211 122467789999988655
Q ss_pred C----CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 162 V----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 162 ~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
. ++.++|+||||+++|+|++|..||...... ........... ...... ......++.+++.+|
T Consensus 190 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~-------~~~~~~~l~~li~~~ 256 (296)
T cd06618 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSLPP-------NEGFSPDFCSFVDLC 256 (296)
T ss_pred CCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCCCC-------CCCCCHHHHHHHHHH
Confidence 3 788999999999999999999998532111 11111111111 111100 001234788999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|..||.+||++++++..
T Consensus 257 l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 257 LTKDHRKRPKYRELLQH 273 (296)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=243.18 Aligned_cols=224 Identities=24% Similarity=0.282 Sum_probs=178.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+-+|+|++.... .....-..+|-.++++++.+.||.+--.|++.+.+|+|+..|+||+|.-+|... ....+++
T Consensus 208 aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~-g~~gF~e 286 (591)
T KOG0986|consen 208 ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNH-GNPGFDE 286 (591)
T ss_pred cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeecc-CCCCCch
Confidence 467777777774332 122334567899999999999999999999999999999999999998877653 3357999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
....-++.+|+.||.+||..+ |++||+||+|||+|+.|+++|+|+|++..+.... ....++||..|||||++.+
T Consensus 287 ~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~n 360 (591)
T KOG0986|consen 287 QRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQN 360 (591)
T ss_pred HHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999998876533 2233489999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..|+...|.|||||++|+|+.|+-||...........++.... ... ...+...++++.+|+...|++
T Consensus 361 e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~----~~~---------~ey~~kFS~eakslc~~LL~K 427 (591)
T KOG0986|consen 361 EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL----EDP---------EEYSDKFSEEAKSLCEGLLTK 427 (591)
T ss_pred CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh----cch---------hhcccccCHHHHHHHHHHHcc
Confidence 9999999999999999999999999965443332222221111 111 122333445788999999999
Q ss_pred CCCCCCC
Q 045452 241 NPNDRPS 247 (303)
Q Consensus 241 dp~~Rps 247 (303)
||++|.-
T Consensus 428 dp~~RLG 434 (591)
T KOG0986|consen 428 DPEKRLG 434 (591)
T ss_pred CHHHhcc
Confidence 9999953
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=239.92 Aligned_cols=238 Identities=19% Similarity=0.259 Sum_probs=180.0
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-C-C----cceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-H-V----NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
++..||||+++.- ..-.+..+-|+++++++. + | -+|.+.++|+..++.|||+|.+ |.|+.+++..+ +-.++
T Consensus 113 ~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~f 189 (415)
T KOG0671|consen 113 TKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPF 189 (415)
T ss_pred CCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC-Ccccc
Confidence 4788999999543 334455667999999992 2 2 3788888899999999999998 77999999653 45678
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC--------------------CCCcEEEecccccccccccc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--------------------EDMKPKISDFGLARIFAKES 138 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~--------------------~~~~~kl~df~~~~~~~~~~ 138 (303)
+...+..+..|++.++++||+.+ ++|-||||+|||+. .+..++++|||.+.....
T Consensus 190 pi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-- 264 (415)
T KOG0671|consen 190 PIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-- 264 (415)
T ss_pred chHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc--
Confidence 99999999999999999999999 99999999999993 244589999999875432
Q ss_pred cccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH--------------H
Q 045452 139 LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE--------------L 204 (303)
Q Consensus 139 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------------~ 204 (303)
.....+.|..|+|||++.+-.|+.++||||+|||++|+.+|...|......+.+..++.... .
T Consensus 265 ---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Ky 341 (415)
T KOG0671|consen 265 ---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKY 341 (415)
T ss_pred ---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhh
Confidence 22456789999999999999999999999999999999999999988775554433222211 1
Q ss_pred hhCCCccccccccccC----------------CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 205 WKGGKGMEFVDSFLDD----------------RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 205 ~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+..+ ..++....... ...+....+|.+|+.+||..||.+|+|+.|+++.
T Consensus 342 f~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 342 FRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred hhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 1111 11111100000 1112223468999999999999999999998864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=252.71 Aligned_cols=217 Identities=23% Similarity=0.314 Sum_probs=168.8
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
++++..++|++.... ..-.+|+.++... +|+||+++.+.+.+..+.|+|||.+.|+-+.+.+.. .. .....
T Consensus 345 ~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~---~~-~~~~e 416 (612)
T KOG0603|consen 345 PTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS---KP-EFCSE 416 (612)
T ss_pred ccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh---cc-hhHHH
Confidence 456677788875441 1223566666655 899999999999999999999999999988777732 22 22267
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-CCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~-~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..|+++|+.++.|||.+| ++||||||+|||+ +..|+++|+|||.+...... ....+-|..|.|||+....
T Consensus 417 ~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~ 488 (612)
T KOG0603|consen 417 ASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQ 488 (612)
T ss_pred HHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccC
Confidence 7789999999999999999 9999999999999 58899999999998766543 2223458899999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|+||||+++|+|++|+.||...... ......... .......+.+..+|+.+||+.|
T Consensus 489 ~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~------------~~~s~~vS~~AKdLl~~LL~~d 550 (612)
T KOG0603|consen 489 EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQM------------PKFSECVSDEAKDLLQQLLQVD 550 (612)
T ss_pred CCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcC------------CccccccCHHHHHHHHHhccCC
Confidence 9999999999999999999999999655433 111111111 1111334457889999999999
Q ss_pred CCCCCCHHHHHHh
Q 045452 242 PNDRPSMLEVSSM 254 (303)
Q Consensus 242 p~~Rps~~~l~~~ 254 (303)
|.+||++.++...
T Consensus 551 P~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 551 PALRLGADEIGAH 563 (612)
T ss_pred hhhCcChhhhccC
Confidence 9999999999753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=240.66 Aligned_cols=238 Identities=26% Similarity=0.322 Sum_probs=172.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++++||+ +++|..++. ...++.
T Consensus 33 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~~~~ 107 (328)
T cd07856 33 LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT----SRPLEK 107 (328)
T ss_pred CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh----cCCCCH
Confidence 47899999987542 22345678899999999999999999999875 45789999998 568887773 345788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+
T Consensus 108 ~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 108 QFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeec
Confidence 889999999999999999998 999999999999999999999999998754321 122345778999998765
Q ss_pred -CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHH--------HHHHHhhCCCccccccccccC-CCC-----hH
Q 045452 161 -GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE--------HAYELWKGGKGMEFVDSFLDD-RNS-----SC 225 (303)
Q Consensus 161 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-~~~-----~~ 225 (303)
..++.++|+||||+++|+|++|..||............. ............++....... ..+ ..
T Consensus 180 ~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (328)
T cd07856 180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN 259 (328)
T ss_pred cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCC
Confidence 568899999999999999999999985332111000000 000000000000000000000 000 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+.++.++|.+||..+|++|||+++++..
T Consensus 260 ~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 260 ADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23578899999999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=241.59 Aligned_cols=240 Identities=23% Similarity=0.244 Sum_probs=170.3
Q ss_pred CCEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC----CeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 6 g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
++.||+|.+... .....+.+.+|+.+++++ +|+||+++++.+... ...+++++|+. ++|..++. ....+
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~---~~~~~ 102 (332)
T cd07857 27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR---SGQPL 102 (332)
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh---cCCCC
Confidence 789999998643 223356778899999999 699999999876432 35788899885 68888874 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeeccccccCch
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE 156 (303)
++..++.++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||++..+...... .......++..|+|||
T Consensus 103 ~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE 179 (332)
T cd07857 103 TDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179 (332)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcH
Confidence 99999999999999999999998 999999999999999999999999999765432211 1122346788999999
Q ss_pred hccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhhCCCc-------cccccccccC
Q 045452 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGKG-------MEFVDSFLDD 220 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~-------~~~~~~~~~~ 220 (303)
.+.+ ..++.++|+||+|+++|+|++|..||.............. ....+..... ..........
T Consensus 180 ~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (332)
T cd07857 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES 259 (332)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh
Confidence 8755 4688999999999999999999999864332111100000 0000000000 0000000000
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
........+.+++.+||+.||.+|||+.+++.
T Consensus 260 -~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 260 -IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred -hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111346889999999999999999999973
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=236.82 Aligned_cols=242 Identities=24% Similarity=0.283 Sum_probs=174.5
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++.|+||.+..... .......+|+..+++++ |+|++++++++..+...++||||+ +++|.+++.... ...+++.
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~ 99 (283)
T cd07830 22 ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK-GKPFSES 99 (283)
T ss_pred CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc-cccCCHH
Confidence 3588999999865432 22234457899999998 999999999999999999999999 788888875422 2468999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-c
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-Q 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~ 160 (303)
.++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+. .
T Consensus 100 ~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~ 173 (283)
T cd07830 100 VIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRS 173 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecC
Confidence 99999999999999999988 99999999999999999999999999876543211 12234678999999874 4
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH-----HHHhh-----CCCcc----ccccccccCCCChHH
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----YELWK-----GGKGM----EFVDSFLDDRNSSCK 226 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~----~~~~~~~~~~~~~~~ 226 (303)
..++.++|+||||+++++|++|..||......+........ ...|. ..... ........... ...
T Consensus 174 ~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 252 (283)
T cd07830 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI-PNA 252 (283)
T ss_pred cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc-ccC
Confidence 45789999999999999999999998544322111000000 00000 00000 00000000000 011
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
...+.++|.+||..+|++|||+++++..
T Consensus 253 ~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 253 SPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 3468899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=240.42 Aligned_cols=241 Identities=23% Similarity=0.266 Sum_probs=174.3
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCc
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
..+|+.||||.+... .......+.+|+.++++++|+||+++++++.... ..++||+|+ +++|.+++.
T Consensus 37 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~---- 111 (343)
T cd07880 37 RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK---- 111 (343)
T ss_pred CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh----
Confidence 357899999998543 2234457889999999999999999999987553 358999998 778887773
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++...... .....++..|+|
T Consensus 112 ~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~a 183 (343)
T cd07880 112 HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRA 183 (343)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccC
Confidence 346899999999999999999999998 999999999999999999999999998755322 122346789999
Q ss_pred chhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhh-----------CCCcccccccccc---
Q 045452 155 PEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK-----------GGKGMEFVDSFLD--- 219 (303)
Q Consensus 155 PE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~--- 219 (303)
||.+.+ ..++.++|+||||+++|++++|..||....... .......... .............
T Consensus 184 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (343)
T cd07880 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD---QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRK 260 (343)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCc
Confidence 998865 357889999999999999999999986432211 0000000000 0000000000000
Q ss_pred ---CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH--HhhccCC
Q 045452 220 ---DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVS--SMLKNET 259 (303)
Q Consensus 220 ---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~--~~L~~~~ 259 (303)
..........+.++|.+||..||++|||+.+++ .+++...
T Consensus 261 ~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 261 KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000011223578999999999999999999998 3444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=244.25 Aligned_cols=234 Identities=27% Similarity=0.318 Sum_probs=172.9
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe------eeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||+|.+... .....+.+.+|+.+++.++|+||+++++++..... .++|++|+ +++|.+++. .
T Consensus 38 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~ 112 (343)
T cd07851 38 KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK----C 112 (343)
T ss_pred CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh----c
Confidence 36889999998653 23344667889999999999999999988765544 89999998 678988873 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||++...... .....++..|+||
T Consensus 113 ~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP 184 (343)
T cd07851 113 QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 184 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCH
Confidence 46899999999999999999999998 999999999999999999999999998765332 1223467889999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc------------ccccccC--
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF------------VDSFLDD-- 220 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~-- 220 (303)
|.+.+ ..++.++||||||+++|+|++|..||....... .+........ .....+ .......
T Consensus 185 E~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (343)
T cd07851 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVG-TPDEELLQKISSESARNYIQSLPQMPK 260 (343)
T ss_pred HHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcC-CCCHHHHhhccchhHHHHHHhccccCC
Confidence 98755 357889999999999999999999985432211 1111111100 000000 0000000
Q ss_pred -C---CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 221 -R---NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 221 -~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
. .....+.++.++|.+||..+|.+|||+.+|+..
T Consensus 261 ~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 261 KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 000114578899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=245.49 Aligned_cols=235 Identities=26% Similarity=0.298 Sum_probs=171.3
Q ss_pred CCCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCc
Q 045452 3 LPCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
..+|+.||+|+++... ....+.+.+|+.++++++|+||+++++++... ...+++++++ +++|.+++.
T Consensus 39 ~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~---- 113 (345)
T cd07877 39 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---- 113 (345)
T ss_pred cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh----
Confidence 3578999999997542 23346788899999999999999999988643 3467888887 788887773
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|
T Consensus 114 ~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~a 185 (345)
T cd07877 114 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 185 (345)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccC
Confidence 335899999999999999999999998 999999999999999999999999998754321 122356889999
Q ss_pred chhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc---------------cccc
Q 045452 155 PEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV---------------DSFL 218 (303)
Q Consensus 155 PE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~ 218 (303)
||.+.+ ..++.++|+|||||++|+|++|..||....... ......... +....... ....
T Consensus 186 PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (345)
T cd07877 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLV-GTPGAELLKKISSESARNYIQSLTQMP 261 (345)
T ss_pred HHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh-CCCCHHHHhhcccHhHHHHHHHhcccC
Confidence 998765 467889999999999999999999985332211 111100000 00000000 0000
Q ss_pred c---CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 219 D---DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 219 ~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
. .......+.++.++|.+||..||.+||++.+++..
T Consensus 262 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 262 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00000123468899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=252.71 Aligned_cols=231 Identities=21% Similarity=0.290 Sum_probs=187.0
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEe-----CCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.++|+.+|+|++..... ..+++..|.++++.+ .|||++.+|+++.- ++.+|||||||.|||..++++... +.
T Consensus 41 ~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~ 118 (953)
T KOG0587|consen 41 VKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GN 118 (953)
T ss_pred eecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-cc
Confidence 46889999999866543 336677899999988 89999999999974 468999999999999999997754 77
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+.+..+..+++.++.|+.+||.+. ++|||||-.|||++.++.|||+|||.+...... ..+.+++.||+.|||||
T Consensus 119 rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 119 RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPE 193 (953)
T ss_pred chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccce
Confidence 7999999999999999999999988 999999999999999999999999999776543 45667789999999999
Q ss_pred hcccC-----CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 157 YARQG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 157 ~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
++.+. .|+..+|+||||++..||..|.+|+...-. +.....+. ... -.....+...++++-
T Consensus 194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mraLF~Ip-RNP-------PPkLkrp~kWs~~Fn 259 (953)
T KOG0587|consen 194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIP-RNP-------PPKLKRPKKWSKKFN 259 (953)
T ss_pred eeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhhhccCC-CCC-------CccccchhhHHHHHH
Confidence 98654 377899999999999999999999732111 11111110 111 112234566777899
Q ss_pred HHHHhcccCCCCCCCCHHHHHHh
Q 045452 232 EIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
++|..||.+|..+||+..++++.
T Consensus 260 dFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 260 DFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHHHHHHhhccccCcchhhhccC
Confidence 99999999999999999998754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=227.40 Aligned_cols=227 Identities=28% Similarity=0.316 Sum_probs=181.0
Q ss_pred CCCEEEEEEccCCChhh-HHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
+|+.||+|++....... .+.+.+|+..+++++|+|++++++++......++++|++.+++|..++.. ...++...+
T Consensus 13 ~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~ 89 (244)
T smart00220 13 TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK---RGRLSEDEA 89 (244)
T ss_pred CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh---ccCCCHHHH
Confidence 58999999997665444 68899999999999999999999999999999999999999999998843 223889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.+++.++.+||+.+ ++|+||+|.||+++.++.++++|||.+....... ......++..|++||.+.+..+
T Consensus 90 ~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~ 163 (244)
T smart00220 90 RFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGY 163 (244)
T ss_pred HHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCC
Confidence 999999999999999998 9999999999999999999999999987765432 2223456889999999988888
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|+|+||++++++++|..||...... ................. ....+.++.+++.+||..+|+
T Consensus 164 ~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~ 230 (244)
T smart00220 164 GKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFPPP-------EWKISPEAKDLIRKLLVKDPE 230 (244)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCccc-------cccCCHHHHHHHHHHccCCch
Confidence 99999999999999999999998542111 11111111111100000 000234788999999999999
Q ss_pred CCCCHHHHHH
Q 045452 244 DRPSMLEVSS 253 (303)
Q Consensus 244 ~Rps~~~l~~ 253 (303)
+||++.++++
T Consensus 231 ~Rp~~~~~~~ 240 (244)
T smart00220 231 KRLTAEEALQ 240 (244)
T ss_pred hccCHHHHhh
Confidence 9999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=264.33 Aligned_cols=238 Identities=20% Similarity=0.247 Sum_probs=187.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.+|+|+++.- ......-|+.|-.+|..-+.+-|+.++-.|.+..++|+||+|++||+|..++.. ...+++
T Consensus 98 ~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk---~~~~pE 174 (1317)
T KOG0612|consen 98 STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK---FDRLPE 174 (1317)
T ss_pred ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh---cCCChH
Confidence 46888999998752 234556788999999998999999999999999999999999999999999943 336999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
+-...++..|+.||..||++| +|||||||+|||+|..|++||+|||.+..+.... .......+|||.|++||++.
T Consensus 175 ~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 175 DWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred HHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHh
Confidence 999999999999999999999 9999999999999999999999999998876433 34455578999999999884
Q ss_pred ---c-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 160 ---Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 160 ---~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+ +.|...+|+||+|+++|||+.|..||-..+..+.+. ++........++ .....+.+..+||.
T Consensus 251 ~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~------KIm~hk~~l~FP-------~~~~VSeeakdLI~ 317 (1317)
T KOG0612|consen 251 QGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG------KIMNHKESLSFP-------DETDVSEEAKDLIE 317 (1317)
T ss_pred hcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH------HHhchhhhcCCC-------cccccCHHHHHHHH
Confidence 2 458899999999999999999999995433322222 222221111111 11224567889999
Q ss_pred hcccCCCCCCCC---HHHHHH--hhccCCCCC
Q 045452 236 LCVQENPNDRPS---MLEVSS--MLKNETTNT 262 (303)
Q Consensus 236 ~cl~~dp~~Rps---~~~l~~--~L~~~~~~~ 262 (303)
+.+. +|+.|.. ++++.. ++.++.+..
T Consensus 318 ~ll~-~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 318 ALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred HHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence 8877 8999988 888864 356655433
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=229.69 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=176.5
Q ss_pred CEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhhcCc--CcccCCCHH
Q 045452 7 EVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDP--IRRLILDWK 81 (303)
Q Consensus 7 ~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~ 81 (303)
+.+|||+++.... ..-....+|+.+++.++|+|++.+..++.. +..++++++|++. +|...|+.+ .....++..
T Consensus 54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~ 132 (438)
T KOG0666|consen 54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRS 132 (438)
T ss_pred hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHH
Confidence 3678898875522 123456789999999999999999999987 7789999999965 566666542 234578899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC----CcEEEeccccccccccccccc-ccceeeccccccCch
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLARIFAKESLKA-NTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~----~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE 156 (303)
.++.+++||+.|+.|||++= |+||||||.|||+..+ |.|||+|||+++.+.+.-... ....-+-|.+|+|||
T Consensus 133 mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 133 MVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred HHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence 99999999999999999988 9999999999999988 999999999999887653332 333456799999999
Q ss_pred hcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccc------cHHHHHHHHhhCCCc---------cc---ccccc
Q 045452 157 YARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL------SILEHAYELWKGGKG---------ME---FVDSF 217 (303)
Q Consensus 157 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~---------~~---~~~~~ 217 (303)
.+.+. .||.+.|+|++|||+.||++..+.|......... +.+....+....... ++ .+..+
T Consensus 210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f 289 (438)
T KOG0666|consen 210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF 289 (438)
T ss_pred HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence 88766 5999999999999999999999888654332111 112222111111000 00 00001
Q ss_pred ccCCCChH-----------HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 218 LDDRNSSC-----------KLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 218 ~~~~~~~~-----------~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
........ .+...++|+.++|..||-+|.|+++.++.
T Consensus 290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 10000000 01136799999999999999999998764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=236.85 Aligned_cols=241 Identities=22% Similarity=0.268 Sum_probs=169.9
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--------eeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--------ERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||+|.+..... .....+.+|+++++.++|+||+++++++.... ..+++|+|+.+ ++...+..
T Consensus 31 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~-- 107 (311)
T cd07866 31 KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN-- 107 (311)
T ss_pred CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc--
Confidence 4689999999854422 22346678999999999999999999875433 46999999864 56666543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc---------cc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN---------TE 144 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~---------~~ 144 (303)
....+++..+..++.|++.||+|||..| ++|+||+|+||+++.++.++|+|||++........... ..
T Consensus 108 ~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 184 (311)
T cd07866 108 PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184 (311)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccc
Confidence 2446899999999999999999999998 99999999999999999999999999876543221111 11
Q ss_pred eeeccccccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC---------ccccc
Q 045452 145 QVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---------GMEFV 214 (303)
Q Consensus 145 ~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 214 (303)
...++..|+|||.+.+. .++.++||||||+++|+|++|..||......... ........... .....
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T cd07866 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---HLIFKLCGTPTEETWPGWRSLPGCE 261 (311)
T ss_pred cceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChhhchhhhhccccc
Confidence 23457789999987554 5788999999999999999999998543322111 11111100000 00000
Q ss_pred cccccCCCC-------hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 215 DSFLDDRNS-------SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 215 ~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
........+ ......+.++|.+||..||.+|||+.+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 262 GVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000 011246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=241.52 Aligned_cols=238 Identities=26% Similarity=0.312 Sum_probs=171.5
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||+|.++... ......+.+|+.+++.++|+||+++++++.... ..+++++|+. .+|..++ .
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~-----~ 111 (342)
T cd07879 38 RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM-----G 111 (342)
T ss_pred CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH-----c
Confidence 578999999986532 223456789999999999999999999987543 4689999985 4665554 2
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++...... .....++..|+||
T Consensus 112 ~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP 183 (342)
T cd07879 112 HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 183 (342)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccCh
Confidence 35888999999999999999999998 999999999999999999999999998654321 1123567889999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc------------cc---cccc
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF------------VD---SFLD 219 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~---~~~~ 219 (303)
|.+.+ ..++.++|+|||||++|+|++|+.||...... ..+....... +.....+ .. ....
T Consensus 184 E~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (342)
T cd07879 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVT-GVPGPEFVQKLEDKAAKSYIKSLPKYPR 259 (342)
T ss_pred hhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhc-CCCCHHHHHHhcccchHHHHhhcCCccc
Confidence 98765 45788999999999999999999999643211 1111111100 0000000 00 0000
Q ss_pred CCC---ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 220 DRN---SSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 220 ~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
... .+..+..+.++|.+||..||++||++.+++.. ++...
T Consensus 260 ~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 260 KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 01123467899999999999999999999843 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=259.21 Aligned_cols=182 Identities=25% Similarity=0.361 Sum_probs=131.1
Q ss_pred eeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 53 RMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 53 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
+||=||||+..++.+++.++... -.....++++++|++||+|+|++| ++||||||.|||++.++.|||+|||++.
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 57889999888887777542111 146789999999999999999999 9999999999999999999999999997
Q ss_pred ccc---------c-------cccccccceeeccccccCchhcccCC---CCCcccchhhHHHHHHHHhCCCCccccCCCc
Q 045452 133 IFA---------K-------ESLKANTEQVVGTIGYIPPEYARQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193 (303)
Q Consensus 133 ~~~---------~-------~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 193 (303)
... . ..........+||..|+|||++.+.. |+.|+|+||||+|++||+.- |..
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~T----- 817 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGT----- 817 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCc-----
Confidence 721 0 01111233468999999999987665 99999999999999999983 321
Q ss_pred cccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 194 NLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..+.+..... .+.+..+.. ..+.....+ .-.++|.+|+++||++||||.+++..
T Consensus 818 sMERa~iL~~-LR~g~iP~~-~~f~~~~~~-----~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 818 SMERASILTN-LRKGSIPEP-ADFFDPEHP-----EEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred hHHHHHHHHh-cccCCCCCC-cccccccch-----HHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 1111221111 222222221 122222222 34589999999999999999999753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=253.36 Aligned_cols=236 Identities=26% Similarity=0.392 Sum_probs=188.3
Q ss_pred CCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-----cc---
Q 045452 6 GEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-----RR--- 75 (303)
Q Consensus 6 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~--- 75 (303)
...||||.++... ....+.+..|+.+|+.+ +|+||+.++|.|..++..++|+||+..|+|..+++... ..
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 5689999997653 35678899999999999 79999999999999999999999999999999997643 01
Q ss_pred -----cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccc-ceeecc
Q 045452 76 -----LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT-EQVVGT 149 (303)
Q Consensus 76 -----~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~-~~~~~~ 149 (303)
..+....++.++.||+.|++||++.. ++||||-.+|||+..+..+|++|||+++........... ....-.
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP 484 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP 484 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence 23888999999999999999999998 999999999999999999999999999876554433322 111124
Q ss_pred ccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+....|+.++||||+|+++||+++ |..||.. ........+....+...+. |.....
T Consensus 485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~------~~~~~~l~~~l~~G~r~~~---------P~~c~~ 549 (609)
T KOG0200|consen 485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG------IPPTEELLEFLKEGNRMEQ---------PEHCSD 549 (609)
T ss_pred eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC------CCcHHHHHHHHhcCCCCCC---------CCCCCH
Confidence 57999999999999999999999999999998 6677743 1111112233333333332 222245
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
++++++..||+.+|++||++.++.++|....
T Consensus 550 eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 550 EIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 8999999999999999999999999998843
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=232.88 Aligned_cols=242 Identities=23% Similarity=0.314 Sum_probs=180.1
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
|+.||||++...++ ..+.+|.++++. |+|+||+.+++.-..++ .+|||++|.+.|||.||| .+..++
T Consensus 234 Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~ 306 (513)
T KOG2052|consen 234 GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVT 306 (513)
T ss_pred CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCC
Confidence 89999999965543 446667777764 59999999999876554 579999999999999999 456799
Q ss_pred HHHHHHHHHHHHHHHHHHHh-----cCCCCeeecCCCCCcEEECCCCcEEEeccccccccccc--ccccccceeeccccc
Q 045452 80 WKKRVHIIEGITQGLLYLQE-----YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE--SLKANTEQVVGTIGY 152 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~-----~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~--~~~~~~~~~~~~~~y 152 (303)
....++++..++.||++||. +|..+|.|||||..||||.++|.+.|+|+|++...... ......+..+||.+|
T Consensus 307 ~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRY 386 (513)
T KOG2052|consen 307 TEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRY 386 (513)
T ss_pred HHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeec
Confidence 99999999999999999995 56677999999999999999999999999999876543 333445667899999
Q ss_pred cCchhcccCC----C--CCcccchhhHHHHHHHHhC----------CCCccccCCC-ccccHHHHHHHHhhCCCcccccc
Q 045452 153 IPPEYARQGV----Y--STKSDVFSFGVLLLQIISG----------KRLSMLCGIN-ENLSILEHAYELWKGGKGMEFVD 215 (303)
Q Consensus 153 ~aPE~~~~~~----~--~~~~DiwslG~il~~ll~g----------~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 215 (303)
||||++...- + -..+||||||+|+||++-+ +.||-..-.. +..+.+.... - ...+-.
T Consensus 387 MAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV---C---v~~~RP 460 (513)
T KOG2052|consen 387 MAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV---C---VQKLRP 460 (513)
T ss_pred cChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce---e---ecccCC
Confidence 9999986542 1 1368999999999999752 2444211111 1111111100 0 011111
Q ss_pred ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 216 SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
..............+.++++.||..||..|-|+--+...|.+...
T Consensus 461 ~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 461 NIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 122234445556678999999999999999999999888887653
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=229.83 Aligned_cols=213 Identities=16% Similarity=0.154 Sum_probs=153.0
Q ss_pred HHHHHhcCCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 045452 28 EVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRL 103 (303)
Q Consensus 28 e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 103 (303)
+...+..++|++++++++.+.... ..+++++++. .++.+.+.. ....++..+..++.|++.||+|||+.+
T Consensus 73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 146 (294)
T PHA02882 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG-- 146 (294)
T ss_pred HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 334556679999999999765543 3467788763 456555532 223567888999999999999999998
Q ss_pred CeeecCCCCCcEEECCCCcEEEeccccccccccccc-----ccccceeeccccccCchhcccCCCCCcccchhhHHHHHH
Q 045452 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-----KANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 178 (303)
++||||||+||+++.++.++|+|||++..+..... ........|+..|+|||.+.+..++.++|||||||++|+
T Consensus 147 -iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 147 -ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred -eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999976532211 111122458999999999999999999999999999999
Q ss_pred HHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhc
Q 045452 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 179 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~ 256 (303)
|++|..||.............. ......-...+. .....+..+.+++..||..+|++||++.+|++.|.
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAK-CDFIKRLHEGKI--------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhCCCCCCccccchHHHHHhH-HHHHHHhhhhhh--------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9999999965532221111110 011110000000 00111346889999999999999999999998763
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=228.17 Aligned_cols=211 Identities=24% Similarity=0.338 Sum_probs=165.9
Q ss_pred HHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-CcccCCCHHHHHHHHHHHHHHHHHHHhc
Q 045452 22 FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILDWKKRVHIIEGITQGLLYLQEY 100 (303)
Q Consensus 22 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 100 (303)
...+..|+.+++.++||||+++++++.+....+++|||+++++|.+++... .....+++..++.++.|++.||.+||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 345667899999999999999999999989999999999999998887542 2345689999999999999999999999
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHH
Q 045452 101 SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 101 ~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 180 (303)
| ++|+||+|+||+++. +.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 126 ~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 126 R---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred C---ccccCCChhheEeec-CCEeecccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 8 999999999999975 579999999987653321 1122244678999999998888899999999999999999
Q ss_pred hCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 181 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+|..||.... .......... ... ...+...+.++.++|.+||..+|++||++.++++.
T Consensus 200 ~~~~~~~~~~------~~~~~~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 200 CLAHAFEGQN------FLSVVLRIVE-GPT---------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hCCCCCCCcc------HHHHHHHHHc-CCC---------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 9999984221 1111111111 111 11123344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=241.14 Aligned_cols=227 Identities=24% Similarity=0.307 Sum_probs=178.3
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++|+.||||++.+. ......++++|+.+++++.||+||.+--.|+..+..++|||.+.|. ....|.. ...+.+++.
T Consensus 587 ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD-MLEMILS-sEkgRL~er 664 (888)
T KOG4236|consen 587 KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD-MLEMILS-SEKGRLPER 664 (888)
T ss_pred ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch-HHHHHHH-hhcccchHH
Confidence 68999999999643 2334578999999999999999999999999999999999999654 4444433 245679999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
..+.++.||+.||.|||.++ |+|+||||+|||+... ..+||||||+++.++..... ..-+||+.|.|||++
T Consensus 665 ~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTPAYLaPEVL 738 (888)
T KOG4236|consen 665 ITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTPAYLAPEVL 738 (888)
T ss_pred HHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCccccCHHHH
Confidence 99999999999999999999 9999999999999754 56999999999998765432 235799999999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.++.|...-|+||+|+|+|--++|..||....... +.+....-..+.....+ .+....+||...|
T Consensus 739 rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFMyPp~PW~e-------------is~~AidlIn~LL 803 (888)
T KOG4236|consen 739 RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFMYPPNPWSE-------------ISPEAIDLINNLL 803 (888)
T ss_pred hhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccccCCCchhh-------------cCHHHHHHHHHHH
Confidence 99999999999999999999999999995332111 11111111111111111 1235679999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
+..-++|-|+.+-+.
T Consensus 804 qVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHhcchHhhcc
Confidence 999999999887653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=241.32 Aligned_cols=220 Identities=20% Similarity=0.244 Sum_probs=184.4
Q ss_pred EEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 9 IAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 9 vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
+|+|+++.. +....+.+..|-++|...+.|.||++|-.|.++...|++||-|-||.|...++ .++.++.....-
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLr---dRg~Fdd~tarF 524 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILR---DRGSFDDYTARF 524 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhh---hcCCcccchhhh
Confidence 677777543 34455678889999999999999999999999999999999999999999994 467799999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 165 (303)
++..+++|+.|||..| |++|||||+|++++.+|-+||.|||++..+++ .....+++||+.|.|||++.++..+.
T Consensus 525 ~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~KTwTFcGTpEYVAPEIILnKGHD~ 598 (732)
T KOG0614|consen 525 YVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GRKTWTFCGTPEYVAPEIILNKGHDR 598 (732)
T ss_pred hHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc---CCceeeecCCcccccchhhhccCcch
Confidence 9999999999999999 99999999999999999999999999998865 44567789999999999999999999
Q ss_pred cccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 166 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
++|.||||+++|||++|.+||...+....++.+-...+.+. +. ........++|.+.+..+|.+|
T Consensus 599 avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------~P---------r~I~k~a~~Lik~LCr~~P~ER 663 (732)
T KOG0614|consen 599 AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------FP---------RRITKTATDLIKKLCRDNPTER 663 (732)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh------cc---------cccchhHHHHHHHHHhcCcHhh
Confidence 99999999999999999999976665555544444333322 11 1122356699999999999999
Q ss_pred CC-----HHHHH
Q 045452 246 PS-----MLEVS 252 (303)
Q Consensus 246 ps-----~~~l~ 252 (303)
.- +.+|.
T Consensus 664 LG~~~~gI~DIk 675 (732)
T KOG0614|consen 664 LGYQKGGINDIK 675 (732)
T ss_pred hccccCChHHHH
Confidence 75 55654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=249.05 Aligned_cols=225 Identities=26% Similarity=0.354 Sum_probs=171.0
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-ccCCCHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-RLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~ 82 (303)
.|+.||||.+-.. ......+|+..++.- +|||||++|+.-.+..+.||..|.| ..+|.+++..... .....-..
T Consensus 532 e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~ 607 (903)
T KOG1027|consen 532 EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDID 607 (903)
T ss_pred CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhccccc
Confidence 3778899887433 234567899999988 8999999999999999999999999 5699999965311 11111134
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---C--CcEEEeccccccccccccc-ccccceeeccccccCch
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---D--MKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPE 156 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~--~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE 156 (303)
.+..+.|++.||++||..+ |+||||||+||||+. + ..++|+|||++.++..... ..+.....|+.+|+|||
T Consensus 608 ~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 608 PISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred HHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHH
Confidence 5788999999999999998 999999999999976 3 4589999999998865432 23345567999999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhC-CCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
++.....+.++|||||||++|+.++| ..||+.. .+....+..+......... ..++ +..+||.
T Consensus 685 ~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--------~~R~~NIl~~~~~L~~L~~-----~~d~---eA~dLI~ 748 (903)
T KOG1027|consen 685 QLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--------LERQANILTGNYTLVHLEP-----LPDC---EAKDLIS 748 (903)
T ss_pred HHhccccCcccchhhcCceEEEEecCCccCCCch--------HHhhhhhhcCccceeeecc-----CchH---HHHHHHH
Confidence 99999888999999999999999986 8999632 2222223332221111111 1111 5679999
Q ss_pred hcccCCCCCCCCHHHHH
Q 045452 236 LCVQENPNDRPSMLEVS 252 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~ 252 (303)
+|+.++|..||++.+|+
T Consensus 749 ~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 749 RMLNPDPQLRPSATDVL 765 (903)
T ss_pred HhcCCCcccCCCHHHHh
Confidence 99999999999999994
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=246.35 Aligned_cols=123 Identities=25% Similarity=0.320 Sum_probs=109.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ......+..|+.+++.++|+||+++++++......|+||||+.+++|.+++.. ...+++
T Consensus 27 ~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~---~~~l~~ 103 (669)
T cd05610 27 NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI---YGYFDE 103 (669)
T ss_pred CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh---cCCCCH
Confidence 368999999986432 33456788999999999999999999999999999999999999999998843 345788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||+++
T Consensus 104 ~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999988 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=203.55 Aligned_cols=244 Identities=21% Similarity=0.245 Sum_probs=178.5
Q ss_pred CCCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+++++.||+|..+.++ ........+|+-+++.++|.|||+++++.-.+..+.+|+|||. ..|..+... -++.++.
T Consensus 24 ~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfds--lng~~d~ 100 (292)
T KOG0662|consen 24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS--LNGDLDP 100 (292)
T ss_pred CCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHh--cCCcCCH
Confidence 5789999999987543 3334567899999999999999999999988899999999994 467776632 3566899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
+.+..++.|++.||.++|+.+ ++|||+||+|++++.+|.+|++|||+++.++-... .....+-|.+|++|.++-+
T Consensus 101 ~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr--cysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 101 EIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred HHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeeceeeeeeccCcceeee
Confidence 999999999999999999998 99999999999999999999999999988764321 1222456899999998765
Q ss_pred C-CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCcc---ccccccccCCCC---------hHH
Q 045452 161 G-VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGM---EFVDSFLDDRNS---------SCK 226 (303)
Q Consensus 161 ~-~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~ 226 (303)
. .|+...|+||.|||+.|+.. |.+.|......+....+.+..........+ .+.+-......+ +..
T Consensus 176 akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~l 255 (292)
T KOG0662|consen 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKL 255 (292)
T ss_pred eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhh
Confidence 5 58999999999999999986 555554443333332222222111111111 111111111111 111
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
...-++++.+.|.-+|.+|.++++.++.
T Consensus 256 ns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 256 NSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1235789999999999999999987764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=225.77 Aligned_cols=235 Identities=26% Similarity=0.327 Sum_probs=178.0
Q ss_pred CCCCCEEEEEEccCCC-------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCc
Q 045452 3 LPCGEVIAVKKLSKSS-------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
+...++||+|+-..+. ..-.+...+|.++-+.|.||.||++|+++.-+ ..+|-|+|||+|.+|.-||. .
T Consensus 485 l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK---Q 561 (775)
T KOG1151|consen 485 LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK---Q 561 (775)
T ss_pred cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH---h
Confidence 4567899999863321 11234567899999999999999999999754 57899999999999988884 4
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccc-----ccccee
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLK-----ANTEQV 146 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~-----~~~~~~ 146 (303)
+..+++.....++.||+.||.||.+.. .+|+|.||||.|||+.. .|.+||.|||++..+....+. .....+
T Consensus 562 hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQg 640 (775)
T KOG1151|consen 562 HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQG 640 (775)
T ss_pred hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeeccc
Confidence 667999999999999999999999864 56999999999999954 477999999999988765444 223456
Q ss_pred eccccccCchhccc----CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCC
Q 045452 147 VGTIGYIPPEYARQ----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRN 222 (303)
Q Consensus 147 ~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.||.+|.+||.+.- ...+.++||||+|+|+|..+.|+.||+..-......... .+..... +....
T Consensus 641 AGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN---TIlkAtE--------VqFP~ 709 (775)
T KOG1151|consen 641 AGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN---TILKATE--------VQFPP 709 (775)
T ss_pred CceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh---chhccee--------ccCCC
Confidence 79999999997632 247889999999999999999999997543222111111 1111111 11122
Q ss_pred ChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 045452 223 SSCKLMRCLEIALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 223 ~~~~~~~l~~li~~cl~~dp~~Rps~~~l~ 252 (303)
.+..+.+...+|++||++--++|...-++.
T Consensus 710 KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 710 KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 233345677999999999999999887775
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=247.43 Aligned_cols=231 Identities=26% Similarity=0.370 Sum_probs=190.4
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
-+||||++... .....+++.+|+..|.+|+|||++++++++..+. +-||++|++.|+|.++++. .+..+..+..+.
T Consensus 726 ipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~--hr~~igsq~lLn 802 (1177)
T KOG1025|consen 726 IPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE--HRDNIGSQDLLN 802 (1177)
T ss_pred ceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH--hhccccHHHHHH
Confidence 36799988654 3456688999999999999999999999997765 8899999999999999976 466788999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 165 (303)
|..||++|+.|||++. ++||||-.+|+||..-..+|+.|||++................-.+.|+|-|.+....++.
T Consensus 803 w~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~th 879 (1177)
T KOG1025|consen 803 WCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTH 879 (1177)
T ss_pred HHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCc
Confidence 9999999999999998 9999999999999999999999999998876655454444445577899999999999999
Q ss_pred cccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
++||||+|+.+||++| |..|+...... ...+. ++...+-.+|+..+.+++-++.+||..|+..
T Consensus 880 qSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dl---------le~geRLsqPpiCtiDVy~~mvkCwmid~~~ 943 (1177)
T KOG1025|consen 880 QSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDL---------LEKGERLSQPPICTIDVYMVMVKCWMIDADS 943 (1177)
T ss_pred hhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHH---------HhccccCCCCCCccHHHHHHHHHHhccCccc
Confidence 9999999999999997 77886433222 12222 2222334566667778999999999999999
Q ss_pred CCCHHHHHHhhccCC
Q 045452 245 RPSMLEVSSMLKNET 259 (303)
Q Consensus 245 Rps~~~l~~~L~~~~ 259 (303)
||+++++...+..-.
T Consensus 944 rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 944 RPTFKELAEEFSRMA 958 (1177)
T ss_pred CccHHHHHHHHHHHh
Confidence 999999976665533
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=236.88 Aligned_cols=241 Identities=20% Similarity=0.213 Sum_probs=180.5
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCC------CcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQH------VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
-|..||||+|+.+... .+.=+.|+++|++|+. -|+++++..|.+.+++|||||.+ ..+|.+.|.....+..+
T Consensus 456 r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL 533 (752)
T KOG0670|consen 456 RGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGL 533 (752)
T ss_pred CCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccce
Confidence 4679999999655332 2444579999999953 38999999999999999999998 67899999887777889
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeeccccccCchh
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
....+..++.|+..||..|..+| |+|.||||+||||+++ ..+||||||.+...+...... ..-+..|.|||+
T Consensus 534 ~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEI 606 (752)
T KOG0670|consen 534 HIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEI 606 (752)
T ss_pred eehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccccH----HHHHHhccCcce
Confidence 99999999999999999999999 9999999999999976 458999999997765433221 123678999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH-----HhhCCC-----------------------
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGK----------------------- 209 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~----------------------- 209 (303)
+.+-+|+...|+||+||++|||.||+..|.......-+........ +...+.
T Consensus 607 iLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r 686 (752)
T KOG0670|consen 607 ILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTER 686 (752)
T ss_pred eecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccc
Confidence 9999999999999999999999999998865443332222221110 000000
Q ss_pred ----cccccc------ccc-----cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 210 ----GMEFVD------SFL-----DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 210 ----~~~~~~------~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+..+. +.+ ...........+.+|+.+||..||++|.|..+.+..
T Consensus 687 ~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 687 EKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred eeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 000000 000 111222334578999999999999999999987753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=204.31 Aligned_cols=182 Identities=24% Similarity=0.337 Sum_probs=150.2
Q ss_pred CCCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcC-cCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFD-PIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~ 79 (303)
.++|+.+|+|.++... ....+++.+|+.+..+. .||++|.+||........++.||.| ..||..+-.. ..++..++
T Consensus 68 ~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ip 146 (282)
T KOG0984|consen 68 IQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIP 146 (282)
T ss_pred ccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCc
Confidence 3689999999997653 34566788899888876 8999999999999999999999999 5677666443 23467799
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+-+++..++.||.|||++- .++|||+||+|||++..|+||+||||++..+.++-... ...|-..|+|||.+.
T Consensus 147 E~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt---~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 147 EDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT---MDAGCKPYMAPERIN 221 (282)
T ss_pred hHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH---HhcCCCccCChhhcC
Confidence 9999999999999999999865 49999999999999999999999999987665432221 124567899999875
Q ss_pred c----CCCCCcccchhhHHHHHHHHhCCCCccccC
Q 045452 160 Q----GVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 160 ~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 190 (303)
. ..|+.++||||||+.+.||.+++.||....
T Consensus 222 ~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 222 PELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 3 358899999999999999999999985443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=235.32 Aligned_cols=185 Identities=26% Similarity=0.369 Sum_probs=152.7
Q ss_pred CCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 5 CGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+...+|+|.+++.+ .......+.|-.+|..-.++-||++|-.|.+++++|+||+|++||++-.+| .+.+-+.+.
T Consensus 653 T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLL---IrmgIFeE~ 729 (1034)
T KOG0608|consen 653 TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFEED 729 (1034)
T ss_pred hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHH---HHhccCHHH
Confidence 44455666665432 234456778999999999999999999999999999999999999998888 466778999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccc---cc-ccc-----------------
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA---KE-SLK----------------- 140 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~---~~-~~~----------------- 140 (303)
....++.++.+|+.++|.+| ++||||||+|||||.+|++||.|||++.-+. +. .+.
T Consensus 730 LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~ 806 (1034)
T KOG0608|consen 730 LARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWA 806 (1034)
T ss_pred HHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhc
Confidence 99999999999999999999 9999999999999999999999999985431 00 000
Q ss_pred -------------------cccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc
Q 045452 141 -------------------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 141 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 195 (303)
......+||..|+|||++....++..+|.||.|+|+|+|+.|++||-.....+..
T Consensus 807 d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 807 DISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred cccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence 0012346899999999999999999999999999999999999999655554433
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=227.87 Aligned_cols=217 Identities=23% Similarity=0.257 Sum_probs=173.7
Q ss_pred CCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+.+.+|||+++.+. ....+--+.|-++|... +-|.++++...|..-+.+|+||||+.||+|--.++ .-+.+.+
T Consensus 373 tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ---Q~GkFKE 449 (683)
T KOG0696|consen 373 TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGKFKE 449 (683)
T ss_pred cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH---HhcccCC
Confidence 56789999998663 23344445677777776 67799999999999999999999999999977774 3455788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
....-++.+|+-||-+||+.| |++||||.+||+++.+|++||.|||++..- -.......+++||+.|+|||++..
T Consensus 450 p~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--i~~~~TTkTFCGTPdYiAPEIi~Y 524 (683)
T KOG0696|consen 450 PVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IFDGVTTKTFCGTPDYIAPEIIAY 524 (683)
T ss_pred chhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--ccCCcceeeecCCCcccccceEEe
Confidence 899999999999999999999 999999999999999999999999998642 122334456899999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.+|..++|.||+|+++|||+.|++||......+....+... ....|...+.+..+++...|.+
T Consensus 525 qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-----------------nvsyPKslSkEAv~ickg~ltK 587 (683)
T KOG0696|consen 525 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-----------------NVSYPKSLSKEAVAICKGLLTK 587 (683)
T ss_pred cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-----------------cCcCcccccHHHHHHHHHHhhc
Confidence 99999999999999999999999999655433322222110 1223334455788999999999
Q ss_pred CCCCCC
Q 045452 241 NPNDRP 246 (303)
Q Consensus 241 dp~~Rp 246 (303)
+|.+|.
T Consensus 588 ~P~kRL 593 (683)
T KOG0696|consen 588 HPGKRL 593 (683)
T ss_pred CCcccc
Confidence 999995
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=211.66 Aligned_cols=244 Identities=22% Similarity=0.367 Sum_probs=172.6
Q ss_pred CCCCEEEEEEccCC-Chh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeC--------CeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKS-SAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--------EERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
++|+.||+|+.-.. ... --....+|+.++..|+|+|++.++.+|... ...|+||.+|+. +|..++..
T Consensus 40 n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-- 116 (376)
T KOG0669|consen 40 NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN-- 116 (376)
T ss_pred CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC--
Confidence 57888999876432 222 223456899999999999999988887532 357999999964 67677743
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc--ccccceeecccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~~~~ 151 (303)
....++...+.+++.+++.||.|+|.+. |+|||+|+.|+||+++|.+||+|||+++.+..... ..+...++-|.+
T Consensus 117 ~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLw 193 (376)
T KOG0669|consen 117 RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLW 193 (376)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeee
Confidence 2356889999999999999999999988 99999999999999999999999999977653321 222233566999
Q ss_pred ccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH-----HHHHhhCCCccccccccccC----C
Q 045452 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH-----AYELWKGGKGMEFVDSFLDD----R 221 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~----~ 221 (303)
|++||.+.+. .++++.|+|..|||+.+|+++.+.+...........+.. ..+.|+.-...++..+.... .
T Consensus 194 YrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~ 273 (376)
T KOG0669|consen 194 YRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKG 273 (376)
T ss_pred cCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcc
Confidence 9999977655 589999999999999999999987653332222211111 11222222222222211000 0
Q ss_pred ---------CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 222 ---------NSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 222 ---------~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.+.....+..+|+.+++..||.+|+.+.+++.
T Consensus 274 ~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 274 QKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00011125679999999999999999998863
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=214.63 Aligned_cols=238 Identities=26% Similarity=0.268 Sum_probs=175.0
Q ss_pred CCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCccc
Q 045452 5 CGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.++.||+|++.... ....++..+|+..+..++|+||++++.++.-.. ..|+|||++ ..+|...+. .
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~-----~ 113 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL-----M 113 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH-----H
Confidence 47889999885442 234567788999999999999999999986433 579999999 568888774 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.++-..+..++.|++.|++|||..| |+||||||+||++..+..+||.|||+++.-+.. .....-+.+..|.|||
T Consensus 114 elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 114 ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPE 187 (369)
T ss_pred hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCch
Confidence 3677889999999999999999999 999999999999999999999999999764332 2333345788999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH----------------HHHHhhC------CC-cccc
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELWKG------GK-GMEF 213 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~------~~-~~~~ 213 (303)
++.+..+...+||||+||++.||++|+..|......+.+..... ....... .. ..-+
T Consensus 188 vil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~f 267 (369)
T KOG0665|consen 188 VILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELF 267 (369)
T ss_pred heeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhC
Confidence 99888899999999999999999999988763222121111100 0000000 00 0011
Q ss_pred ccccccC--CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 VDSFLDD--RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+..... ..+.....-+++++.+||..||++|.++.+++..
T Consensus 268 pD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 268 PDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111 1112333457899999999999999999999865
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=200.57 Aligned_cols=237 Identities=19% Similarity=0.253 Sum_probs=177.0
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
..+.+.++||++++.. .+.+.+|+.+++.| .||||++++++..+. ..+.+++||.++.+...+. ..++
T Consensus 60 ~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~ 130 (338)
T KOG0668|consen 60 ITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLT 130 (338)
T ss_pred cCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh------hhhc
Confidence 3678899999998653 36788999999999 599999999998765 4678999999887664444 3377
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
...+..++.+++.||.|+|++| |.|||+||.|++++.. ..++|+|+|++.+.-... .-+-++.+..|..||.+
T Consensus 131 d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKGPELL 204 (338)
T KOG0668|consen 131 DYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELL 204 (338)
T ss_pred hhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc---eeeeeeehhhcCCchhe
Confidence 7889999999999999999999 9999999999999965 559999999998764322 22234668889999977
Q ss_pred cc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCcccc-HH----------HHHHH----------HhhCCCccccccc
Q 045452 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-IL----------EHAYE----------LWKGGKGMEFVDS 216 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~----------~~~~~----------~~~~~~~~~~~~~ 216 (303)
.. ..++..-|+|||||++..|+..+.||.......... .+ .+..+ ..-+.........
T Consensus 205 Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~ 284 (338)
T KOG0668|consen 205 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSR 284 (338)
T ss_pred eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHH
Confidence 54 458899999999999999999999997655432211 10 01000 0001112222223
Q ss_pred cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 217 FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+...........+..+++.+.|..|..+|+|+.|.+..
T Consensus 285 Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 285 FINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 33333344445678899999999999999999998653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=214.05 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=180.2
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||+|++..... ...+++.+|+.++..++|.|++...++..-. +..|+++|.+ ..+|...|. .-.
T Consensus 76 RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIV---SPQ 151 (449)
T KOG0664|consen 76 RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIV---SPQ 151 (449)
T ss_pred CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheec---cCC
Confidence 4799999999854332 3567889999999999999999988876533 2467888988 457777773 455
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.++.+.++-++.||+.||+|||..+ |+||||||.|++++.|..+||||||+++...... .......+-|..|+|||
T Consensus 152 ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAPE 227 (449)
T KOG0664|consen 152 ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAPE 227 (449)
T ss_pred CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhccHH
Confidence 6888999999999999999999998 9999999999999999999999999998654332 22223345689999999
Q ss_pred hcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH-----------------HHhhCCCccccccccc
Q 045452 157 YARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----------------ELWKGGKGMEFVDSFL 218 (303)
Q Consensus 157 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~ 218 (303)
++-+. .|+.+.||||+|||+.||+.++..|...+.....+.+.... ...++.....-..-..
T Consensus 228 iLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLY 307 (449)
T KOG0664|consen 228 LLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLY 307 (449)
T ss_pred HhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCcccee
Confidence 98765 59999999999999999999998887655444333221110 1111111111111122
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhc
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~ 256 (303)
.-..+..-..+...++.+++..||.+|.+.++.+..+.
T Consensus 308 tlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 308 KIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred eecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 22222222345678999999999999999999876643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=208.81 Aligned_cols=225 Identities=20% Similarity=0.305 Sum_probs=173.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
++.+.+|+|+++.. ..+...-.+.|-.+..+- +||.+|-+...|.....+++|.||.+||+|--.++ +...++
T Consensus 273 ~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmq---rqrklp 349 (593)
T KOG0695|consen 273 KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 349 (593)
T ss_pred ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehh---hhhcCc
Confidence 57788999998753 233344455677776665 89999999999999999999999999999866553 345589
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
++....+...|..||.|||+.| |++||||.+|+|++..|++||.|+|++..- -.......+++||+.|.|||++.
T Consensus 350 eeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~--l~~gd~tstfcgtpnyiapeilr 424 (593)
T KOG0695|consen 350 EEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILR 424 (593)
T ss_pred HHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC--CCCCcccccccCCCcccchhhhc
Confidence 9999999999999999999999 999999999999999999999999998642 22345566789999999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCc-cccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE-NLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
+..|....|.|+||++|+||+.|+-||...+... ..+.-.+........ ...+..+ .+-+...+++..|
T Consensus 425 geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-qiriprs---------lsvkas~vlkgfl 494 (593)
T KOG0695|consen 425 GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRIPRS---------LSVKASHVLKGFL 494 (593)
T ss_pred ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-cccccce---------eehhhHHHHHHhh
Confidence 9999999999999999999999999997655432 222222222211111 1111111 1124558999999
Q ss_pred cCCCCCCC
Q 045452 239 QENPNDRP 246 (303)
Q Consensus 239 ~~dp~~Rp 246 (303)
.+||.+|.
T Consensus 495 nkdp~erl 502 (593)
T KOG0695|consen 495 NKDPKERL 502 (593)
T ss_pred cCCcHHhc
Confidence 99999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=198.81 Aligned_cols=196 Identities=34% Similarity=0.522 Sum_probs=168.3
Q ss_pred CCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
+|+.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++.+++|..++... ...++...+
T Consensus 17 ~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~--~~~~~~~~~ 94 (215)
T cd00180 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEI 94 (215)
T ss_pred CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc--cCCCCHHHH
Confidence 4899999999765432 4577899999999999999999999999989999999999999999998432 146889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccccCchhcccC-
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 161 (303)
..++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+||+.+........ ......+...|.+||.....
T Consensus 95 ~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~ 169 (215)
T cd00180 95 LRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKG 169 (215)
T ss_pred HHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccC
Confidence 999999999999999998 999999999999999 89999999999876543321 12224467899999998776
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
..+.++|+|++|++++++ ..+.+++.+|+..+
T Consensus 170 ~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 170 YYSEKSDIWSLGVILYEL------------------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred CCCchhhhHHHHHHHHHH------------------------------------------------HHHHHHHHHHhhCC
Confidence 788899999999999998 25779999999999
Q ss_pred CCCCCCHHHHHHhh
Q 045452 242 PNDRPSMLEVSSML 255 (303)
Q Consensus 242 p~~Rps~~~l~~~L 255 (303)
|++||++.+++..+
T Consensus 202 p~~R~~~~~l~~~~ 215 (215)
T cd00180 202 PEKRPSAKEILEHL 215 (215)
T ss_pred cccCcCHHHHhhCC
Confidence 99999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=227.51 Aligned_cols=236 Identities=19% Similarity=0.105 Sum_probs=143.7
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEE------EEeCCeeeEEEeeCCCCChhhhhcCcCc-----
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGF------CIDSEERMLVYEYMPNKSLDCYLFDPIR----- 74 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~~~~~~lv~e~~~~~sL~~~l~~~~~----- 74 (303)
|..||+|+++..... +....+ .++...+.+++.++.. .......++||+|+.+++|.+++.....
T Consensus 161 ~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~ 236 (566)
T PLN03225 161 EGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236 (566)
T ss_pred CcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHH
Confidence 789999998643221 111111 1122222222222211 2345678999999999999988854210
Q ss_pred ------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeccccccccccccccc
Q 045452 75 ------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKA 141 (303)
Q Consensus 75 ------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~ 141 (303)
........+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++..+.... ..
T Consensus 237 ~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~ 312 (566)
T PLN03225 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NY 312 (566)
T ss_pred HHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-cc
Confidence 011123456789999999999999988 999999999999985 5889999999997653221 12
Q ss_pred ccceeeccccccCchhcccC----------------------CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHH
Q 045452 142 NTEQVVGTIGYIPPEYARQG----------------------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 199 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 199 (303)
......+++.|+|||.+... .++.++|||||||++|+|+++..++... .....
T Consensus 313 ~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-----~~~~~ 387 (566)
T PLN03225 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-----LIQFN 387 (566)
T ss_pred CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-----HHHHH
Confidence 22345678999999965322 2334669999999999999876653211 00000
Q ss_pred HH-------HHHhhCCCccccccccc-cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 200 HA-------YELWKGGKGMEFVDSFL-DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 200 ~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.. ...|............. ............++||.+||..||++|||+.++++.
T Consensus 388 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 388 RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 00 00111000000000000 000011112245689999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=211.05 Aligned_cols=237 Identities=22% Similarity=0.288 Sum_probs=186.6
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhc-----CcCccc
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLF-----DPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~-----~~~~~~ 76 (303)
.+.+.|-+|.++.. ++-....+..|...+..+.|||+..+.+++... ..++.++++..-|+|..++. +.....
T Consensus 312 n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aq 391 (563)
T KOG1024|consen 312 NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQ 391 (563)
T ss_pred chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCcccc
Confidence 33444556666544 233556778888889999999999999998654 57899999999999999987 433455
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.++..++..++.|++.|++|||..+ ++|.||..+|+++++.-.|||+|=.+++.+-..++.......-....||+||
T Consensus 392 tvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE 468 (563)
T KOG1024|consen 392 TVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE 468 (563)
T ss_pred chhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence 6778889999999999999999999 9999999999999999999999999998776666555555555688999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..|+.++|+||||+++|||+| |+.|+... +..+.... ...+ .+-.+|...+.+|+.++.
T Consensus 469 al~n~~yssasDvWsfGVllWELmtlg~~PyaeI------DPfEm~~y-lkdG---------yRlaQP~NCPDeLf~vMa 532 (563)
T KOG1024|consen 469 ALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI------DPFEMEHY-LKDG---------YRLAQPFNCPDELFTVMA 532 (563)
T ss_pred HHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc------CHHHHHHH-Hhcc---------ceecCCCCCcHHHHHHHH
Confidence 9999999999999999999999997 77787322 22222212 2222 122334444558999999
Q ss_pred hcccCCCCCCCCHHHHHHhhccCC
Q 045452 236 LCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
-||+..|++||+.+++...|.+..
T Consensus 533 cCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 533 CCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHhcCcccCCCHHHHHHHHHHHH
Confidence 999999999999999999988754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=217.59 Aligned_cols=242 Identities=21% Similarity=0.225 Sum_probs=159.8
Q ss_pred CCCCEEEEEEccCCChhhHHHH--------------HHHHHHHhcCCCCc-----ceeEEEEEEe--------CCeeeEE
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEF--------------KNEVMLTAKLQHVN-----LIRVLGFCID--------SEERMLV 56 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~--------------~~e~~~l~~l~h~~-----iv~~~~~~~~--------~~~~~lv 56 (303)
..++.||||.++.......+.| ..|+.++.+++|.+ +++++++|.. ....++|
T Consensus 184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV 263 (507)
T PLN03224 184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLV 263 (507)
T ss_pred ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEE
Confidence 3567899999875543333333 34666677776554 4677777653 3468999
Q ss_pred EeeCCCCChhhhhcCcC---------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 045452 57 YEYMPNKSLDCYLFDPI---------------------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115 (303)
Q Consensus 57 ~e~~~~~sL~~~l~~~~---------------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~ni 115 (303)
|||+.+++|.+++.... ....+++..++.++.|++.+|.|||..+ ++||||||+||
T Consensus 264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NI 340 (507)
T PLN03224 264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENL 340 (507)
T ss_pred EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhE
Confidence 99999999999885321 1123456788899999999999999998 99999999999
Q ss_pred EECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC----------------------CCcccchhhH
Q 045452 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY----------------------STKSDVFSFG 173 (303)
Q Consensus 116 l~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------------------~~~~DiwslG 173 (303)
+++.++.+||+|||++..+..... .......+++.|+|||.+..... ..+.|+||+|
T Consensus 341 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 341 LVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred EECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 999999999999999865433211 11111234789999998753221 1246999999
Q ss_pred HHHHHHHhCCC-CccccCC-CccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC---CCCCCH
Q 045452 174 VLLLQIISGKR-LSMLCGI-NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP---NDRPSM 248 (303)
Q Consensus 174 ~il~~ll~g~~-p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~ 248 (303)
|++++|+++.. ||..... .............|........ .....+..+...++|+.+||..+| .+|+|+
T Consensus 420 vil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~-----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa 494 (507)
T PLN03224 420 VLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY-----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSV 494 (507)
T ss_pred HHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC-----CcccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence 99999999875 5532111 1111111111122221111111 111122234568899999999766 789999
Q ss_pred HHHHHh
Q 045452 249 LEVSSM 254 (303)
Q Consensus 249 ~~l~~~ 254 (303)
.++++.
T Consensus 495 ~eaL~H 500 (507)
T PLN03224 495 GQALSH 500 (507)
T ss_pred HHHhCC
Confidence 999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=196.67 Aligned_cols=229 Identities=20% Similarity=0.289 Sum_probs=171.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEE-EEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGF-CIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++.+.+|+|-+... ......|.+|...--.| .|.||+..|++ |...+.+++++||++-|+|..-+. ...+.+.
T Consensus 47 ~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~----~~GigE~ 121 (378)
T KOG1345|consen 47 QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE----AAGIGEA 121 (378)
T ss_pred CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC----cccccHH
Confidence 56788999988554 33457788898877777 68899998876 455668889999999999988773 3558889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--CCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
..++++.|+++|+.|+|+.+ ++|||||.+||||.. ..+|||||||..+..+... ......-.|.+||...
T Consensus 122 ~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 122 NTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCD 193 (378)
T ss_pred HHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHh
Confidence 99999999999999999998 999999999999963 3579999999987654321 1122356899999664
Q ss_pred cC-----CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 160 QG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 160 ~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.. ...+.+|+|.||+++|++++|.+||......+ ...+.+..|.++..+...+.+... +..+..++
T Consensus 194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~~~~P~~F~~f------s~~a~r~F 264 (378)
T KOG1345|consen 194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKNPALPKKFNPF------SEKALRLF 264 (378)
T ss_pred hccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccCccCchhhccc------CHHHHHHH
Confidence 32 24668999999999999999999998544433 233455666666555444433322 23677899
Q ss_pred HhcccCCCCCCCCHHHHHHh
Q 045452 235 LLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~ 254 (303)
++-|.++|++|--+.+...+
T Consensus 265 kk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 265 KKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHhcCCcccccchhHHHHHH
Confidence 99999999999544444433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=202.09 Aligned_cols=241 Identities=21% Similarity=0.254 Sum_probs=172.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-----C---CcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-----H---VNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFD 71 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~ 71 (303)
.+.+.||+|+.+.. ..-.+..+.||.+|++++ | .+||+++++|.. +.++|+|+|++ |.+|..+|..
T Consensus 101 q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~ 178 (590)
T KOG1290|consen 101 QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY 178 (590)
T ss_pred cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH
Confidence 46789999998544 334566788999999982 3 369999999975 45899999999 7888888865
Q ss_pred cCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---------------------------------
Q 045452 72 PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--------------------------------- 118 (303)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~--------------------------------- 118 (303)
. ....++...+++|+.||+.||.|||... +|+|-||||+|||+.
T Consensus 179 s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d 255 (590)
T KOG1290|consen 179 S-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPD 255 (590)
T ss_pred h-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCccccccccc
Confidence 3 3456899999999999999999999854 499999999999990
Q ss_pred --------------------------------------------------------------------------------
Q 045452 119 -------------------------------------------------------------------------------- 118 (303)
Q Consensus 119 -------------------------------------------------------------------------------- 118 (303)
T Consensus 256 ~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~ 335 (590)
T KOG1290|consen 256 ALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLP 335 (590)
T ss_pred ccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCcccc
Confidence
Q ss_pred -C----------------------------------------------------CCcEEEecccccccccccccccccce
Q 045452 119 -E----------------------------------------------------DMKPKISDFGLARIFAKESLKANTEQ 145 (303)
Q Consensus 119 -~----------------------------------------------------~~~~kl~df~~~~~~~~~~~~~~~~~ 145 (303)
. +-.|||+|||-++...... ..
T Consensus 336 ~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-----T~ 410 (590)
T KOG1290|consen 336 IKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF-----TE 410 (590)
T ss_pred ccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhh-----ch
Confidence 0 0014555555554432211 12
Q ss_pred eeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc---cHHHHHHH--------HhhCC-Ccccc
Q 045452 146 VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL---SILEHAYE--------LWKGG-KGMEF 213 (303)
Q Consensus 146 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~--------~~~~~-~~~~~ 213 (303)
.+.|..|+|||++.+..|+..+||||++|++|||+||...|....-.... ..+....+ +..++ ...++
T Consensus 411 DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdF 490 (590)
T KOG1290|consen 411 DIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDF 490 (590)
T ss_pred hhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhh
Confidence 34588999999999999999999999999999999999999766543321 11111111 11111 11111
Q ss_pred ccc------------------cc-cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 VDS------------------FL-DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~~~------------------~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+.. +. ....+.....++.+++.-||+.+|++||||.+.++.
T Consensus 491 Fnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 491 FNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred hccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 110 00 112344555678999999999999999999998753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=238.57 Aligned_cols=196 Identities=18% Similarity=0.185 Sum_probs=135.4
Q ss_pred cCCC-CcceeEEEEE-------EeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 045452 34 KLQH-VNLIRVLGFC-------IDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTI 105 (303)
Q Consensus 34 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 105 (303)
.++| +||+++++.| ......++++|++ +++|.+++.. ....+++..++.++.||+.||+|||++| |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5777788876 2334567788887 6799999953 2355899999999999999999999998 9
Q ss_pred eecCCCCCcEEECCCCc-------------------EEEecccccccccccc--------------cccccceeeccccc
Q 045452 106 IHRDLKASNILLGEDMK-------------------PKISDFGLARIFAKES--------------LKANTEQVVGTIGY 152 (303)
Q Consensus 106 ~H~dl~p~nil~~~~~~-------------------~kl~df~~~~~~~~~~--------------~~~~~~~~~~~~~y 152 (303)
+||||||+|||++..+. +|++|||+++...... .........|++.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 4555555554321000 00001113468889
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||++.+..++.++|||||||++|||++|..|+.... ......... . ..... .....+..+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~----~----~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR----V----LPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh----h----cChhh-----hhcCHHHHH
Confidence 99999998899999999999999999999887753111 011101000 0 00000 001124568
Q ss_pred HHHhcccCCCCCCCCHHHHHH
Q 045452 233 IALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~ 253 (303)
++.+||.++|.+||++.++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 899999999999999999975
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=215.59 Aligned_cols=230 Identities=22% Similarity=0.309 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+..|+|+++......+.-+++|+-+++..+|+||+.+++.+......|+.||||.||+|.+.-+ -.+++++.++
T Consensus 38 ~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~---~Tgplselqi 114 (829)
T KOG0576|consen 38 RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH---VTGPLSELQI 114 (829)
T ss_pred ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee---ecccchhHHH
Confidence 4688999999988777778888899999999999999999999999999999999999999988763 4577999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc---cc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA---RQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~ 160 (303)
...++..+.+++|||.+| -+|||||-.||++++.|.+|+.|||.+..+... -.....+.||+.|+|||+. ..
T Consensus 115 ayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverk 189 (829)
T KOG0576|consen 115 AYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERK 189 (829)
T ss_pred HHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhc
Confidence 999999999999999999 899999999999999999999999998766532 2333447899999999965 45
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..|...+|||++|+...|+--.++|-... -......-....+..+. ..........-+-++++.||.+
T Consensus 190 ggynqlcdiwa~gitAiel~eLqpplfdl------hpmr~l~LmTkS~~qpp------~lkDk~kws~~fh~fvK~altk 257 (829)
T KOG0576|consen 190 GGYNQLCDIWALGITAIELGELQPPLFDL------HPMRALFLMTKSGFQPP------TLKDKTKWSEFFHNFVKGALTK 257 (829)
T ss_pred ccccccccccccccchhhhhhcCCccccc------chHHHHHHhhccCCCCC------cccCCccchHHHHHHHHHHhcC
Confidence 67899999999999999998888773211 11111111111111111 1112223344677999999999
Q ss_pred CCCCCCCHHHHHH
Q 045452 241 NPNDRPSMLEVSS 253 (303)
Q Consensus 241 dp~~Rps~~~l~~ 253 (303)
+|++|||++.+++
T Consensus 258 npKkRptaeklL~ 270 (829)
T KOG0576|consen 258 NPKKRPTAEKLLQ 270 (829)
T ss_pred CCccCCChhhhee
Confidence 9999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=186.25 Aligned_cols=167 Identities=19% Similarity=0.120 Sum_probs=123.1
Q ss_pred CChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc
Q 045452 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN 142 (303)
Q Consensus 63 ~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 142 (303)
|+|.+++.. .+..+++..++.++.||+.||+|||+.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888853 2456999999999999999999999876 999999999999999 99887654321
Q ss_pred cceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCC
Q 045452 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRN 222 (303)
Q Consensus 143 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
..|+..|+|||++.+..++.++|||||||++|+|++|..||...... ................ . ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~----~---~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDP----R---DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCc----c---cccc
Confidence 24789999999999999999999999999999999999998533211 1111111111110000 0 0001
Q ss_pred ChHHHH--HHHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 223 SSCKLM--RCLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 223 ~~~~~~--~l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+..... ++.+++.+||..+|.+||++.++++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111222 588999999999999999999999886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=188.19 Aligned_cols=176 Identities=36% Similarity=0.500 Sum_probs=151.5
Q ss_pred CCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC-CCHHH
Q 045452 5 CGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI-LDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~-~~~~~ 82 (303)
+++.+|+|.+...... ..+.+.+|+..++.++|+|++++++++......++++|++.+++|.+++... .. +++..
T Consensus 23 ~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~ 99 (225)
T smart00221 23 TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK---GGKLSEEE 99 (225)
T ss_pred CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc---ccCCCHHH
Confidence 4789999999766544 6778999999999999999999999999889999999999999999988532 22 78999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc-ccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA-RQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~ 161 (303)
+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ........+...|++||.+ ...
T Consensus 100 ~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~ 175 (225)
T smart00221 100 ARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLKTVKGTPFYLAPEVLLGGK 175 (225)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cccccceeccCCcCCHhHhcCCC
Confidence 9999999999999999998 9999999999999999999999999987664332 1122234567889999988 666
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCcc
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSM 187 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~ 187 (303)
.++.++|+|+||+++++|++|+.||.
T Consensus 176 ~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 176 GYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 77889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=208.32 Aligned_cols=173 Identities=23% Similarity=0.346 Sum_probs=146.5
Q ss_pred CCCEEEEEEccCCCh---hhHH-----HHHHHHHHHhcCC---CCcceeEEEEEEeCCeeeEEEeeC-CCCChhhhhcCc
Q 045452 5 CGEVIAVKKLSKSSA---QGFE-----EFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYM-PNKSLDCYLFDP 72 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~---~~~~-----~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~ 72 (303)
+...|+||.+.+..- .+.+ .+-.|+.+|..++ |+||++++++|++++.+||+||.- +|.+|.++|.
T Consensus 585 n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE-- 662 (772)
T KOG1152|consen 585 NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE-- 662 (772)
T ss_pred cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhh--
Confidence 467789998865421 1111 2346999999996 999999999999999999999975 5678888884
Q ss_pred CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 73 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
-+..+++...+.++.||+.|+++||+.| |+|||||-+|+.++.+|-+||+|||.+....+.. ...+.||..|
T Consensus 663 -~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~ 734 (772)
T KOG1152|consen 663 -FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDY 734 (772)
T ss_pred -ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccc
Confidence 4667999999999999999999999999 9999999999999999999999999987665443 3347799999
Q ss_pred cCchhcccCCC-CCcccchhhHHHHHHHHhCCCCcc
Q 045452 153 IPPEYARQGVY-STKSDVFSFGVLLLQIISGKRLSM 187 (303)
Q Consensus 153 ~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~ 187 (303)
.|||++.+..| ....|||+||+++|.++....||-
T Consensus 735 aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 735 AAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999998876 456899999999999999888873
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=188.50 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=173.4
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
..+.||+|.+...+ ...++..|++++..+ .+.||+++.+.+.+.+...+|+||++...-.++... ++...+
T Consensus 63 ~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i 134 (418)
T KOG1167|consen 63 KRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEI 134 (418)
T ss_pred ccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc------CCHHHH
Confidence 57899999987654 335688999999999 788999999999999999999999998888777732 678899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeccccccccccc-------c-------c---------
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKE-------S-------L--------- 139 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~-------~-------~--------- 139 (303)
..+++.++.||+++|..| |+||||||.|++.+.. +.-.|+|||++...... . .
T Consensus 135 ~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~ 211 (418)
T KOG1167|consen 135 RWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQ 211 (418)
T ss_pred HHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccc
Confidence 999999999999999999 9999999999999854 67899999999721100 0 0
Q ss_pred -------------------ccccceeeccccccCchhc-ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHH
Q 045452 140 -------------------KANTEQVVGTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 199 (303)
Q Consensus 140 -------------------~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 199 (303)
........||++|+|||++ .....+++.||||.|+|+..++++..||..+...-. .+.
T Consensus 212 ~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~--al~ 289 (418)
T KOG1167|consen 212 SVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDAD--ALA 289 (418)
T ss_pred ccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccc--hHH
Confidence 0001123589999999976 456678899999999999999999999865432211 111
Q ss_pred HHHH-----------HhhCC-------C---cccc--------cccc--------ccCCCChHHHHHHHHHHHhcccCCC
Q 045452 200 HAYE-----------LWKGG-------K---GMEF--------VDSF--------LDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 200 ~~~~-----------~~~~~-------~---~~~~--------~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+... ...+. . ..+. .... ......+..+..+++++.+|+..||
T Consensus 290 ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np 369 (418)
T KOG1167|consen 290 EIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNP 369 (418)
T ss_pred HHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCCh
Confidence 1000 00000 0 0000 0011 1112223334478999999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
.+|.|+++.++.
T Consensus 370 ~kRitAEeALkH 381 (418)
T KOG1167|consen 370 QKRITAEDALKH 381 (418)
T ss_pred hhcccHHHHhcC
Confidence 999999998754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-24 Score=199.18 Aligned_cols=232 Identities=19% Similarity=0.229 Sum_probs=164.3
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHH--HhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVML--TAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..|. |+||++-... .-....|.++++- ...+++||++.+.-........|+|-+|.. -+|.|.| ..+..+..
T Consensus 45 ~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRl---STRPFL~~ 119 (1431)
T KOG1240|consen 45 REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRL---STRPFLVL 119 (1431)
T ss_pred CCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhh---ccchHHHH
Confidence 3455 8999874433 3344444444433 344599999998888777777889999984 5888888 46777888
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccc-----ccccccccceeeccccccCc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA-----KESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~-----~~~~~~~~~~~~~~~~y~aP 155 (303)
-+.+.++.|++.||..+|..| |+|||||.+|||++.-+.+.|.||......- ...+.....+.....+|.||
T Consensus 120 iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAP 196 (1431)
T KOG1240|consen 120 IEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAP 196 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecCh
Confidence 899999999999999999999 9999999999999999999999998764431 11222223333456699999
Q ss_pred hhcccC-----------CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCC
Q 045452 156 EYARQG-----------VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNS 223 (303)
Q Consensus 156 E~~~~~-----------~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
|.+... ..+++-||||+||++.||++ |++||... ++.. +..++ .......+...
T Consensus 197 ERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a----Yr~~~--~~~~e~~Le~I-- 262 (1431)
T KOG1240|consen 197 ERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA----YRSGN--ADDPEQLLEKI-- 262 (1431)
T ss_pred HhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh----HhccC--ccCHHHHHHhC--
Confidence 987542 15678899999999999987 67777421 1111 11111 00111111111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
....++++|..|++.||++|.++++.++.-++..
T Consensus 263 --ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 263 --EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred --cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1125789999999999999999999998865544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-24 Score=198.54 Aligned_cols=214 Identities=23% Similarity=0.285 Sum_probs=162.7
Q ss_pred HHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 045452 25 FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT 104 (303)
Q Consensus 25 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 104 (303)
+..|+-+-..|.|+|++.....+.+.....-.||||++ +|..++. ....+....+--++.|++.|++|+|.+|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG--- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---
Confidence 55667777778999998877777666555555999998 9988883 3346888899999999999999999999
Q ss_pred eeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeeccccccCchhcccCCCCC-cccchhhHHHHHHHHh
Q 045452 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPPEYARQGVYST-KSDVFSFGVLLLQIIS 181 (303)
Q Consensus 105 i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~ 181 (303)
+.|||+|++|++++.+|.+||+|||.+..+...... ......+|+..|+|||++.+..|++ ..||||.|+++..|++
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 999999999999999999999999998765433222 3445578999999999999988876 5899999999999999
Q ss_pred CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 182 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
|+.||..+...+.... ..-........ .-........+.+.+.+|.+||+.||.+|.|+++|++
T Consensus 521 ~~~~Wk~a~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSFK-----TNNYSDQRNIF---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCCccccccccccchh-----hhccccccccc---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 9999987665543320 00000000000 0011111222346789999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=173.29 Aligned_cols=220 Identities=25% Similarity=0.376 Sum_probs=164.7
Q ss_pred HhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 045452 32 TAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111 (303)
Q Consensus 32 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~ 111 (303)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....+.++|+.|+.|+|... -.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999999999999999999999999865 3556889999999999999999999876 13999999
Q ss_pred CCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC-------CCCcccchhhHHHHHHHHhCCC
Q 045452 112 ASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-------YSTKSDVFSFGVLLLQIISGKR 184 (303)
Q Consensus 112 p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~g~~ 184 (303)
..|++++....+|+.|||+.....................|.|||.+.+.. .+.+.|+||+|++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999986653211111111122467899999887642 4667999999999999999999
Q ss_pred CccccCCCccc-cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 185 LSMLCGINENL-SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 185 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
||......... +.+..... .. .....+...... ....++..++..||..+|.+||+++.+...++......
T Consensus 157 ~~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCChHHHHHHHHh---cC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99765544333 22222222 11 111111111100 12226889999999999999999999998888876543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-21 Score=166.02 Aligned_cols=239 Identities=19% Similarity=0.163 Sum_probs=175.9
Q ss_pred CEEEEEEccCCChhhHHHHHHHHHHHhcCC----CCcceeEEEEE-EeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 7 EVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ----HVNLIRVLGFC-IDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 7 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
+.+|+|............+..|..++..+. ..++..+++.. ......++||+.+ |.+|.++..... ...++..
T Consensus 45 ~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~ 122 (322)
T KOG1164|consen 45 KEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRK 122 (322)
T ss_pred eeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHh
Confidence 468888876543332226778888888886 35899999998 4677889999998 889999775433 5679999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-----CcEEEecccccc--ccccccc----ccc--cceeec
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-----MKPKISDFGLAR--IFAKESL----KAN--TEQVVG 148 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-----~~~kl~df~~~~--~~~~~~~----~~~--~~~~~~ 148 (303)
....++.|++.+|++||+.| ++||||||+|+++... ..++|.|||+++ .+..... ..+ ...+.|
T Consensus 123 T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rG 199 (322)
T KOG1164|consen 123 TVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRG 199 (322)
T ss_pred HHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCC
Confidence 99999999999999999999 9999999999999865 359999999998 4322211 111 234569
Q ss_pred cccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
|..|+++....+...+.+.|+||++.++.+++.|..||....................... .....+.
T Consensus 200 T~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~ 267 (322)
T KOG1164|consen 200 TLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR------------FGDLKPE 267 (322)
T ss_pred ccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc------------ccCCChH
Confidence 9999999999999999999999999999999999999965544333222221111111000 1111223
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
.+.++...+-..+..++|....+...|++.....
T Consensus 268 ~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 268 EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 4556666666689999999999999887766554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=163.34 Aligned_cols=230 Identities=20% Similarity=0.315 Sum_probs=169.6
Q ss_pred CcCCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 1 GVLPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 1 g~l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
|+|+ |..++.|+++-. .......|.+|.-.++.+.||||+.+++.|....++.++..|++.|||...++.. .....
T Consensus 209 grwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~-t~vvv 286 (448)
T KOG0195|consen 209 GRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ-TSVVV 286 (448)
T ss_pred cccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC-ccEEE
Confidence 4555 445566777533 3334457888999999999999999999999999999999999999999999763 45567
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEe--cccccccccccccccccceeeccccccCch
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS--DFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~--df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+..+..+++.+++.|++|||+... -+.-.-|+...++++++-+.+|. |--++. ......-.+.|++||
T Consensus 287 d~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf---------qe~gr~y~pawmspe 356 (448)
T KOG0195|consen 287 DHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF---------QEVGRAYSPAWMSPE 356 (448)
T ss_pred ecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee---------eccccccCcccCCHH
Confidence 788999999999999999999762 14445688899999998776654 322211 111123478999999
Q ss_pred hcccCCCC---CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 157 YARQGVYS---TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 157 ~~~~~~~~---~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
.++.++.+ .++|+|||++++|||.|...||..... ++-..+..- ..++..-++..+..+-.|
T Consensus 357 alqrkped~n~raadmwsfaillwel~trevpfadlsp------mecgmkial---------eglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 357 ALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP------MECGMKIAL---------EGLRVHIPPGISRHMNKL 421 (448)
T ss_pred HHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc------hhhhhhhhh---------ccccccCCCCccHHHHHH
Confidence 99877643 479999999999999999999953332 221222221 222333344445577899
Q ss_pred HHhcccCCCCCCCCHHHHHHhhcc
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+.-|+..||.+||.+..++-.|+.
T Consensus 422 m~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHH
Confidence 999999999999999998877764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-20 Score=159.43 Aligned_cols=241 Identities=27% Similarity=0.340 Sum_probs=175.6
Q ss_pred CEEEEEEccCCChh---hHHHHHHHHHHHhcCCCC-cceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 7 EVIAVKKLSKSSAQ---GFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 7 ~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+.+++|.+...... ....+.+|+..++.+.|+ +++++++++......+++++++.++++.+++........+....
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 102 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence 46788888654322 467889999999999888 79999999977777899999999999986663311113688999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeccccccccccccccc----ccceeeccccccCchh
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLKA----NTEQVVGTIGYIPPEY 157 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~ 157 (303)
...++.|++.++.++|..+ ++|||+||+||+++..+ .++++|||.+..+....... ......++..|++||.
T Consensus 103 ~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~ 179 (384)
T COG0515 103 ALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179 (384)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHH
Confidence 9999999999999999999 99999999999999988 69999999987554332221 2345678999999999
Q ss_pred ccc---CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 158 ARQ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 158 ~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
+.+ .......|+|++|++++++++|..||...... ................ .................+.+++
T Consensus 180 ~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 255 (384)
T COG0515 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSNPELISKAASDLL 255 (384)
T ss_pred hcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCccccchhhHHHHHHH
Confidence 987 57888999999999999999999996433321 0011111111111100 0000000000011223577999
Q ss_pred HhcccCCCCCCCCHHHHHHh
Q 045452 235 LLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~ 254 (303)
..|+..+|..|.+..+....
T Consensus 256 ~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 256 KKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCchhcCCHHHHhhc
Confidence 99999999999998887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=155.21 Aligned_cols=236 Identities=17% Similarity=0.178 Sum_probs=172.3
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
|-++++||||.-...+ ...++..|.+.++.| ..++|..+|-|...+.+-.||++++ |.||.|+.. ..+..++..
T Consensus 50 l~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD--~CgR~FSvK 124 (449)
T KOG1165|consen 50 LYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFD--LCGRRFSVK 124 (449)
T ss_pred cccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHH--HhcCcccHH
Confidence 4578999999975543 335788899999998 7899999998888888889999998 889988874 246679999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-----CcEEEecccccccccccccccc-----cceeecccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-----MKPKISDFGLARIFAKESLKAN-----TEQVVGTIG 151 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-----~~~kl~df~~~~~~~~~~~~~~-----~~~~~~~~~ 151 (303)
.+..++.|++.-++++|+.+ +|+|||||+|+||..- ..+.++|||++........... .....||.+
T Consensus 125 TV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTAR 201 (449)
T KOG1165|consen 125 TVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTAR 201 (449)
T ss_pred hHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccccccee
Confidence 99999999999999999999 9999999999999754 3489999999987654332221 222468999
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
||+-....+...+...|+-|||=++++.+-|..||....-....+..+..-+........++... .+.++.
T Consensus 202 YMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g---------~P~efa 272 (449)
T KOG1165|consen 202 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEG---------FPEEFA 272 (449)
T ss_pred eeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhc---------CHHHHH
Confidence 99999999999999999999999999999999999755433333322222221111111111111 122444
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhh
Q 045452 232 EIALLCVQENPNDRPSMLEVSSML 255 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L 255 (303)
..+.-.-..+..+-|..+-+..-+
T Consensus 273 ~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 273 TYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred HHHHHHHhcCcccCCCHHHHHHHH
Confidence 444444455666666666554433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=161.20 Aligned_cols=140 Identities=18% Similarity=0.217 Sum_probs=106.3
Q ss_pred CCCEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCccee-EEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 5 CGEVIAVKKLSKS-----SAQGFEEFKNEVMLTAKLQHVNLIR-VLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~g~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
+|+.||||++... .......+.+|++++++++|+|++. +++ .+..++||||+.|++|.. +. ..
T Consensus 43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~~---~~--- 111 (365)
T PRK09188 43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHL-AR---PH--- 111 (365)
T ss_pred CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHH-hC---cc---
Confidence 6788899986432 2234567899999999999999985 443 246799999999999852 21 11
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEECCCCcEEEecccccccccccccccc------cceeecccc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL-KASNILLGEDMKPKISDFGLARIFAKESLKAN------TEQVVGTIG 151 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl-~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~------~~~~~~~~~ 151 (303)
. ...++.+++.+|.+||+.| |+|||| ||+|||++.++.++|+|||++..+........ .....++..
T Consensus 112 ~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~ 185 (365)
T PRK09188 112 G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKR 185 (365)
T ss_pred c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCc
Confidence 1 1467899999999999998 999999 99999999999999999999987654321111 123456778
Q ss_pred ccCchhcccC
Q 045452 152 YIPPEYARQG 161 (303)
Q Consensus 152 y~aPE~~~~~ 161 (303)
|.|||.+...
T Consensus 186 ~~~pe~~~~~ 195 (365)
T PRK09188 186 TYAPDALTPR 195 (365)
T ss_pred cCCcccCChh
Confidence 9999988543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=148.43 Aligned_cols=248 Identities=17% Similarity=0.173 Sum_probs=185.9
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
..+|+.||||.-...... .++.-|..+++.|+ ..+|..+..+..+...-.+||+.+ |.||.+++.- ....++..
T Consensus 37 i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf--C~R~ftmk 111 (341)
T KOG1163|consen 37 ITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF--CSRRFTMK 111 (341)
T ss_pred ccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHH--HhhhhhHH
Confidence 468999999997544322 35667889999995 468888888888888889999998 8899988753 35568899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEecccccccccccccc-----cccceeecccccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLK-----ANTEQVVGTIGYI 153 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~---~~~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~y~ 153 (303)
+++-++.|++.-++|+|..+ ++||||||+|+|..-+ ..+.++|||++..+...... .......||.+|.
T Consensus 112 TvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYA 188 (341)
T KOG1163|consen 112 TVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYA 188 (341)
T ss_pred hHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeeh
Confidence 99999999999999999999 9999999999999644 45999999999876433221 1122346899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
+-....+...+...|+-|+|.++.++.-|..||.........+..+...+..-......+. ...+.++.-.
T Consensus 189 SinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC---------~G~P~EF~my 259 (341)
T KOG1163|consen 189 SINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLC---------KGFPAEFAMY 259 (341)
T ss_pred hhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHh---------CCCcHHHHHH
Confidence 9888877778889999999999999999999997655444444444333322222211111 1122356677
Q ss_pred HHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKK 267 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 267 (303)
+.-|-..-.++-|....+.+.+.-+...+.....
T Consensus 260 l~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d 293 (341)
T KOG1163|consen 260 LNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYD 293 (341)
T ss_pred HHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCC
Confidence 8888888888889888888887777766665554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=155.86 Aligned_cols=198 Identities=21% Similarity=0.244 Sum_probs=139.8
Q ss_pred CCCcceeEEEEEEe---------------------------CCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHH
Q 045452 36 QHVNLIRVLGFCID---------------------------SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIE 88 (303)
Q Consensus 36 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~ 88 (303)
+|||||+++++|.+ ...+|+||..+ ..+|..++- ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence 69999999998754 23578999987 458888883 33355667778899
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCcEEEC----CCCcEEEecccccccccccccc----cccceeeccccccCchhccc
Q 045452 89 GITQGLLYLQEYSRLTIIHRDLKASNILLG----EDMKPKISDFGLARIFAKESLK----ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 89 ~i~~~l~~lh~~~~~~i~H~dl~p~nil~~----~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~ 160 (303)
|+++|+.|||++| |.|||+|.+|||+. +-..+.++|||.+....+.... ...-...|+-..+|||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999994 3345899999998665443211 11122347889999998865
Q ss_pred CC------CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 161 GV------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 161 ~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+ .-.++|.|+.|-+.||++....||-.-+.. .++...+.... -...+...+..+++++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Yqe~q--------------LPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTYQESQ--------------LPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhhhhhh--------------CCCCcccCChHHHHHH
Confidence 43 124899999999999999999998542221 11111111111 1122233334688999
Q ss_pred HhcccCCCCCCCCHHHHHHhhc
Q 045452 235 LLCVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~ 256 (303)
...|+.||++|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999998766554443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=153.01 Aligned_cols=212 Identities=20% Similarity=0.227 Sum_probs=133.2
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCC----------CcceeEEEEEEe---------C---C-----ee
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQH----------VNLIRVLGFCID---------S---E-----ER 53 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h----------~~iv~~~~~~~~---------~---~-----~~ 53 (303)
.+|+.+|+|.+... ....++.+++|......+.+ -.++..++.... . . +.
T Consensus 35 ~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~ 114 (288)
T PF14531_consen 35 ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNR 114 (288)
T ss_dssp TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESE
T ss_pred cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehh
Confidence 57899999987432 22356788888776666432 233333333321 1 1 34
Q ss_pred eEEEeeCCCCChhhhhcC---c-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccc
Q 045452 54 MLVYEYMPNKSLDCYLFD---P-IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 54 ~lv~e~~~~~sL~~~l~~---~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~ 129 (303)
+++|+-+ .++|.+++.. . .....+....++.+..|++..+++||..| ++|+||+|+|++++.+|.++|+||+
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChH
Confidence 6788887 5688777532 1 11233445566777899999999999999 9999999999999999999999998
Q ss_pred ccccccccccccccceeeccccccCchhcccC--------CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH
Q 045452 130 LARIFAKESLKANTEQVVGTIGYIPPEYARQG--------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 201 (303)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 201 (303)
.....+..... ...+..|.|||..... .++.+.|.|+||+++|.|+++..||...........
T Consensus 191 ~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 191 SLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 87665432211 1234779999976442 367889999999999999999999964432221111
Q ss_pred HHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 202 YELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
.-..+. ..++.+..||..+|+.||.+|
T Consensus 262 ----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 011222 455678899999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.4e-20 Score=148.09 Aligned_cols=148 Identities=15% Similarity=0.200 Sum_probs=110.1
Q ss_pred CCCEEEEEEccCCChhhH---HH------HHHHHHHHhcCCCCcceeEEEEEEeC--------CeeeEEEeeCCCCChhh
Q 045452 5 CGEVIAVKKLSKSSAQGF---EE------FKNEVMLTAKLQHVNLIRVLGFCIDS--------EERMLVYEYMPNKSLDC 67 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~---~~------~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~sL~~ 67 (303)
++..+|||.+++...... +. +.+|+..+.+++|++|..+.+++... ...+++|||++|.+|.+
T Consensus 53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~ 132 (232)
T PRK10359 53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND 132 (232)
T ss_pred CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence 466899999975533222 22 67899999999999999999886643 35789999999999977
Q ss_pred hhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee
Q 045452 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
+.. +++ ....+++.++..+|..| ++|||++|.||+++.+| ++++|||............
T Consensus 133 ~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------ 191 (232)
T PRK10359 133 MPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------ 191 (232)
T ss_pred hhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------
Confidence 631 222 24568999999999999 99999999999999988 9999999875432111000
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHh
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 181 (303)
.+.....+..++|+|+||+.+..+..
T Consensus 192 --------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 192 --------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred --------HHHHHhHhcccccccceeEeehHHHH
Confidence 02333445678999999998876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-20 Score=163.87 Aligned_cols=222 Identities=21% Similarity=0.250 Sum_probs=171.7
Q ss_pred CCCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
-+.|+.+|+|.++.... ........|-.++...+ ||.++++.-.+..+...++++++..||.|...+. ....+.
T Consensus 19 ~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~---~~~~f~ 95 (612)
T KOG0603|consen 19 ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS---KEVMFD 95 (612)
T ss_pred ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccc---cCCchH
Confidence 35677888888865432 12225566788888885 9999999999999999999999999998876663 455677
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+.....+...++-++.++|+.+ ++|+|+|++||+++.+|++++.|||.++..-..... +|+..|+|||++.
T Consensus 96 ~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~ 166 (612)
T KOG0603|consen 96 ELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN 166 (612)
T ss_pred HHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh
Confidence 8888889999999999999999 999999999999999999999999998765432222 7899999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
.....+|.||+|+++++|++|..||.. +....+.. .....+......+.+++..++.
T Consensus 167 --gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~-----------~~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 167 --GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILK-----------AELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhh-----------hccCCchhhhHHHHHHHHHHHh
Confidence 457899999999999999999999964 11111111 0112233344567899999999
Q ss_pred CCCCCCCCH--HHHHHhhccCC
Q 045452 240 ENPNDRPSM--LEVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rps~--~~l~~~L~~~~ 259 (303)
.+|..|.-. ..+.+..+...
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f 245 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEF 245 (612)
T ss_pred hCHHHHhccCcchhHHHhccch
Confidence 999999855 45555555443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-19 Score=142.99 Aligned_cols=124 Identities=19% Similarity=0.147 Sum_probs=93.3
Q ss_pred cCCCCCEEEEEEccCCChh--h-------H-----------------HHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeE
Q 045452 2 VLPCGEVIAVKKLSKSSAQ--G-------F-----------------EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 55 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 55 (303)
+.++|+.||||+++..... . . .....|+..+.++.++++.....+.. ...++
T Consensus 17 ~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~--~~~~i 94 (190)
T cd05147 17 TTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL--KSHVL 94 (190)
T ss_pred ECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe--cCCEE
Confidence 4468999999999654211 1 1 12234999999998777644333322 22389
Q ss_pred EEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCcEEECCCCcEEEecccccccc
Q 045452 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-QEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF 134 (303)
Q Consensus 56 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~ 134 (303)
||||++|+++..... ....++...+..++.|++.+|.++ |..| ++||||||+||+++ ++.++|+|||++...
T Consensus 95 VmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 95 VMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999998877654431 234688899999999999999999 6888 99999999999998 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-20 Score=160.19 Aligned_cols=174 Identities=26% Similarity=0.360 Sum_probs=130.5
Q ss_pred eeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccc
Q 045452 52 ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 52 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~ 131 (303)
.++|.|++|...+|.+++.........++...+.|+.|++.++.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999765566678888999999999999999 66 999999999999999999999999998
Q ss_pred ccccccc----cccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhh
Q 045452 132 RIFAKES----LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWK 206 (303)
Q Consensus 132 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 206 (303)
....... .........|+.+|++||.+.+..|+.++|||+||++++|++. -...+... . .....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------~-t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------A-TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------H-hhhhhh
Confidence 7665433 2233445679999999999999999999999999999999988 22221100 0 001111
Q ss_pred CCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHH
Q 045452 207 GGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLE 250 (303)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 250 (303)
.+..+ ..+.. ..+ +-+.|+.+++...|.+||++.+
T Consensus 474 ~g~ip---~~~~~-d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIP---PEFLQ-DYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCC---hHHhh-cCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 11111 11111 111 2348999999999999995443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.2e-18 Score=135.21 Aligned_cols=170 Identities=19% Similarity=0.147 Sum_probs=120.8
Q ss_pred CCCEEEEEEccCCChh----hHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 5 CGEVIAVKKLSKSSAQ----GFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+.+++.+.+.....- ....+.+|++++++| +|+++++++++ +..+++|+|+.|.+|...+. .
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~----~---- 91 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP----R---- 91 (218)
T ss_pred CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh----h----
Confidence 4667777777544221 122578999999999 45789999886 34699999999988865431 1
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEECCCCcEEEecccccccccccccc----cc-------cceee
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDL-KASNILLGEDMKPKISDFGLARIFAKESLK----AN-------TEQVV 147 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl-~p~nil~~~~~~~kl~df~~~~~~~~~~~~----~~-------~~~~~ 147 (303)
....++.+++.+|.++|..| |+|||| ||.||+++.++.++|+|||++......... .. .....
T Consensus 92 --~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~ 166 (218)
T PRK12274 92 --GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRM 166 (218)
T ss_pred --hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHh
Confidence 11357889999999999999 999999 799999999999999999999755432211 00 11122
Q ss_pred ccccccCchhcccC-CCC-CcccchhhHHHHHHHHhCCCCccccCC
Q 045452 148 GTIGYIPPEYARQG-VYS-TKSDVFSFGVLLLQIISGKRLSMLCGI 191 (303)
Q Consensus 148 ~~~~y~aPE~~~~~-~~~-~~~DiwslG~il~~ll~g~~p~~~~~~ 191 (303)
.++.|+.|+...-- ..+ ...+.++.|+-+|.++|+..+....+.
T Consensus 167 y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 167 YCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 45667777633221 122 456788999999999999998754443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=136.74 Aligned_cols=125 Identities=22% Similarity=0.224 Sum_probs=95.8
Q ss_pred cCCCCCEEEEEEccCCChh--------------------------hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeE
Q 045452 2 VLPCGEVIAVKKLSKSSAQ--------------------------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 55 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 55 (303)
+..+|+.||||+++..... ....+..|...+.++.|+++.....+... ..++
T Consensus 17 ~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~l 94 (190)
T cd05145 17 RTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK--KNVL 94 (190)
T ss_pred EcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec--CCEE
Confidence 3458999999998754211 01234578999999999987554444332 2489
Q ss_pred EEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccc
Q 045452 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF 134 (303)
Q Consensus 56 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~ 134 (303)
||||++|+++..... ....++......++.+++.++.++|. .| ++||||||+||+++ ++.++|+|||++...
T Consensus 95 VmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 95 VMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 999998875543321 23457788999999999999999999 88 99999999999998 789999999998765
Q ss_pred c
Q 045452 135 A 135 (303)
Q Consensus 135 ~ 135 (303)
.
T Consensus 168 ~ 168 (190)
T cd05145 168 D 168 (190)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=157.99 Aligned_cols=224 Identities=15% Similarity=0.117 Sum_probs=160.7
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+-++... ....+++..+. .+ --+.|..+...+...+..++|++|.+.|+|.+++. ....+++
T Consensus 720 ~~~~~~alK~e~P~~~WEfYI~~q~~~RLk--~~-~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e 793 (974)
T KOG1166|consen 720 SNGKLVALKVEKPPNPWEFYICLQVMERLK--PQ-MLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN---TNKVMDE 793 (974)
T ss_pred CCCcEEEEEeecCCCceeeeehHHHHHhhc--hh-hhcchHHHHHHHccCCcceeeeeccccccHHHhhc---cCCCCCc
Confidence 4599999999876643 22233333332 11 12345555555556677899999999999999995 5677999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-------CCCcEEEecccccccccccccccccceeecccccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-------EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-------~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
..++.+..|++..+.+||.++ ||||||||+|+++. .+..++|+|||.+..+.--.........+++..+-
T Consensus 794 ~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~ 870 (974)
T KOG1166|consen 794 YLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFD 870 (974)
T ss_pred hhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccch
Confidence 999999999999999999999 99999999999994 33459999999997765444444455567899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH-HHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR-CLE 232 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~ 232 (303)
++|...|.+|+.+.|.|.|+-+++-|+.|+..- .+.+... ..... .+.....+ ..+
T Consensus 871 C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~~~g~~~-~~~~~-----~~Ry~~~~~W~~ 927 (974)
T KOG1166|consen 871 CIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------VKNGSSW-MVKTN-----FPRYWKRDMWNK 927 (974)
T ss_pred hHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------hcCCcce-ecccc-----chhhhhHHHHHH
Confidence 999999999999999999999999999998531 1221111 11100 11111112 235
Q ss_pred HHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 233 IALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
++..+|..|-..=|.+.+|...|+...
T Consensus 928 ~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 928 FFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred HHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 777777766666678888877776644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.5e-17 Score=131.90 Aligned_cols=113 Identities=19% Similarity=0.219 Sum_probs=89.3
Q ss_pred EEEEccCCChhhHHHHHHHHHHHhcC-----CCCcceeEEEEEEeCC---e-eeEEEee--CCCCChhhhhcCcCcccCC
Q 045452 10 AVKKLSKSSAQGFEEFKNEVMLTAKL-----QHVNLIRVLGFCIDSE---E-RMLVYEY--MPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 10 aiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e~--~~~~sL~~~l~~~~~~~~~ 78 (303)
+||++........+.+.+|+..++.+ .||||++++++++++. . +.+|+|| +.+++|.+++.+ ..+
T Consensus 28 ~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~----~~~ 103 (210)
T PRK10345 28 CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ----CRY 103 (210)
T ss_pred EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc----ccc
Confidence 68887655444557789999999999 5799999999999874 3 3378999 557999999943 235
Q ss_pred CHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCcEEECCC----CcEEEeccccc
Q 045452 79 DWKKRVHIIEGITQGL-LYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLA 131 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l-~~lh~~~~~~i~H~dl~p~nil~~~~----~~~kl~df~~~ 131 (303)
++. ..++.+++.++ +|||+.+ |+||||||+||+++.. +.++|+|++.+
T Consensus 104 ~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 104 EED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 554 35678888777 9999999 9999999999999743 47999995443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4e-16 Score=129.35 Aligned_cols=202 Identities=21% Similarity=0.254 Sum_probs=140.4
Q ss_pred HHHhcCCCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhcCcC-cccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 045452 30 MLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRL 103 (303)
Q Consensus 30 ~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 103 (303)
..+-++-|.|||+++.++.+.. ...++.||+..|++..+|++.. ....+......+|+.||+.||.|||... .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 4445567999999999987543 4689999999999999997632 3556888899999999999999999986 5
Q ss_pred CeeecCCCCCcEEECCCCcEEEeccccccccc---ccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHH
Q 045452 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFA---KESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 180 (303)
+++|+++..+.|++..+|-+|++-- ....+. +...........+.+.|.+||.-...+.+.++|||++|+...+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 6999999999999999988887532 111111 111111122234578999999877777788999999999999998
Q ss_pred hCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 045452 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 181 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~ 252 (303)
.+..-....... ...-........+ ....+ =++++.+|+...|+.||++.+++
T Consensus 277 ilEiq~tnseS~--~~~ee~ia~~i~~------len~l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 277 ILEIQSTNSESK--VEVEENIANVIIG------LENGL-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HheeccCCCcce--eehhhhhhhheee------ccCcc-----------ccCcCcccccCCCCCCcchhhhh
Confidence 877542211111 0000000000000 00000 12789999999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.6e-15 Score=121.94 Aligned_cols=118 Identities=22% Similarity=0.272 Sum_probs=97.3
Q ss_pred CCCEEEEEEccCCCh--------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 5 CGEVIAVKKLSKSSA--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
+|..|++|....... .....+.+|+..+..++|+++.....++......+++|||++|++|.+++...
T Consensus 18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~---- 93 (211)
T PRK14879 18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN---- 93 (211)
T ss_pred CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----
Confidence 577899998654321 11245778999999999999887777777778889999999999999887421
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
.. ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 94 --~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 94 --GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred --cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 11 78899999999999999998 99999999999999 78899999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=4e-15 Score=123.34 Aligned_cols=123 Identities=18% Similarity=0.185 Sum_probs=92.5
Q ss_pred CCCCCEEEEEEccCCChh------------------------hHHHHHHHHHHHhcCCCC--cceeEEEEEEeCCeeeEE
Q 045452 3 LPCGEVIAVKKLSKSSAQ------------------------GFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLV 56 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv 56 (303)
..+|+.||||+++..... ....+..|+..+.++.+. .+.++++. ...++|
T Consensus 51 ~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV 126 (237)
T smart00090 51 DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLV 126 (237)
T ss_pred CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEE
Confidence 468999999998643210 112356899999999653 34455543 235899
Q ss_pred EeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccc
Q 045452 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 57 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~ 135 (303)
|||+.|++|..... ............++.||+.++++||..| .++|+||||+||+++ ++.++|+|||.+....
T Consensus 127 ~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 127 MEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999988866542 2334566677899999999999999876 399999999999999 8899999999876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.2e-16 Score=148.07 Aligned_cols=232 Identities=24% Similarity=0.315 Sum_probs=171.9
Q ss_pred CCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 5 CGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
....+|.|.+.... .........|..+-..+. |.|++++++...+.+..+++++|..|+++...+.. ......+..
T Consensus 45 ~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~ 123 (601)
T KOG0590|consen 45 PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSS 123 (601)
T ss_pred CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc-CCccCCCCc
Confidence 34456666665432 233445556777777775 99999999999999999999999999999777732 122246667
Q ss_pred HHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccc-cccccccceeec-cccccCchh
Q 045452 82 KRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAK-ESLKANTEQVVG-TIGYIPPEY 157 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh-~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~ 157 (303)
..-.++.|+..++.|+| ..+ +.|+|++|+|.+++.++ .+++.|||++..+.. ..........+| +..|.|||.
T Consensus 124 ~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~ 200 (601)
T KOG0590|consen 124 SASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEH 200 (601)
T ss_pred chhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccc
Confidence 78889999999999999 887 99999999999999999 999999999987766 444455555678 999999999
Q ss_pred cccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 ARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
..+. ......|+||+|+++.-+++|..||......... +..|...... ..............+++.+
T Consensus 201 ~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~------~~~~~~~~~~~~~~~~l~k 268 (601)
T KOG0590|consen 201 LSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------YSSWKSNKGR------FTQLPWNSISDQAHDLLHK 268 (601)
T ss_pred ccchhhcCCCcccccccccccccccCCCCcccccccccc------ceeecccccc------cccCccccCChhhhhcccc
Confidence 8874 4567899999999999999999998665544311 1111111100 0000111111245689999
Q ss_pred cccCCCCCCCCHHHHH
Q 045452 237 CVQENPNDRPSMLEVS 252 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~ 252 (303)
++..+|..|.+.+++.
T Consensus 269 ~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 269 ILKENPSNRLSIEELK 284 (601)
T ss_pred cccCCchhcccccccc
Confidence 9999999999999884
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.5e-16 Score=145.96 Aligned_cols=139 Identities=24% Similarity=0.334 Sum_probs=108.0
Q ss_pred HHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccc-------------ccccccceeeccccccCchh
Q 045452 91 TQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE-------------SLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 91 ~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~-------------~~~~~~~~~~~~~~y~aPE~ 157 (303)
+.+++|||..| |+|||+||+|.+|+.-|++|+.|||++...... .........+||+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999998 999999999999999999999999998653211 00111223479999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+....|...+|+|++|+|+|+.+.|..||.....++....+-.....|.... .....++.++|.+.
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d--------------ea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED--------------EALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC--------------cCCCHHHHHHHHHH
Confidence 9999999999999999999999999999976655554444444333343321 11123788999999
Q ss_pred ccCCCCCCC
Q 045452 238 VQENPNDRP 246 (303)
Q Consensus 238 l~~dp~~Rp 246 (303)
|+.+|..|-
T Consensus 296 L~qnp~~Rl 304 (1205)
T KOG0606|consen 296 LRQNPLCRL 304 (1205)
T ss_pred HHhChHhhc
Confidence 999999997
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.8e-15 Score=118.85 Aligned_cols=115 Identities=24% Similarity=0.323 Sum_probs=91.6
Q ss_pred CCCEEEEEEccCCCh--------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 5 CGEVIAVKKLSKSSA--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
+|..|++|....... ....++.+|+.++..++|+++.....++......+++|||++|++|.+++... .
T Consensus 16 ~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~---~ 92 (199)
T TIGR03724 16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEG---N 92 (199)
T ss_pred CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhc---H
Confidence 578899998643311 12356778999999998887655555555666789999999999998877321 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
. .++.+++.+|.+||+.| ++|+|++|.||+++ ++.++++|||.+..
T Consensus 93 ~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 93 D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 0 78999999999999998 99999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.1e-14 Score=119.24 Aligned_cols=118 Identities=21% Similarity=0.205 Sum_probs=90.1
Q ss_pred CCCEEEEEEccCCC-------------hhhHHHHHHHHHHHhcCCCCcc--eeEEEEEEeCC----eeeEEEeeCCC-CC
Q 045452 5 CGEVIAVKKLSKSS-------------AQGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSE----ERMLVYEYMPN-KS 64 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~----~~~lv~e~~~~-~s 64 (303)
+|..++||.+.... ......+.+|+.++..|+|+++ ++.+++..... ..++|||+++| .+
T Consensus 54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~ 133 (239)
T PRK01723 54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARD 133 (239)
T ss_pred CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCC
Confidence 46788999875321 1223567889999999988775 67777654432 23599999987 68
Q ss_pred hhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
|.+++.. ..++.. .+.+|+.++.+||+.| |+|+||||.|||++.++.++|+|||.+..
T Consensus 134 L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 134 LVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 8888732 234443 3578999999999999 99999999999999989999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=116.57 Aligned_cols=118 Identities=19% Similarity=0.197 Sum_probs=90.2
Q ss_pred cCCCCCEEEEEEccCCChh----------------------hHHHHHHHHHHHhcCCCC--cceeEEEEEEeCCeeeEEE
Q 045452 2 VLPCGEVIAVKKLSKSSAQ----------------------GFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLVY 57 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~ 57 (303)
..++|+.||||+++..... ....+..|+..+..+.|+ .+.+.++. ...+++|
T Consensus 35 ~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~ 110 (198)
T cd05144 35 LDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW----NRHAVVM 110 (198)
T ss_pred EcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec----CCceEEE
Confidence 4568999999987543210 112356788888888776 44555442 3458999
Q ss_pred eeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccc
Q 045452 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 58 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~ 135 (303)
||++|++|...... .....++.+++.++.++|+.| ++|+||+|.||+++.++.++|+|||.+..+.
T Consensus 111 e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 111 EYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999998665420 245678899999999999988 9999999999999999999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.5e-14 Score=131.75 Aligned_cols=97 Identities=25% Similarity=0.385 Sum_probs=86.3
Q ss_pred HHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcC
Q 045452 22 FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS 101 (303)
Q Consensus 22 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 101 (303)
.+++.+|+++++.++|++++..+.++......++||||+++++|.+++. ....++.+++.+|.+||+.+
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g 448 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG 448 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC
Confidence 3568899999999999999888877777778899999999999988873 35678999999999999998
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 102 ~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
++||||||+||++ .++.++|+|||++..
T Consensus 449 ---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 449 ---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999 678899999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3e-13 Score=122.20 Aligned_cols=167 Identities=17% Similarity=0.197 Sum_probs=129.2
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
..+|.+|.++.++...........+-+..++.++||||+++++.++.+...|+|+|-+ ..|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 4578899999987665555667788899999999999999999999999999999987 366666633 33567
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..-+.||+.||.+||+.+ +++|++|.-+.++|+..|..||++|.++........ ......-...|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 7788999999999998544 399999999999999999999999998865433221 111122233566666543222
Q ss_pred CCCcccchhhHHHHHHHHhCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGK 183 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~ 183 (303)
-..|.|.|||++++++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-13 Score=106.01 Aligned_cols=116 Identities=22% Similarity=0.233 Sum_probs=96.4
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCC--CcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
++.+++|....... ...+..|+..++.++| .++++++.+....+..+++|||+.++.+..+ +....
T Consensus 21 ~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~ 88 (155)
T cd05120 21 DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEK 88 (155)
T ss_pred CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHH
Confidence 46889999865433 4678889999999966 5899999988877889999999988776433 45567
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
..++.+++.+++++|.....+++|+|++|.||+++..+.++++||+.+..
T Consensus 89 ~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 89 EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 78899999999999987545599999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=104.77 Aligned_cols=121 Identities=21% Similarity=0.243 Sum_probs=83.4
Q ss_pred cCCCCCEEEEEEccCCChh--hHHHH----------------------HHHHHHHhcCCCC--cceeEEEEEEeCCeeeE
Q 045452 2 VLPCGEVIAVKKLSKSSAQ--GFEEF----------------------KNEVMLTAKLQHV--NLIRVLGFCIDSEERML 55 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~--~~~~~----------------------~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~l 55 (303)
+..+|+.||||+++..... ....+ ..|...+..+.+. .+.++++. ...++
T Consensus 17 ~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~~~~l 92 (187)
T cd05119 17 LDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL----NRHVL 92 (187)
T ss_pred ECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec----CCCEE
Confidence 3457999999998654221 11111 3455566665433 34555543 24689
Q ss_pred EEeeCCCCChhh-hhcCcCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 56 VYEYMPNKSLDC-YLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 56 v~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
+|||++++.+.. .+.. .... .....++.+++.++.++|. .+ ++|+||+|+||+++ ++.++++|||.+..
T Consensus 93 v~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 93 VMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECccccc
Confidence 999999854422 1211 0011 5678899999999999999 87 99999999999999 88999999999865
Q ss_pred cc
Q 045452 134 FA 135 (303)
Q Consensus 134 ~~ 135 (303)
..
T Consensus 164 ~~ 165 (187)
T cd05119 164 ID 165 (187)
T ss_pred cc
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-12 Score=116.12 Aligned_cols=79 Identities=25% Similarity=0.295 Sum_probs=59.6
Q ss_pred CCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHH-HHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecc
Q 045452 50 SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQ-GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 50 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~-~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df 128 (303)
....++||||++|++|.++.... ....+ ...++..++. .+..+|..| ++|+|++|.||+++.++.++++||
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~--~~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDf 301 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALD--EAGLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDF 301 (437)
T ss_pred cCCceEEEEeECCcccccHHHHH--hcCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeC
Confidence 44579999999999998875321 11122 3345555555 467788888 999999999999999999999999
Q ss_pred cccccccc
Q 045452 129 GLARIFAK 136 (303)
Q Consensus 129 ~~~~~~~~ 136 (303)
|++..+..
T Consensus 302 G~~~~l~~ 309 (437)
T TIGR01982 302 GIVGRLSE 309 (437)
T ss_pred CCeeECCH
Confidence 99876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=116.93 Aligned_cols=226 Identities=21% Similarity=0.221 Sum_probs=160.7
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.++..+|+|+-+.. .+.....=.+|+..-+.+ .|++.++.+..++.++..++-+|+| +.+|..+... ....++.
T Consensus 141 ~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~--~~~~~p~ 217 (524)
T KOG0601|consen 141 ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHT--PCNFLPD 217 (524)
T ss_pred cCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhc--ccccCCc
Confidence 35678888884332 222223334566666677 6899999999999999999999999 4677777643 2334777
Q ss_pred HHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccc---eeeccccc
Q 045452 81 KKRVHIIEGITQ----GLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTE---QVVGTIGY 152 (303)
Q Consensus 81 ~~~~~~~~~i~~----~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~---~~~~~~~y 152 (303)
..++..+.+... |+.++|..+ ++|-|++|.||+...+ ...+++||++...+.......... ...+...|
T Consensus 218 ~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y 294 (524)
T KOG0601|consen 218 NLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIY 294 (524)
T ss_pred hhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceE
Confidence 788888888888 999999988 9999999999999999 889999999998887654332221 22578899
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
++||..+ ..++...|+|++|.++.+...+..+........ |.......+...+. .-...++..
T Consensus 295 ~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----------W~~~r~~~ip~e~~-----~~~s~~l~~ 357 (524)
T KOG0601|consen 295 AAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----------WSQLRQGYIPLEFC-----EGGSSSLRS 357 (524)
T ss_pred eChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------ccccccccCchhhh-----cCcchhhhh
Confidence 9999775 456889999999999999988776643221111 11111111111111 111225667
Q ss_pred HHHhcccCCCCCCCCHHHHH
Q 045452 233 IALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~ 252 (303)
.+.+|++.+|..|++...+.
T Consensus 358 ~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 358 VTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred HHHHhcCcchhhhhHHHHHh
Confidence 99999999999999988875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=102.88 Aligned_cols=209 Identities=19% Similarity=0.237 Sum_probs=145.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEE----eCCeeeEEEeeCCC-CChhhhhcCc------
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCI----DSEERMLVYEYMPN-KSLDCYLFDP------ 72 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~sL~~~l~~~------ 72 (303)
-||..|++|+++............-+++++++.|.|+|++.+++. .+..+++|++|.++ ++|.++-+..
T Consensus 299 ~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~ 378 (655)
T KOG3741|consen 299 VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR 378 (655)
T ss_pred cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence 378999999996655444444556789999999999999999886 34578999999865 5777665442
Q ss_pred ------CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccccee
Q 045452 73 ------IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV 146 (303)
Q Consensus 73 ------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 146 (303)
..+..+++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++++.+++|...|+...+.....
T Consensus 379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~------- 448 (655)
T KOG3741|consen 379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT------- 448 (655)
T ss_pred cccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC-------
Confidence 12334678999999999999999999999 88899999999999999999998887654433220
Q ss_pred eccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH
Q 045452 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 147 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.+.. ..+-|.=.||.++..|.+|..--.. .+.. ..... ..-...+
T Consensus 449 ---------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~---~d~~--~~s~~-----------------~~I~~~y 494 (655)
T KOG3741|consen 449 ---------EPLES---QQQNDLRDLGLLLLALATGTENSNR---TDST--QSSHL-----------------TRITTTY 494 (655)
T ss_pred ---------cchhH---HhhhhHHHHHHHHHHHhhccccccc---ccch--HHHHH-----------------HHhhhhh
Confidence 11111 2356888999999999998643100 0000 00000 0111223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
+.++++++.-....++++ -++.+++.++-+
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 346778888888888876 677777766544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.3e-11 Score=94.93 Aligned_cols=113 Identities=19% Similarity=0.181 Sum_probs=81.4
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.|+.|++|....... ....+..|+..++.+.+.++ .+++.+. ....++||||++|.++...- . ..
T Consensus 20 ~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~--------~---~~ 85 (170)
T cd05151 20 ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED--------F---SD 85 (170)
T ss_pred CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc--------c---cC
Confidence 467899999855432 22345778888888855444 4555543 33458999999998874320 1 11
Q ss_pred HHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 84 VHIIEGITQGLLYLQEYS--RLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~--~~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
...+.+++.+|+.||..+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 345678999999999887 22359999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-10 Score=92.75 Aligned_cols=97 Identities=18% Similarity=0.205 Sum_probs=73.1
Q ss_pred HHHHHHhcCCC--CcceeEEEEEEeCCeeeEEEeeCCCCChhh-hhcCcCcccCCCHHHHHHHHHHHHHHHHHH-HhcCC
Q 045452 27 NEVMLTAKLQH--VNLIRVLGFCIDSEERMLVYEYMPNKSLDC-YLFDPIRRLILDWKKRVHIIEGITQGLLYL-QEYSR 102 (303)
Q Consensus 27 ~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~ 102 (303)
+|++.|+++.. -++.+++++ ..-++||||+.++.+.. .+ +...++......+..+++.++..+ |..|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g- 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN- 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence 79999999843 466677765 35689999997653321 22 222345556777889999999998 8888
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeccccccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~ 135 (303)
++|+||++.||+++ ++.++++||+.+....
T Consensus 146 --lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 --LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred --eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999997 4679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.1e-10 Score=93.28 Aligned_cols=124 Identities=19% Similarity=0.182 Sum_probs=91.5
Q ss_pred CCCEEEEEEccCCChh-hHH----------HHHHHHHHHhcCCCCcc--eeEEEEEEe-----CCeeeEEEeeCCCC-Ch
Q 045452 5 CGEVIAVKKLSKSSAQ-GFE----------EFKNEVMLTAKLQHVNL--IRVLGFCID-----SEERMLVYEYMPNK-SL 65 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~lv~e~~~~~-sL 65 (303)
+|+.|.||........ ..+ .+.+|...+.+|...+| ..++++... ....++|||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 4678999977544311 111 36789988888844433 455556543 23568999999876 78
Q ss_pred hhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-------CCcEEEecccccc
Q 045452 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-------DMKPKISDFGLAR 132 (303)
Q Consensus 66 ~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-------~~~~kl~df~~~~ 132 (303)
.+++.... ....+......++.+++..++.||..| ++|+|+++.|||++. ++.+.++||+.+.
T Consensus 124 ~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 88874322 234566677899999999999999999 999999999999975 4679999999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.5e-10 Score=86.51 Aligned_cols=97 Identities=25% Similarity=0.376 Sum_probs=77.5
Q ss_pred HHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 045452 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSR 102 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 102 (303)
.+-.+|++++.+++--+|.-.+=+..+.....|+|||.+|..|.+.+... ...++..+..-+.-||..|
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g- 112 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG- 112 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC-
Confidence 34557999999886555554444555667788999999999998888432 2567888888899999999
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
|+|+||.++||++.+.+ +.++|||++..
T Consensus 113 --ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 --IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred --eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999998764 99999999853
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-11 Score=109.47 Aligned_cols=90 Identities=18% Similarity=0.200 Sum_probs=58.7
Q ss_pred CCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhh--cCc-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 045452 37 HVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYL--FDP-IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112 (303)
Q Consensus 37 h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l--~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p 112 (303)
+...+.+-.++.+ ....++||||+.|+.+.+.- ... .....+....+..++.|+. ..| ++|+|+||
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHaDpHP 288 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHADMHP 288 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeCCCCh
Confidence 3333443333332 45678999999999997642 110 0111233334444444443 355 99999999
Q ss_pred CcEEECCCC----cEEEecccccccccc
Q 045452 113 SNILLGEDM----KPKISDFGLARIFAK 136 (303)
Q Consensus 113 ~nil~~~~~----~~kl~df~~~~~~~~ 136 (303)
.||+++.+| .++++|||++..+..
T Consensus 289 GNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 289 GNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHeEEecCCCCCCeEEEEecceEEECCH
Confidence 999999888 999999999977643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2e-09 Score=93.04 Aligned_cols=203 Identities=14% Similarity=0.119 Sum_probs=131.3
Q ss_pred eeEEEeeCCCC-ChhhhhcC---cCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecc
Q 045452 53 RMLVYEYMPNK-SLDCYLFD---PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 53 ~~lv~e~~~~~-sL~~~l~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df 128 (303)
..++|+.+.+. .+..++.. ...-....|+..++.++.++.+.+.||+.| .+-+|++++|+|+++++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 67889888664 33333332 122335689999999999999999999999 999999999999999999999997
Q ss_pred cccccccccccccccceeeccccccCchhcc-----cCCCCCcccchhhHHHHHHHHhC-CCCccccCC-CccccHHHHH
Q 045452 129 GLARIFAKESLKANTEQVVGTIGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGI-NENLSILEHA 201 (303)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~-~~~~~~~~~~ 201 (303)
+......+ .......+|...|.+||... +-.-+...|.|.||+++++++.| +.||..... .+.....+..
T Consensus 162 Dsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 66544322 33334467899999999765 22346689999999999999886 899853222 1222222211
Q ss_pred HHHhh----CCCccccccccccCCCChHHHHHHHHHHHhcccC--CCCCCCCHHHHHHhhccCCCCC
Q 045452 202 YELWK----GGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE--NPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 202 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
..... ...... .........-......+.-++.+|+.. ++.-|||++..+..|.....++
T Consensus 239 Ia~g~f~ya~~~~~g-~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRG-LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCC-CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11000 000000 000011111122233567788899875 4668999999877766554433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=103.74 Aligned_cols=221 Identities=20% Similarity=0.187 Sum_probs=152.8
Q ss_pred CCCCEEEEEEccCCChhhHHH--HHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEE--FKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.++..+++|.+.........+ -..|+.+...+ .|.+++..+..+......++=-|||.++++...+ .....+++
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~ 365 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS---VTSQMLDE 365 (524)
T ss_pred CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh---HHHHhcCc
Confidence 466777777765543322222 23466666666 6889999998888888888999999999887666 24556888
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeecccccc--Cchh
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYI--PPEY 157 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~--aPE~ 157 (303)
..++++..|++.++-++|+.. ++|+|++|+||++..+ +..+++||+....+.... .......++. ++..
T Consensus 366 ~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~ 437 (524)
T KOG0601|consen 366 DPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEIL 437 (524)
T ss_pred chhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec-----ccccccccccccchhh
Confidence 899999999999999999998 9999999999999886 778999999875432111 1111223333 5556
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
.....+..+.|++|||.-+.+.+++...-.... ....+..... ...+. ....+..+...+
T Consensus 438 ~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------------~~~~i~~~~~-p~~~~-~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 438 LEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------------QSLTIRSGDT-PNLPG-LKLQLQVLLKVM 497 (524)
T ss_pred ccccccccccccccccccccccccCcccCcccc------------------cceeeecccc-cCCCc-hHHhhhhhhhhh
Confidence 666778899999999999999999875432111 0000000000 00011 113455788889
Q ss_pred ccCCCCCCCCHHHHHHhh
Q 045452 238 VQENPNDRPSMLEVSSML 255 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L 255 (303)
..+++..||.+.++....
T Consensus 498 ~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHS 515 (524)
T ss_pred cCCccccchhhhhhcccc
Confidence 999999999998886543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-09 Score=86.04 Aligned_cols=120 Identities=26% Similarity=0.256 Sum_probs=76.5
Q ss_pred cCCCCCEEEEEEccCCC-------------h-------------hhHHHHHHHHHHHhcCCCC--cceeEEEEEEeCCee
Q 045452 2 VLPCGEVIAVKKLSKSS-------------A-------------QGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEER 53 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~-------------~-------------~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~ 53 (303)
.-++|..||||+.+... . .......+|.+.|.++..- ++.+++++. .-
T Consensus 6 ~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~ 81 (188)
T PF01163_consen 6 IDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RN 81 (188)
T ss_dssp EECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TT
T ss_pred ECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CC
Confidence 34688999999985321 0 0123456799999999655 566777553 34
Q ss_pred eEEEeeCC--CCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCcEEECCCCcEEEecccc
Q 045452 54 MLVYEYMP--NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLY-LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGL 130 (303)
Q Consensus 54 ~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~ 130 (303)
+|||||++ |..+..+... .++......++.+++..+.. +|..| ++|||+.+.||+++.+ .+.++||+.
T Consensus 82 ~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp EEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTT
T ss_pred EEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCc
Confidence 79999998 5555443311 11234556777778775554 57888 9999999999999887 899999998
Q ss_pred cccc
Q 045452 131 ARIF 134 (303)
Q Consensus 131 ~~~~ 134 (303)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.6e-09 Score=82.59 Aligned_cols=124 Identities=23% Similarity=0.286 Sum_probs=90.7
Q ss_pred CCCEEEEEEccCCC--------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCC-CChhhhhcCcCcc
Q 045452 5 CGEVIAVKKLSKSS--------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN-KSLDCYLFDPIRR 75 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~ 75 (303)
.|+..+||.-.... .-...+-++|++++.++.--+|.-..=++.+.+.-.|+|||++| .++.+++.....
T Consensus 29 ~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~- 107 (229)
T KOG3087|consen 29 SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTME- 107 (229)
T ss_pred CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHcc-
Confidence 46777777542221 12345677899999998766665555566677777899999976 477788765322
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEecccccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLAR 132 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~---~kl~df~~~~ 132 (303)
..........++..|...+.-||..+ ++||||..+||++...+. +.++|||++.
T Consensus 108 ~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 108 DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 22333444789999999999999998 999999999999976544 5899999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=3e-09 Score=87.42 Aligned_cols=125 Identities=19% Similarity=0.278 Sum_probs=92.7
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCC--cceeEEEEEEeC---CeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDS---EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.+++|....... .....+..|+.+++.+.+. .+.+++.+.... +..+++|+|++|.++...+. ...
T Consensus 20 ~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~----~~~ 95 (223)
T cd05154 20 GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL----RPE 95 (223)
T ss_pred cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC----CCC
Confidence 3468899999865432 2445788899999999653 457777776653 26689999999988866552 134
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------CCC
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYS-----------------------------------------------------RLT 104 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~-----------------------------------------------------~~~ 104 (303)
++......++.+++.+|+.||+.. ...
T Consensus 96 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (223)
T cd05154 96 LSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPG 175 (223)
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcE
Confidence 666777778888888888887521 134
Q ss_pred eeecCCCCCcEEECC--CCcEEEecccccc
Q 045452 105 IIHRDLKASNILLGE--DMKPKISDFGLAR 132 (303)
Q Consensus 105 i~H~dl~p~nil~~~--~~~~kl~df~~~~ 132 (303)
++|+|++|.||+++. ++.+.++||+.+.
T Consensus 176 l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 176 LVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred EEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 799999999999998 5678999998774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.9e-10 Score=102.10 Aligned_cols=153 Identities=17% Similarity=0.186 Sum_probs=102.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cc------cceeeccccccCchh
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-AN------TEQVVGTIGYIPPEY 157 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~------~~~~~~~~~y~aPE~ 157 (303)
.-+.+++.|+.++|... .++|++|.|++|.++.++..||++|+++......... .. .........|.|||+
T Consensus 103 ~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 34456669999999865 4999999999999999999999999998655432111 11 111123568999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCC-ccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRL-SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+...+.++|+||+|+++|.+..+..+ +...+...... ......+ ..........+.++++=+.+
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~~~~~--------~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSRNLLN--------AGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhhcccc--------cccccccccCcHHHHHHHHH
Confidence 9988889999999999999999854433 32221111110 0000000 00011112334578899999
Q ss_pred cccCCCCCCCCHHHHH
Q 045452 237 CVQENPNDRPSMLEVS 252 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~ 252 (303)
++..+...||++..+.
T Consensus 248 ~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLL 263 (700)
T ss_pred HhcCCcccCcchhhhh
Confidence 9999999999776664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.6e-10 Score=104.93 Aligned_cols=193 Identities=21% Similarity=0.198 Sum_probs=133.2
Q ss_pred CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 045452 37 HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116 (303)
Q Consensus 37 h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil 116 (303)
+|.++..+.-+......+++++|+.+++|...++. ....+..........+..++.+||... +.|+|++|.|++
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLL 936 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchh
Confidence 34444444333345678999999999988887743 234566666677778889999999877 899999999999
Q ss_pred ECCCCcEEEeccccccccccc-------------------------ccc----cccceeeccccccCchhcccCCCCCcc
Q 045452 117 LGEDMKPKISDFGLARIFAKE-------------------------SLK----ANTEQVVGTIGYIPPEYARQGVYSTKS 167 (303)
Q Consensus 117 ~~~~~~~kl~df~~~~~~~~~-------------------------~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~ 167 (303)
...+|..++.||+.....+.. ... .......+++.|.+||...+..-...+
T Consensus 937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen 937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence 999999999999843222100 000 112234578999999999999999999
Q ss_pred cchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCC
Q 045452 168 DVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS 247 (303)
Q Consensus 168 DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 247 (303)
|+|++|+++++.++|..||...........+......|..+ +.....+..+++...+..+|.+|..
T Consensus 1017 d~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g--------------~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1017 DWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEG--------------PEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred hhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCC--------------ccccChhhhhhhhhhhccCchhccC
Confidence 99999999999999999985443322111111111111110 1111224668999999999999988
Q ss_pred HH
Q 045452 248 ML 249 (303)
Q Consensus 248 ~~ 249 (303)
+.
T Consensus 1083 a~ 1084 (1205)
T KOG0606|consen 1083 AK 1084 (1205)
T ss_pred cc
Confidence 77
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.4e-08 Score=81.19 Aligned_cols=106 Identities=22% Similarity=0.233 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHhcCCCC--cceeEEEEEEeCC----eeeEEEeeCCCC-ChhhhhcCcCcccCCCHHHHHHHHHHHHHHH
Q 045452 22 FEEFKNEVMLTAKLQHV--NLIRVLGFCIDSE----ERMLVYEYMPNK-SLDCYLFDPIRRLILDWKKRVHIIEGITQGL 94 (303)
Q Consensus 22 ~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l 94 (303)
.....+|...+..|..- ...+++++.+... ..++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 34677888888888443 3467777776532 458999999874 788888431 2266677889999999999
Q ss_pred HHHHhcCCCCeeecCCCCCcEEECCCC---cEEEeccccccc
Q 045452 95 LYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARI 133 (303)
Q Consensus 95 ~~lh~~~~~~i~H~dl~p~nil~~~~~---~~kl~df~~~~~ 133 (303)
+-||+.| ++|+|+++.|||++.++ .+.++||+.+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.6e-07 Score=73.64 Aligned_cols=113 Identities=19% Similarity=0.167 Sum_probs=73.1
Q ss_pred CCCEEEEEEccCCChhhHHHHH---------HHHHHHhcC---CCCcceeEEEEEE-----eCCeeeEEEeeCCCCChhh
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFK---------NEVMLTAKL---QHVNLIRVLGFCI-----DSEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~---------~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~sL~~ 67 (303)
+|+.+++|..+.......+.|+ +.+..+..+ .......++.+.+ .....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 5778888888655433333332 333333333 2233334333332 2234578999999988866
Q ss_pred hhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
... +++ .+...+..++.-||+.| ++|+|++|.|++++.++ ++++||+...
T Consensus 133 ~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred chh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence 531 222 24456777889999999 99999999999998654 9999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.2e-07 Score=75.57 Aligned_cols=118 Identities=22% Similarity=0.214 Sum_probs=82.5
Q ss_pred cCCCCCEEEEEEccCCCh----------------------hhHHHHHHHHHHHhcCCCC--cceeEEEEEEeCCeeeEEE
Q 045452 2 VLPCGEVIAVKKLSKSSA----------------------QGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLVY 57 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~ 57 (303)
..++|..+|||.-+.... -+....++|.++|.+|... .+.+.++.- .-.+||
T Consensus 111 ~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~n----RHaVvM 186 (304)
T COG0478 111 IDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAWN----RHAVVM 186 (304)
T ss_pred ECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCccccc----cceeee
Confidence 456799999997642210 1123456799999999544 677777653 447999
Q ss_pred eeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccc
Q 045452 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF 134 (303)
Q Consensus 58 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~ 134 (303)
|+.+|-.|...- ++......++..|+.-+..+-..| ++|+|+.+-||+++.+|.+.++||-.+...
T Consensus 187 e~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 187 EYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCcccccC
Confidence 999887663322 123344455556666666666677 999999999999999999999999766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.8e-07 Score=71.11 Aligned_cols=124 Identities=15% Similarity=0.109 Sum_probs=90.0
Q ss_pred CCEEEEEEccCC------ChhhHHHHHHHHHHHhcCCCC--cceeEEEEEEeC----CeeeEEEeeCCC-CChhhhhcCc
Q 045452 6 GEVIAVKKLSKS------SAQGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDS----EERMLVYEYMPN-KSLDCYLFDP 72 (303)
Q Consensus 6 g~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~----~~~~lv~e~~~~-~sL~~~l~~~ 72 (303)
|+.+-+|..... .+.....|.+|+..+++|..- .+.+++...... ...+||+|-+.+ .+|.+++...
T Consensus 41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~ 120 (216)
T PRK09902 41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQH 120 (216)
T ss_pred CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcC
Confidence 456777776311 134667899999999998433 345555222221 246899997753 5887777442
Q ss_pred CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--EEEeccccccc
Q 045452 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--PKISDFGLARI 133 (303)
Q Consensus 73 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~--~kl~df~~~~~ 133 (303)
.....+......++.+++.+++-||+.| +.|+|+.+.||+++.+|. ++++||..++.
T Consensus 121 -~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 121 -AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred -CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 2234677788899999999999999999 999999999999987777 99999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.7e-07 Score=81.69 Aligned_cols=81 Identities=20% Similarity=0.239 Sum_probs=55.5
Q ss_pred eCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecc
Q 045452 49 DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 49 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df 128 (303)
....-.++|||++|..+.+...- +....+...+.....++. +..+-..| +.|.|.+|.||++..+|.+.+.||
T Consensus 237 ~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 237 YTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred ccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcC
Confidence 35567899999999999887422 223344333333332221 11122234 999999999999999999999999
Q ss_pred cccccccc
Q 045452 129 GLARIFAK 136 (303)
Q Consensus 129 ~~~~~~~~ 136 (303)
|+...+..
T Consensus 310 Gi~g~l~~ 317 (517)
T COG0661 310 GIVGRLDP 317 (517)
T ss_pred cceecCCH
Confidence 99877654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.4e-06 Score=68.19 Aligned_cols=104 Identities=24% Similarity=0.235 Sum_probs=82.3
Q ss_pred HHHHHHHhcCCC-CcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 045452 26 KNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT 104 (303)
Q Consensus 26 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 104 (303)
..|..+++.+++ +++.+++|+| ..+++.||...+++...-..-......+|..+.+++.+++..+.+++....+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888865 6999999999 34789999987655321000012234789999999999999999999866566
Q ss_pred eeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 105 IIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 105 i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
+.-.|++++|+-++++|.+|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.3e-06 Score=67.57 Aligned_cols=124 Identities=15% Similarity=0.135 Sum_probs=72.5
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCC--cceeEEEEEEeCCeeeEEEeeCCCCC-hhhhhcC-----------
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLVYEYMPNKS-LDCYLFD----------- 71 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~s-L~~~l~~----------- 71 (303)
|..+++|...... ......+|.+.++.+..- .+.+++++...++...++|++++|.+ +...+..
T Consensus 22 ~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~ 99 (226)
T TIGR02172 22 TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKI 99 (226)
T ss_pred CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHH
Confidence 4467788876533 234568899999998543 35788888888888899999998863 2111100
Q ss_pred ------cCcc---cCCCHHHHH-HHHHH----------HHH-HHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeccc
Q 045452 72 ------PIRR---LILDWKKRV-HIIEG----------ITQ-GLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 72 ------~~~~---~~~~~~~~~-~~~~~----------i~~-~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~ 129 (303)
.... ......... .+..+ +.. ...+|.. .....++|+|++|.||++++++ +.++||+
T Consensus 100 la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe 178 (226)
T TIGR02172 100 FAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLG 178 (226)
T ss_pred HHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEech
Confidence 0000 001111100 00000 001 1111111 1123479999999999999888 9999998
Q ss_pred ccc
Q 045452 130 LAR 132 (303)
Q Consensus 130 ~~~ 132 (303)
.+.
T Consensus 179 ~a~ 181 (226)
T TIGR02172 179 DFG 181 (226)
T ss_pred hcC
Confidence 764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.9e-06 Score=68.61 Aligned_cols=60 Identities=13% Similarity=0.117 Sum_probs=43.8
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 68 (303)
+..+++|+..... ...+..|+.+++.+ ++--+.+++++....+..++||++++|.++...
T Consensus 22 ~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 22 NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4578888875443 34566788888888 344566788887766678999999999887643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=73.66 Aligned_cols=81 Identities=19% Similarity=0.220 Sum_probs=54.2
Q ss_pred CCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC----CCCcEEE
Q 045452 50 SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG----EDMKPKI 125 (303)
Q Consensus 50 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~----~~~~~kl 125 (303)
.....|+|||++|..+.+.-. .....++...+..-+.+...-.- =..| ++|+|-+|.||++. .++.+.+
T Consensus 274 st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qI--f~~G---ffHaDPHPGNilv~~~~~~~~~ivl 346 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQI--FKTG---FFHADPHPGNILVRPNPEGDEEIVL 346 (538)
T ss_pred CcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHH--HhcC---CccCCCCCCcEEEecCCCCCccEEE
Confidence 346789999999998876532 13344555544444333222111 1234 99999999999998 3677999
Q ss_pred eccccccccccc
Q 045452 126 SDFGLARIFAKE 137 (303)
Q Consensus 126 ~df~~~~~~~~~ 137 (303)
.|||+...+...
T Consensus 347 lDhGl~~~is~~ 358 (538)
T KOG1235|consen 347 LDHGLYAVISHK 358 (538)
T ss_pred EcccccccccHH
Confidence 999998766543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=62.98 Aligned_cols=120 Identities=23% Similarity=0.275 Sum_probs=78.5
Q ss_pred CCCCEEEEEEccCCChhhH---------HH---------------HHHHHHHHhcCC--CCcceeEEEEEEeCCeeeEEE
Q 045452 4 PCGEVIAVKKLSKSSAQGF---------EE---------------FKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVY 57 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~---------~~---------------~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 57 (303)
.++..||+|+++.....-. .+ ...|+.-|+++. +-.+.+.+++. .-.|||
T Consensus 70 ~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvM 145 (268)
T COG1718 70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVM 145 (268)
T ss_pred CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEE
Confidence 4689999999964421100 01 124666666662 34456666665 347999
Q ss_pred eeCCCCCh-hhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeccccccccc
Q 045452 58 EYMPNKSL-DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 58 e~~~~~sL-~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~ 135 (303)
||+....+ .=.| +..++.......+..+++..+.-|-. .+ ++|+||..-|||+. ++.+.++||+.+....
T Consensus 146 EfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 146 EFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred EeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99854311 1112 22223333566677778888877766 66 99999999999999 7899999999886544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.8e-05 Score=76.98 Aligned_cols=195 Identities=22% Similarity=0.224 Sum_probs=134.3
Q ss_pred HHHHHHHHhcCCCCcceeEEEEEEeCCeee----EEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhc
Q 045452 25 FKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEY 100 (303)
Q Consensus 25 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 100 (303)
..-|+..+....|+|++.++.+........ +..++|...++...+. .-...+......+..++.+|++++|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344667777889999999999987655433 4567888888877773 445688889999999999999999987
Q ss_pred CCCCeeecCCCCC---cEEECCCCcEEEe--cccccccccccccccccceeeccccccCchhcccCCCCC--cccchhhH
Q 045452 101 SRLTIIHRDLKAS---NILLGEDMKPKIS--DFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST--KSDVFSFG 173 (303)
Q Consensus 101 ~~~~i~H~dl~p~---nil~~~~~~~kl~--df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DiwslG 173 (303)
. ..|.-+... +--.+..+.+.+. ||+........... .....+..+.++|.......+. ..|+|++|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555444 4445566777777 88887665433211 1123466788888776665554 47999999
Q ss_pred HHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 174 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 174 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.....+..|..+-..... ....+...... .+.+...+|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~----------------------~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV----------------------PVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc----------------------hhhhhccccch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999887765321110 01111111110 4568899999999999999999986
Q ss_pred h
Q 045452 254 M 254 (303)
Q Consensus 254 ~ 254 (303)
.
T Consensus 434 ~ 434 (1351)
T KOG1035|consen 434 H 434 (1351)
T ss_pred c
Confidence 5
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.8e-05 Score=61.06 Aligned_cols=113 Identities=20% Similarity=0.265 Sum_probs=77.0
Q ss_pred CCCCEEEEEEccCCC----------------hhhHHHHHHHHHHHhcCC------CCcceeEEEEEEeCCeeeEEEeeCC
Q 045452 4 PCGEVIAVKKLSKSS----------------AQGFEEFKNEVMLTAKLQ------HVNLIRVLGFCIDSEERMLVYEYMP 61 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~ 61 (303)
++.....||+.+... .....+..+|+.....+. +.+|.+++|+.+++....+|+|...
T Consensus 21 P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~ 100 (199)
T PF10707_consen 21 PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIR 100 (199)
T ss_pred CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEE
Confidence 456667888886554 122445566766666555 7899999999999999999999752
Q ss_pred --CC----ChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEec
Q 045452 62 --NK----SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISD 127 (303)
Q Consensus 62 --~~----sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~----~~kl~d 127 (303)
.| +|.+++ ....++. ...+.+.+ -..+|-+.+ |+.+|++|.||++.... .+.|+|
T Consensus 101 d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 101 DADGNISPTLEDYL----KEGGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCCCCcCccHHHHH----HcCCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 23 566666 3344554 44444444 445566666 99999999999996432 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.8e-05 Score=61.47 Aligned_cols=60 Identities=23% Similarity=0.326 Sum_probs=41.0
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCC--cceeEEEEEEe---CCeeeEEEeeCCCCChhh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHV--NLIRVLGFCID---SEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~~~sL~~ 67 (303)
+..+++|..... .....+..|..+++.+... .+.+++..... ....+++|++++|..+..
T Consensus 20 ~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 20 DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 358899987554 4556777888888888432 35677765433 235689999999988777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=60.97 Aligned_cols=59 Identities=17% Similarity=0.170 Sum_probs=37.3
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCC---cceeEEEEEEeCC---eeeEEEeeCCCCChh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHV---NLIRVLGFCIDSE---ERMLVYEYMPNKSLD 66 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~---~~~lv~e~~~~~sL~ 66 (303)
|..+++|..+... ....+..|...++.+... .+.++++.....+ ..+++|++++|.++.
T Consensus 18 ~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 18 GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 3456777764422 234788899999888432 3455555443322 348899999987774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=7.2e-06 Score=74.99 Aligned_cols=150 Identities=19% Similarity=0.190 Sum_probs=108.1
Q ss_pred HHHHHHHHHHhcCCCCc-ceeEEEEEEeCCeeeEEEeeCCCC-ChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhc
Q 045452 23 EEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLVYEYMPNK-SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEY 100 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 100 (303)
....-++++|.+++||| .+..++-++.....++.++++.++ +..... ......+...+....++.-..+++++|+.
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhcccccccccc
Confidence 34556889999999999 666666666666789999999777 221111 11233344555666677777888888876
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHH
Q 045452 101 SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 101 ~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 180 (303)
- -+|+| ||+... +..+..+|+....+.... ......+++.++|||+.....+....|.|++|.--.++.
T Consensus 356 ~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a 424 (829)
T KOG0576|consen 356 Y---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA 424 (829)
T ss_pred c---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence 4 47887 666554 678999999876654332 344467899999999999999999999999998766776
Q ss_pred hCCCC
Q 045452 181 SGKRL 185 (303)
Q Consensus 181 ~g~~p 185 (303)
-|-+|
T Consensus 425 p~~pP 429 (829)
T KOG0576|consen 425 PGLPP 429 (829)
T ss_pred CCCCC
Confidence 66665
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00012 Score=61.58 Aligned_cols=123 Identities=16% Similarity=0.103 Sum_probs=67.1
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeeeEEEeeCCCCChhhh---------------
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCY--------------- 68 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~~~--------------- 68 (303)
+|+.+++|..........-...+|..+++.+...++ .+++.... -++||+|++|..+...
T Consensus 18 ~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l 93 (256)
T TIGR02721 18 PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALL 93 (256)
T ss_pred CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHH
Confidence 466788887644322211134678888888854333 44554432 3689999998776421
Q ss_pred --hcCc-CcccCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCCeeecCCCCCcEEECCCCcEEEecccc
Q 045452 69 --LFDP-IRRLILDWK-KRVHIIEGI---------TQGLLYLQEY-----SRLTIIHRDLKASNILLGEDMKPKISDFGL 130 (303)
Q Consensus 69 --l~~~-~~~~~~~~~-~~~~~~~~i---------~~~l~~lh~~-----~~~~i~H~dl~p~nil~~~~~~~kl~df~~ 130 (303)
++.. ....+++.. .+..+..++ ...+..+... -...++|+|+.|.||++++++ +.++||..
T Consensus 94 ~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~ 172 (256)
T TIGR02721 94 HQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEY 172 (256)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccc
Confidence 0100 011111211 111221111 1112222111 023489999999999999877 78999988
Q ss_pred cc
Q 045452 131 AR 132 (303)
Q Consensus 131 ~~ 132 (303)
+.
T Consensus 173 a~ 174 (256)
T TIGR02721 173 AS 174 (256)
T ss_pred cC
Confidence 74
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00032 Score=58.14 Aligned_cols=30 Identities=30% Similarity=0.458 Sum_probs=26.3
Q ss_pred CCeeecCCCCCcEEECC-CCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGE-DMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~-~~~~kl~df~~~~ 132 (303)
..++|+|+.+.||++++ ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 35999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00061 Score=66.97 Aligned_cols=59 Identities=17% Similarity=0.342 Sum_probs=41.6
Q ss_pred CEEEEEEccCCC-hhhHHHHHHHHHHHhcCC-CCcc--eeEEEEEEeC---CeeeEEEeeCCCCCh
Q 045452 7 EVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQ-HVNL--IRVLGFCIDS---EERMLVYEYMPNKSL 65 (303)
Q Consensus 7 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~~~sL 65 (303)
..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++||||++|..+
T Consensus 66 ~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 66 KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 357777764432 123346789999999995 6665 7888887654 467899999988654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00044 Score=59.46 Aligned_cols=125 Identities=17% Similarity=0.116 Sum_probs=69.2
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCC--cceeEEEE------EEeCCeeeEEEeeCCCCChhh----hh---
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHV--NLIRVLGF------CIDSEERMLVYEYMPNKSLDC----YL--- 69 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~e~~~~~sL~~----~l--- 69 (303)
++..+++|+.... ....+..|+.++..+.+. .+.+++.. ....+..++++++++|..+.. ..
T Consensus 36 ~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~l 112 (296)
T cd05153 36 DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQI 112 (296)
T ss_pred CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHH
Confidence 3456888887542 234566677777777332 24444432 223456689999999877532 00
Q ss_pred -------cCcCcc--------cCCCHHHH----------HHHHHHHHHHHHHHHh----cCCCCeeecCCCCCcEEECCC
Q 045452 70 -------FDPIRR--------LILDWKKR----------VHIIEGITQGLLYLQE----YSRLTIIHRDLKASNILLGED 120 (303)
Q Consensus 70 -------~~~~~~--------~~~~~~~~----------~~~~~~i~~~l~~lh~----~~~~~i~H~dl~p~nil~~~~ 120 (303)
+..... ....+... ......+..++..+.. .-..+++|+|+.|.|++++.+
T Consensus 113 g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~ 192 (296)
T cd05153 113 GEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGD 192 (296)
T ss_pred HHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCC
Confidence 000000 00010000 0011112233444442 112349999999999999988
Q ss_pred CcEEEecccccc
Q 045452 121 MKPKISDFGLAR 132 (303)
Q Consensus 121 ~~~kl~df~~~~ 132 (303)
+.+.|+||+.+.
T Consensus 193 ~~~~iIDfe~a~ 204 (296)
T cd05153 193 ELSGVIDFYFAC 204 (296)
T ss_pred ceEEEeehhhhc
Confidence 777999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.003 Score=54.96 Aligned_cols=30 Identities=33% Similarity=0.391 Sum_probs=25.7
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
.++||+|++|.||+++++...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 359999999999999976666899998864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0011 Score=51.60 Aligned_cols=109 Identities=21% Similarity=0.214 Sum_probs=75.4
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.|..+|+|+-+.++ ....+..|++++..++..++ .++|.+..+ ++.|||+.|.+|...-.. .+...
T Consensus 44 ~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~------~~rk~- 110 (201)
T COG2112 44 RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIG------GDRKH- 110 (201)
T ss_pred cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhc------ccHHH-
Confidence 45689999987654 34678889999999977666 456655432 466999999888665421 12222
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCC-CCcEEECCCCcEEEecccccc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLK-ASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~-p~nil~~~~~~~kl~df~~~~ 132 (303)
+..++.....|-..| |-|+.|. |...++..++.+.|+||..+.
T Consensus 111 ---l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 111 ---LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred ---HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 334445555556667 9999987 666666666699999999876
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00038 Score=56.74 Aligned_cols=122 Identities=22% Similarity=0.255 Sum_probs=60.9
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCC-CcceeEEEEEEeCCeeeEEEeeCCCCChhhh-hcC------------
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCY-LFD------------ 71 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~------------ 71 (303)
++.|++|+..... ...-.-..|...++.+.. ..-.++++++.+ ..|.+|+++.+|..- +..
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 5789999986653 334455678888888844 344667766533 367799877665321 111
Q ss_pred --c---C---cccCCCHHHHHHH----------------------HHHHHHHHHHHH----hcC-CCCeeecCCCCCcEE
Q 045452 72 --P---I---RRLILDWKKRVHI----------------------IEGITQGLLYLQ----EYS-RLTIIHRDLKASNIL 116 (303)
Q Consensus 72 --~---~---~~~~~~~~~~~~~----------------------~~~i~~~l~~lh----~~~-~~~i~H~dl~p~nil 116 (303)
+ . .....-+..+..| +..+..-+..+. ..+ ...++|+|+.|.||+
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0 0 0000011222222 011112222221 111 134899999999999
Q ss_pred E-CCCCcEEEecccccc
Q 045452 117 L-GEDMKPKISDFGLAR 132 (303)
Q Consensus 117 ~-~~~~~~kl~df~~~~ 132 (303)
+ +.++.++++||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0016 Score=57.29 Aligned_cols=122 Identities=20% Similarity=0.291 Sum_probs=69.9
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeeeEEEeeCCCCChhhh-hcC------------
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCY-LFD------------ 71 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~------------ 71 (303)
++.|++|+..........+ .+|..+++.+...++ .++++.+..+ .|.+|+++.++... +.+
T Consensus 65 ~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~ 139 (344)
T PLN02236 65 GRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLR 139 (344)
T ss_pred CCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHH
Confidence 4789999886554333333 678888888844444 4667666332 58999987776421 100
Q ss_pred --cC---c--ccCCCHHHHHHHHHHHH-----------------HHHHHH----Hh-cCCCCeeecCCCCCcEEECC-CC
Q 045452 72 --PI---R--RLILDWKKRVHIIEGIT-----------------QGLLYL----QE-YSRLTIIHRDLKASNILLGE-DM 121 (303)
Q Consensus 72 --~~---~--~~~~~~~~~~~~~~~i~-----------------~~l~~l----h~-~~~~~i~H~dl~p~nil~~~-~~ 121 (303)
+. . .....+..+..|+.++. ..+..| .. .....++|+|+++.||++++ ++
T Consensus 140 ~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~ 219 (344)
T PLN02236 140 EFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR 219 (344)
T ss_pred HHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC
Confidence 00 0 00111233333332221 111111 11 12335899999999999986 46
Q ss_pred cEEEecccccc
Q 045452 122 KPKISDFGLAR 132 (303)
Q Consensus 122 ~~kl~df~~~~ 132 (303)
.+.++||..+.
T Consensus 220 ~~~lID~Eya~ 230 (344)
T PLN02236 220 AITIIDYEYAS 230 (344)
T ss_pred cEEEEeehhcc
Confidence 79999998874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0019 Score=55.88 Aligned_cols=30 Identities=33% Similarity=0.431 Sum_probs=26.6
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
.+++|+|+++.|++++.++.+.++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 459999999999999988877999998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0026 Score=54.83 Aligned_cols=119 Identities=18% Similarity=0.278 Sum_probs=77.1
Q ss_pred CCEEEEEEccC--CChhhHHHHHHHHHHHhcCC--CCcceeEEEEEEeCC--eeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 6 GEVIAVKKLSK--SSAQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 6 g~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
++.++++ .+. ..........+|+.+++.+. .--..+.+++|..+. ..+.||++++|..+.+.+.. ....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~----~~~~ 122 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP----ESLG 122 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc----ccch
Confidence 6677777 321 22344556678888888873 234566777777665 77999999988644333211 0011
Q ss_pred HHHHHHHH-HHHHHHHHHHHhc-------------------------------------------------------CCC
Q 045452 80 WKKRVHII-EGITQGLLYLQEY-------------------------------------------------------SRL 103 (303)
Q Consensus 80 ~~~~~~~~-~~i~~~l~~lh~~-------------------------------------------------------~~~ 103 (303)
.+.+ ..++..|+.||+- +..
T Consensus 123 ----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 123 ----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 1122 2555555555532 224
Q ss_pred CeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 104 TIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
.++|||+++.|++++.++-+-++||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 589999999999999998899999998754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.005 Score=53.04 Aligned_cols=56 Identities=14% Similarity=0.034 Sum_probs=39.4
Q ss_pred EEEEEEccCCChhhHHHHHHHHHHHhcCC-C--CcceeEEEEEEeC---CeeeEEEeeCCCCCh
Q 045452 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-H--VNLIRVLGFCIDS---EERMLVYEYMPNKSL 65 (303)
Q Consensus 8 ~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~~~sL 65 (303)
.+++|..+.. .....+..|...++.|. + -.+.++++++... +..++|||+++|.++
T Consensus 39 ~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 39 NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 4666775431 12246788999999884 3 3678899887643 568999999998765
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0028 Score=54.71 Aligned_cols=57 Identities=16% Similarity=0.253 Sum_probs=36.7
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCCeeeEEEeeCCCCChhh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 67 (303)
++.+++|+...... ......+|..++..+...+ ..+++.++. -.+|++|++|.++..
T Consensus 29 ~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i~G~~l~~ 86 (302)
T cd05156 29 PRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFIPSRTLTT 86 (302)
T ss_pred CCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhheeCCCcCCH
Confidence 67899999755432 2234567888888874333 345666553 246899998877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00015 Score=72.88 Aligned_cols=159 Identities=13% Similarity=-0.019 Sum_probs=112.8
Q ss_pred HHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCc-ccCCCHHHHHHHHHHHHHHHHHHHhcC-
Q 045452 26 KNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYS- 101 (303)
Q Consensus 26 ~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~- 101 (303)
..|....+...|+++...+.-.... ...+..++++.+|.+.+.|-+... ...++...+.....+.+....-+|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3444555566898888776665433 356899999999999888755433 233444444333333345555555433
Q ss_pred -CCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHH
Q 045452 102 -RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 102 -~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 180 (303)
.+-.+|+++++.|.++..+.++|++++|+.+.-. .. ........+++.|+.|++...-.++.++|+|..|+-+|...
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccC-ch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 3447999999999999999999999999987221 11 22233356788999999998888888899999999999999
Q ss_pred hCCCCc
Q 045452 181 SGKRLS 186 (303)
Q Consensus 181 ~g~~p~ 186 (303)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 988776
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0019 Score=52.24 Aligned_cols=101 Identities=14% Similarity=0.090 Sum_probs=65.1
Q ss_pred EEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHH
Q 045452 10 AVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIE 88 (303)
Q Consensus 10 aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~ 88 (303)
.+|+++..... .-..|..+.++++++. +|+++..= +...+.++.|.|..... . ...+..
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---~-------------~~N~i~ 148 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---N-------------FSNFIT 148 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---c-------------hhHHHH
Confidence 45555433222 3345677888888775 56776622 44467899999865422 0 011222
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccc
Q 045452 89 GITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 89 ~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~ 131 (303)
.-+..|.-.|+.+ .+.+|||..|+||+-|+.|.+||.|-+..
T Consensus 149 agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 149 AGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 2245666778543 35999999999999999999999997643
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0062 Score=53.28 Aligned_cols=29 Identities=31% Similarity=0.465 Sum_probs=25.3
Q ss_pred CeeecCCCCCcEEECC-CCcEEEecccccc
Q 045452 104 TIIHRDLKASNILLGE-DMKPKISDFGLAR 132 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~-~~~~kl~df~~~~ 132 (303)
.++|+|+.+.||++++ ++.++++||..+.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 4799999999999975 4789999999874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.015 Score=51.88 Aligned_cols=59 Identities=17% Similarity=0.134 Sum_probs=38.9
Q ss_pred CCC-CEEEEEEccCC------C-hhhHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeeeEEEeeCCCCC
Q 045452 4 PCG-EVIAVKKLSKS------S-AQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKS 64 (303)
Q Consensus 4 ~~g-~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~s 64 (303)
.+| +.|+||.-.+. . +...++...|.+.|+.+. ..++.+++.+ +.+..++|||++++..
T Consensus 48 ~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 48 TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 445 48999975321 1 224567777888888762 2357777776 3456789999997643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.01 Score=51.70 Aligned_cols=28 Identities=39% Similarity=0.609 Sum_probs=25.2
Q ss_pred eeecCCCCCcEEECCCCc-EEEecccccc
Q 045452 105 IIHRDLKASNILLGEDMK-PKISDFGLAR 132 (303)
Q Consensus 105 i~H~dl~p~nil~~~~~~-~kl~df~~~~ 132 (303)
+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.009 Score=52.00 Aligned_cols=71 Identities=18% Similarity=0.193 Sum_probs=54.9
Q ss_pred eeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccc
Q 045452 52 ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 52 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~ 131 (303)
..|++|++- |+++... ..-...++..++++-+..++-+...- .+-|||+.-.||+++ +|+|.|+||.++
T Consensus 300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 456777775 5555221 22456788889998888888777644 489999999999999 999999999999
Q ss_pred cc
Q 045452 132 RI 133 (303)
Q Consensus 132 ~~ 133 (303)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 84
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0032 Score=53.90 Aligned_cols=92 Identities=17% Similarity=0.189 Sum_probs=64.3
Q ss_pred HHHHHHHhcCC-CC-cceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 045452 26 KNEVMLTAKLQ-HV-NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRL 103 (303)
Q Consensus 26 ~~e~~~l~~l~-h~-~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 103 (303)
.+|+..|+.|. |. -+.+.+++. .-++||+++.|-.|...- ...+.. .+...++..+.-|-..|
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~------~v~d~~---~ly~~lm~~Iv~la~~G-- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVR------HVEDPP---TLYDDLMGLIVRLANHG-- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeee------ecCChH---HHHHHHHHHHHHHHHcC--
Confidence 46888888883 33 355666554 458999999888884432 112222 33444455555666667
Q ss_pred CeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 104 TIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
++|||++--||++++++.++++||--...
T Consensus 223 -lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 -LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred -ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999976543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.02 Score=48.79 Aligned_cols=29 Identities=31% Similarity=0.607 Sum_probs=24.6
Q ss_pred CeeecCCCCCcEEECCCCc-EEEecccccc
Q 045452 104 TIIHRDLKASNILLGEDMK-PKISDFGLAR 132 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~-~kl~df~~~~ 132 (303)
.++|+|++|.||+++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997555 5799999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.03 Score=47.87 Aligned_cols=57 Identities=19% Similarity=0.260 Sum_probs=35.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC---CCCcceeEEEEEEeCCeeeEEEeeCCCC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLVYEYMPNK 63 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 63 (303)
.+++.+.||.-.. .....|..|+.-|+.| ..-.+.+++++....+..+++|||++.+
T Consensus 38 ~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678889998752 2234567788777777 3446789999988877889999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.1 Score=45.62 Aligned_cols=28 Identities=39% Similarity=0.529 Sum_probs=23.5
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
.+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4489999999999995 3 57899999764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.058 Score=43.34 Aligned_cols=84 Identities=25% Similarity=0.415 Sum_probs=55.7
Q ss_pred HHHHHHHHHhcC---CCCcc--eeEEEEEEeCC------------------eeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 24 EFKNEVMLTAKL---QHVNL--IRVLGFCIDSE------------------ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 24 ~~~~e~~~l~~l---~h~~i--v~~~~~~~~~~------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.|..|-+...+| .+.++ |+++|+..-.. ...||.||..... .+..
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~ 167 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI 167 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch
Confidence 567788888877 34455 89999874331 1245666654332 1222
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~ 131 (303)
. -+.+|.+-+..+|..| |+-+|+++.|.. .-+|+||+.+
T Consensus 168 ~----~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 R----DIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred h----HHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 2 3445556667788888 999999999986 3489999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.092 Score=46.06 Aligned_cols=98 Identities=17% Similarity=0.197 Sum_probs=63.0
Q ss_pred HHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCe
Q 045452 27 NEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTI 105 (303)
Q Consensus 27 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i 105 (303)
.|++-|.+|+..+|.-.--+.. . .-.|||+|+.... +..-..+...++...+..+-.+++..+.-|.+ ++ +
T Consensus 215 KE~RNLkRl~~aGIP~PePIlL-k-~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~---L 286 (520)
T KOG2270|consen 215 KEMRNLKRLNNAGIPCPEPILL-K-NHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR---L 286 (520)
T ss_pred HHHHHHHHHHhcCCCCCCceee-e-cceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc---e
Confidence 4777777775544422111111 1 2359999985322 22122344557777777777777777777754 44 9
Q ss_pred eecCCCCCcEEECCCCcEEEeccccccc
Q 045452 106 IHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 106 ~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
||.||.--|+|+. +|.++++|.+-+..
T Consensus 287 VHADLSEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 287 VHADLSEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred eccchhhhhheEE-CCEEEEEEcccccc
Confidence 9999999999986 46899999887654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.0087 Score=54.34 Aligned_cols=47 Identities=28% Similarity=0.268 Sum_probs=37.4
Q ss_pred HHHHHHHHHHhcCCCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhc
Q 045452 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~ 70 (303)
..+.-....++.+.|+|...++++.... ....+|||++ +.||.+.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 4456677888999999999999887654 3577899998 678988874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.16 Score=46.33 Aligned_cols=56 Identities=9% Similarity=0.088 Sum_probs=35.3
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeeeEEEeeCCCCChh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLD 66 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~ 66 (303)
++.|++|+......... .-.+|..+++.+...+| .++++.+. -+.+.+|++|.+|.
T Consensus 138 ~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~efi~g~~l~ 194 (442)
T PTZ00296 138 RRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEEWLYGDPLR 194 (442)
T ss_pred CceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEEeeCCccCC
Confidence 57899999865443332 33467777777744444 45666552 35689999887553
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.019 Score=45.54 Aligned_cols=28 Identities=21% Similarity=0.349 Sum_probs=25.0
Q ss_pred CeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 104 TIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..+|+|+.|.|++++++| ++++||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 479999999999998877 9999999874
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.17 Score=41.51 Aligned_cols=59 Identities=22% Similarity=0.296 Sum_probs=42.8
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcC---CCCcceeEEEEEEeCCeeeEEEeeCCCCChh
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 66 (303)
+..++.+|+-. .....-|..|+.-|+.| +.-.+.+++.+.....+.|+||+|++.+.+.
T Consensus 38 g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 34556666643 23345677788777777 3456788999998899999999999887664
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.052 Score=45.96 Aligned_cols=30 Identities=27% Similarity=0.357 Sum_probs=27.3
Q ss_pred CeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 104 TIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
.+||+|+.|.|++.++.+.++|+||..+..
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 489999999999999989999999988753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.13 Score=45.85 Aligned_cols=29 Identities=31% Similarity=0.259 Sum_probs=24.2
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
...+|.|+.+.||+.++ +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 34899999999999765 469999998874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.49 Score=42.51 Aligned_cols=29 Identities=21% Similarity=0.400 Sum_probs=24.2
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..++|||+.+.||+++.++ .+++|..++.
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 4489999999999999875 8888877653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.1 Score=45.13 Aligned_cols=29 Identities=28% Similarity=0.368 Sum_probs=25.0
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
.+++|+|+++.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999987 678999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.36 Score=48.87 Aligned_cols=31 Identities=35% Similarity=0.455 Sum_probs=25.4
Q ss_pred CCeeecCCCCCcEEECCCC--cE-EEeccccccc
Q 045452 103 LTIIHRDLKASNILLGEDM--KP-KISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~--~~-kl~df~~~~~ 133 (303)
..++|+|+++.||+++.++ .+ -|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999999875 45 4999998753
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.18 Score=42.77 Aligned_cols=37 Identities=30% Similarity=0.380 Sum_probs=28.7
Q ss_pred HHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChh
Q 045452 26 KNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66 (303)
Q Consensus 26 ~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 66 (303)
.+|+...+.| -|..-.++|+-|.+ .++++|+.|.+|.
T Consensus 126 e~Ev~afk~L~a~G~ap~Ly~tF~N----GLvyefi~g~tL~ 163 (391)
T KOG4720|consen 126 ENEVIAFKLLAAYGFAPKLYGTFNN----GLVYEFIQGKTLE 163 (391)
T ss_pred HHHHHHHHHHHHcCcChhhhheecC----ceEEeeecCcccC
Confidence 4577777777 57777889998865 4999999998884
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 303 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-31 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-108
Identities = 94/265 (35%), Positives = 141/265 (53%), Gaps = 13/265 (4%)
Query: 1 GVLPCGEVIAVKKLSK----SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLV 56
G + +AVKKL+ ++ + ++F E+ + AK QH NL+ +LGF D ++ LV
Sbjct: 50 GYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108
Query: 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
Y YMPN SL L L W R I +G G+ +L E IHRD+K++NIL
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
L E KISDFGLAR K + T ++VGT Y+ PE R G + KSD++SFGV+L
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVL 224
Query: 177 LQIISGKRLSMLCGINENLSILEHAYELWKGGKGME-FVDSFLDDRNSSCKLMRCLEIAL 235
L+II+G + L L+ E+ K +E ++D ++D +S+ + +A
Sbjct: 225 LEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVAS 281
Query: 236 LCVQENPNDRPSMLEVSSMLKNETT 260
C+ E N RP + +V +L+ T
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-108
Identities = 102/262 (38%), Positives = 153/262 (58%), Gaps = 5/262 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G L G ++AVK+L + QG E +F+ EV + + H NL+R+ GFC+ ER+LVY Y
Sbjct: 49 GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 60 MPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
M N S+ L + + LDW KR I G +GL YL ++ IIHRD+KA+NILL
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
E+ + + DFGLA++ + T V GTIG+I PEY G S K+DVF +GV+LL+
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 179 IISGKRLSMLCGI--NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236
+I+G+R L + ++++ +L+ L K K VD L ++ + +++ALL
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL 287
Query: 237 CVQENPNDRPSMLEVSSMLKNE 258
C Q +P +RP M EV ML+ +
Sbjct: 288 CTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-97
Identities = 89/257 (34%), Positives = 148/257 (57%), Gaps = 4/257 (1%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GVL G +A+K+ + S+QG EEF+ E+ + +H +L+ ++GFC + E +L+Y+YM
Sbjct: 58 GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 61 PNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
N +L +L+ + + W++R+ I G +GL YL + IIHRD+K+ NILL E
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
+ PKI+DFG+++ + + V GT+GYI PEY +G + KSDV+SFGV+L ++
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 180 ISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
+ + + E +++ E A E G+ + VD L D+ L + + A+ C+
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 240 ENPNDRPSMLEVSSMLK 256
+ DRPSM +V L+
Sbjct: 295 LSSEDRPSMGDVLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 9e-75
Identities = 61/276 (22%), Positives = 105/276 (38%), Gaps = 27/276 (9%)
Query: 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEY 59
E +AVK Q ++ + EV ++H N+++ +G + L+ +
Sbjct: 45 LLNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-------QEYSRLTIIHRDLKA 112
SL +L + ++ W + HI E + +GL YL ++ + I HRD+K+
Sbjct: 104 HEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-----YSTKS 167
N+LL ++ I+DFGLA F +T VGT Y+ PE + +
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 168 DVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-----FLDDRN 222
D+++ G++L ++ S + L E + E V L D
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW 279
Query: 223 SSCKLMRCL-EIALLCVQENPNDRPSMLEVSSMLKN 257
M L E C + R S V +
Sbjct: 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-61
Identities = 66/301 (21%), Positives = 106/301 (35%), Gaps = 44/301 (14%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-----DSEERMLVYEY 59
+AVK S ++ Q F K + ++H N+ R + E +LV EY
Sbjct: 35 DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL------QEYSRLTIIHRDLKAS 113
PN SL YL DW + +T+GL YL ++ + I HRDL +
Sbjct: 94 YPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQ------VVGTIGYIPPEYARQGV----- 162
N+L+ D ISDFGL+ L E+ VGTI Y+ PE V
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX 209
Query: 163 --YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG----MEFVDS 216
+ D+++ G++ +I + A++ G M+ + S
Sbjct: 210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM---AFQTEVGNHPTFEDMQVLVS 266
Query: 217 FLDDR-------NSSCKLMRCL-EIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKP 268
R + +R L E C ++ R + + K
Sbjct: 267 REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
Query: 269 A 269
+
Sbjct: 327 S 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-56
Identities = 66/260 (25%), Positives = 115/260 (44%), Gaps = 30/260 (11%)
Query: 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G +AVK L + A+ EF EV + +L+H N++ +G +V EY+
Sbjct: 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL L R LD ++R+ + + +G+ YL I+HR+LK+ N+L+ +
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
K+ DFGL+R+ A L + + GT ++ PE R + KSDV+SFGV+L ++ +
Sbjct: 178 VKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIALLC 237
++ NL+ + + K +E + ++ C
Sbjct: 236 QQP------WGNLNPAQVVAAVGFKCKRLEI--------PRNLNPQVAAIIE------GC 275
Query: 238 VQENPNDRPSMLEVSSMLKN 257
P RPS + +L+
Sbjct: 276 WTNEPWKRPSFATIMDLLRP 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-53
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 41/270 (15%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
GEV+ +K+L + + F EV + L+H N+++ +G + + EY+ +
Sbjct: 34 TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L + + W +RV + I G+ YL + IIHRDL + N L+ E+
Sbjct: 94 LRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVV 148
Query: 125 ISDFGLARIFAKESLKANTEQ------------VVGTIGYIPPEYARQGVYSTKSDVFSF 172
++DFGLAR+ E + + VVG ++ PE Y K DVFSF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYEL-WKGGKGMEFVDSFLDDRNSSCKLMRC- 230
G++L +II + + + L +G + C
Sbjct: 209 GIVLCEIIGRVN------ADPDYLPRTMDFGLNVRGFLDRYCPPN-------------CP 249
Query: 231 ---LEIALLCVQENPNDRPSMLEVSSMLKN 257
I + C +P RPS +++ L+
Sbjct: 250 PSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-51
Identities = 70/258 (27%), Positives = 126/258 (48%), Gaps = 23/258 (8%)
Query: 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G+V AVK L+ + + Q + FKNEV + K +HVN++ +G+ + +V ++
Sbjct: 46 HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 103
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL +L + + KK + I +G+ YL +IIHRDLK++NI L ED
Sbjct: 104 SSLYHHLHASETKF--EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNT 158
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPE---YARQGVYSTKSDVFSFGVLLLQI 179
KI DFGLA ++ S EQ+ G+I ++ PE YS +SDV++FG++L ++
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 180 ISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
++G+ N++ + E+ G + + K + C++
Sbjct: 219 MTGQLPY------SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK-----RLMAECLK 267
Query: 240 ENPNDRPSMLEVSSMLKN 257
+ ++RPS + + ++
Sbjct: 268 KKRDERPSFPRILAEIEE 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-51
Identities = 72/270 (26%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 5 CGEVIAVKKLSKS----SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ +AVK +Q E + E L A L+H N+I + G C+ LV E+
Sbjct: 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L+ L + V+ I +G+ YL + + + IIHRDLK+SNIL+ +
Sbjct: 89 RGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 121 MKP--------KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
++ KI+DFGLAR + + + + G ++ PE R ++S SDV+S+
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KL 227
GVLL ++++G+ + L AY + + S+C KL
Sbjct: 201 GVLLWELLTGEVPF------RGIDGLAVAYGVAMNKLALP--------IPSTCPEPFAKL 246
Query: 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
M C +P+ RPS + L
Sbjct: 247 ME------DCWNPDPHSRPSFTNILDQLTT 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-51
Identities = 60/259 (23%), Positives = 107/259 (41%), Gaps = 34/259 (13%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ +A+K++ S + + F E+ +++ H N++++ G C++ LV EY S
Sbjct: 30 RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGS 85
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-P 123
L L + +QG+ YL +IHRDLK N+LL
Sbjct: 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI DFG A + + N G+ ++ PE YS K DVFS+G++L ++I+ +
Sbjct: 146 KICDFGTAC-DIQTHMTNNK----GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGM-----EFVDSFLDDRNSSCKLMRCLEIALLCV 238
+ + + W G + + + LM C
Sbjct: 201 KPF------DEIGGPAFRIM-WAVHNGTRPPLIKNLPKPI------ESLMTR------CW 241
Query: 239 QENPNDRPSMLEVSSMLKN 257
++P+ RPSM E+ ++ +
Sbjct: 242 SKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-49
Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 47/271 (17%)
Query: 6 GEVIAVKKLSKSSAQG-------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
V+A+K L ++G F+EF+ EV + + L H N++++ G +V E
Sbjct: 44 KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVME 101
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
++P L L D + + W ++ ++ I G+ Y+Q I+HRDL++ NI L
Sbjct: 102 FVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQ 158
Query: 119 E-----DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--YARQGVYSTKSDVFS 171
+ K++DFGL++ +G ++ PE A + Y+ K+D +S
Sbjct: 159 SLDENAPVCAKVADFGLSQQSVHSVSGL-----LGNFQWMAPETIGAEEESYTEKADTYS 213
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM-----EFVDSFLDDRNSSCK 226
F ++L I++G+ + S + + +G+ E L
Sbjct: 214 FAMILYTILTGEGPF------DEYSYGKIKFINMIREEGLRPTIPEDCPPRL------RN 261
Query: 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
++ LC +P RP + L
Sbjct: 262 VIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-48
Identities = 57/267 (21%), Positives = 113/267 (42%), Gaps = 38/267 (14%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
GEV A++ + + + FK EVM + +H N++ +G C+ ++ +
Sbjct: 56 GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+L + D +++LD K I + I +G+ YL +++ I+H+DLK+ N+ ++ K
Sbjct: 115 TLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL--HAK-GILHKDLKSKNVFY-DNGKV 168
Query: 124 KISDFGLARIFAKESLKANTEQ---VVGTIGYIPPEYARQGV---------YSTKSDVFS 171
I+DFGL I ++ G + ++ PE RQ +S SDVF+
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-KLMRC 230
G + ++ + + + +++ G K + K +
Sbjct: 229 LGTIWYELHAREWPF------KTQPAEAIIWQMGTGMK--------PNLSQIGMGKEIS- 273
Query: 231 LEIALLCVQENPNDRPSMLEVSSMLKN 257
+I L C +RP+ ++ ML+
Sbjct: 274 -DILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-47
Identities = 54/265 (20%), Positives = 101/265 (38%), Gaps = 41/265 (15%)
Query: 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYM 60
G I VK L S + +F E H N++ VLG C L+ +M
Sbjct: 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P SL L + ++D + V + +G+ +L L I L + ++++ ED
Sbjct: 92 PYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDED 149
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ---GVYSTKSDVFSFGVLLL 177
M +IS + F + ++ PE ++ +D++SF VLL
Sbjct: 150 MTARISMADVKFSFQSPG-------RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGM-----EFVDSFLDDRNSSCKLMRCLE 232
++++ + +LS +E +G+ + + KLM+
Sbjct: 203 ELVTREVPF------ADLSNMEIGM--KVALEGLRPTIPPGISPHV------SKLMK--- 245
Query: 233 IALLCVQENPNDRPSMLEVSSMLKN 257
+C+ E+P RP + +L+
Sbjct: 246 ---ICMNEDPAKRPKFDMIVPILEK 267
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-43
Identities = 63/283 (22%), Positives = 104/283 (36%), Gaps = 43/283 (15%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKNE--VMLTAKLQHVNLIRVLGFCIDSEER----MLVYE 58
GE +AVK + E + T ++H N++ + I L+ +
Sbjct: 59 RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-----QEYSRLTIIHRDLKAS 113
Y N SL +D ++ LD K + + GL +L + I HRDLK+
Sbjct: 116 YHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQ--VVGTIGYIPPE------YARQGVYST 165
NIL+ ++ I+D GLA F ++ + + VGT Y+PPE
Sbjct: 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK----GMEFVDSFLDDR 221
+D++SFG++L ++ C + + Y M + R
Sbjct: 232 MADMYSFGLILWEVARR------CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285
Query: 222 ---NSSCKLMRCL-EIALL---CVQENPNDRPSMLEVSSMLKN 257
+ CL ++ L C NP R + L V L
Sbjct: 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-43
Identities = 59/289 (20%), Positives = 111/289 (38%), Gaps = 55/289 (19%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKNE--VMLTAKLQHVNLIRVLGFCIDSE----ERMLVYE 58
GE +AVK S ++ + + E + T L+H N++ + + S + L+
Sbjct: 30 QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-----QEYSRLTIIHRDLKAS 113
Y SL +D ++ LD + I+ I GL +L + I HRDLK+
Sbjct: 87 YHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQ--VVGTIGYIPPE------YARQGVYST 165
NIL+ ++ + I+D GLA + ++ + + + VGT Y+ PE
Sbjct: 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK 202
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG-------------KGM- 211
+ D+++FG++L ++ N + + +
Sbjct: 203 RVDIWAFGLVLWEVARR------MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR 256
Query: 212 -EFVDSFLDDRNSS--CKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
+ + D + KLM+ C +NP+ R + L + L
Sbjct: 257 PNIPNRWFSDPTLTSLAKLMK------ECWYQNPSARLTALRIKKTLTK 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 43/286 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNK 63
G ++AVK+L S +F+ E+ + L +++ G + LV EY+P+
Sbjct: 52 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L +L R LD + + I +G+ YL +HRDL A NIL+ +
Sbjct: 112 CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHV 166
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQ 178
KI+DFGLA++ + VV G P PE ++S +SDV+SFGV+L +
Sbjct: 167 KIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222
Query: 179 IIS--------GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC----- 225
+ + + G ++ L EL + G+ + +C
Sbjct: 223 LFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP--------APPACPAEVH 274
Query: 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFS 271
+LM LC +P DRPS + L + + + AF+
Sbjct: 275 ELM------KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 69/271 (25%), Positives = 103/271 (38%), Gaps = 46/271 (16%)
Query: 1 GVLPCGEV-IAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
G L +AVK +F E + + H N++R++G C + +V E
Sbjct: 133 GRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+ +L RL + K + ++ G+ YL IHRDL A N L+
Sbjct: 193 LVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVT 247
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFG 173
E KISDFG++R A A+ G + +P PE G YS++SDV+SFG
Sbjct: 248 EKNVLKISDFGMSREEADGVYAAS-----GGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302
Query: 174 VLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----K 226
+LL + S G Y + EFV+ C +
Sbjct: 303 ILLWETFSLGAS----------------PYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
LM C P RPS + L++
Sbjct: 347 LM------EQCWAYEPGQRPSFSTIYQELQS 371
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 60/281 (21%), Positives = 106/281 (37%), Gaps = 39/281 (13%)
Query: 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYM 60
GE +AVK S + + + E+ T L+H N++ + + LV +Y
Sbjct: 64 RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-----QEYSRLTIIHRDLKASNI 115
+ SL FD + R + + + + GL +L + I HRDLK+ NI
Sbjct: 123 EHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQ--VVGTIGYIPPE------YARQGVYSTKS 167
L+ ++ I+D GLA + + VGT Y+ PE + ++
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238
Query: 168 DVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG----KGMEFVDSF------ 217
D+++ G++ +I C I + Y + M V
Sbjct: 239 DIYAMGLVFWEIARR------CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 292
Query: 218 LDDRNSSCKLMRCL-EIALLCVQENPNDRPSMLEVSSMLKN 257
+ +R SC+ +R + +I C N R + L + L
Sbjct: 293 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-41
Identities = 75/272 (27%), Positives = 114/272 (41%), Gaps = 30/272 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNK 63
GEV+AVKKL S+ + +F+ E+ + LQH N+++ G C + R L+ EY+P
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
SL YL + +D K + I +G+ YL IHRDL NIL+ + +
Sbjct: 99 SLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 124 KISDFGLARIFAKESLKANTEQ-VVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLL 177
KI DFGL ++ L + E V G P PE + +S SDV+SFGV+L
Sbjct: 154 KIGDFGLTKV-----LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCL 231
++ + S I +E + + R C +M
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM--- 265
Query: 232 EIALLCVQENPNDRPSMLEVSSMLKNETTNTN 263
C N N RPS +++ + N
Sbjct: 266 ---TECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 74/266 (27%), Positives = 113/266 (42%), Gaps = 30/266 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNK 63
GEV+AVKKL S+ + +F+ E+ + LQH N+++ G C + R L+ EY+P
Sbjct: 70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
SL YL + +D K + I +G+ YL IHRDL NIL+ + +
Sbjct: 130 SLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 184
Query: 124 KISDFGLARIFAKESLKANTEQ-VVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLL 177
KI DFGL ++ L + E V G P PE + +S SDV+SFGV+L
Sbjct: 185 KIGDFGLTKV-----LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCL 231
++ + S I +E + + R C +M
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM--- 296
Query: 232 EIALLCVQENPNDRPSMLEVSSMLKN 257
C N N RPS +++ +
Sbjct: 297 ---TECWNNNVNQRPSFRDLALRVDQ 319
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 33/261 (12%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L K EEF E + +++H NL+++LG C ++ E+M +L YL
Sbjct: 249 AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
+ R + +++ I+ + YL + IHR+L A N L+GE+ K++DFG
Sbjct: 308 REC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 130 LARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSML 188
L+R+ ++ A+ I + PE +S KSDV++FGVLL +I + G
Sbjct: 364 LSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 189 CGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIALLCVQENPN 243
+++ +LE Y + +R C +LM C Q NP+
Sbjct: 423 IDLSQVYELLEKDYRM---------------ERPEGCPEKVYELM------RACWQWNPS 461
Query: 244 DRPSMLEVSSMLKNETTNTNT 264
DRPS E+ + ++
Sbjct: 462 DRPSFAEIHQAFETMFQESSI 482
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 62/281 (22%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L ++S ++F+ E L LQH +++R G C + ++V+EYM + L+ +L
Sbjct: 75 AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 70 ------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ + L + + + + G++YL + L +HRDL N L+
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLV 191
Query: 118 GEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFS 171
G+ + KI DFG++R I++ + + +P PE ++T+SDV+S
Sbjct: 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGR------TMLPIRWMPPESILYRKFTTESDVWS 245
Query: 172 FGVLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC- 225
FGV+L +I + GK+ LS N + G+ +E R +C
Sbjct: 246 FGVVLWEIFTYGKQPWYQLS-----NTEA------IDCITQGRELE--------RPRACP 286
Query: 226 ----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
+MR C Q P R S+ +V + L+
Sbjct: 287 PEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAP 321
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 63/282 (22%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L + ++F+ E L LQH ++++ G C D + ++V+EYM + L+ +L
Sbjct: 49 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
Query: 70 -------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ L + +HI I G++YL + +HRDL N L
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCL 165
Query: 117 LGEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVF 170
+G ++ KI DFG++R +++ + + +P PE ++T+SDV+
Sbjct: 166 VGANLLVKIGDFGMSRDVYSTDYYRVGGH------TMLPIRWMPPESIMYRKFTTESDVW 219
Query: 171 SFGVLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC 225
SFGV+L +I + GK+ LS N + E G+ +E R C
Sbjct: 220 SFGVILWEIFTYGKQPWFQLS-----NTEV------IECITQGRVLE--------RPRVC 260
Query: 226 -----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
+M C Q P R ++ E+ +L T
Sbjct: 261 PKEVYDVML------GCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 70/273 (25%), Positives = 120/273 (43%), Gaps = 44/273 (16%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + + + +F +E + + H N+IR+ G M+V EYM N SLD +
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + + + V ++ G+ G+ YL S L +HRDL A N+L+ ++ K+SDF
Sbjct: 141 LRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R+ + A T G IP PE +S+ SDV+SFGV++ ++++ G
Sbjct: 196 GLSRVLEDDPDAAYTTTG----GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
+R Y + V+ + C +LM L
Sbjct: 252 ER----------------PYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM------LD 289
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269
C ++ RP ++ S+L + + + A
Sbjct: 290 CWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 44/273 (16%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + + +F E + + H N+IR+ G + M++ EYM N +LD +
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + + + V ++ GI G+ YL + + +HRDL A NIL+ ++ K+SDF
Sbjct: 137 LREKDGEFSV--LQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R+ + T G IP PE +++ SDV+SFG+++ ++++ G
Sbjct: 192 GLSRVLEDDPEATYTTSG----GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
+R Y + M+ ++ F C +LM +
Sbjct: 248 ER----------------PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM------MQ 285
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269
C Q+ RP ++ S+L ++ K A
Sbjct: 286 CWQQERARRPKFADIVSILDKLIRAPDSLKTLA 318
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 72/273 (26%), Positives = 111/273 (40%), Gaps = 46/273 (16%)
Query: 6 GEVIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
GE++AVK L + + Q +K E+ + L H ++I+ G C D+ LV EY+P
Sbjct: 60 GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL YL R + + + + I +G+ YL IHRDL A N+LL D
Sbjct: 120 GSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRL 172
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLL 177
KI DFGLA+ + + V G P PE ++ + SDV+SFGV L
Sbjct: 173 VKIGDFGLAKAVPEG----HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 178 QIIS-GKRLSMLCGINENLSIL-------EHAYELWKGGKGMEFVDSFLDDRNSSC---- 225
++++ L + EL + G+ + R C
Sbjct: 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP--------RPDKCPAEV 280
Query: 226 -KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
LM C + + RP+ + +LK
Sbjct: 281 YHLM------KNCWETEASFRPTFENLIPILKT 307
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 4e-39
Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 34/266 (12%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
A+K L K E F E + KL+H L+++ + E +V EYM SL +L
Sbjct: 295 AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 352
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
L + V + I G+ Y+ R+ +HRDL+A+NIL+GE++ K++DFG
Sbjct: 353 KGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFG 408
Query: 130 LARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSML 188
LAR+ A I + PE A G ++ KSDV+SFG+LL ++ + G+
Sbjct: 409 LARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467
Query: 189 CGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIALLCVQENPN 243
E L +E Y + C LM C ++ P
Sbjct: 468 MVNREVLDQVERGYRM---------------PCPPECPESLHDLM------CQCWRKEPE 506
Query: 244 DRPSMLEVSSMLKNETTNTNTPKKPA 269
+RP+ + + L++ T+T +P
Sbjct: 507 ERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 34/266 (12%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
A+K L K E F E + KL+H L+++ + E +V EYM SL +L
Sbjct: 212 AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 269
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
L + V + I G+ Y+ R+ +HRDL+A+NIL+GE++ K++DFG
Sbjct: 270 KGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFG 325
Query: 130 LARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSML 188
LAR+ A I + PE A G ++ KSDV+SFG+LL ++ + G+
Sbjct: 326 LARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
Query: 189 CGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIALLCVQENPN 243
E L +E Y + C LM C ++ P
Sbjct: 385 MVNREVLDQVERGYRM---------------PCPPECPESLHDLM------CQCWRKEPE 423
Query: 244 DRPSMLEVSSMLKNETTNTNTPKKPA 269
+RP+ + + L++ T+T +P
Sbjct: 424 ERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-39
Identities = 72/270 (26%), Positives = 118/270 (43%), Gaps = 51/270 (18%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L K EEF E + +++H NL+++LG C ++ E+M +L YL
Sbjct: 42 AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
+ R + +++ I+ + YL + IHRDL A N L+GE+ K++DFG
Sbjct: 101 REC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 130 LARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-GK 183
L+R+ ++ A+ P PE +S KSDV++FGVLL +I + G
Sbjct: 157 LSRLMTGDTYTAHAG------AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 210
Query: 184 R----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEIA 234
+ +++ +LE Y + +R C +LM
Sbjct: 211 SPYPGID----LSQVYELLEKDYRM---------------ERPEGCPEKVYELM------ 245
Query: 235 LLCVQENPNDRPSMLEVSSMLKNETTNTNT 264
C Q NP+DRPS E+ + ++
Sbjct: 246 RACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 75/273 (27%), Positives = 122/273 (44%), Gaps = 44/273 (16%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + + +F E + + H N+IR+ G S+ M+V EYM N SLD +
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + + V ++ GI G+ YL S + +HRDL A NIL+ ++ K+SDF
Sbjct: 137 LRKHDAQF--TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDF 191
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL R+ + A T + G IP PE +++ SDV+S+G++L +++S G
Sbjct: 192 GLGRVLEDDPEAAYTTRG----GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
+R Y ++ VD + C +LM L
Sbjct: 248 ER----------------PYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM------LD 285
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269
C Q++ N+RP ++ S+L N + K
Sbjct: 286 CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 42/262 (16%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
A+K + + A E+F E + KL H L+++ G C++ LV E+M + L YL
Sbjct: 36 AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL 94
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
+R + + + + + +G+ YL +IHRDL A N L+GE+ K+SDFG
Sbjct: 95 RT--QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFG 149
Query: 130 LARIFAKESLKANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRL 185
+ R + ++T GT + + PE YS+KSDV+SFGVL+ ++ S GK
Sbjct: 150 MTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI- 204
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALLCVQ 239
YE + +E + + F + ++M C +
Sbjct: 205 ---------------PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM------NHCWR 243
Query: 240 ENPNDRPSMLEVSSMLKNETTN 261
E P DRP+ + L +
Sbjct: 244 ERPEDRPAFSRLLRQLAEIAES 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 34/266 (12%)
Query: 6 GEVIAVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
GE +AVK L +S + K E+ + L H N+++ G C + L+ E++P+
Sbjct: 50 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL YL P + ++ K+++ I +G+ YL +HRDL A N+L+ + +
Sbjct: 110 GSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQ 164
Query: 123 PKISDFGLARIFAKESLKANTEQ-VVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
KI DFGL + ++ + E V P PE Q + SDV+SFGV L
Sbjct: 165 VKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 177 LQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMR 229
++++ S + L ++ + + + + +C +LM
Sbjct: 220 HELLTYCDSDSS--PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLM- 276
Query: 230 CLEIALLCVQENPNDRPSMLEVSSML 255
C + P++R S +
Sbjct: 277 -----RKCWEFQPSNRTSFQNLIEGF 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 62/277 (22%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + EEF++E ML A+LQH N++ +LG + +++ Y + L +
Sbjct: 43 AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102
Query: 69 L-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
L D + L+ VH++ I G+ YL S ++H+DL N+
Sbjct: 103 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNV 159
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVF 170
L+ + + KISD GL R + A + +P PE G +S SD++
Sbjct: 160 LVYDKLNVKISDLGLFRE-----VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 214
Query: 171 SFGVLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC 225
S+GV+L ++ S G + S N+++ E+ + + + C
Sbjct: 215 SYGVVLWEVFSYGLQPYCGYS-----NQDV------VEMIRNRQVLP--------CPDDC 255
Query: 226 -----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
LM + C E P+ RP ++ S L+
Sbjct: 256 PAWVYALM------IECWNEFPSRRPRFKDIHSRLRA 286
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-38
Identities = 61/265 (23%), Positives = 110/265 (41%), Gaps = 42/265 (15%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K + K + +EF E + L H L+++ G C ++ EYM N L Y
Sbjct: 51 VAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + R ++ + + + + + + YL +HRDL A N L+ + K+SDF
Sbjct: 110 LRE--MRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 129 GLARIFAKESLKANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKR 184
GL+R + ++ G+ + + PPE +S+KSD+++FGVL+ +I S GK
Sbjct: 165 GLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
Query: 185 LSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALLCV 238
YE + + E + R +M C
Sbjct: 221 ----------------PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM------YSCW 258
Query: 239 QENPNDRPSMLEVSSMLKNETTNTN 263
E ++RP+ + S + + +
Sbjct: 259 HEKADERPTFKILLSNILDVMDEES 283
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-37
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 42/259 (16%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK + K + +EF E KL H L++ G C +V EY+ N L Y
Sbjct: 35 VAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L+ + + + + +G+ +L IHRDL A N L+ D+ K+SDF
Sbjct: 94 LRS--HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDF 148
Query: 129 GLARIFAKESLKANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKR 184
G+ R + ++ GT + + PE YS+KSDV++FG+L+ ++ S GK
Sbjct: 149 GMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
Query: 185 LSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALLCV 238
Y+L+ + + V R ++M C
Sbjct: 205 ----------------PYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM------YSCW 242
Query: 239 QENPNDRPSMLEVSSMLKN 257
E P RP+ ++ S ++
Sbjct: 243 HELPEKRPTFQQLLSSIEP 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 49/268 (18%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKS 64
G +AVK + + + F E + +L+H NL+++LG ++ + +V EYM S
Sbjct: 216 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL R +L + + + + YL +HRDL A N+L+ ED K
Sbjct: 274 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAK 329
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQI 179
+SDFGL + + +P PE R+ +STKSDV+SFG+LL +I
Sbjct: 330 VSDFGLTKEASSTQDTGK----------LPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379
Query: 180 IS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRCLEI 233
S G+ + + + +E Y++ D C +M
Sbjct: 380 YSFGRVPYPRIPLKDVVPRVEKGYKM---------------DAPDGCPPAVYDVM----- 419
Query: 234 ALLCVQENPNDRPSMLEVSSMLKNETTN 261
C + RP+ L++ L++ T+
Sbjct: 420 -KNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 65/267 (24%), Positives = 111/267 (41%), Gaps = 46/267 (17%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK + K + E F E + LQH L+++ E ++ E+M SL +L
Sbjct: 216 AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL 273
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
K + I +G+ ++ + IHRDL+A+NIL+ + KI+DFG
Sbjct: 274 KSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 130 LARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-GK 183
LAR+ A P PE G ++ KSDV+SFG+LL++I++ G+
Sbjct: 330 LARVIEDNEYTAREG------AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALLC 237
Y + + ++ + R +C +M + C
Sbjct: 384 I----------------PYPGMSNPEVIRALERGYRMPRPENCPEELYNIM------MRC 421
Query: 238 VQENPNDRPSMLEVSSMLKNETTNTNT 264
+ P +RP+ + S+L + T T +
Sbjct: 422 WKNRPEERPTFEYIQSVLDDFYTATES 448
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-37
Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 60/274 (21%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K +++ +S + EF NE + + +++R+LG + +++ E M L Y
Sbjct: 59 AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 69 L-------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L + K + + I G+ YL + +HRDL A N ++ ED
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDF 175
Query: 122 KPKISDFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVL 175
KI DFG+ R I+ + + + G +P PE + GV++T SDV+SFGV+
Sbjct: 176 TVKIGDFGMTRDIYETDYYRKGGK------GLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 176 LLQIISGKRLSMLCGI------NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC---- 225
L +I + L NE + G ++ + +C
Sbjct: 230 LWEIAT------LAEQPYQGLSNEQV------LRFVMEGGLLD--------KPDNCPDML 269
Query: 226 -KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 258
+LMR +C Q NP RPS LE+ S +K E
Sbjct: 270 FELMR------MCWQYNPKMRPSFLEIISSIKEE 297
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 45/277 (16%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + + EE E + +L + ++R++G C +E MLV E L +
Sbjct: 41 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKF 99
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L +R + ++ ++ G+ YL +HRDL A N+LL KISDF
Sbjct: 100 LVG--KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL++ + ++ + G P PE +S++SDV+S+GV + + +S G
Sbjct: 155 GLSKALGAD----DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
++ Y+ KG + M F++ + C LM
Sbjct: 211 QK----------------PYKKMKGPEVMAFIEQGKRMECPPECPPELYALM------SD 248
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQ 273
C DRP L V ++ + + +
Sbjct: 249 CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 285
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 52/267 (19%)
Query: 9 IAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLD 66
AVK L++ + +F E ++ H N++ +LG C+ SE ++V YM + L
Sbjct: 56 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
++ + + K + + +G+ YL +HRDL A N +L E K++
Sbjct: 116 NFIRNETHNPTV--KDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVA 170
Query: 127 DFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGLAR ++ KE + + T +P E + ++TKSDV+SFGVLL +++
Sbjct: 171 DFGLARDMYDKEYYSVHNK----TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
Query: 181 S-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRC 230
+ G ++ ++ G+ + + C ++M
Sbjct: 227 TRGAPPYPDVN-----TFDI------TVYLLQGRRLL--------QPEYCPDPLYEVM-- 265
Query: 231 LEIALLCVQENPNDRPSMLEVSSMLKN 257
L C RPS E+ S +
Sbjct: 266 ----LKCWHPKAEMRPSFSELVSRISA 288
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 73/284 (25%), Positives = 113/284 (39%), Gaps = 58/284 (20%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + S Q +F E ++ +K H N++R +G + S R ++ E M L +
Sbjct: 64 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123
Query: 69 L----FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
L P + L +H+ I G YL IHRD+ A N LL G
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGR 180
Query: 122 KPKISDFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVL 175
KI DFG+AR I+ + G +P PE +G++++K+D +SFGVL
Sbjct: 181 VAKIGDFGMARDIYRASYYR------KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 176 LLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC----- 225
L +I S G S N+ + E G M+ +C
Sbjct: 235 LWEIFSLGYMPYPSKS-----NQEV------LEFVTSGGRMD--------PPKNCPGPVY 275
Query: 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269
++M C Q P DRP+ + ++ T + +
Sbjct: 276 RIMT------QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 72/283 (25%), Positives = 111/283 (39%), Gaps = 56/283 (19%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + S Q +F E ++ +K H N++R +G + S R ++ E M L +
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 164
Query: 69 L----FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
L P + L +H+ I G YL IHRD+ A N LL G
Sbjct: 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGR 221
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
KI DFG+AR + G +P PE +G++++K+D +SFGVLL
Sbjct: 222 VAKIGDFGMAR-----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
Query: 177 LQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----K 226
+I S G S N+ + E G M+ +C +
Sbjct: 277 WEIFSLGYMPYPSKS-----NQEV------LEFVTSGGRMD--------PPKNCPGPVYR 317
Query: 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269
+M C Q P DRP+ + ++ T + +
Sbjct: 318 IMT------QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 354
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 59/273 (21%), Positives = 106/273 (38%), Gaps = 49/273 (17%)
Query: 10 AVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
+K L K+ E F + +KL H +L+ G C+ +E +LV E++ SLD YL
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP------ 123
+ + WK + + + + + +L T+IH ++ A NILL +
Sbjct: 104 KKNKNCINILWK--LEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPP 158
Query: 124 --KISDFGLAR-IFAKESLKANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQI 179
K+SD G++ + K+ L+ I ++PPE + +D +SFG L +I
Sbjct: 159 FIKLSDPGISITVLPKDILQER-------IPWVPPECIENPKNLNLATDKWSFGTTLWEI 211
Query: 180 IS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC---KLMRCLEIA 234
S G + + ++F + + L+
Sbjct: 212 CSGGDK----------------PLSALDSQRKLQFYEDRHQLPAPKAAELANLI------ 249
Query: 235 LLCVQENPNDRPSMLEVSSMLKNETTNTNTPKK 267
C+ P+ RPS + L + T P+
Sbjct: 250 NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 54/268 (20%)
Query: 9 IAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKSLD 66
A+K LS+ + Q E F E +L L H N++ ++G + E ++ YM + L
Sbjct: 52 CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
++ P R + K + + +G+ YL + +HRDL A N +L E K++
Sbjct: 112 QFIRSPQRNPTV--KDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVA 166
Query: 127 DFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGLAR I +E +P E + ++TKSDV+SFGVLL +++
Sbjct: 167 DFGLARDILDREYYSVQQ----HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 181 S-GKR----LSMLCGINEN-LSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMR 229
+ G + + L L + C ++M
Sbjct: 223 TRGAPPYRHID-----PFDLTHFLAQGRRL---------------PQPEYCPDSLYQVM- 261
Query: 230 CLEIALLCVQENPNDRPSMLEVSSMLKN 257
C + +P RP+ + ++
Sbjct: 262 -----QQCWEADPAVRPTFRVLVGEVEQ 284
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-36
Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 9 IAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK L K + + F E L +LQH L+R+ E ++ EYM N SL +
Sbjct: 40 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L P + L K + + I +G+ ++ IHRDL+A+NIL+ + + KI+DF
Sbjct: 98 LKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADF 153
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GLAR+ A P PE G ++ KSDV+SFG+LL +I++ G
Sbjct: 154 GLARLIEDNEYTAREG------AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
+ Y + ++ ++ + R +C +LM L
Sbjct: 208 RI----------------PYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM------RL 245
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTNTPKKP 268
C +E P DRP+ + S+L++ T T +P
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 67/269 (24%), Positives = 107/269 (39%), Gaps = 47/269 (17%)
Query: 10 AVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK K + +E E + +L + ++R++G C ++E MLV E L+
Sbjct: 48 AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNK 106
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
YL + + K + ++ ++ G+ YL +HRDL A N+LL KISD
Sbjct: 107 YL---QQNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISD 160
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS- 181
FGL++ + T G P PE +S+KSDV+SFGVL+ + S
Sbjct: 161 FGLSKALRADE----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIAL 235
G++ Y KG + ++ + C LM
Sbjct: 217 GQK----------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM------N 254
Query: 236 LCVQENPNDRPSMLEVSSMLKNETTNTNT 264
LC + +RP V L+N +
Sbjct: 255 LCWTYDVENRPGFAAVELRLRNYYYDVVN 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 72/286 (25%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L ++SA +F+ E L A+ + N++++LG C + L++EYM L+ +
Sbjct: 81 AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140
Query: 69 L---------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
L L +++ I + G+ YL S +H
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVH 197
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGV 162
RDL N L+GE+M KI+DFGL+R ++ + IP PE
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSR-----NIYSADYYKADGNDAIPIRWMPPESIFYNR 252
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGI------NENLSILEHAYELWKGGKGMEFVDS 216
Y+T+SDV+++GV+L +I S +E + + G +
Sbjct: 253 YTTESDVWAYGVVLWEIFS------YGLQPYYGMAHEEV------IYYVRDGNILA---- 296
Query: 217 FLDDRNSSC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
+C LMR LC + P DRPS + +L+
Sbjct: 297 ----CPENCPLELYNLMR------LCWSKLPADRPSFCSIHRILQR 332
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 73/284 (25%), Positives = 117/284 (41%), Gaps = 59/284 (20%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L ++ + + +E+ + + +H N+I +LG C ++ EY +L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
YL + + + +K V + +G+ YL + IHRDL A N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 187
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
+L+ E+ KI+DFGLAR T G +P PE VY+ +SDV
Sbjct: 188 VLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 170 FSFGVLLLQIISGKRLSML--CGI-NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC- 225
+SFGVL+ +I + L GI E L ++L K G M+ + ++C
Sbjct: 243 WSFGVLMWEIFT---LGGSPYPGIPVEEL------FKLLKEGHRMD--------KPANCT 285
Query: 226 ----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTP 265
+MR C P+ RP+ ++ L T T
Sbjct: 286 NELYMMMR------DCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 69/281 (24%), Positives = 106/281 (37%), Gaps = 57/281 (20%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLD 66
AVK L ++ +E+ + + H+N++ +LG C M++ E+ +L
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 67 CYL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
YL + + + L + + + +G+ +L + IHRDL A
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 177
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSD 168
NILL E KI DFGLAR K+ + V +P PE VY+ +SD
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 169 VFSFGVLLLQIISGKRLSML--CGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC- 225
V+SFGVLL +I S L G+ + E K G M
Sbjct: 233 VWSFGVLLWEIFS---LGASPYPGVKID----EEFCRRLKEGTRMR--------APDYTT 277
Query: 226 ----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
+ M C P+ RP+ E+ L N
Sbjct: 278 PEMYQTML------DCWHGEPSQRPTFSELVEHLGNLLQAN 312
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 51/269 (18%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKS 64
G +AVK + + + F E + +L+H NL+++LG ++ + +V EYM S
Sbjct: 44 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL R +L + + + + YL +HRDL A N+L+ ED K
Sbjct: 102 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAK 157
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQI 179
+SDFGL + + +P PE R+ +STKSDV+SFG+LL +I
Sbjct: 158 VSDFGLTKEASSTQDTGK----------LPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 180 IS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLE 232
S G+ Y + V+ + D C ++M
Sbjct: 208 YSFGRV----------------PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM---- 247
Query: 233 IALLCVQENPNDRPSMLEVSSMLKNETTN 261
C + RPS L++ L++ T+
Sbjct: 248 --KNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 47/182 (25%), Positives = 95/182 (52%), Gaps = 18/182 (9%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K+L + +S + +E +E + A + + ++ R+LG C+ L+ + MP L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
+ + + + + ++ I +G+ YL++ ++HRDL A N+L+ KI+DF
Sbjct: 107 VRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GLA++ L A ++ G +P E +Y+ +SDV+S+GV + ++++ G
Sbjct: 162 GLAKL-----LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 183 KR 184
+
Sbjct: 217 SK 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 72/277 (25%), Positives = 112/277 (40%), Gaps = 52/277 (18%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L S + A E +E+ + + L QH N++ +LG C +++ EY L
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 68 YL-----------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+L I + +H + QG+ +L + IHRD+ A N+L
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 196
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFS 171
L KI DFGLAR +S +V +P PE VY+ +SDV+S
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251
Query: 172 FGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC----- 225
+G+LL +I S G + GI N Y+L K G M + +
Sbjct: 252 YGILLWEIFSLGL--NPYPGILVN----SKFYKLVKDGYQMA--------QPAFAPKNIY 297
Query: 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
+M+ C P RP+ ++ S L+ +
Sbjct: 298 SIMQ------ACWALEPTHRPTFQQICSFLQEQAQED 328
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 73/281 (25%), Positives = 117/281 (41%), Gaps = 59/281 (20%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L ++ + + +E+ + + +H N+I +LG C ++ EY +L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
YL + + + +K V + +G+ YL + IHRDL A N
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 233
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
+L+ E+ KI+DFGLAR T G +P PE VY+ +SDV
Sbjct: 234 VLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 170 FSFGVLLLQIISGKRLSML--CGI-NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC- 225
+SFGVL+ +I + L GI E L ++L K G M+ + ++C
Sbjct: 289 WSFGVLMWEIFT---LGGSPYPGIPVEEL------FKLLKEGHRMD--------KPANCT 331
Query: 226 ----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
+MR C P+ RP+ ++ L T T
Sbjct: 332 NELYMMMRD------CWHAVPSQRPTFKQLVEDLDRILTLT 366
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 50/267 (18%), Positives = 98/267 (36%), Gaps = 47/267 (17%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K +S E+F E + + H ++++++G + ++ E L +
Sbjct: 47 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 105
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L L + ++ L YL +HRD+ A N+L+ + K+ DF
Sbjct: 106 LQVRKYSLDL--ASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R ++ + G +P PE +++ SDV+ FGV + +I+ G
Sbjct: 161 GLSRYM------EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
+ ++ K + +++ +C LM
Sbjct: 215 VK----------------PFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM------TK 252
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTN 263
C +P+ RP E+ + L
Sbjct: 253 CWAYDPSRRPRFTELKAQLSTILEEEK 279
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 62/267 (23%), Positives = 111/267 (41%), Gaps = 52/267 (19%)
Query: 9 IAVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLD 66
AVK L++ + +F E ++ H N++ +LG C+ SE ++V YM + L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
++ + + K + + +G+ +L +HRDL A N +L E K++
Sbjct: 180 NFIRNETHNPTV--KDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 234
Query: 127 DFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGLAR ++ KE + T +P E + ++TKSDV+SFGVLL +++
Sbjct: 235 DFGLARDMYDKEFDSVHN----KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 181 S-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-----KLMRC 230
+ G ++ ++ G+ + + C ++M
Sbjct: 291 TRGAPPYPDVN-----TFDI------TVYLLQGRRLL--------QPEYCPDPLYEVM-- 329
Query: 231 LEIALLCVQENPNDRPSMLEVSSMLKN 257
L C RPS E+ S +
Sbjct: 330 ----LKCWHPKAEMRPSFSELVSRISA 352
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 79/281 (28%), Positives = 118/281 (41%), Gaps = 58/281 (20%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K++ +S +F E+ + KL H N+I +LG C L EY P+ +L
Sbjct: 56 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L L ++ +H + +G+ YL S+ IHRDL A N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 172
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
IL+GE+ KI+DFGL+R V T+G +P E VY+T SDV
Sbjct: 173 ILVGENYVAKIADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 170 FSFGVLLLQIIS-GKRLSMLCGI-NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227
+S+GVLL +I+S G CG+ L YE G +E K
Sbjct: 225 WSYGVLLWEIVSLGGTPY--CGMTCAEL------YEKLPQGYRLE-------------KP 263
Query: 228 MRCL----EIALLCVQENPNDRPSMLEVSSMLKNETTNTNT 264
+ C ++ C +E P +RPS ++ L T
Sbjct: 264 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 67/282 (23%), Positives = 111/282 (39%), Gaps = 56/282 (19%)
Query: 10 AVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L S E +E+ + + L H+N++ +LG C +++ EY L
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 68 YL---------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+L L LD + + + +G+ +L + IHRDL A
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAA 173
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKS 167
NILL KI DFGLAR +S VV +P PE VY+ +S
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 168 DVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC- 225
DV+S+G+ L ++ S G S G+ + Y++ K G M
Sbjct: 229 DVWSYGIFLWELFSLGS--SPYPGMPVD----SKFYKMIKEGFRML--------SPEHAP 274
Query: 226 ----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTN 263
+M+ C +P RP+ ++ +++ + + +
Sbjct: 275 AEMYDIMK------TCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-35
Identities = 54/189 (28%), Positives = 77/189 (40%), Gaps = 20/189 (10%)
Query: 3 LPCGEVI--AVKKL---SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
P G+ + AVK L S + ++F EV L H NLIR+ G + + +V
Sbjct: 41 APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVT 99
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E P SL L +L + +G+ YL IHRDL A N+LL
Sbjct: 100 ELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLL 154
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSF 172
KI DFGL R + V+ +P PE + +S SD + F
Sbjct: 155 ATRDLVKIGDFGLMRALPQND----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 210
Query: 173 GVLLLQIIS 181
GV L ++ +
Sbjct: 211 GVTLWEMFT 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-35
Identities = 57/261 (21%), Positives = 101/261 (38%), Gaps = 47/261 (18%)
Query: 10 AVKKLSK-SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK K + E+F +E ++ L H ++++++G + E ++ E P L Y
Sbjct: 44 AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHY 102
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L + V I + + YL + +HRD+ NIL+ K+ DF
Sbjct: 103 LERNKNSLKV--LTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDF 157
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R E + ++ +P PE ++T SDV+ F V + +I+S G
Sbjct: 158 GLSRYIEDE------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
K+ + + + ++ + C LM
Sbjct: 212 KQ----------------PFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLM------TR 249
Query: 237 CVQENPNDRPSMLEVSSMLKN 257
C +P+DRP E+ L +
Sbjct: 250 CWDYDPSDRPRFTELVCSLSD 270
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 45/278 (16%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + EE E + +L + ++R++G C +E MLV E L +
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKF 425
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L +R + ++ ++ G+ YL +HR+L A N+LL KISDF
Sbjct: 426 LVG--KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL++ + ++ + G P PE +S++SDV+S+GV + + +S G
Sbjct: 481 GLSKALGAD----DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
++ Y+ KG + M F++ + C LM
Sbjct: 537 QK----------------PYKKMKGPEVMAFIEQGKRMECPPECPPELYALM------SD 574
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQV 274
C DRP L V ++ + + + + +V
Sbjct: 575 CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEV 612
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 45/178 (25%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+K + KS Q F+ + ++ L H +++R+LG C LV +Y+P SL +
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDH 104
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
+ L + ++ I +G+ YL ++HR+L A N+LL + +++DF
Sbjct: 105 VRQHRGALGP--QLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADF 159
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
G+A + L + +Q++ + P E G Y+ +SDV+S+GV + ++++
Sbjct: 160 GVADL-----LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 74/280 (26%), Positives = 114/280 (40%), Gaps = 57/280 (20%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L S ++ + + +E+ + + +H N+I +LG C ++ EY +L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
YL L K V + +G+ YL + IHRDL A N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 221
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
+L+ ED KI+DFGLAR T G +P PE +Y+ +SDV
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 170 FSFGVLLLQIISGKRLSML--CGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC-- 225
+SFGVLL +I + L G+ +E ++L K G M+ + S+C
Sbjct: 277 WSFGVLLWEIFT---LGGSPYPGVP-----VEELFKLLKEGHRMD--------KPSNCTN 320
Query: 226 ---KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
+MR C P+ RP+ ++ L T
Sbjct: 321 ELYMMMR------DCWHAVPSQRPTFKQLVEDLDRIVALT 354
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 60/279 (21%)
Query: 10 AVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPN 62
AVK KL SS + EEF +E H N+IR+LG CI+ + M++ +M
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 63 KSLDCYL---FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
L YL + + + + I G+ YL S +HRDL A N +L +
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRD 182
Query: 120 DMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFG 173
DM ++DFGL++ I++ + + +P E VY++KSDV++FG
Sbjct: 183 DMTVCVADFGLSKKIYSGDYYRQGRI------AKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 174 VLLLQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC--- 225
V + +I + G + N + Y+ G ++ + C
Sbjct: 237 VTMWEIATRGMTPYPGVQ-----NHEM------YDYLLHGHRLK--------QPEDCLDE 277
Query: 226 --KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
++M C + +P DRP+ + L+ +
Sbjct: 278 LYEIMYS------CWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 79/283 (27%), Positives = 119/283 (42%), Gaps = 66/283 (23%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L +S + +E + ++ H ++I++ G C +L+ EY SL +
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 69 L---------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
L D L + I+QG+ YL + + ++H
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVH 173
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGV 162
RDL A NIL+ E K KISDFGL+R +E V + G IP E +
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHI 228
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSML--CGI-NENLSILEHAYELWKGGKGMEFVDSFLD 219
Y+T+SDV+SFGVLL +I++ L GI E L + L K G ME
Sbjct: 229 YTTQSDVWSFGVLLWEIVT---LGGNPYPGIPPERL------FNLLKTGHRME------- 272
Query: 220 DRNSSC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
R +C +LM C ++ P+ RP ++S L+
Sbjct: 273 -RPDNCSEEMYRLMLQ------CWKQEPDKRPVFADISKDLEK 308
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 55/291 (18%)
Query: 9 IAVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYM 60
+AVK K ++ EEF E + H ++ +++G + S + M++ +M
Sbjct: 54 VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 61 PNKSLDCYLFD---PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ L +L L + V + I G+ YL S IHRDL A N +L
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCML 170
Query: 118 GEDMKPKISDFGLAR-IFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFS 171
EDM ++DFGL+R I++ + + +P E +Y+ SDV++
Sbjct: 171 AEDMTVCVADFGLSRKIYSGDYYRQGCA------SKLPVKWLALESLADNLYTVHSDVWA 224
Query: 172 FGVLLLQIISGKRLSML--CGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC---- 225
FGV + +I++ GI Y GG ++ + C
Sbjct: 225 FGVTMWEIMT---RGQTPYAGIE-----NAEIYNYLIGGNRLK--------QPPECMEEV 268
Query: 226 -KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVD 275
LM C +P RPS + L+N + + ++
Sbjct: 269 YDLMYQ------CWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN 313
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 46/178 (25%), Positives = 93/178 (52%), Gaps = 17/178 (9%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K+L +S + +E +E + A + + ++ R+LG C+ + L+ + MP L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 106
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
+ + + + + ++ I +G+ YL++ ++HRDL A N+L+ KI+DF
Sbjct: 107 VRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
GLA++ L A ++ G +P E +Y+ +SDV+S+GV + ++++
Sbjct: 162 GLAKL-----LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 61/289 (21%)
Query: 10 AVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L + + E +E+ + +L H N++ +LG C S L++EY L
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 68 YL--------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
YL + +L ++ + + +G+ +L + +H
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVH 195
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGV 162
RDL A N+L+ KI DFGLAR +S VV +P PE +G+
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGI 250
Query: 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDR 221
Y+ KSDV+S+G+LL +I S G + GI + + Y+L + G M+ +
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGV--NPYPGIPVD----ANFYKLIQNGFKMD--------Q 296
Query: 222 NSSC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTP 265
+M+ C + RPS ++S L + +
Sbjct: 297 PFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 51/267 (19%), Positives = 101/267 (37%), Gaps = 47/267 (17%)
Query: 10 AVKKL-SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K + +S E+F E + + H ++++++G + ++ E L +
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 480
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L R+ LD + ++ L YL +HRD+ A N+L+ + K+ DF
Sbjct: 481 LQV--RKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDF 535
Query: 129 GLARIFAKESLKANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R ++ + G +P PE +++ SDV+ FGV + +I+ G
Sbjct: 536 GLSRYM------EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDS-FLDDRNSSC-----KLMRCLEIALL 236
+ ++ K + +++ +C LM
Sbjct: 590 VK----------------PFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM------TK 627
Query: 237 CVQENPNDRPSMLEVSSMLKNETTNTN 263
C +P+ RP E+ + L
Sbjct: 628 CWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 58/269 (21%), Positives = 100/269 (37%), Gaps = 62/269 (23%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +K++ ++ E+ + EV AKL HVN++ G + ++S
Sbjct: 36 GKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91
Query: 66 DCYLF---------DPIRRLILDWKKR-------VHIIEGITQGLLYLQEYSRLTIIHRD 109
LF + + I + + + E IT+G+ Y+ +I+RD
Sbjct: 92 TKCLFIQMEFCDKGT-LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRD 147
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
LK SNI L + + KI DFGL + + + GT+ Y+ PE Y + D+
Sbjct: 148 LKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDL 204
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-GMEFVDSFLDDRNS----- 223
++ G++L EL E F D R+
Sbjct: 205 YALGLIL-------------------------AELLHVCDTAFETSKFFTDLRDGIISDI 239
Query: 224 -SCKLMRCLEIALLCVQENPNDRPSMLEV 251
K L+ + + P DRP+ E+
Sbjct: 240 FDKKEKTLLQ---KLLSKKPEDRPNTSEI 265
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 46/183 (25%), Positives = 91/183 (49%), Gaps = 12/183 (6%)
Query: 6 GEVIAVKKLSKSSA--QGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+A+K + + + F+ EV +++L H N++ ++ + + LV EY+
Sbjct: 36 NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILLGEDM 121
+L Y+ L ++ I G+ +++ + I+HRD+K NIL+ +
Sbjct: 96 PTLSEYI---ESHGPLSVDTAINFTNQILDGI----KHAHDMRIVHRDIKPQNILIDSNK 148
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI DFG+A+ ++ SL T V+GT+ Y PE A+ +D++S G++L +++
Sbjct: 149 TLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 182 GKR 184
G+
Sbjct: 208 GEP 210
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G +K+++ S S++ EE + EV + A ++H N+++ ++ +V +Y
Sbjct: 49 GRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108
Query: 64 SLDCYL----FDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
L + + ILDW ++ I L ++ + I+HRD+K+ NI L
Sbjct: 109 DLFKRINAQKGVLFQEDQILDW-----FVQ-ICLALKHVHD---RKILHRDIKSQNIFLT 159
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+D ++ DFG+AR+ A +GT Y+ PE Y+ KSD+++ G +L +
Sbjct: 160 KDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYE 217
Query: 179 IISGKR 184
+ + K
Sbjct: 218 LCTLKH 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-29
Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 23/193 (11%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMP 61
G+++ K+L + + +EV L +L+H N++R ID L V EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEG--------ITQGLLYL--QEYSRLTIIHRDLK 111
L I + K+R ++ E +T L + T++HRDLK
Sbjct: 91 GGDL----ASVITKGT---KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
+N+ L K+ DFGLARI ++ A T VGT Y+ PE + Y+ KSD++S
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 172 FGVLLLQIISGKR 184
G LL ++ +
Sbjct: 202 LGCLLYELCALMP 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 52/292 (17%), Positives = 106/292 (36%), Gaps = 48/292 (16%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM---------- 54
A+K++ + + E+ EV AKL+H ++R ++
Sbjct: 30 DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89
Query: 55 --LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+ + ++L ++ + +HI I + + +L ++HRDLK
Sbjct: 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKP 146
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQV----------VGTIGYIPPEYARQGV 162
SNI D K+ DFGL ++ + VGT Y+ PE
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRN 222
YS K D+FS G++L + +L + + + ++ +F F
Sbjct: 207 YSHKVDIFSLGLILFE--------LLYPFSTQMERVRTLTDVRNL----KFPPLFTQKYP 254
Query: 223 SSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET-TNTNTPKKPAFSKQ 273
+++ + +P +RP + + ++N + + P K ++
Sbjct: 255 CEYVMVQ------DMLSPSPMERPEAINI---IENAVFEDLDFPGKTVLRQR 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 53/269 (19%)
Query: 6 GEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVYEYMP 61
++ A+K ++ A Q + ++NE+ KLQ + IR+ + I + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG- 110
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
N L+ +L ++ +D +R + + + + + ++ I+H DLK +N L+ + M
Sbjct: 111 NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM 164
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-----------YARQGVYSTKSDVF 170
K+ DFG+A ++ + VGT+ Y+PPE + S KSDV+
Sbjct: 165 -LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 171 SFGVLLLQIISGKRLSMLCG------INENLSILEHAYELWKGGKGMEFVDSFLDDRNSS 224
S G +L M G I +S L E F D
Sbjct: 224 SLGCILYY--------MTYGKTPFQQIINQISKLHA-----IIDPNHEI--EFPDIPEKD 268
Query: 225 CK--LMRCLEIALLCVQENPNDRPSMLEV 251
+ L CL + +P R S+ E+
Sbjct: 269 LQDVLKCCL-------KRDPKQRISIPEL 290
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 43/189 (22%), Positives = 86/189 (45%), Gaps = 21/189 (11%)
Query: 6 GEVIAVKKL---SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G +A+KK+ A+ + E+ L +L H N+I+ I+ E +V E
Sbjct: 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 63 KSLDCYLFDPIRR-------LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
L + ++ + + ++ + L ++ ++HRD+K +N+
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKY-----FVQ-LCSALEHMHS---RRVMHRDIKPANV 167
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+ K+ D GL R F+ ++ A++ +VGT Y+ PE + Y+ KSD++S G L
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 176 LLQIISGKR 184
L ++ + +
Sbjct: 226 LYEMAALQS 234
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 61/269 (22%), Positives = 107/269 (39%), Gaps = 53/269 (19%)
Query: 6 GEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVYEYMP 61
++ A+K ++ A Q + ++NE+ KLQ + IR+ + I + +V E
Sbjct: 80 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 138
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
N L+ +L ++ +D +R + + + + + ++ I+H DLK +N L+ D
Sbjct: 139 NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDG 191
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-----------YARQGVYSTKSDVF 170
K+ DFG+A ++ + VG + Y+PPE + S KSDV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 171 SFGVLLLQIISGKRLSMLCG------INENLSILEHAYELWKGGKGMEFVDSFLDDRNSS 224
S G +L M G I +S L E F D
Sbjct: 252 SLGCILYY--------MTYGKTPFQQIINQISKLHA-----IIDPNHEI--EFPDIPEKD 296
Query: 225 CK--LMRCLEIALLCVQENPNDRPSMLEV 251
+ L CL + +P R S+ E+
Sbjct: 297 LQDVLKCCL-------KRDPKQRISIPEL 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 30/249 (12%)
Query: 6 GEVIAVK--KLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEY 59
+A + K + + FK E + LQH N++R + + LV E
Sbjct: 51 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-G 118
M + +L YL R ++ K I +GL +L IIHRDLK NI + G
Sbjct: 111 MTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITG 166
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
KI D GLA + KA V+GT ++ PE + Y DV++FG+ +L+
Sbjct: 167 PTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLE 221
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238
+ + + S ++A ++++ SF K EI C+
Sbjct: 222 MATSEY---------PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK-----EIIEGCI 267
Query: 239 QENPNDRPS 247
++N ++R S
Sbjct: 268 RQNKDERYS 276
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 53/269 (19%)
Query: 6 GEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVYEYMP 61
++ A+K ++ A Q + ++NE+ KLQ + IR+ + I + +V E
Sbjct: 33 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 91
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
N L+ +L ++ +D +R + + + + + ++ I+H DLK +N L+ + M
Sbjct: 92 NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM 145
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-----------YARQGVYSTKSDVF 170
K+ DFG+A ++ + VGT+ Y+PPE + S KSDV+
Sbjct: 146 -LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 171 SFGVLLLQIISGKRLSMLCG------INENLSILEHAYELWKGGKGMEFVDSFLDDRNSS 224
S G +L M G I +S L E F D
Sbjct: 205 SLGCILYY--------MTYGKTPFQQIINQISKLHA-----IIDPNHEI--EFPDIPEKD 249
Query: 225 CK--LMRCLEIALLCVQENPNDRPSMLEV 251
+ L CL + +P R S+ E+
Sbjct: 250 LQDVLKCCL-------KRDPKQRISIPEL 271
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 60/274 (21%), Positives = 102/274 (37%), Gaps = 51/274 (18%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----------- 54
A+KK+ + + +EVML A L H ++R ++ +
Sbjct: 31 SRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 55 --LVYEYMPNKSLDCYLFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+ EY N +L +D I L + + I + L Y+ IIHRDL
Sbjct: 90 LFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDL 142
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQ------------VVGTIGYIPPE-Y 157
K NI + E KI DFGLA+ + + +GT Y+ E
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202
Query: 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSF 217
G Y+ K D++S G++ + M+ + + + + + +EF F
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFE--------MIYPFSTGME-RVNILKKLRSVS-IEFPPDF 252
Query: 218 LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEV 251
D++ K +I L + +PN RP +
Sbjct: 253 DDNKMKVEK-----KIIRLLIDHDPNKRPGARTL 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 57/260 (21%), Positives = 94/260 (36%), Gaps = 40/260 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+AVK++ F EV +L +H N+IR D + + + E
Sbjct: 48 NRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA--- 101
Query: 65 LDCYLFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--- 119
L + + + + + +++ T GL +L L I+HRDLK NIL+
Sbjct: 102 --ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNA 156
Query: 120 --DMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGV---YSTKSDVFSFG 173
+K ISDFGL + + V GT G+I PE + + D+FS G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 174 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCL 231
+ +IS + +IL A L + + + + +
Sbjct: 217 CVFYYVISEGSHPFGKSLQRQANILLGACSL--------DCLHPEKHEDVIARELIEKMI 268
Query: 232 EIALLCVQENPNDRPSMLEV 251
+P RPS V
Sbjct: 269 -------AMDPQKRPSAKHV 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 16/188 (8%)
Query: 6 GEVIAVKKLSKSSA--QGFEE-FKNEVMLTAKLQHVNLIRVL--GFCIDSEERM--LVYE 58
+AVK L A F F+ E A L H ++ V G + +V E
Sbjct: 37 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILL 117
Y+ +L + + K+ + +I Q L +S + IIHRD+K +NI++
Sbjct: 97 YVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL----NFSHQNGIIHRDVKPANIMI 149
Query: 118 GEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFG+AR A T V+GT Y+ PE AR +SDV+S G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 177 LQIISGKR 184
++++G+
Sbjct: 210 YEVLTGEP 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 56/247 (22%), Positives = 108/247 (43%), Gaps = 26/247 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
IA+K++ + ++ + E+ L L+H N+++ LG ++ + E +P SL
Sbjct: 47 QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPK 124
L L + + + I +GL YL + I+HRD+K N+L+ K
Sbjct: 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK 163
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQIISG 182
ISDFG ++ A + T GT+ Y+ PE +G Y +D++S G ++++ +G
Sbjct: 164 ISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALLCVQE 240
K + E + + +++ E +S + K +++C E
Sbjct: 222 KP--PFYELGEPQAAM---FKVGMFKVHPEIPESMSAE----AKAFILKCFEP------- 265
Query: 241 NPNDRPS 247
+P+ R
Sbjct: 266 DPDKRAC 272
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 38/185 (20%), Positives = 74/185 (40%), Gaps = 22/185 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-----LVYEY 59
G + +K L S + E A++ H +++++ F ++ +V EY
Sbjct: 106 GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ +SL L + + + I L YL + +++ DLK NI+L E
Sbjct: 166 VGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTE 217
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
+ + K+ D G + + + GT G+ PE R G + +D+++ G L +
Sbjct: 218 E-QLKLIDLGAVS-----RINS-FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269
Query: 180 ISGKR 184
Sbjct: 270 TLDLP 274
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 25/188 (13%)
Query: 6 GEVIAVKKLSKSSAQGF---EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
EV A K + KS E+ E+ + L H +++ G + + + +V E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCR 124
Query: 62 NKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+SL + +R +K + + + I G YL R +IHRDLK N+
Sbjct: 125 RRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNL 172
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
L ED++ KI DFGLA + + + GT YI PE + +S + DV+S G +
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 176 LLQIISGK 183
+ ++ GK
Sbjct: 231 MYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 25/191 (13%)
Query: 3 LPCGEVIAVKKLSKSSAQGF---EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYE 58
EV A K + KS E+ E+ + L H +++ G + + + +V E
Sbjct: 37 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLE 95
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+SL + +R +K + + + I G YL R +IHRDLK
Sbjct: 96 LCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKL 143
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
N+ L ED++ KI DFGLA + + + GT YI PE + +S + DV+S
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 173 GVLLLQIISGK 183
G ++ ++ GK
Sbjct: 202 GCIMYTLLVGK 212
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 39/183 (21%), Positives = 77/183 (42%), Gaps = 12/183 (6%)
Query: 6 GEVIAVKKLSKSSA--QGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
++A+K +S++ + F + E +LQ +++ + F + + +
Sbjct: 59 ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILLGEDM 121
L L R+ L + V I+ I L + + HRD+K NIL+ D
Sbjct: 119 VDLAAML---RRQGPLAPPRAVAIVRQIGSAL----DAAHAAGATHRDVKPENILVSADD 171
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ DFG+A E L VGT+ Y+ PE + + ++D+++ +L + ++
Sbjct: 172 FAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230
Query: 182 GKR 184
G
Sbjct: 231 GSP 233
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 57/181 (31%), Positives = 94/181 (51%), Gaps = 10/181 (5%)
Query: 6 GEVIAVKKLSKSS--AQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G +A+K + K + G + +NEV + +L+H +++ + + DS LV E N
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
++ YL + ++ + + R H + I G+LYL + I+HRDL SN+LL +M
Sbjct: 96 GEMNRYLKNRVKPF-SENEAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMN 150
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGLA K T + GT YI PE A + + +SDV+S G + ++ G
Sbjct: 151 IKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 183 K 183
+
Sbjct: 209 R 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 43/231 (18%), Positives = 85/231 (36%), Gaps = 34/231 (14%)
Query: 34 KLQHVNLIRVLGFCIDSEERMLVY---EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGI 90
++ + +G S ++ +Y + ++L ++ + +HI I
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI 173
Query: 91 TQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV---- 146
+ + +L ++HRDLK SNI D K+ DFGL ++ +
Sbjct: 174 AEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 147 ------VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH 200
VGT Y+ PE YS K D+FS G++L +++ M E
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----------ER 279
Query: 201 AYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEV 251
+ + ++F F +++ + +P +RP ++
Sbjct: 280 V-RIITDVRNLKFPLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDI 323
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 55/279 (19%), Positives = 98/279 (35%), Gaps = 57/279 (20%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G +AVK++ + E+ +LT H N+IR + E
Sbjct: 39 GRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC---- 91
Query: 65 LDCYLFDPI--------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ L D + + + ++ I G+ +L L IIHRDLK NIL
Sbjct: 92 -NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNIL 147
Query: 117 L-------------GEDMKPKISDFGLARIFA--KESLKANTEQVVGTIGYIPPE----- 156
+ E+++ ISDFGL + + S + N GT G+ PE
Sbjct: 148 VSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEES 207
Query: 157 --YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV 214
+ + D+FS G + I+S + + +I+ + L E
Sbjct: 208 NNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL------DEMK 261
Query: 215 DSFLDDRNSSCK--LMRCLEIALLCVQENPNDRPSMLEV 251
+ + + ++ +P RP+ ++V
Sbjct: 262 CLHDRSLIAEATDLISQMIDH-------DPLKRPTAMKV 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-25
Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 6 GEVIAVKKLSKS--SAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
++A+K L K+ G E + EV + + L+H N++R+ G+ D+ L+ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 63 KSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
++ + +++L D ++ I + L Y +IHRD+K N+LLG
Sbjct: 94 GTV----YRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAG 146
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ KI+DFG + S + + GT+ Y+PPE ++ K D++S GVL + +
Sbjct: 147 ELKIADFGWSVH--APSSRRTD--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 182 GK 183
GK
Sbjct: 203 GK 204
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 48/178 (26%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+++++ E NE+++ + ++ N++ L + +E +V EY+ SL
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 105 T----DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E K +T +VGT ++ PE + Y K D++S G++ +++I G+
Sbjct: 158 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 44/193 (22%), Positives = 80/193 (41%), Gaps = 21/193 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPN 62
G++ A+K + S + E + KL H N++++ ++ R L+ E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---- 118
SL L +P L + + ++ + G+ +L+E I+HR++K NI+
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED 150
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--------YARQGVYSTKSDVF 170
K++DFG AR + + GT Y+ P+ Q Y D++
Sbjct: 151 GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 171 SFGVLLLQIISGK 183
S GV +G
Sbjct: 208 SIGVTFYHAATGS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 50/178 (28%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G +AVK + Q E NEV++ QH N++ + + EE ++ E++ +L
Sbjct: 70 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ L+ ++ + E + Q L YL +IHRD+K+ +ILL D + K+
Sbjct: 130 T----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +K+ K + +VGT ++ PE + +Y+T+ D++S G+++++++ G+
Sbjct: 183 SDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 43/177 (24%), Positives = 71/177 (40%), Gaps = 17/177 (9%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++ V K + S E+ K E + L+H +++ +L +V+E+M
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD--- 112
Query: 68 YLFDPIRRLILDW-----KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GE 119
L I + H + I + L Y + IIHRD+K +LL
Sbjct: 113 -LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKEN 168
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ FG+A + L A VGT ++ PE ++ Y DV+ GV+L
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 18/190 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-------LVY 57
GE +A+K+ + + E + E+ + KL H N++ D +++ L
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS-AREVPDGLQKLAPNDLPLLAM 97
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
EY L YL L ++ I+ L YL E IIHRDLK NI+L
Sbjct: 98 EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVL 154
Query: 118 ---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
+ + KI D G A+ + L + VGT+ Y+ PE Q Y+ D +SFG
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 175 LLLQIISGKR 184
L + I+G R
Sbjct: 212 LAFECITGFR 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 15/175 (8%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G++ A+K + KS A +NE+ + K++H N++ + + LV + +
Sbjct: 34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS---- 89
Query: 66 DCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
LFD I R + K +I+ + + YL E I+HRDLK N+L E+
Sbjct: 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENS 146
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K I+DFGL+++ + GT GY+ PE Q YS D +S GV+
Sbjct: 147 KIMITDFGLSKMEQNGIMS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 28/191 (14%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEYMP 61
G A+K++ Q EE + E + H N++R++ +C+ L+ +
Sbjct: 54 GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113
Query: 62 NKSLDCYLFDPIRRLILDWKKR------VHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+L ++ I RL D + ++ GI +GL + HRDLK +NI
Sbjct: 114 RGTL----WNEIERL-KDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNI 165
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVV-------GTIGYIPPE---YARQGVYST 165
LLG++ +P + D G + + TI Y PE V
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE 225
Query: 166 KSDVFSFGVLL 176
++DV+S G +L
Sbjct: 226 RTDVWSLGCVL 236
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 4e-24
Identities = 32/283 (11%), Positives = 70/283 (24%), Gaps = 56/283 (19%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFC--------------- 47
E A+K + S E A+L +
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 48 -----IDSEERMLVYEY---MPNKSLD-CYLFDPIRRLI-----LDWKKRVHIIEGITQG 93
++ V Y MP S+D LF + + + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153
LQ ++H N+ + D + + D + + Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYA 258
Query: 154 PPEY--ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI---NENLSILEHAYELWKGG 208
P E+ A ++ + + G+ + + + C ++ +++
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYR--------VWCLFLPFGLVTPGIKGSWKRPSLR 310
Query: 209 KGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEV 251
+F + + L + R LE
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIG-RFLNF--DRRRRLLPLEA 350
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 4e-24
Identities = 44/193 (22%), Positives = 80/193 (41%), Gaps = 21/193 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPN 62
G++ A+K + S + E + KL H N++++ ++ R L+ E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---- 118
SL L +P L + + ++ + G+ +L+E I+HR++K NI+
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED 150
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--------YARQGVYSTKSDVF 170
K++DFG AR + + GT Y+ P+ Q Y D++
Sbjct: 151 GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 171 SFGVLLLQIISGK 183
S GV +G
Sbjct: 208 SIGVTFYHAATGS 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 50/184 (27%), Positives = 78/184 (42%), Gaps = 21/184 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
A KK+ K + + FK E+ + L H N+IR+ D+ + LV E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL------ 87
Query: 66 DCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---G 118
C LF+ + + + I++ + + Y + L + HRDLK N L
Sbjct: 88 -CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDS 143
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
D K+ DFGLA F K T VGT Y+ P+ Y + D +S GV++
Sbjct: 144 PDSPLKLIDFGLAARF-KPGKMMRT--KVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYV 199
Query: 179 IISG 182
++ G
Sbjct: 200 LLCG 203
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 21/186 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G AVKK+ + E++ A L ++ + G + + E + SL
Sbjct: 83 GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137
Query: 66 DCYL--FDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-M 121
+ + L + + +GL YL I+H D+KA N+LL D
Sbjct: 138 GQLIKQMGCLPEDRAL------YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGS 188
Query: 122 KPKISDFGLARIFAKESLKANTEQ---VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ + DFG A + L + + GT ++ PE K D++S ++L
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
Query: 179 IISGKR 184
+++G
Sbjct: 249 MLNGCH 254
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 64/259 (24%), Positives = 104/259 (40%), Gaps = 44/259 (16%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
A+K + K+ S + EV + L H N++++ F D LV E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC---- 117
Query: 64 SLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-- 117
LFD I R+ + II+ + G+ YL + I+HRDLK N+LL
Sbjct: 118 ---YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLES 171
Query: 118 -GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+D KI DFGL+ +F + ++ +GT YI PE + Y K DV+S GV+L
Sbjct: 172 KEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 177 LQIISGKRLSMLCGINEN---LSILEHAYELWKGGKGMEFVDSFLDDRNSSCK-LMRCLE 232
+++G G + + + Y F + + K L++
Sbjct: 228 FILLAGYPP--FGGQTDQEILRKVEKGKY---------TFDSPEWKNVSEGAKDLIK--- 273
Query: 233 IALLCVQENPNDRPSMLEV 251
+L + R S +
Sbjct: 274 -QMLQF--DSQRRISAQQA 289
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 22/179 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G A K + E + E+ + L+H L+ + D E +++YE+
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF------ 235
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
LF+ + + + V + + +GL ++ E +H DLK NI+
Sbjct: 236 -MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTK 291
Query: 119 EDMKPKISDFGLARIFAK-ESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ K+ DFGL +S+K GT + PE A +D++S GVL
Sbjct: 292 RSNELKLIDFGLTAHLDPKQSVK----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 22/179 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G V K ++ KNE+ + +L H LI + D E +L+ E+
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF------ 129
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
LFD I + + ++ + +GL ++ E +I+H D+K NI+
Sbjct: 130 -LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 119 EDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ KI DFGLA E +K T + PE + +D+++ GVL
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVK----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-23
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 6 GEVIAVKKLSKS-----------------SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 48
+ A+KK KS +++FKNE+ + +++ + G
Sbjct: 54 NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113
Query: 49 DSEERMLVYEYMPNKSLDCYL-----FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRL 103
+ +E ++YEYM N S+ + D + + II+ + Y+ ++
Sbjct: 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI--HNEK 171
Query: 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--YARQG 161
I HRD+K SNIL+ ++ + K+SDFG + + +K GT ++PPE
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G--SRGTYEFMPPEFFSNESS 227
Query: 162 VYSTKSDVFSFGVLL 176
K D++S G+ L
Sbjct: 228 YNGAKVDIWSLGICL 242
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G +A K + + EE KNE+ + +L H NLI++ + +LV EY
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY------ 167
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
LFD I L + ++ I +G+ ++ + + I+H DLK NIL
Sbjct: 168 -VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNR 223
Query: 119 EDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ + KI DFGLAR + +E LK GT ++ PE S +D++S GV+
Sbjct: 224 DAKQIKIIDFGLARRYKPREKLK----VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-23
Identities = 52/250 (20%), Positives = 92/250 (36%), Gaps = 41/250 (16%)
Query: 6 GEVIAVKKLSKSSAQGFEEFK--NEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPN 62
G + AVK+ + + EV K+ QH +R+ + L E
Sbjct: 82 GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140
Query: 63 KSLDCYLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
SL + L + + + + L +L ++H D+K +NI LG
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGY-----LRD-TLLALAHLHSQG---LVHLDVKPANIFLG 191
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ K+ DFGL + G Y+ PE QG Y T +DVFS G+ +L+
Sbjct: 192 PRGRCKLGDFGLLVELGTAG-AGEVQ--EGDPRYMAPE-LLQGSYGTAADVFSLGLTILE 247
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGM-EFVDSFLDDRNSSCKLMRCLEIALLC 237
+ C + EL GG+G + +L ++ + ++
Sbjct: 248 --------VACNM-----------ELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288
Query: 238 VQENPNDRPS 247
++ +P R +
Sbjct: 289 LEPDPKLRAT 298
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 60/187 (32%), Positives = 82/187 (43%), Gaps = 24/187 (12%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G+ AVK +SK E EV L +L H N++++ F D LV E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV--- 107
Query: 63 KSLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL- 117
LFD I R II + G+ Y+ + I+HRDLK N+LL
Sbjct: 108 ----YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLE 160
Query: 118 --GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+D +I DFGL+ F + +GT YI PE G Y K DV+S GV+
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216
Query: 176 LLQIISG 182
L ++SG
Sbjct: 217 LYILLSG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 61/183 (33%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 6 GEVIAVKKLSKSSAQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+ AVK ++K+SA+ EV L KL H N++++ DS +V E
Sbjct: 47 QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GE 119
LFD I +R II+ + G+ Y+ + I+HRDLK NILL +
Sbjct: 107 E----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEK 159
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D KI DFGL+ F + + + +GT YI PE R Y K DV+S GV+L +
Sbjct: 160 DCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYIL 215
Query: 180 ISG 182
+SG
Sbjct: 216 LSG 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 44/189 (23%), Positives = 80/189 (42%), Gaps = 26/189 (13%)
Query: 6 GEVIAVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G +K ++K +Q E+ + E+ + L H N+I++ D +V E
Sbjct: 47 GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106
Query: 65 LDCYLFDPIRRLILDWKKRVH--------IIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
L + R++ + +++ + L Y ++H+DLK NIL
Sbjct: 107 L----LE---RIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENIL 156
Query: 117 L---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
KI DFGLA +F K + GT Y+ PE ++ + K D++S G
Sbjct: 157 FQDTSPHSPIKIIDFGLAELF-KSDEHSTN--AAGTALYMAPEVFKRD-VTFKCDIWSAG 212
Query: 174 VLLLQIISG 182
V++ +++G
Sbjct: 213 VVMYFLLTG 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 7e-23
Identities = 58/250 (23%), Positives = 94/250 (37%), Gaps = 17/250 (6%)
Query: 4 PCGEVIAVKKLS-KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
P G V+A K + + + E+ + + ++ G E + E+M
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 63 KSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SLD L I IL + + +GL YL + I+HRD+K SNIL+
Sbjct: 116 GSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSR 168
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ K+ DFG++ AN+ VGT Y+ PE + YS +SD++S G+ L+++
Sbjct: 169 GEIKLCDFGVSGQLIDS--MANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 181 SGK---RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237
G+ + + S M E+
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 238 VQENPNDRPS 247
V E P PS
Sbjct: 285 VNEPPPKLPS 294
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-23
Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 25/187 (13%)
Query: 6 GEVIAVKKLSKS--SAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
++A+K L KS +G E + E+ + + L+H N++R+ + D + L+ E+ P
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 63 KSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
L + +++ R +E + L Y +IHRD+K N+L
Sbjct: 99 GEL----YKELQK-----HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLL 146
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+G + KI+DFG + SL+ T + GT+ Y+PPE + K D++ GVL
Sbjct: 147 MGYKGELKIADFGWSVH--APSLRRRT--MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 177 LQIISGK 183
+ + G
Sbjct: 203 YEFLVGM 209
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 49/179 (27%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 6 GEVIAVKKLSKSSAQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+V+A+K + A+ E+ + E+ + ++ + + G + + ++ EY+ S
Sbjct: 47 QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
D + LD + I+ I +GL YL IHRD+KA+N+LL E + K
Sbjct: 107 AL----DLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVK 159
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
++DFG+A +K NT VGT ++ PE +Q Y +K+D++S G+ +++ G+
Sbjct: 160 LADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 62/187 (33%), Positives = 89/187 (47%), Gaps = 25/187 (13%)
Query: 6 GEVIAVKKLSKSSAQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+ AVK ++K+SA+ EV L KL H N++++ DS +V E
Sbjct: 47 QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL---- 102
Query: 64 SLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-- 117
LFD I +R II+ + G+ Y+ + I+HRDLK NILL
Sbjct: 103 ---YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLES 156
Query: 118 -GEDMKPKISDFGLARIFAK-ESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+D KI DFGL+ F + +K +GT YI PE +G Y K DV+S GV+
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQNTKMK----DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
Query: 176 LLQIISG 182
L ++SG
Sbjct: 212 LYILLSG 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-22
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 16/177 (9%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G A K ++ SA+ F++ + E + KLQH N++R+ + LV++ +
Sbjct: 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GE 119
L F+ I R H I+ I + + Y I+HR+LK N+LL +
Sbjct: 91 EL----FEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 143
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K++DFGLA +S + GT GY+ PE ++ YS D+++ GV+L
Sbjct: 144 GAAVKLADFGLAIEV-NDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 16/177 (9%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G A K ++ SA+ F++ + E + KLQH N++R+ + LV++ +
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GE 119
L F+ I R H I+ I + + Y I+HR+LK N+LL +
Sbjct: 114 EL----FEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 166
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K++DFGLA +S + GT GY+ PE ++ YS D+++ GV+L
Sbjct: 167 GAAVKLADFGLAIEV-NDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 25/223 (11%), Positives = 63/223 (28%), Gaps = 50/223 (22%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHV----------------NLIRVLGF 46
GE V + + ++ K EV+ L+ + +L++
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 47 C------IDSEERMLVYEYMPNKSLDCYLFDPIRRLI--------LDWKKRVHIIEGITQ 92
+D + ++ + + L L+ L R+ + + +
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 93 GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152
L L Y ++H L+ +I+L + ++ F S + +
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAVSPIGRGFAPPET 278
Query: 153 IPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
+ + D ++ G+ + + C
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYW--------IWCA 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 37/271 (13%), Positives = 77/271 (28%), Gaps = 62/271 (22%)
Query: 7 EVIAVKKLSK----SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
EV+ ++ L A+ F L Q +IRV D + Y
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 63 KSLDCYLFDPIRRLI-----LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+S + + L R+ + + + L L Y ++H L+ +I+L
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVL 239
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY-----------ARQGVYSTK 166
+ ++ F + + G+ PPE R+ + +
Sbjct: 240 DQRGGVFLTGFEHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 167 SDVFSFGVLLLQIISGKRLSMLCGI----NENLSILEHAYELWKGGKGMEFVDSFLDDRN 222
D ++ G+++ + C + E++ +
Sbjct: 294 FDAWALGLVIYW--------IWCADLPITKDAALGG------------SEWIFRSCKNIP 333
Query: 223 SSCK--LMRCLEIALLCVQENPNDRPSMLEV 251
+ L L + DR L+
Sbjct: 334 QPVRALLEGFL-------RYPKEDRLLPLQA 357
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 35/179 (19%), Positives = 70/179 (39%), Gaps = 23/179 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ K + K E+ + +H N++ + EE ++++E+
Sbjct: 30 KKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF------ 82
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
+F+ I L+ ++ V + + + L +L I H D++ NI+
Sbjct: 83 -ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTR 138
Query: 119 EDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
KI +FG AR ++ + + Y PE + V ST +D++S G L+
Sbjct: 139 RSSTIKIIEFGQARQLKPGDNFR----LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 23/183 (12%)
Query: 6 GEVIAVKKLSKSSAQG------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G A K + K ++ EE + EV + ++ H N+I + + + +L+ E
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 60 MPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL- 117
+ L FD + ++ L ++ I+ I G+ YL I H DLK NI+L
Sbjct: 97 VSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLL 149
Query: 118 ---GEDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
K+ DFGLA K + GT ++ PE ++D++S G
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIG 205
Query: 174 VLL 176
V+
Sbjct: 206 VIT 208
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 71/289 (24%), Positives = 113/289 (39%), Gaps = 57/289 (19%)
Query: 6 GEVIAVKKLSKS-------------SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 52
A+K + KS + EE NE+ L L H N+I++ D +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 53 RMLVYEYMPNKSLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 108
LV E+ LF+ I R D +I++ I G+ YL + I+HR
Sbjct: 121 FYLVTEF-------YEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHR 170
Query: 109 DLKASNILL---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYST 165
D+K NILL + KI DFGL+ F + K +GT YI PE + Y+
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRD--RLGTAYYIAPE-VLKKKYNE 226
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINEN---LSILEHAYELWKGGKGMEFVDSFLDDRN 222
K DV+S GV++ ++ G G N+ + + Y F + + +
Sbjct: 227 KCDVWSCGVIMYILLCGYPP--FGGQNDQDIIKKVEKGKY---------YFDFNDWKNIS 275
Query: 223 SSCK-LMRCLEIALLCVQENPNDRPSMLEVSSM--LKNETTNTNTPKKP 268
K L++ +L + N R + E + +K N N +
Sbjct: 276 DEAKELIKL----MLTY--DYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 59/299 (19%), Positives = 96/299 (32%), Gaps = 51/299 (17%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERM-------LVY 57
G A+K+L + + EV KL H N+++ +E L+
Sbjct: 53 GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ L +L R L + I + + ++ + IIHRDLK N+LL
Sbjct: 113 TELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLL 171
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQ----------VVGTIGYIPPE---YARQGVYS 164
K+ DFG A + + + Q T Y PE
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 165 TKSDVFSFGVLLLQIISGKRLSMLCGI-----NENLSILEHAYELWKGGKGMEFVDSFLD 219
K D+++ G +L + L I+ Y S
Sbjct: 232 EKQDIWALGCIL--------YLLCFRQHPFEDGAKLRIVNGKY-------------SIPP 270
Query: 220 DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQVDEIG 278
L A+L Q NP +R S+ EV L+ N K ++ +++ G
Sbjct: 271 HDTQYTVF-HSLIRAML--QVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNG 326
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 11/179 (6%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+++A+K++ +E E+ + + ++++ G + + +V EY S+
Sbjct: 54 GQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 66 -DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
D L + I++ +GL YL IHRD+KA NILL + K
Sbjct: 112 SDIIRLRNKT---LTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAK 165
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
++DFG+A K NT V+GT ++ PE ++ Y+ +D++S G+ +++ GK
Sbjct: 166 LADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 23/183 (12%)
Query: 6 GEVIAVKKLSKSSAQGF------EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G A K + K ++ EE + EV + ++ H N+I + + + +L+ E
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96
Query: 60 MPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL- 117
+ L FD + ++ L ++ I+ I G+ YL I H DLK NI+L
Sbjct: 97 VSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLL 149
Query: 118 ---GEDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
K+ DFGLA K + GT ++ PE ++D++S G
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIG 205
Query: 174 VLL 176
V+
Sbjct: 206 VIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 6 GEVIAVKKLSKSSAQGFEE--FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+ A ++ + + E + L+H N++R+ + L+++ +
Sbjct: 36 GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GE 119
L F+ I R H I+ I + +L+ + + ++HR+LK N+LL +
Sbjct: 96 EL----FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLK 148
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K++DFGLA E GT GY+ PE R+ Y D+++ GV+L
Sbjct: 149 GAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 5e-21
Identities = 56/287 (19%), Positives = 100/287 (34%), Gaps = 50/287 (17%)
Query: 3 LPCGEVIAVKK--LSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
P GE + V++ L S + + E+ ++ H N++ I E +V +M
Sbjct: 49 KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHI---IEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
S D I +D + I ++G+ + L Y+ +HR +KAS+IL+
Sbjct: 109 AYGSA----KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILI 161
Query: 118 GEDMKPKISDFGLARIFAKESLKANT-----EQVVGTIGYIPPEYARQGV--YSTKSDVF 170
D K +S + + V + ++ PE +Q + Y KSD++
Sbjct: 162 SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 171 SFGV-------------------LLLQIISGK--RLSMLCGINENLSILEHAYELWKGGK 209
S G+ +LL+ ++G L I + + + G
Sbjct: 222 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGL 281
Query: 210 GMEFVDSFLDDRNSSCKLMRCLE---------IALLCVQENPNDRPS 247
S N + C+Q NP+ RPS
Sbjct: 282 SDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE-QCLQRNPDARPS 327
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 25/190 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
AVK + KS EE E++L QH N+I + D + +V E M L
Sbjct: 47 NMEFAVKIIDKSKRDPTEE--IEILLRY-GQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103
Query: 66 DCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
D I R+ ++ ++ IT+ + YL ++HRDLK SNIL +
Sbjct: 104 ----LDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNP 156
Query: 122 KP-KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ +I DFG A+ E+ T T ++ PE + Y D++S GVLL
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL---- 210
Query: 181 SGKRLSMLCG 190
+ML G
Sbjct: 211 ----YTMLTG 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-21
Identities = 42/184 (22%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G + A K + S + E++ E+ + A H ++++LG + ++ E+ P ++
Sbjct: 44 GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + + R L + + + + L +L IIHRDLKA N+L+ + ++
Sbjct: 104 DAIMLELDRGLTEPQIQ--VVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRL 158
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGY------IPPEYARQGVYSTKSDVFSFGVLLLQI 179
+DFG++ K K ++ +GT Y + E + Y K+D++S G+ L+++
Sbjct: 159 ADFGVSAKNLKTLQKRDS--FIGT-PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
Query: 180 ISGK 183
+
Sbjct: 216 AQIE 219
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 54/200 (27%), Positives = 81/200 (40%), Gaps = 34/200 (17%)
Query: 6 GEVIAVKKLSKSSAQGFEE--------FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
+ +A++ +SK + E+ + KL H +I++ F D+E+ +V
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 218
Query: 58 EYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
E M L FD + L + + YL E IIHRDLK N+L
Sbjct: 219 ELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVL 271
Query: 117 L---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE---YARQGVYSTKSDVF 170
L ED KI+DFG ++I + SL + GT Y+ PE Y+ D +
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 171 SFGVLLLQIISGKRLSMLCG 190
S GV+L L G
Sbjct: 329 SLGVIL--------FICLSG 340
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-21
Identities = 44/186 (23%), Positives = 76/186 (40%), Gaps = 29/186 (15%)
Query: 6 GEVIAVKKLSKS------SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G+ A K + K EE + EV + +++H N+I + + + +L+ E
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89
Query: 60 MPNKSLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
LFD + + L + ++ I G+ YL I H DLK NI
Sbjct: 90 -------VSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENI 139
Query: 116 LL----GEDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
+L + + K+ DFG+A A K + GT ++ PE ++D++
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPEIVNYEPLGLEADMW 195
Query: 171 SFGVLL 176
S GV+
Sbjct: 196 SIGVIT 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-21
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 6 GEVIAVKKLSKSSAQGF---------EEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERML 55
+ AVK + + F E EV + K+ H N+I++ + L
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 56 VYEYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
V++ M L FD + ++ L K+ I+ + + + L + L I+HRDLK N
Sbjct: 102 VFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPEN 154
Query: 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE------YARQGVYSTKSD 168
ILL +DM K++DFG + +V GT Y+ PE Y + D
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 169 VFSFGVLL 176
++S GV++
Sbjct: 212 MWSTGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 42/187 (22%), Positives = 78/187 (41%), Gaps = 33/187 (17%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYMPN 62
G+ A K L K E +E+ + + +I + ++ E +L+ EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY--- 110
Query: 63 KSLDCY---LFDPIRRLILDWKKR------VHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
+F + + + + +I+ I +G+ YL + I+H DLK
Sbjct: 111 ----AAGGEIFS---LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQ 160
Query: 114 NILL---GEDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
NILL KI DFG++R L+ +++GT Y+ PE +T +D+
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHACELR----EIMGTPEYLAPEILNYDPITTATDM 216
Query: 170 FSFGVLL 176
++ G++
Sbjct: 217 WNIGIIA 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 29/186 (15%)
Query: 6 GEVIAVKKLSKSSAQGF------EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G A K + K + E+ + EV + ++QH N+I + + + +L+ E
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 60 MPNKSLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
LFD + + L ++ ++ I G+ YL L I H DLK NI
Sbjct: 96 -------VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENI 145
Query: 116 LL----GEDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
+L + KI DFGLA K + GT ++ PE ++D++
Sbjct: 146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPEFVAPEIVNYEPLGLEADMW 201
Query: 171 SFGVLL 176
S GV+
Sbjct: 202 SIGVIT 207
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 45/194 (23%), Positives = 88/194 (45%), Gaps = 27/194 (13%)
Query: 4 PCGEVIAVKKLSKSSAQGFEEFKNEVM----LTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
P G+++AVK++ + +E K +M + + G + + E
Sbjct: 30 PSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
M + SLD + + ++D + + I I + L +L +S+L++IHRD+K S
Sbjct: 88 M-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL--HSKLSVIHRDVKPS 139
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE----YARQGVYSTKSDV 169
N+L+ + K+ DFG++ + + G Y+ PE Q YS KSD+
Sbjct: 140 NVLINALGQVKMCDFGISGYLVD-DVAKDI--DAGCKPYMAPERINPELNQKGYSVKSDI 196
Query: 170 FSFGVLLLQIISGK 183
+S G+ ++++ +
Sbjct: 197 WSLGITMIELAILR 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-20
Identities = 51/180 (28%), Positives = 70/180 (38%), Gaps = 31/180 (17%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
+ +G+ +L + IHRDL A NILL E KI DFGLAR K+
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML--CGINENLSILEHAYELWKG 207
+ ++ PE VY+ +SDV+SFGVLL +I S L G+ + E K
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---LGASPYPGVKID----EEFCRRLKE 311
Query: 208 GKGMEFVDSFLDDRNSSC-----KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262
G M + M C P+ RP+ E+ L N
Sbjct: 312 GTRMR--------APDYTTPEMYQTML------DCWHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 13/127 (10%)
Query: 9 IAVKKL-SKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSL 65
+AVK L ++ +E+ +L H+N++ +LG C M++ E+ +L
Sbjct: 55 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL KR + T+G + Q + I DLK +
Sbjct: 115 STYL----------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 126 SDFGLAR 132
S F +
Sbjct: 165 SGFVEEK 171
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 60/296 (20%), Positives = 94/296 (31%), Gaps = 77/296 (26%)
Query: 8 VIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++ K+ + + + E K EV L KL H N+ R+ D + LV E L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL-- 115
Query: 68 YLFDPIRRLILDWKKRV-----------------------------------------HI 86
D + I D + +I
Sbjct: 116 --LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173
Query: 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLKANTE 144
+ I L YL I HRD+K N L + + K+ DFGL++ F K +
Sbjct: 174 MRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 145 --QVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGI----NENLS 196
GT ++ PE Y K D +S GVLL +L G N +
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL--------HLLLMGAVPFPGVNDA 282
Query: 197 ILEHAYELWKGGKGMEFVDSFLDDRNSSCK-LMRCLEIALLCVQENPNDRPSMLEV 251
K + F + + + + L+ LL N ++R +
Sbjct: 283 DT---ISQVLNKK-LCFENPNYNVLSPLARDLLSN----LLNR--NVDERFDAMRA 328
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 25/190 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ AVK +SK + E+ + H N++++ D LV E +
Sbjct: 36 NQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92
Query: 65 LDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GED 120
L F+ I ++ + +I+ + + ++ + + ++HRDLK N+L ++
Sbjct: 93 L----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDN 145
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
++ KI DFG AR+ ++ T T+ Y PE Q Y D++S GV+L
Sbjct: 146 LEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL---- 199
Query: 181 SGKRLSMLCG 190
+ML G
Sbjct: 200 ----YTMLSG 205
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 26/186 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEE--------FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
+ +A+K +SK + E+ + KL H +I++ F D+E+ +V
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 93
Query: 58 EYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
E M L FD + L + + YL E IIHRDLK N+L
Sbjct: 94 ELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVL 146
Query: 117 L---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE---YARQGVYSTKSDVF 170
L ED KI+DFG ++I + SL + GT Y+ PE Y+ D +
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 203
Query: 171 SFGVLL 176
S GV+L
Sbjct: 204 SLGVIL 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ A+K L K+ + + + E+ + +L H N+I++ E LV E
Sbjct: 78 QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL------ 129
Query: 66 DCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---G 118
LFD I + + ++ I + + YL E I+HRDLK N+L
Sbjct: 130 -VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPA 185
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
D KI+DFGL++I + L + V GT GY PE R Y + D++S G++
Sbjct: 186 PDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-20
Identities = 45/187 (24%), Positives = 83/187 (44%), Gaps = 26/187 (13%)
Query: 6 GEVIAVKKLSKSSAQG--------FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLV 56
G AVK + ++ + E + E + ++ H ++I ++ S LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 57 YEYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
++ M L FD + ++ L K+ I+ + + + +L I+HRDLK NI
Sbjct: 179 FDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENI 231
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE------YARQGVYSTKSDV 169
LL ++M+ ++SDFG + ++ GT GY+ PE Y + D+
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288
Query: 170 FSFGVLL 176
++ GV+L
Sbjct: 289 WACGVIL 295
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-20
Identities = 48/207 (23%), Positives = 75/207 (36%), Gaps = 44/207 (21%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ AVK + K EV + + Q H N++ ++ F + + LV+E M S
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97
Query: 65 LDCYLFDPIRRLILDWKKRVH--------IIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ I KR H +++ + L +L I HRDLK NIL
Sbjct: 98 I----LSHIH-------KRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENIL 143
Query: 117 L---GEDMKPKISDFGLARIFAKESLKANTEQ-----VVGTIGYIPPE-----YARQGVY 163
+ KI DF L + G+ Y+ PE +Y
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 164 STKSDVFSFGVLLLQIISGKRLSMLCG 190
+ D++S GV+L I +L G
Sbjct: 204 DKRCDLWSLGVILY-I-------LLSG 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-20
Identities = 54/263 (20%), Positives = 98/263 (37%), Gaps = 48/263 (18%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERM----LVYEYM 60
G+ A+K L S + + EV +++ +L + ++ E M
Sbjct: 54 GQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108
Query: 61 PNKSLDCYLFDPIRRLILDW---KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
L F I+ ++ I+ I + +L I HRD+K N+L
Sbjct: 109 EGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLY 161
Query: 118 ---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
+D K++DFG A+ + +L+ T Y+ PE Y D++S GV
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 175 LLLQIISGKRLSMLCGI-----NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK-LM 228
++ I +LCG N +I + G+ F + + + K L+
Sbjct: 218 IMY-I-------LLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPNPEWSEVSEDAKQLI 268
Query: 229 RCLEIALLCVQENPNDRPSMLEV 251
R LL +P +R ++ +
Sbjct: 269 RL----LLKT--DPTERLTITQF 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 23/191 (12%)
Query: 4 PCGEVIAVKKLSKSSAQGFEEFKNEVM----LTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G VIAVK++ +S + EE K +M + +++ G I + + + E
Sbjct: 48 KTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 60 MPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
M + PI IL + I + L YL + +IHRD+K SNILL
Sbjct: 106 MGTCAEKLKKRMQGPIPERIL-----GKMTVAIVKALYYL--KEKHGVIHRDVKPSNILL 158
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-----YARQGVYSTKSDVFSF 172
E + K+ DFG++ + G Y+ PE + Y ++DV+S
Sbjct: 159 DERGQIKLCDFGISGRLVD-DKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215
Query: 173 GVLLLQIISGK 183
G+ L+++ +G+
Sbjct: 216 GISLVELATGQ 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 59/184 (32%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 6 GEVIAVKKLS---KSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
EV+A+KK+S K S + +++ EV KL+H N I+ G + LV EY
Sbjct: 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ D + + L + + G QGL YL ++ +IHRD+KA NILL E
Sbjct: 139 SASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 192
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPE---YARQGVYSTKSDVFSFGVLLLQI 179
K+ DFG A AN+ VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 193 VKLGDFG----SASIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
Query: 180 ISGK 183
K
Sbjct: 247 AERK 250
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 26/194 (13%)
Query: 4 PCGEVIAVKKLSKSSAQGFEEFKNEVM----LTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
P G+++AVK++ + + +E K +M + +++ G + + E
Sbjct: 45 PSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
M + S D + + + I + L +L L IIHRD+K S
Sbjct: 103 M-STSFD----KFYKYVYSVLDDVIPEEILGKITLATVKALNHL--KENLKIIHRDIKPS 155
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE----YARQGVYSTKSDV 169
NILL K+ DFG++ K G Y+ PE A + Y +SDV
Sbjct: 156 NILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDV 212
Query: 170 FSFGVLLLQIISGK 183
+S G+ L ++ +G+
Sbjct: 213 WSLGITLYELATGR 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 22/191 (11%), Positives = 52/191 (27%), Gaps = 16/191 (8%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ +K ++ F + ++ + +LV E +L
Sbjct: 95 KQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 66 DCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ + ++ + + + + + IIH D+K N +LG
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211
Query: 124 -----------KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
+ D G + T G+ E ++ + D F
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 173 GVLLLQIISGK 183
+ ++ G
Sbjct: 272 AATVYCMLFGT 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 3 LPCGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
P E +A+K+++ Q +E E+ ++ H N++ + +E LV + +
Sbjct: 37 APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96
Query: 62 NKSL-----DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
S+ + +LD I+ + +GL YL + IHRD+KA NIL
Sbjct: 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNIL 153
Query: 117 LGEDMKPKISDFGLA-----RIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVF 170
LGED +I+DFG++ + T VGT ++ PE Q Y K+D++
Sbjct: 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGTPCWMAPEVMEQVRGYDFKADIW 211
Query: 171 SFGVLLLQIISGK 183
SFG+ +++ +G
Sbjct: 212 SFGITAIELATGA 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-18
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
G ++A+K++ + E+ L +L H N++ ++ LV+
Sbjct: 45 GRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+M K L L + L K + + +G+ + ++ I+HRDLK N+L+
Sbjct: 99 EFME-KDLKKVLDENKTGLQDSQIK--IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLI 152
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGV 174
D K++DFGLAR F +++ T +VV T+ Y P+ +++ YST D++S G
Sbjct: 153 NSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWYRAPDVLMGSKK--YSTSVDIWSIGC 208
Query: 175 LLLQIISGKRLSMLCGINE 193
+ ++I+GK L G+ +
Sbjct: 209 IFAEMITGKPL--FPGVTD 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
GE A+KK+ E+ E+ + +L+H N++++ + +LV+
Sbjct: 26 GETFALKKIR------LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E++ + L L L K + + G+ Y + ++HRDLK N+L+
Sbjct: 80 EHLD-QDLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDRR---VLHRDLKPQNLLI 133
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGV 174
+ + KI+DFGLAR F ++ T ++V T+ Y P+ +++ YST D++S G
Sbjct: 134 NREGELKIADFGLARAFGIP-VRKYTHEIV-TLWYRAPDVLMGSKK--YSTTIDIWSVGC 189
Query: 175 LLLQIISGKRLSMLCGINE 193
+ ++++G L G++E
Sbjct: 190 IFAEMVNGTPL--FPGVSE 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-18
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
+++A+KK+ ++ E+ L +L H N+I +L LV+++M
Sbjct: 35 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L+ + D L K + QGL YL ++ I+HRDLK +N+LL E+
Sbjct: 95 E-TDLEVIIKDNSLVLTPSHIK--AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN 148
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLL 177
K++DFGLA+ F +A T QVV T Y PE AR Y D+++ G +L
Sbjct: 149 GVLKLADFGLAKSFGSP-NRAYTHQVV-TRWYRAPELLFGARM--YGVGVDMWAVGCILA 204
Query: 178 QIISGK 183
+++
Sbjct: 205 ELLLRV 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 5e-18
Identities = 45/179 (25%), Positives = 87/179 (48%), Gaps = 27/179 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
E++A+K++ ++ E+ L +L+H N++R+ ++ LV+
Sbjct: 27 HEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+ + L Y L + K + + +GL + + ++HRDLK N+L+
Sbjct: 81 EFCD-QDLKKYFDSCNGDLDPEIVK--SFLFQLLKGLGFCHSRN---VLHRDLKPQNLLI 134
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFG 173
+ + K+++FGLAR F ++ + +VV T+ Y PP+ A+ YST D++S G
Sbjct: 135 NRNGELKLANFGLARAFGIP-VRCYSAEVV-TLWYRPPDVLFGAKL--YSTSIDMWSAG 189
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 44/197 (22%), Positives = 77/197 (39%), Gaps = 36/197 (18%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERM----LVYEYM 60
E A+K L + + EV L + +++R++ + +V E +
Sbjct: 87 QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141
Query: 61 PNKSLDCYLFDPIRRLILDW---KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
L F I+ ++ I++ I + + YL + I HRD+K N+L
Sbjct: 142 DGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLY 194
Query: 118 ---GEDMKPKISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
+ K++DFG A+ + SL T Y+ PE Y D++S G
Sbjct: 195 TSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 174 VLLLQIISGKRLSMLCG 190
V++ I +LCG
Sbjct: 251 VIMY-I-------LLCG 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEV-MLTAKLQHVNLIRVLG------FCIDSEERMLVYE 58
G++ A+K + + EE K E+ ML H N+ G ++ LV E
Sbjct: 49 GQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107
Query: 59 YMPNKSL-DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ S+ D L + L + +I I +GL +L ++ +IHRD+K N+LL
Sbjct: 108 FCGAGSVTD--LIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLL 162
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-----YARQGVYSTKSDVFSF 172
E+ + K+ DFG++ + + NT +GT ++ PE Y KSD++S
Sbjct: 163 TENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 173 GVLLLQIISGK 183
G+ +++ G
Sbjct: 221 GITAIEMAEGA 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 27/200 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K++ S +G E+ L +L+H N++R+ + LV+E+M
Sbjct: 30 GVYVALKEVKLDSEEGT----PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGIT----QGLLYLQEYSRLTIIHRDLKASNIL 116
L Y+ D +++++ QGL + E I+HRDLK N+L
Sbjct: 86 D-NDLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLL 140
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFG 173
+ + + K+ DFGLAR F + + +VV T+ Y P+ +R YST D++S G
Sbjct: 141 INKRGQLKLGDFGLARAFGIP-VNTFSSEVV-TLWYRAPDVLMGSRT--YSTSIDIWSCG 196
Query: 174 VLLLQIISGKRLSMLCGINE 193
+L ++I+GK L G N+
Sbjct: 197 CILAEMITGKPL--FPGTND 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 19/185 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
G ++A+KK +S + K E+ L +L+H NL+ +L C + LV+E++
Sbjct: 50 GRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV- 106
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ ++ L L ++ + I G+ + ++ IIHRD+K NIL+ +
Sbjct: 107 DHTILDDLELFPNGLDYQVVQK--YLFQIINGIGFCHSHN---IIHRDIKPENILVSQSG 161
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQ 178
K+ DFG AR A + ++V T Y PE + Y DV++ G L+ +
Sbjct: 162 VVKLCDFGFARTLAAP-GEVYDDEVA-TRWYRAPELLVGDVK--YGKAVDVWAIGCLVTE 217
Query: 179 IISGK 183
+ G+
Sbjct: 218 MFMGE 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 38/201 (18%)
Query: 6 GEVIAVKKLSK----SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEY 59
+ A+K++ SA E+ L +L+H N+I + + +R L+++Y
Sbjct: 48 DKDYALKQIEGTGISMSACR------EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEG--------ITQGLLYLQEYSRLTIIHRDLK 111
D + R KK V + G I G+ YL ++HRDLK
Sbjct: 102 A---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLK 155
Query: 112 ASNILLGEDMKP----KISDFGLARIFAK--ESLKANTEQVVGTIGYIPPEY---ARQGV 162
+NIL+ + KI+D G AR+F + L VV T Y PE AR
Sbjct: 156 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARH-- 212
Query: 163 YSTKSDVFSFGVLLLQIISGK 183
Y+ D+++ G + ++++ +
Sbjct: 213 YTKAIDIWAIGCIFAELLTSE 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-17
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
G+++A+KK +S K E+ + +L+H NL+ +L LV+EY
Sbjct: 28 GQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC- 84
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ ++ L R + K I Q + + +++ IHRD+K NIL+ +
Sbjct: 85 DHTVLHELDRYQRGVPEHLVKS--ITWQTLQAVNFCHKHN---CIHRDVKPENILITKHS 139
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQ 178
K+ DFG AR+ ++V T Y PE Q Y DV++ G + +
Sbjct: 140 VIKLCDFGFARLLTGP-SDYYDDEVA-TRWYRSPELLVGDTQ--YGPPVDVWAIGCVFAE 195
Query: 179 IISGK 183
++SG
Sbjct: 196 LLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 35/204 (17%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
E +A+K++ E + EV L +LQH N+I + + L++
Sbjct: 59 NETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
EY L Y+ D + + K + + G+ + +HRDLK N+LL
Sbjct: 113 EYA-ENDLKKYM-DKNPDVSMRVIK--SFLYQLINGVNFCHSR---RCLHRDLKPQNLLL 165
Query: 118 GEDMKP-----KISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDV 169
KI DFGLAR F ++ T +++ T+ Y PPE +R YST D+
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIP-IRQFTHEII-TLWYRPPEILLGSRH--YSTSVDI 221
Query: 170 FSFGVLLLQIISGKRLSMLCGINE 193
+S + +++ L G +E
Sbjct: 222 WSIACIWAEMLMKTPL--FPGDSE 243
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
++A+K++ +G EV L L+H N++ + + LV+EY+
Sbjct: 27 DNLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+K L YL D + + K + + +GL Y ++HRDLK N+L+ E
Sbjct: 83 -DKDLKQYLDDCGNIINMHNVK--LFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINER 136
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLL 177
+ K++DFGLAR + K +VV T+ Y PP+ + YST+ D++ G +
Sbjct: 137 GELKLADFGLARAKSIP-TKTYDNEVV-TLWYRPPDILLGSTD--YSTQIDMWGVGCIFY 192
Query: 178 QIISGKRLSMLCGINE 193
++ +G+ L G
Sbjct: 193 EMATGRPL--FPGSTV 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-17
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 42/198 (21%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-EVMLTAKLQHVNLIRVLGFCIDSEERM------LVYE 58
GE++A+KK+ + + FKN E+ + KL H N++R+ F S E+ LV +
Sbjct: 79 GELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG---------ITQGLLYLQEYSRLTIIHRD 109
Y+P Y R+ + + + + + L Y+ I HRD
Sbjct: 134 YVP---ETVY------RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRD 181
Query: 110 LKASNILLGEDMKP-KISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYST 165
+K N+LL D K+ DFG A+ + + N + + Y PE A Y++
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYIC-SRYYRAPELIFGATD--YTS 236
Query: 166 KSDVFSFGVLLLQIISGK 183
DV+S G +L +++ G+
Sbjct: 237 SIDVWSAGCVLAELLLGQ 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 37/204 (18%), Positives = 76/204 (37%), Gaps = 33/204 (16%)
Query: 6 GEVIAVKK--LSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPN 62
G + A+K+ + + + EV A L QH +++R + + ++ EY
Sbjct: 36 GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95
Query: 63 KSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
SL + + R + + ++ + +GL Y+ S ++H D+K SNI +
Sbjct: 96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTS 152
Query: 122 KP-------------------KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162
P KI D G + E G ++ E ++
Sbjct: 153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS----SPQVE--EGDSRFLANEVLQENY 206
Query: 163 -YSTKSDVFSFGVLLLQIISGKRL 185
+ K+D+F+ + ++ + L
Sbjct: 207 THLPKADIFALALTVVCAAGAEPL 230
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 40/202 (19%)
Query: 4 PCGEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEER 53
+A+KK+S F++ E+ + + +H N+I + + E+
Sbjct: 50 LNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 54 M----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
M +V + M + L+ ++ L + + I +GL Y+ + ++HRD
Sbjct: 102 MKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRD 153
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPE----YARQGVY 163
LK SN+LL KI DFGLAR+ + TE V T Y PE Y
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKG---Y 209
Query: 164 STKSDVFSFGVLLLQIISGKRL 185
+ D++S G +L +++S + +
Sbjct: 210 TKSIDIWSVGCILAEMLSNRPI 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTA--------KLQHVNLIRVLGFCIDSEERM--- 54
G+ +A+KK+ E K +TA L+H N++ ++ C
Sbjct: 42 GQKVALKKVL------MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95
Query: 55 -----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
LV+++ L L + + + L K +++ + GL Y+ I+HRD
Sbjct: 96 KGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIK--RVMQMLLNGLYYIHRNK---ILHRD 149
Query: 110 LKASNILLGEDMKPKISDFGLARIF---AKESLKANTEQVVGTIGYIPPEY---ARQGVY 163
+KA+N+L+ D K++DFGLAR F T +VV T+ Y PPE R Y
Sbjct: 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERD--Y 206
Query: 164 STKSDVFSFGVLLLQIISGK 183
D++ G ++ ++ +
Sbjct: 207 GPPIDLWGAGCIMAEMWTRS 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 34/195 (17%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVL------GFCIDS 50
+A+KKLS+ F+N E++L + H N+I +L +
Sbjct: 87 DRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 51 EERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
++ LV E M D L I+ + + +++ + G+ +L IIHRDL
Sbjct: 140 QDVYLVMELM-----DANLCQVIQMELDHERMS-YLLYQMLCGIKHLHS---AGIIHRDL 190
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
K SNI++ D KI DFGLAR T VV T Y PE Y D++
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
Query: 171 SFGVLLLQIISGKRL 185
S G ++ +++ K L
Sbjct: 248 SVGCIMGEMVRHKIL 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 38/197 (19%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCIDSEERM-- 54
G +A+KKL + F++ E+ L ++H N+I +L E
Sbjct: 50 GAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
LV +M L ++ L + ++ + +GL Y+ IIHRDL
Sbjct: 103 TDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDL 154
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--YARQGVYSTKSD 168
K N+ + ED + KI DFGLAR E T VV T Y PE Y+ D
Sbjct: 155 KPGNLAVNEDCELKILDFGLARQADSEM----TGYVV-TRWYRAPEVILNWMR-YTQTVD 208
Query: 169 VFSFGVLLLQIISGKRL 185
++S G ++ ++I+GK L
Sbjct: 209 IWSVGCIMAEMITGKTL 225
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 58/303 (19%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPN 62
G +A+K + K+ + ++ EV + L H N+++ L I++E+ + L+ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK-LFEVIETEKTLYLIMEYASG 98
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ FD + R+ E I + Y + I+HRDLKA N+L
Sbjct: 99 GEV----FDYLVA-----HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLL 146
Query: 117 LGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS-TKSDVFSFGVL 175
L DM KI+DFG + F + G Y PE + Y + DV+S GV+
Sbjct: 147 LDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 203
Query: 176 LLQIISGKRLSMLCGI----NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMR 229
L +++ G +NL L + +G + ++ ++ C+ L R
Sbjct: 204 L--------YTLVSGSLPFDGQNLKELRE-----RVLRGKYRIPFYM---STDCENLLKR 247
Query: 230 CLEIALLCVQENPNDRPSMLEVSS---MLKNETTNTNTPKKPAFSKQVDEIGIELLSTTN 286
L + NP R ++ ++ + + P D+ I+++
Sbjct: 248 FLVL-------NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMG 300
Query: 287 LEK 289
+
Sbjct: 301 YSQ 303
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 23/191 (12%)
Query: 6 GEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
A+K L K E + ++L H ++ L F +E++ Y
Sbjct: 55 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK-LYFTFQDDEKLYFGLSYAK 113
Query: 62 NKSLDCYLFDPIRRL--ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
N L IR++ + R + E I L YL IIHRDLK NILL E
Sbjct: 114 NGEL----LKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNE 165
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
DM +I+DFG A++ + ES +A VGT Y+ PE + SD+++ G ++ Q
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ- 224
Query: 180 ISGKRLSMLCG 190
++ G
Sbjct: 225 -------LVAG 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 56/195 (28%), Positives = 84/195 (43%), Gaps = 34/195 (17%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCI--DSEERM 54
+A+KKLS+ F+N E++L + H N+I +L S E
Sbjct: 50 ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+V E M D L I+ + + +++ + G+ +L IIHRDL
Sbjct: 103 QDVYIVMELM-----DANLCQVIQMELDHERMS-YLLYQMLCGIKHLHSAG---IIHRDL 153
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
K SNI++ D KI DFGLAR + T VV T Y PE Y D++
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYKENVDIW 210
Query: 171 SFGVLLLQIISGKRL 185
S G ++ ++I G L
Sbjct: 211 SVGCIMGEMIKGGVL 225
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-16
Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 31/194 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN------EVMLTAKLQHV--NLIRVLGFCIDSEERMLVY 57
+A+K + K + E N EV+L K+ +IR+L + + +L+
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLK 111
E P D LFD I + + + + + + ++HRD+K
Sbjct: 128 ER-PEPVQD--LFDFITE-----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIK 176
Query: 112 ASNILL-GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS-TKSDV 169
NIL+ + K+ DFG + GT Y PPE+ R Y + V
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 170 FSFGVLLLQIISGK 183
+S G+LL ++ G
Sbjct: 233 WSLGILLYDMVCGD 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 33/195 (16%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN------EV----MLTAKLQHVNLIRVLGFCIDSEERML 55
+A+K + ++ G+ + EV + A H +IR+L + E ML
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRD 109
V E P + D LFD I K + + + + ++HRD
Sbjct: 116 VLER-PLPAQD--LFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRD 164
Query: 110 LKASNILL-GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS-TKS 167
+K NIL+ K+ DFG + E GT Y PPE+ + Y +
Sbjct: 165 IKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVYSPPEWISRHQYHALPA 220
Query: 168 DVFSFGVLLLQIISG 182
V+S G+LL ++ G
Sbjct: 221 TVWSLGILLYDMVCG 235
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G++ A KKL K +G NE + K+ ++ L + ++++ + LV M
Sbjct: 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMN 267
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L +++ + + + + E I GL L I++RDLK NILL +
Sbjct: 268 GGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHG 323
Query: 122 KPKISDFGLARIFAKE-SLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ISD GL A + VGT+GY+ PE + Y+ D ++ G LL ++I
Sbjct: 324 HIRISDLGL----AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 181 SGK 183
+G+
Sbjct: 380 AGQ 382
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 32/200 (16%)
Query: 6 GEVIAVKKLSKSSAQGFEE--FKN---------EVMLTAKLQHVNLIRVLG-FCIDSEER 53
G +A+K++ + + G + E+ L H N++ + F E
Sbjct: 46 GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105
Query: 54 M----LVYEYMPNKSLDCYLFDPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
M LV E M L I R+++ + + + I GL L E ++H
Sbjct: 106 MHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVH 157
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--YARQGVYST 165
RDL NILL ++ I DF LAR ++ K T V Y PE +G ++
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTADANK--THYVT-HRWYRAPELVMQFKG-FTK 213
Query: 166 KSDVFSFGVLLLQIISGKRL 185
D++S G ++ ++ + K L
Sbjct: 214 LVDMWSAGCVMAEMFNRKAL 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 43/198 (21%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-EVMLTAKLQHVNLIRVLGFCIDSEERM------LVYE 58
EV A+KK+ + + FKN E+ + ++H N++ + F + ++ LV E
Sbjct: 65 DEV-AIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG---------ITQGLLYLQEYSRLTIIHRD 109
Y+P Y R + K + + + L Y+ + I HRD
Sbjct: 119 YVP---ETVY------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRD 166
Query: 110 LKASNILLGEDMKP-KISDFGLARIFAKESLKANTEQVVGTIGYIPPEY---ARQGVYST 165
+K N+LL K+ DFG A+I + + N + + Y PE A Y+T
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYIC-SRYYRAPELIFGATN--YTT 221
Query: 166 KSDVFSFGVLLLQIISGK 183
D++S G ++ +++ G+
Sbjct: 222 NIDIWSTGCVMAELMQGQ 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 11/183 (6%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G++ A KKL+K +G++ E + AK+ ++ L + +++ + LV M
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMN 268
Query: 62 NKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+ ++++ + + I GL +L + II+RDLK N+LL +D
Sbjct: 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDD 325
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ISD GLA K GT G++ PE Y D F+ GV L ++I
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 181 SGK 183
+ +
Sbjct: 384 AAR 386
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 39/197 (19%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCIDSEERM-- 54
GE +A+KKLS+ F++ E++L +QH N+I +L +
Sbjct: 49 GEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
LV +M L + + K + +++ + +GL Y+ ++HRDL
Sbjct: 102 YDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ-YLVYQMLKGLKYIHSAG---VVHRDL 152
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--YARQGVYSTKSD 168
K N+ + ED + KI DFGLAR E T VV T Y PE + Y+ D
Sbjct: 153 KPGNLAVNEDCELKILDFGLARHADAEM----TGYVV-TRWYRAPEVILSWMH-YNQTVD 206
Query: 169 VFSFGVLLLQIISGKRL 185
++S G ++ ++++GK L
Sbjct: 207 IWSVGCIMAEMLTGKTL 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 25/189 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAK----LQHVNLIRV-----LGFCIDSEERM-L 55
G++ A+K L K + K L L V+ + + + +++
Sbjct: 214 GKMYAMKCLDKKRIKM----KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+ + M L +L + + R + E I GL ++ +++RDLK +NI
Sbjct: 270 ILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILGLEHMHN---RFVVYRDLKPANI 323
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGV 174
LL E +ISD GL A + K VGT GY+ PE + Y + +D FS G
Sbjct: 324 LLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 175 LLLQIISGK 183
+L +++ G
Sbjct: 380 MLFKLLRGH 388
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 25/192 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEEF----KNEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEY 59
AVK L K + K E+ L +L+H N+I+++ + E++ +V EY
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKAS 113
+ + D + +KR + + + GL YL I+H+D+K
Sbjct: 90 CVCGMQE--MLDSVP------EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPG 138
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-QGVYS-TKSDVFS 171
N+LL KIS G+A + G+ + PPE A +S K D++S
Sbjct: 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWS 198
Query: 172 FGVLLLQIISGK 183
GV L I +G
Sbjct: 199 AGVTLYNITTGL 210
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 51/212 (24%)
Query: 4 PCGEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVL---------- 44
C + +A+KK+ + E+ + +L H N+++V
Sbjct: 34 DCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 45 GFCIDSEERM----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEY 100
+ S + +V EYM + L + + + L + + + +GL Y+
Sbjct: 85 TDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA 139
Query: 101 SRLTIIHRDLKASNILL-GEDMKPKISDFGLARIFAKESLKAN--TEQVVGTIGYIPPE- 156
+ ++HRDLK +N+ + ED+ KI DFGLARI +E +V T Y P
Sbjct: 140 N---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRL 195
Query: 157 ---YARQGVYSTKSDVFSFGVLLLQIISGKRL 185
Y+ D+++ G + ++++GK L
Sbjct: 196 LLSPNN---YTKAIDMWAAGCIFAEMLTGKTL 224
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-15
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 30/194 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNK 63
E +AVK + A E K E+ + L H N+++ G L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGG 90
Query: 64 SLDCYLFDPI---RRLILDWKKRV--HIIEGITQGLLYLQEYS-RLTIIHRDLKASNILL 117
L FD I + +R ++ G+ Y + I HRD+K N+LL
Sbjct: 91 EL----FDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIGITHRDIKPENLLL 138
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLL 176
E KISDFGLA +F + + ++ GT+ Y+ PE R+ ++ DV+S G++L
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
Query: 177 LQIISGKRLSMLCG 190
+ML G
Sbjct: 199 --------TAMLAG 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-15
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 26 KNEVMLTAKLQHVNLIR---VLGFCIDSEERML--VYEYMPNKSLDCYLFDPIRRLILDW 80
E+ + KL H N+++ VL D E L V+E + + + L
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLD---DPNEDHLYMVFELVNQGPV----MEVPTLKPLSE 136
Query: 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK 140
+ + + +G+ YL IIHRD+K SN+L+GED KI+DFG++ F
Sbjct: 137 DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 141 ANTEQVVGTIGYIPPE--YARQGVYS-TKSDVFSFGVLL 176
+ VGT ++ PE + ++S DV++ GV L
Sbjct: 194 LSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 43/205 (20%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM- 54
GE++A+KK+ F E+ + +H N+I + DS E
Sbjct: 36 GEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87
Query: 55 ---LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
++ E M L I +L + I + + L + +IHRDLK
Sbjct: 88 EVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLK 139
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLKAN---------TEQVVGTIGYIPPE--YARQ 160
SN+L+ + K+ DFGLARI + + + E V T Y PE
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSA 198
Query: 161 GVYSTKSDVFSFGVLLLQIISGKRL 185
YS DV+S G +L ++ + +
Sbjct: 199 K-YSRAMDVWSCGCILAELFLRRPI 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTA-----------KLQHVNLIRVLGFCIDSEER- 53
G +A+K + + + ++ +H N++R++ C S
Sbjct: 34 GHFVALKSVRVPNG---GGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90
Query: 54 ----MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
LV+E++ ++ L YL D L + ++ +GL +L I+HRD
Sbjct: 91 EIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRD 145
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
LK NIL+ K++DFGLARI++ + A T VV T+ Y PE Q Y+T D+
Sbjct: 146 LKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVV-TLWYRAPEVLLQSTYATPVDM 202
Query: 170 FSFGVLLLQIISGKRLSMLCGINE 193
+S G + ++ K L CG +E
Sbjct: 203 WSVGCIFAEMFRRKPL--FCGNSE 224
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 32/204 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTA-----------KLQHVNLIRVL----GFCIDS 50
G +A+K++ + + + L+ +H N++R+ D
Sbjct: 37 GRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90
Query: 51 EERM-LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
E ++ LV+E++ ++ L YL D + + + ++ + +GL +L + ++HRD
Sbjct: 91 ETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRD 145
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
LK NIL+ + K++DFGLARI++ + A T VV T+ Y PE Q Y+T D+
Sbjct: 146 LKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV-TLWYRAPEVLLQSSYATPVDL 202
Query: 170 FSFGVLLLQIISGKRLSMLCGINE 193
+S G + ++ K L G ++
Sbjct: 203 WSVGCIFAEMFRRKPL--FRGSSD 224
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-15
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 21/188 (11%)
Query: 6 GEVIAVKKLSKS--------SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LV 56
+ + VK + K + E+ + ++++H N+I+VL +++ LV
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLV 107
Query: 57 YEYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
E + LD LF I R LD +I + + YL+ IIHRD+K NI
Sbjct: 108 MEKHGS-GLD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENI 161
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS-TKSDVFSFGV 174
++ ED K+ DFG A + L GTI Y PE Y + +++S GV
Sbjct: 162 VIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV 218
Query: 175 LLLQIISG 182
L ++
Sbjct: 219 TLYTLVFE 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-15
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 38/197 (19%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCIDSEERM-- 54
G +AVKKLS+ F++ E+ L ++H N+I +L +
Sbjct: 54 GLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
LV M L + ++ L +I I +GL Y+ IIHRDL
Sbjct: 107 NDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDL 158
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE--YARQGVYSTKSD 168
K SN+ + ED + KI DFGLAR A E T V T Y PE Y+ D
Sbjct: 159 KPSNLAVNEDCELKILDFGLARHTADEM----TGYVA-TRWYRAPEIMLNWMH-YNQTVD 212
Query: 169 VFSFGVLLLQIISGKRL 185
++S G ++ ++++G+ L
Sbjct: 213 IWSVGCIMAELLTGRTL 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 30/194 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNK 63
E +AVK + A E K E+ + L H N+++ G L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGG 90
Query: 64 SLDCYLFDPI---RRLILDWKKRV--HIIEGITQGLLYLQEYS-RLTIIHRDLKASNILL 117
L FD I + +R ++ G+ Y + I HRD+K N+LL
Sbjct: 91 EL----FDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIGITHRDIKPENLLL 138
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLL 176
E KISDFGLA +F + + ++ GT+ Y+ PE R+ ++ DV+S G++L
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
Query: 177 LQIISGKRLSMLCG 190
+ML G
Sbjct: 199 --------TAMLAG 204
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 42/207 (20%), Positives = 83/207 (40%), Gaps = 48/207 (23%)
Query: 3 LPCGEVIAVKKLSKSSAQGFEE--FKN----EVMLTAKLQHVNLIRVLGFCIDSEER--- 53
G +A+KK+ ++ F+N + A L H N++++ + ER
Sbjct: 45 KSTGMSVAIKKV-------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97
Query: 54 ----MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEG---------ITQGLLYLQEY 100
+V EY+P + R ++ +R + + + L
Sbjct: 98 DIYLNVVMEYVP---DTLH------RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148
Query: 101 SRLTIIHRDLKASNILL-GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY-- 157
S + + HRD+K N+L+ D K+ DFG A+ + + N + + Y PE
Sbjct: 149 S-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYIC-SRYYRAPELIF 204
Query: 158 -ARQGVYSTKSDVFSFGVLLLQIISGK 183
+ Y+T D++S G + +++ G+
Sbjct: 205 GNQH--YTTAVDIWSVGCIFAEMMLGE 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
+ L YLQ IIHRD+K NILL E I+DF +A + +E+ + T + GT
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITT--MAGT 177
Query: 150 IGYIPPE-YARQGV--YSTKSDVFSFGVLLLQIISGKR 184
Y+ PE ++ + YS D +S GV +++ G+R
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-13
Identities = 18/179 (10%), Positives = 47/179 (26%), Gaps = 42/179 (23%)
Query: 10 AVKKL--SKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
A+ + +E + + +++ + RVL ++V E++ SL
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ 119
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILLGEDMKPKI 125
+ ++ + + + R + S + + D
Sbjct: 120 EVADTS-----PSPVGAIRAMQSLAAAA----DAAHRAGVALSIDHPSRVRVSID----- 165
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
G V+ +P + D+ G L ++ +
Sbjct: 166 ---GDV--------------VLAYPATMPDANPQ-------DDIRGIGASLYALLVNRW 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 3 LPCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYE 58
G +AVK L++ S + K E+ +H ++I+ L I + +V E
Sbjct: 33 QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK-LYQVISTPTDFFMVME 91
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKA 112
Y+ L FD I + RV +E I + Y R ++HRDLK
Sbjct: 92 YVSGGEL----FDYICK-----HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKP 139
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS-TKSDVFS 171
N+LL M KI+DFGL+ + + T G+ Y PE +Y+ + D++S
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEF-LRT--SCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 172 FGVLLLQIISGKRLSMLCG 190
GV+L ++LCG
Sbjct: 197 CGVIL--------YALLCG 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 41/189 (21%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVY--EYMPN 62
E + VK L + + K E+ + L+ N+I + D R E++ N
Sbjct: 61 NEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117
Query: 63 KSLDCYLFDPIRRLILDWKKRVHI---IEGITQGLLYLQEYSRLTIIHRDLKASNILL-G 118
+ L I + I + L Y +S I+HRD+K N+++
Sbjct: 118 TDFKQL----YQTLTDY-----DIRFYMYEILKALDYC--HSM-GIMHRDVKPHNVMIDH 165
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE---YARQGVYSTKSDVFSFGVL 175
E K ++ D+GLA + + +V + + PE + Y D++S G +
Sbjct: 166 EHRKLRLIDWGLAEFY--HPGQEYNVRVA-SRYFKGPELLVDYQM--YDYSLDMWSLGCM 220
Query: 176 LLQIISGKR 184
L +I K
Sbjct: 221 LASMIFRKE 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 37/171 (21%), Positives = 65/171 (38%), Gaps = 30/171 (17%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM- 54
+ +A+KK+++ F++ E+ + +L+ +IR+ D +
Sbjct: 51 EKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103
Query: 55 ---LVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+V E D L + + L + I+ + G ++ E IIHRDL
Sbjct: 104 ELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDL 155
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161
K +N LL +D K+ DFGLAR E + P +
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I L YL +S +++RDLK N++L +D KI+DFGL + K+ T GT
Sbjct: 257 IVSALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
Y+ PE Y D + GV++ + M+CG
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYE--------MMCG 345
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 35/178 (19%), Positives = 63/178 (35%), Gaps = 34/178 (19%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM- 54
V+A+KK+ F++ E+ + +L H ++++VL E+
Sbjct: 78 KRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 55 ---LVYEYMPNKSLDCYLFDPIR---RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 108
+V E D R L K ++ + G+ Y+ I+HR
Sbjct: 131 ELYVVLEIA-----DSDFKKLFRTPVYLTELHIK--TLLYNLLVGVKYVHSAG---ILHR 180
Query: 109 DLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166
DLK +N L+ +D K+ DFGLAR + + + +
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 28/197 (14%)
Query: 6 GEVIAVKKLSKSSAQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G+V A+K ++K E F+ E + + + L F E + LV EY
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LHFAFQDENYLYLVMEYYV 144
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L L R+ + R ++ E I + + +HRD+K NILL
Sbjct: 145 GGDLLTLLSKFGERIPAEMA-RFYLAE-IVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199
Query: 122 KPKISDFGLA-RIFAKESLKANTEQVVGTIGYIPPE-------YARQGVYSTKSDVFSFG 173
+++DFG ++ A ++++ VGT Y+ PE G Y + D ++ G
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 174 VLLLQIISGKRLSMLCG 190
V + M G
Sbjct: 258 VFAYE--------MFYG 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 45/200 (22%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKS 64
E++AVK + + +A E + E++ L+H N++R I + + ++ EY
Sbjct: 45 KELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIIMEYASGGE 102
Query: 65 LDCYLFDPIRRLILDWKKRVH----------IIEGITQGLLYLQEYS-RLTIIHRDLKAS 113
L ++ I R ++ G+ Y + I HRDLK
Sbjct: 103 L----YERICN-----AGRFSEDEARFFFQQLLSGV--------SYCHSMQICHRDLKLE 145
Query: 114 NILLGEDMKP--KISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVF 170
N LL P KI DFG ++ S + VGT YI PE RQ +DV+
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS--TVGTPAYIAPEVLLRQEYDGKIADVW 202
Query: 171 SFGVLLLQIISGKRLSMLCG 190
S GV L ML G
Sbjct: 203 SCGVTL--------YVMLVG 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 26/195 (13%)
Query: 6 GEVIAVKKLSKSSAQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
+V A+K L+K E F+ E + + L + + + LV +Y
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT-LHYAFQDDNNLYLVMDYYV 157
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L L RL + R ++ E + + + + L +HRD+K NIL+ +
Sbjct: 158 GGDLLTLLSKFEDRLPEEMA-RFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNG 212
Query: 122 KPKISDFGLA-RIFAKESLKANTEQVVGTIGYIPPE-----YARQGVYSTKSDVFSFGVL 175
+++DFG ++ +++++ VGT YI PE +G Y + D +S GV
Sbjct: 213 HIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 176 LLQIISGKRLSMLCG 190
+ + ML G
Sbjct: 271 MYE--------MLYG 277
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-11
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I+ L +L + II+RDLK NI+L K++DFGL + + +T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
I Y+ PE + ++ D +S G L+ ML G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYD--------MLTG 217
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 35/199 (17%)
Query: 3 LPCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYE 58
G +AVK L++ S + + E+ +H ++I+ L I + + +V E
Sbjct: 38 ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK-LYQVISTPSDIFMVME 96
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKA 112
Y+ L FD I + R+ E I G+ Y R ++HRDLK
Sbjct: 97 YVSGGEL----FDYICK-----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKP 144
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS-TKSDVFS 171
N+LL M KI+DFGL+ + + T G+ Y PE +Y+ + D++S
Sbjct: 145 ENVLLDAHMNAKIADFGLSNMMSDGEF-LRT--SCGSPNYAAPEVISGRLYAGPEVDIWS 201
Query: 172 FGVLLLQIISGKRLSMLCG 190
GV+L ++LCG
Sbjct: 202 SGVIL--------YALLCG 212
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
+ L +L L II+RDLK NILL E+ K++DFGL++ KA + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
+ Y+ PE + ++ +D +SFGVL+ + ML G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFE--------MLTG 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 42/199 (21%), Positives = 72/199 (36%), Gaps = 61/199 (30%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM----LVYEYM 60
E A+K L + + EV L + Q +++R++ + +V E
Sbjct: 43 QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC- 96
Query: 61 PNKSLDCY---LFDPIRRLILDW---KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
LF I+ ++ I++ I + + YL + I HRD+K N
Sbjct: 97 ------LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 147
Query: 115 ILL---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
+L + K++DFG FAKE+ Y D++S
Sbjct: 148 LLYTSKRPNAILKLTDFG----FAKETTGEK--------------------YDKSCDMWS 183
Query: 172 FGVLLLQIISGKRLSMLCG 190
GV++ I +LCG
Sbjct: 184 LGVIMY-I-------LLCG 194
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 6 GEVIAVKKLSKSSAQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
+ +A+K +S+ + + E+ L+H ++I+ L I + + +V EY
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK-LYDVITTPTDIVMVIEYAG 92
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGIT--QGLLYLQEYS-RLTIIHRDLKASNILLG 118
+ LFD I KKR+ EG Q ++ EY R I+HRDLK N+LL
Sbjct: 93 GE-----LFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS-TKSDVFSFGVLLL 177
+++ KI+DFGL+ I + T G+ Y PE +Y+ + DV+S G++L
Sbjct: 143 DNLNVKIADFGLSNIMTDGNF-LKT--SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL- 198
Query: 178 QIISGKRLSMLCG 190
ML G
Sbjct: 199 -------YVMLVG 204
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I L YL +++RD+K N++L +D KI+DFGL + + T GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
Y+ PE Y D + GV++ + M+CG
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYE--------MMCG 201
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 47/212 (22%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN---------EVMLTAKLQ-HVNLIRVLGFCI--DSEER 53
GEV+AVKK+ + F+N E+M+ +L H N++ +L + +
Sbjct: 34 GEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86
Query: 54 MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
LV++YM + L IR IL+ + +++ + + + YL ++HRD+K S
Sbjct: 87 YLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPS 138
Query: 114 NILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV----------- 162
NILL + K++DFGL+R F N + + + +
Sbjct: 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA 198
Query: 163 ---------YSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G +L +I+ GK +
Sbjct: 199 PEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I L++L + II+RDLK N+LL + K++DFG+ + + T GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
YI PE ++ +Y D ++ GVLL + MLCG
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYE--------MLCG 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 31/101 (30%), Positives = 44/101 (43%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I L YL L I++RDLK NILL ++DFGL + + + +T GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGT 202
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
Y+ PE + Y D + G +L + ML G
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYE--------MLYG 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I+ L YL E II+RDLK N+LL + K++D+G+ + + +T GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
YI PE R Y D ++ GVL+ + M+ G
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFE--------MMAG 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVV 147
I GL +LQ II+RDLK N++L + KI+DFG+ KE++ T+
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFC 182
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE Y D ++FGVLL + ML G
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE--------MLAG 217
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN--TEQVV 147
I GL +LQ II+RDLK N++L + KI+DFG+ KE++ T+
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFC 503
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE Y D ++FGVLL + ML G
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE--------MLAG 538
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I+ L YL E II+RDLK N+LL + K++D+G+ + + +T GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
YI PE R Y D ++ GVL+ + M+ G
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFE--------MMAG 249
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 9e-11
Identities = 39/101 (38%), Positives = 49/101 (48%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I GL +L I++RDLK NILL +D KI+DFG+ + K NT GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 181
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
YI PE Y+ D +SFGVLL + ML G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYE--------MLIG 214
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 42/232 (18%), Positives = 87/232 (37%), Gaps = 74/232 (31%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKN-EVMLTAKLQHVNLIRVLGFCIDSEERM---------- 54
G+ A+KK+ + +KN E+ + L HVN+I+++ + + +
Sbjct: 32 GKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86
Query: 55 ----------------------------LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86
++ EY+P + +++ + +
Sbjct: 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DTLH------KVLKSFIRSGRS 137
Query: 87 IEG---------ITQGLLYLQEYSRLTIIHRDLKASNILL-GEDMKPKISDFGLARIFAK 136
I + + + ++ L I HRD+K N+L+ +D K+ DFG A+
Sbjct: 138 IPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP 194
Query: 137 ESLKANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+ + + + Y PE A + Y+ D++S G + ++I GK L
Sbjct: 195 S--EPSVAYIC-SRFYRAPELMLGATE--YTPSIDLWSIGCVFGELILGKPL 241
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 22/107 (20%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN---TEQV 146
I L +L + L II+RD+K NILL + ++DFGL +KE +
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL----SKEFVADETERAYDF 220
Query: 147 VGTIGYIPPE---YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GTI Y+ P+ G + D +S GVL+ + +L G
Sbjct: 221 CGTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYE--------LLTG 258
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 31/106 (29%), Positives = 48/106 (45%), Gaps = 18/106 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA-RIFAKESLKANTEQVVG 148
+ L + + IHRD+K N+LL + K++DFG ++ + ++ +T VG
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVG 231
Query: 149 TIGYIPPE----YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
T YI PE G Y + D +S GV L + ML G
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE--------MLVG 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 16/101 (15%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
I YL L +I+RDLK N+L+ + +++DFG FAK +K T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKR-VKGRTWTLCGT 201
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
+ PE Y+ D ++ GVL+ + M G
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYE--------MAAG 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 4e-09
Identities = 37/101 (36%), Positives = 49/101 (48%), Gaps = 16/101 (15%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149
+ L YL II+RDLK NILL ++ KI+DFG FAK + T + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFG----FAKY-VPDVTYTLCGT 166
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
YI PE Y+ D +SFG+L+ + ML G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYE--------MLAG 199
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 8e-07
Identities = 37/179 (20%), Positives = 59/179 (32%), Gaps = 67/179 (37%)
Query: 67 CYLFDPIRRLILDWKKR-----------VHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
C +F+ + +L W + II+ + QGL YL ++ IIH D+K NI
Sbjct: 121 CMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENI 178
Query: 116 LLG-------------------------------------------------EDMKPKIS 126
LL E +K KI+
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 127 DFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
D G A K + + T Y E Y+T +D++S + ++ +G L
Sbjct: 239 DLGNACWVHKHF-----TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 4e-06
Identities = 50/332 (15%), Positives = 103/332 (31%), Gaps = 88/332 (26%)
Query: 1 GVLPCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRV----LGFCIDSEERM- 54
GVL G K+ A +V L+ K+Q ++ L C E +
Sbjct: 157 GVLGSG---------KTWVA-------LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
L+Y+ PN + I+ I + + + LL + Y ++ ++
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLLVLLNV 253
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG-TIGYIPPEYARQGVYSTKSDV 169
+ + + +I K T+ + T +I ++ + T +V
Sbjct: 254 QNAKAW-------NAFNLS-CKILLTTRFKQVTDFLSAATTTHISLDHHSMTL--TPDEV 303
Query: 170 FSFGVLLLQIISGKRLSML----CGIN--------ENLSILEHAYELWK---GGKGMEFV 214
S LLL+ + R L N E++ ++ WK K +
Sbjct: 304 KS---LLLKYL-DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 215 DSFLDDRNSSCKLMRCL--EIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFSK 272
+S L+ + R + +++ P + S++ +
Sbjct: 360 ESSLNVLEPA--EYRKMFDRLSVF-----PPSAHIPTILLSLIWFDVI----------KS 402
Query: 273 QVDEIGIELLSTTNLEK------CSAYDVSFS 298
V + +L + +EK S +
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 13/107 (12%)
Query: 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP------KISDFGLARIFAKES 138
I + + GL Y+ + R IIH D+K N+L+ P KI+D G A + E
Sbjct: 135 QISKQLLLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEH 191
Query: 139 LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+ T Y PE + +D++S L+ ++I+G L
Sbjct: 192 YT----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 4e-05
Identities = 15/80 (18%), Positives = 27/80 (33%), Gaps = 6/80 (7%)
Query: 55 LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+V E+ + +R + I+ +T L + L HRDL N
Sbjct: 139 IVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 115 ILLGEDMKPKISDFGLARIF 134
+LL + K+ +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSS 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 36/141 (25%), Positives = 56/141 (39%), Gaps = 18/141 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP--KISDFGLARIFAKESLKANTEQVV 147
I Q L L + IIH DLK NILL + + K+ DFG + + + + +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYI 260
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL-------SMLCGINENLSILEH 200
+ Y PE Y D++S G +L ++++G L L + E L +
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320
Query: 201 AYELWKGGKGMEFVDSFLDDR 221
L + FV S R
Sbjct: 321 KL-LDASKRAKNFVSSKGYPR 340
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 24/148 (16%), Positives = 55/148 (37%), Gaps = 20/148 (13%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFK-----------NEVMLTAKLQHVNLIRVLGFCID 49
P + ++K L + F E N+ + + +GF +
Sbjct: 70 DSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH 128
Query: 50 SEE-RMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 108
++ R LV + +SL D + +L + + + + L +L E +H
Sbjct: 129 QDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHG 183
Query: 109 DLKASNILLGEDMKPKI--SDFGLARIF 134
++ A NI + + + ++ + +G A +
Sbjct: 184 NVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP--KISDFGLARIFAKESLKANTEQVV 147
+ LL+L L+IIH DLK NILL + KI DFG + + + Q +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIY----QYI 219
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+ Y PE Y D++S G +L+++ +G+ L
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 11/32 (34%), Positives = 21/32 (65%), Gaps = 2/32 (6%)
Query: 105 IIHRDLKASNILLGEDMKPKI--SDFGLARIF 134
+H D+KA+N+LLG ++ +D+GL+ +
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 12/32 (37%), Positives = 19/32 (59%), Gaps = 2/32 (6%)
Query: 105 IIHRDLKASNILLGEDMKPKI--SDFGLARIF 134
+H D+KASN+LL ++ D+GLA +
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.45 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.48 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.45 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.27 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.72 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.74 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.52 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.85 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 82.78 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.81 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=370.49 Aligned_cols=238 Identities=28% Similarity=0.470 Sum_probs=196.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 73 (303)
.+|+.||||+++.......+.|.+|+.++++++|||||+++++|.+++..+||||||++|+|.++|....
T Consensus 41 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~ 120 (299)
T 4asz_A 41 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120 (299)
T ss_dssp --CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----
T ss_pred CCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccC
Confidence 3688999999987777778899999999999999999999999999999999999999999999996421
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............||+.|+
T Consensus 121 ~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ym 197 (299)
T 4asz_A 121 PPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197 (299)
T ss_dssp CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhc
Confidence 2346899999999999999999999998 9999999999999999999999999998765544333444457899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
|||++.+..++.++|||||||++|||+| |+.||...... .... .... +.... .+...+.++.+
T Consensus 198 APE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~---~i~~-~~~~~---------~p~~~~~~~~~ 261 (299)
T 4asz_A 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE---CITQ-GRVLQ---------RPRTCPQEVYE 261 (299)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH---HHHH-TCCCC---------CCTTCCHHHHH
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HHHc-CCCCC---------CCccchHHHHH
Confidence 9999999999999999999999999998 89999543211 1111 1111 11111 12223457899
Q ss_pred HHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 233 IALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
|+.+||+.||++|||+.+|.+.|++...
T Consensus 262 li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 262 LMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=369.28 Aligned_cols=238 Identities=26% Similarity=0.437 Sum_probs=187.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----------
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 73 (303)
.+|+.||||+++.......+.|.+|+.++++++|||||+++++|.+....+||||||++|+|.+++....
T Consensus 69 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~ 148 (329)
T 4aoj_A 69 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148 (329)
T ss_dssp --CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC--------
T ss_pred CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccc
Confidence 3688999999987777778899999999999999999999999999999999999999999999986532
Q ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccc
Q 045452 74 --RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 74 --~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............||+.
T Consensus 149 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ 225 (329)
T 4aoj_A 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225 (329)
T ss_dssp ---CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGG
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCccccccc
Confidence 2346899999999999999999999998 99999999999999999999999999987654443333444678999
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||++.+..++.++|||||||++|||+| |+.||...... ..+. ....+ ...+ .+...+.++
T Consensus 226 ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~---~i~~g-~~~~---------~p~~~~~~~ 289 (329)
T 4aoj_A 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAID---CITQG-RELE---------RPRACPPEV 289 (329)
T ss_dssp GCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHH---HHHHT-CCCC---------CCTTCCHHH
T ss_pred ccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHH---HHHcC-CCCC---------CcccccHHH
Confidence 999999999999999999999999999998 89999543211 1111 11111 1111 122234578
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 231 LEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
.+|+.+||+.||++|||+.+|++.|+....
T Consensus 290 ~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 999999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=363.24 Aligned_cols=236 Identities=25% Similarity=0.396 Sum_probs=192.2
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 73 (303)
.+++.||||.++.. .....+.|.+|+.++++++|||||+++++|.+++..++|||||++|+|.++|....
T Consensus 54 ~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~ 133 (308)
T 4gt4_A 54 EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133 (308)
T ss_dssp --CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC---
T ss_pred CCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccc
Confidence 46789999999754 33456789999999999999999999999999999999999999999999995421
Q ss_pred ----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecc
Q 045452 74 ----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGT 149 (303)
Q Consensus 74 ----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 149 (303)
....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.............||
T Consensus 134 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp --CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred cccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccC
Confidence 1346899999999999999999999998 999999999999999999999999999876554434444456789
Q ss_pred ccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
+.|+|||++.+..++.++|||||||++|||+| |..||...... . .......+...+ .+...+.
T Consensus 211 ~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------~-~~~~i~~~~~~~---------~p~~~~~ 274 (308)
T 4gt4_A 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D-VVEMIRNRQVLP---------CPDDCPA 274 (308)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------H-HHHHHHTTCCCC---------CCTTCCH
T ss_pred CcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC---------CcccchH
Confidence 99999999999999999999999999999998 89998543211 1 112222222221 1222345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 789999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=361.17 Aligned_cols=227 Identities=22% Similarity=0.314 Sum_probs=187.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+.+|||||||+||+|.+++. +..+++..+
T Consensus 97 ~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~l~e~~~ 172 (346)
T 4fih_A 97 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 172 (346)
T ss_dssp TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH----HSCCCHHHH
T ss_pred CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH----cCCCCHHHH
Confidence 5799999999975544455678899999999999999999999999999999999999999999883 356999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+.... ......+||+.|+|||++.+..|
T Consensus 173 ~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 173 AAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCC
Confidence 999999999999999999 9999999999999999999999999998765432 22334689999999999999999
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|||||||++|+|++|..||...... ..+. ...... ... .......+.++.+||.+||..||+
T Consensus 248 ~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~---~i~~~~-~~~-------~~~~~~~s~~~~dli~~~L~~dP~ 313 (346)
T 4fih_A 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK---MIRDNL-PPR-------LKNLHKVSPSLKGFLDRLLVRDPA 313 (346)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHHSS-CCC-------CSCGGGSCHHHHHHHHHHSCSSTT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---HHHcCC-CCC-------CCccccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999999999543211 1111 111111 000 011122345788999999999999
Q ss_pred CCCCHHHHHH
Q 045452 244 DRPSMLEVSS 253 (303)
Q Consensus 244 ~Rps~~~l~~ 253 (303)
+|||++++++
T Consensus 314 ~R~ta~e~l~ 323 (346)
T 4fih_A 314 QRATAAELLK 323 (346)
T ss_dssp TSCCHHHHTT
T ss_pred HCcCHHHHhc
Confidence 9999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=360.95 Aligned_cols=242 Identities=19% Similarity=0.188 Sum_probs=191.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.... ..+|+.++++++|||||++++++.+++.+|||||||+||+|.+++. ....+++..+
T Consensus 81 ~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~ 152 (336)
T 4g3f_A 81 QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRA 152 (336)
T ss_dssp TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH---HHSSCCHHHH
T ss_pred CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH---HcCCCCHHHH
Confidence 5799999999975422 2469999999999999999999999999999999999999999994 3457999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccc---cccceeeccccccCchhcc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLK---ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~ 159 (303)
..++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+++.+...... ......+||+.|+|||++.
T Consensus 153 ~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 229 (336)
T 4g3f_A 153 LYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229 (336)
T ss_dssp HHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC
Confidence 999999999999999998 99999999999999987 5999999999876543221 1223457999999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||...........+ ....... ...+...+.++.+||.+||+
T Consensus 230 ~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~--------~~~~~~~s~~~~~li~~~L~ 295 (336)
T 4g3f_A 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPI--------REIPPSCAPLTAQAIQEGLR 295 (336)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCCGG--------GGSCTTSCHHHHHHHHHHTC
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCCCc--------hhcCccCCHHHHHHHHHHcc
Confidence 999999999999999999999999999654433322211 1111100 01122234578899999999
Q ss_pred CCCCCCCCHHHHHHhhccCCCCCCCCCCCCc
Q 045452 240 ENPNDRPSMLEVSSMLKNETTNTNTPKKPAF 270 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 270 (303)
.||++|||+.||++.|.........-..||.
T Consensus 296 ~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 296 KEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred CCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 9999999999999888776555444444543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=352.33 Aligned_cols=239 Identities=26% Similarity=0.379 Sum_probs=183.3
Q ss_pred CEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 7 EVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
..||||+++.. .....+.|.+|+.++++++|||||++++++.. +.++||||||++|+|.++|.. ....+++..+.
T Consensus 59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~ 135 (307)
T 3omv_A 59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV--QETKFQMFQLI 135 (307)
T ss_dssp SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT--SCCCCCHHHHH
T ss_pred CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh--cCCCCCHHHHH
Confidence 36999999744 34567889999999999999999999998854 578999999999999999864 24569999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc---C
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ---G 161 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~ 161 (303)
.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...............||+.|+|||++.+ .
T Consensus 136 ~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~ 212 (307)
T 3omv_A 136 DIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212 (307)
T ss_dssp HHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC
T ss_pred HHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC
Confidence 99999999999999998 99999999999999999999999999987654333333445679999999999864 3
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|||++|+.||...... .........+...... ...+...+.++.+|+.+||+.|
T Consensus 213 ~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~p~~-----~~~~~~~~~~l~~li~~cl~~d 281 (307)
T 3omv_A 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYASPDL-----SKLYKNCPKAMKRLVADCVKKV 281 (307)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCCCCS-----TTSCTTSCHHHHHHHHHHTCSS
T ss_pred CCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCCc-----ccccccchHHHHHHHHHHcCCC
Confidence 5889999999999999999999999533211 1111112211111100 0111223357889999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~ 262 (303)
|++|||+.+|++.|+.+..++
T Consensus 282 P~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 282 KEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp STTSCCHHHHHHHHHHHHTTC
T ss_pred HhHCcCHHHHHHHHHHHhccC
Confidence 999999999999887766544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=359.74 Aligned_cols=228 Identities=22% Similarity=0.324 Sum_probs=188.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++.. .....+.+.+|+.++++|+|||||++++++.+++.+|||||||+||+|.++|... ....+++.
T Consensus 47 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~-~~~~~~e~ 125 (350)
T 4b9d_A 47 EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQED 125 (350)
T ss_dssp TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-TTCCCCHH
T ss_pred CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc-CCCCCCHH
Confidence 57999999999654 3455678999999999999999999999999999999999999999999998542 34557899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+.... ......+||+.|+|||++.+.
T Consensus 126 ~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~ 200 (350)
T 4b9d_A 126 QILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENK 200 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCC
Confidence 99999999999999999999 9999999999999999999999999998764321 122345799999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|+.||...+. .........+.. .. .+...+.++.+||.+||+.|
T Consensus 201 ~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~-~~---------~~~~~s~~~~~li~~~L~~d 264 (350)
T 4b9d_A 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGSF-PP---------VSLHYSYDLRSLVSQLFKRN 264 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC-CC---------CCTTSCHHHHHHHHHHTCSS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCC-CC---------CCccCCHHHHHHHHHHccCC
Confidence 999999999999999999999999954321 111122222211 11 11123457889999999999
Q ss_pred CCCCCCHHHHHH
Q 045452 242 PNDRPSMLEVSS 253 (303)
Q Consensus 242 p~~Rps~~~l~~ 253 (303)
|++|||++++++
T Consensus 265 P~~R~s~~e~l~ 276 (350)
T 4b9d_A 265 PRDRPSVNSILE 276 (350)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhHCcCHHHHhc
Confidence 999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=354.97 Aligned_cols=227 Identities=24% Similarity=0.291 Sum_probs=189.4
Q ss_pred CCCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
..+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+++.+|+|||||+||+|.+++. +...++
T Consensus 54 ~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~---~~~~l~ 130 (311)
T 4aw0_A 54 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFD 130 (311)
T ss_dssp TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCC
T ss_pred CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCC
Confidence 368999999999643 23456789999999999999999999999999999999999999999999994 456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+............+||+.|+|||++.
T Consensus 131 e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~ 207 (311)
T 4aw0_A 131 ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999998876544444555678999999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||...+.. ........... . .+...+.++.+||.+||.
T Consensus 208 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~~--~---------~p~~~s~~~~dli~~lL~ 270 (311)
T 4aw0_A 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKLEY--D---------FPEKFFPKARDLVEKLLV 270 (311)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC--C---------CCTTCCHHHHHHHHHHSC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC--C---------CCcccCHHHHHHHHHHcc
Confidence 999999999999999999999999999543211 11112222111 1 112233478899999999
Q ss_pred CCCCCCCCHHHHH
Q 045452 240 ENPNDRPSMLEVS 252 (303)
Q Consensus 240 ~dp~~Rps~~~l~ 252 (303)
.||++|||+++++
T Consensus 271 ~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 271 LDATKRLGCEEME 283 (311)
T ss_dssp SSGGGSTTSGGGT
T ss_pred CCHhHCcChHHHc
Confidence 9999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=362.91 Aligned_cols=227 Identities=22% Similarity=0.316 Sum_probs=187.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.......+.+.+|+.+|+.++|||||++++++.+.+.+|||||||+||+|.+++. ...+++..+
T Consensus 174 ~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~----~~~l~e~~~ 249 (423)
T 4fie_A 174 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 249 (423)
T ss_dssp TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH----HSCCCHHHH
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh----ccCCCHHHH
Confidence 5799999999976655556778999999999999999999999999999999999999999999883 445999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+.... ......+||+.|+|||++.+..|
T Consensus 250 ~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y 324 (423)
T 4fie_A 250 AAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY 324 (423)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCC
Confidence 999999999999999999 9999999999999999999999999998765432 22344689999999999999999
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|||||||++|+|++|..||..... ........... ... .......+.++.+||.+||..||+
T Consensus 325 ~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-~~~-------~~~~~~~s~~~~dli~~~L~~dP~ 390 (423)
T 4fie_A 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL-PPR-------LKNLHKVSPSLKGFLDRLLVRDPA 390 (423)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCC-------CSCTTSSCHHHHHHHHHHSCSSTT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC-CCC-------CcccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999999953321 11111111111 000 011112334788999999999999
Q ss_pred CCCCHHHHHH
Q 045452 244 DRPSMLEVSS 253 (303)
Q Consensus 244 ~Rps~~~l~~ 253 (303)
+|||+.|+++
T Consensus 391 ~R~ta~ell~ 400 (423)
T 4fie_A 391 QRATAAELLK 400 (423)
T ss_dssp TSCCHHHHTT
T ss_pred HCcCHHHHhc
Confidence 9999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=343.10 Aligned_cols=227 Identities=26% Similarity=0.368 Sum_probs=180.2
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|++... .....+.|.+|+.++++++|||||++++++.+ ...+|||||||+||+|.+++. +...
T Consensus 49 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~---~~~~ 125 (290)
T 3fpq_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKV 125 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH---hcCC
Confidence 57899999998543 44566789999999999999999999999875 346899999999999999994 3567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+++..+..|+.||+.||+|||+++ .+|+||||||+|||++. +|.+||+|||++...... .....+||+.|+|||
T Consensus 126 l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE 200 (290)
T 3fpq_A 126 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE 200 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHH
Confidence 999999999999999999999865 24999999999999984 799999999999754322 233467999999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
++.+ .++.++|||||||++|+|++|+.||..... ..........+....... . ..+.++.+||.+
T Consensus 201 ~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~~----~----~~~~~~~~li~~ 265 (290)
T 3fpq_A 201 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFD----K----VAIPEVKEIIEG 265 (290)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGG----G----CCCHHHHHHHHH
T ss_pred HcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCCCC----c----cCCHHHHHHHHH
Confidence 9875 589999999999999999999999953221 111122222221111111 1 112368899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 045452 237 CVQENPNDRPSMLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~ 253 (303)
||..||++|||++++++
T Consensus 266 ~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 266 CIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=338.95 Aligned_cols=223 Identities=23% Similarity=0.327 Sum_probs=173.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+.+|+||||| +|+|.+++. .+..+++
T Consensus 36 ~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~---~~~~l~e 111 (275)
T 3hyh_A 36 TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV---QRDKMSE 111 (275)
T ss_dssp TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH---HSCSCCH
T ss_pred CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH---HcCCCCH
Confidence 57999999999654 2344678999999999999999999999999999999999999 678988884 3567999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||++| |+||||||+|||++.++++||+|||++....... .....+||+.|+|||++.+
T Consensus 112 ~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 112 QEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISG 185 (275)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSS
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcC
Confidence 999999999999999999999 9999999999999999999999999997654322 2234679999999999988
Q ss_pred CCC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..+ +.++|||||||++|+|++|+.||...... ........+.. ..+...+.++.+||.+||+
T Consensus 186 ~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNISNGVY-----------TLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHcc
Confidence 876 57999999999999999999999533211 11111111111 1111233578899999999
Q ss_pred CCCCCCCCHHHHHH
Q 045452 240 ENPNDRPSMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~~l~~ 253 (303)
.||++|||++++++
T Consensus 249 ~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 249 VNPLNRISIHEIMQ 262 (275)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHc
Confidence 99999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=351.10 Aligned_cols=238 Identities=28% Similarity=0.408 Sum_probs=191.8
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCC-CcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCc------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~------ 74 (303)
.+++.||||.++... ....+.|.+|+.++.+++| ||||+++++|... ..+++|||||++|+|.++|+....
T Consensus 92 ~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~ 171 (353)
T 4ase_A 92 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171 (353)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-
T ss_pred cCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence 456789999997653 3456789999999999965 8999999999764 568999999999999999965221
Q ss_pred -------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee
Q 045452 75 -------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 75 -------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............
T Consensus 172 ~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~ 248 (353)
T 4ase_A 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248 (353)
T ss_dssp ------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred ccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeecccc
Confidence 345899999999999999999999999 9999999999999999999999999998765544344445567
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||+.|+|||++.+..++.++|||||||++|||+| |..||........ + ......+.... .+...
T Consensus 249 gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~---~---~~~i~~g~~~~---------~p~~~ 313 (353)
T 4ase_A 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F---CRRLKEGTRMR---------APDYT 313 (353)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---H---HHHHHHTCCCC---------CCTTC
T ss_pred ccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH---H---HHHHHcCCCCC---------CCccC
Confidence 8999999999999999999999999999999998 8999964432211 1 11112121111 12223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
+.++.+++.+||+.||++|||+.+|++.|++..
T Consensus 314 ~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 314 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 357899999999999999999999999988754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=344.35 Aligned_cols=220 Identities=20% Similarity=0.272 Sum_probs=173.5
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++... ......+.+|+.++++++|||||++++++.+++.+|+|||||+||+|.+++. +...+++.
T Consensus 50 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~ 126 (304)
T 3ubd_A 50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEE 126 (304)
T ss_dssp TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH---HHCCCCHH
T ss_pred CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH---hcCCCCHH
Confidence 468899999996542 2234468889999999999999999999999999999999999999999994 45679999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+.
T Consensus 127 ~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~ 201 (304)
T 3ubd_A 127 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRR 201 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccC
Confidence 99999999999999999999 9999999999999999999999999997654322 223346799999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|+.||...+.. ........... ..+...+.++.+||.+||+.|
T Consensus 202 ~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~d 264 (304)
T 3ubd_A 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILKAKL-----------GMPQFLSPEAQSLLRMLFKRN 264 (304)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHcCCC-----------CCCCcCCHHHHHHHHHHcccC
Confidence 9999999999999999999999999543211 11112222111 111223457889999999999
Q ss_pred CCCCCCH
Q 045452 242 PNDRPSM 248 (303)
Q Consensus 242 p~~Rps~ 248 (303)
|++|||+
T Consensus 265 P~~R~ta 271 (304)
T 3ubd_A 265 PANRLGA 271 (304)
T ss_dssp GGGSTTC
T ss_pred HHHCCCC
Confidence 9999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=334.88 Aligned_cols=234 Identities=21% Similarity=0.289 Sum_probs=174.4
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------------eeeEEEeeCCCCChhhhhc
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------------ERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~lv~e~~~~~sL~~~l~ 70 (303)
.+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+ .+|+|||||.+|+|.+++.
T Consensus 28 ~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~ 107 (299)
T 4g31_A 28 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107 (299)
T ss_dssp TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHH
T ss_pred CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHH
Confidence 57999999999654 3445678999999999999999999999987644 3689999999999999997
Q ss_pred CcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc----------
Q 045452 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK---------- 140 (303)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~---------- 140 (303)
........++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+......
T Consensus 108 ~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~ 184 (299)
T 4g31_A 108 GRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184 (299)
T ss_dssp TCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC-------------------
T ss_pred hcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccc
Confidence 6444445667788999999999999999999 999999999999999999999999999876533211
Q ss_pred cccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccC
Q 045452 141 ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDD 220 (303)
Q Consensus 141 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......+||+.|+|||++.+..++.++|||||||++|+|++ ||... .......... .....+..
T Consensus 185 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~~~~~~~-~~~~~p~~------- 248 (299)
T 4g31_A 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERVRTLTDV-RNLKFPPL------- 248 (299)
T ss_dssp -------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHHHHHHH-HTTCCCHH-------
T ss_pred cccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHHHHHHHH-hcCCCCCC-------
Confidence 11233579999999999999999999999999999999996 66311 1111111111 11111110
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~ 258 (303)
.......+.+||.+||+.||++|||+.++++ ++++.
T Consensus 249 --~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 249 --FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp --HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred --CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 0112235678999999999999999999987 45543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=336.75 Aligned_cols=246 Identities=22% Similarity=0.234 Sum_probs=179.8
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+|+.||||+++..... ...+..|+..+.+++|||||++++++..++ .++||||||++|+|.+++. ...+++
T Consensus 25 ~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~----~~~l~~ 99 (303)
T 3hmm_A 25 RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTV 99 (303)
T ss_dssp TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH----HCCBCH
T ss_pred CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHH----hCCCCH
Confidence 5899999999654322 122345666677889999999999998654 5799999999999999994 446899
Q ss_pred HHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeecccccc
Q 045452 81 KKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYI 153 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~-----~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~ 153 (303)
..+.+++.|++.||+|||+. +..+|+||||||+|||++.++++||+|||+++........ ......+||+.|+
T Consensus 100 ~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym 179 (303)
T 3hmm_A 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccccc
Confidence 99999999999999999986 1224999999999999999999999999999876543221 2233457999999
Q ss_pred CchhcccC------CCCCcccchhhHHHHHHHHhCCCCccccCCCcc--------ccHHHHHHHHhh-CCCccccccccc
Q 045452 154 PPEYARQG------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--------LSILEHAYELWK-GGKGMEFVDSFL 218 (303)
Q Consensus 154 aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~~~~ 218 (303)
|||++.+. .++.++|||||||++|||++|..||........ ............ ....+.+..
T Consensus 180 APE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~--- 256 (303)
T 3hmm_A 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN--- 256 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG---
T ss_pred CHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCc---
Confidence 99998764 356789999999999999999887754332111 011112222111 111111111
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
..........+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 257 -~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 257 -RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp -GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1112234557889999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=328.79 Aligned_cols=244 Identities=20% Similarity=0.279 Sum_probs=182.3
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++... ..+|||||||. |+|.+++. ..
T Consensus 77 ~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~---~~ 152 (398)
T 4b99_A 77 LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH---SS 152 (398)
T ss_dssp TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT---SS
T ss_pred CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHH---hc
Confidence 57999999999654 334567788999999999999999999997643 57899999995 67988884 45
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc--cccccceeecccccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES--LKANTEQVVGTIGYI 153 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~~~~y~ 153 (303)
..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+.... ........+||+.|+
T Consensus 153 ~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~ 229 (398)
T 4b99_A 153 QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229 (398)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhc
Confidence 67999999999999999999999999 9999999999999999999999999998764332 122334468999999
Q ss_pred CchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc------------cccccC
Q 045452 154 PPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV------------DSFLDD 220 (303)
Q Consensus 154 aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~ 220 (303)
|||++.+. .++.++||||+||++|+|++|..||...+..+....+. ... +....... ......
T Consensus 230 APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~---~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
T 4b99_A 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM---MVL-GTPSPAVIQAVGAERVRAYIQSLPPR 305 (398)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH---HHH-CCCCGGGTC-----CHHHHHHSSCCC
T ss_pred CHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH---Hhc-CCCChHHhhhhhhhhhhhhhhcCCCc
Confidence 99998765 56899999999999999999999996443222211111 111 10000000 000000
Q ss_pred CC------ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccC
Q 045452 221 RN------SSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 221 ~~------~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~ 258 (303)
.. .+..+.++.+||.+||..||++|||+.++++ +|++.
T Consensus 306 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 306 QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00 0112346789999999999999999999986 45543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=316.14 Aligned_cols=255 Identities=35% Similarity=0.563 Sum_probs=212.4
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCCH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~ 80 (303)
+..+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++.... ....+++
T Consensus 59 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 138 (321)
T 2qkw_B 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138 (321)
T ss_dssp ECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCH
T ss_pred EECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCH
Confidence 456799999999987766677889999999999999999999999999999999999999999999986532 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++................|+..|+|||.+.+
T Consensus 139 ~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2qkw_B 139 EQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC
Confidence 999999999999999999998 99999999999999999999999999976543322223334568999999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|+.||.............+..............+...........+..+.+++.+||+.
T Consensus 216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 295 (321)
T 2qkw_B 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295 (321)
T ss_dssp CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence 89999999999999999999999999766655555555544444444444444444455556677788999999999999
Q ss_pred CCCCCCCHHHHHHhhccCC
Q 045452 241 NPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~ 259 (303)
||++|||+.++++.|+...
T Consensus 296 dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 296 SSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SGGGSCCHHHHHHHHHHHH
T ss_pred CcccCcCHHHHHHHHHHHh
Confidence 9999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=344.33 Aligned_cols=233 Identities=21% Similarity=0.253 Sum_probs=190.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|+++.......+.+.+|+.+|+.++|||||++++++.+...+|||||||.||+|.+++.. ....+++..+
T Consensus 180 ~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~--~~~~l~e~~~ 257 (573)
T 3uto_A 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEA 257 (573)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC--TTSCEEHHHH
T ss_pred CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH--hCCCCCHHHH
Confidence 58999999999777666778899999999999999999999999999999999999999999998853 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC--CcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED--MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~--~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..+.... .....+||+.|+|||++.+.
T Consensus 258 ~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~ 331 (573)
T 3uto_A 258 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGK 331 (573)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCC
Confidence 999999999999999999 9999999999999854 889999999998765432 23346799999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|..||...... ............ +... .....+.++.+||.+||..|
T Consensus 332 ~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~--~~~~-----~~~~~s~~~~dli~~~L~~d 398 (573)
T 3uto_A 332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWN--MDDS-----AFSGISEDGKDFIRKLLLAD 398 (573)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC--CCSG-----GGTTSCHHHHHHHHTTSCSS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCC--CCcc-----cccCCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999543221 111122221111 0000 01112346889999999999
Q ss_pred CCCCCCHHHHHH--hhcc
Q 045452 242 PNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 242 p~~Rps~~~l~~--~L~~ 257 (303)
|++|||+.++++ +|+.
T Consensus 399 p~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 399 PNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp GGGSCCHHHHHHSTTTSC
T ss_pred hhHCcCHHHHhcCcCcCC
Confidence 999999999987 3544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=319.89 Aligned_cols=176 Identities=23% Similarity=0.303 Sum_probs=148.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+++.||||.+.... ...++.+|+.+++.+ +||||+++++++.+.+++|+||||+++|+|.+++. .+++..
T Consensus 47 ~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~ 118 (361)
T 4f9c_A 47 GPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN------SLSFQE 118 (361)
T ss_dssp SCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT------TCCHHH
T ss_pred CCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc------CCCHHH
Confidence 467899999986543 335678899999998 79999999999999999999999999999999883 388999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccc---------------------
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLK--------------------- 140 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~--------------------- 140 (303)
+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++........
T Consensus 119 ~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (361)
T 4f9c_A 119 VREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------
T ss_pred HHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccc
Confidence 9999999999999999999 9999999999999876 89999999999765332110
Q ss_pred -----cccceeeccccccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccC
Q 045452 141 -----ANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 141 -----~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~ 190 (303)
......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus 196 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp ----------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 112234799999999998765 58999999999999999999999996443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=335.80 Aligned_cols=225 Identities=22% Similarity=0.220 Sum_probs=179.0
Q ss_pred CCCCEEEEEEccCCC------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++... .......+.++.+++.++|||||+++++|.+.+.+|+|||||+||+|..+|. ....
T Consensus 212 ~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~---~~~~ 288 (689)
T 3v5w_A 212 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGV 288 (689)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCC
T ss_pred CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH---hcCC
Confidence 589999999995431 1122233445677788899999999999999999999999999999999994 4567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..+..++.||+.||.|||++| |+||||||+|||++.+|++||+|||++..+.... ....+||+.|+|||+
T Consensus 289 l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEv 361 (689)
T 3v5w_A 289 FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 361 (689)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHH
Confidence 999999999999999999999999 9999999999999999999999999998765432 334689999999999
Q ss_pred cc-cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 AR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+. +..|+.++|+|||||++|+|++|..||............. ...... ...+...+.++.+||.+
T Consensus 362 l~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~-----------~~~p~~~S~~a~dLI~~ 427 (689)
T 3v5w_A 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMA-----------VELPDSFSPELRSLLEG 427 (689)
T ss_dssp HSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCC-----------CCCCTTSCHHHHHHHHH
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCC-----------CCCCccCCHHHHHHHHH
Confidence 86 4579999999999999999999999996544332211111 111111 11122234578899999
Q ss_pred cccCCCCCCCC-----HHHHH
Q 045452 237 CVQENPNDRPS-----MLEVS 252 (303)
Q Consensus 237 cl~~dp~~Rps-----~~~l~ 252 (303)
||..||++|++ +++|+
T Consensus 428 lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 428 LLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HTCSCGGGCTTCSSSTHHHHT
T ss_pred HccCCHhHCCCCCCCCHHHHh
Confidence 99999999998 57765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=307.14 Aligned_cols=257 Identities=39% Similarity=0.628 Sum_probs=203.7
Q ss_pred cCCCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCC
Q 045452 2 VLPCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~ 79 (303)
...+|+.||||+++.... .....+.+|+.+++.++||||+++++++......++||||+.+++|.+++.... ....++
T Consensus 50 ~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 129 (326)
T 3uim_A 50 RLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129 (326)
T ss_dssp CCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCC
T ss_pred EecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCC
Confidence 456899999999975532 233468899999999999999999999999999999999999999999987633 244589
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+....+++||||||+||+++.++.+||+|||++........ .......|+..|+|||.+.
T Consensus 130 ~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 208 (326)
T 3uim_A 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLS 208 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhc
Confidence 999999999999999999999212299999999999999999999999999986643321 2223345899999999998
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCC--CccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI--NENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+..++.++||||||+++|+|++|..||..... ........+..............+...........+..+.+++.+|
T Consensus 209 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 288 (326)
T 3uim_A 209 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLC 288 (326)
T ss_dssp HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHH
T ss_pred cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHH
Confidence 88899999999999999999999999953321 1222223333333333334444455555566777788999999999
Q ss_pred ccCCCCCCCCHHHHHHhhccCC
Q 045452 238 VQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L~~~~ 259 (303)
|+.||.+|||+.++++.|++..
T Consensus 289 l~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 289 TQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TCSCGGGSCCHHHHHHHHHTSS
T ss_pred hCcCCccCCCHHHHHHHhcCcc
Confidence 9999999999999999998743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=300.48 Aligned_cols=228 Identities=23% Similarity=0.363 Sum_probs=186.5
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
..+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++. ...+++..
T Consensus 42 ~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~ 117 (297)
T 3fxz_A 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQ 117 (297)
T ss_dssp TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH----HSCCCHHH
T ss_pred CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHh----hcCCCHHH
Confidence 36799999999976655566788999999999999999999999999999999999999999999984 34589999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..
T Consensus 118 ~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 192 (297)
T 3fxz_A 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKA 192 (297)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCC
Confidence 9999999999999999998 99999999999999999999999999876543322 223356899999999999999
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++|||||||++|+|++|..||..... ............. ....+...+..+.++|.+||+.||
T Consensus 193 ~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp 258 (297)
T 3fxz_A 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP--------ELQNPEKLSAIFRDFLNRCLEMDV 258 (297)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC--------CCSCGGGSCHHHHHHHHHHSCSST
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC--------CCCCccccCHHHHHHHHHHccCCh
Confidence 99999999999999999999999953321 1111111111110 011122234468899999999999
Q ss_pred CCCCCHHHHHH
Q 045452 243 NDRPSMLEVSS 253 (303)
Q Consensus 243 ~~Rps~~~l~~ 253 (303)
++|||+.++++
T Consensus 259 ~~Rps~~ell~ 269 (297)
T 3fxz_A 259 EKRGSAKELLQ 269 (297)
T ss_dssp TTSCCHHHHTT
T ss_pred hHCcCHHHHhh
Confidence 99999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=302.61 Aligned_cols=238 Identities=26% Similarity=0.412 Sum_probs=192.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|++........+.+.+|+.++++++||||+++++++.++...++||||+.+++|.+++.. ....+++..+
T Consensus 33 ~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 110 (310)
T 3s95_A 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQR 110 (310)
T ss_dssp TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--CCTTSCHHHH
T ss_pred CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh--ccCCCCHHHH
Confidence 57999999999777777888999999999999999999999999999999999999999999999854 2456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc------------ccceeecccc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA------------NTEQVVGTIG 151 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~------------~~~~~~~~~~ 151 (303)
+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......... ......|+..
T Consensus 111 ~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 187 (310)
T 3s95_A 111 VSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187 (310)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGG
T ss_pred HHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcc
Confidence 999999999999999999 9999999999999999999999999998764332211 1113568999
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc--cHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
|+|||.+.+..++.++||||||+++|+|++|..||......... .......... .+...+..
T Consensus 188 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~ 251 (310)
T 3s95_A 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY----------------CPPNCPPS 251 (310)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT----------------CCTTCCTT
T ss_pred eeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc----------------CCCCCCHH
Confidence 99999999999999999999999999999999988543322111 1111111100 01111235
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
+.+++.+||+.||++|||+.++++.|+++....
T Consensus 252 l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 252 FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 789999999999999999999999998876443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=301.57 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=183.9
Q ss_pred CCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 5 CGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++........+++..
T Consensus 59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 138 (309)
T 3p86_A 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138 (309)
T ss_dssp TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHH
T ss_pred CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHH
Confidence 58899999986543 4456788999999999999999999999999999999999999999999996544344599999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||+.| .+++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.+..
T Consensus 139 ~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 139 RLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp HHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCC
Confidence 9999999999999999865 239999999999999999999999999987543321 1223356899999999999999
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++||||||+++|+|++|..||...... ............. ..+...+.++.+||.+||..||
T Consensus 216 ~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP 280 (309)
T 3p86_A 216 SNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRL---------EIPRNLNPQVAAIIEGCWTNEP 280 (309)
T ss_dssp CCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCC---------CCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999533211 1111111111111 1122233478899999999999
Q ss_pred CCCCCHHHHHHhhccCCCCCCCC
Q 045452 243 NDRPSMLEVSSMLKNETTNTNTP 265 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~~~~~~~ 265 (303)
.+|||+.++++.|+.......++
T Consensus 281 ~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 281 WKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp GGSCCHHHHHHHHHHHHC-----
T ss_pred hhCcCHHHHHHHHHHHHHhCCCC
Confidence 99999999999999887654443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=310.14 Aligned_cols=237 Identities=27% Similarity=0.393 Sum_probs=190.9
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC--------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------- 73 (303)
.++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+....++||||+.+|+|.+++....
T Consensus 111 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 190 (370)
T 2psq_A 111 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190 (370)
T ss_dssp TCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC------
T ss_pred CcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccc
Confidence 456789999997653 34567899999999999 89999999999999999999999999999999986432
Q ss_pred -----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeec
Q 045452 74 -----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG 148 (303)
Q Consensus 74 -----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 148 (303)
....+++..++.++.||+.||+|||+.| ++||||||+|||++.++.+||+|||++..+.............+
T Consensus 191 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 267 (370)
T 2psq_A 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267 (370)
T ss_dssp -----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTS
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCc
Confidence 1235789999999999999999999998 99999999999999999999999999987654333223333456
Q ss_pred cccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
+..|+|||++.+..++.++|||||||++|+|++ |..||....... .. .....+... ..+...+
T Consensus 268 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~~~~ 331 (370)
T 2psq_A 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LF----KLLKEGHRM---------DKPANCT 331 (370)
T ss_dssp CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHHTTCCC---------CCCTTSC
T ss_pred ccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhcCCCC---------CCCCCCC
Confidence 789999999999999999999999999999999 999986433221 11 111111111 1122233
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.++.++|.+||..||++|||+.++++.|+++.
T Consensus 332 ~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 47889999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=300.94 Aligned_cols=225 Identities=24% Similarity=0.360 Sum_probs=184.6
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++......++||||+++++|.+++. ....+++.
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~ 114 (328)
T 3fe3_A 38 LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV---AHGRMKEK 114 (328)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH---HHCCCCHH
T ss_pred CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH---HcCCCCHH
Confidence 68999999998644 44566788999999999999999999999999999999999999999999984 34569999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+.... .....+|++.|+|||++.+.
T Consensus 115 ~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 188 (328)
T 3fe3_A 115 EARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGK 188 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCC
Confidence 99999999999999999998 9999999999999999999999999997654322 22345689999999999888
Q ss_pred CCC-CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.+. .++|||||||++|+|++|..||..... .........+.. ..+...+.++.+|+.+||..
T Consensus 189 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~ 251 (328)
T 3fe3_A 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKY-----------RIPFYMSTDCENLLKRFLVL 251 (328)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHCCS
T ss_pred CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHCCC
Confidence 765 689999999999999999999954321 111112222211 11112234788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
||.+|||++++++.
T Consensus 252 dP~~R~t~~eil~h 265 (328)
T 3fe3_A 252 NPIKRGTLEQIMKD 265 (328)
T ss_dssp STTTSCCHHHHTTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=295.38 Aligned_cols=249 Identities=35% Similarity=0.504 Sum_probs=197.6
Q ss_pred CCCEEEEEEccCC----ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKS----SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+....+++|||+++++|.+++........+++
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 132 (307)
T 2nru_A 53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132 (307)
T ss_dssp SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCH
T ss_pred CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCH
Confidence 6889999998643 234567899999999999999999999999999999999999999999999865444567999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++................|+..|+|||.+.+
T Consensus 133 ~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence 999999999999999999998 99999999999999999999999999876554332223334568999999998865
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++|+|++|..||................... ........+... ...+...+..+.+++.+||..
T Consensus 210 -~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~ 286 (307)
T 2nru_A 210 -EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE-EKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286 (307)
T ss_dssp -EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT-SCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCS
T ss_pred -CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh-hhhhhhhccccc-cccchHHHHHHHHHHHHHcCC
Confidence 47889999999999999999999997655444333322221111 011111111111 234556677899999999999
Q ss_pred CCCCCCCHHHHHHhhccCC
Q 045452 241 NPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~ 259 (303)
||.+|||+.++++.|++..
T Consensus 287 ~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 287 KKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp STTTSCCHHHHHHHHHHHC
T ss_pred CcccCcCHHHHHHHHHHHh
Confidence 9999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=294.19 Aligned_cols=255 Identities=18% Similarity=0.217 Sum_probs=195.5
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--eeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++||||+.+++|.+++........+++
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 111 (319)
T 4euu_A 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111 (319)
T ss_dssp TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCH
T ss_pred CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCH
Confidence 468999999997543 344677889999999999999999999998765 77999999999999999976544455999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~----~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
..++.++.||+.||+|||+.| ++||||||+||++ +.++.+||+|||++....... ......|+..|+|||
T Consensus 112 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 185 (319)
T 4euu_A 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHH
Confidence 999999999999999999999 9999999999999 888889999999998765432 122346899999999
Q ss_pred hcc--------cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH-HHHHhhCCCccc----------cccc-
Q 045452 157 YAR--------QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH-AYELWKGGKGME----------FVDS- 216 (303)
Q Consensus 157 ~~~--------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~- 216 (303)
++. +..++.++|||||||++|+|++|..||.............. ............ +...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 4euu_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (319)
T ss_dssp HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccC
Confidence 886 46788999999999999999999999975544332222222 211111110000 0000
Q ss_pred cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCC
Q 045452 217 FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~ 264 (303)
.............+.++|.+||+.||++|||++++++...+......+
T Consensus 266 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~ 313 (319)
T 4euu_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNS 313 (319)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC----
T ss_pred CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCc
Confidence 111234456677899999999999999999999999998887655443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=298.45 Aligned_cols=231 Identities=25% Similarity=0.343 Sum_probs=181.8
Q ss_pred CCCCEEEEEEccCCCh-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSA-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....+++..
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 106 (323)
T 3tki_A 30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPD 106 (323)
T ss_dssp TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB---TTTBCCHHH
T ss_pred CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh---hcCCCCHHH
Confidence 4799999999865432 334678899999999999999999999999999999999999999999984 345699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+.............|+..|+|||++.+..
T Consensus 107 ~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 183 (323)
T 3tki_A 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (323)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSS
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCC
Confidence 9999999999999999998 9999999999999999999999999997665433333334467899999999998776
Q ss_pred C-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 Y-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
+ +.++|||||||++|+|++|..||......... ...+....... ......+..+.+||.+||..|
T Consensus 184 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~d 249 (323)
T 3tki_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYL--------NPWKKIDSAPLALLHKILVEN 249 (323)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTCTTS--------TTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhcccccC--------CccccCCHHHHHHHHHHccCC
Confidence 5 77899999999999999999999644322111 11111111000 001122346789999999999
Q ss_pred CCCCCCHHHHHHh
Q 045452 242 PNDRPSMLEVSSM 254 (303)
Q Consensus 242 p~~Rps~~~l~~~ 254 (303)
|++|||+.++++.
T Consensus 250 P~~R~t~~eil~h 262 (323)
T 3tki_A 250 PSARITIPDIKKD 262 (323)
T ss_dssp TTTSCCHHHHTTC
T ss_pred hhhCcCHHHHhhC
Confidence 9999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=294.33 Aligned_cols=228 Identities=24% Similarity=0.368 Sum_probs=186.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.......+.+.+|+.+++.++||||+++++++......++||||+.+++|.+++. ...+++..+
T Consensus 68 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~ 143 (321)
T 2c30_A 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQI 143 (321)
T ss_dssp TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHH
T ss_pred CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHH
Confidence 4799999999976666667889999999999999999999999999999999999999999999884 345899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..+
T Consensus 144 ~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2c30_A 144 ATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLY 218 (321)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCC
Confidence 999999999999999998 99999999999999999999999999876643321 1233568999999999998889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++||||||+++|+|++|..||...... ......... ..... ......+..+.++|.+||..||+
T Consensus 219 ~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~~~~~~~-~~~~~-------~~~~~~~~~l~~li~~~l~~dp~ 284 (321)
T 2c30_A 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDS-PPPKL-------KNSHKVSPVLRDFLERMLVRDPQ 284 (321)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-SCCCC-------TTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC-CCCCc-------CccccCCHHHHHHHHHHccCChh
Confidence 99999999999999999999999543211 111111111 11110 01112234688999999999999
Q ss_pred CCCCHHHHHHh
Q 045452 244 DRPSMLEVSSM 254 (303)
Q Consensus 244 ~Rps~~~l~~~ 254 (303)
+|||+.++++.
T Consensus 285 ~Rps~~ell~h 295 (321)
T 2c30_A 285 ERATAQELLDH 295 (321)
T ss_dssp TSCCHHHHHTS
T ss_pred hCcCHHHHhcC
Confidence 99999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.94 Aligned_cols=244 Identities=24% Similarity=0.298 Sum_probs=185.4
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.|+.||||+++.... .......|+.++++++||||+++++++.... .+++||||+++|+|.+++. ...+++
T Consensus 46 ~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~ 120 (322)
T 3soc_A 46 LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSW 120 (322)
T ss_dssp TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH----HCCBCH
T ss_pred CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHH----hcCCCH
Confidence 378999999965433 3345566999999999999999999998754 3699999999999999984 345899
Q ss_pred HHHHHHHHHHHHHHHHHHhc----------CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccc
Q 045452 81 KKRVHIIEGITQGLLYLQEY----------SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTI 150 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~----------~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 150 (303)
..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++..+.............|+.
T Consensus 121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~ 197 (322)
T 3soc_A 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCG
T ss_pred HHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCc
Confidence 99999999999999999998 7 9999999999999999999999999998765443333333457899
Q ss_pred cccCchhcccC-----CCCCcccchhhHHHHHHHHhCCCCccccCCCccccH---------HHHHHHHhhCCCccccccc
Q 045452 151 GYIPPEYARQG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI---------LEHAYELWKGGKGMEFVDS 216 (303)
Q Consensus 151 ~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~ 216 (303)
.|+|||++.+. .++.++|||||||++|+|++|..||........... ...................
T Consensus 198 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (322)
T 3soc_A 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277 (322)
T ss_dssp GGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred cccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc
Confidence 99999998763 455688999999999999999999865433221111 1111111111111111111
Q ss_pred cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 217 FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.......+.++.+||.+||+.||++|||+.++++.|+++.
T Consensus 278 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 278 ---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp ---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1112234456899999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.89 Aligned_cols=235 Identities=25% Similarity=0.352 Sum_probs=188.5
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||.++.. .....+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.. .+..+++..
T Consensus 137 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~ 214 (377)
T 3cbl_A 137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKT 214 (377)
T ss_dssp TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--HGGGCCHHH
T ss_pred cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHH
Confidence 37899999999754 334456788999999999999999999999999999999999999999999853 234589999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++................++..|+|||.+.+..
T Consensus 215 ~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 215 LLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC
Confidence 9999999999999999999 9999999999999999999999999997654332222222234577899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|||||||++|+|++ |..||...... ........+.... .+...+.++.+||.+||+.|
T Consensus 292 ~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~d 355 (377)
T 3cbl_A 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLP---------CPELCPDAVFRLMEQCWAYE 355 (377)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSS
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 99998543211 1111111111111 11222347889999999999
Q ss_pred CCCCCCHHHHHHhhccCC
Q 045452 242 PNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~ 259 (303)
|++|||+.++++.|++..
T Consensus 356 P~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 356 PGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred chhCcCHHHHHHHHHHHH
Confidence 999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=289.66 Aligned_cols=242 Identities=21% Similarity=0.320 Sum_probs=188.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++. ....+++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~ 110 (294)
T 4eqm_A 34 ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSV 110 (294)
T ss_dssp TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHCSCCH
T ss_pred CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH---hcCCCCH
Confidence 57899999998543 34456789999999999999999999999999999999999999999999984 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++....... ........|++.|+|||.+.+
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 111 DTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcC
Confidence 999999999999999999999 9999999999999999999999999997664332 122233568999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||.... ............ .... .. ......+..+.++|.+||..
T Consensus 187 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~-~~~~-~~----~~~~~~~~~l~~li~~~l~~ 254 (294)
T 4eqm_A 187 EATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDS-VPNV-TT----DVRKDIPQSLSNVILRATEK 254 (294)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHSSC-CCCH-HH----HSCTTSCHHHHHHHHHHSCS
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhcc-CCCc-ch----hcccCCCHHHHHHHHHHhcC
Confidence 999999999999999999999999995332 111111222211 1111 00 11112234788999999999
Q ss_pred CCCCCC-CHHHHHHhhccCCCCCCC
Q 045452 241 NPNDRP-SMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 241 dp~~Rp-s~~~l~~~L~~~~~~~~~ 264 (303)
||++|| ++.++.+.|.........
T Consensus 255 dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 255 DKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp SGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred CHhHccccHHHHHHHHHHHHhhccC
Confidence 999999 999999999987755443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=295.48 Aligned_cols=244 Identities=30% Similarity=0.423 Sum_probs=187.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++.......+.+.+|+.++++++||||+++++++... ...++||||+++++|.+++... ...+++.
T Consensus 37 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~ 114 (295)
T 3ugc_A 37 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHI 114 (295)
T ss_dssp SCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC--GGGCCHH
T ss_pred CCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc--ccccCHH
Confidence 47899999999877777778899999999999999999999998653 5689999999999999998542 3458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 160 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 115 KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC
Confidence 99999999999999999998 999999999999999999999999999876433211 12222346778999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCC--------C-ccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGI--------N-ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
..++.++||||||+++|+|++|..|+..... . .................. ...+...+.++.
T Consensus 192 ~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~ 262 (295)
T 3ugc_A 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR---------LPRPDGCPDEIY 262 (295)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC---------CCCCTTCCHHHH
T ss_pred CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc---------CCCCcCcCHHHH
Confidence 9999999999999999999999988753211 0 000001111111111111 111222345789
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
+++.+||+.||++|||+.++++.|++....
T Consensus 263 ~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 263 MIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999999999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=302.96 Aligned_cols=237 Identities=25% Similarity=0.395 Sum_probs=187.6
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+..||||+++.. .....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++.. ....+++..+
T Consensus 76 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 153 (325)
T 3kul_A 76 RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQL 153 (325)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT--TTTCSCHHHH
T ss_pred CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh--cccCCCHHHH
Confidence 4556999999765 445667899999999999999999999999999999999999999999999854 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcccCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 154 ~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 154 VGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC
Confidence 999999999999999999 999999999999999999999999999876543211 1122234577899999999888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||||+++|+|++ |..||....... .. ......... ..+...+..+.+||.+||..|
T Consensus 231 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~-~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~d 294 (325)
T 3kul_A 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VI-SSVEEGYRL---------PAPMGCPHALHQLMLDCWHKD 294 (325)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HH-HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HH-HHHHcCCCC---------CCCCCcCHHHHHHHHHHccCC
Confidence 9999999999999999999 999985332111 11 111111111 111223347889999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~ 262 (303)
|++|||+.++++.|+......
T Consensus 295 p~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 295 RAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp GGGSCCHHHHHHHHHHHHHSC
T ss_pred hhhCcCHHHHHHHHHHHHhCc
Confidence 999999999999999876443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=299.01 Aligned_cols=240 Identities=28% Similarity=0.431 Sum_probs=191.5
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc--------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 74 (303)
.+++.||||.++.. .....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++.....
T Consensus 75 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 154 (343)
T 1luf_A 75 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154 (343)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccccc
Confidence 46689999999765 344567899999999999999999999999999999999999999999999864211
Q ss_pred -------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc
Q 045452 75 -------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA 141 (303)
Q Consensus 75 -------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~ 141 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..........
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (343)
T 1luf_A 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231 (343)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred ccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCcccc
Confidence 256899999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccC
Q 045452 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDD 220 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . ............
T Consensus 232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~~-------- 296 (343)
T 1luf_A 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE------E-VIYYVRDGNILA-------- 296 (343)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHHHHTTCCCC--------
T ss_pred ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH------H-HHHHHhCCCcCC--------
Confidence 3334567889999999988889999999999999999999 99998533211 1 111111111111
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
.+...+.++.++|.+||..||++|||+.++++.|++.....
T Consensus 297 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 297 -CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 11223347889999999999999999999999999977544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=299.86 Aligned_cols=238 Identities=29% Similarity=0.418 Sum_probs=191.2
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc--------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 74 (303)
.+|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 130 (314)
T 2ivs_A 51 AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130 (314)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC--
T ss_pred cCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccc
Confidence 45689999999754 345667899999999999999999999999999999999999999999999865321
Q ss_pred -------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc
Q 045452 75 -------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA 141 (303)
Q Consensus 75 -------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~ 141 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..........
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 207 (314)
T 2ivs_A 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207 (314)
T ss_dssp --------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE
T ss_pred cccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccce
Confidence 234889999999999999999999998 9999999999999999999999999998765433333
Q ss_pred ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccC
Q 045452 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDD 220 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .........
T Consensus 208 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~---~~~~~~~~~--------- 271 (314)
T 2ivs_A 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER----LF---NLLKTGHRM--------- 271 (314)
T ss_dssp CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH---HHHHTTCCC---------
T ss_pred eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HH---HHhhcCCcC---------
Confidence 3333456788999999988889999999999999999999 999985433221 11 111111111
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
..+...+..+.++|.+||..||++|||+.++++.|++...
T Consensus 272 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 272 ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1112233578899999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=292.20 Aligned_cols=237 Identities=26% Similarity=0.371 Sum_probs=189.2
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
...++..||+|+++... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++.
T Consensus 28 ~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~ 104 (268)
T 3sxs_A 28 KWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPS 104 (268)
T ss_dssp EETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH--HGGGCCHH
T ss_pred EecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH--cCCCCCHH
Confidence 34677889999996543 2346789999999999999999999999999999999999999999999854 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+.......... .....++..|+|||.+.+.
T Consensus 105 ~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 180 (268)
T 3sxs_A 105 QLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYF 180 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhcc
Confidence 99999999999999999998 9999999999999999999999999997664432221 2223456789999999988
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++|+|++ |..||...... .......... .. ..+...+..+.+++.+||+.
T Consensus 181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~ 244 (268)
T 3sxs_A 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGH-RL---------YRPHLASDTIYQIMYSCWHE 244 (268)
T ss_dssp EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC-CC---------CCCTTSCHHHHHHHHHTTCS
T ss_pred CCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCC-CC---------CCCCcChHHHHHHHHHHcCC
Confidence 89999999999999999999 99998533211 1111111111 10 11111234788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~ 261 (303)
||++|||+.++++.|+.....
T Consensus 245 ~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 245 LPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SGGGSCCHHHHHHHHGGGCC-
T ss_pred ChhhCcCHHHHHHHHHHhhhc
Confidence 999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=302.16 Aligned_cols=228 Identities=22% Similarity=0.288 Sum_probs=183.0
Q ss_pred CCCCEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSA------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++. ....
T Consensus 35 ~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~ 111 (361)
T 2yab_A 35 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---QKES 111 (361)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT---TCSC
T ss_pred CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH---hcCC
Confidence 4799999999965432 135789999999999999999999999999999999999999999999984 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEecccccccccccccccccceeecccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~----~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
+++..+..++.||+.||.|||+.| ++||||||+||+++.++ .+||+|||++..+.... ......|++.|+
T Consensus 112 l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~ 185 (361)
T 2yab_A 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFV 185 (361)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEE
Confidence 999999999999999999999998 99999999999998877 79999999998765422 223356899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||++.+..++.++|||||||++|+|++|..||...... ........... .+..... ...+..+.+|
T Consensus 186 aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~~~--~~~~~~~-----~~~s~~~~~l 252 (361)
T 2yab_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAVSY--DFDEEFF-----SQTSELAKDF 252 (361)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC--CCCHHHH-----TTSCHHHHHH
T ss_pred CchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC--CCCchhc-----cCCCHHHHHH
Confidence 999999989999999999999999999999999543211 11111111110 0000000 1123468899
Q ss_pred HHhcccCCCCCCCCHHHHHH
Q 045452 234 ALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~ 253 (303)
|.+||..||++|||+.++++
T Consensus 253 i~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 253 IRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=308.40 Aligned_cols=239 Identities=28% Similarity=0.421 Sum_probs=189.4
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC----cccCC
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----RRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~ 78 (303)
.+++.||||+++.. .......+.+|+.++++++||||+++++++.+....++||||+.+|+|.+++.... ....+
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 178 (367)
T 3l9p_A 99 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178 (367)
T ss_dssp -CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCC
T ss_pred CcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccc
Confidence 46789999999654 34556678899999999999999999999999999999999999999999986522 12458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEecccccccccccccccccceeeccccccCc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~---~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
++..++.++.||+.||+|||+.| |+||||||+|||++.++ .+||+|||++..+.............++..|+||
T Consensus 179 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 179 AMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence 99999999999999999999999 99999999999999555 4999999999765443333333345678899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
|++.+..++.++|||||||++|+|++ |..||...... ............. .+...+..+.+|+
T Consensus 256 E~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-------~~~~~i~~~~~~~---------~~~~~~~~l~~li 319 (367)
T 3l9p_A 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMD---------PPKNCPGPVYRIM 319 (367)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCccCCHHHHHHH
Confidence 99998999999999999999999998 99998543211 1111112111111 1112234688999
Q ss_pred HhcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
.+||+.||++|||+.++++.|+.....
T Consensus 320 ~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 320 TQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999998876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=300.40 Aligned_cols=241 Identities=27% Similarity=0.389 Sum_probs=189.1
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 74 (303)
.+++.||||+++.. .....+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 73 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 152 (344)
T 1rjb_A 73 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152 (344)
T ss_dssp SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----
T ss_pred CcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcccccccccc
Confidence 45678999999754 234457889999999999 999999999999999999999999999999999865322
Q ss_pred -------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc
Q 045452 75 -------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA 141 (303)
Q Consensus 75 -------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~ 141 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..........
T Consensus 153 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 229 (344)
T 1rjb_A 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229 (344)
T ss_dssp ----------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE
T ss_pred chhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccce
Confidence 134789999999999999999999998 9999999999999999999999999998765443333
Q ss_pred ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccC
Q 045452 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDD 220 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...........
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~--------- 294 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKM--------- 294 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHTTCCC---------
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH------HHHHHhcCCCC---------
Confidence 3344567889999999988889999999999999999998 9999865432211 11111111111
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
..+...+.++.+||.+||..||.+|||+.++++.|+......
T Consensus 295 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 295 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 111222357889999999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=293.83 Aligned_cols=225 Identities=20% Similarity=0.235 Sum_probs=183.4
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|..++. ....+++
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~ 104 (337)
T 1o6l_A 28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTE 104 (337)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCH
T ss_pred CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 57999999999653 23355778899999999999999999999999999999999999999998884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| ++||||||+||+++.+|.+||+|||++...... .......+|++.|+|||++.+
T Consensus 105 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 105 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSS
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC--CCcccccccChhhCChhhhcC
Confidence 999999999999999999998 999999999999999999999999998753322 122334678999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+|||||++|+|++|..||...... ........... ..+...+.++.++|.+||..
T Consensus 180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEI-----------RFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhhc
Confidence 89999999999999999999999999533211 11111111110 11122334788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||++|| +++++++
T Consensus 243 dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp STTTSTTCSTTTHHHHHT
T ss_pred CHHHhcCCCCCCHHHHHc
Confidence 999999 8998875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=300.97 Aligned_cols=239 Identities=28% Similarity=0.412 Sum_probs=189.6
Q ss_pred CCCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC-eeeEEEeeCCCCChhhhhcCcCc-----
Q 045452 3 LPCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIR----- 74 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~----- 74 (303)
..+|+.||||+++... ....+.+.+|+.+++++ +||||+++++++.... ..++||||+.+|+|.+++.....
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~ 128 (359)
T 3vhe_A 49 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128 (359)
T ss_dssp TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSC
T ss_pred cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccccc
Confidence 4567899999997643 44567899999999999 8999999999998765 48999999999999999865321
Q ss_pred ----------------------------------------------------------ccCCCHHHHHHHHHHHHHHHHH
Q 045452 75 ----------------------------------------------------------RLILDWKKRVHIIEGITQGLLY 96 (303)
Q Consensus 75 ----------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~ 96 (303)
...+++..++.++.||+.||+|
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 208 (359)
T 3vhe_A 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208 (359)
T ss_dssp C------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHH
Confidence 1228899999999999999999
Q ss_pred HHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHH
Q 045452 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176 (303)
Q Consensus 97 lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 176 (303)
||+.+ ++||||||+||+++.++.+||+|||++..+.............++..|+|||++.+..++.++||||||+++
T Consensus 209 LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 285 (359)
T 3vhe_A 209 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285 (359)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHH
Confidence 99998 999999999999999999999999999876544333334445678899999999999999999999999999
Q ss_pred HHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhh
Q 045452 177 LQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSML 255 (303)
Q Consensus 177 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L 255 (303)
|+|++ |..||........ .... ....... ..+...+.++.+++.+||+.||.+|||+.++++.|
T Consensus 286 ~ellt~g~~p~~~~~~~~~---~~~~---~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 286 WEIFSLGASPYPGVKIDEE---FCRR---LKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp HHHTTTSCCSSTTCCCSHH---HHHH---HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcCCCCCCccchhHH---HHHH---HHcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 99998 9999864432221 1111 1111111 11112234788999999999999999999999999
Q ss_pred ccCC
Q 045452 256 KNET 259 (303)
Q Consensus 256 ~~~~ 259 (303)
++..
T Consensus 351 ~~~~ 354 (359)
T 3vhe_A 351 GNLL 354 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=301.10 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=194.9
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 74 (303)
.+++.||||+++.. .....+.+.+|+.+++++ +||||+++++++...+..++||||+.+++|.+++.....
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 178 (382)
T 3tt0_A 99 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178 (382)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCC
T ss_pred ccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccc
Confidence 34568999999755 344567899999999999 999999999999999999999999999999999864321
Q ss_pred ------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeec
Q 045452 75 ------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG 148 (303)
Q Consensus 75 ------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 148 (303)
...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++................+
T Consensus 179 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 255 (382)
T 3tt0_A 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255 (382)
T ss_dssp CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCC
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCC
Confidence 245899999999999999999999998 99999999999999999999999999987654433333334456
Q ss_pred cccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
+..|+|||++.+..++.++|||||||++|+|++ |..||..... ............... +...+
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~ 319 (382)
T 3tt0_A 256 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMDK---------PSNCT 319 (382)
T ss_dssp GGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCC---------CSSCC
T ss_pred CcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCCC---------CccCC
Confidence 889999999999999999999999999999999 9999853321 111122222211111 11223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCC
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPK 266 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 266 (303)
.++.+||.+||+.||++|||+.++++.|++.........
T Consensus 320 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 320 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 478899999999999999999999999998775444333
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=293.32 Aligned_cols=234 Identities=28% Similarity=0.436 Sum_probs=187.5
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
..+++.||+|+++... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++..
T Consensus 31 ~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~ 107 (269)
T 4hcu_A 31 WLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAET 107 (269)
T ss_dssp ETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT--TTTCCCHHH
T ss_pred ecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh--cCcccCHHH
Confidence 4578889999996543 2346789999999999999999999999999999999999999999999854 344689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||++||+.| ++||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..
T Consensus 108 ~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 183 (269)
T 4hcu_A 108 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 183 (269)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCC
Confidence 9999999999999999999 99999999999999999999999999976543221 1122234577899999999889
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||||+++|+|++ |..||...... ... ........ ...+...+..+.+++.+||..|
T Consensus 184 ~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~-~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVV-EDISTGFR---------LYKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHH-HHHhcCcc---------CCCCCcCCHHHHHHHHHHccCC
Confidence 9999999999999999999 89998533211 111 11111111 1111222347889999999999
Q ss_pred CCCCCCHHHHHHhhccCC
Q 045452 242 PNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~ 259 (303)
|++|||+.++++.|++..
T Consensus 248 p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 248 PEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred cccCcCHHHHHHHHHHHH
Confidence 999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=291.24 Aligned_cols=249 Identities=16% Similarity=0.135 Sum_probs=195.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++.... ..+.+.+|+..++.+ +|+|++++++++......++||||+ +++|.+++... ...+++..
T Consensus 33 ~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~ 107 (298)
T 1csn_A 33 LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC--GRKFSVKT 107 (298)
T ss_dssp TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHH
T ss_pred CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh--ccCCCHHH
Confidence 679999999986443 224577899999999 8999999999999999999999999 99999998542 34589999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-----EEEecccccccccccccc-----cccceeeccccc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-----PKISDFGLARIFAKESLK-----ANTEQVVGTIGY 152 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~-----~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~y 152 (303)
++.++.||+.||+|||+.| ++||||||+||+++.++. +||+|||++......... .......|+..|
T Consensus 108 ~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 184 (298)
T 1csn_A 108 VAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred HHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCccc
Confidence 9999999999999999998 999999999999987776 999999999876543221 122345689999
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||.+.+..++.++||||||+++|+|++|+.||........................... .. ..+.++.+
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~~~~~l~~ 255 (298)
T 1csn_A 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-----CA----GFPEEFYK 255 (298)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-----TT----TSCHHHHH
T ss_pred CCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH-----Hh----hCcHHHHH
Confidence 9999999989999999999999999999999999765443333322222221111111000 00 12347889
Q ss_pred HHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCCCC
Q 045452 233 IALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 269 (303)
++.+||..||++|||+.+|++.|++...........+
T Consensus 256 li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~ 292 (298)
T 1csn_A 256 YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 292 (298)
T ss_dssp HHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSC
T ss_pred HHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCc
Confidence 9999999999999999999999999876655544433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.55 Aligned_cols=241 Identities=15% Similarity=0.129 Sum_probs=190.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++..... .+.+.+|+.+++++ +|+||+++++++......++||||+ +++|.+++... ...+++..
T Consensus 32 ~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~ 106 (330)
T 2izr_A 32 YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC--DRTFSLKT 106 (330)
T ss_dssp TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHH
T ss_pred CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc--CCCCCHHH
Confidence 6789999999865432 24578899999999 9999999999999999999999999 99999998542 45699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-----EEEeccccccccccccccc-----ccceeeccccc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-----PKISDFGLARIFAKESLKA-----NTEQVVGTIGY 152 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~-----~kl~df~~~~~~~~~~~~~-----~~~~~~~~~~y 152 (303)
++.++.||+.||+|||+.| ++||||||+||+++.++. +||+|||++..+....... ......|+..|
T Consensus 107 ~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y 183 (330)
T 2izr_A 107 VLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183 (330)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccc
Confidence 9999999999999999998 999999999999999887 9999999998764332211 12345789999
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||++.+..++.++|||||||++|+|++|..||........................ ... ....+ ++.+
T Consensus 184 ~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-----~~~----~~~~p-~~~~ 253 (330)
T 2izr_A 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI-----EVL----CENFP-EMAT 253 (330)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-----HHH----TTTCH-HHHH
T ss_pred cChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-----HHH----hccCh-HHHH
Confidence 9999999999999999999999999999999999765433332222222111110000 000 00112 6889
Q ss_pred HHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 233 IALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
++..||..||.+||++.+|.+.|++.....
T Consensus 254 li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 254 YLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 999999999999999999999988765443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=296.14 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=192.5
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEE--eCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--DSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..+|+.||||++........+.+.+|+.++++++|+||+++++++. .....++||||+++++|.+++.. ....+++
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~ 126 (327)
T 3lxl_A 49 DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDA 126 (327)
T ss_dssp SSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH--HGGGCCH
T ss_pred CCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh--cccCCCH
Confidence 3578999999998877777788999999999999999999999987 44578999999999999999854 2345899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 159 (303)
..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.
T Consensus 127 ~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (327)
T 3lxl_A 127 SRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc
Confidence 999999999999999999998 999999999999999999999999999876533221 2223345788899999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCC--------ccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++||||||+++|+|++|..||...... .................. ...+...+..+.
T Consensus 204 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~ 274 (327)
T 3lxl_A 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR---------LPAPPACPAEVH 274 (327)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC---------CCCCTTCCHHHH
T ss_pred cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC---------CCCCCcccHHHH
Confidence 888999999999999999999999998532211 011111111122221111 111223345788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKK 267 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 267 (303)
+||.+||..||++|||+.++++.|+...........
T Consensus 275 ~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 275 ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 999999999999999999999999998765544443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.45 Aligned_cols=252 Identities=19% Similarity=0.211 Sum_probs=185.2
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++... ....+++.
T Consensus 50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 128 (389)
T 3gni_B 50 PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-FMDGMNEL 128 (389)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-CTTCCCHH
T ss_pred CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh-cccCCCHH
Confidence 47999999999644 3455678889999999999999999999999999999999999999999998542 23558999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-----ccccceeeccccccCch
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-----KANTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE 156 (303)
.+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........ ........|+..|+|||
T Consensus 129 ~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (389)
T 3gni_B 129 AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205 (389)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHH
Confidence 99999999999999999999 99999999999999999999999998865432211 11122246788999999
Q ss_pred hccc--CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH-HHHHhhCC-------------------------
Q 045452 157 YARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH-AYELWKGG------------------------- 208 (303)
Q Consensus 157 ~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~------------------------- 208 (303)
++.+ ..++.++|||||||++|+|++|..||.............. ........
T Consensus 206 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (389)
T 3gni_B 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285 (389)
T ss_dssp HHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------------
T ss_pred HHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccc
Confidence 9987 5789999999999999999999999965433221111000 00000000
Q ss_pred ---CccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 209 ---KGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 209 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
..............+...+..+.+||.+||+.||++|||+.++++. +++..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 286 TTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 0000000000001122234578899999999999999999999853 65544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=292.60 Aligned_cols=240 Identities=22% Similarity=0.266 Sum_probs=180.5
Q ss_pred CCCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..+|+.||+|+++... ....+.+.+|+.++++++||||+++++++.+....++||||+.+ +|.+++.. ....+++
T Consensus 42 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~ 118 (311)
T 3niz_A 42 DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE--NKTGLQD 118 (311)
T ss_dssp ETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT--CTTCCCH
T ss_pred ECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh--ccCCCCH
Confidence 3578999999996543 23456788999999999999999999999999999999999975 77777754 3445899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+
T Consensus 119 ~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 119 SQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcC
Confidence 999999999999999999998 9999999999999999999999999997664322 12223467999999998876
Q ss_pred -CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccc----------------ccccCCCC
Q 045452 161 -GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVD----------------SFLDDRNS 223 (303)
Q Consensus 161 -~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~ 223 (303)
..++.++|||||||++|+|++|..||......+....+. ............. ........
T Consensus 194 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (311)
T 3niz_A 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF---SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSII 270 (311)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH---HHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHS
T ss_pred CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHHCCCChHHhhhhhccchhhhcccccccCCcHHHhC
Confidence 568999999999999999999999997554443322222 1111111000000 00000001
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...+.++.+||.+||..||++|||++++++
T Consensus 271 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 112347889999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=311.95 Aligned_cols=241 Identities=27% Similarity=0.412 Sum_probs=191.5
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++.++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+.+|+|.+++... ....+++.
T Consensus 208 ~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~ 284 (454)
T 1qcf_A 208 TYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLP 284 (454)
T ss_dssp EETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHH
T ss_pred EECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cCCCCCHH
Confidence 45678899999997543 35678999999999999999999999986 66789999999999999999642 23468899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.......... .....++..|+|||.+...
T Consensus 285 ~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 360 (454)
T 1qcf_A 285 KLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFG 360 (454)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccCHHHhccC
Confidence 99999999999999999998 9999999999999999999999999998764322111 1223357789999999988
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++|+|++ |..||...... .... ....+ ... ..+...+.++.+||.+||..
T Consensus 361 ~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~---~i~~~-~~~---------~~~~~~~~~l~~li~~cl~~ 424 (454)
T 1qcf_A 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR---ALERG-YRM---------PRPENCPEELYNIMMRCWKN 424 (454)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---HHHHT-CCC---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHcC-CCC---------CCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999999 99998533211 1111 11111 111 11122345788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTNTNTP 265 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~~~~~ 265 (303)
||++|||+++|++.|++..+....+
T Consensus 425 dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 425 RPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp SGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred ChhHCcCHHHHHHHHHHHHhccccc
Confidence 9999999999999999988765543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=301.49 Aligned_cols=229 Identities=24% Similarity=0.282 Sum_probs=186.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|+++.......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ....+++..+
T Consensus 112 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~l~~~~~ 189 (373)
T 2x4f_A 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDT 189 (373)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH--TGGGCCHHHH
T ss_pred CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCCHHHH
Confidence 57999999999877666778899999999999999999999999999999999999999999888853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE--CCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~--~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||+.+ ++||||||+|||+ +.++.+||+|||++..+..... .....|++.|+|||++.+.
T Consensus 190 ~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 263 (373)
T 2x4f_A 190 ILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYD 263 (373)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCC
Confidence 999999999999999999 9999999999999 6678999999999987643321 2234689999999999988
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|..||...... .............. .. .....+.++.+||.+||..|
T Consensus 264 ~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~~--~~-----~~~~~~~~~~~li~~~L~~d 330 (373)
T 2x4f_A 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWDLE--DE-----EFQDISEEAKEFISKLLIKE 330 (373)
T ss_dssp BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCSC--SG-----GGTTSCHHHHHHHHTTSCSS
T ss_pred CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCCC--hh-----hhccCCHHHHHHHHHHcCCC
Confidence 8999999999999999999999999543211 11112222111100 00 00112347889999999999
Q ss_pred CCCCCCHHHHHH
Q 045452 242 PNDRPSMLEVSS 253 (303)
Q Consensus 242 p~~Rps~~~l~~ 253 (303)
|.+|||+.++++
T Consensus 331 p~~Rps~~e~l~ 342 (373)
T 2x4f_A 331 KSWRISASEALK 342 (373)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHhc
Confidence 999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=296.76 Aligned_cols=234 Identities=17% Similarity=0.233 Sum_probs=186.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|.++... .....+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ....+++..+
T Consensus 28 ~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~ 104 (321)
T 1tki_A 28 SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREI 104 (321)
T ss_dssp TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHH
T ss_pred CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh--cCCCCCHHHH
Confidence 478999999996543 3456788999999999999999999999999999999999999999999853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--CCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+.++.||+.||.|||+.| ++||||||+||+++. ++.+||+|||++..+.... ......+++.|+|||++.+.
T Consensus 105 ~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCC
Confidence 999999999999999998 999999999999987 7899999999998764322 22335689999999999988
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++||||||+++|+|++|..||...... .............. .... ...+.++.++|.+||..|
T Consensus 179 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~--~~~~-----~~~s~~~~~li~~~L~~d 245 (321)
T 1tki_A 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFD--EEAF-----KEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCC--HHHH-----TTSCHHHHHHHHTTSCSS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCCCC--hhhh-----ccCCHHHHHHHHHHcCCC
Confidence 8899999999999999999999999543211 11111111111000 0000 012346889999999999
Q ss_pred CCCCCCHHHHHH--hhccCC
Q 045452 242 PNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 242 p~~Rps~~~l~~--~L~~~~ 259 (303)
|.+|||+.++++ ++.+..
T Consensus 246 p~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 246 RKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp GGGSCCHHHHHHSHHHHSCG
T ss_pred hhHCcCHHHHhcChhhccCc
Confidence 999999999986 455543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=305.75 Aligned_cols=230 Identities=20% Similarity=0.284 Sum_probs=184.4
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++. ....+++.
T Consensus 34 ~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~---~~~~~~e~ 110 (444)
T 3soa_A 34 LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---AREYYSEA 110 (444)
T ss_dssp TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH---HCSCCCHH
T ss_pred CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH---HcCCCCHH
Confidence 578999999986543 3455678999999999999999999999999999999999999999998884 34569999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~---~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
.+..++.||+.||+|||+.| |+||||||+||+++ .++.+||+|||++........ ......|++.|+|||++
T Consensus 111 ~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l 185 (444)
T 3soa_A 111 DASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVL 185 (444)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHh
Confidence 99999999999999999999 99999999999998 567899999999976654321 12235689999999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+..++.++|||||||++|+|++|..||...... ........+.... .. ......+.++.+||.+||
T Consensus 186 ~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~--~~-----~~~~~~s~~~~~li~~~L 252 (444)
T 3soa_A 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAYDF--PS-----PEWDTVTPEAKDLINKML 252 (444)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCCC--CT-----TTTTTSCHHHHHHHHHHS
T ss_pred cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCCCC--Cc-----cccccCCHHHHHHHHHHc
Confidence 9989999999999999999999999999543211 1111111111100 00 001122347889999999
Q ss_pred cCCCCCCCCHHHHHHh
Q 045452 239 QENPNDRPSMLEVSSM 254 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~ 254 (303)
..||++|||+.++++.
T Consensus 253 ~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 253 TINPSKRITAAEALKH 268 (444)
T ss_dssp CSSTTTSCCHHHHHHS
T ss_pred CCChhHCCCHHHHhcC
Confidence 9999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=296.59 Aligned_cols=229 Identities=23% Similarity=0.320 Sum_probs=183.1
Q ss_pred CCCCEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSA------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....
T Consensus 34 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~ 110 (326)
T 2y0a_A 34 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKES 110 (326)
T ss_dssp TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT---TSSC
T ss_pred CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH---hcCC
Confidence 4789999999865432 246789999999999999999999999999999999999999999999984 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEecccccccccccccccccceeecccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~----~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
+++..++.++.||+.||.|||+.| ++||||||+||+++.++ .+||+|||++..+.... ......|++.|+
T Consensus 111 ~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~ 184 (326)
T 2y0a_A 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFV 184 (326)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcC
Confidence 899999999999999999999998 99999999999999887 79999999997764322 122346899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||++.+..++.++|||||||++|+|++|..||....... .. ........ ....... ...+..+.+|
T Consensus 185 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~~~~~~~--~~~~~~~-----~~~~~~~~~l 251 (326)
T 2y0a_A 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANVSAVNY--EFEDEYF-----SNTSALAKDF 251 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHTCC--CCCHHHH-----TTSCHHHHHH
T ss_pred CceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHhcCC--CcCcccc-----ccCCHHHHHH
Confidence 9999998899999999999999999999999995332111 11 11111110 0000000 1112468899
Q ss_pred HHhcccCCCCCCCCHHHHHHh
Q 045452 234 ALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~ 254 (303)
|.+||..||++|||+.++++.
T Consensus 252 i~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 252 IRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.68 Aligned_cols=229 Identities=23% Similarity=0.314 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++. ....+++.
T Consensus 52 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~ 128 (362)
T 2bdw_A 52 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEA 128 (362)
T ss_dssp TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT---TCSCCCHH
T ss_pred CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCCHH
Confidence 47899999999654 34456789999999999999999999999999999999999999999998884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~---~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
.+..++.||+.||+|||+.| ++||||||+||+++.++ .+||+|||++....... ......|++.|+|||++
T Consensus 129 ~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~ 202 (362)
T 2bdw_A 129 DASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVL 202 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHH
Confidence 99999999999999999998 99999999999998654 59999999997665322 12235689999999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+..++.++|||||||++|+|++|..||...... ........+.... ... .....+.++.+||.+||
T Consensus 203 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~~~~--~~~-----~~~~~~~~~~~li~~~L 269 (362)
T 2bdw_A 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDY--PSP-----EWDTVTPEAKSLIDSML 269 (362)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCC--CTT-----GGGGSCHHHHHHHHHHS
T ss_pred ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC--Ccc-----cccCCCHHHHHHHHHHc
Confidence 9989999999999999999999999999543211 1111111111100 000 00112347889999999
Q ss_pred cCCCCCCCCHHHHHHh
Q 045452 239 QENPNDRPSMLEVSSM 254 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~ 254 (303)
..||++|||+.++++.
T Consensus 270 ~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 270 TVNPKKRITADQALKV 285 (362)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred CCChhhCcCHHHHhcC
Confidence 9999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=300.55 Aligned_cols=230 Identities=21% Similarity=0.244 Sum_probs=185.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++.. ....+++..+
T Consensus 74 ~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~l~~~~~ 151 (387)
T 1kob_A 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEV 151 (387)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TTCCBCHHHH
T ss_pred CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--hcCCCCHHHH
Confidence 47899999999877666667899999999999999999999999999999999999999999998853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--CCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||+.| ++||||||+||+++. .+.+||+|||++....... ......|+..|+|||++.+.
T Consensus 152 ~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 225 (387)
T 1kob_A 152 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDRE 225 (387)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc---ceeeeccCCCccCchhccCC
Confidence 999999999999999998 999999999999974 4779999999998764332 12234689999999999988
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|..||..... ............. .........+.++.+||.+||..|
T Consensus 226 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~d 292 (387)
T 1kob_A 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE-------FDEDAFSSVSPEAKDFIKNLLQKE 292 (387)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC-------CCSSTTTTSCHHHHHHHHTTSCSS
T ss_pred CCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-------CCccccccCCHHHHHHHHHHcCCC
Confidence 899999999999999999999999964321 1111111111110 001111123347889999999999
Q ss_pred CCCCCCHHHHHHh
Q 045452 242 PNDRPSMLEVSSM 254 (303)
Q Consensus 242 p~~Rps~~~l~~~ 254 (303)
|++|||+.++++.
T Consensus 293 P~~Rpt~~ell~h 305 (387)
T 1kob_A 293 PRKRLTVHDALEH 305 (387)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhHCcCHHHHhhC
Confidence 9999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=293.64 Aligned_cols=238 Identities=25% Similarity=0.381 Sum_probs=191.4
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 74 (303)
.+++.||+|+++... ....+.+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 130 (313)
T 1t46_A 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (313)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred chhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccc
Confidence 567899999997553 34567899999999999 999999999999999999999999999999999864321
Q ss_pred --------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccccee
Q 045452 75 --------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV 146 (303)
Q Consensus 75 --------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 146 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...............
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 207 (313)
T 1t46_A 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (313)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred cccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCC
Confidence 225899999999999999999999998 999999999999999999999999999876554333333344
Q ss_pred eccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChH
Q 045452 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC 225 (303)
Q Consensus 147 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ........ ...+..
T Consensus 208 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~---~~~~~~~~---------~~~~~~ 272 (313)
T 1t46_A 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FY---KMIKEGFR---------MLSPEH 272 (313)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---HH---HHHHHTCC---------CCCCTT
T ss_pred CCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---HH---HHhccCCC---------CCCccc
Confidence 56789999999988899999999999999999998 9999864432211 11 11111110 011122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.+..+.++|.+||..||.+|||+.++++.|++..
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2347889999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=303.15 Aligned_cols=236 Identities=27% Similarity=0.418 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.++..||||.++.. .....+.+.+|+.++++++||||+++++++......++||||+++++|.+++.. ....+++..
T Consensus 71 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~ 148 (373)
T 2qol_A 71 KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQ 148 (373)
T ss_dssp SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCSCHHH
T ss_pred CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh--CCCCCCHHH
Confidence 36788999999765 345567899999999999999999999999999999999999999999999964 234689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 161 (303)
++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+.
T Consensus 149 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (373)
T 2qol_A 149 LVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC
Confidence 9999999999999999998 999999999999999999999999999776433211 111122346789999999999
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++|+|++ |..||...... . .......... ...+...+..+.+++.+||+.
T Consensus 226 ~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~-~~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~ 289 (373)
T 2qol_A 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------D-VIKAVDEGYR---------LPPPMDCPAALYQLMLDCWQK 289 (373)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------H-HHHHHHTTEE---------CCCCTTCBHHHHHHHHHHTCS
T ss_pred CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC---------CCCCccccHHHHHHHHHHhCc
Confidence 99999999999999999998 99998533211 1 1111111110 111122335788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~ 260 (303)
||++||++.++++.|+....
T Consensus 290 dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 290 DRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=311.71 Aligned_cols=244 Identities=27% Similarity=0.408 Sum_probs=188.8
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++.++..||||+++... ...+.+.+|+.++++++||||+++++++.. +..++||||+.+|+|.+++... ....+++.
T Consensus 204 ~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~ 280 (452)
T 1fmk_A 204 TWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLP 280 (452)
T ss_dssp EETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHH
T ss_pred EECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-CCCCCCHH
Confidence 44567789999997543 345789999999999999999999999865 6789999999999999999532 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++......... ......++..|+|||.+.+.
T Consensus 281 ~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 356 (452)
T 1fmk_A 281 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG 356 (452)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcC
Confidence 99999999999999999998 999999999999999999999999999766433211 12223457889999999988
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++|+|++ |..||...... . .......+... ..+...+..+.+||.+||..
T Consensus 357 ~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~ 420 (452)
T 1fmk_A 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRM---------PCPPECPESLHDLMCQCWRK 420 (452)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCC---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999999 89998533211 1 11111111111 11222345788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTNTNTPKKP 268 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 268 (303)
||++|||+++|++.|++..........+
T Consensus 421 dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 421 EPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 9999999999999999998776665544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=292.08 Aligned_cols=235 Identities=25% Similarity=0.380 Sum_probs=187.9
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
...++..||+|+++.... ..+.+.+|+.++++++|+||+++++++.+....++||||+.+++|.+++.. ....+++.
T Consensus 44 ~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~ 120 (283)
T 3gen_A 44 KWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQ 120 (283)
T ss_dssp EETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC--GGGCCCHH
T ss_pred EEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH--hccCCCHH
Confidence 345778899999975432 346788999999999999999999999999999999999999999999854 24569999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+.
T Consensus 121 ~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 196 (283)
T 3gen_A 121 QLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYS 196 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccC
Confidence 99999999999999999998 99999999999999999999999999976543221 111223457789999999988
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++|+|++ |..||...... ........ ... ...+...+..+.++|.+||+.
T Consensus 197 ~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~ 260 (283)
T 3gen_A 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQ-GLR---------LYRPHLASEKVYTIMYSCWHE 260 (283)
T ss_dssp CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHT-TCC---------CCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhc-ccC---------CCCCCcCCHHHHHHHHHHccC
Confidence 89999999999999999998 99998543211 11111111 110 111112234788999999999
Q ss_pred CCCCCCCHHHHHHhhccCC
Q 045452 241 NPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~ 259 (303)
||.+|||+.++++.|++..
T Consensus 261 ~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 261 KADERPTFKILLSNILDVM 279 (283)
T ss_dssp SGGGSCCHHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHHHh
Confidence 9999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=292.61 Aligned_cols=241 Identities=27% Similarity=0.365 Sum_probs=188.6
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++||||+++++|.+++. ...+++
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~ 133 (318)
T 3lxp_A 58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGL 133 (318)
T ss_dssp -CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGG----GSCCCH
T ss_pred CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHh----hCCCCH
Confidence 378999999997653 45567899999999999999999999999874 57899999999999999984 344899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 159 (303)
..++.++.||+.||++||+.| ++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.
T Consensus 134 ~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 134 AQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence 999999999999999999999 999999999999999999999999999876543221 2223345788899999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCC--------ccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++||||||+++|+|++|..||...... ................. ....+...+.++.
T Consensus 211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~ 281 (318)
T 3lxp_A 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE---------RLPRPDKCPAEVY 281 (318)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC---------CCCCCTTCCHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc---------CCCCCccccHHHH
Confidence 888999999999999999999999998533211 00000111111111111 1112222345789
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
+||.+||..||++|||+.++++.|+....
T Consensus 282 ~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 282 HLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=283.24 Aligned_cols=230 Identities=30% Similarity=0.425 Sum_probs=175.6
Q ss_pred CCCEEEEEEccCCC----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ...+++
T Consensus 29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~ 104 (271)
T 3dtc_A 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPP 104 (271)
T ss_dssp TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT----SSCCCH
T ss_pred cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh----cCCCCH
Confidence 48899999986543 2345788999999999999999999999999999999999999999999883 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--------CCcEEEecccccccccccccccccceeeccccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--------DMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~--------~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
..++.++.|++.||+|||+.|..+++||||||+||+++. ++.+||+|||.+........ ....|+..|
T Consensus 105 ~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y 180 (271)
T 3dtc_A 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAW 180 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccce
Confidence 999999999999999999987555889999999999986 77899999999976543221 234679999
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||.+.+..++.++||||||+++|+|++|..||.... ............... ..+...+..+.+
T Consensus 181 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 245 (271)
T 3dtc_A 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAMNKLAL---------PIPSTCPEPFAK 245 (271)
T ss_dssp SCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHTSCCCC---------CCCTTCCHHHHH
T ss_pred eCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHhhhcCCCCC---------CCCcccCHHHHH
Confidence 99999999999999999999999999999999995322 111111211111111 111222347889
Q ss_pred HHHhcccCCCCCCCCHHHHHHhhcc
Q 045452 233 IALLCVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~L~~ 257 (303)
++.+||..||.+|||+.++++.|+.
T Consensus 246 li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 246 LMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=296.59 Aligned_cols=227 Identities=23% Similarity=0.309 Sum_probs=182.8
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+....++||||+.+|+|..++.. ...+++
T Consensus 38 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~ 114 (384)
T 4fr4_A 38 DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ---NVHFKE 114 (384)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT---TCCCCH
T ss_pred CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh---cCCCCH
Confidence 578999999986432 23457788999999999999999999999999999999999999999999853 456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||.|||+.| |+||||||+||+++.+|.+||+|||++..+... .......||+.|+|||++.+
T Consensus 115 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 115 ETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeecc
Confidence 999999999999999999999 999999999999999999999999999765432 22234578999999999864
Q ss_pred ---CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 161 ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 161 ---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
..++.++|||||||++|+|++|..||............... .... ...+...+..+.+||.+|
T Consensus 189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~-----------~~~p~~~s~~~~~li~~l 254 (384)
T 4fr4_A 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ETTV-----------VTYPSAWSQEMVSLLKKL 254 (384)
T ss_dssp CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HHCC-----------CCCCTTSCHHHHHHHHHH
T ss_pred CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hhcc-----------cCCCCcCCHHHHHHHHHH
Confidence 45889999999999999999999999654433222221111 1110 011122335788999999
Q ss_pred ccCCCCCCCC-HHHHHH
Q 045452 238 VQENPNDRPS-MLEVSS 253 (303)
Q Consensus 238 l~~dp~~Rps-~~~l~~ 253 (303)
|..||.+||+ +++++.
T Consensus 255 L~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 255 LEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCSSGGGSCCSHHHHHT
T ss_pred hcCCHhHhcccHHHHHc
Confidence 9999999998 777764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.77 Aligned_cols=225 Identities=21% Similarity=0.269 Sum_probs=178.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+....|+||||+.+|+|..++. ....++
T Consensus 46 ~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 122 (353)
T 3txo_A 46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD 122 (353)
T ss_dssp TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 57899999999654 233556788899999988 79999999999999999999999999999999984 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.
T Consensus 123 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 123 EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC--CccccccCCCcCeEChhhcC
Confidence 9999999999999999999998 999999999999999999999999998753322 22233467899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||...... ........... ..+...+..+.++|.+||.
T Consensus 198 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~-----------~~p~~~~~~~~~li~~lL~ 260 (353)
T 3txo_A 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEV-----------VYPTWLHEDATGILKSFMT 260 (353)
T ss_dssp HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTC
T ss_pred CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhh
Confidence 888999999999999999999999999543221 11112122111 1111233468899999999
Q ss_pred CCCCCCCCH------HHHHH
Q 045452 240 ENPNDRPSM------LEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~------~~l~~ 253 (303)
.||++||++ +++++
T Consensus 261 ~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 261 KNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SSGGGSTTSGGGTCTHHHHT
T ss_pred hCHHHccCCcccCCHHHHhh
Confidence 999999998 66654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=298.11 Aligned_cols=239 Identities=27% Similarity=0.388 Sum_probs=189.1
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 74 (303)
.+++.||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||+.+++|.+++.....
T Consensus 65 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 144 (334)
T 2pvf_A 65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144 (334)
T ss_dssp ---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC
T ss_pred ccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccc
Confidence 46789999999755 345567899999999999 999999999999999999999999999999999865321
Q ss_pred ------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeec
Q 045452 75 ------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG 148 (303)
Q Consensus 75 ------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 148 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++................+
T Consensus 145 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 221 (334)
T 2pvf_A 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221 (334)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCC
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCc
Confidence 234889999999999999999999998 99999999999999999999999999987654432223333456
Q ss_pred cccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ..+...+
T Consensus 222 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~ 285 (334)
T 2pvf_A 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRM---------DKPANCT 285 (334)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTCCC---------CCCTTCC
T ss_pred ccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-------HHHHHhcCCCC---------CCCccCC
Confidence 788999999988889999999999999999999 999985332111 11111111111 1112223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
.++.++|.+||..||.+|||+.++++.|++....
T Consensus 286 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4788999999999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=290.15 Aligned_cols=238 Identities=26% Similarity=0.401 Sum_probs=191.0
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-------cc
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------RL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~ 76 (303)
+++.||||.++.. .......+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++..... ..
T Consensus 54 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 133 (322)
T 1p4o_A 54 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133 (322)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCC
Confidence 5788999999754 334566789999999999999999999999999999999999999999999854211 14
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++................++..|+|||
T Consensus 134 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChh
Confidence 5689999999999999999999998 9999999999999999999999999998665443333334456788999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++||||||+++|+|++ |..||...... . ............ .+...+..+.++|.
T Consensus 211 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~---------~~~~~~~~l~~li~ 274 (322)
T 1p4o_A 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLRFVMEGGLLD---------KPDNCPDMLFELMR 274 (322)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHHHHHTTCCCC---------CCTTCCHHHHHHHH
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------H-HHHHHHcCCcCC---------CCCCCCHHHHHHHH
Confidence 9998889999999999999999999 88888533211 1 111111111111 11222347889999
Q ss_pred hcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 236 LCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
+||..||.+|||+.++++.|++...+
T Consensus 275 ~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 275 MCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 99999999999999999999997653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=291.76 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=189.8
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCc-CcccCC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDP-IRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~ 78 (303)
.+|+.||||++........+.+.+|+.+++.++||||+++++++.. ....++||||+.+++|.+++... .....+
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 131 (317)
T 2buj_A 52 HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131 (317)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCC
T ss_pred CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCC
Confidence 5789999999977777778889999999999999999999999873 34789999999999999988542 124668
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-------cccceeecccc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-------ANTEQVVGTIG 151 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-------~~~~~~~~~~~ 151 (303)
++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||.+......... .......|+..
T Consensus 132 ~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 208 (317)
T 2buj_A 132 TEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208 (317)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999998 999999999999999999999999988654321111 01112346899
Q ss_pred ccCchhcccCC---CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 152 YIPPEYARQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 152 y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
|+|||.+.+.. ++.++||||||+++|+|++|..||......... ... ...... ........+.
T Consensus 209 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~---~~~~~~---------~~~~~~~~~~ 274 (317)
T 2buj_A 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VAL---AVQNQL---------SIPQSPRHSS 274 (317)
T ss_dssp GCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHH---HHHCC-----------CCCCTTSCH
T ss_pred cCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhH---HhhccC---------CCCccccCCH
Confidence 99999987554 688999999999999999999998532111100 000 011100 0111122234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCC
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPK 266 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 266 (303)
++.++|.+||..||.+|||+.++++.|+....+.+.+.
T Consensus 275 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 78899999999999999999999999999876555443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=284.54 Aligned_cols=226 Identities=24% Similarity=0.308 Sum_probs=176.0
Q ss_pred CCCCEEEEEEccCCCh--------------------------hhHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeE
Q 045452 4 PCGEVIAVKKLSKSSA--------------------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERML 55 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 55 (303)
.+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 115 (298)
T 2zv2_A 36 NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYM 115 (298)
T ss_dssp TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEE
T ss_pred CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEE
Confidence 5789999999864421 123568899999999999999999999986 568899
Q ss_pred EEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccc
Q 045452 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 56 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~ 135 (303)
||||+++++|.+++ ....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+.
T Consensus 116 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 188 (298)
T 2zv2_A 116 VFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188 (298)
T ss_dssp EEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCccccc
Confidence 99999999998765 3456999999999999999999999998 9999999999999999999999999997665
Q ss_pred ccccccccceeeccccccCchhcccCC---CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccc
Q 045452 136 KESLKANTEQVVGTIGYIPPEYARQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGME 212 (303)
Q Consensus 136 ~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (303)
.... ......|+..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .............
T Consensus 189 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-- 258 (298)
T 2zv2_A 189 GSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI------MCLHSKIKSQALE-- 258 (298)
T ss_dssp SSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC--
T ss_pred cccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH------HHHHHHHhcccCC--
Confidence 3321 122356899999999987665 36789999999999999999999953321 1111111111100
Q ss_pred cccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 213 FVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 213 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
. ......+.++.++|.+||..||++|||+.++++
T Consensus 259 ~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 259 F-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp C-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 0 001112347889999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=288.70 Aligned_cols=230 Identities=22% Similarity=0.268 Sum_probs=179.9
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-------------------------------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------------------------------- 51 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------------------------- 51 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (332)
T 3qd2_B 29 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108 (332)
T ss_dssp TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------
T ss_pred CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccc
Confidence 479999999996543 345678999999999999999999999986543
Q ss_pred --------------------------eeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 045452 52 --------------------------ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTI 105 (303)
Q Consensus 52 --------------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 105 (303)
..++||||+.+++|.+++.........++..++.++.||+.||+|||+.| +
T Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 185 (332)
T 3qd2_B 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---L 185 (332)
T ss_dssp -----------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---e
Confidence 27999999999999999977555556677789999999999999999998 9
Q ss_pred eecCCCCCcEEECCCCcEEEecccccccccccccc----------cccceeeccccccCchhcccCCCCCcccchhhHHH
Q 045452 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLK----------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175 (303)
Q Consensus 106 ~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 175 (303)
+||||||+||+++.++.+||+|||++......... .......|+..|+|||.+.+..++.++|||||||+
T Consensus 186 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 265 (332)
T 3qd2_B 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265 (332)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHH
T ss_pred eecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHH
Confidence 99999999999999999999999999876543211 11233468999999999999999999999999999
Q ss_pred HHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 176 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+|+|++|..|+.. ... ............ ........+.++|.+||+.||++|||+.++++.
T Consensus 266 l~el~~~~~~~~~--------~~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 266 LFELLYSFSTQME--------RVR-IITDVRNLKFPL---------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHSCCCCHHH--------HHH-HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcCCChhH--------HHH-HHHHhhccCCCc---------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 9999998776421 011 111111111110 011222467899999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=296.66 Aligned_cols=235 Identities=24% Similarity=0.406 Sum_probs=175.3
Q ss_pred EEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCee------eEEEeeCCCCChhhhhcCcC---ccc
Q 045452 8 VIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYMPNKSLDCYLFDPI---RRL 76 (303)
Q Consensus 8 ~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~---~~~ 76 (303)
.||||+++.. .....+.+.+|+.++++++||||+++++++...... +++|||+.+++|.+++.... ...
T Consensus 53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 132 (323)
T 3qup_A 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132 (323)
T ss_dssp EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence 8999999754 344567899999999999999999999999877654 99999999999999885421 122
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++................++..|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 5899999999999999999999999 9999999999999999999999999998765443333333345678899999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|||||||++|+|++ |..||........ .. . ....... ..+...+.++.+++.
T Consensus 210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~---~-~~~~~~~---------~~~~~~~~~l~~li~ 273 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---YN---Y-LIGGNRL---------KQPPECMEEVYDLMY 273 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---H-HHTTCCC---------CCCTTCCHHHHHHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---HH---H-HhcCCCC---------CCCCccCHHHHHHHH
Confidence 9999999999999999999999999 8999864332211 11 1 1111111 111222347889999
Q ss_pred hcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 236 LCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
+||..||++|||+.++++.|++....
T Consensus 274 ~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 274 QCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999887643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=295.35 Aligned_cols=223 Identities=21% Similarity=0.305 Sum_probs=180.8
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++.... ......+.+|+.+++.++||||+++++++.+....++||||+ +|+|.+++. ....+++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~---~~~~l~~ 107 (336)
T 3h4j_B 32 KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV---EKKRMTE 107 (336)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH---HHCSCCH
T ss_pred CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH---HcCCCCH
Confidence 689999999986432 123457889999999999999999999999999999999999 788888874 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++....... .....+|++.|+|||++.+
T Consensus 108 ~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 108 DEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVING 181 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999997654332 2233568999999999988
Q ss_pred CCC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..+ +.++|||||||++|+|++|..||............ .. .....+...+..+.+||.+||.
T Consensus 182 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----------------~~-~~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----------------NS-CVYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------CS-SCCCCCTTSCHHHHHHHHTTSC
T ss_pred CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------Hc-CCCCCcccCCHHHHHHHHHHcC
Confidence 776 67999999999999999999999644322211100 00 0011222234578899999999
Q ss_pred CCCCCCCCHHHHHH
Q 045452 240 ENPNDRPSMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~~l~~ 253 (303)
.||.+|||++++++
T Consensus 245 ~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 245 ADPMQRITIQEIRR 258 (336)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhHCcCHHHHHh
Confidence 99999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.64 Aligned_cols=234 Identities=28% Similarity=0.421 Sum_probs=189.8
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
++..||||.++... ...+.+.+|+.++++++||||+++++++......++||||+.+|+|.+++... ....+++..++
T Consensus 244 ~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~ 321 (495)
T 1opk_A 244 YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLL 321 (495)
T ss_dssp GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHH
T ss_pred CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-CcCCCCHHHHH
Confidence 47899999997543 34678999999999999999999999999999999999999999999998642 23558999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++......... ......++..|+|||.+.+..++
T Consensus 322 ~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 397 (495)
T 1opk_A 322 YMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFS 397 (495)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCC
Confidence 99999999999999998 999999999999999999999999999876433221 12223456789999999988899
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++|||||||++|+|++ |..||........ . ......... ..+...+.++.+||.+||+.||+
T Consensus 398 ~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~ 461 (495)
T 1opk_A 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y----ELLEKDYRM---------ERPEGCPEKVYELMRACWQWNPS 461 (495)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCcChh
Confidence 99999999999999999 8899864332211 1 111111111 11222335788999999999999
Q ss_pred CCCCHHHHHHhhccCCC
Q 045452 244 DRPSMLEVSSMLKNETT 260 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~~~ 260 (303)
+|||+.+|++.|+....
T Consensus 462 ~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 462 DRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp GSCCHHHHHHHHHTSCS
T ss_pred HCcCHHHHHHHHHHHHh
Confidence 99999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=293.26 Aligned_cols=231 Identities=22% Similarity=0.313 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccC
Q 045452 4 PCGEVIAVKKLSKSS-----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~ 77 (303)
.+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.... ....
T Consensus 47 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 126 (351)
T 3c0i_A 47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV 126 (351)
T ss_dssp TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCC
T ss_pred CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCC
Confidence 578999999985321 1246789999999999999999999999999999999999999999988775422 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEecccccccccccccccccceeeccccccC
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~---~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
+++..++.++.||+.||+|||+.+ ++||||||+||+++.++. +||+|||++........ ......|++.|+|
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~a 201 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMA 201 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccC
Confidence 899999999999999999999998 999999999999987655 99999999987654321 2233568999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||++.+..++.++|||||||++|+|++|..||.... ... ......+..... .... ...+.++.+||
T Consensus 202 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~---~~~i~~~~~~~~--~~~~-----~~~s~~~~~li 267 (351)
T 3c0i_A 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL---FEGIIKGKYKMN--PRQW-----SHISESAKDLV 267 (351)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH---HHHHHHTCCCCC--HHHH-----TTSCHHHHHHH
T ss_pred HHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH---HHHHHcCCCCCC--cccc-----ccCCHHHHHHH
Confidence 999998889999999999999999999999995421 111 111111111000 0000 01234788999
Q ss_pred HhcccCCCCCCCCHHHHHH
Q 045452 235 LLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~ 253 (303)
.+||..||++|||+.++++
T Consensus 268 ~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCChhHCcCHHHHhc
Confidence 9999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=287.59 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=187.4
Q ss_pred CCCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++... ...++||||+++++|.+++.. ....++
T Consensus 47 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~ 124 (302)
T 4e5w_A 47 DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKIN 124 (302)
T ss_dssp SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH--HTTTCC
T ss_pred CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh--ccccCC
Confidence 3579999999997543 34567899999999999999999999999876 668999999999999999853 234589
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 158 (303)
+..++.++.|++.||++||+.| ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+
T Consensus 125 ~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 201 (302)
T 4e5w_A 125 LKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeee
Confidence 9999999999999999999998 999999999999999999999999999876543221 222334577889999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccC--------CCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG--------INENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
.+..++.++||||||+++|+|++|..|+.... ..................... ..+...+..+
T Consensus 202 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l 272 (302)
T 4e5w_A 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL---------PCPPNCPDEV 272 (302)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC---------CCCTTCCHHH
T ss_pred cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC---------CCCCCCCHHH
Confidence 98889999999999999999999998864221 111111111222222222111 1122234578
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 231 LEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
.+||.+||..||.+|||+.++++.|++.
T Consensus 273 ~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 273 YQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 8999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=286.64 Aligned_cols=232 Identities=23% Similarity=0.364 Sum_probs=181.5
Q ss_pred CEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 7 EVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 7 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
..||+|++........+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++.. ....+++..++.+
T Consensus 41 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i 118 (289)
T 4fvq_A 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEV 118 (289)
T ss_dssp EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHH
T ss_pred hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHH
Confidence 57999999776666778899999999999999999999999999999999999999999999854 2344899999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--------EEEecccccccccccccccccceeeccccccCchhc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--------PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~--------~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
+.||+.||+|||+.+ ++||||||+||+++.++. +||+|||.+...... ....++..|+|||.+
T Consensus 119 ~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 119 AKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECI 189 (289)
T ss_dssp HHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHH
T ss_pred HHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHh
Confidence 999999999999999 999999999999998887 999999998654321 223468899999998
Q ss_pred cc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
.+ ..++.++||||||+++|+|++|..|+...... ... ......... ... ..+.++.+++.+|
T Consensus 190 ~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~-~~~~~~~~~--~~~---------~~~~~l~~li~~~ 252 (289)
T 4fvq_A 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRK-LQFYEDRHQ--LPA---------PKAAELANLINNC 252 (289)
T ss_dssp HCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHH-HHHHHTTCC--CCC---------CSSCTTHHHHHHH
T ss_pred CCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHH-HHHhhccCC--CCC---------CCCHHHHHHHHHH
Confidence 87 67899999999999999999966554322111 111 111111100 000 0112577999999
Q ss_pred ccCCCCCCCCHHHHHHhhccCCCCCCCCC
Q 045452 238 VQENPNDRPSMLEVSSMLKNETTNTNTPK 266 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 266 (303)
|+.||++|||+.++++.|++..++..+..
T Consensus 253 l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 253 MDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp SCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred cCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999998666554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.91 Aligned_cols=222 Identities=23% Similarity=0.316 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++. ....+++
T Consensus 29 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~ 105 (318)
T 1fot_A 29 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPN 105 (318)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HTSSCCH
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH---HcCCCCH
Confidence 579999999996542 2345678899999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||.|||+.| ++||||||+||+++.+|.+||+|||++...... .....|++.|+|||++.+
T Consensus 106 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 106 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcC
Confidence 999999999999999999998 999999999999999999999999999765432 233568999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+|||||++|+|++|..||..... ............ ..+...+.++.++|.+||..
T Consensus 178 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~-----------~~p~~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL-----------RFPPFFNEDVKDLLSRLITR 240 (318)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHhcc
Confidence 9999999999999999999999999954321 111112222111 11122334788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||++|| +++++++
T Consensus 241 dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHHcCCCcCCCHHHHhc
Confidence 999999 8888873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=295.35 Aligned_cols=237 Identities=27% Similarity=0.386 Sum_probs=188.6
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---------
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 73 (303)
.++.||+|.++.. .....+.+.+|+.+++++ +||||+++++++.+....++||||+++|+|.+++....
T Consensus 75 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 154 (333)
T 2i1m_A 75 AVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154 (333)
T ss_dssp CCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC---
T ss_pred chhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccc
Confidence 4468999999755 344567899999999999 89999999999999999999999999999999985421
Q ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccc
Q 045452 74 --RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 74 --~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++................++..
T Consensus 155 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T 2i1m_A 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231 (333)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGG
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCcc
Confidence 1345789999999999999999999998 99999999999999999999999999986654433333334456789
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ........ ...+...+..+
T Consensus 232 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~---~~~~~~~~---------~~~~~~~~~~l 296 (333)
T 2i1m_A 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---FY---KLVKDGYQ---------MAQPAFAPKNI 296 (333)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---HH---HHHHHTCC---------CCCCTTCCHHH
T ss_pred ccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---HH---HHHhcCCC---------CCCCCCCCHHH
Confidence 999999988889999999999999999998 8889864332211 11 11111110 11111223478
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 231 LEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.++|.+||+.||.+|||+.++++.|++..
T Consensus 297 ~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 297 YSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=286.13 Aligned_cols=241 Identities=21% Similarity=0.239 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|+++... ....+.+.+|+.++++++||||+++++++.++...++||||+.+ ++.+++.. ....+++.
T Consensus 25 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~l~~~ 101 (292)
T 3o0g_A 25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS--CNGDLDPE 101 (292)
T ss_dssp TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH--TTTCCCHH
T ss_pred CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh--CCCCCCHH
Confidence 578999999986543 33457788999999999999999999999999999999999976 55555432 24569999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+.
T Consensus 102 ~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 176 (292)
T 3o0g_A 102 IVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCC
Confidence 99999999999999999998 9999999999999999999999999997664322 122334679999999998766
Q ss_pred C-CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc---------------cccccCCCChH
Q 045452 162 V-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV---------------DSFLDDRNSSC 225 (303)
Q Consensus 162 ~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~ 225 (303)
. ++.++|||||||++|+|++|..||...... .................... ...........
T Consensus 177 ~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (292)
T 3o0g_A 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254 (292)
T ss_dssp SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTT
T ss_pred CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccc
Confidence 5 799999999999999999998886433221 11222222211111000000 00000011122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+.++.+||.+||+.||++|||++++++.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 255 LNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 34578899999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=291.51 Aligned_cols=242 Identities=24% Similarity=0.351 Sum_probs=192.6
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.++..||||+++.. .....+.+.+|+.++++++||||+++++++ ..+..++||||+.+++|.+++.. ....+++..
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~ 111 (287)
T 1u59_A 35 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSN 111 (287)
T ss_dssp -CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT--CTTTSCHHH
T ss_pred CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh--CCccCCHHH
Confidence 36788999999765 345677899999999999999999999999 56678999999999999999853 345689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 161 (303)
++.++.|++.||.+||+.| ++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+.
T Consensus 112 ~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 112 VAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC
Confidence 9999999999999999998 999999999999999999999999999876433211 112223457899999999888
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++||||||+++|+|++ |..||....... ........... ..+...+.++.++|.+||..
T Consensus 189 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~---------~~~~~~~~~l~~li~~~l~~ 252 (287)
T 1u59_A 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM---------ECPPECPPELYALMSDCWIY 252 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHTTCS
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC---------CCCCCcCHHHHHHHHHHcCC
Confidence 89999999999999999998 999985433211 11111111111 11122345788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTNTNTPKK 267 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~~~~~~~ 267 (303)
||++||++.++++.|++...+..++..
T Consensus 253 ~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 253 KWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 999999999999999998766555443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=298.30 Aligned_cols=227 Identities=21% Similarity=0.305 Sum_probs=177.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|+++... ....+.+..|..++.++ +||||+++++++.+....++||||+.+|+|..++. ....++
T Consensus 75 ~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~---~~~~l~ 151 (396)
T 4dc2_A 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 151 (396)
T ss_dssp TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH---HcCCCC
Confidence 578999999996542 23345678899999887 89999999999999999999999999999998884 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| |+||||||+|||++.+|.+||+|||++...... .......+||+.|+|||++.
T Consensus 152 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~ 226 (396)
T 4dc2_A 152 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILR 226 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC--CCccccccCCcccCCchhhc
Confidence 9999999999999999999999 999999999999999999999999998753221 22234467899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc--cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+..++.++|+|||||++|+|++|..||......... .............. ...+...+.++.+||.+|
T Consensus 227 ~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~li~~l 296 (396)
T 4dc2_A 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSF 296 (396)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----------CCCCTTSCHHHHHHHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----------cCCCCcCCHHHHHHHHHH
Confidence 999999999999999999999999999644322211 11111111111110 011122334788999999
Q ss_pred ccCCCCCCCCH
Q 045452 238 VQENPNDRPSM 248 (303)
Q Consensus 238 l~~dp~~Rps~ 248 (303)
|+.||++||++
T Consensus 297 L~~dP~~R~~~ 307 (396)
T 4dc2_A 297 LNKDPKERLGC 307 (396)
T ss_dssp TCSCTTTSTTC
T ss_pred hcCCHhHcCCC
Confidence 99999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=294.58 Aligned_cols=230 Identities=22% Similarity=0.278 Sum_probs=172.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++. ....+++..+
T Consensus 43 ~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 118 (361)
T 3uc3_A 43 LTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDEA 118 (361)
T ss_dssp TTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHH
T ss_pred CCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH---hcCCCCHHHH
Confidence 4789999999965432 33668899999999999999999999999999999999999999999884 3456999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--EEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||+.| ++||||||+||+++.++. +||+|||++...... .......|++.|+|||++.+.
T Consensus 119 ~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 192 (361)
T 3uc3_A 119 RFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQ 192 (361)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCC
Confidence 999999999999999999 999999999999987765 999999998643221 122334689999999999887
Q ss_pred CCCCc-ccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTK-SDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~-~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.+ +|||||||++|+|++|..||............. .......... ......+.++.+||.+||..
T Consensus 193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~---------~~~~~~s~~~~~li~~~L~~ 261 (361)
T 3uc3_A 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI--QRILSVKYSI---------PDDIRISPECCHLISRIFVA 261 (361)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH--HHHHTTCCCC---------CTTSCCCHHHHHHHHHHSCS
T ss_pred CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH--HHHhcCCCCC---------CCcCCCCHHHHHHHHHHccC
Confidence 77655 899999999999999999996544332222111 1111111100 00001234688999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
||++|||+.++++.
T Consensus 262 dP~~Rps~~ell~h 275 (361)
T 3uc3_A 262 DPATRISIPEIKTH 275 (361)
T ss_dssp CTTTSCCHHHHHTS
T ss_pred ChhHCcCHHHHHhC
Confidence 99999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.04 Aligned_cols=231 Identities=23% Similarity=0.379 Sum_probs=179.7
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||+|.++.. .....+.+.+|+.++++++||||+++++++..+ ..+++++|+.+|+|.+++.. ....+++..++.+
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~ 122 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNW 122 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH--STTSCCHHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHH
Confidence 3588888543 334567899999999999999999999999875 47899999999999999854 2456899999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.+
T Consensus 123 ~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 199 (327)
T 3poz_A 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199 (327)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCch
Confidence 999999999999998 99999999999999999999999999987654433333333456789999999999999999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+|||||||++|+|++ |..||........ . ........ ...+...+.++.+++.+||+.||++|
T Consensus 200 ~Di~slG~il~ellt~g~~p~~~~~~~~~----~---~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~R 263 (327)
T 3poz_A 200 SDVWSYGVTVWELMTFGSKPYDGIPASEI----S---SILEKGER---------LPQPPICTIDVYMIMVKCWMIDADSR 263 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCGGGH----H---HHHHTTCC---------CCCCTTBCHHHHHHHHHHTCSCGGGS
T ss_pred hhhhhhHHHHHHHHhcCCCCccCCCHHHH----H---HHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhC
Confidence 999999999999999 9999864332221 1 11111111 11122233478899999999999999
Q ss_pred CCHHHHHHhhccCCC
Q 045452 246 PSMLEVSSMLKNETT 260 (303)
Q Consensus 246 ps~~~l~~~L~~~~~ 260 (303)
||+.++++.|+....
T Consensus 264 ps~~ell~~l~~~~~ 278 (327)
T 3poz_A 264 PKFRELIIEFSKMAR 278 (327)
T ss_dssp CCHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHh
Confidence 999999999887653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=293.33 Aligned_cols=222 Identities=19% Similarity=0.199 Sum_probs=182.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++
T Consensus 64 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~ 140 (350)
T 1rdq_E 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSE 140 (350)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HCCCCH
T ss_pred CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH---cCCCCH
Confidence 479999999986432 23457788999999999999999999999999999999999999999999843 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||.|||+.| ++||||||+||+++.+|.+||+|||++...... .....|++.|+|||++.+
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcC
Confidence 999999999999999999999 999999999999999999999999999865432 233578999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|+|||||++|+|++|..||..... .........+.. . .+...+.++.++|.+||..
T Consensus 213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~--~---------~p~~~~~~~~~li~~lL~~ 275 (350)
T 1rdq_E 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV--R---------FPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--C---------CCTTCCHHHHHHHHHHSCS
T ss_pred CCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCC--C---------CCCCCCHHHHHHHHHHhhc
Confidence 8999999999999999999999999954321 111111112111 1 1112234788999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 045452 241 NPNDRPS-----MLEVSS 253 (303)
Q Consensus 241 dp~~Rps-----~~~l~~ 253 (303)
||++||+ ++++++
T Consensus 276 dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 276 DLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHhccCCccCCHHHHHh
Confidence 9999998 788864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.60 Aligned_cols=227 Identities=21% Similarity=0.319 Sum_probs=179.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++.. .....+.+.+|+.+++++ +||||+++++++.+....++||||+.+|+|..++. ....++
T Consensus 32 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~l~ 108 (345)
T 3a8x_A 32 KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 108 (345)
T ss_dssp TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 57899999999654 334566788999999988 89999999999999999999999999999999884 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| ++||||||+||+++.+|.+||+|||++...... .......+|++.|+|||++.
T Consensus 109 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 183 (345)
T 3a8x_A 109 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILR 183 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC--CCcccccCCCccccCccccC
Confidence 9999999999999999999998 999999999999999999999999998753221 12233457899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccc--cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+..++.++|+|||||++|+|++|..||......... .............. . ..+...+.++.++|.+|
T Consensus 184 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~---------~~p~~~s~~~~~li~~l 253 (345)
T 3a8x_A 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-I---------RIPRSLSVKAASVLKSF 253 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-C---------CCCTTSCHHHHHHHHHH
T ss_pred CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-C---------CCCCCCCHHHHHHHHHH
Confidence 989999999999999999999999999653322111 11111111111110 0 11122334788999999
Q ss_pred ccCCCCCCCCH
Q 045452 238 VQENPNDRPSM 248 (303)
Q Consensus 238 l~~dp~~Rps~ 248 (303)
|..||++||++
T Consensus 254 L~~dP~~R~~~ 264 (345)
T 3a8x_A 254 LNKDPKERLGC 264 (345)
T ss_dssp TCSSTTTSTTC
T ss_pred hcCCHhHCCCC
Confidence 99999999996
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=283.52 Aligned_cols=239 Identities=18% Similarity=0.192 Sum_probs=179.4
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++.. ...+++
T Consensus 57 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 133 (309)
T 2h34_A 57 VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR---QGPLAP 133 (309)
T ss_dssp TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH---HCSCCH
T ss_pred CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh---cCCCCH
Confidence 47899999999654 233457889999999999999999999999999999999999999999999843 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ .......++..|+|||.+.+
T Consensus 134 ~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 134 PRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcC
Confidence 999999999999999999998 99999999999999999999999999876543321 12223468899999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||..... ............. . ...+...+.++.++|.+||..
T Consensus 210 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~--~-----~~~~~~~~~~l~~li~~~l~~ 275 (309)
T 2h34_A 210 SHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPR--P-----STVRPGIPVAFDAVIARGMAK 275 (309)
T ss_dssp ----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCC--G-----GGTSTTCCTHHHHHHHHHTCS
T ss_pred CCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCC--c-----cccCCCCCHHHHHHHHHhccC
Confidence 8899999999999999999999999853221 1111111111100 0 011111223688999999999
Q ss_pred CCCCCC-CHHHHHHhhccCCCCCC
Q 045452 241 NPNDRP-SMLEVSSMLKNETTNTN 263 (303)
Q Consensus 241 dp~~Rp-s~~~l~~~L~~~~~~~~ 263 (303)
||++|| +++++++.|++......
T Consensus 276 dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 276 NPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp SGGGSCSSHHHHHHHHHHTCC---
T ss_pred CHHHHHHhHHHHHHHHHHHHHhhc
Confidence 999999 99999999998775543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=304.42 Aligned_cols=229 Identities=28% Similarity=0.417 Sum_probs=184.2
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-eeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.|+.||||+++... ..+.+.+|+.++++++||||+++++++.... ..++||||+.+|+|.+++... ....+++..+
T Consensus 215 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~ 291 (450)
T 1k9a_A 215 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 291 (450)
T ss_dssp TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-CTTTCCHHHH
T ss_pred cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-CCCCCCHHHH
Confidence 47899999997653 4577899999999999999999999987765 789999999999999999642 2234789999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...... .....++..|+|||.+.+..+
T Consensus 292 ~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~ 363 (450)
T 1k9a_A 292 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF 363 (450)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCC
Confidence 999999999999999998 999999999999999999999999998754321 112346789999999999999
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++||||||+++|+|++ |..||......... . ....+... ..+...+.++.+||.+||..||
T Consensus 364 ~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~----~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dp 427 (450)
T 1k9a_A 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P----RVEKGYKM---------DAPDGCPPAVYDVMKNCWHLDA 427 (450)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCCCC---------CCCCcCCHHHHHHHHHHcCCCh
Confidence 999999999999999998 99998644332211 1 11111111 1122234578899999999999
Q ss_pred CCCCCHHHHHHhhccCCC
Q 045452 243 NDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~~ 260 (303)
++|||+.++++.|++...
T Consensus 428 ~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 428 ATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHHH
Confidence 999999999999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=291.14 Aligned_cols=233 Identities=21% Similarity=0.256 Sum_probs=163.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++... ....+.+|+.+++.++ ||||+++++++.+....++||||+++++|.+++.. ...+++..
T Consensus 34 ~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~ 107 (325)
T 3kn6_A 34 KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK---KKHFSETE 107 (325)
T ss_dssp TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---CSCCCHHH
T ss_pred CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh---cCCCCHHH
Confidence 57899999999643 3456778999999996 99999999999999999999999999999999843 45699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~---~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.||+.||+|||+.| ++||||||+||+++.++ .+||+|||++....... .......++..|+|||++.
T Consensus 108 ~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~ 182 (325)
T 3kn6_A 108 ASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLN 182 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------
T ss_pred HHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCCCcCccCHHHhc
Confidence 9999999999999999998 99999999999997765 79999999997654322 1223356799999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||.....................+... .... .....+.++.+||.+||.
T Consensus 183 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~-----~~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-FEGE-----AWKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-CCSH-----HHHTSCHHHHHHHHHHHC
T ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-CCcc-----cccCCCHHHHHHHHHHCC
Confidence 9999999999999999999999999997544322222222222222211110 0000 001123478899999999
Q ss_pred CCCCCCCCHHHHHH
Q 045452 240 ENPNDRPSMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~~l~~ 253 (303)
.||++|||+.++++
T Consensus 257 ~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 257 VDPNKRLKMSGLRY 270 (325)
T ss_dssp CCTTTCCCTTTSTT
T ss_pred CChhHCCCHHHHhc
Confidence 99999999999873
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=290.47 Aligned_cols=231 Identities=20% Similarity=0.284 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++... ......+.+|+.+++.+ +||||+++++++.+....++||||+.+++|.+++... ....+++
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~ 130 (327)
T 3lm5_A 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSE 130 (327)
T ss_dssp TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCH
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCH
Confidence 479999999986542 33467889999999999 5699999999999999999999999999999988542 2456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
..++.++.||+.||+|||+.| ++||||||+||+++. ++.+||+|||++....... ......|++.|+|||+
T Consensus 131 ~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 204 (327)
T 3lm5_A 131 NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEI 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCee
Confidence 999999999999999999998 999999999999998 7899999999998664322 1223568999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+.+..++.++||||||+++|+|++|..||....... ........... .........+..+.++|.+|
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~~ 271 (327)
T 3lm5_A 205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQVNVD-------YSEETFSSVSQLATDFIQSL 271 (327)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC-------CCTTTTTTSCHHHHHHHHHH
T ss_pred ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhcccc-------cCchhhcccCHHHHHHHHHH
Confidence 999999999999999999999999999995432111 11111111100 00111112234688999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|..||++|||++++++.
T Consensus 272 L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 272 LVKNPEKRPTAEICLSH 288 (327)
T ss_dssp SCSSGGGSCCHHHHTTC
T ss_pred cCCChhhCcCHHHHhCC
Confidence 99999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=283.33 Aligned_cols=238 Identities=29% Similarity=0.425 Sum_probs=174.6
Q ss_pred CCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 6 g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
...||+|+++.. .....+.+.+|+.++++++|+||+++++++ .....++||||+.+++|.+++.. ....+++..+
T Consensus 46 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 122 (289)
T 3og7_A 46 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKL 122 (289)
T ss_dssp SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT--C---CCHHHH
T ss_pred cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh--ccCCCCHHHH
Confidence 446999998654 345567899999999999999999999965 55678999999999999998854 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc---c
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---Q 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~ 160 (303)
+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++................|+..|+|||.+. +
T Consensus 123 ~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 199 (289)
T 3og7_A 123 IDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199 (289)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----
T ss_pred HHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCC
Confidence 999999999999999998 9999999999999999999999999987654332223333456899999999886 5
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||....... ................ ......+..+.+||.+||..
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~ 268 (289)
T 3og7_A 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDLS-----KVRSNCPKRMKRLMAECLKK 268 (289)
T ss_dssp CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCTT-----SSCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcchh-----hccccCCHHHHHHHHHHccC
Confidence 567889999999999999999999996433211 1111111111111000 11112234788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~ 260 (303)
||.+|||+.++++.|++...
T Consensus 269 ~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 269 KRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SGGGSCCHHHHHHHHHHTTC
T ss_pred ChhhCCCHHHHHHHHHHHhh
Confidence 99999999999999988653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=284.17 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=182.9
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
.++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+++++|.+++........++...++
T Consensus 30 ~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (307)
T 2eva_A 30 RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 105 (307)
T ss_dssp TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHH
T ss_pred CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHH
Confidence 4788999999643 34578899999999999999999999876 4589999999999999999764444457899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-EEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~-~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
.++.|++.||+|||+.+..+++||||||+||+++.++. +||+|||++...... .....|+..|+|||.+.+..+
T Consensus 106 ~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 180 (307)
T 2eva_A 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNY 180 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCC
Confidence 99999999999999943334999999999999988886 799999998755322 122357999999999999899
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++||||||+++|+|++|..||....... ....... ........ ....+..+.+++.+||..||+
T Consensus 181 ~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~ 246 (307)
T 2eva_A 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAV-HNGTRPPL---------IKNLPKPIESLMTRCWSKDPS 246 (307)
T ss_dssp CTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHH-HTTCCCCC---------BTTCCHHHHHHHHHHTCSSGG
T ss_pred CcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHH-hcCCCCCc---------ccccCHHHHHHHHHHhcCChh
Confidence 999999999999999999999986432211 1111111 11111111 111234688999999999999
Q ss_pred CCCCHHHHHHhhccCCCCCCCCCCC
Q 045452 244 DRPSMLEVSSMLKNETTNTNTPKKP 268 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~~~~~~~~~~~ 268 (303)
+|||+.++++.|++..........|
T Consensus 247 ~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 247 QRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp GSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred hCcCHHHHHHHHHHHHHhccCCCCc
Confidence 9999999999999877655554443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=288.28 Aligned_cols=233 Identities=29% Similarity=0.426 Sum_probs=189.1
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+|+.||+|.++.. ....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++... ....+++..++
T Consensus 37 ~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~ 114 (288)
T 3kfa_A 37 YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLL 114 (288)
T ss_dssp GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHH
T ss_pred CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHH
Confidence 5889999999654 345678899999999999999999999999999999999999999999998542 34568999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.||++||+.| ++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++
T Consensus 115 ~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 190 (288)
T 3kfa_A 115 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFS 190 (288)
T ss_dssp HHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCC
Confidence 99999999999999999 99999999999999999999999999987654332 222234567889999999988999
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++||||||+++|+|++ |..||......... ......... ..+...+..+.+++.+||..||.
T Consensus 191 ~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~ 254 (288)
T 3kfa_A 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDYRM---------ERPEGCPEKVYELMRACWQWNPS 254 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhccCCC---------CCCCCCCHHHHHHHHHHhCCChh
Confidence 99999999999999999 88998643322211 111111111 11122234788999999999999
Q ss_pred CCCCHHHHHHhhccCC
Q 045452 244 DRPSMLEVSSMLKNET 259 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~~ 259 (303)
+|||+.++++.|++..
T Consensus 255 ~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 255 DRPSFAEIHQAFETMF 270 (288)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=289.01 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=181.6
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---cccCCC
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---RRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~ 79 (303)
.+|+.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||+. ++|.+++.... ....++
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~ 106 (317)
T 2pmi_A 28 TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLE 106 (317)
T ss_dssp SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCC
T ss_pred CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCC
Confidence 478999999986543 3345678899999999999999999999999999999999997 58988875421 124589
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.
T Consensus 107 ~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~ 181 (317)
T 2pmi_A 107 LNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLM 181 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhh
Confidence 9999999999999999999998 9999999999999999999999999997654321 1122346799999999987
Q ss_pred c-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc---c------c-----------ccccc
Q 045452 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM---E------F-----------VDSFL 218 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~-----------~~~~~ 218 (303)
+ ..++.++|||||||++|+|++|..||........ .............. . . .....
T Consensus 182 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (317)
T 2pmi_A 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVL 258 (317)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhh
Confidence 6 4689999999999999999999999964432211 11111111100000 0 0 00000
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
........+.++.+||.+||..||++|||+.++++.
T Consensus 259 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 259 QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000111223478899999999999999999999853
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=285.41 Aligned_cols=238 Identities=25% Similarity=0.302 Sum_probs=178.2
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCcceeEEEEEEeC----CeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
+|+.||||++... ....+..|.+++.. ++||||+++++++... ...++||||+++|+|.+++. ...+
T Consensus 30 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~ 102 (301)
T 3q4u_A 30 QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTL 102 (301)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT----TCCB
T ss_pred CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh----hccc
Confidence 6889999998654 23445556666665 7999999999997653 45899999999999999993 3469
Q ss_pred CHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeec
Q 045452 79 DWKKRVHIIEGITQGLLYLQ--------EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVG 148 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~ 148 (303)
++..++.++.||+.||+||| +.+ ++||||||+||+++.++.+||+|||++......... .......|
T Consensus 103 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 179 (301)
T 3q4u_A 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179 (301)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccc
Confidence 99999999999999999999 777 999999999999999999999999999765433221 11223468
Q ss_pred cccccCchhcccC------CCCCcccchhhHHHHHHHHhC----------CCCccccCCCccccHHHHHHHHhh-CCCcc
Q 045452 149 TIGYIPPEYARQG------VYSTKSDVFSFGVLLLQIISG----------KRLSMLCGINENLSILEHAYELWK-GGKGM 211 (303)
Q Consensus 149 ~~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 211 (303)
+..|+|||.+.+. .++.++|||||||++|+|++| ..||.......... ........ .....
T Consensus 180 t~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~--~~~~~~~~~~~~~~ 257 (301)
T 3q4u_A 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF--EDMRKVVCVDQQRP 257 (301)
T ss_dssp CGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH--HHHHHHHTTSCCCC
T ss_pred ccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch--hhhhHHHhccCCCC
Confidence 9999999998776 345689999999999999999 77775433222111 11111111 11111
Q ss_pred ccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 212 EFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
.... .......+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus 258 ~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 258 NIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111 112233456899999999999999999999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=285.23 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+.+ +|.+++.. ....+++.
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~ 100 (288)
T 1ob3_A 24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV--CEGGLESV 100 (288)
T ss_dssp TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT--STTCCCHH
T ss_pred CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh--cccCCCHH
Confidence 5789999999865432 2346788999999999999999999999999999999999975 88888754 23568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+.
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 175 (288)
T 1ob3_A 101 TAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGS 175 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccccccccccccCchheeCC
Confidence 99999999999999999998 9999999999999999999999999987654321 112234679999999998654
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc--------ccccc-------cCCCChH
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF--------VDSFL-------DDRNSSC 225 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-------~~~~~~~ 225 (303)
.++.++|||||||++|+|++|..||...... .................. .+... .......
T Consensus 176 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T 1ob3_A 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKG 252 (288)
T ss_dssp CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCS
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhh
Confidence 5899999999999999999999999643321 111211111111100000 00000 0011112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+.++.+||.+||..||++|||+.++++.
T Consensus 253 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 253 LDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 34578899999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=278.81 Aligned_cols=230 Identities=24% Similarity=0.347 Sum_probs=183.7
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....+++..
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 106 (276)
T 2yex_A 30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPD 106 (276)
T ss_dssp TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHH
T ss_pred CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh---hccCCCHHH
Confidence 47899999998643 33456788999999999999999999999999999999999999999999984 345689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..
T Consensus 107 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (276)
T 2yex_A 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSS
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCC
Confidence 9999999999999999998 9999999999999999999999999997654332222233456899999999998766
Q ss_pred C-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 Y-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
+ +.++||||||+++|+|++|..||........ . ...+....... ......+..+.++|.+||..|
T Consensus 184 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~ 249 (276)
T 2yex_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTYL--------NPWKKIDSAPLALLHKILVEN 249 (276)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H----HHHHHTTCTTS--------TTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHhhhccccc--------CchhhcCHHHHHHHHHHCCCC
Confidence 4 6789999999999999999999965432211 1 11111111000 011122347889999999999
Q ss_pred CCCCCCHHHHHH
Q 045452 242 PNDRPSMLEVSS 253 (303)
Q Consensus 242 p~~Rps~~~l~~ 253 (303)
|++|||+.++++
T Consensus 250 p~~Rps~~~il~ 261 (276)
T 2yex_A 250 PSARITIPDIKK 261 (276)
T ss_dssp TTTSCCHHHHTT
T ss_pred chhCCCHHHHhc
Confidence 999999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.77 Aligned_cols=229 Identities=22% Similarity=0.347 Sum_probs=185.4
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....+++
T Consensus 39 ~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~ 115 (476)
T 2y94_A 39 LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC---KNGRLDE 115 (476)
T ss_dssp TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT---SSSSCCH
T ss_pred CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 479999999996442 2345678999999999999999999999999999999999999999999984 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .....+|++.|+|||++.+
T Consensus 116 ~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccC
Confidence 999999999999999999998 9999999999999999999999999998764422 2233568999999999988
Q ss_pred CCC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..+ +.++|||||||++|+|++|..||....... .......+.. ..+...+.++.+||.+||.
T Consensus 190 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~-----------~~p~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICDGIF-----------YTPQYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHHTTCC-----------CCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCCc-----------CCCccCCHHHHHHHHHHcC
Confidence 765 679999999999999999999996432211 1111111110 0111123478899999999
Q ss_pred CCCCCCCCHHHHHH--hhccC
Q 045452 240 ENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 240 ~dp~~Rps~~~l~~--~L~~~ 258 (303)
.||++|||+.++++ ++.+.
T Consensus 253 ~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 253 VDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp SSTTTSCCHHHHHTCHHHHTT
T ss_pred CCchhCcCHHHHHhCHHhhhc
Confidence 99999999999986 46553
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=286.48 Aligned_cols=234 Identities=28% Similarity=0.427 Sum_probs=187.1
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
..+++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....+++|||+++++|.+++.. ....+++..
T Consensus 29 ~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~ 105 (267)
T 3t9t_A 29 WLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAET 105 (267)
T ss_dssp ETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH--TTTCCCHHH
T ss_pred ecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh--CcccCCHHH
Confidence 45788999999965433 346789999999999999999999999999999999999999999999854 234589999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||++||+.| ++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..
T Consensus 106 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 181 (267)
T 3t9t_A 106 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 181 (267)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccChhhhcCCC
Confidence 9999999999999999999 99999999999999999999999999876543211 1112234577899999999888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||||+++|+|++ |..||...... ..... ...... ...+...+..+.+++.+||..|
T Consensus 182 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~-i~~~~~---------~~~~~~~~~~l~~li~~~l~~~ 245 (267)
T 3t9t_A 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVED-ISTGFR---------LYKPRLASTHVYQIMNHCWRER 245 (267)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH-HHTTCC---------CCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHH-HhcCCc---------CCCCccCcHHHHHHHHHHccCC
Confidence 9999999999999999999 89998533211 11111 111111 1111222347889999999999
Q ss_pred CCCCCCHHHHHHhhccCC
Q 045452 242 PNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~ 259 (303)
|++|||+.++++.|++..
T Consensus 246 p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 246 PEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=286.87 Aligned_cols=232 Identities=21% Similarity=0.338 Sum_probs=174.8
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+..||+|.++.. .....+.+.+|+..+++++||||+++++++ ..+..++||||+.+++|.+++.. ....+++..+
T Consensus 42 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 118 (281)
T 1mp8_A 42 PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQV--RKYSLDLASL 118 (281)
T ss_dssp CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHH
T ss_pred CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHh--cCCCCCHHHH
Confidence 3567999998754 344567899999999999999999999998 45678999999999999999853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..+
T Consensus 119 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 119 ILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCC
Confidence 999999999999999998 999999999999999999999999999776443211 1222345778999999998889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++||||||+++|+|++ |..||........ .. .. ....... .+...+..+.+++.+||..||
T Consensus 195 ~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~---~i-~~~~~~~---------~~~~~~~~l~~li~~~l~~~p 258 (281)
T 1mp8_A 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---RI-ENGERLP---------MPPNCPPTLYSLMTKCWAYDP 258 (281)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---HH-HTTCCCC---------CCTTCCHHHHHHHHHHTCSSG
T ss_pred CCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH---HH-HcCCCCC---------CCCCCCHHHHHHHHHHccCCh
Confidence 999999999999999996 8899864332221 11 11 1111111 112233578899999999999
Q ss_pred CCCCCHHHHHHhhccCC
Q 045452 243 NDRPSMLEVSSMLKNET 259 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~ 259 (303)
++|||+.++++.|++..
T Consensus 259 ~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 259 SRRPRFTELKAQLSTIL 275 (281)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=290.22 Aligned_cols=236 Identities=24% Similarity=0.309 Sum_probs=175.8
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe----eeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----RMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||+++.. .......+.+|+.++++++||||+++++++..... .++||||+++++|.+++. ...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~ 111 (311)
T 3ork_A 35 RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEG 111 (311)
T ss_dssp TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH---HHC
T ss_pred CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH---hcC
Confidence 67899999999754 33455688999999999999999999999876543 499999999999999984 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aP 155 (303)
.+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..+...... .......|+..|+||
T Consensus 112 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 112 PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188 (311)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCH
Confidence 6899999999999999999999998 999999999999999999999999999766433211 222335689999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++||||||+++|+|++|..||..... ............... ... ....+.++.++|.
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~---~~~----~~~~~~~l~~li~ 255 (311)
T 3ork_A 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP---SAR----HEGLSADLDAVVL 255 (311)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCH---HHH----STTCCHHHHHHHH
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCc---ccc----cCCCCHHHHHHHH
Confidence 999999999999999999999999999999953321 111122222211110 000 0112346889999
Q ss_pred hcccCCCCCCCCHHHH-HHhhccC
Q 045452 236 LCVQENPNDRPSMLEV-SSMLKNE 258 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l-~~~L~~~ 258 (303)
+||+.||++||++.++ ...|...
T Consensus 256 ~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 256 KALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHhcCHhhChhhHHHHHHHHHHH
Confidence 9999999999966555 4445544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=290.09 Aligned_cols=225 Identities=22% Similarity=0.263 Sum_probs=172.6
Q ss_pred CCCCEEEEEEccCCC----hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++. ....++
T Consensus 43 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~ 119 (327)
T 3a62_A 43 NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFM 119 (327)
T ss_dssp TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH---HHSSCC
T ss_pred CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH---hCCCCC
Confidence 589999999997542 2345667889999999999999999999999999999999999999999984 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++....... .......|+..|+|||++.
T Consensus 120 ~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 194 (327)
T 3a62_A 120 EDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILM 194 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCc
Confidence 9999999999999999999998 9999999999999999999999999987543221 1122346899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++||||||+++|+|++|..||...... ........... ..+...+.++.++|.+||.
T Consensus 195 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~-----------~~p~~~~~~~~~li~~~L~ 257 (327)
T 3a62_A 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCKL-----------NLPPYLTQEARDLLKKLLK 257 (327)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHHh
Confidence 888999999999999999999999999543211 11111121111 1112233478899999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 045452 240 ENPNDRP-----SMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rp-----s~~~l~~ 253 (303)
.||++|| ++.++++
T Consensus 258 ~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 258 RNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp SCGGGSTTSSTTTHHHHHH
T ss_pred cCHhhccCCCCCCHHHHHc
Confidence 9999999 6777765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=291.61 Aligned_cols=238 Identities=26% Similarity=0.404 Sum_probs=178.4
Q ss_pred CCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhcCc---Cc
Q 045452 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDP---IR 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~---~~ 74 (303)
+++.||+|.++.. .....+.+.+|+.++++++||||+++++++.... ..++||||+.+++|.+++... ..
T Consensus 61 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~ 140 (313)
T 3brb_A 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140 (313)
T ss_dssp CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTS
T ss_pred ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcC
Confidence 4568999999754 3445678999999999999999999999998754 359999999999999988431 23
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..++.++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++................++..|+|
T Consensus 141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 217 (313)
T 3brb_A 141 PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217 (313)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence 456899999999999999999999998 99999999999999999999999999977654332233333456789999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+..++.++||||||+++|+|++ |..||....... ... . ........ .+...+.++.++
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~-~~~~~~~~---------~~~~~~~~l~~l 281 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD---Y-LLHGHRLK---------QPEDCLDELYEI 281 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH---H-HHTTCCCC---------CBTTCCHHHHHH
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH---H-HHcCCCCC---------CCccccHHHHHH
Confidence 999999899999999999999999999 888885433221 111 1 11111111 111223478899
Q ss_pred HHhcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 234 ALLCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
|.+||..||.+|||+.++++.|++....
T Consensus 282 i~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 282 MYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999886543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=294.84 Aligned_cols=231 Identities=23% Similarity=0.379 Sum_probs=176.7
Q ss_pred EEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHH
Q 045452 9 IAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87 (303)
Q Consensus 9 vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 87 (303)
||+|.++.. .....+.+.+|+.++++++||||+++++++..+. .+++++|+.+++|.+++.. ....+++..++.++
T Consensus 47 v~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~ 123 (327)
T 3lzb_A 47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWC 123 (327)
T ss_dssp EEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHH
T ss_pred EEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHH
Confidence 577777543 3446678999999999999999999999998654 7899999999999999854 24568999999999
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcc
Q 045452 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKS 167 (303)
Q Consensus 88 ~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 167 (303)
.||+.||+|||+.| ++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++
T Consensus 124 ~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 200 (327)
T 3lzb_A 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200 (327)
T ss_dssp HHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHH
Confidence 99999999999999 999999999999999999999999999876544333333334567899999999999999999
Q ss_pred cchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCC
Q 045452 168 DVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRP 246 (303)
Q Consensus 168 DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 246 (303)
|||||||++|+|++ |..||........ . ........ ...+...+.++.++|.+||..||.+||
T Consensus 201 Di~slG~il~ell~~g~~p~~~~~~~~~----~---~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rp 264 (327)
T 3lzb_A 201 DVWSYGVTVWELMTFGSKPYDGIPASEI----S---SILEKGER---------LPQPPICTIDVYMIMRKCWMIDADSRP 264 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCGGGH----H---HHHHTTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHH----H---HHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999999999 9999864332221 1 11111111 111222334788999999999999999
Q ss_pred CHHHHHHhhccCCCC
Q 045452 247 SMLEVSSMLKNETTN 261 (303)
Q Consensus 247 s~~~l~~~L~~~~~~ 261 (303)
|+.++++.|+.....
T Consensus 265 s~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 265 KFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHHHhC
Confidence 999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=294.93 Aligned_cols=249 Identities=18% Similarity=0.247 Sum_probs=193.0
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--eeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++||||+.+++|.+++........+++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 111 (396)
T 4eut_A 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111 (396)
T ss_dssp TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCH
T ss_pred CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCH
Confidence 468999999997543 344677889999999999999999999998765 77999999999999999976444445999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~----~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
..++.++.||+.||+|||+.| ++||||||+||++ +.++.+||+|||++....... ......|+..|+|||
T Consensus 112 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 185 (396)
T 4eut_A 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHH
Confidence 999999999999999999999 9999999999999 788889999999997664332 122346899999999
Q ss_pred hccc--------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccc-------------ccc
Q 045452 157 YARQ--------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGME-------------FVD 215 (303)
Q Consensus 157 ~~~~--------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~ 215 (303)
++.+ ..++.++|||||||++|+|++|..||............. .....+..... +..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~~~~~~~ 263 (396)
T 4eut_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM--YKIITGKPSGAISGVQKAENGPIDWSG 263 (396)
T ss_dssp HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH--HHHHHSCCTTCCEEEECSTTCCEEEES
T ss_pred HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH--HHHhcCCCcccchhheeccCCCcccCc
Confidence 8865 456789999999999999999999997544433222222 12222211100 000
Q ss_pred c-cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 216 S-FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 216 ~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
. .............+.+++.+||..||++|||+.++++.+.+...
T Consensus 264 ~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 0 11123345667789999999999999999999999888877554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=288.24 Aligned_cols=243 Identities=31% Similarity=0.449 Sum_probs=187.9
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
..+++.||+|.++... ...+.+.+|+.++++++||||+++++++. .+..++||||+.+++|.+++... ....+++..
T Consensus 34 ~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~ 110 (279)
T 1qpc_A 34 YNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTINK 110 (279)
T ss_dssp ETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH-HHHTCCHHH
T ss_pred EcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC-CCCCCCHHH
Confidence 4567899999996543 34578899999999999999999999986 45689999999999999998542 223689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||++||+.| ++||||||+||+++.++.+||+|||.+......... ......++..|+|||.+.+..
T Consensus 111 ~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 186 (279)
T 1qpc_A 111 LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGT 186 (279)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCC
Confidence 9999999999999999998 999999999999999999999999999876543221 112234577899999998888
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||||+++|+|++ |..||...... .. .......... ..+...+..+.+++.+||..|
T Consensus 187 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~ 250 (279)
T 1qpc_A 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EV-IQNLERGYRM---------VRPDNCPEELYQLMRLCWKER 250 (279)
T ss_dssp ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HH-HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HH-HHHHhcccCC---------CCcccccHHHHHHHHHHhccC
Confidence 8999999999999999999 89998533211 11 1111111111 111223357889999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCCCCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNTNTPKKP 268 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~~~~~~~ 268 (303)
|++|||+.++++.|++.......+..|
T Consensus 251 p~~Rps~~~l~~~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 251 PEDRPTFDYLRSVLEDFFTATEGQYQP 277 (279)
T ss_dssp GGGSCCHHHHHHHHHHHHHHC------
T ss_pred hhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence 999999999999999987665554443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.85 Aligned_cols=238 Identities=29% Similarity=0.413 Sum_probs=189.2
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCC-eeeEEEeeCCCCChhhhhcCcCc------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~------ 74 (303)
.+|+.||||+++... ....+.+.+|+.+++++ +||||+++++++...+ ..++||||+++++|.+++.....
T Consensus 55 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (316)
T 2xir_A 55 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134 (316)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-
T ss_pred ccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccccc
Confidence 577899999997653 34557889999999999 7999999999988755 58999999999999999865322
Q ss_pred -------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee
Q 045452 75 -------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 75 -------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
...+++..++.++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++................
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 211 (316)
T 2xir_A 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211 (316)
T ss_dssp ------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred ccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCC
Confidence 123789999999999999999999998 9999999999999999999999999998765443333334456
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ......... ..+...
T Consensus 212 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~~~~~~~~~---------~~~~~~ 276 (316)
T 2xir_A 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FC---RRLKEGTRM---------RAPDYT 276 (316)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---HH---HHHHHTCCC---------CCCTTC
T ss_pred cceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH---HH---HHhccCccC---------CCCCCC
Confidence 7889999999998899999999999999999998 9999854432211 11 111111111 111122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
+..+.++|.+||+.||.+|||+.++++.|++..
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 347889999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=293.52 Aligned_cols=230 Identities=20% Similarity=0.245 Sum_probs=172.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhc-CCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAK-LQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ...+|+||||+.+|+|.+++... ....+
T Consensus 85 ~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~l 158 (400)
T 1nxk_A 85 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAF 158 (400)
T ss_dssp TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CC
T ss_pred CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh-CCCCC
Confidence 57899999999632 356678887754 599999999999876 55789999999999999999652 23458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccccccceeeccccccCc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
++..+..++.||+.||.|||+.| |+||||||+|||++. ++.+||+|||++....... .....+|+..|+||
T Consensus 159 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 159 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232 (400)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCH
Confidence 99999999999999999999998 999999999999997 7889999999997654321 22345689999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|++.+..++.++|||||||++|+|++|..||................. .+... .. .......+.++.+||.
T Consensus 233 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--~~~~~--~~-----~~~~~~~s~~~~~li~ 303 (400)
T 1nxk_A 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--MGQYE--FP-----NPEWSEVSEEVKMLIR 303 (400)
T ss_dssp GGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH--HTCCC--CC-----TTTTTTSCHHHHHHHH
T ss_pred hhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH--cCccc--CC-----CcccccCCHHHHHHHH
Confidence 999999999999999999999999999999965443322111111111 11100 00 0001122347889999
Q ss_pred hcccCCCCCCCCHHHHHHh
Q 045452 236 LCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~ 254 (303)
+||..||++|||+.++++.
T Consensus 304 ~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 304 NLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.40 Aligned_cols=239 Identities=22% Similarity=0.267 Sum_probs=179.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||+++.......+.+.+|+.++.++ +||||+++++++.+.+..++||||+.+++|.+++.. ...+++..
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~ 112 (316)
T 2ac3_A 36 ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELE 112 (316)
T ss_dssp SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---HSSCCHHH
T ss_pred CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc---cCCCCHHH
Confidence 57899999999766656678899999999985 899999999999999999999999999999999843 45689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEeccccccccccccc-----ccccceeeccccccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESL-----KANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~---~kl~df~~~~~~~~~~~-----~~~~~~~~~~~~y~a 154 (303)
++.++.||+.||+|||+.+ ++||||||+||+++.++. +||+|||++........ ........|+..|+|
T Consensus 113 ~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 189 (316)
T 2ac3_A 113 ASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCC
T ss_pred HHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccC
Confidence 9999999999999999998 999999999999998776 99999999876532211 111223458999999
Q ss_pred chhccc-----CCCCCcccchhhHHHHHHHHhCCCCccccCCCccc-cH-------HHHHHHHhhCCCccccccccccCC
Q 045452 155 PEYARQ-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL-SI-------LEHAYELWKGGKGMEFVDSFLDDR 221 (303)
Q Consensus 155 PE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
||++.+ ..++.++|||||||++|+|++|..||......... .. ............ ........
T Consensus 190 PE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~--- 265 (316)
T 2ac3_A 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK-YEFPDKDW--- 265 (316)
T ss_dssp HHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC-CCCCHHHH---
T ss_pred hHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC-cccCchhc---
Confidence 999865 45788999999999999999999999654332200 00 011111111110 00000000
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
...+.++.+||.+||..||++|||+.++++.
T Consensus 266 --~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 266 --AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp --TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0123468899999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=296.09 Aligned_cols=258 Identities=16% Similarity=0.155 Sum_probs=191.1
Q ss_pred CCCEEEEEEccCCChhhH-----------HHHHHHHHHHhcCCCCcceeEEEEEEeC----CeeeEEEeeCCCCChhhhh
Q 045452 5 CGEVIAVKKLSKSSAQGF-----------EEFKNEVMLTAKLQHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l 69 (303)
.++.||||++........ ..+..|+..++.++|+||+++++++... ...++||||+ +++|.+++
T Consensus 64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~ 142 (364)
T 3op5_A 64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY 142 (364)
T ss_dssp TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHH
T ss_pred cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHH
Confidence 478999999876543211 1233466677888999999999999765 4589999999 99999998
Q ss_pred cCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC--CCCcEEEecccccccccccccc-----cc
Q 045452 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLK-----AN 142 (303)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~--~~~~~kl~df~~~~~~~~~~~~-----~~ 142 (303)
.. ....+++..++.++.||+.||+|||+.| ++||||||+|||++ .++.+||+|||++..+...... ..
T Consensus 143 ~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 217 (364)
T 3op5_A 143 EA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217 (364)
T ss_dssp HH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCS
T ss_pred Hh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCc
Confidence 54 2356999999999999999999999998 99999999999999 8899999999999776433211 11
Q ss_pred cceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCC
Q 045452 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRN 222 (303)
Q Consensus 143 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||......... ......... .....+.+..+..
T Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~-- 292 (364)
T 3op5_A 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY--VRDSKIRYR-ENIASLMDKCFPA-- 292 (364)
T ss_dssp SCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH--HHHHHHHHH-HCHHHHHHHHSCT--
T ss_pred ccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH--HHHHHHHhh-hhHHHHHHHhccc--
Confidence 12345899999999999999999999999999999999999999743322111 111111111 1111112211111
Q ss_pred ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCCCCccccc
Q 045452 223 SSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAFSKQV 274 (303)
Q Consensus 223 ~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~~~ 274 (303)
...+.++.+++..||..||.+||++.+|++.|++............+.+..
T Consensus 293 -~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 293 -ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV 343 (364)
T ss_dssp -TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred -ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence 112347889999999999999999999999999988776666655554443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=281.15 Aligned_cols=232 Identities=24% Similarity=0.451 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccCCChh-------hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSSAQ-------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.. ++||||+.+++|.+++.. ...
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~--~~~ 117 (287)
T 4f0f_A 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAH 117 (287)
T ss_dssp TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC--TTS
T ss_pred CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc--ccC
Confidence 57899999998654321 1267889999999999999999999986544 799999999999888754 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-----EEEecccccccccccccccccceeecccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-----PKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~-----~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
.+++..++.++.|++.||+|||+.+ .+++||||||+||+++.++. +||+|||++..... ......|+..
T Consensus 118 ~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~ 191 (287)
T 4f0f_A 118 PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQ 191 (287)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCT
T ss_pred CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCcc
Confidence 6899999999999999999999865 23999999999999988776 99999999875432 2233568999
Q ss_pred ccCchhc--ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 152 YIPPEYA--RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 152 y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
|+|||.+ ....++.++|||||||++|+|++|..||....... ............... .+...+.+
T Consensus 192 y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~---------~~~~~~~~ 258 (287)
T 4f0f_A 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPT---------IPEDCPPR 258 (287)
T ss_dssp TSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHSCCCCC---------CCTTSCHH
T ss_pred ccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhccCCCCC---------CCcccCHH
Confidence 9999998 34557889999999999999999999996433221 111111111111111 12223347
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
+.++|.+||+.||++|||+.++++.|+++
T Consensus 259 l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 259 LRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 88999999999999999999999999763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=291.38 Aligned_cols=230 Identities=23% Similarity=0.394 Sum_probs=179.9
Q ss_pred EEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHH
Q 045452 9 IAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87 (303)
Q Consensus 9 vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 87 (303)
||+|.+.... ....+.+.+|+.++++++||||+++++++. +...++||+|+.+++|.+++... ...+++..++.++
T Consensus 45 v~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ 121 (325)
T 3kex_A 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWG 121 (325)
T ss_dssp EEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHH
T ss_pred EEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHH
Confidence 7888775432 233456778999999999999999999985 56789999999999999998642 4568899999999
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcc
Q 045452 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKS 167 (303)
Q Consensus 88 ~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 167 (303)
.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+.............++..|+|||.+.+..++.++
T Consensus 122 ~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 198 (325)
T 3kex_A 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 198 (325)
T ss_dssp HHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhh
Confidence 99999999999999 999999999999999999999999999877544333333445678899999999988999999
Q ss_pred cchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCC
Q 045452 168 DVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRP 246 (303)
Q Consensus 168 DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 246 (303)
||||||+++|+|++ |..||......... ........... +...+.++.+++.+||..||++||
T Consensus 199 Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rp 262 (325)
T 3kex_A 199 DVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGERLAQ---------PQICTIDVYMVMVKCWMIDENIRP 262 (325)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCBCCC---------CTTBCTTTTHHHHHHTCSCTTTSC
T ss_pred HhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCCCCC---------CCcCcHHHHHHHHHHcCCChhhCc
Confidence 99999999999999 99999644322211 11111111111 111122467999999999999999
Q ss_pred CHHHHHHhhccCCC
Q 045452 247 SMLEVSSMLKNETT 260 (303)
Q Consensus 247 s~~~l~~~L~~~~~ 260 (303)
|+.++++.|+....
T Consensus 263 s~~el~~~l~~~~~ 276 (325)
T 3kex_A 263 TFKELANEFTRMAR 276 (325)
T ss_dssp CHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=313.80 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=192.6
Q ss_pred cCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 2 VLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++.++..||||+++... ...+.|.+|+.++++++|+||+++++++.+ +..++||||+.+|+|.+++... ....+++.
T Consensus 287 ~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~ 363 (535)
T 2h8h_A 287 TWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLP 363 (535)
T ss_dssp EETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH-HHTTCCHH
T ss_pred EECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc-CCCCCCHH
Confidence 45567789999997654 345789999999999999999999999865 6789999999999999999532 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++..+...... ......++..|+|||.+.+.
T Consensus 364 ~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 439 (535)
T 2h8h_A 364 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYG 439 (535)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHHHhccC
Confidence 99999999999999999998 999999999999999999999999999766432211 11123356789999999988
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|||||||++|+|++ |..||...... . .......+.... .+...+..+.+||.+||..
T Consensus 440 ~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~~---------~~~~~~~~l~~li~~cl~~ 503 (535)
T 2h8h_A 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRMP---------CPPECPESLHDLMCQCWRK 503 (535)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------H-HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCC
Confidence 99999999999999999999 89998533211 1 111111111111 1122334788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTNTNTPKKP 268 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 268 (303)
||++|||+++|++.|++..........+
T Consensus 504 dP~~RPt~~~l~~~L~~~~~~~~~~~~~ 531 (535)
T 2h8h_A 504 EPEERPTFEYLQAFLEDYFTSTEPQYQP 531 (535)
T ss_dssp SGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred ChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence 9999999999999999998776655543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=294.10 Aligned_cols=224 Identities=24% Similarity=0.279 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++... ....+.+..|..++..+ +||||+++++++.+....++||||+++|+|.+++. ....++
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 116 (345)
T 1xjd_A 40 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD 116 (345)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 578999999996542 23456778899999876 99999999999999999999999999999999984 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.+|.+||+|||++...... .......+|++.|+|||++.
T Consensus 117 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 191 (345)
T 1xjd_A 117 LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILL 191 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC--CCcccCCCCCcccCChhhhc
Confidence 9999999999999999999998 999999999999999999999999998754322 12233467899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|..||...... ........... ..+...+.++.++|.+||.
T Consensus 192 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~ 254 (345)
T 1xjd_A 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDNP-----------FYPRWLEKEAKDLLVKLFV 254 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCC-----------CCCcccCHHHHHHHHHHhc
Confidence 999999999999999999999999999543211 11111111110 1111223478899999999
Q ss_pred CCCCCCCCHH-HHH
Q 045452 240 ENPNDRPSML-EVS 252 (303)
Q Consensus 240 ~dp~~Rps~~-~l~ 252 (303)
.||++||++. +++
T Consensus 255 ~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 255 REPEKRLGVRGDIR 268 (345)
T ss_dssp SSGGGSBTTBSCGG
T ss_pred CCHhHcCCChHHHH
Confidence 9999999997 664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=288.02 Aligned_cols=245 Identities=16% Similarity=0.141 Sum_probs=185.9
Q ss_pred CCCEEEEEEccCCChh-----------hHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhh
Q 045452 5 CGEVIAVKKLSKSSAQ-----------GFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l 69 (303)
++..||+|++...... ....+.+|+..++.++||||+++++++.. ....++||||+ +++|.+++
T Consensus 64 ~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 142 (345)
T 2v62_A 64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142 (345)
T ss_dssp GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC
T ss_pred ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHH
Confidence 6789999998655321 11235678889999999999999999988 67899999999 99999998
Q ss_pred cCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC--cEEEeccccccccccccc-----ccc
Q 045452 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM--KPKISDFGLARIFAKESL-----KAN 142 (303)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~--~~kl~df~~~~~~~~~~~-----~~~ 142 (303)
.. ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+|||++..+..... ...
T Consensus 143 ~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 216 (345)
T 2v62_A 143 GQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216 (345)
T ss_dssp BG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCG
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcc
Confidence 53 347999999999999999999999998 99999999999998877 999999999977643221 111
Q ss_pred cceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCC
Q 045452 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRN 222 (303)
Q Consensus 143 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||........ .............. ....... .
T Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~---~ 290 (345)
T 2v62_A 217 RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--AVQTAKTNLLDELP-QSVLKWA---P 290 (345)
T ss_dssp GGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--HHHHHHHHHHHTTT-HHHHHHS---C
T ss_pred ccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--HHHHHHHhhccccc-HHHHhhc---c
Confidence 2345689999999999998899999999999999999999999954322211 11111111111110 0000000 0
Q ss_pred ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCC
Q 045452 223 SSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 223 ~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
....+.++.++|.+||..||++|||+.+|++.|++...+.
T Consensus 291 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 291 SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 1122347889999999999999999999999999976544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=282.07 Aligned_cols=228 Identities=23% Similarity=0.317 Sum_probs=182.3
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|++... .....+.+.+|+.++++++||||+++++++......++||||+.+++|.+++. ....+++.
T Consensus 29 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~ 105 (284)
T 3kk8_A 29 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEA 105 (284)
T ss_dssp TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH---hcCCCCHH
Confidence 56899999998643 34556788999999999999999999999999999999999999999988874 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~---~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
.+..++.|++.||.|||+.| ++||||||+||+++.++. +||+|||.+........ .....|+..|+|||.+
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 179 (284)
T 3kk8_A 106 DASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVL 179 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhh
Confidence 99999999999999999999 999999999999986655 99999999976543221 2234689999999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+..++.++||||||+++|+|++|..||...... .............. .......+.++.++|.+||
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l 246 (284)
T 3kk8_A 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYDYP-------SPEWDTVTPEAKSLIDSML 246 (284)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC-------TTTTTTSCHHHHHHHHHHS
T ss_pred cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccccCC-------chhhcccCHHHHHHHHHHc
Confidence 9999999999999999999999999999543211 11111111111000 0011122347889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
+.||++|||+.++++
T Consensus 247 ~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 247 TVNPKKRITADQALK 261 (284)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred ccChhhCCCHHHHhc
Confidence 999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=292.01 Aligned_cols=240 Identities=24% Similarity=0.255 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccCC-----ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc----
Q 045452 4 PCGEVIAVKKLSKS-----SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR---- 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---- 74 (303)
.+|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.....
T Consensus 49 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~ 128 (345)
T 3hko_A 49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128 (345)
T ss_dssp TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTT
T ss_pred CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccc
Confidence 57889999998643 334567899999999999999999999999999999999999999999998842100
Q ss_pred ---------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC
Q 045452 75 ---------------------------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121 (303)
Q Consensus 75 ---------------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~ 121 (303)
...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~ 205 (345)
T 3hko_A 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNK 205 (345)
T ss_dssp EEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCC
Confidence 122467788899999999999999998 99999999999998776
Q ss_pred --cEEEeccccccccccccc--ccccceeeccccccCchhccc--CCCCCcccchhhHHHHHHHHhCCCCccccCCCccc
Q 045452 122 --KPKISDFGLARIFAKESL--KANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 122 --~~kl~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 195 (303)
.+||+|||++..+..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus 206 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--- 282 (345)
T 3hko_A 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA--- 282 (345)
T ss_dssp SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH---
Confidence 899999999976543211 112234568999999999865 56889999999999999999999999543221
Q ss_pred cHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCC
Q 045452 196 SILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
............... ......+..+.+||.+||..||.+|||+.++++ ++++..
T Consensus 283 ---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 283 ---DTISQVLNKKLCFEN-------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp ---HHHHHHHHCCCCTTS-------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred ---HHHHHHHhcccccCC-------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 112222222111110 000112347889999999999999999999986 355443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=291.61 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=178.5
Q ss_pred CCCCEEEEEEccCCChh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+....++||||+. ++|.+++.. ....+++..
T Consensus 25 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~ 101 (324)
T 3mtl_A 25 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD--CGNIINMHN 101 (324)
T ss_dssp TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh--cCCCCCHHH
Confidence 47899999999654322 12245579999999999999999999999999999999996 588888754 244689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-C
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 161 (303)
++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+ .
T Consensus 102 ~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~ 176 (324)
T 3mtl_A 102 VKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGST 176 (324)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCC
Confidence 9999999999999999998 9999999999999999999999999987554321 12223467999999998876 5
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccccccc-----------------CCCCh
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLD-----------------DRNSS 224 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~ 224 (303)
.++.++|||||||++|+|++|..||......+. ............ ......... .....
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (324)
T 3mtl_A 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPT-EETWPGILSNEEFKTYNYPKYRAEALLSHAP 252 (324)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC-TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCT
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCC-hHhchhhhcchhhcccccccccchhhhhhcC
Confidence 689999999999999999999999964432221 111111111110 000000000 00011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCCCCCCC
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNETTNTNT 264 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~~~~~~ 264 (303)
..+.++.+||.+||+.||++|||++++++ ++.+.......
T Consensus 253 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 253 RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294 (324)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred CCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence 12346889999999999999999999986 56665544433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=284.66 Aligned_cols=241 Identities=21% Similarity=0.296 Sum_probs=182.0
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~ 79 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++...+..++||||+.+++|.+++.... ....++
T Consensus 55 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (310)
T 2wqm_A 55 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134 (310)
T ss_dssp TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCC
T ss_pred CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCC
Confidence 57999999998643 34566788999999999999999999999999999999999999999999885421 245689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||.|||+.| ++|+||+|+||+++.++.+||+|||++........ ......++..|+|||.+.
T Consensus 135 ~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 209 (310)
T 2wqm_A 135 ERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIH 209 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhC
Confidence 9999999999999999999998 99999999999999999999999999876543221 122346789999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++||||||+++|+|++|..||...... ....... ......... .....+.++.++|.+||.
T Consensus 210 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~--------~~~~~~~~l~~li~~~l~ 276 (310)
T 2wqm_A 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCDYPPL--------PSDHYSEELRQLVNMCIN 276 (310)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHH-HHTTCSCCC--------CTTTSCHHHHHHHHHHTC
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHH-hhcccCCCC--------cccccCHHHHHHHHHHcC
Confidence 888999999999999999999999998543211 1111111 111111111 111223478899999999
Q ss_pred CCCCCCCCHHHHHHhhccCCCCC
Q 045452 240 ENPNDRPSMLEVSSMLKNETTNT 262 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~~~~~ 262 (303)
.||++|||+.++++.|++.....
T Consensus 277 ~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 277 PDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHHHHhh
Confidence 99999999999999998876433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.71 Aligned_cols=230 Identities=23% Similarity=0.360 Sum_probs=175.8
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCC--CcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
..+|+.||||+++.. .....+.+.+|+.+++.++| +||+++++++......++|||+ .+++|.+++. ....+
T Consensus 30 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~---~~~~~ 105 (343)
T 3dbq_A 30 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSI 105 (343)
T ss_dssp CTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHH---HSCCC
T ss_pred eCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHH---hcCCC
Confidence 467899999998644 34456788999999999976 9999999999999999999995 5889999985 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++..+.............|++.|+|||++
T Consensus 106 ~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 181 (343)
T 3dbq_A 106 DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHH
Confidence 99999999999999999999998 99999999999997 678999999999876544333333445789999999998
Q ss_pred cc-----------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 159 RQ-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 159 ~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
.+ ..++.++|||||||++|+|++|..||.... ................. .+...+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~ 247 (343)
T 3dbq_A 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHEIE---------FPDIPE 247 (343)
T ss_dssp HHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTSCCC---------CCCCSC
T ss_pred hhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCcccC---------CcccCC
Confidence 65 567889999999999999999999995321 12222222222111111 111223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.++.+||.+||..||.+|||+.++++.
T Consensus 248 ~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 248 KDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 468899999999999999999999854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=283.22 Aligned_cols=227 Identities=22% Similarity=0.284 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.++..||+|++........+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++. ....+++..+
T Consensus 32 ~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~ 108 (277)
T 3f3z_A 32 GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDA 108 (277)
T ss_dssp TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHCSCCHHHH
T ss_pred CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH---HcCCCCHHHH
Confidence 4678999999976655667889999999999999999999999999999999999999999998884 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
+.++.|++.||+|||+.| ++|+||||+||++ +.++.++|+|||++..+.... ......++..|+|||.+.+
T Consensus 109 ~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 109 ARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc
Confidence 999999999999999999 9999999999999 788999999999987654332 2233468999999999876
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
. ++.++||||||+++|+|++|..||...... ............. ..... ...+..+.++|.+||+.
T Consensus 183 ~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~li~~~l~~ 248 (277)
T 3f3z_A 183 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTF--PEKDW-----LNVSPQAESLIRRLLTK 248 (277)
T ss_dssp C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC--CHHHH-----TTSCHHHHHHHHHHTCS
T ss_pred c-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC--Cchhh-----hcCCHHHHHHHHHHccC
Confidence 5 899999999999999999999999543211 1111111111100 00000 01134788999999999
Q ss_pred CCCCCCCHHHHHH
Q 045452 241 NPNDRPSMLEVSS 253 (303)
Q Consensus 241 dp~~Rps~~~l~~ 253 (303)
||++|||+.++++
T Consensus 249 dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 249 SPKQRITSLQALE 261 (277)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.08 Aligned_cols=225 Identities=23% Similarity=0.257 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++... ....+.+..|..++..+ +||||+++++++.+....|+||||++||+|.+++. ....++
T Consensus 43 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 119 (353)
T 2i0e_A 43 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK 119 (353)
T ss_dssp TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCC
Confidence 457899999996542 23456788999999988 89999999999999999999999999999999984 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||.|||+.| |+||||||+||+++.+|.+||+|||++...... .......+|++.|+|||++.
T Consensus 120 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 194 (353)
T 2i0e_A 120 EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIA 194 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCccccChhhhc
Confidence 9999999999999999999998 999999999999999999999999998753221 12233467899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|..||...... ........... ..+...+.++.+||.+||.
T Consensus 195 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~ 257 (353)
T 2i0e_A 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHNV-----------AYPKSMSKEAVAICKGLMT 257 (353)
T ss_dssp TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTC
T ss_pred CCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCCC-----------CCCCCCCHHHHHHHHHHhh
Confidence 999999999999999999999999999543211 11111111111 1112234578899999999
Q ss_pred CCCCCCCC-----HHHHHH
Q 045452 240 ENPNDRPS-----MLEVSS 253 (303)
Q Consensus 240 ~dp~~Rps-----~~~l~~ 253 (303)
.||.+||+ ++++++
T Consensus 258 ~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 258 KHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SCTTSCTTCSTTHHHHHHT
T ss_pred cCHHHcCCCCCCCHHHHhc
Confidence 99999995 566653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=277.20 Aligned_cols=231 Identities=21% Similarity=0.319 Sum_probs=183.6
Q ss_pred CCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+. ...++||||+++++|.+++... ....+++
T Consensus 32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 110 (271)
T 3kmu_A 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQ 110 (271)
T ss_dssp TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC-SSCCCCH
T ss_pred CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc-ccCCCCH
Confidence 4889999999754 345567899999999999999999999999877 6889999999999999999652 2335899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.+ ..++||||||+||+++.++.++++|||++..... ....+++.|+|||.+.+
T Consensus 111 ~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 111 SQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQK 182 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhcc
Confidence 999999999999999999764 2499999999999999999999999988654222 22457899999999987
Q ss_pred CCCCC---cccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 161 GVYST---KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 161 ~~~~~---~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
..++. ++||||||+++|+|++|..||.... ................ .+...+.++.+++.+|
T Consensus 183 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~ 247 (271)
T 3kmu_A 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEGLRPT---------IPPGISPHVSKLMKIC 247 (271)
T ss_dssp CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSCCCCC---------CCTTCCHHHHHHHHHH
T ss_pred CCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcCCCCC---------CCCCCCHHHHHHHHHH
Confidence 65554 7999999999999999999985332 1111122222221111 1122334788999999
Q ss_pred ccCCCCCCCCHHHHHHhhccCC
Q 045452 238 VQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~L~~~~ 259 (303)
|..||++|||++++++.|++..
T Consensus 248 l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 248 MNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCChhhCcCHHHHHHHHHHhh
Confidence 9999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=313.68 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=186.8
Q ss_pred CCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
++..||||+++... ....+.+.+|+.++++++||||+++++++.. +..++||||+.+|+|.+++.. ....+++..+
T Consensus 362 ~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~ 438 (613)
T 2ozo_A 362 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNV 438 (613)
T ss_dssp CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT--CTTTSCHHHH
T ss_pred CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh--ccCCCCHHHH
Confidence 56789999997653 3467889999999999999999999999975 578999999999999999854 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCchhcccCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..... ........++..|+|||++.+..
T Consensus 439 ~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~ 515 (613)
T 2ozo_A 439 AELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515 (613)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC
Confidence 999999999999999998 99999999999999999999999999987643221 11112233567899999999899
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|||||||++|+|++ |..||......+ .......+.... .+...+.++.+||.+||..|
T Consensus 516 ~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~d 579 (613)
T 2ozo_A 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME---------CPPECPPELYALMSDCWIYK 579 (613)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHTTCSS
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 999996433221 111112221111 12223357899999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~~~ 264 (303)
|++||++.+|++.|++.......
T Consensus 580 P~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 580 WEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp TTTSCCHHHHHHHHHHHHHHHSC
T ss_pred hhHCcCHHHHHHHHHHHHHHhcc
Confidence 99999999999999987654433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=298.91 Aligned_cols=234 Identities=22% Similarity=0.258 Sum_probs=182.6
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....|+||||++||+|.+++. ...+++
T Consensus 92 ~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~----~~~~~e 167 (410)
T 3v8s_A 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPE 167 (410)
T ss_dssp TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HCCCCH
T ss_pred CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH----cCCCCH
Confidence 478999999986421 1223457889999999999999999999999999999999999999999884 345899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| |+||||||+|||++.+|.+||+|||++..+.... .......+||+.|+|||++.+
T Consensus 168 ~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 168 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhc
Confidence 999999999999999999999 9999999999999999999999999997664332 122334679999999999876
Q ss_pred CC----CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 161 GV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 161 ~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.. ++.++|||||||++|+|++|..||...........+....... .+. .....+.++.+||.+
T Consensus 244 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------~~p-------~~~~~s~~~~~li~~ 310 (410)
T 3v8s_A 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------TFP-------DDNDISKEAKNLICA 310 (410)
T ss_dssp TTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------CCC-------TTCCCCHHHHHHHHH
T ss_pred cCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc------cCC-------CcccccHHHHHHHHH
Confidence 65 7889999999999999999999996433221111111100000 000 001123478899999
Q ss_pred cccCCCCC--CCCHHHHHHh--hccC
Q 045452 237 CVQENPND--RPSMLEVSSM--LKNE 258 (303)
Q Consensus 237 cl~~dp~~--Rps~~~l~~~--L~~~ 258 (303)
||..+|.+ ||+++++++. +++.
T Consensus 311 lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 311 FLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HccChhhhCCCCCHHHHhcCccccCC
Confidence 99999988 9999999853 5554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.32 Aligned_cols=235 Identities=26% Similarity=0.380 Sum_probs=185.1
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++.||||+++... ....+.+.+|+.+++.++||||+++++++ ..+..++||||+.+++|.+++.. ...+++.
T Consensus 42 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 117 (291)
T 1xbb_A 42 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ---NRHVKDK 117 (291)
T ss_dssp SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH---CTTCCHH
T ss_pred CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHH
Confidence 457899999997543 33467899999999999999999999999 66788999999999999999853 4558999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 160 (303)
.++.++.||+.||+|||+.| ++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+
T Consensus 118 ~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 118 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc
Confidence 99999999999999999998 999999999999999999999999999766433221 11222345688999999988
Q ss_pred CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..++.++||||||+++|+|++ |..||...... ............. .+...+..+.++|.+||.
T Consensus 195 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~ 258 (291)
T 1xbb_A 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG---------CPAGCPREMYDLMNLCWT 258 (291)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTC
T ss_pred CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcC
Confidence 888999999999999999999 99998543211 1111111111111 112234578899999999
Q ss_pred CCCCCCCCHHHHHHhhccCCCC
Q 045452 240 ENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
.||++|||+.++++.|++.+..
T Consensus 259 ~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 259 YDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999987643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=287.86 Aligned_cols=228 Identities=22% Similarity=0.304 Sum_probs=167.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++... ..+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++.. ...+++..+
T Consensus 76 ~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 150 (349)
T 2w4o_A 76 GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE---KGYYSERDA 150 (349)
T ss_dssp TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT---CSSCCHHHH
T ss_pred CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh---cCCCCHHHH
Confidence 468899999997543 346688899999999999999999999999999999999999999999843 456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
+.++.||+.||.|||+.| ++||||||+||+++. ++.+||+|||++....... ......|+..|+|||++.+
T Consensus 151 ~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 151 ADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcC
Confidence 999999999999999998 999999999999975 8899999999987654321 1223568999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||....... .. ......... .... ......+.++.+||.+||..
T Consensus 225 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~~~i~~~~~--~~~~-----~~~~~~~~~~~~li~~~L~~ 292 (349)
T 2w4o_A 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM---FRRILNCEY--YFIS-----PWWDEVSLNAKDLVRKLIVL 292 (349)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH---HHHHHTTCC--CCCT-----TTTTTSCHHHHHHHHTTSCS
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH---HHHHHhCCC--ccCC-----chhhhCCHHHHHHHHHHccC
Confidence 899999999999999999999999985432211 01 111111111 0000 11112234788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
||++|||+.++++.
T Consensus 293 dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 293 DPKKRLTTFQALQH 306 (349)
T ss_dssp SGGGSCCHHHHHHS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=286.17 Aligned_cols=242 Identities=29% Similarity=0.427 Sum_probs=188.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC--eeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++.......+.+.+|+.++++++||||+++++++.... ..++||||+++++|.+++... ...+++.
T Consensus 68 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~ 145 (326)
T 2w1i_A 68 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHI 145 (326)
T ss_dssp SCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS--TTSSCHH
T ss_pred CCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc--ccCCCHH
Confidence 579999999998777777788999999999999999999999987654 789999999999999998542 3458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 160 (303)
.++.++.||+.||++||+.| ++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+
T Consensus 146 ~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 146 KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC
Confidence 99999999999999999998 999999999999999999999999999876543221 11222346778999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccC--------CCcc-ccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCG--------INEN-LSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
..++.++||||||+++|+|++|..||.... .... ................. ..+...+.++.
T Consensus 223 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~ 293 (326)
T 2w1i_A 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL---------PRPDGCPDEIY 293 (326)
T ss_dssp CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC---------CCCTTCCHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC---------CCCCcccHHHH
Confidence 888999999999999999999999875321 0000 00011111111111111 11222345788
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
++|.+||..||++|||+.++++.|++..
T Consensus 294 ~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 294 MIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=285.61 Aligned_cols=243 Identities=21% Similarity=0.247 Sum_probs=178.0
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||+.+++|..++. ....+++.
T Consensus 26 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 102 (311)
T 4agu_A 26 DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR---YQRGVPEH 102 (311)
T ss_dssp TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---TSSCCCHH
T ss_pred CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh---hhcCCCHH
Confidence 469999999986543 3345778899999999999999999999999999999999999999988874 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc-
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 160 (303)
.+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||.+........ ......++..|+|||.+.+
T Consensus 103 ~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 177 (311)
T 4agu_A 103 LVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGD 177 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcC
Confidence 99999999999999999999 99999999999999999999999999976543221 1223467999999998876
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH--------HHHhhCCCc---ccccccccc---CCCChHH
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKG---MEFVDSFLD---DRNSSCK 226 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~~~~---~~~~~~~ 226 (303)
..++.++||||||+++|+|++|..||......+........ ...+..... ......... .......
T Consensus 178 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 4agu_A 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI 257 (311)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccc
Confidence 56799999999999999999999999644322211111110 000000000 000000000 0000112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+..+.+||.+||..||++|||++++++.
T Consensus 258 ~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 258 SYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 3468899999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.48 Aligned_cols=229 Identities=22% Similarity=0.271 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSA------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~ 111 (321)
T 2a2a_A 35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KES 111 (321)
T ss_dssp TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---CSC
T ss_pred CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh---cCC
Confidence 4789999999865422 1467899999999999999999999999999999999999999999999853 456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEecccccccccccccccccceeecccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~----~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
+++..++.++.|++.||+|||+.| ++||||||+||+++.++ .+||+|||++....... ......|+..|+
T Consensus 112 ~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~ 185 (321)
T 2a2a_A 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFV 185 (321)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCcc
Confidence 899999999999999999999998 99999999999999888 79999999997665422 122346899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||.+.+..++.++||||||+++|+|++|..||...... ........... ..... .. ...+..+.++
T Consensus 186 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~--~~~~~-~~----~~~~~~~~~l 252 (321)
T 2a2a_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSVSY--DFDEE-FF----SHTSELAKDF 252 (321)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC--CCCHH-HH----TTCCHHHHHH
T ss_pred CcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhccc--ccChh-hh----cccCHHHHHH
Confidence 999999889999999999999999999999999533211 11111111110 00000 00 1122468899
Q ss_pred HHhcccCCCCCCCCHHHHHHh
Q 045452 234 ALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~~ 254 (303)
|.+||..||++|||+.++++.
T Consensus 253 i~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 253 IRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.73 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=187.2
Q ss_pred CCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCee-eEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 6 GEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 6 g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
+..||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+.. +++|+|+.+++|.+++.. ....+++..+
T Consensus 49 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~ 126 (298)
T 3pls_A 49 RIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDL 126 (298)
T ss_dssp EEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC--TTCCCBHHHH
T ss_pred eeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc--cccCCCHHHH
Confidence 347999998754 345567899999999999999999999999876655 999999999999999864 3456889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc--ccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++..+..... ........++..|+|||.+.+.
T Consensus 127 ~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (298)
T 3pls_A 127 ISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203 (298)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC
Confidence 999999999999999998 99999999999999999999999999976543321 1222234568899999999998
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++||||||+++|+|++|..|+....... .... ........ ..+...+..+.+++.+||..|
T Consensus 204 ~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~ 268 (298)
T 3pls_A 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTH----FLAQGRRL---------PQPEYCPDSLYQVMQQCWEAD 268 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHH----HhhcCCCC---------CCCccchHHHHHHHHHHccCC
Confidence 99999999999999999999666653322111 1111 11111111 111122347889999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNTNTP 265 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~~~~ 265 (303)
|.+|||+.++++.|++........
T Consensus 269 p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 269 PAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp GGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred hhhCcCHHHHHHHHHHHHHHHhcc
Confidence 999999999999999876655443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=281.54 Aligned_cols=231 Identities=24% Similarity=0.369 Sum_probs=181.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||.++.......+.+.+|+.+++.++||||+++++++......++||||+++++|.+++........+++..+
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (295)
T 2clq_A 45 SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124 (295)
T ss_dssp TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHH
T ss_pred CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHH
Confidence 57899999999776666678899999999999999999999999999999999999999999999865433445778999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
..++.|++.||+|||+.| ++|+||+|+||+++. ++.+||+|||.+....... .......|+..|+|||.+.+..
T Consensus 125 ~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 199 (295)
T 2clq_A 125 GFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGP 199 (295)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGG
T ss_pred HHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCC
Confidence 999999999999999998 999999999999987 8999999999987654321 1122346799999999987643
Q ss_pred --CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 163 --YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 163 --~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
++.++||||||+++|+|++|..||........ ... ...... .. ...+...+.++.++|.+||..
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~~--~~---------~~~~~~~~~~~~~li~~~l~~ 265 (295)
T 2clq_A 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMF-KVGMFK--VH---------PEIPESMSAEAKAFILKCFEP 265 (295)
T ss_dssp GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHH-HHHHHC--CC---------CCCCTTSCHHHHHHHHHTTCS
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHH-hhcccc--cc---------ccccccCCHHHHHHHHHHccC
Confidence 78899999999999999999999864322110 000 001110 00 111222334788999999999
Q ss_pred CCCCCCCHHHHHH
Q 045452 241 NPNDRPSMLEVSS 253 (303)
Q Consensus 241 dp~~Rps~~~l~~ 253 (303)
||++|||+.++++
T Consensus 266 dp~~Rps~~~ll~ 278 (295)
T 2clq_A 266 DPDKRACANDLLV 278 (295)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=290.38 Aligned_cols=242 Identities=29% Similarity=0.396 Sum_probs=186.2
Q ss_pred CCCE--EEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-------
Q 045452 5 CGEV--IAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------- 73 (303)
Q Consensus 5 ~g~~--vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------- 73 (303)
+|.. ||+|.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||+++++|.+++....
T Consensus 49 ~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 128 (327)
T 1fvr_A 49 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128 (327)
T ss_dssp TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHH
T ss_pred CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccc
Confidence 4554 499988643 334556789999999999 99999999999999999999999999999999986532
Q ss_pred ------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee
Q 045452 74 ------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 74 ------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... .......
T Consensus 129 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~ 202 (327)
T 1fvr_A 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGR 202 (327)
T ss_dssp HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----
T ss_pred ccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCC
Confidence 2346899999999999999999999998 999999999999999999999999998643321 1122234
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . .......... ...+...
T Consensus 203 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~-~~~~~~~~~~---------~~~~~~~ 266 (327)
T 1fvr_A 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKLPQGYR---------LEKPLNC 266 (327)
T ss_dssp CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHGGGTCC---------CCCCTTB
T ss_pred CCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------H-HHHHhhcCCC---------CCCCCCC
Confidence 5788999999988888999999999999999998 99998533211 1 1111111111 1112223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCCC
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKP 268 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 268 (303)
+..+.++|.+||..||.+|||+.++++.|+..........+.
T Consensus 267 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 308 (327)
T 1fvr_A 267 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcccc
Confidence 357889999999999999999999999999877655444433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=280.77 Aligned_cols=224 Identities=25% Similarity=0.370 Sum_probs=179.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||+++++|.+++. ....+++
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~---~~~~~~~ 108 (279)
T 3fdn_A 32 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDE 108 (279)
T ss_dssp TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCH
T ss_pred cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH---hcCCCCH
Confidence 567899999985432 2235678899999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .....++..|+|||.+.+
T Consensus 109 ~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 109 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhcc
Confidence 999999999999999999998 9999999999999999999999999886543221 223467999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||....... ......... ...+...+..+.+||.+||..
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-----------FTFPDFVTEGARDLISRLLKH 244 (279)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-----------CCCCTTSCHHHHHHHHHHCCS
T ss_pred CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHhCC-----------CCCCCcCCHHHHHHHHHHhcc
Confidence 999999999999999999999999985332111 111111111 011122334788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
||++|||+.++++.
T Consensus 245 ~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 245 NPSQRPMLREVLEH 258 (279)
T ss_dssp SGGGSCCHHHHHHC
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.57 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=183.6
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
..||+|.++.. .....+.+.+|+.++++++||||+++++++.. ....++||||+.+++|.+++.. ....+++..++
T Consensus 54 ~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~ 131 (298)
T 3f66_A 54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLI 131 (298)
T ss_dssp EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC--TTCCCCHHHHH
T ss_pred eEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh--cccCCCHHHHH
Confidence 36899998754 34566789999999999999999999999654 4578999999999999999854 34568899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeeccccccCchhcccCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..
T Consensus 132 ~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (298)
T 3f66_A 132 GFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208 (298)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC
Confidence 99999999999999998 999999999999999999999999999866433211 1222345678899999999999
Q ss_pred CCCcccchhhHHHHHHHHhC-CCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||||+++|+|++| .+||........ .. ...... .. ..+...+..+.+++.+||..|
T Consensus 209 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~---~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~~ 272 (298)
T 3f66_A 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV---YLLQGR-RL---------LQPEYCPDPLYEVMLKCWHPK 272 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HH---HHHTTC-CC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HH---HHhcCC-CC---------CCCccCCHHHHHHHHHHcCCC
Confidence 99999999999999999994 555543322221 11 111111 10 111112347889999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNTNT 264 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~~~ 264 (303)
|++|||+.++++.|++......+
T Consensus 273 p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 273 AEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp GGGSCCHHHHHHHHHHHHHTSCC
T ss_pred hhhCcCHHHHHHHHHHHHHhhcc
Confidence 99999999999999987655443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=291.06 Aligned_cols=238 Identities=29% Similarity=0.423 Sum_probs=185.6
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc----ccCC
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR----RLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~ 78 (303)
.+|+.||||.+... .......+.+|+.++++++||||+++++++.+....++||||+++++|.+++..... ...+
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 137 (327)
T 2yfx_A 58 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137 (327)
T ss_dssp --CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSC
T ss_pred CccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccc
Confidence 46789999999654 345567889999999999999999999999999999999999999999999865321 2458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccccccceeeccccccCc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
++..++.++.||+.||.|||+.| ++||||||+||+++. +..+||+|||++................++..|+||
T Consensus 138 ~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 138 AMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCH
Confidence 89999999999999999999998 999999999999984 446999999999765443333333334578899999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
|.+.+..++.++||||||+++|+|++ |..||...... ............. .+...+..+.++|
T Consensus 215 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~~li 278 (327)
T 2yfx_A 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMD---------PPKNCPGPVYRIM 278 (327)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred hHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 99988889999999999999999998 88888533211 1111111111111 1122234788999
Q ss_pred HhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
.+||..||.+|||+.++++.|.....
T Consensus 279 ~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 279 TQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 99999999999999999999887654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=282.70 Aligned_cols=231 Identities=24% Similarity=0.356 Sum_probs=181.3
Q ss_pred CCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+..||+|.++.. .....+.+.+|+.+++.++||||+++++++.+ +..++||||+.+++|.+++.. ....+++..++
T Consensus 40 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~ 116 (281)
T 3cc6_A 40 KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLER--NKNSLKVLTLV 116 (281)
T ss_dssp EEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH--HTTTCCHHHHH
T ss_pred cceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHh--ccccCCHHHHH
Confidence 456999999765 44567889999999999999999999999864 567899999999999999853 23458999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++
T Consensus 117 ~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 192 (281)
T 3cc6_A 117 LYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFT 192 (281)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCC
Confidence 99999999999999998 999999999999999999999999999766443211 12223457889999999988899
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++||||||+++|+|++ |..||........ .... .... .. ..+...+..+.++|.+||..||+
T Consensus 193 ~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~---~~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVL---EKGD-RL---------PKPDLCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHH---HHTC-CC---------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred chhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHH---hcCC-CC---------CCCCCCCHHHHHHHHHHccCCch
Confidence 99999999999999998 9999864332221 1111 1111 00 01112234688999999999999
Q ss_pred CCCCHHHHHHhhccCC
Q 045452 244 DRPSMLEVSSMLKNET 259 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~~ 259 (303)
+|||+.++++.|++..
T Consensus 257 ~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 257 DRPRFTELVCSLSDVY 272 (281)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=285.27 Aligned_cols=231 Identities=24% Similarity=0.340 Sum_probs=181.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++. ....+++..+
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 108 (304)
T 2jam_A 32 LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDA 108 (304)
T ss_dssp TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSCCCHHHH
T ss_pred CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHH---HcCCCCHHHH
Confidence 4799999999976655455678899999999999999999999999999999999999999999884 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
+.++.|++.||.|||+.| ++|+||||+||++ +.++.++|+|||++...... ......|+..|+|||.+.+
T Consensus 109 ~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 109 SLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSS
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhcc
Confidence 999999999999999998 9999999999999 78899999999998654322 1223457999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||...... .... ....+... . ........+..+.++|.+||..
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~---~i~~~~~~--~-----~~~~~~~~~~~~~~li~~~l~~ 248 (304)
T 2jam_A 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE---KIKEGYYE--F-----ESPFWDDISESAKDFICHLLEK 248 (304)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHHCCCC--C-----CTTTTTTSCHHHHHHHHHHHCS
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHcCCCC--C-----CccccccCCHHHHHHHHHHcCC
Confidence 89999999999999999999999998543211 1111 11111110 0 0111122234788999999999
Q ss_pred CCCCCCCHHHHHH--hhcc
Q 045452 241 NPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 241 dp~~Rps~~~l~~--~L~~ 257 (303)
||++|||+.++++ ++.+
T Consensus 249 dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 249 DPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp STTTSCCHHHHHTSHHHHS
T ss_pred ChhHCcCHHHHhcCccccC
Confidence 9999999999986 4544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=279.96 Aligned_cols=250 Identities=18% Similarity=0.190 Sum_probs=191.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEE-EeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFC-IDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++..... .+.+.+|+.+++.++|++++..+..+ ......++||||+ +++|.+++.. ....+++..
T Consensus 32 ~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~ 106 (296)
T 3uzp_A 32 AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKT 106 (296)
T ss_dssp TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh--hccCCCHHH
Confidence 6799999999865432 24588999999999888766655555 5667889999999 9999999853 234689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEecccccccccccccc-----cccceeeccccccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLK-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~---~~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~y~a 154 (303)
++.++.||+.||+|||+.+ ++||||||+||+++ .++.+||+|||++......... .......|+..|+|
T Consensus 107 ~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 183 (296)
T 3uzp_A 107 VLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183 (296)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCC
Confidence 9999999999999999998 99999999999995 7889999999999876543221 11234568999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++||||||+++|+|++|+.||.......................... .. ...+.++.+++
T Consensus 184 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~~~~~~l~~li 254 (296)
T 3uzp_A 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LC----KGYPSEFATYL 254 (296)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-----HT----TTSCHHHHHHH
T ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH-----HH----hhCCHHHHHHH
Confidence 9999998999999999999999999999999976544433333333222111110000 00 11124688999
Q ss_pred HhcccCCCCCCCCHHHHHHhhccCCCCCCCCCCCCc
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPAF 270 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 270 (303)
.+||+.||++|||+.++++.|++.......+...++
T Consensus 255 ~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 290 (296)
T 3uzp_A 255 NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 290 (296)
T ss_dssp HHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCC
T ss_pred HHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccc
Confidence 999999999999999999999998766665554433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=280.28 Aligned_cols=226 Identities=28% Similarity=0.419 Sum_probs=163.1
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++
T Consensus 34 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~ 111 (278)
T 3cok_A 34 HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSE 111 (278)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT--CSSCCCH
T ss_pred cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh--ccCCCCH
Confidence 579999999996432 22357789999999999999999999999999999999999999999999854 2356899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++|+||+|+||+++.++.+||+|||.+....... .......++..|+|||.+.+
T Consensus 112 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 112 NEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcC
Confidence 999999999999999999998 9999999999999999999999999987654321 11223467899999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||.......... ..... . ...+...+.++.++|.+||..
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~----~-------~~~~~~~~~~~~~li~~~l~~ 249 (278)
T 3cok_A 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLA----D-------YEMPSFLSIEAKDLIHQLLRR 249 (278)
T ss_dssp -----CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSS----C-------CCCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhhc----c-------cCCccccCHHHHHHHHHHccc
Confidence 889999999999999999999999996543322111 00000 0 011222345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 045452 241 NPNDRPSMLEVSS 253 (303)
Q Consensus 241 dp~~Rps~~~l~~ 253 (303)
||++|||+.++++
T Consensus 250 dp~~Rps~~~~l~ 262 (278)
T 3cok_A 250 NPADRLSLSSVLD 262 (278)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CHhhCCCHHHHhc
Confidence 9999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.95 Aligned_cols=239 Identities=23% Similarity=0.259 Sum_probs=171.9
Q ss_pred CCCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+. ++|.+++. ....+++
T Consensus 56 ~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~ 131 (329)
T 3gbz_A 56 TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMD---KNPDVSM 131 (329)
T ss_dssp TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHH---HCTTCCH
T ss_pred CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHh---hcCCCCH
Confidence 35789999999975532 234667899999999999999999999999999999999997 58988884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-----CCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-----GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~-----~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..++.++.||+.||+|||+.+ ++||||||+||++ +.++.+||+|||++..+.... .......++..|+||
T Consensus 132 ~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 132 RVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPP 206 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCH
Confidence 999999999999999999998 9999999999999 455669999999997664321 122234679999999
Q ss_pred hhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc---------ccc-------cc
Q 045452 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF---------VDS-------FL 218 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~-------~~ 218 (303)
|++.+. .++.++|||||||++|+|++|..||....... ................. ... ..
T Consensus 207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
T 3gbz_A 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL 283 (329)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCH
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccH
Confidence 998764 48999999999999999999999996433221 11111111111000000 000 00
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
........+.++.+||.+||+.||++|||++++++
T Consensus 284 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00001112357889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.02 Aligned_cols=239 Identities=26% Similarity=0.331 Sum_probs=176.7
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCC--eeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||||++... .....+.+.+|+.+++.+. ||||+++++++...+ ..|+||||+. ++|..++. ...+
T Consensus 32 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~ 106 (388)
T 3oz6_A 32 RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR----ANIL 106 (388)
T ss_dssp TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHH----HTCC
T ss_pred CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHH----cCCC
Confidence 57999999998543 3455677889999999996 999999999997544 6899999996 58888873 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc-------------------c
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES-------------------L 139 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~-------------------~ 139 (303)
++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 107 ~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (388)
T 3oz6_A 107 EPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183 (388)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccc
Confidence 99999999999999999999999 9999999999999999999999999997653211 0
Q ss_pred ccccceeeccccccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc----
Q 045452 140 KANTEQVVGTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV---- 214 (303)
Q Consensus 140 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 214 (303)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ +........ ....+..
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~-~p~~~~~~~~~ 259 (388)
T 3oz6_A 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ---LERIIGVID-FPSNEDVESIQ 259 (388)
T ss_dssp ------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC-CCCHHHHHTSC
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcC-CCCHHHHHhcc
Confidence 111233578999999999876 5789999999999999999999999964432221 111111110 0000000
Q ss_pred ------------------ccccc------------CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 215 ------------------DSFLD------------DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 215 ------------------~~~~~------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
..... .......+.++.+||.+||..||++|||++++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 00000 00000123468899999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=290.79 Aligned_cols=230 Identities=23% Similarity=0.352 Sum_probs=176.5
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCC--CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
..+|+.||||+++.. .....+.+.+|+.++++++ |+||+++++++......++||| +.+++|.+++.. ...+
T Consensus 77 ~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~---~~~~ 152 (390)
T 2zmd_A 77 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSI 152 (390)
T ss_dssp CTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH---CSSC
T ss_pred cCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh---cCCC
Confidence 456899999998644 3455678999999999996 5999999999999999999999 568899999853 4468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++..+.............|++.|+|||++
T Consensus 153 ~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 228 (390)
T 2zmd_A 153 DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228 (390)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHh
Confidence 89999999999999999999998 99999999999995 588999999999876543322233345789999999998
Q ss_pred cc-----------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 159 RQ-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 159 ~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
.+ ..++.++|||||||++|+|++|..||.... ................. .+...+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~ 294 (390)
T 2zmd_A 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHEIE---------FPDIPE 294 (390)
T ss_dssp HCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTSCCC---------CCCCSC
T ss_pred hhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCccccCC---------CCccch
Confidence 65 357889999999999999999999995321 11222222222211111 111123
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.++.+||.+||..||++|||+.++++.
T Consensus 295 ~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 468899999999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=301.82 Aligned_cols=230 Identities=24% Similarity=0.277 Sum_probs=185.4
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++.... ......+.+|+.+++.++||||+++++++.+....++||||++||+|.+++... ....+++
T Consensus 207 ~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~-~~~~l~e 285 (576)
T 2acx_A 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GQAGFPE 285 (576)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS-SSCCCCH
T ss_pred CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc-CCCCCCH
Confidence 579999999996432 234567889999999999999999999999999999999999999999988643 2345899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||++..+.... ......||+.|+|||++.+
T Consensus 286 ~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcC
Confidence 999999999999999999998 9999999999999999999999999997664322 1223478999999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||...........+........ ...+...+.++.+||.+||..
T Consensus 360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~-------------~~~p~~~s~~~~dLI~~lL~~ 426 (576)
T 2acx_A 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP-------------EEYSERFSPQARSLCSQLLCK 426 (576)
T ss_dssp CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC-------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc-------------ccCCccCCHHHHHHHHHhccC
Confidence 8899999999999999999999999975443322222222111111 011122334788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||.+|| +++++++
T Consensus 427 dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 427 DPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SGGGSTTCSSSHHHHHHT
T ss_pred CHHHcCCCCCCCHHHHHh
Confidence 999999 7888864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.58 Aligned_cols=234 Identities=25% Similarity=0.409 Sum_probs=180.6
Q ss_pred CCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+..||||.++.. .......+.+|+.++++++||||+++++++......++||||+.+++|.+++.. ....+++..++
T Consensus 73 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~ 150 (333)
T 1mqb_A 73 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLV 150 (333)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHH
T ss_pred cccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHH
Confidence 346999999754 344566889999999999999999999999999999999999999999999853 23568999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcccCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..+
T Consensus 151 ~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 151 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 99999999999999998 999999999999999999999999999776433211 11122345778999999998889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++||||||+++|+|++ |..||...... ............. .+...+..+.+++.+||..||
T Consensus 228 ~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p 291 (333)
T 1mqb_A 228 TSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRLP---------TPMDCPSAIYQLMMQCWQQER 291 (333)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCCC---------CCTTCBHHHHHHHHHHTCSST
T ss_pred CchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCCcCC---------CcccCCHHHHHHHHHHcCCCh
Confidence 999999999999999998 99998533211 1111111111111 111223478899999999999
Q ss_pred CCCCCHHHHHHhhccCCC
Q 045452 243 NDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~~ 260 (303)
++||++.++++.|++...
T Consensus 292 ~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 292 ARRPKFADIVSILDKLIR 309 (333)
T ss_dssp TTSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=288.84 Aligned_cols=220 Identities=21% Similarity=0.260 Sum_probs=179.2
Q ss_pred CCCCCEEEEEEccCCCh--------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCC-ChhhhhcCcC
Q 045452 3 LPCGEVIAVKKLSKSSA--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK-SLDCYLFDPI 73 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~ 73 (303)
..+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+.+| +|.+++..
T Consensus 46 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-- 123 (335)
T 3dls_A 46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-- 123 (335)
T ss_dssp TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT--
T ss_pred CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh--
Confidence 35789999999865421 13346778999999999999999999999999999999998666 99888843
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... ......|+..|+
T Consensus 124 -~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~ 196 (335)
T 3dls_A 124 -HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYC 196 (335)
T ss_dssp -CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCcccc
Confidence 446999999999999999999999998 9999999999999999999999999997664432 223356899999
Q ss_pred CchhcccCCC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 154 PPEYARQGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 154 aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
|||++.+..+ +.++|||||||++|+|++|..||...... .... ...+...+.++.+
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~~~-----------~~~~~~~~~~l~~ 253 (335)
T 3dls_A 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VEAA-----------IHPPYLVSKELMS 253 (335)
T ss_dssp CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TTTC-----------CCCSSCCCHHHHH
T ss_pred ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hhhc-----------cCCCcccCHHHHH
Confidence 9999987776 77899999999999999999998532110 0000 0011112347889
Q ss_pred HHHhcccCCCCCCCCHHHHHHh
Q 045452 233 IALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~ 254 (303)
||.+||..||++|||+.++++.
T Consensus 254 li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.27 Aligned_cols=225 Identities=21% Similarity=0.231 Sum_probs=172.9
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .......+.+|+.+++.++||||+++++++...+..++||||+++++|.+++. ....+++
T Consensus 171 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 247 (446)
T 4ejn_A 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSE 247 (446)
T ss_dssp TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH---HHSCCCH
T ss_pred CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH---hcCCCCH
Confidence 57899999999643 33345677889999999999999999999999999999999999999998884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
..+..++.||+.||+|||+ .| |+||||||+|||++.++.+||+|||++...... ........|++.|+|||++.
T Consensus 248 ~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 322 (446)
T 4ejn_A 248 DRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLE 322 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC--CcccccccCCccccCHhhcC
Confidence 9999999999999999998 88 999999999999999999999999998753322 12223357899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||...... ........... ..+...+.++.+||.+||.
T Consensus 323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~-----------~~p~~~~~~~~~li~~~L~ 385 (446)
T 4ejn_A 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI-----------RFPRTLGPEAKSLLSGLLK 385 (446)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTC
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC-----------CCCccCCHHHHHHHHHHcc
Confidence 999999999999999999999999999543211 11111111110 1111223478899999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 045452 240 ENPNDRP-----SMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rp-----s~~~l~~ 253 (303)
.||++|| +++++++
T Consensus 386 ~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 386 KDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SSTTTSTTCSTTTHHHHHT
T ss_pred cCHHHhCCCCCCCHHHHHh
Confidence 9999999 9999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=286.41 Aligned_cols=224 Identities=30% Similarity=0.394 Sum_probs=179.4
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++......++||||+. |+|.+++.. ....+++
T Consensus 77 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~--~~~~l~~ 153 (348)
T 1u5q_A 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQE 153 (348)
T ss_dssp TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH--HTSCCCH
T ss_pred cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH--hcCCCCH
Confidence 679999999986442 3345678999999999999999999999999999999999996 577777643 2456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ....|++.|+|||++.
T Consensus 154 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~ 224 (348)
T 1u5q_A 154 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILA 224 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhcc
Confidence 999999999999999999998 999999999999999999999999998765422 2346899999999884
Q ss_pred --cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
...++.++|||||||++|+|++|..||..... ............. .. .....+..+.++|.+|
T Consensus 225 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~-~~--------~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-AL--------QSGHWSEYFRNFVDSC 289 (348)
T ss_dssp TSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CC--------CCTTSCHHHHHHHHHH
T ss_pred ccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-CC--------CCCCCCHHHHHHHHHH
Confidence 56688999999999999999999999854321 1112222222111 10 1112234688999999
Q ss_pred ccCCCCCCCCHHHHHHh
Q 045452 238 VQENPNDRPSMLEVSSM 254 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~~ 254 (303)
|+.||++|||++++++.
T Consensus 290 l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TCSSGGGSCCHHHHTTC
T ss_pred cccChhhCcCHHHHhhC
Confidence 99999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=285.37 Aligned_cols=231 Identities=26% Similarity=0.340 Sum_probs=186.3
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|++... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+.+++|.+++. ....+++
T Consensus 64 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~~ 140 (335)
T 2owb_A 64 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTE 140 (335)
T ss_dssp TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH---HHCSCCH
T ss_pred CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh---ccCCCCH
Confidence 46889999998644 34566788999999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......|+..|+|||.+.+
T Consensus 141 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 141 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhcc
Confidence 999999999999999999998 9999999999999999999999999997654322 12233568999999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||....... .......... ..+......+.+||.+||+.
T Consensus 216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~ 278 (335)
T 2owb_A 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNEY-----------SIPKHINPVAASLIQKMLQT 278 (335)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcCCC-----------CCCccCCHHHHHHHHHHccC
Confidence 889999999999999999999999985432111 1111111110 01112234688999999999
Q ss_pred CCCCCCCHHHHHH--hhccCC
Q 045452 241 NPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 241 dp~~Rps~~~l~~--~L~~~~ 259 (303)
||++|||+.++++ ++....
T Consensus 279 dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 279 DPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp SGGGSCCGGGGGGSHHHHTSC
T ss_pred ChhHCcCHHHHhcCccccCCC
Confidence 9999999999986 455543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.91 Aligned_cols=229 Identities=21% Similarity=0.310 Sum_probs=176.6
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-CcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++... .....+++.
T Consensus 45 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 124 (285)
T 3is5_A 45 SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124 (285)
T ss_dssp TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHH
T ss_pred cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHH
Confidence 578999999986543 345678999999999999999999999999999999999999999999888542 124669999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
.++.++.|++.||+|||+.| ++||||||+||++ +.++.+||+|||++..+.... ......++..|+|||.+
T Consensus 125 ~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~ 198 (285)
T 3is5_A 125 YVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVF 198 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHh
Confidence 99999999999999999998 9999999999999 456789999999997654322 22335689999999988
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
. ..++.++||||||+++|+|++|..||...... ................. . ..+..+.++|.+||
T Consensus 199 ~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~----~----~~~~~~~~li~~~L 263 (285)
T 3is5_A 199 K-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAVEC----R----PLTPQAVDLLKQML 263 (285)
T ss_dssp T-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC------C----CCCHHHHHHHHHHT
T ss_pred c-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccccc----C----cCCHHHHHHHHHHc
Confidence 6 45788999999999999999999999543211 11111111111110000 0 01246889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
..||++|||+.++++
T Consensus 264 ~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 264 TKDPERRPSAAQVLH 278 (285)
T ss_dssp CSCTTTSCCHHHHHT
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=280.68 Aligned_cols=249 Identities=17% Similarity=0.173 Sum_probs=190.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEE-EeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFC-IDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++..... .+.+.+|+.+++.++|++++..+..+ ......++||||+ +++|.+++.. ....+++..
T Consensus 32 ~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~ 106 (296)
T 4hgt_A 32 AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKT 106 (296)
T ss_dssp TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTSCCCHHH
T ss_pred CCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH--hcCCCCHHH
Confidence 6789999998754322 23577899999999888766665555 5677889999999 9999999853 244589999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEecccccccccccccc-----cccceeeccccccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLK-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~---~~~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~y~a 154 (303)
++.++.||+.||+|||+.+ ++||||||+||++ +.++.+||+|||++......... .......|+..|+|
T Consensus 107 ~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 183 (296)
T 4hgt_A 107 VLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183 (296)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccc
Confidence 9999999999999999999 9999999999999 78899999999999876543221 12234568999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|||||||++|+|++|..||.......................... .... .+.++.++|
T Consensus 184 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~l~~li 254 (296)
T 4hgt_A 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LCKG----YPSEFATYL 254 (296)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-----HTTT----SCHHHHHHH
T ss_pred hHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh-----hhcc----CCHHHHHHH
Confidence 9999998999999999999999999999999976554444443333222211111000 0011 124788999
Q ss_pred HhcccCCCCCCCCHHHHHHhhccCCCCCCCCCCCC
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 269 (303)
.+||+.||++|||+.++++.|++...........+
T Consensus 255 ~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~ 289 (296)
T 4hgt_A 255 NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 289 (296)
T ss_dssp HHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCC
T ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCc
Confidence 99999999999999999999999876665554433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=291.78 Aligned_cols=244 Identities=21% Similarity=0.204 Sum_probs=173.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEe--------CCeeeEEEeeCCCCChhhhhcCcCc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCID--------SEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
.+|+.||||++........+.+.+|+.+++++. ||||+++++++.. ....+++|||+. |+|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~ 129 (337)
T 3ll6_A 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES 129 (337)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT
T ss_pred CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc
Confidence 478999999997777677788999999999995 9999999999953 335799999995 788888865334
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc----------ccc
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA----------NTE 144 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~----------~~~ 144 (303)
...+++..++.++.||+.||+|||+.+ .+++||||||+||+++.++.+||+|||++.......... ...
T Consensus 130 ~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (337)
T 3ll6_A 130 RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208 (337)
T ss_dssp TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----------------
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhc
Confidence 567999999999999999999999865 249999999999999999999999999998765322111 111
Q ss_pred eeeccccccCchhc---ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCC
Q 045452 145 QVVGTIGYIPPEYA---RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDR 221 (303)
Q Consensus 145 ~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
...++..|+|||++ .+..++.++||||||+++|+|++|..||....... ....... ..
T Consensus 209 ~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------~~~~~~~---------~~ 269 (337)
T 3ll6_A 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----------IVNGKYS---------IP 269 (337)
T ss_dssp ---------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------------CC---------CC
T ss_pred cccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----------hhcCccc---------CC
Confidence 34588999999988 56668889999999999999999999985322111 0000000 00
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCCC
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKP 268 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 268 (303)
........+.+||.+||+.||.+|||+.++++.|+...........+
T Consensus 270 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 01111124779999999999999999999999999877654444333
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=288.84 Aligned_cols=242 Identities=26% Similarity=0.345 Sum_probs=177.8
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||++... .....+.+.+|+.++++++||||+++++++......++||||+.+++|.+++. ....+++.
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 124 (331)
T 4aaa_A 48 DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL---FPNGLDYQ 124 (331)
T ss_dssp TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---STTCCCHH
T ss_pred CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh---hccCCCHH
Confidence 46899999998544 33445678899999999999999999999999999999999999998888763 34458999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+.... .......++..|+|||.+.+.
T Consensus 125 ~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 125 VVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCC
Confidence 99999999999999999999 9999999999999999999999999997654322 122234679999999998775
Q ss_pred -CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhh------CCCccccccccccCCCChHH
Q 045452 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWK------GGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 162 -~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~------~~~~~~~~~~~~~~~~~~~~ 226 (303)
.++.++|||||||++|+|++|..||.............. ....+. +................+..
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (331)
T 4aaa_A 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL 279 (331)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTS
T ss_pred CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccch
Confidence 688999999999999999999999864432211111100 000000 00000000000000001122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
+..+.+||.+||+.||++|||+.++++
T Consensus 280 ~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 280 SEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 457899999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=287.42 Aligned_cols=244 Identities=24% Similarity=0.267 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccCCChh-----hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSSAQ-----GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||||+++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+.+ +|..++.. ....+
T Consensus 33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~ 109 (346)
T 1ua2_A 33 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD--NSLVL 109 (346)
T ss_dssp SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT--CCSSC
T ss_pred CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh--cCcCC
Confidence 46899999999653221 124678999999999999999999999999999999999975 78887754 23468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++..+.... .......++..|+|||.+
T Consensus 110 ~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 110 TPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELL 184 (346)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHh
Confidence 88999999999999999999999 9999999999999999999999999997664322 122234679999999998
Q ss_pred ccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccc------ccccC---CC-----C
Q 045452 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVD------SFLDD---RN-----S 223 (303)
Q Consensus 159 ~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---~~-----~ 223 (303)
.+. .++.++|||||||++|+|++|..||...... ..+................+ ..... .. .
T Consensus 185 ~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (346)
T 1ua2_A 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 261 (346)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred hCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhh
Confidence 654 4788999999999999999999998543321 11222222111110000000 00000 00 0
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccC
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNE 258 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~ 258 (303)
...+.++.+||.+||..||++|||+.++++. +.+.
T Consensus 262 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 262 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 1223578899999999999999999999864 5443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.22 Aligned_cols=238 Identities=24% Similarity=0.354 Sum_probs=178.1
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
..||+|.++.. .....+.+.+|+.++++++||||+++++++.. .+..++||||+.+++|.+++.. ....+++..++
T Consensus 118 ~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~ 195 (373)
T 3c1x_A 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLI 195 (373)
T ss_dssp EEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC--TTCCCBHHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh--cccCCCHHHHH
Confidence 46899998654 34566889999999999999999999999764 4578999999999999999954 23457889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeeccccccCchhcccCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+...... .......++..|+|||.+.+..
T Consensus 196 ~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 272 (373)
T 3c1x_A 196 GFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272 (373)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC
Confidence 99999999999999998 999999999999999999999999999765433211 1122234678899999999999
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|||||||++|+|++ |.+||........ .. .... +... ..+...+..+.+++.+||..|
T Consensus 273 ~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~---~~~~-~~~~---------~~p~~~~~~l~~li~~cl~~d 336 (373)
T 3c1x_A 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV---YLLQ-GRRL---------LQPEYCPDPLYEVMLKCWHPK 336 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH---HHHT-TCCC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH---HHHc-CCCC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999999 6667654332221 11 1111 1111 111222347889999999999
Q ss_pred CCCCCCHHHHHHhhccCCCCCCCC
Q 045452 242 PNDRPSMLEVSSMLKNETTNTNTP 265 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~~~~~~ 265 (303)
|++|||+.++++.|++........
T Consensus 337 p~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 337 AEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp GGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred hhhCcCHHHHHHHHHHHHHhcccc
Confidence 999999999999999877655443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=294.00 Aligned_cols=236 Identities=18% Similarity=0.185 Sum_probs=181.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|..++..++||||+++++++.+.+..|+||||+++|+|.+++... +..+++
T Consensus 84 ~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~ 161 (412)
T 2vd5_A 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPA 161 (412)
T ss_dssp TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCCH
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCH
Confidence 579999999996432 223345788999999999999999999999999999999999999999998531 346899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.||+.||.|||+.| |+||||||+|||++.+|++||+|||++........ ......+||+.|+|||++.
T Consensus 162 ~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~ 237 (412)
T 2vd5_A 162 EMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQA 237 (412)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhh
Confidence 999999999999999999998 99999999999999999999999999976643221 1223357899999999987
Q ss_pred ------cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 160 ------QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 160 ------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
...++.++|+|||||++|+|++|..||...........+....... .... .....+.++.+|
T Consensus 238 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~---------~~~~~s~~~~dl 305 (412)
T 2vd5_A 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL---SLPL---------VDEGVPEEARDF 305 (412)
T ss_dssp HHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---CCC-------------CCCHHHHHH
T ss_pred cccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc---CCCc---------cccCCCHHHHHH
Confidence 3568899999999999999999999996433211111111000000 0000 011123478899
Q ss_pred HHhcccCCCCCC---CCHHHHHH--hhccC
Q 045452 234 ALLCVQENPNDR---PSMLEVSS--MLKNE 258 (303)
Q Consensus 234 i~~cl~~dp~~R---ps~~~l~~--~L~~~ 258 (303)
|.+||. +|.+| |+++++++ ++++.
T Consensus 306 i~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 306 IQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 999999 99998 58999874 35544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=288.68 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=182.1
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++..+...++||||+++++|.+++.. ...+++..
T Consensus 56 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~ 132 (360)
T 3eqc_A 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQI 132 (360)
T ss_dssp TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH---HSSCCHHH
T ss_pred CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH---cCCCCHHH
Confidence 47899999999765 445567899999999999999999999999999999999999999999999843 45689999
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+..++.+++.||+|||+. | ++||||||+||+++.++.+||+|||++...... ......|+..|+|||++.+.
T Consensus 133 ~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 205 (360)
T 3eqc_A 133 LGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 205 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCC
Confidence 999999999999999985 7 999999999999999999999999998655322 12234689999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH---------HHHH--------------hhCCCcccccc---
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH---------AYEL--------------WKGGKGMEFVD--- 215 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---------~~~~--------------~~~~~~~~~~~--- 215 (303)
.++.++|||||||++|+|++|..||.............. .... .......+..+
T Consensus 206 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
T 3eqc_A 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285 (360)
T ss_dssp CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHh
Confidence 999999999999999999999999964332111000000 0000 00000000000
Q ss_pred -ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 216 -SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 216 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...........+.++.+||.+||+.||++|||++++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000111122447889999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=295.21 Aligned_cols=237 Identities=17% Similarity=0.225 Sum_probs=182.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|+++... ......+.+|+.++..++||||+++++++.+....++||||+.+|+|.+++.. ....+++
T Consensus 97 ~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e 174 (437)
T 4aw2_A 97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPE 174 (437)
T ss_dssp TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT--TTTCCCH
T ss_pred CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH--ccCCCCH
Confidence 468999999996432 11233478899999999999999999999999999999999999999999954 2456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....... .......+||+.|+|||++.
T Consensus 175 ~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~ 250 (437)
T 4aw2_A 175 EMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQA 250 (437)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhh
Confidence 999999999999999999999 9999999999999999999999999997654322 12223357899999999986
Q ss_pred ----cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 160 ----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 160 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
...++.++|||||||++|+|++|..||......+....+....... .+. ......+.++.+||.
T Consensus 251 ~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------~~p------~~~~~~s~~~~dLi~ 318 (437)
T 4aw2_A 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------QFP------TQVTDVSENAKDLIR 318 (437)
T ss_dssp HHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------CCC------SSCCCSCHHHHHHHH
T ss_pred cccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc------cCC------cccccCCHHHHHHHH
Confidence 4568999999999999999999999996433221111111000000 000 000112347889999
Q ss_pred hcccCCCCC--CCCHHHHHH--hhccC
Q 045452 236 LCVQENPND--RPSMLEVSS--MLKNE 258 (303)
Q Consensus 236 ~cl~~dp~~--Rps~~~l~~--~L~~~ 258 (303)
+||..+|+. ||+++++++ ++++.
T Consensus 319 ~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 319 RLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp TTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HHhcccccccCCCCHHHHhCCCccCCC
Confidence 999888887 999999975 35543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.33 Aligned_cols=227 Identities=22% Similarity=0.286 Sum_probs=182.5
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-cccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~ 79 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+....|+||||++||+|..++.... ....++
T Consensus 208 ~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~ 287 (543)
T 3c4z_A 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287 (543)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCC
T ss_pred CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhccccccc
Confidence 579999999996432 2345678899999999999999999999999999999999999999999886532 245699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||.|||+.| |+||||||+||+++.+|.+||+|||++..+..... .....+||+.|+|||++.
T Consensus 288 e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~ 362 (543)
T 3c4z_A 288 EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLL 362 (543)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhc
Confidence 9999999999999999999998 99999999999999999999999999987643321 123357899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|..||...........+.. ....... ..+...+..+.+||.+||.
T Consensus 363 ~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~--~i~~~~~-----------~~p~~~s~~~~~li~~lL~ 429 (543)
T 3c4z_A 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--RVLEQAV-----------TYPDKFSPASKDFCEALLQ 429 (543)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH--HHHHCCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH--HHhhccc-----------CCCcccCHHHHHHHHHhcc
Confidence 99999999999999999999999999975443222221111 1111110 1112233478899999999
Q ss_pred CCCCCCCCH
Q 045452 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rps~ 248 (303)
.||++||++
T Consensus 430 ~dP~~R~~~ 438 (543)
T 3c4z_A 430 KDPEKRLGF 438 (543)
T ss_dssp SSGGGSCCC
T ss_pred CCHhHCCCC
Confidence 999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=282.38 Aligned_cols=242 Identities=25% Similarity=0.302 Sum_probs=178.2
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCcceeEEEEEEeC----CeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
+|+.||||++.... ...+..|.+++.. ++||||+++++++... ...++||||+++++|.+++. ...+
T Consensus 59 ~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~ 131 (337)
T 3mdy_A 59 RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTL 131 (337)
T ss_dssp TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHH----HCCB
T ss_pred CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhh----ccCC
Confidence 48899999985442 2344455555555 4999999999999887 68899999999999999983 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhc--------CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeec
Q 045452 79 DWKKRVHIIEGITQGLLYLQEY--------SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVG 148 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~--------~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~ 148 (303)
++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++..+...... .......|
T Consensus 132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 208 (337)
T 3mdy_A 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208 (337)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCS
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCcc
Confidence 9999999999999999999988 6 999999999999999999999999999765433211 11223568
Q ss_pred cccccCchhcccCCCCCc------ccchhhHHHHHHHHhC----------CCCccccCCCccccHHHHHHHHhhCCCccc
Q 045452 149 TIGYIPPEYARQGVYSTK------SDVFSFGVLLLQIISG----------KRLSMLCGINENLSILEHAYELWKGGKGME 212 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~------~DiwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (303)
+..|+|||++.+...+.. +|||||||++|+|++| ..||......... ...............
T Consensus 209 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 286 (337)
T 3mdy_A 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS--YEDMREIVCIKKLRP 286 (337)
T ss_dssp CGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCC
T ss_pred CcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc--hhhhHHHHhhhccCc
Confidence 999999999987776665 9999999999999999 5555432222111 111111111111100
Q ss_pred cccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCC
Q 045452 213 FVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 213 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~ 261 (303)
.. .........+.++.+|+.+||+.||++|||+.++++.|+.....
T Consensus 287 ~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 287 SF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 00 11111224566799999999999999999999999999886643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=282.14 Aligned_cols=228 Identities=24% Similarity=0.363 Sum_probs=182.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe----------------CCeeeEEEeeCCCCChhh
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----------------SEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~sL~~ 67 (303)
.+|+.||+|.++... +.+.+|+.++++++||||+++++++.. ....++||||+++++|.+
T Consensus 34 ~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (284)
T 2a19_B 34 IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109 (284)
T ss_dssp TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHH
T ss_pred CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHH
Confidence 479999999997554 346789999999999999999998864 345799999999999999
Q ss_pred hhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee
Q 045452 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 68 ~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
++... ....+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.+||+|||++....... ......
T Consensus 110 ~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~ 182 (284)
T 2a19_B 110 WIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSK 182 (284)
T ss_dssp HHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCC
T ss_pred HHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccC
Confidence 98542 2356899999999999999999999998 9999999999999999999999999987665432 122345
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++..|+|||.+.+..++.++||||||+++|+|++|..|+... ........... .+...+
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~~~~~------------~~~~~~ 241 (284)
T 2a19_B 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDLRDGI------------ISDIFD 241 (284)
T ss_dssp SCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHTTC------------CCTTSC
T ss_pred CcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHhhccc------------ccccCC
Confidence 799999999999888999999999999999999999886321 01111111111 111223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCC
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTN 263 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~ 263 (303)
..+.++|.+||..||.+|||+.++++.|........
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 468899999999999999999999999988765443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.82 Aligned_cols=229 Identities=21% Similarity=0.335 Sum_probs=177.5
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.. ....+++..+
T Consensus 42 ~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~ 119 (302)
T 2j7t_A 42 ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQI 119 (302)
T ss_dssp TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH--HTSCCCHHHH
T ss_pred CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh--hccCCCHHHH
Confidence 46899999999776666778899999999999999999999999999999999999999999988753 2456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc-----
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA----- 158 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----- 158 (303)
+.++.||+.||.|||+.| ++|+||+|+||+++.++.+||+|||++....... .......|+..|+|||.+
T Consensus 120 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 194 (302)
T 2j7t_A 120 QVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETM 194 (302)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccC
Confidence 999999999999999998 9999999999999999999999999875432211 112234679999999987
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+..++.++||||||+++|+|++|..||..... ............... ..+...+..+.++|.+||
T Consensus 195 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l 260 (302)
T 2j7t_A 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPTL--------LTPSKWSVEFRDFLKIAL 260 (302)
T ss_dssp TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCCC--------SSGGGSCHHHHHHHHHHS
T ss_pred CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCccc--------CCccccCHHHHHHHHHHc
Confidence 356788999999999999999999999854321 111112222111100 111222347889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
..||++|||+.++++
T Consensus 261 ~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 261 DKNPETRPSAAQLLE 275 (302)
T ss_dssp CSCTTTSCCHHHHTT
T ss_pred ccChhhCCCHHHHhc
Confidence 999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=289.18 Aligned_cols=238 Identities=24% Similarity=0.291 Sum_probs=182.0
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++.... ..++||||+ +++|.+++. .
T Consensus 48 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~ 122 (367)
T 1cm8_A 48 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK----H 122 (367)
T ss_dssp TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH----H
T ss_pred CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHh----c
Confidence 57999999999643 3345678899999999999999999999997653 469999999 889998884 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... .....++..|+||
T Consensus 123 ~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP 194 (367)
T 1cm8_A 123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAP 194 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCH
Confidence 46899999999999999999999998 999999999999999999999999999765432 2234679999999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccc-------------------ccc
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGME-------------------FVD 215 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~ 215 (303)
|++.+ ..++.++|||||||++|+|++|+.||........ +....... +....+ ...
T Consensus 195 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (367)
T 1cm8_A 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVT-GTPPAEFVQRLQSDEAKNYMKGLPELEK 270 (367)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHH-CCCCHHHHHTCSCHHHHHHHHHSCCCCC
T ss_pred HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhc-CCCCHHHHHHhhhHHHHHHHHhCCCCCC
Confidence 98877 6789999999999999999999999964332211 11111110 000000 000
Q ss_pred ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCC
Q 045452 216 SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
.... ......+..+.+||.+||..||++|||++++++ +++...
T Consensus 271 ~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 271 KDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0000 011122347889999999999999999999987 465544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=281.32 Aligned_cols=226 Identities=23% Similarity=0.345 Sum_probs=184.3
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||+++... ....+.+.+|+.+++.++||||+++++++......++||||+++++|.+++. ...+++..
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~ 120 (303)
T 3a7i_A 45 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQ 120 (303)
T ss_dssp TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT----TSCCCHHH
T ss_pred CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh----cCCCCHHH
Confidence 578999999986543 3456889999999999999999999999999999999999999999999983 35689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..
T Consensus 121 ~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 195 (303)
T 3a7i_A 121 IATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSA 195 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCC
Confidence 9999999999999999998 99999999999999999999999999976654321 223356899999999999888
Q ss_pred CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
++.++||||||+++|+|++|..||..... ........... .. ..+...+..+.++|.+||..||
T Consensus 196 ~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~dp 259 (303)
T 3a7i_A 196 YDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLIPKNN-PP---------TLEGNYSKPLKEFVEACLNKEP 259 (303)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CC---------CCCSSCCHHHHHHHHHHCCSSG
T ss_pred CCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHhhcCC-CC---------CCccccCHHHHHHHHHHcCCCh
Confidence 99999999999999999999999853321 11111111111 11 1111223468899999999999
Q ss_pred CCCCCHHHHHHh
Q 045452 243 NDRPSMLEVSSM 254 (303)
Q Consensus 243 ~~Rps~~~l~~~ 254 (303)
++|||+.++++.
T Consensus 260 ~~Rps~~~ll~~ 271 (303)
T 3a7i_A 260 SFRPTAKELLKH 271 (303)
T ss_dssp GGSCCHHHHTTC
T ss_pred hhCcCHHHHhhC
Confidence 999999999763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=312.60 Aligned_cols=233 Identities=26% Similarity=0.375 Sum_probs=183.7
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+++.||||+++.. .....+.+.+|+.++++++||||+++++++. .+..++||||+.+|+|.+++. ....+++.
T Consensus 394 ~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~---~~~~l~~~ 469 (635)
T 4fl3_A 394 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDK 469 (635)
T ss_dssp SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHH---HCTTCCHH
T ss_pred CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHh---hCCCCCHH
Confidence 35788999999754 3345688999999999999999999999986 456899999999999999994 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..... ........++..|+|||++.+
T Consensus 470 ~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 470 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546 (635)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC
Confidence 99999999999999999998 99999999999999999999999999987643321 122222345788999999999
Q ss_pred CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..++.++|||||||++|+|++ |..||...... ........+.... .+...+.++.+||.+||+
T Consensus 547 ~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG---------CPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTC
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcC
Confidence 999999999999999999998 99998543221 1111122221111 112233578999999999
Q ss_pred CCCCCCCCHHHHHHhhccCC
Q 045452 240 ENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~~~ 259 (303)
.||++|||+.+|++.|++..
T Consensus 611 ~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 611 YDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp SSTTTSCCHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=287.19 Aligned_cols=228 Identities=23% Similarity=0.284 Sum_probs=177.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||+++..... ..+|++++.++ +||||+++++++.+....++||||+.+|+|.+++.. ...+++..
T Consensus 45 ~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~---~~~~~~~~ 117 (342)
T 2qr7_A 45 ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR---QKFFSERE 117 (342)
T ss_dssp TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---CTTCCHHH
T ss_pred CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHH
Confidence 47899999999655322 34678888887 899999999999999999999999999999998853 45689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC----CcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~----~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
+..++.||+.||+|||+.| ++||||||+||++... +.+||+|||++....... .......++..|+|||++
T Consensus 118 ~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVL 192 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHh
Confidence 9999999999999999998 9999999999998543 359999999997654332 122335689999999999
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+..++.++|||||||++|+|++|..||............. ....+... .........+.++.+||.+||
T Consensus 193 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L 262 (342)
T 2qr7_A 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIGSGKFS-------LSGGYWNSVSDTAKDLVSKML 262 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HHHHCCCC-------CCSTTTTTSCHHHHHHHHHHT
T ss_pred cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HHccCCcc-------cCccccccCCHHHHHHHHHHC
Confidence 88888999999999999999999999996432222111111 11111110 001111223457889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
..||++|||+.++++
T Consensus 263 ~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 263 HVDPHQRLTAALVLR 277 (342)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CCChhHCcCHHHHhc
Confidence 999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=290.80 Aligned_cols=222 Identities=20% Similarity=0.212 Sum_probs=169.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHH-HhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVML-TAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++... ......+..|..+ ++.++||||+++++++.+.+..|+||||+.||+|.+++. ....++
T Consensus 61 ~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 137 (373)
T 2r5t_A 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFL 137 (373)
T ss_dssp TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCC
Confidence 468999999996542 2334556677776 467899999999999999999999999999999999884 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| ++||||||+|||++.+|.+||+|||++...... .......+|++.|+|||++.
T Consensus 138 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 212 (373)
T 2r5t_A 138 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLH 212 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhC
Confidence 9999999999999999999999 999999999999999999999999998753322 12233467899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|+|||||++|+|++|..||..... ............ . .+...+..+.+||.+||.
T Consensus 213 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~--~---------~~~~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL--Q---------LKPNITNSARHLLEGLLQ 275 (373)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCC--C---------CCSSSCHHHHHHHHHHTC
T ss_pred CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhccc--C---------CCCCCCHHHHHHHHHHcc
Confidence 99999999999999999999999999953321 111112222110 0 111223478899999999
Q ss_pred CCCCCCCCHHH
Q 045452 240 ENPNDRPSMLE 250 (303)
Q Consensus 240 ~dp~~Rps~~~ 250 (303)
.||.+||++.+
T Consensus 276 ~dp~~R~~~~~ 286 (373)
T 2r5t_A 276 KDRTKRLGAKD 286 (373)
T ss_dssp SSGGGSTTTTT
T ss_pred cCHHhCCCCCC
Confidence 99999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=277.21 Aligned_cols=227 Identities=22% Similarity=0.358 Sum_probs=183.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||.+.... ..+.+.+|+.+++.++||||+++++++......++||||+.+++|.+++.. ....+++..+
T Consensus 52 ~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~ 127 (314)
T 3com_A 52 ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEI 127 (314)
T ss_dssp TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--HTCCCCHHHH
T ss_pred CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh--cCCCCCHHHH
Confidence 468999999986543 346788999999999999999999999999999999999999999998842 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.+|+.||.|||+.| ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..+
T Consensus 128 ~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 202 (314)
T 3com_A 128 ATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGY 202 (314)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCB
T ss_pred HHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCC
Confidence 999999999999999998 9999999999999999999999999997654322 12233467899999999998889
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++||||||+++|+|++|..||..... ............ ... ..+...+..+.++|.+||..||+
T Consensus 203 ~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~-------~~~~~~~~~l~~li~~~l~~dp~ 268 (314)
T 3com_A 203 NCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNPP-PTF-------RKPELWSDNFTDFVKQCLVKSPE 268 (314)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCC-------SSGGGSCHHHHHHHHHHTCSCTT
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCC-ccc-------CCcccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999853321 111111111110 000 11222335788999999999999
Q ss_pred CCCCHHHHHH
Q 045452 244 DRPSMLEVSS 253 (303)
Q Consensus 244 ~Rps~~~l~~ 253 (303)
+|||+.++++
T Consensus 269 ~Rpt~~~ll~ 278 (314)
T 3com_A 269 QRATATQLLQ 278 (314)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHHh
Confidence 9999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=280.93 Aligned_cols=240 Identities=25% Similarity=0.332 Sum_probs=177.2
Q ss_pred CCCCEEEEEEccCCC-----hhhHHHHHHHHHHHhcC---CCCcceeEEEEEEeCC-----eeeEEEeeCCCCChhhhhc
Q 045452 4 PCGEVIAVKKLSKSS-----AQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~ 70 (303)
.+|+.||||+++... ......+.+|+.+++.+ +||||+++++++.... ..+++|||+. ++|.+++.
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 110 (308)
T 3g33_A 32 HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLD 110 (308)
T ss_dssp TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHH
T ss_pred CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHh
Confidence 578999999986332 11234566677777666 5999999999998765 5799999996 59999886
Q ss_pred CcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccc
Q 045452 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTI 150 (303)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 150 (303)
.. ....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... ......++.
T Consensus 111 ~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~ 183 (308)
T 3g33_A 111 KA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTL 183 (308)
T ss_dssp TC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCC
T ss_pred hc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccc
Confidence 53 2334899999999999999999999999 9999999999999999999999999997654322 223346799
Q ss_pred cccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc------ccccccCC---
Q 045452 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF------VDSFLDDR--- 221 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~--- 221 (303)
.|+|||++.+..++.++|||||||++|+|++|..||........ ................ ........
T Consensus 184 ~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (308)
T 3g33_A 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPR 260 (308)
T ss_dssp SSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCC
T ss_pred cccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhccchhhccccccCCCCCC
Confidence 99999999989999999999999999999999999964332221 1111111111100000 00000000
Q ss_pred ----CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 222 ----NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 222 ----~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.....+..+.+||.+||+.||++|||+.++++.
T Consensus 261 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 261 PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 001123478899999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=275.75 Aligned_cols=228 Identities=22% Similarity=0.310 Sum_probs=184.0
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++
T Consensus 37 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 113 (284)
T 2vgo_A 37 QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---HGRFDE 113 (284)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---HSSCCH
T ss_pred CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh---cCCCCH
Confidence 468899999985432 22356788999999999999999999999999999999999999999999843 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++....... .....|+..|+|||.+.+
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 114 QRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhcc
Confidence 999999999999999999998 9999999999999999999999999986554321 223467999999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||...... ........... ..+...+..+.++|.+||..
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNVDL-----------KFPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC-----------CCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcccc-----------CCCCcCCHHHHHHHHHHhhc
Confidence 88999999999999999999999998543211 11111111110 11122334788999999999
Q ss_pred CCCCCCCHHHHHH--hhccC
Q 045452 241 NPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 241 dp~~Rps~~~l~~--~L~~~ 258 (303)
||.+|||+.++++ +++..
T Consensus 250 ~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 250 HPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp SGGGSCCHHHHHTCHHHHHH
T ss_pred CHhhCCCHHHHhhCHHHHhh
Confidence 9999999999985 45543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.90 Aligned_cols=239 Identities=23% Similarity=0.257 Sum_probs=173.4
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...|+||||+.++ |.+.+.
T Consensus 85 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~----- 158 (464)
T 3ttj_A 85 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----- 158 (464)
T ss_dssp TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT-----
T ss_pred CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh-----
Confidence 57899999999654 345567888999999999999999999999654 3579999999764 656652
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++....... ......|++.|+||
T Consensus 159 ~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aP 232 (464)
T 3ttj_A 159 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 232 (464)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCH
T ss_pred hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCH
Confidence 23889999999999999999999999 9999999999999999999999999997654321 22335789999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH----------------HHHhhCCC---ccc---c
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA----------------YELWKGGK---GME---F 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~---~~~---~ 213 (303)
|++.+..++.++|||||||++|+|++|+.||......+....+... ........ ... .
T Consensus 233 E~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (464)
T 3ttj_A 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 312 (464)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHH
T ss_pred HHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHh
Confidence 9999999999999999999999999999999643321111111000 00000000 000 0
Q ss_pred ccccccCC---CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 VDSFLDDR---NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
........ .....+.++.+||.+||..||++|||++++++.
T Consensus 313 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 313 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 001124578999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=301.61 Aligned_cols=231 Identities=27% Similarity=0.328 Sum_probs=183.7
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++. ....+++
T Consensus 49 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~ 125 (484)
T 3nyv_A 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSE 125 (484)
T ss_dssp TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCBH
T ss_pred CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH---hcCCCCH
Confidence 478999999985432 3456789999999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
..+..++.||+.||+|||+.| ++||||||+||++ +.++.+||+|||++..+.... ......|++.|+|||+
T Consensus 126 ~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 199 (484)
T 3nyv_A 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEV 199 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCcee
Confidence 999999999999999999998 9999999999999 567899999999997664332 2223468999999999
Q ss_pred cccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+.+ .++.++|||||||++|+|++|..||...... ........+....... .....+.++.+||.+|
T Consensus 200 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~~ 265 (484)
T 3nyv_A 200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGKYTFELP-------QWKKVSESAKDLIRKM 265 (484)
T ss_dssp HHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCSG-------GGGGSCHHHHHHHHHH
T ss_pred ecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCCCCc-------ccccCCHHHHHHHHHH
Confidence 876 6899999999999999999999999643211 1111112211111100 0112234788999999
Q ss_pred ccCCCCCCCCHHHHHH--hhcc
Q 045452 238 VQENPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 238 l~~dp~~Rps~~~l~~--~L~~ 257 (303)
|..||++|||+.++++ +++.
T Consensus 266 L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 266 LTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp TCSSGGGSCCHHHHHTSHHHHH
T ss_pred CCCChhHCcCHHHHhhChhhcc
Confidence 9999999999999985 3544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=283.57 Aligned_cols=223 Identities=21% Similarity=0.218 Sum_probs=171.1
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||++.... .........|+..+..+ +|+||+++++++.++...++||||+ +++|.+++.. ....+++
T Consensus 80 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~l~~ 156 (311)
T 3p1a_A 80 EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA--WGASLPE 156 (311)
T ss_dssp TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--HCSCCCH
T ss_pred CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh--cCCCCCH
Confidence 479999999986542 33344555566665555 9999999999999999999999999 6788888754 2456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ......|+..|+|||++.+
T Consensus 157 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 157 AQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC
Confidence 999999999999999999998 9999999999999999999999999987654322 2223458999999999876
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|||||||++|+|++|..|+.... ............ .. +...+.++.++|.+||+.
T Consensus 231 -~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~----~~----~~~~~~~l~~li~~~L~~ 291 (311)
T 3p1a_A 231 -SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPP----EF----TAGLSSELRSVLVMMLEP 291 (311)
T ss_dssp -CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCH----HH----HTTSCHHHHHHHHHHSCS
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCc----cc----ccCCCHHHHHHHHHHcCC
Confidence 68999999999999999999976653211 111111111110 00 111234788999999999
Q ss_pred CCCCCCCHHHHHHh
Q 045452 241 NPNDRPSMLEVSSM 254 (303)
Q Consensus 241 dp~~Rps~~~l~~~ 254 (303)
||++|||+.++++.
T Consensus 292 dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 292 DPKLRATAEALLAL 305 (311)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhhCcCHHHHHhC
Confidence 99999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=299.70 Aligned_cols=233 Identities=25% Similarity=0.331 Sum_probs=182.0
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++.. .......+.+|+.++++++||||+++++++.+....++||||+.+++|.+++. ....+++.
T Consensus 45 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~ 121 (486)
T 3mwu_A 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEH 121 (486)
T ss_dssp TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHH---hcCCCCHH
Confidence 47899999998543 22346788999999999999999999999999999999999999999998884 34569999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~---~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
.+..++.||+.||.|||+.| |+||||||+||+++ .++.+||+|||++..+.... ......|++.|+|||++
T Consensus 122 ~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 195 (486)
T 3mwu_A 122 DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVL 195 (486)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGG
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHh
Confidence 99999999999999999999 99999999999995 45679999999997654322 22334689999999998
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+ .++.++|||||||++|+|++|..||...... ........+....... .....+.++.+||.+||
T Consensus 196 ~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~~L 261 (486)
T 3mwu_A 196 RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFDLP-------QWRTISDDAKDLIRKML 261 (486)
T ss_dssp GS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCSCSG-------GGGGSCHHHHHHHHHHT
T ss_pred CC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCCc-------ccCCCCHHHHHHHHHHc
Confidence 76 4899999999999999999999999543211 1111111111111100 01112347889999999
Q ss_pred cCCCCCCCCHHHHHHh--hccCC
Q 045452 239 QENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
..||++|||+.++++. +++..
T Consensus 262 ~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 262 TFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCChhhCcCHHHHhcCHhhccCc
Confidence 9999999999999864 55543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=279.45 Aligned_cols=228 Identities=21% Similarity=0.285 Sum_probs=179.5
Q ss_pred CCCCEEEEEEccCCCh------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSA------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++. ....
T Consensus 28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~ 104 (283)
T 3bhy_A 28 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKES 104 (283)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH---hcCC
Confidence 4789999999864421 246789999999999999999999999999999999999999999999984 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEecccccccccccccccccceeecccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~----~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
+++..++.++.||+.||.+||+.| ++|+||+|+||+++.++ .+||+|||.+....... ......++..|+
T Consensus 105 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 178 (283)
T 3bhy_A 105 LTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFV 178 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCcc
Confidence 899999999999999999999998 99999999999998877 79999999997654322 122345789999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||.+.+..++.++||||||+++|+|++|..||...... ............ .... .. ...+..+.++
T Consensus 179 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--~~~~-~~----~~~~~~~~~l 245 (283)
T 3bhy_A 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVNYD--FDEE-YF----SNTSELAKDF 245 (283)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC--CCHH-HH----TTCCHHHHHH
T ss_pred CcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcccC--Ccch-hc----ccCCHHHHHH
Confidence 999999889999999999999999999999998543211 111111111100 0000 00 1113468899
Q ss_pred HHhcccCCCCCCCCHHHHHH
Q 045452 234 ALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~ 253 (303)
+.+||..||++|||+.++++
T Consensus 246 i~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 246 IRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHh
Confidence 99999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=293.43 Aligned_cols=172 Identities=25% Similarity=0.370 Sum_probs=140.6
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...|+||||+ +++|.+++. ...
T Consensus 76 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---~~~ 151 (458)
T 3rp9_A 76 LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR---TPV 151 (458)
T ss_dssp C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH---SSC
T ss_pred CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc---cCC
Confidence 47899999998653 344567899999999999999999999998543 4689999998 578888884 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc----------------
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK---------------- 140 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~---------------- 140 (303)
.+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++.........
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (458)
T 3rp9_A 152 YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228 (458)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-----------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccc
Confidence 6999999999999999999999998 999999999999999999999999999876422110
Q ss_pred ---------cccceeeccccccCchhc-ccCCCCCcccchhhHHHHHHHHhC
Q 045452 141 ---------ANTEQVVGTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISG 182 (303)
Q Consensus 141 ---------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g 182 (303)
......+||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 229 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp ----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 112335679999999975 566799999999999999999993
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=299.32 Aligned_cols=227 Identities=26% Similarity=0.330 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++. ....+++.
T Consensus 60 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~ 136 (494)
T 3lij_A 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEV 136 (494)
T ss_dssp TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH---HcCCCCHH
Confidence 478999999986543 3345778899999999999999999999999999999999999999988884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
.++.++.||+.||+|||+.| ++||||||+||+++.. +.+||+|||++..+.... ......|++.|+|||++
T Consensus 137 ~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l 210 (494)
T 3lij_A 137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVL 210 (494)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHH
Confidence 99999999999999999998 9999999999999764 459999999997765432 22335689999999988
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
. ..++.++|||||||++|+|++|..||...... ........+..... .... ...+..+.+||.+||
T Consensus 211 ~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~--~~~~-----~~~s~~~~~li~~~L 276 (494)
T 3lij_A 211 R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYTFD--SPEW-----KNVSEGAKDLIKQML 276 (494)
T ss_dssp T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC--SGGG-----TTSCHHHHHHHHHHT
T ss_pred c-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC--chhc-----ccCCHHHHHHHHHHC
Confidence 6 45899999999999999999999999643221 11111111111100 0000 112346889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
..||.+|||+.++++
T Consensus 277 ~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 277 QFDSQRRISAQQALE 291 (494)
T ss_dssp CSSTTTSCCHHHHHT
T ss_pred CCChhhCccHHHHhc
Confidence 999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=275.43 Aligned_cols=229 Identities=27% Similarity=0.346 Sum_probs=184.9
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|++... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+.+++|.+++. ....+++
T Consensus 38 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~ 114 (294)
T 2rku_A 38 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTE 114 (294)
T ss_dssp TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCSCCH
T ss_pred CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH---hcCCCCH
Confidence 46889999998643 34456788999999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++|+||+|+||+++.++.+||+|||++....... .......++..|+|||.+.+
T Consensus 115 ~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 115 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhcc
Confidence 999999999999999999998 9999999999999999999999999997654322 12223467899999999988
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++||||||+++|+|++|..||...... ........... ..+...+..+.++|.+||..
T Consensus 190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~ 252 (294)
T 2rku_A 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEY-----------SIPKHINPVAASLIQKMLQT 252 (294)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhccC-----------CCccccCHHHHHHHHHHccc
Confidence 88999999999999999999999998543211 11111111110 11112234688999999999
Q ss_pred CCCCCCCHHHHHH--hhcc
Q 045452 241 NPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 241 dp~~Rps~~~l~~--~L~~ 257 (303)
||++|||++++++ ++..
T Consensus 253 ~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 253 DPTARPTINELLNDEFFTS 271 (294)
T ss_dssp SGGGSCCGGGGGGSHHHHT
T ss_pred ChhhCcCHHHHhhChheec
Confidence 9999999999986 3544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=288.23 Aligned_cols=231 Identities=22% Similarity=0.293 Sum_probs=181.6
Q ss_pred CCCCEEEEEEccCCC----hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||||+++... ....+.+.+|+.+++.+ +||||+++++++......++||||+.+++|.+++.. ...+
T Consensus 80 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~ 156 (355)
T 1vzo_A 80 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERF 156 (355)
T ss_dssp TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH---HSCC
T ss_pred CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH---cCCC
Confidence 589999999986432 22345677899999999 799999999999999999999999999999999843 4568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++..+.... ........|+..|+|||++
T Consensus 157 ~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 157 TEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIV 232 (355)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhh
Confidence 99999999999999999999998 9999999999999999999999999997654322 1122235689999999998
Q ss_pred ccC--CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 159 RQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+. .++.++|||||||++|+|++|..||...........+.. ...... ...+...+..+.+||.+
T Consensus 233 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~~~~~~li~~ 299 (355)
T 1vzo_A 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSE-----------PPYPQEMSALAKDLIQR 299 (355)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHCC-----------CCCCTTSCHHHHHHHHH
T ss_pred cCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhccC-----------CCCCcccCHHHHHHHHH
Confidence 753 478899999999999999999999975544332222221 111111 01112223468899999
Q ss_pred cccCCCCCCC-----CHHHHHHh
Q 045452 237 CVQENPNDRP-----SMLEVSSM 254 (303)
Q Consensus 237 cl~~dp~~Rp-----s~~~l~~~ 254 (303)
||..||++|| |+.++++.
T Consensus 300 ~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 300 LLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HhhhCHHHhcCCCCCCHHHHHcC
Confidence 9999999999 88988764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=281.09 Aligned_cols=228 Identities=28% Similarity=0.400 Sum_probs=176.5
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
+|+.||+|+++... ..+.+.+|+.++++++||||+++++++... ...++||||+++++|.+++... ....+++..+
T Consensus 43 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 119 (278)
T 1byg_A 43 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 119 (278)
T ss_dssp TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHH
T ss_pred cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc-ccccCCHHHH
Confidence 57899999997543 457789999999999999999999997654 4789999999999999998542 2234789999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||++||+.| ++|+||||+||+++.++.++|+|||++....... ....++..|+|||.+.+..+
T Consensus 120 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 191 (278)
T 1byg_A 120 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 191 (278)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCC
Confidence 999999999999999998 9999999999999999999999999987544321 22346789999999998889
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++||||||+++|+|++ |..||........ . ........ ...+...+..+.++|.+||..||
T Consensus 192 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p 255 (278)
T 1byg_A 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKGYK---------MDAPDGCPPAVYEVMKNCWHLDA 255 (278)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H----HHHTTTCC---------CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHhcCCC---------CCCcccCCHHHHHHHHHHhcCCh
Confidence 999999999999999998 9999864432211 1 11111111 11122234578899999999999
Q ss_pred CCCCCHHHHHHhhccCC
Q 045452 243 NDRPSMLEVSSMLKNET 259 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~ 259 (303)
++|||+.++++.|++..
T Consensus 256 ~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 256 AMRPSFLQLREQLEHIK 272 (278)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHH
Confidence 99999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=272.78 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=178.4
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++. ....
T Consensus 49 ~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~ 125 (290)
T 1t4h_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKV 125 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH---HccC
Confidence 57889999998643 45567789999999999999999999999875 346899999999999999984 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+++..++.++.||+.||+|||+.+ .+++|+||||+||+++ .++.+||+|||++...... ......|+..|+|||
T Consensus 126 ~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE 200 (290)
T 1t4h_A 126 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE 200 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHH
Confidence 899999999999999999999865 2499999999999998 7899999999998654332 122345899999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.+ .++.++||||||+++|+|++|..||...... ................. ...+.++.++|.+
T Consensus 201 ~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~ 265 (290)
T 1t4h_A 201 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD--------KVAIPEVKEIIEG 265 (290)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG--------GCCCHHHHHHHHH
T ss_pred HHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccccC--------CCCCHHHHHHHHH
Confidence 8874 4899999999999999999999999533211 11112222111111111 1112368899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 045452 237 CVQENPNDRPSMLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~ 253 (303)
||..||.+|||+.++++
T Consensus 266 ~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 266 CIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=289.73 Aligned_cols=176 Identities=24% Similarity=0.275 Sum_probs=152.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-----CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-----HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||||+++. .......+..|+.+++.++ ||||+++++++......++||||+ +++|.+++... ....+
T Consensus 58 ~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~ 134 (360)
T 3llt_A 58 DNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGF 134 (360)
T ss_dssp TTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCC
T ss_pred CCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCC
Confidence 5789999999964 3445567788999999886 999999999999999999999999 89999998542 23358
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-------------------------CCcEEEeccccccc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-------------------------DMKPKISDFGLARI 133 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-------------------------~~~~kl~df~~~~~ 133 (303)
++..++.++.||+.||+|||+.| |+||||||+|||++. ++.+||+|||++..
T Consensus 135 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~ 211 (360)
T 3llt_A 135 HIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCcee
Confidence 99999999999999999999999 999999999999975 78899999999975
Q ss_pred ccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccC
Q 045452 134 FAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 190 (303)
.... .....|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 212 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 212 KSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp TTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 4332 223467999999999999999999999999999999999999996543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=288.23 Aligned_cols=229 Identities=22% Similarity=0.342 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccCCC--------hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc
Q 045452 4 PCGEVIAVKKLSKSS--------AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
.+|+.||||+++... ....+.+.+|+.+++++ +||||+++++++......++||||+.+++|.+++. .
T Consensus 117 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~ 193 (365)
T 2y7j_A 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---E 193 (365)
T ss_dssp TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH---H
T ss_pred CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH---h
Confidence 479999999986543 12245678999999999 89999999999999999999999999999999984 3
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..+..++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||++..+.... ......|++.|+|
T Consensus 194 ~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~a 267 (365)
T 2y7j_A 194 KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLA 267 (365)
T ss_dssp HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccC
Confidence 456899999999999999999999998 9999999999999999999999999987665322 2233568999999
Q ss_pred chhccc------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHH
Q 045452 155 PEYARQ------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228 (303)
Q Consensus 155 PE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
||++.+ ..++.++|||||||++|+|++|..||..... .........+..... .... ...+.
T Consensus 268 PE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~--~~~~-----~~~~~ 334 (365)
T 2y7j_A 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLRMIMEGQYQFS--SPEW-----DDRSS 334 (365)
T ss_dssp HHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCCC--HHHH-----SSSCH
T ss_pred hhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCCC--Cccc-----ccCCH
Confidence 998863 3578899999999999999999999954321 111111111111100 0000 01123
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 229 RCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 229 ~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+.++|.+||..||++|||+.++++.
T Consensus 335 ~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 335 TVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 68899999999999999999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=288.59 Aligned_cols=247 Identities=15% Similarity=0.172 Sum_probs=186.9
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCccee---------------EEEEEEe-CCeeeEEEeeCCCCChhhh
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIR---------------VLGFCID-SEERMLVYEYMPNKSLDCY 68 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~ 68 (303)
+|+.||||.++.. +.+.+|+.++++++||||++ +++++.. +...++||||+ +++|.++
T Consensus 74 ~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 147 (352)
T 2jii_A 74 QKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSA 147 (352)
T ss_dssp ---CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHH
T ss_pred cCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHH
Confidence 5899999998654 35778999999999999887 6778776 67889999999 9999999
Q ss_pred hcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC--cEEEecccccccccccccc-----c
Q 045452 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM--KPKISDFGLARIFAKESLK-----A 141 (303)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~--~~kl~df~~~~~~~~~~~~-----~ 141 (303)
+... ....+++..++.++.||+.||+|||+.| ++||||||+||+++.++ .+||+|||++..+...... .
T Consensus 148 l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 223 (352)
T 2jii_A 148 LDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223 (352)
T ss_dssp HHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTT
T ss_pred HHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccc
Confidence 9642 2367999999999999999999999998 99999999999999998 8999999999776533211 1
Q ss_pred ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCC
Q 045452 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDR 221 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||....... ............. ...+......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~-- 298 (352)
T 2jii_A 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT--EDIMKQKQKFVDK-PGPFVGPCGH-- 298 (352)
T ss_dssp SSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--HHHHHHHHHHHHS-CCCEECTTSC--
T ss_pred ccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH--HHHHHHHHhccCC-hhhhhhhccc--
Confidence 1123468999999999999889999999999999999999999997554221 1111111111111 1111111100
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCC
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKK 267 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 267 (303)
....+.++.+||.+||..||++|||+.++++.|++..........
T Consensus 299 -~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 343 (352)
T 2jii_A 299 -WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPY 343 (352)
T ss_dssp -EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTT
T ss_pred -cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcC
Confidence 011134788999999999999999999999999988766554443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.35 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=178.7
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHH--HhcCCCCcceeEEEEEEe-----CCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVML--TAKLQHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
+|+.||||+++... ...+..|.++ +..++|+||+++++.+.. ...+++||||+++|+|.+++. ...
T Consensus 35 ~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~ 107 (336)
T 3g2f_A 35 DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHT 107 (336)
T ss_dssp TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHH----HCC
T ss_pred CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHh----hcc
Confidence 68899999996443 2334444444 455899999999986643 225789999999999999983 334
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhc---------CCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc------ccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEY---------SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------KAN 142 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~---------~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~------~~~ 142 (303)
.++..++.++.||+.||+|||+. + ++||||||+|||++.++.+||+|||++..+..... ...
T Consensus 108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 184 (336)
T 3g2f_A 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184 (336)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC--------
T ss_pred cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccc
Confidence 58899999999999999999998 7 99999999999999999999999999987653321 111
Q ss_pred cceeeccccccCchhccc-------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHH-----------HHHHHH
Q 045452 143 TEQVVGTIGYIPPEYARQ-------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL-----------EHAYEL 204 (303)
Q Consensus 143 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-----------~~~~~~ 204 (303)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|..||............ ......
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (336)
T 3g2f_A 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL 264 (336)
T ss_dssp -CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHH
T ss_pred cccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhh
Confidence 223458999999999876 34567899999999999999998877544432221111 111111
Q ss_pred hh-CCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCC
Q 045452 205 WK-GGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETTNTNTPK 266 (303)
Q Consensus 205 ~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 266 (303)
.. ......+... .......+.++.+||.+||..||++|||+.++++.|+++........
T Consensus 265 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 265 VSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 11 1111111111 11223355679999999999999999999999999999776554443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=290.69 Aligned_cols=176 Identities=26% Similarity=0.365 Sum_probs=145.7
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++|+||+++++++... ...|+||||+. ++|.+++. ...
T Consensus 49 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~ 124 (432)
T 3n9x_A 49 NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK---TPI 124 (432)
T ss_dssp TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH---SSC
T ss_pred CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh---ccC
Confidence 57899999999754 334567889999999999999999999999766 57899999985 59999884 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc----------------
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK---------------- 140 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~---------------- 140 (303)
.+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++.........
T Consensus 125 ~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (432)
T 3n9x_A 125 FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201 (432)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccc
Confidence 6999999999999999999999999 999999999999999999999999999876433211
Q ss_pred ----cccceeeccccccCchhc-ccCCCCCcccchhhHHHHHHHHhCCCCc
Q 045452 141 ----ANTEQVVGTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 141 ----~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p~ 186 (303)
......+||..|+|||++ ....++.++|||||||++|+|++|..||
T Consensus 202 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ---------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 112445789999999985 5667999999999999999999865554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=281.34 Aligned_cols=240 Identities=25% Similarity=0.359 Sum_probs=167.9
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-----CcccC
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-----IRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~~~~ 77 (303)
.+|+.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .....
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 117 (303)
T 2vwi_A 38 PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117 (303)
T ss_dssp ---CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCS
T ss_pred CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCC
Confidence 478999999986543 345577889999999999999999999999999999999999999999988531 12456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc---ccccceeeccccccC
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL---KANTEQVVGTIGYIP 154 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~~~~y~a 154 (303)
+++..++.++.||+.||.|||+.| ++|+||+|+||+++.++.+||+|||++........ ........++..|+|
T Consensus 118 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~a 194 (303)
T 2vwi_A 118 LDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194 (303)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccC
Confidence 899999999999999999999998 99999999999999999999999999876543211 112233568999999
Q ss_pred chhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 155 PEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+ ..++.++||||||+++|+|++|..||....... ... ...... .................+.++.++
T Consensus 195 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 267 (303)
T 2vwi_A 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLM---LTLQND-PPSLETGVQDKEMLKKYGKSFRKM 267 (303)
T ss_dssp HHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHTSS-CCCTTC-----CCCCCCCHHHHHH
T ss_pred HHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHH---HHhccC-CCccccccccchhhhhhhHHHHHH
Confidence 998865 568899999999999999999999986443221 111 111111 111111111111112223478899
Q ss_pred HHhcccCCCCCCCCHHHHHH
Q 045452 234 ALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~ 253 (303)
|.+||..||.+|||+.++++
T Consensus 268 i~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 268 ISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhhCcCHHHHhh
Confidence 99999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=283.67 Aligned_cols=231 Identities=14% Similarity=0.086 Sum_probs=183.2
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc--CcccC
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP--IRRLI 77 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~ 77 (303)
..+|+.||||+++.... ..+..|+.+++.++ |+||+++++++...+..++||||+++|+|.+++... .....
T Consensus 92 ~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 168 (365)
T 3e7e_A 92 AKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168 (365)
T ss_dssp --CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCS
T ss_pred cccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccC
Confidence 45789999999976543 45667777777775 999999999999999999999999999999998542 13456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-----------CCcEEEeccccccccccccccccccee
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-----------DMKPKISDFGLARIFAKESLKANTEQV 146 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-----------~~~~kl~df~~~~~~~~~~~~~~~~~~ 146 (303)
+++..++.++.||+.||+|||+.| |+||||||+|||++. ++.+||+|||++..+............
T Consensus 169 l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 245 (365)
T 3e7e_A 169 MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCS
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeee
Confidence 999999999999999999999998 999999999999998 899999999999765433333334446
Q ss_pred eccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH
Q 045452 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 147 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.||..|+|||++.+..++.++|||||||++|+|++|+.||......... ........ ..
T Consensus 246 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------------------~~~~~~~~---~~ 304 (365)
T 3e7e_A 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------------------PEGLFRRL---PH 304 (365)
T ss_dssp SCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE------------------ECSCCTTC---SS
T ss_pred cCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee------------------echhcccc---Cc
Confidence 7899999999999999999999999999999999999998543221100 00001010 11
Q ss_pred HHHHHHHHHhcccCCCCCC-CCHHHHHHhhccCCC
Q 045452 227 LMRCLEIALLCVQENPNDR-PSMLEVSSMLKNETT 260 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~R-ps~~~l~~~L~~~~~ 260 (303)
...+.+++..||..+|.+| |++.++.+.|++...
T Consensus 305 ~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 3457789999999999999 578888887777553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=283.56 Aligned_cols=241 Identities=20% Similarity=0.304 Sum_probs=177.3
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--------CCeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--------SEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||||++.... ......+.+|+.+++.++||||+++++++.. .+..++||||+.+ +|.+.+..
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-- 116 (351)
T 3mi9_A 40 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN-- 116 (351)
T ss_dssp TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC--
T ss_pred CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh--
Confidence 579999999986443 2234577899999999999999999999987 3468999999975 67666643
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc--cccccceeecccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES--LKANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~--~~~~~~~~~~~~~ 151 (303)
....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++..+.... .........|+..
T Consensus 117 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~ 193 (351)
T 3mi9_A 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193 (351)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccC
Confidence 2345899999999999999999999999 9999999999999999999999999997664221 1122233567999
Q ss_pred ccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccccc-----------cc
Q 045452 152 YIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSF-----------LD 219 (303)
Q Consensus 152 y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 219 (303)
|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ... .+.......... ..
T Consensus 194 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (351)
T 3mi9_A 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQL-CGSITPEVWPNVDNYELYEKLELVK 269 (351)
T ss_dssp GCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHH-HCCCCTTTSTTGGGCGGGTSSCCCS
T ss_pred ccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHH-hCCCChhhccccccchhhccccccc
Confidence 999998876 45899999999999999999999998643322111111 111 111111100000 00
Q ss_pred C-CCCh-------HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 220 D-RNSS-------CKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 220 ~-~~~~-------~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
. .... ..+..+.+||.+||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 270 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 0000 012357899999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=275.39 Aligned_cols=232 Identities=25% Similarity=0.346 Sum_probs=179.0
Q ss_pred EEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 8 VIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 8 ~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
.||+|+++.. .....+.+.+|+.++++++||||+++++++.... .++||||+.+++|.+++.. ....+++..++
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~ 124 (291)
T 1u46_A 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK--HQGHFLLGTLS 124 (291)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH--HGGGSCHHHHH
T ss_pred EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh--ccCCcCHHHHH
Confidence 6899998754 2345678999999999999999999999997654 8999999999999999854 23568999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcccCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
.++.|++.||.+||+.+ ++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..+
T Consensus 125 ~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (291)
T 1u46_A 125 RYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201 (291)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCC
Confidence 99999999999999998 999999999999999999999999999776433221 12223456778999999988888
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++||||||+++|+|++ |..||..... ............... .+...+.++.++|.+||..||
T Consensus 202 ~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p 266 (291)
T 1u46_A 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP---------RPEDCPQDIYNVMVQCWAHKP 266 (291)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCC---------CCTTCCHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCCC---------CCcCcCHHHHHHHHHHccCCc
Confidence 999999999999999999 9999853321 111112111111111 112233578899999999999
Q ss_pred CCCCCHHHHHHhhccCCC
Q 045452 243 NDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~~ 260 (303)
.+|||+.++++.|++...
T Consensus 267 ~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 267 EDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp GGSCCHHHHHHHHHHHC-
T ss_pred ccCcCHHHHHHHHHHhCc
Confidence 999999999999988653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=282.01 Aligned_cols=240 Identities=26% Similarity=0.292 Sum_probs=169.2
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCc
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...+++|+++ +++|.+++.
T Consensus 51 ~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---- 125 (367)
T 2fst_X 51 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---- 125 (367)
T ss_dssp TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------
T ss_pred CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh----
Confidence 357899999999654 334567888999999999999999999998754 5679999999 788988873
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... .....++..|+|
T Consensus 126 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~a 197 (367)
T 2fst_X 126 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRA 197 (367)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccC
Confidence 356999999999999999999999998 999999999999999999999999999765432 223468999999
Q ss_pred chhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc------------cccccCC
Q 045452 155 PEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV------------DSFLDDR 221 (303)
Q Consensus 155 PE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~ 221 (303)
||++.+ ..++.++|||||||++|+|++|+.||....... .+........ ....+.. .......
T Consensus 198 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (367)
T 2fst_X 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVG-TPGAELLKKISSESARNYIQSLTQMP 273 (367)
T ss_dssp HHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC-SCCHHHHTTCCCHHHHHHHHTSCCCC
T ss_pred hHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC-CCCHHHHHHhhhHHHHHHHhccCCCC
Confidence 999876 678999999999999999999999996433211 1111111110 0000000 0000000
Q ss_pred -C-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 222 -N-----SSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 222 -~-----~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
. ....+..+.+||.+||..||++|||+.++++. +++..
T Consensus 274 ~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 274 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0 00113468899999999999999999999863 55443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.24 Aligned_cols=225 Identities=20% Similarity=0.327 Sum_probs=174.1
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|+..++.++||||+++++++......++||||+.+++|.+++.. ...+++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 110 (276)
T 2h6d_A 34 LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEE 110 (276)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---HCSCCH
T ss_pred CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc---cCCCCH
Confidence 478999999986442 23456889999999999999999999999999999999999999999999843 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||++||+.| ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 111 MEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999987654322 1223467899999999987
Q ss_pred CCC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..+ +.++||||||+++|+|++|..||...... ... ........ ..+...+..+.++|.+||+
T Consensus 185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~~-----------~~~~~~~~~l~~li~~~l~ 247 (276)
T 2h6d_A 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF---KKIRGGVF-----------YIPEYLNRSVATLLMHMLQ 247 (276)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCC-----------CCCTTSCHHHHHHHHHHTC
T ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH---HHhhcCcc-----------cCchhcCHHHHHHHHHHcc
Confidence 765 57999999999999999999998532211 111 11111110 0111223468899999999
Q ss_pred CCCCCCCCHHHHHHh
Q 045452 240 ENPNDRPSMLEVSSM 254 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~ 254 (303)
.||++|||+.++++.
T Consensus 248 ~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 248 VDPLKRATIKDIREH 262 (276)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CChhhCCCHHHHHhC
Confidence 999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.26 Aligned_cols=223 Identities=19% Similarity=0.268 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc-ccCCC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-RLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~ 79 (303)
.+|+.||||.++.. .......+.+|+..+..+ +||||+++++++.+.+..++||||+++++|.+++..... ...++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 113 (289)
T 1x8b_A 34 LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK 113 (289)
T ss_dssp TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCC
T ss_pred CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCC
Confidence 47999999998754 233456788999999999 999999999999999999999999999999999854221 25689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-------------------CcEEEecccccccccccccc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-------------------MKPKISDFGLARIFAKESLK 140 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-------------------~~~kl~df~~~~~~~~~~~~ 140 (303)
+..++.++.||+.||+|||+.| ++||||||+||+++.+ ..++|+|||.+.......
T Consensus 114 ~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-- 188 (289)
T 1x8b_A 114 EAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-- 188 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC--
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc--
Confidence 9999999999999999999998 9999999999999844 479999999987654322
Q ss_pred cccceeeccccccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccccccc
Q 045452 141 ANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLD 219 (303)
Q Consensus 141 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (303)
...++..|+|||.+.+. .++.++|||||||++|+|++|..++... ... ..........
T Consensus 189 ----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~----~~~~~~~~~~------- 247 (289)
T 1x8b_A 189 ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------DQW----HEIRQGRLPR------- 247 (289)
T ss_dssp ----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------HHH----HHHHTTCCCC-------
T ss_pred ----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------hHH----HHHHcCCCCC-------
Confidence 23479999999998766 5667999999999999999998776321 111 1111111111
Q ss_pred CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 220 DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.+...+.++.++|.+||..||++|||+.++++.
T Consensus 248 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 248 --IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111223478899999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=278.14 Aligned_cols=236 Identities=27% Similarity=0.319 Sum_probs=181.8
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCcC-cccCC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI-RRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~ 78 (303)
.+|+.||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++.... ....+
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 108 (279)
T 2w5a_A 29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108 (279)
T ss_dssp TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCC
T ss_pred CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCC
Confidence 47899999999654 34556789999999999999999999998854 568899999999999999986422 23458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~--~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
++..++.++.|++.||+|||+.+ ..+++|+||+|+||+++.++.+||+|||.+....... .......++..|+|||
T Consensus 109 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 186 (279)
T 2w5a_A 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPE 186 (279)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHH
T ss_pred CHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChH
Confidence 99999999999999999999876 2349999999999999999999999999987654322 1122345789999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.+..++.++||||||+++|+|++|..||...... ........+ ... ..+...+.++.++|.+
T Consensus 187 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~-~~~---------~~~~~~~~~l~~li~~ 250 (279)
T 2w5a_A 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREG-KFR---------RIPYRYSDELNEIITR 250 (279)
T ss_dssp HHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT-CCC---------CCCTTSCHHHHHHHHH
T ss_pred HhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHhhc-ccc---------cCCcccCHHHHHHHHH
Confidence 999888999999999999999999999998643211 111111111 111 1111233578899999
Q ss_pred cccCCCCCCCCHHHHHHhhcc
Q 045452 237 CVQENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~~L~~ 257 (303)
||..||++|||+.++++.+..
T Consensus 251 ~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 251 MLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HTCSSGGGSCCHHHHHTSTTC
T ss_pred HcCCCcccCCCHHHHHhChhh
Confidence 999999999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=274.71 Aligned_cols=235 Identities=22% Similarity=0.228 Sum_probs=179.9
Q ss_pred CCCCEEEEEEccCCC----hhhHHHHHHHHHHHhcCCCCcceeEEEEEE--eCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--DSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++... ....+.+.+|+.++++++||||+++++++. +....++||||+.++ |.+++... ....
T Consensus 28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~ 105 (305)
T 2wtk_C 28 ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV-PEKR 105 (305)
T ss_dssp TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS-TTCS
T ss_pred CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC-cccc
Confidence 578999999996542 234678999999999999999999999985 445789999999876 66666432 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..++.++.||+.||.|||+.| ++||||||+||+++.++.++|+|||.+................++..|+|||.
T Consensus 106 ~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 182 (305)
T 2wtk_C 106 FPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182 (305)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhh
Confidence 899999999999999999999998 99999999999999999999999999977653332333334568999999999
Q ss_pred cccCC--CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 158 ARQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 158 ~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+.+.. ++.++||||||+++|+|++|..||...... ........... ..+...+..+.++|.
T Consensus 183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~~~-----------~~~~~~~~~l~~li~ 245 (305)
T 2wtk_C 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIGKGSY-----------AIPGDCGPPLSDLLK 245 (305)
T ss_dssp HTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCC-----------CCCSSSCHHHHHHHH
T ss_pred ccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHhcCCC-----------CCCCccCHHHHHHHH
Confidence 87654 367999999999999999999998643211 11111111110 011122347889999
Q ss_pred hcccCCCCCCCCHHHHHH--hhccCCC
Q 045452 236 LCVQENPNDRPSMLEVSS--MLKNETT 260 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~--~L~~~~~ 260 (303)
+||..||++|||+.++++ ++++...
T Consensus 246 ~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 246 GMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHccCChhhCCCHHHHhcCcccccCCC
Confidence 999999999999999985 4655443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=279.82 Aligned_cols=240 Identities=22% Similarity=0.255 Sum_probs=182.8
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhc--CCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
+|+.||||+++.. ....+.+|++++.. ++||||+++++++.... ..++||||+.+++|.+++. ...+
T Consensus 64 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~ 136 (342)
T 1b6c_B 64 RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTV 136 (342)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHH----HCCB
T ss_pred cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHh----ccCc
Confidence 5889999999643 34567788888877 79999999999998876 7899999999999999984 3458
Q ss_pred CHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc--ccceeec
Q 045452 79 DWKKRVHIIEGITQGLLYLQ--------EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA--NTEQVVG 148 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~--~~~~~~~ 148 (303)
++..++.++.|++.||+||| +.+ ++||||||+||+++.++.+||+|||++.......... ......|
T Consensus 137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~g 213 (342)
T 1b6c_B 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213 (342)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCC
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCc
Confidence 99999999999999999999 667 9999999999999999999999999997665432211 2233568
Q ss_pred cccccCchhcccCC------CCCcccchhhHHHHHHHHhC----------CCCccccCCCccccHHHHHHHHhh-CCCcc
Q 045452 149 TIGYIPPEYARQGV------YSTKSDVFSFGVLLLQIISG----------KRLSMLCGINENLSILEHAYELWK-GGKGM 211 (303)
Q Consensus 149 ~~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 211 (303)
+..|+|||.+.+.. ++.++||||||+++|+|++| ..||......... ......... .....
T Consensus 214 t~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 291 (342)
T 1b6c_B 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRKVVCEQKLRP 291 (342)
T ss_dssp CGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCC
T ss_pred CcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc--HHHHHHHHHHHHhCC
Confidence 99999999987653 33689999999999999999 6677543322111 111111111 11111
Q ss_pred ccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 212 EFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
.+.. ..........+.+|+.+||..||++|||+.++++.|+++..
T Consensus 292 ~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 292 NIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1111 11123445678999999999999999999999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=297.99 Aligned_cols=233 Identities=28% Similarity=0.338 Sum_probs=182.1
Q ss_pred CCCCEEEEEEccCCCh-------------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhc
Q 045452 4 PCGEVIAVKKLSKSSA-------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~ 70 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+.+|+|.+++.
T Consensus 59 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 138 (504)
T 3q5i_A 59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII 138 (504)
T ss_dssp TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH
Confidence 5789999999864321 235678899999999999999999999999999999999999999998884
Q ss_pred CcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEecccccccccccccccccceee
Q 045452 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~---~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+.| ++||||||+||+++.++ .+||+|||++..+.... ......
T Consensus 139 ---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~ 209 (504)
T 3q5i_A 139 ---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRL 209 (504)
T ss_dssp ---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCC
T ss_pred ---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---cccccc
Confidence 3456999999999999999999999998 99999999999998776 69999999997665432 223356
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
|++.|+|||++.+ .++.++|||||||++|+|++|..||....... .......+....... .. ...+
T Consensus 210 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~~~--~~-----~~~s 275 (504)
T 3q5i_A 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKKVEKGKYYFDFN--DW-----KNIS 275 (504)
T ss_dssp SCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCHH--HH-----TTSC
T ss_pred CCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCCCCcc--cc-----CCCC
Confidence 8999999999874 58999999999999999999999996432211 111111111110000 00 0123
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH--hhccCC
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
.++.+||.+||..||.+|||++++++ ++++..
T Consensus 276 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 47889999999999999999999985 355433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.60 Aligned_cols=219 Identities=16% Similarity=0.181 Sum_probs=167.6
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHH---HHHhcCCCCcceeEE-------EEEEeCC-----------------ee
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEV---MLTAKLQHVNLIRVL-------GFCIDSE-----------------ER 53 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~~~~-----------------~~ 53 (303)
.+|+.||||+++.. .....+.+.+|+ ..+++++||||++++ +++...+ ..
T Consensus 96 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 175 (377)
T 3byv_A 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175 (377)
T ss_dssp CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESE
T ss_pred CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEE
Confidence 57999999999633 344667899999 455556899999998 7766553 27
Q ss_pred eEEEeeCCCCChhhhhcCcCc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccc
Q 045452 54 MLVYEYMPNKSLDCYLFDPIR----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 54 ~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~ 129 (303)
+++|||+ +|+|.+++..... ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 176 ~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG 251 (377)
T 3byv_A 176 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 251 (377)
T ss_dssp EEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEech
Confidence 8999999 6899999854211 112334888899999999999999998 9999999999999999999999999
Q ss_pred ccccccccccccccceeeccccccCchhcccC-----------CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHH
Q 045452 130 LARIFAKESLKANTEQVVGTIGYIPPEYARQG-----------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 198 (303)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 198 (303)
++..... ......| ..|+|||++.+. .++.++|||||||++|+|++|..||............
T Consensus 252 ~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~ 325 (377)
T 3byv_A 252 HLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325 (377)
T ss_dssp GCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG
T ss_pred hheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh
Confidence 9875332 2223456 999999999877 7899999999999999999999998543322211100
Q ss_pred HHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 199 EHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.. .....+.++.+||.+||..||++|||+.++++
T Consensus 326 ---------------~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 326 ---------------FR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp ---------------GS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ---------------hh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 00 00112347889999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=276.81 Aligned_cols=228 Identities=23% Similarity=0.308 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccCCC---------hhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSS---------AQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||||+++... ....+.+.+|+.+++++. ||||+++++++......++||||+.+++|.+++.
T Consensus 40 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--- 116 (298)
T 1phk_A 40 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--- 116 (298)
T ss_dssp TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---
T ss_pred CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHh---
Confidence 478999999986542 123467889999999995 9999999999999999999999999999999984
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
....+++..++.++.||+.||.|||+.| ++|+||+|+||+++.++.+||+|||++..+.... ......++..|+
T Consensus 117 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 190 (298)
T 1phk_A 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 190 (298)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCcccc
Confidence 3456899999999999999999999998 9999999999999999999999999987654322 122346789999
Q ss_pred Cchhcc------cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 154 PPEYAR------QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 154 aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
|||.+. ...++.++||||||+++|+|++|..||..... ............... .......+
T Consensus 191 aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~~~ 257 (298)
T 1phk_A 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQFG-------SPEWDDYS 257 (298)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCCC-------TTTGGGSC
T ss_pred CHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcCCcccC-------cccccccC
Confidence 999875 44678899999999999999999999854321 111111111111100 00111234
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
..+.++|.+||..||++|||+.++++
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHh
Confidence 57889999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.96 Aligned_cols=235 Identities=20% Similarity=0.257 Sum_probs=179.6
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
..+|+.||||+++... .+.+.+|+.++++++ ||||+++++++.+ ....++||||+.+++|.+++. .++
T Consensus 58 ~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~ 128 (330)
T 3nsz_A 58 ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLT 128 (330)
T ss_dssp TTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG------GCC
T ss_pred CCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH------hCC
Confidence 3578999999997543 467889999999996 9999999999987 567899999999999988873 288
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccccccceeeccccccCchhc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++ .+||+|||++....... ......++..|+|||.+
T Consensus 129 ~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~ 202 (330)
T 3nsz_A 129 DYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 202 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhh
Confidence 8999999999999999999999 99999999999999776 89999999997654322 12234678999999998
Q ss_pred cc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH---------HHhh--------------CCCccccc
Q 045452 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY---------ELWK--------------GGKGMEFV 214 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---------~~~~--------------~~~~~~~~ 214 (303)
.+ ..++.++|||||||++|+|++|..||....... ..+.... .... ........
T Consensus 203 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (330)
T 3nsz_A 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 280 (330)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCG
T ss_pred cCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccch
Confidence 76 668999999999999999999999985433211 1111000 0000 00001111
Q ss_pred cccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 215 DSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 215 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
............+.++.+||.+||+.||++|||++++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp GGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111222222245678999999999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.00 Aligned_cols=229 Identities=25% Similarity=0.307 Sum_probs=169.4
Q ss_pred CCCCEEEEEEccCCC--------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKSS--------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||++.... ......+.+|+.++++++||||+++++++. .+..++||||+.+++|.+++. ..
T Consensus 158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~---~~ 233 (419)
T 3i6u_A 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVV---GN 233 (419)
T ss_dssp TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTS---SS
T ss_pred CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHh---cc
Confidence 578999999986431 112235789999999999999999999975 556899999999999999884 34
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEecccccccccccccccccceeeccccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~---~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++ .+||+|||++....... ......|++.|
T Consensus 234 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y 307 (419)
T 3i6u_A 234 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTY 307 (419)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCc
Confidence 56999999999999999999999998 99999999999997544 59999999998764322 22335689999
Q ss_pred cCchhccc---CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 153 IPPEYARQ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 153 ~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
+|||++.+ ..++.++|||||||++|+|++|..||......... .. ........ ...... ...+..
T Consensus 308 ~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~----~i~~~~~~-~~~~~~-----~~~~~~ 375 (419)
T 3i6u_A 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KD----QITSGKYN-FIPEVW-----AEVSEK 375 (419)
T ss_dssp CCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HH----HHHTTCCC-CCHHHH-----TTSCHH
T ss_pred cCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HH----HHhcCCCC-CCchhh-----cccCHH
Confidence 99998853 56788999999999999999999999644322211 11 11111100 000000 012346
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+.+||.+||+.||++|||+.++++.
T Consensus 376 ~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 376 ALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhCC
Confidence 8899999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=275.31 Aligned_cols=228 Identities=22% Similarity=0.337 Sum_probs=173.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEe------CCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++.. ....++||||+.+++|.+++... ...
T Consensus 47 ~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 124 (326)
T 2x7f_A 47 KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGN 124 (326)
T ss_dssp TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGG
T ss_pred CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccC
Confidence 579999999986543 3346788999999998 89999999999987 46789999999999999998642 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..++.++.||+.||+|||+.| ++|+||+|+||+++.++.+||+|||++....... .......++..|+|||
T Consensus 125 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 199 (326)
T 2x7f_A 125 TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPE 199 (326)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChh
Confidence 6899999999999999999999998 9999999999999999999999999987654321 1223346899999999
Q ss_pred hcc-----cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 157 YAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 157 ~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+. +..++.++|||||||++|+|++|..||..... ............ ... .....+..+.
T Consensus 200 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~--------~~~~~~~~l~ 264 (326)
T 2x7f_A 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIPRNPA-PRL--------KSKKWSKKFQ 264 (326)
T ss_dssp HHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCC--------SCSCSCHHHH
T ss_pred hhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCcc-ccC--------CccccCHHHH
Confidence 986 45688999999999999999999999853221 111111111111 111 1111234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHH
Q 045452 232 EIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~ 253 (303)
++|.+||..||.+|||+.++++
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccChhhCCCHHHHhh
Confidence 9999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=290.34 Aligned_cols=240 Identities=18% Similarity=0.193 Sum_probs=186.1
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCC-CcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||+++..... ..+..|+.+++.++| +++..+..++......++||||+ +++|.+++.. ....+++..
T Consensus 30 ~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~--~~~~l~~~~ 104 (483)
T 3sv0_A 30 QTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF--CSRKLSLKT 104 (483)
T ss_dssp TTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh--hcCCCCHHH
Confidence 67999999987644322 347789999999976 56666777777888899999999 9999999853 245699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEecccccccccccccc-----cccceeeccccccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLK-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~---~~~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~y~a 154 (303)
++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..+...... .......|+..|+|
T Consensus 105 ~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 181 (483)
T 3sv0_A 105 VLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181 (483)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccC
Confidence 9999999999999999998 9999999999999 57899999999999876543221 11224578999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|||||||++|+|++|..||...........+..............+. .. .+.++.+||
T Consensus 182 PE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~-----~~----~p~~l~~li 252 (483)
T 3sv0_A 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC-----RG----YPTEFASYF 252 (483)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH-----TT----SCHHHHHHH
T ss_pred HHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh-----cC----CcHHHHHHH
Confidence 999999999999999999999999999999997655443333333222211111111100 11 124788999
Q ss_pred HhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
..||..||++||++.+|++.|++...
T Consensus 253 ~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 253 HYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999998887643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.82 Aligned_cols=241 Identities=22% Similarity=0.230 Sum_probs=181.8
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC--------CCcceeEEEEEE----eCCeeeEEEeeCCCCChhhhhc
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ--------HVNLIRVLGFCI----DSEERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~ 70 (303)
..+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++. +....++||||+ +++|.+++.
T Consensus 59 ~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~ 136 (397)
T 1wak_A 59 IQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII 136 (397)
T ss_dssp TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHH
T ss_pred cCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHH
Confidence 357899999999643 445677889999999985 788999999987 455889999999 566666654
Q ss_pred CcCcccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCC----------------------------
Q 045452 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDM---------------------------- 121 (303)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~---------------------------- 121 (303)
.. ....+++..++.++.||+.||+|||+. | |+||||||+|||++.++
T Consensus 137 ~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (397)
T 1wak_A 137 KS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212 (397)
T ss_dssp HT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC-----------------
T ss_pred hc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCcccc
Confidence 32 235689999999999999999999998 8 99999999999999775
Q ss_pred ---------------------cEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHH
Q 045452 122 ---------------------KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 122 ---------------------~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 180 (303)
.+||+|||.+...... .....|+..|+|||++.+..++.++|||||||++|+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp ----CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 7999999999765432 22346799999999999988999999999999999999
Q ss_pred hCCCCccccCCCccccHHHH---HHHHhhC---------CCccccccc-------------------cccCCCChHHHHH
Q 045452 181 SGKRLSMLCGINENLSILEH---AYELWKG---------GKGMEFVDS-------------------FLDDRNSSCKLMR 229 (303)
Q Consensus 181 ~g~~p~~~~~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~-------------------~~~~~~~~~~~~~ 229 (303)
+|..||.............. ....... .....+... ......+...+..
T Consensus 288 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (397)
T 1wak_A 288 TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367 (397)
T ss_dssp HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHH
T ss_pred hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHH
Confidence 99999976554432222111 1111110 000000000 0001234555678
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
+.+||.+||..||++|||+.++++.
T Consensus 368 ~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 368 FTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhccChhhcCCHHHHhhC
Confidence 9999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=278.68 Aligned_cols=242 Identities=23% Similarity=0.241 Sum_probs=171.9
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++.... ..++||||+. ++|.+++.
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 121 (371)
T 2xrw_A 48 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----- 121 (371)
T ss_dssp TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH-----
T ss_pred CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh-----
Confidence 57899999998653 3445677889999999999999999999997654 6899999996 46777773
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....... ......|+..|+||
T Consensus 122 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aP 195 (371)
T 2xrw_A 122 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 195 (371)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCH
T ss_pred hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCH
Confidence 34889999999999999999999998 9999999999999999999999999997654321 12235689999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH----------------HHHHhhCCCc---cc---c
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELWKGGKG---ME---F 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~---~~---~ 213 (303)
|++.+..++.++|||||||++|+|++|..||...........+.. .......... .. .
T Consensus 196 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 2xrw_A 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 275 (371)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHH
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhh
Confidence 999998999999999999999999999999964332111000000 0000000000 00 0
Q ss_pred ccccccCC---CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhcc
Q 045452 214 VDSFLDDR---NSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 214 ~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~ 257 (303)
........ .....+..+.+||.+||..||++|||++++++ +++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00000000 01122557899999999999999999999986 3544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=277.62 Aligned_cols=244 Identities=22% Similarity=0.260 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||++... .....+.+.+|+.++++++||||+++++++... ...++||||+. ++|.+++. ...
T Consensus 50 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~----~~~ 124 (364)
T 3qyz_A 50 LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK----TQH 124 (364)
T ss_dssp TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHH----HCC
T ss_pred CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHH----hCC
Confidence 47889999999754 344557889999999999999999999999765 36899999996 58888873 345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE 156 (303)
+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++......... .......|++.|+|||
T Consensus 125 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 201 (364)
T 3qyz_A 125 LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCH
Confidence 999999999999999999999998 999999999999999999999999999876533221 1223457899999999
Q ss_pred hcc-cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc-----------ccccccccC----
Q 045452 157 YAR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM-----------EFVDSFLDD---- 220 (303)
Q Consensus 157 ~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~---- 220 (303)
++. +..++.++|||||||++|+|++|..||......+....+. ......... .........
T Consensus 202 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (364)
T 3qyz_A 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLNCIINLKARNYLLSLPHKNKVP 278 (364)
T ss_dssp HHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred HhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCC
Confidence 764 4558999999999999999999999996544333222111 111000000 000000000
Q ss_pred --CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccC
Q 045452 221 --RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 221 --~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~ 258 (303)
......+.++.+||.+||..||++|||+.++++ ++++.
T Consensus 279 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 279 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 000112346889999999999999999999986 35544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=278.80 Aligned_cols=236 Identities=23% Similarity=0.348 Sum_probs=180.8
Q ss_pred CCCEEEEEEccCCChh-----------------hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhh
Q 045452 5 CGEVIAVKKLSKSSAQ-----------------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 67 (303)
+|+.||||.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 132 (348)
T 2pml_X 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK 132 (348)
T ss_dssp TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSE
T ss_pred CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHH
Confidence 7899999998643211 12789999999999999999999999999999999999999999999
Q ss_pred h------hcCcCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc
Q 045452 68 Y------LFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK 140 (303)
Q Consensus 68 ~------l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~ 140 (303)
+ +.. .....+++..++.++.||+.||.|||+ .| ++|+||+|+||+++.++.++|+|||.+......
T Consensus 133 ~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 205 (348)
T 2pml_X 133 FDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--- 205 (348)
T ss_dssp ESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---
T ss_pred HHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc---
Confidence 8 532 125679999999999999999999998 88 999999999999999999999999999765433
Q ss_pred cccceeeccccccCchhcccC-CCCC-cccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccc-cc
Q 045452 141 ANTEQVVGTIGYIPPEYARQG-VYST-KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVD-SF 217 (303)
Q Consensus 141 ~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 217 (303)
......++..|+|||.+.+. .++. ++||||||+++|+|++|..||....... ................. ..
T Consensus 206 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~i~~~~~~~~~~~~~~ 279 (348)
T 2pml_X 206 -KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-----ELFNNIRTKNIEYPLDRNHF 279 (348)
T ss_dssp -EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-----HHHHHHTSCCCCCCCSSSSS
T ss_pred -cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHhccCcCCccchhhh
Confidence 22334679999999999877 5666 9999999999999999999996443311 11111111111000000 00
Q ss_pred c-------cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 218 L-------DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 218 ~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
. ........+.++.+||.+||..||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 280 LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00001223457889999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=273.70 Aligned_cols=228 Identities=25% Similarity=0.312 Sum_probs=173.4
Q ss_pred CCCCEEEEEEccCCC--------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKSS--------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||++.... ......+.+|+.++++++||||+++++++... ..++||||+.+++|.+++. ..
T Consensus 33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~---~~ 108 (322)
T 2ycf_A 33 KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVV---GN 108 (322)
T ss_dssp TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEETHHHHS---TT
T ss_pred CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceEEEEecCCCCcHHHHHh---cc
Confidence 578999999986432 12234578999999999999999999998665 4899999999999999884 34
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEecccccccccccccccccceeeccccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~---~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
..+++..++.++.||+.||.|||+.| ++||||||+||+++.++. +||+|||++....... ......|+..|
T Consensus 109 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y 182 (322)
T 2ycf_A 109 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTY 182 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCc
Confidence 56899999999999999999999998 999999999999987665 9999999997654321 12234579999
Q ss_pred cCchhcc---cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHH
Q 045452 153 IPPEYAR---QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229 (303)
Q Consensus 153 ~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
+|||++. ...++.++|||||||++|+|++|..||......... ..... .+.. ....... ...+..
T Consensus 183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~---~~~~--~~~~~~~-----~~~~~~ 250 (322)
T 2ycf_A 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT---SGKY--NFIPEVW-----AEVSEK 250 (322)
T ss_dssp CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH---HTCC--CCCHHHH-----TTSCHH
T ss_pred cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH---hCcc--ccCchhh-----hhcCHH
Confidence 9999874 456889999999999999999999999654332211 11111 1100 0000000 012347
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 045452 230 CLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 230 l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
+.++|.+||..||++|||+.++++
T Consensus 251 ~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 251 ALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcccCHhhCCCHHHHhh
Confidence 889999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=279.00 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=176.1
Q ss_pred CEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 7 EVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
..||+|+++... ....+.+.+|+.++++++|+||+++++++.+....+++|||+.+++|.+++.. ....+++..++
T Consensus 56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~ 133 (319)
T 2y4i_B 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTR 133 (319)
T ss_dssp SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHH
T ss_pred CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh--cCCCCCHHHHH
Confidence 358999986432 23345677899999999999999999999999999999999999999999854 23468999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc---cccccceeeccccccCchhccc-
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES---LKANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~- 160 (303)
.++.||+.||+|||+.| ++||||||+||+++ ++.++|+|||++....... .........|+..|+|||.+.+
T Consensus 134 ~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 209 (319)
T 2y4i_B 134 QIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209 (319)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCB
T ss_pred HHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhc
Confidence 99999999999999998 99999999999998 6799999999986543211 1122223457899999998864
Q ss_pred --------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 161 --------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 161 --------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
..++.++||||||+++|+|++|..||...... ..... ............ ..+.++.+
T Consensus 210 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~~--------~~~~~l~~ 274 (319)
T 2y4i_B 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQ-MGTGMKPNLSQI--------GMGKEISD 274 (319)
T ss_dssp SCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHH-HHTTCCCCCCCS--------SCCTTHHH
T ss_pred cccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-hccCCCCCCCcC--------CCCHHHHH
Confidence 34688999999999999999999998533211 11111 111111111110 11235789
Q ss_pred HHHhcccCCCCCCCCHHHHHHhhccCCCCCCCCCCCC
Q 045452 233 IALLCVQENPNDRPSMLEVSSMLKNETTNTNTPKKPA 269 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 269 (303)
++.+||..||++|||+.++++.|++..........|.
T Consensus 275 li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 275 ILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311 (319)
T ss_dssp HHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence 9999999999999999999999999887665544443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.30 Aligned_cols=229 Identities=20% Similarity=0.292 Sum_probs=165.7
Q ss_pred CCCCEEEEEEccCCC-h-hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-CcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS-A-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~ 80 (303)
.+|+.||+|+++... . ...+.+.++...++.++||||+++++++.+....++||||++ ++|.+++... .....+++
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~ 108 (290)
T 3fme_A 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE 108 (290)
T ss_dssp TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCH
T ss_pred CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCH
Confidence 579999999997553 2 233445556666888899999999999999999999999996 5887776431 23457999
Q ss_pred HHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc-
Q 045452 81 KKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA- 158 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~- 158 (303)
..++.++.|++.||+|||+. | ++||||||+||+++.++.+||+|||++....... ......|+..|+|||.+
T Consensus 109 ~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 109 DILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERIN 182 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcC
Confidence 99999999999999999997 8 9999999999999999999999999997654322 12223588999999996
Q ss_pred ---ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 159 ---RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 159 ---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+..++.++||||||+++|+|++|..||..... .............. . ......+.++.++|.
T Consensus 183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~li~ 248 (290)
T 3fme_A 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSP-Q--------LPADKFSAEFVDFTS 248 (290)
T ss_dssp CCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCC-C--------CCTTTSCHHHHHHHH
T ss_pred hhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCC-C--------cccccCCHHHHHHHH
Confidence 455688899999999999999999999953221 11111122221111 1 111122347889999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 045452 236 LCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~ 253 (303)
+||+.||++|||+.++++
T Consensus 249 ~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 249 QCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHhhcChhhCcCHHHHHh
Confidence 999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=283.56 Aligned_cols=231 Identities=12% Similarity=0.075 Sum_probs=160.0
Q ss_pred CCCCEEEEEEccCCCh---hhHHHHHHHHHHHhcC--CCCcceeEE-------EEEEeC-----------------Ceee
Q 045452 4 PCGEVIAVKKLSKSSA---QGFEEFKNEVMLTAKL--QHVNLIRVL-------GFCIDS-----------------EERM 54 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~~~~-----------------~~~~ 54 (303)
.+|+.||||+++.... ...+.+.+|+.+++.| +||||++++ +++... ...+
T Consensus 85 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (371)
T 3q60_A 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164 (371)
T ss_dssp TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEE
T ss_pred CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEE
Confidence 5789999999976532 3456777885544444 699988755 455433 2379
Q ss_pred EEEeeCCCCChhhhhcCcCcccCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecc
Q 045452 55 LVYEYMPNKSLDCYLFDPIRRLILDWKKR------VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 55 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~------~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df 128 (303)
+||||+. ++|.+++... +..+....+ ..++.||+.||+|||+.| |+||||||+|||++.++.+||+||
T Consensus 165 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DF 238 (371)
T 3q60_A 165 LLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDV 238 (371)
T ss_dssp EEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCG
T ss_pred EEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEec
Confidence 9999998 8999998642 233455555 677899999999999999 999999999999999999999999
Q ss_pred cccccccccccccccceeeccccccCchhccc--CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhh
Q 045452 129 GLARIFAKESLKANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 206 (303)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 206 (303)
|++....... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... +.
T Consensus 239 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~ 305 (371)
T 3q60_A 239 SALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WK 305 (371)
T ss_dssp GGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CC
T ss_pred ceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hh
Confidence 9998654321 12345699999999987 678999999999999999999999996543221100 00
Q ss_pred CCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 207 GGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
....................+..+.+||.+||+.||++|||+.++++
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000111111123457889999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=298.78 Aligned_cols=225 Identities=23% Similarity=0.251 Sum_probs=182.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+.+|+||||+++|+|..++.. ...++
T Consensus 364 ~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~~ 440 (674)
T 3pfq_A 364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK 440 (674)
T ss_dssp SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH---HSSCC
T ss_pred CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh---cCCCC
Confidence 57889999999643 223456778899999988 899999999999999999999999999999999853 45699
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.
T Consensus 441 ~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 441 EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC--CcccccccCCCcccCHhhhc
Confidence 9999999999999999999998 999999999999999999999999998753322 12234467999999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++||||||+++|+|++|..||..... ............ ..+...+.++.+||.+||.
T Consensus 516 ~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~ 578 (674)
T 3pfq_A 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV-----------AYPKSMSKEAVAICKGLMT 578 (674)
T ss_dssp CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC-----------CCCccCCHHHHHHHHHHcc
Confidence 99999999999999999999999999964321 111112222110 1122234578899999999
Q ss_pred CCCCCCCCH-----HHHHH
Q 045452 240 ENPNDRPSM-----LEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~-----~~l~~ 253 (303)
.||++||++ ++|++
T Consensus 579 ~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 579 KHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSSTTCTTCSTTHHHHHHS
T ss_pred CCHHHCCCCCCCcHHHHhc
Confidence 999999997 66653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=272.31 Aligned_cols=230 Identities=23% Similarity=0.352 Sum_probs=174.2
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCC--CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
..+|+.||||+++.. .....+.+.+|+.++++++ |+||+++++++......+++|| +.+++|.+++.. ...+
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~ 124 (313)
T 3cek_A 49 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSI 124 (313)
T ss_dssp CTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH---CSSC
T ss_pred cCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh---cCCC
Confidence 457899999998643 3456678999999999996 5999999999999999999999 558899999853 4568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..++.++.|++.||.|||+.+ ++||||||+||++++ +.+||+|||++................|+..|+|||.+
T Consensus 125 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (313)
T 3cek_A 125 DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHH
Confidence 99999999999999999999998 999999999999964 89999999999876543322233345689999999998
Q ss_pred cc-----------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 159 RQ-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 159 ~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
.+ ..++.++||||||+++|+|++|..||.... ................. .+...+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~ 266 (313)
T 3cek_A 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHEIE---------FPDIPE 266 (313)
T ss_dssp TTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTSCCC---------CCCCSC
T ss_pred hhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----HHHHHHHHHHhcccccC---------Ccccch
Confidence 65 467889999999999999999999985322 11122222222111111 111123
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.++.++|.+||..||++|||+.++++.
T Consensus 267 ~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 267 KDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 478899999999999999999999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=273.87 Aligned_cols=244 Identities=22% Similarity=0.285 Sum_probs=179.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEE--------------eCCeeeEEEeeCCCCChhhhh
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--------------DSEERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~l 69 (303)
.+|+.||+|++........+.+.+|+.++++++||||+++++++. .....++||||+. ++|.+++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 112 (320)
T 2i6l_A 34 DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL 112 (320)
T ss_dssp TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHH
T ss_pred CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHh
Confidence 468999999998777777788999999999999999999999874 3467899999997 6898888
Q ss_pred cCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEeccccccccccccc-ccccceee
Q 045452 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESL-KANTEQVV 147 (303)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-~~~~~kl~df~~~~~~~~~~~-~~~~~~~~ 147 (303)
. ...+++..++.++.||+.||+|||+.| ++||||||+||+++ .++.+||+|||++........ ........
T Consensus 113 ~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 185 (320)
T 2i6l_A 113 E----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185 (320)
T ss_dssp T----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGG
T ss_pred h----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccc
Confidence 3 356899999999999999999999998 99999999999997 567899999999986543211 11222345
Q ss_pred ccccccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC----------Cccccccc
Q 045452 148 GTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG----------KGMEFVDS 216 (303)
Q Consensus 148 ~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~ 216 (303)
++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ........... ........
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (320)
T 2i6l_A 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILESIPVVHEEDRQELLSVIPVYIRN 262 (320)
T ss_dssp SCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHSCCCCHHHHHHHHTTSCHHHHH
T ss_pred ccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCchhhhhhhhhcCcccccc
Confidence 6889999998765 6788999999999999999999999964432111 11111100000 00000000
Q ss_pred ccc-C-----CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccC
Q 045452 217 FLD-D-----RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 217 ~~~-~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~ 258 (303)
... . ......+.++.++|.+||..||++|||+.++++ +++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 263 DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred cccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 000 0 001112357889999999999999999999986 45543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.31 Aligned_cols=245 Identities=21% Similarity=0.275 Sum_probs=179.3
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++.. .......+.+|+.++++++||||+++++++... ...++||||+. ++|.+++. ...
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~ 108 (353)
T 2b9h_A 34 PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIS----TQM 108 (353)
T ss_dssp TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHH----HCC
T ss_pred CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHh----hcC
Confidence 47899999999654 344567788999999999999999999998754 57899999996 68888873 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc--------ccceeecc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA--------NTEQVVGT 149 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~--------~~~~~~~~ 149 (303)
+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++.......... ......|+
T Consensus 109 ~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt 185 (353)
T 2b9h_A 109 LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccc
Confidence 899999999999999999999998 9999999999999999999999999998764322111 11224679
Q ss_pred ccccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCC---cccc---------ccc
Q 045452 150 IGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---GMEF---------VDS 216 (303)
Q Consensus 150 ~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~~ 216 (303)
..|+|||++.+ ..++.++|||||||++|+|++|..||........ ............ .... ...
T Consensus 186 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (353)
T 2b9h_A 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262 (353)
T ss_dssp GGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHT
T ss_pred ccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCchhccccccccchhhHHhhc
Confidence 99999998754 6788999999999999999999999964432111 111111100000 0000 000
Q ss_pred ccc------CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCC
Q 045452 217 FLD------DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 217 ~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
... .......+.++.+||.+||..||++|||+.++++ +++...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 0000122347889999999999999999999986 455543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=271.77 Aligned_cols=227 Identities=26% Similarity=0.323 Sum_probs=178.9
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++......++||||+.+++|.+++. ....+++.
T Consensus 45 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~ 121 (287)
T 2wei_A 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEH 121 (287)
T ss_dssp TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHH---hcCCCCHH
Confidence 47899999998643 23456789999999999999999999999999999999999999999988884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
.++.++.||+.||.+||+.| ++|+||+|+||+++.+ +.+||+|||++........ .....++..|+|||.+
T Consensus 122 ~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 195 (287)
T 2wei_A 122 DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVL 195 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHh
Confidence 99999999999999999998 9999999999999764 4699999999876543221 1223578999999988
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+. ++.++||||||+++|+|++|..||...... ........+........ ....+.++.++|.+||
T Consensus 196 ~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l 261 (287)
T 2wei_A 196 RGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFDLPQ-------WRTISDDAKDLIRKML 261 (287)
T ss_dssp TTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCSGG-------GTTSCHHHHHHHHHHT
T ss_pred cCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCCCchh-------hhhcCHHHHHHHHHHc
Confidence 764 789999999999999999999998543211 11111111111111000 0112347889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
..||++|||+.++++
T Consensus 262 ~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 262 TFHPSLRITATQCLE 276 (287)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred ccChhhCcCHHHHhc
Confidence 999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=283.14 Aligned_cols=248 Identities=19% Similarity=0.277 Sum_probs=170.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCcC------cc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI------RR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~------~~ 75 (303)
.+++.||||++..... ...+.+|+.++++++||||+++++++.. ....++||||+. ++|.+++.... ..
T Consensus 46 ~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 122 (405)
T 3rgf_A 46 KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKP 122 (405)
T ss_dssp SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-----
T ss_pred CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccc
Confidence 3688999999965432 2467889999999999999999999965 668999999996 57777764311 12
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEeccccccccccccc-ccccceeeccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESL-KANTEQVVGTI 150 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~----~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~ 150 (303)
..+++..++.++.||+.||+|||+.| |+||||||+|||+ +.++.+||+|||++..+..... ........|+.
T Consensus 123 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~ 199 (405)
T 3rgf_A 123 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199 (405)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecC
Confidence 34899999999999999999999999 9999999999999 6778999999999987653221 12233457899
Q ss_pred cccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCc------cccHHHHHHHHhhCCCcccccc--------
Q 045452 151 GYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE------NLSILEHAYELWKGGKGMEFVD-------- 215 (303)
Q Consensus 151 ~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~-------- 215 (303)
.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+..............+..
T Consensus 200 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 279 (405)
T 3rgf_A 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHS 279 (405)
T ss_dssp TTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHH
T ss_pred cccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchh
Confidence 99999998774 58999999999999999999999996433210 0111222111111110000000
Q ss_pred ----cc----ccC--------CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhcc
Q 045452 216 ----SF----LDD--------RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 216 ----~~----~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~ 257 (303)
.. ... ......+..+.+||.+||..||++|||++++++ ++.+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 280 TLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp HHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred hhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 00 000 000000236789999999999999999999986 3554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=281.22 Aligned_cols=244 Identities=21% Similarity=0.238 Sum_probs=173.1
Q ss_pred CCCCCEEEEEEccCCC-----------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChh
Q 045452 3 LPCGEVIAVKKLSKSS-----------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLD 66 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~ 66 (303)
..+|+.||||++.... ....+.+.+|+.++++++||||+++++++... ...++||||+. ++|.
T Consensus 43 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 121 (362)
T 3pg1_A 43 DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLA 121 (362)
T ss_dssp CTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHH
T ss_pred CCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHH
Confidence 4569999999985432 22347889999999999999999999998643 36799999997 5787
Q ss_pred hhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccccee
Q 045452 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV 146 (303)
Q Consensus 67 ~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 146 (303)
+++.. ....+++..++.++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++....... .....
T Consensus 122 ~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 193 (362)
T 3pg1_A 122 QVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHY 193 (362)
T ss_dssp HHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC----------------
T ss_pred HHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccccc---cccee
Confidence 77753 3456899999999999999999999998 9999999999999999999999999997543321 22234
Q ss_pred eccccccCchhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhC------------------
Q 045452 147 VGTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG------------------ 207 (303)
Q Consensus 147 ~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------ 207 (303)
.++..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ..........
T Consensus 194 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (362)
T 3pg1_A 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYL 270 (362)
T ss_dssp --CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHT
T ss_pred cccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChHHhhhccchhhhHHH
Confidence 67899999998876 6789999999999999999999999964432211 1111111000
Q ss_pred -CCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 208 -GKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 208 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
........... .......+..+.+||.+||+.||++|||+.++++. +++..
T Consensus 271 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 271 RNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp TTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 00000000000 00011123468899999999999999999999863 54443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.51 Aligned_cols=176 Identities=21% Similarity=0.234 Sum_probs=149.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC------CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL------QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++.. ......+.+|+.+++.+ +|+||+++++++......++||||+. ++|.+++... ....
T Consensus 120 ~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~ 196 (429)
T 3kvw_A 120 KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN-KFQG 196 (429)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT-TTCC
T ss_pred CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc-cCCC
Confidence 46899999999643 34456677788877776 57799999999999999999999995 6888888542 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--EEEecccccccccccccccccceeeccccccCc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--PKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...... .....+++.|+||
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aP 268 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAP 268 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccCh
Confidence 899999999999999999999998 999999999999999887 999999998654322 2234679999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccC
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 190 (303)
|++.+..++.++|||||||++|+|++|..||....
T Consensus 269 E~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999899999999999999999999999986443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=283.54 Aligned_cols=237 Identities=19% Similarity=0.230 Sum_probs=174.1
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC--------------------------------
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-------------------------------- 50 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------------------------------- 50 (303)
..+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (383)
T 3eb0_A 29 IESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVI 104 (383)
T ss_dssp TTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------------------------------
T ss_pred CCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccccccccc
Confidence 368999999998654322 23699999999999999999998543
Q ss_pred ------CeeeEEEeeCCCCChhhhhcCc-CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCc
Q 045452 51 ------EERMLVYEYMPNKSLDCYLFDP-IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMK 122 (303)
Q Consensus 51 ------~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-~~~~ 122 (303)
...++||||++ ++|.+.+... ..+..+++..++.++.||+.||+|||+.| ++||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~ 180 (383)
T 3eb0_A 105 VNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNT 180 (383)
T ss_dssp -----CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTE
T ss_pred ccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCc
Confidence 34889999997 5777766431 23456999999999999999999999998 99999999999997 6889
Q ss_pred EEEecccccccccccccccccceeeccccccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH
Q 045452 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 201 (303)
Q Consensus 123 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 201 (303)
+||+|||++..+.... ......++..|+|||.+.+. .++.++||||+||++|+|++|+.||......+. +...
T Consensus 181 ~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i 254 (383)
T 3eb0_A 181 LKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ---LVRI 254 (383)
T ss_dssp EEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred EEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH---HHHH
Confidence 9999999998654322 12234578999999988765 489999999999999999999999964332211 1111
Q ss_pred HHHhhCCC---------------ccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 202 YELWKGGK---------------GMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 202 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
........ .............+...+.++.+||.+||..||++|||+.++++
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 255 IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110000 00000000111122223457889999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=267.86 Aligned_cols=230 Identities=24% Similarity=0.356 Sum_probs=171.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-------------CCeeeEEEeeCCCCChhhhhc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-------------SEERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~ 70 (303)
.+|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+ ....++||||+++++|.+++.
T Consensus 29 ~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 107 (303)
T 1zy4_A 29 LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107 (303)
T ss_dssp TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHH
T ss_pred CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhh
Confidence 57999999999543 4456788999999999999999999998865 346799999999999999985
Q ss_pred CcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-----------
Q 045452 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL----------- 139 (303)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~----------- 139 (303)
. ....+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||.+........
T Consensus 108 ~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 182 (303)
T 1zy4_A 108 S--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182 (303)
T ss_dssp H--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC--------------
T ss_pred c--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccc
Confidence 4 2345788999999999999999999998 99999999999999999999999999876542210
Q ss_pred -ccccceeeccccccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccccccc
Q 045452 140 -KANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSF 217 (303)
Q Consensus 140 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (303)
........|+..|+|||.+.+. .++.++|||||||++|+|++ ||... ..... ......... ..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~~~~-~~~~~~~~~-~~----- 247 (303)
T 1zy4_A 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----MERVN-ILKKLRSVS-IE----- 247 (303)
T ss_dssp -----------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHH-HHHHHHSTT-CC-----
T ss_pred cccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hhHHH-HHHhccccc-cc-----
Confidence 1112234688999999998765 68999999999999999998 43211 11111 111111110 01
Q ss_pred ccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 218 LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.........+..+.++|.+||..||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111222333468899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=275.91 Aligned_cols=240 Identities=19% Similarity=0.246 Sum_probs=180.8
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCC------cceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHV------NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++.. ....+.+.+|+.+++.++|+ +++++++++......++||||+ +++|.+++... ....
T Consensus 38 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~ 114 (339)
T 1z57_A 38 AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN-GFLP 114 (339)
T ss_dssp TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCC
T ss_pred CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc-CCCC
Confidence 47899999999643 44557788999999988655 4999999999999999999999 88999988542 2346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-------------------CCcEEEecccccccccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-------------------DMKPKISDFGLARIFAKES 138 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-------------------~~~~kl~df~~~~~~~~~~ 138 (303)
+++..++.++.||+.||+|||+.| ++||||||+||+++. ++.+||+|||++......
T Consensus 115 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~- 190 (339)
T 1z57_A 115 FRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH- 190 (339)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-
T ss_pred CcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-
Confidence 889999999999999999999998 999999999999987 668999999998754322
Q ss_pred cccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH-----HhhCCCcccc
Q 045452 139 LKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGMEF 213 (303)
Q Consensus 139 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 213 (303)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..... .+........
T Consensus 191 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 266 (339)
T 1z57_A 191 ----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY 266 (339)
T ss_dssp ----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGG
T ss_pred ----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhH
Confidence 2234679999999999988999999999999999999999999964432221111111000 0000000000
Q ss_pred c---------------------cc-cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 V---------------------DS-FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~---------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
. .. ..........+.++.+||.+||..||.+|||+.++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 267 FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0 00 00011233446689999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.28 Aligned_cols=243 Identities=18% Similarity=0.215 Sum_probs=172.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe------eeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.++..||+|++...... ..+|+.+++.++||||+++++++..... .++||||+.++.+............
T Consensus 62 ~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~ 137 (394)
T 4e7w_A 62 VESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT 137 (394)
T ss_dssp TTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSC
T ss_pred CCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCC
Confidence 34556888887543221 2369999999999999999999975443 7899999976544333221123556
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+++..++.++.||+.||+|||+.| |+||||||+||+++ .++.+||+|||++........ .....++..|+|||
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE 211 (394)
T 4e7w_A 138 MPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPE 211 (394)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHH
Confidence 899999999999999999999998 99999999999998 789999999999976543221 22346799999999
Q ss_pred hcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC---------------CccccccccccC
Q 045452 157 YARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG---------------KGMEFVDSFLDD 220 (303)
Q Consensus 157 ~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~ 220 (303)
++.+. .++.++|||||||++|+|++|+.||......+. +.......... ............
T Consensus 212 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (394)
T 4e7w_A 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSK 288 (394)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHH
T ss_pred HHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHH
Confidence 88665 589999999999999999999999964432211 11111110000 000000000000
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
......+.++.+||.+||..||++|||+.++++. +++..
T Consensus 289 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 289 VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 1111233578999999999999999999999863 55543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=274.05 Aligned_cols=233 Identities=25% Similarity=0.334 Sum_probs=173.6
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCee------eEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++...... ++||||+. ++|.+++.
T Consensus 65 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 138 (371)
T 4exu_A 65 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----- 138 (371)
T ss_dssp TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT-----
T ss_pred CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh-----
Confidence 57999999999754 334467888999999999999999999999876654 99999996 67877762
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... .....++..|+||
T Consensus 139 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aP 210 (371)
T 4exu_A 139 MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 210 (371)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCH
Confidence 33899999999999999999999998 999999999999999999999999999765432 2234579999999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccc------------cccC--
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS------------FLDD-- 220 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~-- 220 (303)
|.+.+ ..++.++|||||||++|+|++|..||......+. ........ +....+.... ....
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (371)
T 4exu_A 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVT-GVPGTEFVQKLNDKAAKSYIQSLPQTPR 286 (371)
T ss_dssp HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH-CCCCHHHHTTCSCHHHHHHHHHSCCCCC
T ss_pred HHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh-CCCcHHHHHHhhhhhhhhhhhccCCCcc
Confidence 99877 6789999999999999999999999964332111 11111100 0000000000 0000
Q ss_pred ----CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 221 ----RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 221 ----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
......+..+.+||.+||+.||++|||+.++++.
T Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 287 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0001123478899999999999999999999853
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=276.54 Aligned_cols=243 Identities=18% Similarity=0.200 Sum_probs=179.8
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-----------CCcceeEEEEEEeCC----eeeEEEeeCCCCChhhh
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-----------HVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCY 68 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~ 68 (303)
.+|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++.... ..+++||++ +++|.++
T Consensus 42 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 119 (373)
T 1q8y_A 42 VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119 (373)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHH
T ss_pred CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHH
Confidence 57899999999643 345567888999998885 889999999998654 789999999 8899998
Q ss_pred hcCcCcccCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEC------CCCcEEEeccccccccccccccc
Q 045452 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLG------EDMKPKISDFGLARIFAKESLKA 141 (303)
Q Consensus 69 l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~------~~~~~kl~df~~~~~~~~~~~~~ 141 (303)
+... ....+++..++.++.||+.||+|||+. | ++||||||+||+++ ..+.+||+|||++......
T Consensus 120 ~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---- 191 (373)
T 1q8y_A 120 IKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 191 (373)
T ss_dssp HHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----
T ss_pred HHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----
Confidence 8542 234589999999999999999999997 8 99999999999994 4457999999999765432
Q ss_pred ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccH---HHHHHHHhhCCC---------
Q 045452 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI---LEHAYELWKGGK--------- 209 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~--------- 209 (303)
.....++..|+|||++.+..++.++|||||||++|+|++|..||........... +...........
T Consensus 192 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 270 (373)
T 1q8y_A 192 -YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 270 (373)
T ss_dssp -CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred -CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccch
Confidence 2224679999999999999999999999999999999999999975443221111 111111110000
Q ss_pred ---------cccccc----------ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhcc
Q 045452 210 ---------GMEFVD----------SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 210 ---------~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~ 257 (303)
...... .......+...+.++.+||.+||..||++|||+.++++ ++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 271 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339 (373)
T ss_dssp HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhc
Confidence 000000 00011244566778999999999999999999999986 3444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.13 Aligned_cols=232 Identities=21% Similarity=0.339 Sum_probs=181.4
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+..||+|.++.. .....+.+.+|+.++++++||||+++++++. .+..++||||+.+|+|.+++.. ....+++..+
T Consensus 417 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~ 493 (656)
T 2j0j_A 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKFSLDLASL 493 (656)
T ss_dssp CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH--TTTTCCHHHH
T ss_pred ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh--ccCCCCHHHH
Confidence 3567999998754 3445678999999999999999999999984 5678999999999999999853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||.|||+.| ++||||||+|||++.++.+||+|||++......... ......++..|+|||.+.+..+
T Consensus 494 ~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 494 ILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCC
Confidence 999999999999999998 999999999999999999999999999876443211 1222346789999999998899
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++||||||+++|+|++ |..||......+ ... ....+. ... .+...+..+.++|.+||..||
T Consensus 570 ~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~---~i~~~~-~~~---------~~~~~~~~l~~li~~~l~~dP 633 (656)
T 2j0j_A 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RIENGE-RLP---------MPPNCPPTLYSLMTKCWAYDP 633 (656)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHHTC-CCC---------CCTTCCHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHcCC-CCC---------CCccccHHHHHHHHHHcCCCh
Confidence 999999999999999997 889985332111 111 111111 111 112223478899999999999
Q ss_pred CCCCCHHHHHHhhccCC
Q 045452 243 NDRPSMLEVSSMLKNET 259 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~ 259 (303)
++|||+.++++.|++..
T Consensus 634 ~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 634 SRRPRFTELKAQLSTIL 650 (656)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHH
Confidence 99999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=272.58 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=178.1
Q ss_pred CCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcC---CCCcceeEEEEEE-----eCCeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKL---QHVNLIRVLGFCI-----DSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||+|+++... ......+.+|+.+++.+ +||||+++++++. .....++||||+. ++|.+++...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~- 112 (326)
T 1blx_A 35 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV- 112 (326)
T ss_dssp TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS-
T ss_pred CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc-
Confidence 468899999986432 12223455677666665 8999999999987 4567899999997 6998888542
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
....+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.+||+|||++....... ......++..|+
T Consensus 113 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~ 186 (326)
T 1blx_A 113 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYR 186 (326)
T ss_dssp CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---Ccccccccccee
Confidence 2345899999999999999999999998 9999999999999999999999999987654321 223356799999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccc------cc-------cccC
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFV------DS-------FLDD 220 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-------~~~~ 220 (303)
|||.+.+..++.++||||||+++|+|++|..||....... .................. .. ....
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 1blx_A 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 263 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGG
T ss_pred CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcccCccccccchhhhcccCcchhh
Confidence 9999998889999999999999999999999996443221 111111111100000000 00 0000
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~ 258 (303)
......+..+.+||.+||..||.+|||+.++++ ++++.
T Consensus 264 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 264 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 111223457889999999999999999999984 34443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=272.62 Aligned_cols=235 Identities=17% Similarity=0.215 Sum_probs=155.6
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||++... .. ...+....++.++||||+++++++.. ....++||||+.+++|.+++... ....++
T Consensus 52 ~~~~~vavK~~~~~-~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~ 126 (336)
T 3fhr_A 52 RTGQKCALKLLYDS-PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-GDQAFT 126 (336)
T ss_dssp TTCCEEEEEEEESS-HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCB
T ss_pred CCCCEEEEEEecCc-HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc-CCCCCC
Confidence 47999999999653 21 22223344566799999999999976 44589999999999999999653 234689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccccccceeeccccccCch
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+..++.++.||+.||+|||+.| ++||||||+||+++. ++.+||+|||++....... .....+++.|+|||
T Consensus 127 ~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 127 EREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPE 199 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChh
Confidence 9999999999999999999998 999999999999986 4559999999987654322 22346799999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.+..++.++||||||+++|+|++|..||.................... ...........+.++.+||.+
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~ 270 (336)
T 3fhr_A 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---------YGFPNPEWSEVSEDAKQLIRL 270 (336)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CCCTTTSTTCCHHHHHHHHH
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc---------cccCchhhccCCHHHHHHHHH
Confidence 99888889999999999999999999999954432211110000000000 000011111234478899999
Q ss_pred cccCCCCCCCCHHHHHH--hhccCC
Q 045452 237 CVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
||..||++|||+.++++ ++++..
T Consensus 271 ~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 271 LLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp HSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred HCCCChhHCcCHHHHhcCccccccc
Confidence 99999999999999997 566544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=281.89 Aligned_cols=241 Identities=21% Similarity=0.262 Sum_probs=172.7
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCc-Cccc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDP-IRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~-~~~~ 76 (303)
.+|+.||||++..... ...+|+.+++.++|+||+++++++... ...++||||+.+ +|.+.+... ....
T Consensus 77 ~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~ 151 (420)
T 1j1b_A 77 DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151 (420)
T ss_dssp TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTC
T ss_pred CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccC
Confidence 4799999999865432 234699999999999999999998642 136799999975 565554321 2345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEecccccccccccccccccceeeccccccCc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
.+++..++.++.||+.||+|||+.| |+||||||+|||++.+ +.+||+|||++..+..... .....++..|+||
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aP 225 (420)
T 1j1b_A 152 TLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAP 225 (420)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCH
Confidence 6899999999999999999999998 9999999999999965 5689999999986543221 1234679999999
Q ss_pred hhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCC----------Ccccc--c---ccccc
Q 045452 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG----------KGMEF--V---DSFLD 219 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~--~---~~~~~ 219 (303)
|++.+. .++.++|||||||++|+|++|+.||......+ .+.......... ...+. . .....
T Consensus 226 E~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~ 302 (420)
T 1j1b_A 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 302 (420)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHH
T ss_pred HHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHH
Confidence 988664 68999999999999999999999996433221 111111110000 00000 0 00000
Q ss_pred CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccC
Q 045452 220 DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNE 258 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~ 258 (303)
.......+.++.+||.+||..||.+|||+.++++ ++++.
T Consensus 303 ~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 303 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0011223457889999999999999999999985 45443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=275.23 Aligned_cols=231 Identities=25% Similarity=0.310 Sum_probs=173.9
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe------eeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++..... .++||||+. ++|.+++.
T Consensus 47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 120 (353)
T 3coi_A 47 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----- 120 (353)
T ss_dssp TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT-----
T ss_pred CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc-----
Confidence 57999999999654 33446788899999999999999999999987654 499999996 58877762
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++...... .....++..|+||
T Consensus 121 ~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aP 192 (353)
T 3coi_A 121 LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 192 (353)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCH
Confidence 24899999999999999999999998 999999999999999999999999998764322 2234679999999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc-------------------cccc
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM-------------------EFVD 215 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~ 215 (303)
|.+.+ ..++.++|||||||++|+|++|..||........ +....... +.... ....
T Consensus 193 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T 3coi_A 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVT-GVPGTEFVQKLNDKAAKSYIQSLPQTPR 268 (353)
T ss_dssp HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHH-CBCCHHHHTTCSCHHHHHHHHTSCBCSS
T ss_pred HHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHh-CCCCHHHHHHHhhHHHHHHHHhCcCCCC
Confidence 98876 6789999999999999999999999964432111 11111100 00000 0000
Q ss_pred ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 216 SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
... .......+.++.+||.+||..||++|||+.++++
T Consensus 269 ~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 269 KDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0111223457889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.97 Aligned_cols=249 Identities=18% Similarity=0.214 Sum_probs=176.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe-------eeEEEeeCCCCChhhhhcC-cCcc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-------RMLVYEYMPNKSLDCYLFD-PIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~~lv~e~~~~~sL~~~l~~-~~~~ 75 (303)
.+|+.||||++.... .....+.+++..++.++||||+++++++..... .++||||+.+ +|...+.. ....
T Consensus 46 ~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~ 123 (360)
T 3e3p_A 46 STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ 123 (360)
T ss_dssp TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTT
T ss_pred CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcc
Confidence 578999999985442 233456678888899999999999999976443 7899999976 44443322 1245
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQ--EYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh--~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
..+++..+..++.|++.||.||| +.| ++||||||+||+++. ++.+||+|||++..+..... .....|+..|
T Consensus 124 ~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y 197 (360)
T 3e3p_A 124 VAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYY 197 (360)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGG
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcce
Confidence 66899999999999999999999 887 999999999999996 89999999999986653321 1224578999
Q ss_pred cCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH--------HHHhh-CCCcccccc------c
Q 045452 153 IPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWK-GGKGMEFVD------S 216 (303)
Q Consensus 153 ~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~------~ 216 (303)
+|||++.+. .++.++|||||||++|+|++|..||...........+... ..... ......... .
T Consensus 198 ~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
T 3e3p_A 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWS 277 (360)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHH
T ss_pred eCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcc
Confidence 999988655 4899999999999999999999999654322211111100 00000 000000000 0
Q ss_pred cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCCC
Q 045452 217 FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNETT 260 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~~ 260 (303)
..........+.++.+||.+||+.||.+|||+.++++ ++++...
T Consensus 278 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 278 NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0001111223567899999999999999999999985 3555443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.28 Aligned_cols=232 Identities=21% Similarity=0.306 Sum_probs=157.9
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHH-HHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc--CcccCCC
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP--IRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~ 79 (303)
.+|+.||||+++... ......+..|+. +++.++||||+++++++...+..++||||+.+ +|.+++... .....++
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 123 (327)
T 3aln_A 45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIP 123 (327)
T ss_dssp TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCC
T ss_pred CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCc
Confidence 479999999997553 334455556665 67778999999999999999999999999975 777776421 1245689
Q ss_pred HHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 80 WKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
+..+..++.|++.||.|||+. | ++||||||+||+++.++.+||+|||++....... ......|+..|+|||.+
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 124 EEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERI 197 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceee
Confidence 999999999999999999998 8 9999999999999999999999999997654322 11223588999999998
Q ss_pred ----ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 159 ----RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 159 ----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+..++.++||||||+++|+|++|..||....... . ............ .........+..+.+||
T Consensus 198 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li 266 (327)
T 3aln_A 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----D-QLTQVVKGDPPQ-----LSNSEEREFSPSFINFV 266 (327)
T ss_dssp --------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCC-----CCCCSSCCCCHHHHHHH
T ss_pred ccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----H-HHHHHhcCCCCC-----CCCcccccCCHHHHHHH
Confidence 45668899999999999999999999985432110 0 000000000001 11111112334788999
Q ss_pred HhcccCCCCCCCCHHHHHH
Q 045452 235 LLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~ 253 (303)
.+||..||++|||+.++++
T Consensus 267 ~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 267 NLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHTCSSGGGSCCHHHHTT
T ss_pred HHHhhCChhhCcCHHHHHh
Confidence 9999999999999999965
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=279.55 Aligned_cols=231 Identities=22% Similarity=0.264 Sum_probs=167.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCccc----CC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL----IL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~----~~ 78 (303)
.+|+.||||.+... ..+.+.+|+.+++++ +||||+++++++.+....++||||+. |+|.+++....... ..
T Consensus 37 ~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~ 112 (434)
T 2rio_A 37 FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQ 112 (434)
T ss_dssp SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC----------
T ss_pred ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhc
Confidence 46899999998653 235678899999876 89999999999999999999999995 69999986532111 11
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-------------CcEEEecccccccccccccc--ccc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-------------MKPKISDFGLARIFAKESLK--ANT 143 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~-------------~~~kl~df~~~~~~~~~~~~--~~~ 143 (303)
++..++.++.||+.||+|||+.| |+||||||+||+++.+ +.+||+|||++......... ...
T Consensus 113 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 189 (434)
T 2rio_A 113 KEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189 (434)
T ss_dssp --CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------
T ss_pred cchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeee
Confidence 23345789999999999999998 9999999999999654 48999999999876543211 122
Q ss_pred ceeeccccccCchhccc-------CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCcccccc
Q 045452 144 EQVVGTIGYIPPEYARQ-------GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVD 215 (303)
Q Consensus 144 ~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (303)
....|+..|+|||++.+ ..++.++|||||||++|+|++ |..||...... . ...........
T Consensus 190 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~---~~i~~~~~~~~--- 258 (434)
T 2rio_A 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-----E---SNIIRGIFSLD--- 258 (434)
T ss_dssp -----CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----H---HHHHHTCCCCC---
T ss_pred cCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----H---HHHhcCCCCcc---
Confidence 33568999999999865 568899999999999999999 89998532211 1 11111111111
Q ss_pred ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 216 SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
..........+.++.++|.+||..||++|||+.++++
T Consensus 259 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 259 -EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0111223445668999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.87 Aligned_cols=176 Identities=24% Similarity=0.277 Sum_probs=147.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CC-----cceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HV-----NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++.. ......+..|+.+++.++ |+ +|+++++++......++||||+. ++|.+++... ....
T Consensus 77 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~ 153 (382)
T 2vx3_A 77 VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT-NFRG 153 (382)
T ss_dssp TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT-TTSC
T ss_pred CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc-CcCC
Confidence 47899999999643 344567778888888874 54 49999999999999999999995 5998888542 2245
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh--cCCCCeeecCCCCCcEEEC--CCCcEEEecccccccccccccccccceeecccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQE--YSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~--~~~~~i~H~dl~p~nil~~--~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
+++..+..++.|++.||.|||. .| |+||||||+|||++ .++.+||+|||++...... .....++..|+
T Consensus 154 ~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~ 225 (382)
T 2vx3_A 154 VSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYR 225 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCcccc
Confidence 8999999999999999999994 55 99999999999995 4788999999999766432 22346799999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccC
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 190 (303)
|||++.+..++.++|||||||++|+|++|..||....
T Consensus 226 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999999999999996543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.34 Aligned_cols=227 Identities=25% Similarity=0.292 Sum_probs=166.2
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+....++||||+. |+|.+++... ........
T Consensus 46 ~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~--~~~~~~~~ 119 (432)
T 3p23_A 46 FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHLGLE 119 (432)
T ss_dssp SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS--SCCCCSSC
T ss_pred eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc--CCCccchh
Confidence 47899999998654322 346799999999 89999999999999999999999995 6999988642 22344456
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-----CCcEEEeccccccccccccc-ccccceeeccccccCch
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-----DMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPE 156 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-----~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE 156 (303)
++.++.||+.||+|||+.| |+||||||+||+++. ...+||+|||++........ ........|++.|+|||
T Consensus 120 ~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE 196 (432)
T 3p23_A 120 PITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196 (432)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGG
T ss_pred HHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChh
Confidence 6789999999999999999 999999999999953 23588999999987653321 12233456899999999
Q ss_pred hcc---cCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHH
Q 045452 157 YAR---QGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232 (303)
Q Consensus 157 ~~~---~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
++. ...++.++|||||||++|+|++ |..||...... . ............ ..........+.+
T Consensus 197 ~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~-~~~~~~~~~~~~------~~~~~~~~~~~~~ 262 (432)
T 3p23_A 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------Q-ANILLGACSLDC------LHPEKHEDVIARE 262 (432)
T ss_dssp GTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------H-HHHHTTCCCCTT------SCTTCHHHHHHHH
T ss_pred hhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------H-HHHHhccCCccc------cCccccccHHHHH
Confidence 987 4567789999999999999999 88888422111 0 111111111110 1112233456789
Q ss_pred HHHhcccCCCCCCCCHHHHHH
Q 045452 233 IALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 233 li~~cl~~dp~~Rps~~~l~~ 253 (303)
||.+||+.||++|||+.++++
T Consensus 263 li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 263 LIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCHhhCCCHHHHHh
Confidence 999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=263.05 Aligned_cols=228 Identities=21% Similarity=0.317 Sum_probs=164.2
Q ss_pred CCCCEEEEEEccCCC-hh-hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSS-AQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.||||+++... .. ..+.+.++..+++.++||||+++++++......++||||+ ++.+..+... ....+++.
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~--~~~~~~~~ 124 (318)
T 2dyl_A 48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR--MQGPIPER 124 (318)
T ss_dssp TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH--HTSCCCHH
T ss_pred cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH--hccCCCHH
Confidence 479999999997543 22 2344455556778889999999999999999999999999 5555444422 24568999
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc-
Q 045452 82 KRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~-~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 159 (303)
.++.++.|++.||.|||+. | ++|+||||+||+++.++.+||+|||++....... ......++..|+|||.+.
T Consensus 125 ~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 198 (318)
T 2dyl_A 125 ILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDP 198 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhccc
Confidence 9999999999999999995 8 9999999999999999999999999987654322 122345799999999984
Q ss_pred ----cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 160 ----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 160 ----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
...++.++||||||+++|+|++|..||...... ............ .... .....+.++.++|.
T Consensus 199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~-~~~~-------~~~~~~~~l~~li~ 265 (318)
T 2dyl_A 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP-PLLP-------GHMGFSGDFQSFVK 265 (318)
T ss_dssp -------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-CCCC-------SSSCCCHHHHHHHH
T ss_pred ccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-CCCC-------ccCCCCHHHHHHHH
Confidence 456788999999999999999999998643211 111112222111 0000 00112347889999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 045452 236 LCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~ 253 (303)
+||..||.+|||+.++++
T Consensus 266 ~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 266 DCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHTCSCTTTSCCHHHHTT
T ss_pred HHccCChhHCcCHHHHhh
Confidence 999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=271.31 Aligned_cols=233 Identities=18% Similarity=0.233 Sum_probs=175.9
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCc------ceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN------LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
++.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++......++||||+ +++|.+++... ....++
T Consensus 45 ~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~ 121 (355)
T 2eu9_A 45 KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN-NFQPYP 121 (355)
T ss_dssp TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCC
T ss_pred ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhc-cCCCCC
Confidence 478999999643 445677888999999987655 899999999999999999999 66676666432 234689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-------------------CCCCcEEEecccccccccccccc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-------------------GEDMKPKISDFGLARIFAKESLK 140 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~-------------------~~~~~~kl~df~~~~~~~~~~~~ 140 (303)
+..++.++.||+.||+|||+.| ++||||||+||++ +.++.+||+|||++......
T Consensus 122 ~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--- 195 (355)
T 2eu9_A 122 LPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--- 195 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc---
Confidence 9999999999999999999998 9999999999999 56788999999998754322
Q ss_pred cccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc-------
Q 045452 141 ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF------- 213 (303)
Q Consensus 141 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 213 (303)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. .... ......
T Consensus 196 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~p~~~~~~~~~~ 269 (355)
T 2eu9_A 196 --HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME---KILG-PIPSHMIHRTRKQ 269 (355)
T ss_dssp --CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHC-CCCHHHHHHCSCG
T ss_pred --ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcC-CCcHHHhhhccch
Confidence 223468999999999998899999999999999999999999996443222111111 1110 000000
Q ss_pred ---c--------------------cc-cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 214 ---V--------------------DS-FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 214 ---~--------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
. .. ............++.+||.+||..||++|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 270 KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00 0001122334557889999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=288.94 Aligned_cols=242 Identities=24% Similarity=0.269 Sum_probs=181.0
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe------CCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++.......
T Consensus 37 ~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~ 116 (676)
T 3qa8_A 37 DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116 (676)
T ss_dssp TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTT
T ss_pred CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCC
Confidence 57899999998754 45566789999999999999999999999765 667899999999999999997654445
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEecccccccccccccccccceeecccccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~---~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
.+++..++.++.+++.||+|||+.| ++||||||+||+++.++. +||+|||.+....... ......|+..|+
T Consensus 117 ~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~ 190 (676)
T 3qa8_A 117 GLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYL 190 (676)
T ss_dssp CCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccC
Confidence 6899999999999999999999998 999999999999997765 9999999998764432 123356899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCcccc-HH-HHHHHH-hhCC---Cccccccc-cccCCCChHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-IL-EHAYEL-WKGG---KGMEFVDS-FLDDRNSSCK 226 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~-~~~~~~-~~~~---~~~~~~~~-~~~~~~~~~~ 226 (303)
|||.+.+..++.++||||||+++|+|++|..||.......... .. ...... .... ....+... ..........
T Consensus 191 APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~l 270 (676)
T 3qa8_A 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL 270 (676)
T ss_dssp SSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGG
T ss_pred ChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhh
Confidence 9999999999999999999999999999999995432110000 00 000000 0000 00000000 1112234456
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHH
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEV 251 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l 251 (303)
+..+.++|.+||..||++|||+.++
T Consensus 271 s~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 271 AGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp HHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hHHHHHHHHHHccCCHhhCcCHHHH
Confidence 7789999999999999999999774
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.35 Aligned_cols=218 Identities=24% Similarity=0.335 Sum_probs=170.2
Q ss_pred CCCCEEEEEEccCCCh------hhHHHHHHHHHHHhcC----CCCcceeEEEEEEeCCeeeEEEee-CCCCChhhhhcCc
Q 045452 4 PCGEVIAVKKLSKSSA------QGFEEFKNEVMLTAKL----QHVNLIRVLGFCIDSEERMLVYEY-MPNKSLDCYLFDP 72 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~ 72 (303)
.+|+.||||+++.... .....+.+|+.++.++ +|+||+++++++...+..++|||+ +.+++|.+++..
T Consensus 54 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~- 132 (312)
T 2iwi_A 54 TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE- 132 (312)
T ss_dssp TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-
T ss_pred cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-
Confidence 5789999999965432 1223456788888888 899999999999999999999999 789999999843
Q ss_pred CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEecccccccccccccccccceeecccc
Q 045452 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLKANTEQVVGTIG 151 (303)
Q Consensus 73 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 151 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++ .++.+||+|||++....... .....++..
T Consensus 133 --~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~ 203 (312)
T 2iwi_A 133 --KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRV 203 (312)
T ss_dssp --HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTT
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCccc
Confidence 456899999999999999999999999 99999999999999 88999999999987765432 223457899
Q ss_pred ccCchhcccCCCC-CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHH
Q 045452 152 YIPPEYARQGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||.+.+..+. .++||||||+++|+|++|..||.... ....... ..+...+..+
T Consensus 204 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~-----------~~~~~~~~~~ 260 (312)
T 2iwi_A 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAEL-----------HFPAHVSPDC 260 (312)
T ss_dssp TSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTCC-----------CCCTTSCHHH
T ss_pred ccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhcc-----------CCcccCCHHH
Confidence 9999988766654 48999999999999999999985221 0111100 0111223478
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHh
Q 045452 231 LEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 231 ~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.++|.+||..||++|||+.++++.
T Consensus 261 ~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 261 CALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=269.42 Aligned_cols=218 Identities=23% Similarity=0.352 Sum_probs=174.9
Q ss_pred CCCCCEEEEEEccCCCh------hhHHHHHHHHHHHhcCC--CCcceeEEEEEEeCCeeeEEEeeCCC-CChhhhhcCcC
Q 045452 3 LPCGEVIAVKKLSKSSA------QGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPN-KSLDCYLFDPI 73 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~ 73 (303)
..+|+.||||+++.... ...+.+.+|+.++++++ |+||+++++++...+..+++||++.+ ++|.+++.
T Consensus 65 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~--- 141 (320)
T 3a99_A 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--- 141 (320)
T ss_dssp TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---
T ss_pred CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHh---
Confidence 35789999999864421 12245678999999995 59999999999999999999999976 89999884
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEecccccccccccccccccceeeccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
....+++..++.++.||+.||+|||+.+ ++||||||+||+++ .++.+||+|||++....... .....|+..|
T Consensus 142 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y 214 (320)
T 3a99_A 142 ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 214 (320)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccC
Confidence 3456899999999999999999999998 99999999999999 77899999999987665332 1224589999
Q ss_pred cCchhcccCCC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..+ +.++||||||+++|+|++|..||.... ....... . .+...+.++.
T Consensus 215 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~-------~----~~~~~~~~~~ 271 (320)
T 3a99_A 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV-------F----FRQRVSSECQ 271 (320)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC-------C----CSSCCCHHHH
T ss_pred CChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccc-------c----ccccCCHHHH
Confidence 99999876665 678999999999999999999984221 1111110 0 0111234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHH
Q 045452 232 EIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~ 253 (303)
+||.+||..||++|||++++++
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=283.89 Aligned_cols=214 Identities=21% Similarity=0.280 Sum_probs=169.6
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCe-----eeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-----RMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
+|+.||||.+... .......+.+|+.++++++||||+++++++...+. .|+||||+++++|.+++.. .+
T Consensus 105 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l 179 (681)
T 2pzi_A 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KL 179 (681)
T ss_dssp TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CC
T ss_pred CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CC
Confidence 6899999998644 44566788999999999999999999999987665 7999999999999887632 68
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..++.++.||+.+|.|||+.| |+||||||+||+++.+ .+||+|||++...... ....|++.|+|||++
T Consensus 180 ~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~ 249 (681)
T 2pzi_A 180 PVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIV 249 (681)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHH
Confidence 99999999999999999999998 9999999999999885 8999999999765432 334689999999998
Q ss_pred ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
.+.. +.++|||||||++|+|++|..||......... ...........+.+||.+||
T Consensus 250 ~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 250 RTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-----------------------EDDPVLKTYDSYGRLLRRAI 305 (681)
T ss_dssp HHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------------TTCHHHHHCHHHHHHHHHHT
T ss_pred cCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------------ccccccccCHHHHHHHhhhc
Confidence 7654 88999999999999999998887432111000 00000112246889999999
Q ss_pred cCCCCCCCC-HHHHHHhhcc
Q 045452 239 QENPNDRPS-MLEVSSMLKN 257 (303)
Q Consensus 239 ~~dp~~Rps-~~~l~~~L~~ 257 (303)
..||++||+ ++++...|..
T Consensus 306 ~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHH
Confidence 999999995 5666555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=253.53 Aligned_cols=210 Identities=20% Similarity=0.246 Sum_probs=159.8
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHH-hcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLT-AKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||+|+++.. ..+.+|+.++ +.++||||+++++++.. ....++||||+++++|.+++... ....+
T Consensus 41 ~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 114 (299)
T 3m2w_A 41 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAF 114 (299)
T ss_dssp TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC-TTCCC
T ss_pred CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc-cCCCC
Confidence 57899999999643 4566788887 55699999999999987 66789999999999999998642 23468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccccccceeeccccccCc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
++..++.++.|++.||+|||+.| ++||||||+||+++. ++.+||+|||++....
T Consensus 115 ~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------- 171 (299)
T 3m2w_A 115 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------- 171 (299)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--------------------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc--------------------
Confidence 99999999999999999999999 999999999999998 7889999999885432
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCC----hHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNS----SCKLMRCL 231 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 231 (303)
+..++.++|||||||++|+|++|..||......... . ......... ....+ ...+.++.
T Consensus 172 ----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~-~~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (299)
T 3m2w_A 172 ----GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------P-GMKTRIRMG--QYEFPNPEWSEVSEEVK 234 (299)
T ss_dssp ----TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------C-CSCCSSCTT--CCSSCHHHHTTSCHHHH
T ss_pred ----cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------H-HHHHHHhhc--cccCCchhcccCCHHHH
Confidence 234577899999999999999999998533211100 0 000000000 00001 11235788
Q ss_pred HHHHhcccCCCCCCCCHHHHHH--hhccCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
++|.+||..||++|||+.++++ ++.+..
T Consensus 235 ~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 9999999999999999999986 455544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=248.61 Aligned_cols=210 Identities=12% Similarity=0.078 Sum_probs=162.3
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... ....+.+.+|+..+++++||||+++++++.+.+..|+||||++|++|.+++.. . ...
T Consensus 54 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~-~~~ 128 (286)
T 3uqc_A 54 ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S-PSP 128 (286)
T ss_dssp TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C-CCH
T ss_pred CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C-CCh
Confidence 468999999997553 34557889999999999999999999999999999999999999999999842 2 355
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.| ++||||||+||+++.+|.+||++++. ++
T Consensus 129 ~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~----------------------~~------ 177 (286)
T 3uqc_A 129 VGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP------ 177 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC----------------------CT------
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc----------------------cC------
Confidence 678899999999999999999 99999999999999999999985432 22
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|||||||++|+|++|+.||............. ...... .. ... ......+.++.++|.+||+.
T Consensus 178 -~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~--~~-~~~----~~~~~~~~~l~~li~~~l~~ 246 (286)
T 3uqc_A 178 -DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQ--PI-EPA----DIDRDIPFQISAVAARSVQG 246 (286)
T ss_dssp -TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSC--BC-CHH----HHCTTSCHHHHHHHHHHHCT
T ss_pred -CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccC--CC-Chh----hcccCCCHHHHHHHHHHccc
Confidence 25889999999999999999999996544322110000 000000 00 000 00111234688999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~ 261 (303)
||++| |+.++++.|++....
T Consensus 247 dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 247 DGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp TSSCC-CHHHHHHHHHHHHC-
T ss_pred CCccC-CHHHHHHHHHHHhcc
Confidence 99999 999999999986643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=264.76 Aligned_cols=219 Identities=16% Similarity=0.172 Sum_probs=159.2
Q ss_pred CCCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCC-Ccc---------ee------------EEEEEEe-----CCe
Q 045452 3 LPCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQH-VNL---------IR------------VLGFCID-----SEE 52 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i---------v~------------~~~~~~~-----~~~ 52 (303)
..+|+.||||+++... ....+.+.+|+.+++.++| .|. +. ++.++.. ...
T Consensus 100 ~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (413)
T 3dzo_A 100 QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179 (413)
T ss_dssp TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCS
T ss_pred cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccc
Confidence 4679999999987332 2336789999999999977 221 11 1111111 224
Q ss_pred eeEEEeeCCCCChhhhhcC----cCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecc
Q 045452 53 RMLVYEYMPNKSLDCYLFD----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 53 ~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df 128 (303)
++++|+++ +++|.+++.. ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 180 ~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DF 255 (413)
T 3dzo_A 180 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255 (413)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCG
T ss_pred eEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEec
Confidence 67778876 6889888742 112455788899999999999999999999 999999999999999999999999
Q ss_pred cccccccccccccccceeeccccccCchhc----------ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHH
Q 045452 129 GLARIFAKESLKANTEQVVGTIGYIPPEYA----------RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 198 (303)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 198 (303)
|++...... .....| ..|+|||++ .+..++.++|||||||++|+|++|+.||............
T Consensus 256 G~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~ 329 (413)
T 3dzo_A 256 EHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329 (413)
T ss_dssp GGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG
T ss_pred cceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH
Confidence 998765432 233467 999999998 5555788999999999999999999999643322211100
Q ss_pred HHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 045452 199 EHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~ 252 (303)
.... . ..+..+.+||.+||..||++|||+.+++
T Consensus 330 ---------------~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 330 ---------------FRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp ---------------GSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ---------------Hhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 0000 0 1124788999999999999999977664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=254.56 Aligned_cols=218 Identities=14% Similarity=0.067 Sum_probs=162.2
Q ss_pred CCCEEEEEEccCCC--------hhhHHHHHHHHHHHhcCC---------CCcceeEEEEEE-------------------
Q 045452 5 CGEVIAVKKLSKSS--------AQGFEEFKNEVMLTAKLQ---------HVNLIRVLGFCI------------------- 48 (303)
Q Consensus 5 ~g~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv~~~~~~~------------------- 48 (303)
+|+.||||+++... ....+.+.+|+.+++.++ |+||+++.+++.
T Consensus 42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~ 121 (336)
T 2vuw_A 42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121 (336)
T ss_dssp TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence 68999999996542 234577888999888875 777777777643
Q ss_pred -----------eCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEE
Q 045452 49 -----------DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKASNIL 116 (303)
Q Consensus 49 -----------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~~i~H~dl~p~nil 116 (303)
.....++||||+.+|++.+.+. +..+++..++.++.||+.||+||| +.| |+||||||+|||
T Consensus 122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NIL 194 (336)
T 2vuw_A 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVL 194 (336)
T ss_dssp TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEE
T ss_pred ccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEE
Confidence 2678999999999997766662 245899999999999999999999 899 999999999999
Q ss_pred ECCCC--------------------cEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHH-
Q 045452 117 LGEDM--------------------KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL- 175 (303)
Q Consensus 117 ~~~~~--------------------~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i- 175 (303)
++.++ .+||+|||+++..... ...||..|+|||++.+.. +.++||||+|++
T Consensus 195 l~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~ 266 (336)
T 2vuw_A 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKE 266 (336)
T ss_dssp EEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHH
T ss_pred EeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCC
Confidence 99887 8999999999865432 347899999999998777 889999998777
Q ss_pred HHHHHhCCCCccccCCCccccHHHHHH-HHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 045452 176 LLQIISGKRLSMLCGINENLSILEHAY-ELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVS 252 (303)
Q Consensus 176 l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~ 252 (303)
.++++.|..||... ....... .......... ..........+.++.+||.+||+.| |+++++
T Consensus 267 ~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 267 NNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKT----KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSS----CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CcccccccCCCcch------hhhhHHHHhhhhhhccCc----ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 67788899987321 0001111 1111100000 0001112345668999999999977 898888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-33 Score=257.12 Aligned_cols=170 Identities=17% Similarity=0.148 Sum_probs=127.5
Q ss_pred CCCEEEEEEccCCC----------hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC
Q 045452 5 CGEVIAVKKLSKSS----------AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 5 ~g~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.|+.+|+|.+.... ....++|.+|+++|+++ .|+||++++++++++...||||||++|++|.++|..
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-- 335 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-- 335 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT--
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh--
Confidence 58899999986431 23456799999999999 799999999999999999999999999999999953
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
+..++.. +++.||+.||+|+|++| |+||||||+|||++.+|.+||+|||+++...... ......+||+.|+
T Consensus 336 -~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~Ym 406 (569)
T 4azs_A 336 -GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVF 406 (569)
T ss_dssp -TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHH
T ss_pred -CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhc
Confidence 4556654 47899999999999999 9999999999999999999999999998664332 2233467999999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCc
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 186 (303)
|||++.+. +..++|+||+|++++.+.++..++
T Consensus 407 APE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 407 VNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHC------------------CCCCTTHHHH
T ss_pred cHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 99999765 467899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-25 Score=202.16 Aligned_cols=166 Identities=19% Similarity=0.181 Sum_probs=134.4
Q ss_pred CCCEEEEEEccCCC---h-----hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCccc
Q 045452 5 CGEVIAVKKLSKSS---A-----QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 76 (303)
.++.+++|+..... . ...+++.+|+.++++++||||+++..++......++||||+++++|.+++..
T Consensus 358 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----- 432 (540)
T 3en9_A 358 LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----- 432 (540)
T ss_dssp SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----
T ss_pred CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----
Confidence 57788999864322 1 1245689999999999999999666666677788999999999999999843
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc-----ccceeecccc
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA-----NTEQVVGTIG 151 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~-----~~~~~~~~~~ 151 (303)
+..++.|++.+|+|||+.+ |+||||||+|||++. .+||+|||+++......... ......||+.
T Consensus 433 ------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~ 501 (540)
T 3en9_A 433 ------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHH 501 (540)
T ss_dssp ------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCG
T ss_pred ------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCC
Confidence 5689999999999999999 999999999999998 99999999998765432111 1234578999
Q ss_pred ccCchhccc--CCCCCcccchhhHHHHHHHHhCCCCc
Q 045452 152 YIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 152 y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~ 186 (303)
|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 502 y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 502 EKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp GGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999999977 56788899999988888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=6.2e-21 Score=161.71 Aligned_cols=124 Identities=19% Similarity=0.074 Sum_probs=97.8
Q ss_pred CCCCCEEEEEEccCCCh------------------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCC
Q 045452 3 LPCGEVIAVKKLSKSSA------------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 64 (303)
..+|+.||||.++.... .....+.+|+.++++++ | +++++++.. +..++||||++|++
T Consensus 111 ~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~ 186 (282)
T 1zar_A 111 SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKE 186 (282)
T ss_dssp ETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEE
T ss_pred eCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCc
Confidence 35799999999964321 13567889999999998 4 555555433 56699999999999
Q ss_pred hhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccc
Q 045452 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTE 144 (303)
Q Consensus 65 L~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 144 (303)
|.+ +.. .....++.|++.||.+||+.| ++||||||+||+++ ++.+||+|||++..
T Consensus 187 L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~----------- 241 (282)
T 1zar_A 187 LYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE----------- 241 (282)
T ss_dssp GGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE-----------
T ss_pred HHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE-----------
Confidence 987 421 124579999999999999999 99999999999999 99999999999853
Q ss_pred eeeccccccCchhcc
Q 045452 145 QVVGTIGYIPPEYAR 159 (303)
Q Consensus 145 ~~~~~~~y~aPE~~~ 159 (303)
+..+.|||.+.
T Consensus 242 ----~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ----VGEEGWREILE 252 (282)
T ss_dssp ----TTSTTHHHHHH
T ss_pred ----CCCCCHHHHHH
Confidence 34567888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=132.70 Aligned_cols=116 Identities=19% Similarity=0.202 Sum_probs=87.0
Q ss_pred CCCCE--EEEEEccCCChh------------------------hHHHHHHHHHHHhcCCCCcc--eeEEEEEEeCCeeeE
Q 045452 4 PCGEV--IAVKKLSKSSAQ------------------------GFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERML 55 (303)
Q Consensus 4 ~~g~~--vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~l 55 (303)
.+|+. ||||+++..... ....+.+|+..+..+.|+++ ..+++. ...++
T Consensus 70 ~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~l 145 (258)
T 1zth_A 70 FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVL 145 (258)
T ss_dssp ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEE
T ss_pred CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEE
Confidence 47888 999987543211 12367889999999987754 445543 35689
Q ss_pred EEeeCCC-C----ChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEECCCCcEEEeccc
Q 045452 56 VYEYMPN-K----SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 56 v~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~~i~H~dl~p~nil~~~~~~~kl~df~ 129 (303)
||||+.+ | +|.++... .++..+..++.|++.+|.+|| ..| ++||||||.|||++. .++|+|||
T Consensus 146 VmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG 214 (258)
T 1zth_A 146 LMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMG 214 (258)
T ss_dssp EEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCT
T ss_pred EEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECc
Confidence 9999942 3 55544321 234567889999999999999 888 999999999999998 89999999
Q ss_pred ccccc
Q 045452 130 LARIF 134 (303)
Q Consensus 130 ~~~~~ 134 (303)
++...
T Consensus 215 ~a~~~ 219 (258)
T 1zth_A 215 QAVTL 219 (258)
T ss_dssp TCEET
T ss_pred ccccC
Confidence 98654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-14 Score=126.23 Aligned_cols=117 Identities=15% Similarity=0.135 Sum_probs=80.8
Q ss_pred cCCCCCEEEEEEccCCCh--------------hhHHH--------HHHHHHHHhcCCCCcc--eeEEEEEEeCCeeeEEE
Q 045452 2 VLPCGEVIAVKKLSKSSA--------------QGFEE--------FKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVY 57 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~lv~ 57 (303)
+.++|+.||||+++.... ..... ...|...+.++.+.++ ...++.. ..+|||
T Consensus 115 ~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~----~~~LVM 190 (397)
T 4gyi_A 115 ADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS----RHTIVM 190 (397)
T ss_dssp ECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE----TTEEEE
T ss_pred ECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc----CceEEE
Confidence 346899999998753210 00111 2346666666644433 3333322 237999
Q ss_pred eeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----------cEEEec
Q 045452 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----------KPKISD 127 (303)
Q Consensus 58 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~----------~~kl~d 127 (303)
||+.|++|..+.. . .....++.||+.+|.+||+.| ++||||||.|||++.+| .+.|+|
T Consensus 191 E~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 191 SLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp ECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred EecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 9999988865542 1 123567899999999999998 99999999999998776 389999
Q ss_pred ccccccc
Q 045452 128 FGLARIF 134 (303)
Q Consensus 128 f~~~~~~ 134 (303)
|+-+...
T Consensus 259 ~~Q~V~~ 265 (397)
T 4gyi_A 259 FPQMVSM 265 (397)
T ss_dssp CTTCEET
T ss_pred eCCcccC
Confidence 9977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.1e-12 Score=106.11 Aligned_cols=120 Identities=18% Similarity=0.105 Sum_probs=92.2
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
+|+.+++|............+.+|+.+++.+ ++..+.++++++...+..++|||+++|.+|.+.+. +....
T Consensus 36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~--------~~~~~ 107 (263)
T 3tm0_A 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE--------DEQSP 107 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC--------TTTCH
T ss_pred CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC--------CcccH
Confidence 4688999998653222234578899999988 46778899999998889999999999999876541 11223
Q ss_pred HHHHHHHHHHHHHHHhcC--------------------------------------------------------CCCeee
Q 045452 84 VHIIEGITQGLLYLQEYS--------------------------------------------------------RLTIIH 107 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~--------------------------------------------------------~~~i~H 107 (303)
..++.+++.+++.||... ...++|
T Consensus 108 ~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~H 187 (263)
T 3tm0_A 108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH 187 (263)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEEC
Confidence 477889999999999811 133899
Q ss_pred cCCCCCcEEECCCCcEEEecccccc
Q 045452 108 RDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 108 ~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
+|++|.||+++.++.+.|+||+.+.
T Consensus 188 gDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 188 GDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCcCcEEEECCcEEEEEEchhcc
Confidence 9999999999876666799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.3e-10 Score=96.60 Aligned_cols=115 Identities=17% Similarity=0.184 Sum_probs=84.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCc--ceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
.+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|. ... .+
T Consensus 42 ~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~-- 108 (264)
T 1nd4_A 42 QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LA-- 108 (264)
T ss_dssp TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------CC--
T ss_pred CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------CC--
Confidence 45778999997554 2245678999988884434 567899888878899999999998884 211 11
Q ss_pred HHHHHHHHHHHHHHHHHhcC-------------------------------------------------------CCCee
Q 045452 82 KRVHIIEGITQGLLYLQEYS-------------------------------------------------------RLTII 106 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~-------------------------------------------------------~~~i~ 106 (303)
...++.+++..++.||... ...++
T Consensus 109 -~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 187 (264)
T 1nd4_A 109 -PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT 187 (264)
T ss_dssp -HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEE
T ss_pred -HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEE
Confidence 1256777778888888643 12299
Q ss_pred ecCCCCCcEEECCCCcEEEecccccc
Q 045452 107 HRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 107 H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
|+|++|.||+++.++.+.|+||+.+.
T Consensus 188 HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 188 HGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCcEEEECCcEEEEEcchhcc
Confidence 99999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.1e-09 Score=93.82 Aligned_cols=123 Identities=15% Similarity=0.253 Sum_probs=90.8
Q ss_pred CCEEEEEEcc--CCC-hhhHHHHHHHHHHHhcCC--CCcceeEEEEEEeC---CeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 6 GEVIAVKKLS--KSS-AQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDS---EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 6 g~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
+..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||||++|..+.+.. ...
T Consensus 61 ~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-----~~~ 135 (359)
T 3dxp_A 61 GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-----LPG 135 (359)
T ss_dssp SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-----CTT
T ss_pred CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-----ccc
Confidence 4677888875 322 123356778999999986 44578899988766 3589999999998875422 123
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------------------C
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYS-------------------------------------------------------R 102 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~-------------------------------------------------------~ 102 (303)
++......++.+++..|+.||... .
T Consensus 136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 215 (359)
T 3dxp_A 136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL 215 (359)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence 677888899999999999999731 2
Q ss_pred CCeeecCCCCCcEEECCCCc--EEEeccccccc
Q 045452 103 LTIIHRDLKASNILLGEDMK--PKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~--~kl~df~~~~~ 133 (303)
..++|+|+++.||+++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 45999999999999997753 69999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=1.9e-09 Score=92.00 Aligned_cols=171 Identities=18% Similarity=0.174 Sum_probs=107.0
Q ss_pred CEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCc--ceeEEEEEEeCC---eeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 7 EVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVN--LIRVLGFCIDSE---ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 7 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..+++|+.... .....+.+|+.+++.+ .+.. +.+++....... ..|+||++++|.++..... ..++.
T Consensus 41 ~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-----~~l~~ 113 (304)
T 3sg8_A 41 RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-----NNLPK 113 (304)
T ss_dssp TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-----HTSCH
T ss_pred CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-----ccCCH
Confidence 45788886432 3456788999999887 4433 345555543333 3589999999988865331 23667
Q ss_pred HHHHHHHHHHHHHHHHHHhcC-------------------------------------------------------CCCe
Q 045452 81 KKRVHIIEGITQGLLYLQEYS-------------------------------------------------------RLTI 105 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~-------------------------------------------------------~~~i 105 (303)
.....++.+++..++.||... ...+
T Consensus 114 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 193 (304)
T 3sg8_A 114 QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCL 193 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEE
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCcee
Confidence 777888888888888888621 1347
Q ss_pred eecCCCCCcEEECC--CCcEEEeccccccccccccccccc------------ceeeccccccC-chhcccCCCCCcccch
Q 045452 106 IHRDLKASNILLGE--DMKPKISDFGLARIFAKESLKANT------------EQVVGTIGYIP-PEYARQGVYSTKSDVF 170 (303)
Q Consensus 106 ~H~dl~p~nil~~~--~~~~kl~df~~~~~~~~~~~~~~~------------~~~~~~~~y~a-PE~~~~~~~~~~~Diw 170 (303)
+|+|++|.||+++. .+.+.++||+.+..-......... ........... |+.... ...-.+.|
T Consensus 194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~ 271 (304)
T 3sg8_A 194 IHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYW 271 (304)
T ss_dssp ECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHH
T ss_pred EeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHH
Confidence 99999999999998 556899999987542111000000 00000001111 121110 01125789
Q ss_pred hhHHHHHHHHhCCCCc
Q 045452 171 SFGVLLLQIISGKRLS 186 (303)
Q Consensus 171 slG~il~~ll~g~~p~ 186 (303)
++|.++|.+.+|..+|
T Consensus 272 ~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 272 SFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCHHH
Confidence 9999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=4.2e-07 Score=75.83 Aligned_cols=118 Identities=16% Similarity=0.144 Sum_probs=85.6
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
++..+++|.-... ....+..|...++.+. +--+.++++++.+.+..++||++++|.++.+.... .....
T Consensus 49 ~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-------~~~~~ 118 (272)
T 4gkh_A 49 NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-------YPDSG 118 (272)
T ss_dssp TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-------CGGGH
T ss_pred CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC-------CHHHH
Confidence 4667888886533 3456778998888883 33477899999999999999999999887665421 11223
Q ss_pred HHHHHHHHHHHHHHHhcC-------------------------------------------------------CCCeeec
Q 045452 84 VHIIEGITQGLLYLQEYS-------------------------------------------------------RLTIIHR 108 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~-------------------------------------------------------~~~i~H~ 108 (303)
..+..+++..|+.||... ...++|+
T Consensus 119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG 198 (272)
T 4gkh_A 119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG 198 (272)
T ss_dssp HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence 455666777777777421 1237899
Q ss_pred CCCCCcEEECCCCcEEEecccccc
Q 045452 109 DLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 109 dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
|+++.||+++.++.+-|+||+.+.
T Consensus 199 Dl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 199 DFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCeEEEECCeEEEEEECcccc
Confidence 999999999987777899998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.1e-06 Score=74.83 Aligned_cols=120 Identities=18% Similarity=0.182 Sum_probs=81.2
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCC---cceeEEEEEE-eCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHV---NLIRVLGFCI-DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
|+.+++|+.. .......+..|+.+++.+.+. .+.+++.+.. ..+..+++|++++|.++..... ..++..
T Consensus 39 g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~-----~~l~~~ 111 (306)
T 3tdw_A 39 NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM-----AVLPDD 111 (306)
T ss_dssp TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH-----TTSCHH
T ss_pred CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh-----hhCCHH
Confidence 4567888742 233456788999999999542 3567777764 3456789999999988865321 113444
Q ss_pred HHHHHHHHHHHHHHHHHhcC---------------------------------------------------------CCC
Q 045452 82 KRVHIIEGITQGLLYLQEYS---------------------------------------------------------RLT 104 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~---------------------------------------------------------~~~ 104 (303)
....++.+++..|+.||... ...
T Consensus 112 ~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~ 191 (306)
T 3tdw_A 112 AKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPR 191 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCE
T ss_pred HHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCe
Confidence 55555555555555555422 224
Q ss_pred eeecCCCCCcEEECC---CCc-EEEecccccc
Q 045452 105 IIHRDLKASNILLGE---DMK-PKISDFGLAR 132 (303)
Q Consensus 105 i~H~dl~p~nil~~~---~~~-~kl~df~~~~ 132 (303)
++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 699999999999997 355 5899999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.3e-06 Score=74.31 Aligned_cols=62 Identities=6% Similarity=0.020 Sum_probs=42.0
Q ss_pred CCEEEEEEccCCC---hhhHHHHHHHHHHHhcCC-C--CcceeEEEEEEeC---CeeeEEEeeCCCCChhh
Q 045452 6 GEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQ-H--VNLIRVLGFCIDS---EERMLVYEYMPNKSLDC 67 (303)
Q Consensus 6 g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~~~sL~~ 67 (303)
|+.+++|+..... ......+..|+.+++.+. + -.+.+++.++.+. +..++|||+++|.++.+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 6678899875432 101245677888888873 3 3567888887655 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=7e-05 Score=64.26 Aligned_cols=30 Identities=27% Similarity=0.398 Sum_probs=26.8
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 459999999999999888899999999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00072 Score=57.88 Aligned_cols=31 Identities=29% Similarity=0.540 Sum_probs=26.7
Q ss_pred CCeeecCCCCCcEEECCC----CcEEEeccccccc
Q 045452 103 LTIIHRDLKASNILLGED----MKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~----~~~kl~df~~~~~ 133 (303)
..++|||+++.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 459999999999999874 6799999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00038 Score=55.24 Aligned_cols=103 Identities=12% Similarity=-0.000 Sum_probs=65.2
Q ss_pred CChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccc
Q 045452 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKAN 142 (303)
Q Consensus 63 ~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 142 (303)
-||.+.|.. .+.+++++++|.++.|.+.+|..+-... . -..+=+.|..|++..+|+|.+.+ +.+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 367777753 4778999999999999999987763211 1 11333456899999999988864 1110
Q ss_pred cceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCC
Q 045452 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185 (303)
Q Consensus 143 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 185 (303)
.....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1134566887653 3345677899999999988874433
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00037 Score=60.86 Aligned_cols=123 Identities=17% Similarity=0.208 Sum_probs=74.0
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhh-hcC-----------
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY-LFD----------- 71 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~----------- 71 (303)
+++.+++|+.... ........+|..+++.|. +.-..++++++.+ .+||+|++|.+|..- +..
T Consensus 81 ~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 81 EPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHH
T ss_pred CCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHH
Confidence 4578999997332 223455668998888873 3334677776643 399999998766421 110
Q ss_pred ---c-C--c-ccCCC--HHHHHHHHHHHHH-------------------HHHHH----Hhc-CCCCeeecCCCCCcEEEC
Q 045452 72 ---P-I--R-RLILD--WKKRVHIIEGITQ-------------------GLLYL----QEY-SRLTIIHRDLKASNILLG 118 (303)
Q Consensus 72 ---~-~--~-~~~~~--~~~~~~~~~~i~~-------------------~l~~l----h~~-~~~~i~H~dl~p~nil~~ 118 (303)
+ . . ..... +..+.+|..++-. .+..| ... ....++|+|+.+.||+++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 0 0 0 11111 3455556544422 12222 222 234599999999999998
Q ss_pred CC----CcEEEecccccc
Q 045452 119 ED----MKPKISDFGLAR 132 (303)
Q Consensus 119 ~~----~~~kl~df~~~~ 132 (303)
.+ +.+.++||..+.
T Consensus 236 ~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 236 SEPENADSLMLVDFEYSS 253 (379)
T ss_dssp SCC---CCEEECCCTTCE
T ss_pred CCCCccCcEEEEecccCC
Confidence 76 789999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0014 Score=55.60 Aligned_cols=58 Identities=21% Similarity=0.139 Sum_probs=45.3
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCC---CCcceeEEEEEEeCCeeeEEEeeCCCCCh
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 65 (303)
++..+++|..... ....+..|+..++.|. ...+.+++.+....+..++|||+++|..+
T Consensus 58 ~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 58 EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4677888887533 3466788988888882 35788999998888889999999998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00031 Score=61.76 Aligned_cols=29 Identities=34% Similarity=0.449 Sum_probs=24.8
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..++|||+.+.||+++.+ .++++||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 349999999999999876 48999998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00089 Score=56.05 Aligned_cols=59 Identities=22% Similarity=0.255 Sum_probs=40.8
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-C--CcceeEEEEEEeCCeeeEEEeeCCCCCh
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-H--VNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL 65 (303)
+.+|+.|++|+...........+..|+..|+.|. . -.+.++++.. ..+++||++.++..
T Consensus 36 l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 36 LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 5789999999976554444445778998888873 2 2355666543 34789999877654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0012 Score=58.41 Aligned_cols=30 Identities=20% Similarity=0.399 Sum_probs=26.4
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
..++|||++|.||+++.++ ++++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4499999999999998876 99999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0009 Score=59.53 Aligned_cols=54 Identities=13% Similarity=0.157 Sum_probs=35.2
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCCh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 65 (303)
++.+++|+..... ....+..|+.+++.+. +.-..++++.+.+ .+|++|++|.++
T Consensus 105 ~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp CSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 5789999984421 1244557888888873 3233677776532 389999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0012 Score=56.18 Aligned_cols=30 Identities=30% Similarity=0.361 Sum_probs=25.6
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..++|+|+++.||+++.++.+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 349999999999999887666899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0012 Score=55.67 Aligned_cols=30 Identities=23% Similarity=0.272 Sum_probs=24.8
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 34899999999999 5566789999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0059 Score=51.90 Aligned_cols=28 Identities=39% Similarity=0.504 Sum_probs=24.4
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..++|+|+++.||+++ + .+.++||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4489999999999998 4 89999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0022 Score=57.44 Aligned_cols=55 Identities=13% Similarity=0.163 Sum_probs=34.2
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcc-eeEEEEEEeCCeeeEEEeeCCCCCh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL 65 (303)
++.+++|+.......... -..|+.+++.|...++ .++++++. + .+||+|++|.+|
T Consensus 133 ~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 133 QAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp TEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred CceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467889987543222111 1468888888854444 57777762 2 369999987655
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0041 Score=53.93 Aligned_cols=29 Identities=24% Similarity=0.455 Sum_probs=24.3
Q ss_pred CCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..++|+|+++.||+++.++ +.++||+.+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 3489999999999998655 8999998774
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.87 E-value=0.007 Score=53.56 Aligned_cols=30 Identities=27% Similarity=0.500 Sum_probs=26.0
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 44899999999999 7778899999998753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.05 E-value=0.33 Score=38.43 Aligned_cols=114 Identities=10% Similarity=0.061 Sum_probs=73.4
Q ss_pred CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCCc
Q 045452 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLL-YLQEYSRLTIIHRDLKASN 114 (303)
Q Consensus 36 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~~~~i~H~dl~p~n 114 (303)
.||++ -..+-.+.+.+.+.+..-+++.=...+ ..++...+++++..|+.... +++ .-+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence 67777 444456666766666655333222233 23778899999998877655 333 27889999999
Q ss_pred EEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCc
Q 045452 115 ILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 115 il~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 186 (303)
++++.++.+++.-.|+-..+ +|.-+ +..-=.-++=|++..++.++..|
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-------------------pP~e~-----~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-------------------PPDEW-----DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCCCcEEEEEcCCcccC-------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999987764322 22111 11111225667888888887776
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.74 E-value=0.29 Score=38.68 Aligned_cols=115 Identities=10% Similarity=0.052 Sum_probs=75.0
Q ss_pred CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 045452 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115 (303)
Q Consensus 36 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~ni 115 (303)
.||+++.. .+....+.+.+.+..-. ....+- .-...+....++++..|+....+++. -+|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 67888866 55556666555555443 222221 12337788999999999887754432 58889999999
Q ss_pred EECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCc
Q 045452 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 116 l~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 186 (303)
+++.++.+++.-.|+-..+ +|. .++...-.-.+=|++..+++++..|
T Consensus 111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999987764322 111 0011111235668888999998887
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.52 E-value=0.097 Score=44.70 Aligned_cols=31 Identities=26% Similarity=0.473 Sum_probs=27.0
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeccccccc
Q 045452 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dl~p~nil~~~~~~~kl~df~~~~~ 133 (303)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.85 E-value=0.22 Score=43.55 Aligned_cols=29 Identities=34% Similarity=0.486 Sum_probs=24.9
Q ss_pred eeecCCCCCcEEE------CCCCcEEEeccccccc
Q 045452 105 IIHRDLKASNILL------GEDMKPKISDFGLARI 133 (303)
Q Consensus 105 i~H~dl~p~nil~------~~~~~~kl~df~~~~~ 133 (303)
++|+|+.+.||++ +..+.++++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998753
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=82.78 E-value=19 Score=33.70 Aligned_cols=45 Identities=24% Similarity=0.201 Sum_probs=34.3
Q ss_pred HHHHHHHHHHH--HHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 81 KKRVHIIEGIT--QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 81 ~~~~~~~~~i~--~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..+..++.++| +.+.|+=..| |=+++|||++.+|.+.-+|||.+.
T Consensus 529 ~ar~nF~~SlA~~Svv~YILGlG-------DRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 529 EVMDTYIKSCAGYCVITYLLGVG-------DRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTCC-------CCCTTTEEECTTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHHccCC-------CCCCcceEEeCCCCEEEEeehhhh
Confidence 44555665544 5666665555 889999999999999999999873
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.81 E-value=28 Score=32.03 Aligned_cols=84 Identities=13% Similarity=0.074 Sum_probs=51.8
Q ss_pred eeEEEEEEeCCeeeEEEeeCCCCChhhhh----------cCcCcc----cCCCHHHHHHHHHHHH--HHHHHHHhcCCCC
Q 045452 41 IRVLGFCIDSEERMLVYEYMPNKSLDCYL----------FDPIRR----LILDWKKRVHIIEGIT--QGLLYLQEYSRLT 104 (303)
Q Consensus 41 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l----------~~~~~~----~~~~~~~~~~~~~~i~--~~l~~lh~~~~~~ 104 (303)
++.|.+...+....+ .|++++.++.+.+ ...... ....+..+..++.++| +.+.|+=..|
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGig--- 477 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVG--- 477 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTCC---
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeecc---
Confidence 556666666555444 4555554444433 221110 0122445566666544 5666775555
Q ss_pred eeecCCCCCcEEECCCCcEEEecccccc
Q 045452 105 IIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 105 i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
|=+++|||++.+|++.=+|||.+.
T Consensus 478 ----DRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 478 ----DRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp ----CCCTTSEEECTTSCEEECCCSSCT
T ss_pred ----CCCCcceeEcCCCCEeeeehHHhh
Confidence 888999999999999999999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 303 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-62
Identities = 65/259 (25%), Positives = 125/259 (48%), Gaps = 20/259 (7%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G + + ++ + Q + FKNEV + K +HVN++ +G+ + + +V ++
Sbjct: 27 GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 85
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SL +L + K + I QG+ YL S IIHRDLK++NI L ED
Sbjct: 86 EGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHED 140
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---QGVYSTKSDVFSFGVLLL 177
+ KI DFGLA + ++ S EQ+ G+I ++ PE R + YS +SDV++FG++L
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY 200
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237
++++G+ N++ + + G + + + K + C
Sbjct: 201 ELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK-----RLMAEC 249
Query: 238 VQENPNDRPSMLEVSSMLK 256
+++ ++RP ++ + ++
Sbjct: 250 LKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-57
Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 22/262 (8%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +AVK L + S + F E L +LQH L+R+ E ++ EYM
Sbjct: 32 GYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N SL +L P + L K + + I +G+ +++E + IHRDL+A+NIL+ +
Sbjct: 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT 145
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ KI+DFGLAR+ A I + PE G ++ KSDV+SFG+LL +I+
Sbjct: 146 LSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
+ R+ N + + + G M D+ ++ ++ LC +E
Sbjct: 205 THGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEE---------LYQLMRLCWKE 249
Query: 241 NPNDRPSMLEVSSMLKNETTNT 262
P DRP+ + S+L++ T T
Sbjct: 250 RPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-56
Identities = 66/256 (25%), Positives = 113/256 (44%), Gaps = 22/256 (8%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G + +A+K + + A E+F E + KL H L+++ G C++ LV+E+M
Sbjct: 24 GYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+ L YL +R + + + + + +G+ YL+E +IHRDL A N L+GE+
Sbjct: 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN 137
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
K+SDFG+ R + ++ + + PE YS+KSDV+SFGVL+ ++
Sbjct: 138 QVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
S ++ N + + G L +I C +E
Sbjct: 197 SEGKIPYENRSNSEV--------VEDISTGFRLYKPRLAST-------HVYQIMNHCWKE 241
Query: 241 NPNDRPSMLEVSSMLK 256
P DRP+ + L
Sbjct: 242 RPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-55
Identities = 58/274 (21%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMP 61
GE +AVK S + + + E+ T L+H N++ + + LV +Y
Sbjct: 26 GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-----YSRLTIIHRDLKASNIL 116
+ S LFD + R + + + + GL +L + I HRDLK+ NIL
Sbjct: 85 HGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140
Query: 117 LGEDMKPKISDFGLARIF--AKESLKANTEQVVGTIGYIPPEYARQGV------YSTKSD 168
+ ++ I+D GLA A +++ VGT Y+ PE + ++D
Sbjct: 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200
Query: 169 VFSFGVLLLQIISGKRLSMLCGINE----NLSILEHAYELWKGGKGMEFVDSFLDDRNSS 224
+++ G++ +I + + + +L + + E + + + + +R S
Sbjct: 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 260
Query: 225 CKLMRCL-EIALLCVQENPNDRPSMLEVSSMLKN 257
C+ +R + +I C N R + L + L
Sbjct: 261 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-54
Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 22/269 (8%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K L + E F E + KL+H L+++ + E +V EYM
Sbjct: 36 GTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SL +L + + + V + I G+ Y++ + +HRDL+A+NIL+GE+
Sbjct: 94 SKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 149
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ K++DFGLAR+ A I + PE A G ++ KSDV+SFG+LL ++
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
+ R+ +N + + + G M + ++ C ++
Sbjct: 209 TKGRVPYPGMVNREV------LDQVERGYRMPCPPECPES---------LHDLMCQCWRK 253
Query: 241 NPNDRPSMLEVSSMLKNETTNTNTPKKPA 269
P +RP+ + + L++ T+T +P
Sbjct: 254 EPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 5e-54
Identities = 64/274 (23%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 6 GEVIAVKKLSKSSAQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
++AVK L + ++ + +F+ E L A+ + N++++LG C + L++EYM
Sbjct: 43 FTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGD 102
Query: 65 LDCYLFDPIRRLI---------------------LDWKKRVHIIEGITQGLLYLQEYSRL 103
L+ +L + L +++ I + G+ YL E
Sbjct: 103 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 160
Query: 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163
+HRDL N L+GE+M KI+DFGL+R I ++PPE Y
Sbjct: 161 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219
Query: 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNS 223
+T+SDV+++GV+L +I S +E + + G + ++ +
Sbjct: 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV------IYYVRDGNILACPENCPLE--- 270
Query: 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKN 257
+ LC + P DRPS + +L+
Sbjct: 271 ------LYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-54
Identities = 59/257 (22%), Positives = 108/257 (42%), Gaps = 22/257 (8%)
Query: 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K + + S +EF E + L H L+++ G C ++ EYM
Sbjct: 23 GKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N L YL + R ++ + + + + + + YL+ +HRDL A N L+ +
Sbjct: 82 ANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQ 136
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
K+SDFGL+R + ++ + + PPE +S+KSD+++FGVL+ +I
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
S + YE + + E + L + I C E
Sbjct: 196 SLGK---------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240
Query: 241 NPNDRPSMLEVSSMLKN 257
++RP+ + S + +
Sbjct: 241 KADERPTFKILLSNILD 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-53
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 37/276 (13%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L S+ E +E+ + + L H+N++ +LG C +++ EY
Sbjct: 53 AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 64 SLDCYLFDPIRRLI---------------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 108
L +L I LD + + + +G+ +L IHR
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHR 169
Query: 109 DLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSD 168
DL A NILL KI DFGLAR +S + ++ PE VY+ +SD
Sbjct: 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
Query: 169 VFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM 228
V+S+G+ L ++ S + + Y++ K G M + +
Sbjct: 230 VWSYGIFLWELFSLGSSPY-----PGMPVDSKFYKMIKEGFRMLSPEHAPAE-------- 276
Query: 229 RCLEIALLCVQENPNDRPSMLEVSSMLK---NETTN 261
+I C +P RP+ ++ +++ +E+TN
Sbjct: 277 -MYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-53
Identities = 66/253 (26%), Positives = 114/253 (45%), Gaps = 27/253 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKS 64
G +AVK + + + F E + +L+H NL+++LG ++ + + +V EYM S
Sbjct: 30 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL R +L + + + + YL+ + +HRDL A N+L+ ED K
Sbjct: 88 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAK 143
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+SDFGL + + + + + PE R+ +STKSDV+SFG+LL +I S R
Sbjct: 144 VSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 198
Query: 185 LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244
+ +++ + G M+ D E+ C +
Sbjct: 199 VPYPRIPLKDV------VPRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAM 243
Query: 245 RPSMLEVSSMLKN 257
RPS L++ L++
Sbjct: 244 RPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-52
Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 23/253 (9%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K L + + + EE E + +L + ++R++G C +E MLV E
Sbjct: 36 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 94
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L +L +R + ++ ++ G+ YL+E + +HRDL A N+LL K
Sbjct: 95 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK 149
Query: 125 ISDFGLARIF-AKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
ISDFGL++ A +S + + PE +S++SDV+S+GV + + +S
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243
+ + + GK ME + + C
Sbjct: 210 QKPYKKMKGPEV------MAFIEQGKRMECPPECPPE---------LYALMSDCWIYKWE 254
Query: 244 DRPSMLEVSSMLK 256
DRP L V ++
Sbjct: 255 DRPDFLTVEQRMR 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-52
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 37/274 (13%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G V+A K + + E+ + + ++ G E + E+M S
Sbjct: 31 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
LD L + + + + + +GL YL + I+HRD+K SNIL+ + K
Sbjct: 91 LDQVLK---KAGRIPEQILGKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSRGEIK 145
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+ DFG++ VGT Y+ PE + YS +SD++S G+ L+++ G+
Sbjct: 146 LCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
Query: 185 ---------LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR------ 229
L ++ G E G+ + + +L+
Sbjct: 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261
Query: 230 ------------CLEIALLCVQENPNDRPSMLEV 251
+ C+ +NP +R + ++
Sbjct: 262 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 4e-52
Identities = 72/252 (28%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+AVK L + + + EEF E + +++H NL+++LG C ++ E+M +L
Sbjct: 42 SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL + R + +++ I+ + YL + IHRDL A N L+GE+ K+
Sbjct: 101 LDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKV 156
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+DFGL+R+ ++ A+ I + PE +S KSDV++FGVLL +I +
Sbjct: 157 ADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245
GI+ L YEL + ME + + E+ C Q NP+DR
Sbjct: 216 -PYPGID-----LSQVYELLEKDYRMERPEGCPEK---------VYELMRACWQWNPSDR 260
Query: 246 PSMLEVSSMLKN 257
PS E+ +
Sbjct: 261 PSFAEIHQAFET 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-51
Identities = 63/253 (24%), Positives = 105/253 (41%), Gaps = 25/253 (9%)
Query: 6 GEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMP 61
G+++ K+L S + +EV L +L+H N++R ID L V EY
Sbjct: 29 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88
Query: 62 NKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYL--QEYSRLTIIHRDLKASNILLG 118
L + + R LD + + ++ +T L + T++HRDLK +N+ L
Sbjct: 89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 148
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
K+ DFGLARI ++ A VGT Y+ PE + Y+ KSD++S G LL +
Sbjct: 149 GKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 206
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238
+ + ++ + + GK + D+ EI +
Sbjct: 207 LCALMPP--FTAFSQ-----KELAGKIREGKFRRIPYRYSDE---------LNEIITRML 250
Query: 239 QENPNDRPSMLEV 251
RPS+ E+
Sbjct: 251 NLKDYHRPSVEEI 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-51
Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 25/255 (9%)
Query: 6 GEVIAVKKLSKSSAQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+ +AVK L + +E E + +L + ++R++G C ++E MLV E
Sbjct: 34 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 92
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L+ YL + K + ++ ++ G+ YL+ +HRDL A N+LL
Sbjct: 93 PLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYA 146
Query: 124 KISDFGLARIFAKESLKANTE-QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KISDFGL++ + + + + PE +S+KSDV+SFGVL+ + S
Sbjct: 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242
+ + + + G+ M + ++ LC +
Sbjct: 207 GQKPYRGMKGSEV------TAMLEKGERMGCPAGCPRE---------MYDLMNLCWTYDV 251
Query: 243 NDRPSMLEVSSMLKN 257
+RP V L+N
Sbjct: 252 ENRPGFAAVELRLRN 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-51
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 39/275 (14%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L + + E +E+ + +L H N++ +LG C S L++EY
Sbjct: 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126
Query: 64 SLDCYLFDPIRRL--------------------ILDWKKRVHIIEGITQGLLYLQEYSRL 103
L YL + +L ++ + + +G+ +L+ S
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184
Query: 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163
+HRDL A N+L+ KI DFGLAR +S + ++ PE +G+Y
Sbjct: 185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNS 223
+ KSDV+S+G+LL +I S + + + Y+L + G M+ ++
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPY-----PGIPVDANFYKLIQNGFKMDQPFYATEE--- 295
Query: 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 258
I C + RPS ++S L +
Sbjct: 296 ------IYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 1e-50
Identities = 60/265 (22%), Positives = 116/265 (43%), Gaps = 24/265 (9%)
Query: 6 GEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K L + + +F +E + + H N+I + G S M++ E+M N S
Sbjct: 54 EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 113
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
LD +L + + V ++ GI G+ YL + + +HRDL A NIL+ ++ K
Sbjct: 114 LDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCK 168
Query: 125 ISDFGLARIFAKESLKANTEQVVG---TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+SDFGL+R ++ +G I + PE + +++ SDV+S+G+++ +++S
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241
N+++ + + ++ L C Q++
Sbjct: 229 YGERPYWDMTNQDV------INAIEQDYRLPPPMDCPSA---------LHQLMLDCWQKD 273
Query: 242 PNDRPSMLEVSSMLKNETTNTNTPK 266
N RP ++ + L N N+ K
Sbjct: 274 RNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-50
Identities = 65/261 (24%), Positives = 112/261 (42%), Gaps = 26/261 (9%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K ++++++ EF NE + + +++R+LG + +++ E M
Sbjct: 50 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 109
Query: 65 LDCYLFDPIRRLI-------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
L YL + K + + I G+ YL +HRDL A N ++
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
ED KI DFG+ R + + + + ++ PE + GV++T SDV+SFGV+L
Sbjct: 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237
+I + NE + G ++ D+ D E+ +C
Sbjct: 227 EIATLAEQPYQGLSNEQV------LRFVMEGGLLDKPDNCPDM---------LFELMRMC 271
Query: 238 VQENPNDRPSMLEVSSMLKNE 258
Q NP RPS LE+ S +K E
Sbjct: 272 WQYNPKMRPSFLEIISSIKEE 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-50
Identities = 49/251 (19%), Positives = 103/251 (41%), Gaps = 26/251 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ A K + S + E++ E+ + A H N++++L ++ E+ ++
Sbjct: 37 SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + + R L + + + L YL + IIHRDLKA NIL D K+
Sbjct: 97 DAVMLELERP--LTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKL 151
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYA-----RQGVYSTKSDVFSFGVLLLQII 180
+DFG++ + + ++ +GT ++ PE + Y K+DV+S G+ L+++
Sbjct: 152 ADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240
+ + L+ + ++ K S + C+++
Sbjct: 210 EIEPP------HHELNPMRVLLKIAKSEPPTLAQPSRWSS--------NFKDFLKKCLEK 255
Query: 241 NPNDRPSMLEV 251
N + R + ++
Sbjct: 256 NVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 8e-50
Identities = 67/252 (26%), Positives = 105/252 (41%), Gaps = 33/252 (13%)
Query: 6 GEVIAVKKLSKSSAQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
EV+A+KK+S S Q +++ EV KL+H N I+ G + LV EY
Sbjct: 40 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ D + + L + + G QGL YL ++ +IHRD+KA NILL E
Sbjct: 100 SASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 153
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---QGVYSTKSDVFSFGVLLLQI 179
K+ DFG A I A VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 154 VKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
Query: 180 ISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239
K N++ + Y + + + + C+Q
Sbjct: 208 AERKPP------LFNMNAMSALYHIAQNESPALQSGHWSEY---------FRNFVDSCLQ 252
Query: 240 ENPNDRPSMLEV 251
+ P DRP+ +
Sbjct: 253 KIPQDRPTSEVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 9e-50
Identities = 59/253 (23%), Positives = 99/253 (39%), Gaps = 30/253 (11%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER----MLVYEY 59
+A +L + + FK E + LQH N++R + + +LV E
Sbjct: 34 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-G 118
M + +L YL R ++ K I +GL +L + IIHRDLK NI + G
Sbjct: 94 MTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITG 149
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
KI D GLA + + V+GT ++ PE + Y DV++FG+ +L+
Sbjct: 150 PTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLE 204
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238
+ + + Y G D EI C+
Sbjct: 205 MATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAIP--------EVKEIIEGCI 250
Query: 239 QENPNDRPSMLEV 251
++N ++R S+ ++
Sbjct: 251 RQNKDERYSIKDL 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-49
Identities = 56/255 (21%), Positives = 104/255 (40%), Gaps = 24/255 (9%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNK 63
AVK L++ + G +F E ++ H N++ +LG C+ SE ++V YM +
Sbjct: 55 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L ++ + + + ++ + +HRDL A N +L E
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAK-----GMKFLASKKFVHRDLAARNCMLDEKFTV 169
Query: 124 KISDFGLARIFAKESLKANTEQ--VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K++DFGLAR + + + + ++ E + ++TKSDV+SFGVLL ++++
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241
+++ + L +G + L E+ L C
Sbjct: 230 RGAP-----PYPDVNTFDITVYLLQGRR-------LLQPEYCP---DPLYEVMLKCWHPK 274
Query: 242 PNDRPSMLEVSSMLK 256
RPS E+ S +
Sbjct: 275 AEMRPSFSELVSRIS 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-49
Identities = 57/248 (22%), Positives = 104/248 (41%), Gaps = 22/248 (8%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
E +AVK + A E K E+ + L H N+++ G + + L EY
Sbjct: 30 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L + + + + G++YL + I HRD+K N+LL E K
Sbjct: 90 LFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLK 143
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR-QGVYSTKSDVFSFGVLLLQIISGK 183
ISDFGLA +F + + ++ GT+ Y+ PE + + ++ DV+S G++L +++G+
Sbjct: 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243
+++ WK K +D L + + ENP+
Sbjct: 204 L--PWDQPSDSCQEYSD----WKEKKTYLNPWKKIDS--------APLALLHKILVENPS 249
Query: 244 DRPSMLEV 251
R ++ ++
Sbjct: 250 ARITIPDI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-48
Identities = 57/261 (21%), Positives = 110/261 (42%), Gaps = 22/261 (8%)
Query: 8 VIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+A+K L + +F E + + H N+IR+ G + M++ EYM N +LD
Sbjct: 38 PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 97
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
+L + + + V ++ GI G+ Y + + +HRDL A NIL+ ++ K+S
Sbjct: 98 KFLRE--KDGEFSVLQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVS 152
Query: 127 DFGLARIFAKESLKANTEQ-VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
DFGL+R+ + T I + PE +++ SDV+SFG+++ ++++
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245
N + + G + ++ + C Q+ R
Sbjct: 213 PYWELSNHEV------MKAINDGFRLPTPMDCPS---------AIYQLMMQCWQQERARR 257
Query: 246 PSMLEVSSMLKNETTNTNTPK 266
P ++ S+L ++ K
Sbjct: 258 PKFADIVSILDKLIRAPDSLK 278
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-48
Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 40/283 (14%)
Query: 8 VIAVKKLSK-SSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
A+K++ + +S +F E+ + KL H N+I +LG C L EY P+ +L
Sbjct: 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 98
Query: 66 DCYL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+L L ++ +H + +G+ YL + IHRDL A
Sbjct: 99 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAA 155
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
NIL+GE+ KI+DFGL+R + ++ E VY+T SDV+S+
Sbjct: 156 RNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232
GVLL +I+S CG+ YE G +E + D+ +
Sbjct: 213 GVLLWEIVSLGGTPY-CGMTC-----AELYEKLPQGYRLEKPLNCDDE---------VYD 257
Query: 233 IALLCVQENPNDRPSMLEV----SSMLKNETTNTNTPKKPAFS 271
+ C +E P +RPS ++ + ML+ T NT F+
Sbjct: 258 LMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFT 300
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-48
Identities = 57/246 (23%), Positives = 105/246 (42%), Gaps = 23/246 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+++++ E NE+++ + ++ N++ L + +E +V EY+ S
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS- 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
L D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 104 ---LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 126 SDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+DFG E K +T +VGT ++ PE + Y K D++S G++ +++I G+
Sbjct: 158 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 186 SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245
N + L Y + G L + C+ + R
Sbjct: 216 ------YLNENPLRALYLIATNGTPELQNPEKLSA--------IFRDFLNRCLDMDVEKR 261
Query: 246 PSMLEV 251
S E+
Sbjct: 262 GSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-48
Identities = 63/255 (24%), Positives = 99/255 (38%), Gaps = 24/255 (9%)
Query: 6 GEVIAVKKLSK---SSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+AVK L S + ++F EV L H NLIR+ G + +M V E P
Sbjct: 36 TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPL 94
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL L +L R + +G+ YL+ IHRDL A N+LL
Sbjct: 95 GSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDL 149
Query: 123 PKISDFGLARIFAK-ESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI DFGL R + + E + PE + +S SD + FGV L ++ +
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241
+ L+ + +++ K G+ + + D + + C
Sbjct: 210 YGQEPW-----IGLNGSQILHKIDKEGERLPRPEDCPQD---------IYNVMVQCWAHK 255
Query: 242 PNDRPSMLEVSSMLK 256
P DRP+ + + L
Sbjct: 256 PEDRPTFVALRDFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-47
Identities = 57/251 (22%), Positives = 103/251 (41%), Gaps = 34/251 (13%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
++A+K L K+ A + + EV + + L+H N++R+ G+ D+ L+ EY P
Sbjct: 31 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
++ L + D ++ I + L Y +IHRD+K N+LLG +
Sbjct: 91 GTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGE 144
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFG + + GT+ Y+PPE ++ K D++S GVL + + G
Sbjct: 145 LKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM--RCLEIALLCVQE 240
K ++ E + + ++ ++
Sbjct: 201 KP-------------------PFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 241 NPNDRPSMLEV 251
NP+ RP + EV
Sbjct: 242 NPSQRPMLREV 252
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-47
Identities = 52/249 (20%), Positives = 110/249 (44%), Gaps = 22/249 (8%)
Query: 9 IAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K+L ++ S + +E +E + A + + ++ R+LG C+ L+ + MP L
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD 99
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
Y+ + + + + ++ I +G+ YL++ ++HRDL A N+L+ KI+D
Sbjct: 100 YVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITD 154
Query: 128 FGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLA++ E + + E I ++ E +Y+ +SDV+S+GV + ++++
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214
Query: 188 LCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDRPS 247
+ + + G+ + D I + C + + RP
Sbjct: 215 DGIPASEI------SSILEKGERLPQPPICTID---------VYMIMVKCWMIDADSRPK 259
Query: 248 MLEVSSMLK 256
E+
Sbjct: 260 FRELIIEFS 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 6e-46
Identities = 68/268 (25%), Positives = 105/268 (39%), Gaps = 33/268 (12%)
Query: 6 GEVIAVKKLSKSSAQG-FEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPN 62
+AVK L + + +E+ +L H+N++ +LG C M++ E+
Sbjct: 43 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF 102
Query: 63 KSLDCYLF-------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
+L YL + + + L + + + +G+ +L IHRD
Sbjct: 103 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
L A NILL E KI DFGLAR K+ + ++ PE VY+ +SDV
Sbjct: 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 219
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR 229
+SFGVLL +I S + I E K G M D +
Sbjct: 220 WSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRMRAPDYTTPE--------- 265
Query: 230 CLEIALLCVQENPNDRPSMLEVSSMLKN 257
+ L C P+ RP+ E+ L N
Sbjct: 266 MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-45
Identities = 45/253 (17%), Positives = 96/253 (37%), Gaps = 23/253 (9%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K ++ E+F E + + H ++++++G + ++ E
Sbjct: 35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGE 93
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L +L L D + ++ L YL+ +HRD+ A N+L+ + K
Sbjct: 94 LRSFLQVRKYSL--DLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVK 148
Query: 125 ISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+ DFGL+R + + + I ++ PE +++ SDV+ FGV + +I+
Sbjct: 149 LGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207
Query: 185 LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244
N ++ + G+ + + + C +P+
Sbjct: 208 KPFQGVKNNDV------IGRIENGERLPMPPNCPPT---------LYSLMTKCWAYDPSR 252
Query: 245 RPSMLEVSSMLKN 257
RP E+ + L
Sbjct: 253 RPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-44
Identities = 64/267 (23%), Positives = 107/267 (40%), Gaps = 33/267 (12%)
Query: 6 GEVIAVKKLSK-SSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L ++ + + +E+ + + +H N+I +LG C ++ EY
Sbjct: 45 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104
Query: 64 SLDCYLFDPIRRLI-------------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+L YL + L K V + +G+ YL IHRDL
Sbjct: 105 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDL 161
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
A N+L+ ED KI+DFGLAR T + ++ PE +Y+ +SDV+
Sbjct: 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 221
Query: 171 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRC 230
SFGVLL +I + +E ++L K G M+ + ++
Sbjct: 222 SFGVLLWEIFTLGGSPY------PGVPVEELFKLLKEGHRMDKPSNCTNE---------L 266
Query: 231 LEIALLCVQENPNDRPSMLEVSSMLKN 257
+ C P+ RP+ ++ L
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 3e-44
Identities = 52/250 (20%), Positives = 97/250 (38%), Gaps = 27/250 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G A K + E + E+ + L+H L+ + D E +++YE+M L
Sbjct: 51 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKP 123
+ D + + + V + + +GL ++ E + +H DLK NI+ +
Sbjct: 111 FEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNEL 165
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K+ DFGL + + + GT + PE A +D++S GVL ++SG
Sbjct: 166 KLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALLCVQEN 241
G N++ ++ W DS + K + + L +
Sbjct: 223 SP--FGGENDDETLRNVKSCDWN------MDDSAFSGISEDGKDFIRKLLLA-------D 267
Query: 242 PNDRPSMLEV 251
PN R ++ +
Sbjct: 268 PNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-44
Identities = 56/251 (22%), Positives = 96/251 (38%), Gaps = 30/251 (11%)
Query: 6 GEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
A+K L K E + ++L H +++ D E+ Y N
Sbjct: 33 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L Y+ D + + L+ IIHRDLK NILL EDM
Sbjct: 93 GELLKYIRKIGS---FDETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMH 146
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+I+DFG A++ + ES +A VGT Y+ PE + SD+++ G ++ Q+++G
Sbjct: 147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALLCVQE 240
NE Y +++ K ++ F + + + + L +
Sbjct: 207 LPP--FRAGNE--------YLIFQ--KIIKLEYDFPEKFFPKARDLVEKLLVL------- 247
Query: 241 NPNDRPSMLEV 251
+ R E+
Sbjct: 248 DATKRLGCEEM 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (367), Expect = 9e-42
Identities = 48/250 (19%), Positives = 94/250 (37%), Gaps = 27/250 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G V K ++ KNE+ + +L H LI + D E +L+ E++ L
Sbjct: 54 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--GEDMKP 123
+ + + ++ + +GL ++ E +I+H D+K NI+ +
Sbjct: 114 FDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSV 168
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI DFGLA + + + T + PE + +D+++ GVL ++SG
Sbjct: 169 KIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALLCVQEN 241
G ++ ++ W EF + + K + L+
Sbjct: 226 SP--FAGEDDLETLQNVKRCDW------EFDEDAFSSVSPEAKDFIKNLLQK-------E 270
Query: 242 PNDRPSMLEV 251
P R ++ +
Sbjct: 271 PRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 6e-40
Identities = 57/252 (22%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 6 GEVIAVKKLSKSSAQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+++A+K ++K + +G E +NE+ + K++H N++ + L+ + +
Sbjct: 34 QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
L + + + + +I + + YL + I+HRDLK N+L ED
Sbjct: 94 LFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDS 147
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K ISDFGL+++ S+ GT GY+ PE Q YS D +S GV+ ++
Sbjct: 148 KIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALLCVQ 239
G + + + ++ K EF + DD + S K + +E
Sbjct: 205 GYPPF------YDENDAKLFEQILKA--EYEFDSPYWDDISDSAKDFIRHLMEK------ 250
Query: 240 ENPNDRPSMLEV 251
+P R + +
Sbjct: 251 -DPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (342), Expect = 8e-39
Identities = 59/259 (22%), Positives = 106/259 (40%), Gaps = 28/259 (10%)
Query: 6 GEVIAVKKLSKSSAQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER----MLVYE 58
+AVK L A+ + F+ E A L H ++ V +V E
Sbjct: 32 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
Y+ +L + + K+ + +I Q L + + IIHRD+K +NI++
Sbjct: 92 YVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMIS 145
Query: 119 EDMKPKISDFGLARIFAKE-SLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
K+ DFG+AR A + T V+GT Y+ PE AR +SDV+S G +L
Sbjct: 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 205
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237
++++G+ S + AY+ + + + ++ + L
Sbjct: 206 EVLTGEPP------FTGDSPVSVAYQHVREDP--IPPSARHEGLSADLD-----AVVLKA 252
Query: 238 VQENPNDRP-SMLEVSSML 255
+ +NP +R + E+ + L
Sbjct: 253 LAKNPENRYQTAAEMRADL 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-38
Identities = 60/299 (20%), Positives = 116/299 (38%), Gaps = 25/299 (8%)
Query: 6 GEVIAVKKLSKSSAQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+KK+S Q + + E+ + + +H N+I + + Y+
Sbjct: 33 KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
+ L+ ++ L + + I +GL Y+ ++HRDLK SN+LL K
Sbjct: 93 MGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 149
Query: 125 ISDFGLARIFAKESLKANTE-QVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIISG 182
I DFGLAR+ + + V T Y PE TKS D++S G +L +++S
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 183 KRLSMLCGINENLSILEHAY-----ELWKGGKGMEFVDSFLDDRNSSCKLMR-------- 229
+ + + L+ + E ++ + L + +
Sbjct: 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 269
Query: 230 -CLEIALLCVQENPNDRPSMLEV--SSMLKNETTNTNTPKKPA---FSKQVDEIGIELL 282
L++ + NP+ R + + L+ ++ P A F ++D++ E L
Sbjct: 270 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 328
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-37
Identities = 45/274 (16%), Positives = 92/274 (33%), Gaps = 30/274 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ K + K E+ + +H N++ + EE ++++E++ +
Sbjct: 30 KKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKP 123
+ L+ ++ V + + + L +L ++ I H D++ NI+
Sbjct: 89 FERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTI 143
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI +FG AR N + Y PE + V ST +D++S G L+ ++SG
Sbjct: 144 KIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALLCVQEN 241
+ E + F + + + + R L
Sbjct: 201 NP--FLAETN-----QQIIENIMNAEY-TFDEEAFKEISIEAMDFVDRLLVK-------E 245
Query: 242 PNDRPSMLEV--SSMLKNETTNTNTPKKPAFSKQ 273
R + E LK + +T +
Sbjct: 246 RKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (329), Expect = 1e-36
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 14/182 (7%)
Query: 6 GEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G A+K L K + E +E ++ + + H +IR+ G D+++ ++ +Y+
Sbjct: 29 GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L L R K + L L+ II+RDLK NILL ++
Sbjct: 89 GELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSKDIIYRDLKPENILLDKNGH 142
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFG A+ + T + GT YI PE Y+ D +SFG+L+ ++++G
Sbjct: 143 IKITDFGFAKY-----VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197
Query: 183 KR 184
Sbjct: 198 YT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 6e-36
Identities = 60/264 (22%), Positives = 103/264 (39%), Gaps = 42/264 (15%)
Query: 6 GEVIAVKKLSKSSAQGF---------EEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERML 55
+ AVK + + F E EV + K+ H N+I++ + L
Sbjct: 28 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
V++ M L YL ++ L K+ I+ + + + L + L I+HRDLK NI
Sbjct: 88 VFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENI 141
Query: 116 LLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR------QGVYSTKSDV 169
LL +DM K++DFG + +V GT Y+ PE Y + D+
Sbjct: 142 LLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 198
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--L 227
+S GV++ +++G + + + G +F DD + + K +
Sbjct: 199 WSTGVIMYTLLAGSPP------FWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTVKDLV 250
Query: 228 MRCLEIALLCVQENPNDRPSMLEV 251
R L + P R + E
Sbjct: 251 SRFLVV-------QPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (321), Expect = 1e-35
Identities = 45/260 (17%), Positives = 81/260 (31%), Gaps = 24/260 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GE +A+K + + E + +Q I + +C + ++ + SL
Sbjct: 32 GEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL---LGEDMK 122
+ R+ K + + + + + Y+ IHRD+K N L +
Sbjct: 90 EDLFNFCSRKF--SLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNL 144
Query: 123 PKISDFGLARIFAKESLKAN-----TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
I DFGLA+ + + + + GT Y S + D+ S G +L+
Sbjct: 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 204
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237
G E E K M L S C
Sbjct: 205 YFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEVLCKGYPSE----FATYLNFC 255
Query: 238 VQENPNDRPSMLEVSSMLKN 257
+D+P + + +N
Sbjct: 256 RSLRFDDKPDYSYLRQLFRN 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-35
Identities = 58/249 (23%), Positives = 89/249 (35%), Gaps = 33/249 (13%)
Query: 6 GEVIAVKKLSKSSA---QGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
+ A+K L K E E +L+ +H L + E V EY+
Sbjct: 27 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L ++ + D + I GL +L I++RDLK NILL +D
Sbjct: 87 GGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 140
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI+DFG+ + K NT GT YI PE Y+ D +SFGVLL +++
Sbjct: 141 HIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 198
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLM--RCLEIALLCVQ 239
G+ + G E S D + + ++ +
Sbjct: 199 GQS-------------------PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 240 ENPNDRPSM 248
P R +
Sbjct: 240 REPEKRLGV 248
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (318), Expect = 4e-35
Identities = 36/262 (13%), Positives = 80/262 (30%), Gaps = 26/262 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ +A+K + S + ++E L I + + ++ + SL
Sbjct: 30 NQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSL 87
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP-- 123
+ L R+ K + + + + E S +++RD+K N L+G
Sbjct: 88 EDLLDLCGRKF--SVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNA 142
Query: 124 ---KISDFGLARIFAKESLKAN-----TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+ DFG+ + + K + + + GT Y+ S + D+ + G +
Sbjct: 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235
+ + G N E E + E F ++ +
Sbjct: 203 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE---------FYKYMH 253
Query: 236 LCVQENPNDRPSMLEVSSMLKN 257
+ P + +
Sbjct: 254 YARNLAFDATPDYDYLQGLFSK 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 127 bits (320), Expect = 7e-35
Identities = 53/256 (20%), Positives = 93/256 (36%), Gaps = 35/256 (13%)
Query: 6 GEVIAVKKLSKSSAQG------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G++ A+K L K + + + L + ++ + ++ + +
Sbjct: 29 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M L +L + + I GL ++ +++RDLK +NILL E
Sbjct: 89 MNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDE 142
Query: 120 DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQ 178
+ISD GLA F+K+ VGT GY+ PE ++GV Y + +D FS G +L +
Sbjct: 143 HGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 198
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALL 236
++ G + I + D + + L L
Sbjct: 199 LLRGHSPFRQHKTKDKHEIDR---------MTLTMAVELPDSFSPELRSLLEGLL----- 244
Query: 237 CVQENPNDRPSMLEVS 252
Q + N R L
Sbjct: 245 --QRDVNRRLGCLGRG 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-34
Identities = 54/258 (20%), Positives = 102/258 (39%), Gaps = 36/258 (13%)
Query: 6 GEVIAVKKLSKSSAQGF------EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G A K + K + E+ + EV + ++QH N+I + + + +L+ E
Sbjct: 35 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L + + L ++ ++ I L + L I H DLK NI+L +
Sbjct: 95 VAGGELFDF---LAEKESLTEEEATEFLKQI---LNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 120 DMKP----KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
P KI DFGLA + + + GT ++ PE ++D++S GV+
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEI 233
++SG + E L+ + EF D + + ++ K + R L
Sbjct: 206 TYILLSGASPFLGDTKQETLANVSA--------VNYEFEDEYFSNTSALAKDFIRRLL-- 255
Query: 234 ALLCVQENPNDRPSMLEV 251
++P R ++ +
Sbjct: 256 -----VKDPKKRMTIQDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-34
Identities = 56/264 (21%), Positives = 101/264 (38%), Gaps = 24/264 (9%)
Query: 6 GEVIAVKKLSKSSAQG--FEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K++ + + EV + L +H N++R+ C S +
Sbjct: 33 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92
Query: 61 PNKSLDC---YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ +D D + + + ++ + +GL +L + ++HRDLK NIL+
Sbjct: 93 VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILV 149
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K++DFGLARI++ + VV T+ Y PE Q Y+T D++S G +
Sbjct: 150 TSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206
Query: 178 QIISGKRLSMLCGINENLS-----ILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232
++ K L + L I E W + K + ++
Sbjct: 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266
Query: 233 IALL-----CVQENPNDRPSMLEV 251
C+ NP R S
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-34
Identities = 58/260 (22%), Positives = 100/260 (38%), Gaps = 20/260 (7%)
Query: 6 GEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
GEV+A+KK+ + E+ L +L H N++++L + LV+E++
Sbjct: 27 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ + L K Q L L ++HRDLK N+L+ +
Sbjct: 87 LKKFMDASALTGIPLPLIKSYLF-----QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI 141
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K++DFGLAR F + T +VV P YST D++S G + ++++ +
Sbjct: 142 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
Query: 184 RLSMLCGINENL-----SILEHAYELWKGGKGM-----EFVDSFLDDRNSSCKLMRCLEI 233
L + L ++ +W G M F D + +
Sbjct: 201 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 260
Query: 234 ALL--CVQENPNDRPSMLEV 251
+LL + +PN R S
Sbjct: 261 SLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 7e-34
Identities = 52/256 (20%), Positives = 92/256 (35%), Gaps = 42/256 (16%)
Query: 6 GEVIAVKKLSKSSAQGFEE------FKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVY 57
+A+K + K + E EV+L K+ +IR+L + + +L+
Sbjct: 29 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E R L + + + + + ++HRD+K NIL+
Sbjct: 89 ERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILI 143
Query: 118 GED-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVL 175
+ + K+ DFG + GT Y PPE+ R Y +S V+S G+L
Sbjct: 144 DLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235
L ++ G ++ + + F R SS C +
Sbjct: 200 LYDMVCGDI-------------------PFEHDEEIIRGQVFFRQRVSS----ECQHLIR 236
Query: 236 LCVQENPNDRPSMLEV 251
C+ P+DRP+ E+
Sbjct: 237 WCLALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-33
Identities = 57/263 (21%), Positives = 101/263 (38%), Gaps = 25/263 (9%)
Query: 6 GEVIAVKKLSKSSAQGFEE-----FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
+++A+KK+ ++ E+ L +L H N+I +L LV+++M
Sbjct: 23 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
D + L+L + QGL YL ++ I+HRDLK +N+LL E+
Sbjct: 83 ET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 136
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQI 179
K++DFGLA+ F + V T Y PE +Y D+++ G +L ++
Sbjct: 137 GVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 194
Query: 180 ISGKRLSMLCGINENLS-ILEHAY----ELWKGGKGMEFVDSFLDDRNSSCKLM------ 228
+ + L+ I E E W + +F +
Sbjct: 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254
Query: 229 RCLEIALLCVQENPNDRPSMLEV 251
L++ NP R + +
Sbjct: 255 DLLDLIQGLFLFNPCARITATQA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (303), Expect = 4e-33
Identities = 52/265 (19%), Positives = 99/265 (37%), Gaps = 21/265 (7%)
Query: 1 GVLPCGEVIAVKKL--SKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
GE A+KK+ K E+ + +L+H N++++ + +LV+E
Sbjct: 21 AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
++ L+ + + G+ Y + ++HRDLK N+L+
Sbjct: 81 HLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLIN 134
Query: 119 EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ + KI+DFGLAR F K ++V P YST D++S G + +
Sbjct: 135 REGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
Query: 179 IISGKRL-------SMLCGINENL-----SILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226
+++G L L I L + EL K + +
Sbjct: 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253
Query: 227 LMRCLEIALLCVQENPNDRPSMLEV 251
+++ ++ +PN R + +
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-33
Identities = 55/265 (20%), Positives = 95/265 (35%), Gaps = 28/265 (10%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM------LVYEY 59
GE++A+KK+ + E+ + KL H N++R+ F S E+ LV +Y
Sbjct: 45 GELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+P + L + + + L Y+ I HRD+K N+LL
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDP 157
Query: 120 D-MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
D K+ DFG A+ + + + P Y++ DV+S G +L +
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 179 IISGKRL-------SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231
++ G+ + L I + L EF + +
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275
Query: 232 E---IALL--CVQENPNDRPSMLEV 251
IAL ++ P R + LE
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-32
Identities = 51/274 (18%), Positives = 104/274 (37%), Gaps = 34/274 (12%)
Query: 6 GEVIAVKKLSKSSAQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM--------L 55
G+ +A+KK+ + + E+ + L+H N++ ++ C L
Sbjct: 35 GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
V+++ + ++ + +++ + GL Y+ I+HRD+KA+N+
Sbjct: 95 VFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 148
Query: 116 LLGEDMKPKISDFGLARIF--AKESLKANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSF 172
L+ D K++DFGLAR F AK S V T+ Y PPE Y D++
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGMEFVDSFLDDRNSSCKL 227
G ++ ++ + + L+++ E+W E + + K+
Sbjct: 209 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV 268
Query: 228 MRCLEIALL----------CVQENPNDRPSMLEV 251
L+ + + +P R +
Sbjct: 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-31
Identities = 48/263 (18%), Positives = 95/263 (36%), Gaps = 26/263 (9%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
E++A+K++ E+ L +L+H N++R+ ++ LV+E+
Sbjct: 27 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ + + Q L L ++HRDLK N+L+ + +
Sbjct: 87 LKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140
Query: 124 KISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K+++FGLAR F + + +VV P +YST D++S G + ++ +
Sbjct: 141 KLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR-------------- 229
R L N+ L+ + L ++ +
Sbjct: 200 R--PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 230 -CLEIALLCVQENPNDRPSMLEV 251
++ ++ NP R S E
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-30
Identities = 50/256 (19%), Positives = 97/256 (37%), Gaps = 33/256 (12%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER----MLVYEYM 60
E A+K L + + EV L + Q +++R++ + ++V E +
Sbjct: 37 QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--- 117
L + D + ++ I++ I + + YL + I HRD+K N+L
Sbjct: 92 DGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK 147
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K++DFG A+ + + T Y+ PE Y D++S GV++
Sbjct: 148 RPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 204
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIAL 235
++ G N L+I + G+ EF + + + K + L
Sbjct: 205 ILLCGYPPFY---SNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLL---- 256
Query: 236 LCVQENPNDRPSMLEV 251
+ P R ++ E
Sbjct: 257 ---KTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-30
Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 11/182 (6%)
Query: 6 GEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G A+K L K + E + +H L + + V EY
Sbjct: 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L +L R + ++ + + L+ +++RD+K N++L +D
Sbjct: 90 GELFFHL---SRERVFTEERARFYG---AEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGL + + A + GT Y+ PE Y D + GV++ +++ G
Sbjct: 144 IKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 183 KR 184
+
Sbjct: 202 RL 203
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-29
Identities = 59/291 (20%), Positives = 110/291 (37%), Gaps = 26/291 (8%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE-YMPN 62
G +A+KKL + S + E+ L ++H N+I +L E + Y+
Sbjct: 43 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ L ++ L + ++ + +GL Y+ IIHRDLK N+ + ED +
Sbjct: 103 PFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCE 159
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI DFGLAR E T VV P Y+ D++S G ++ ++I+G
Sbjct: 160 LKILDFGLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 183 KRL--------SMLCGINENLSILEHAYELWKGGKGMEFVDSFLD----DRNSSCKLMRC 230
K L + + + + + + ++ + D S
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 231 LEIALL--CVQENPNDRPSMLEV--SSMLKNETTNTNTPKKPAFSKQVDEI 277
L + LL + + R + E ++ + P+ + D++
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDV 326
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-27
Identities = 50/252 (19%), Positives = 106/252 (42%), Gaps = 31/252 (12%)
Query: 6 GEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYM 60
G++ A+K L K++ A+ E + E + ++ L+ + + L+ +Y+
Sbjct: 52 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI 111
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L +L R + + + + +L L+ +L II+RD+K NILL +
Sbjct: 112 NGGELFTHLSQRERFTEHEVQIY------VGEIVLALEHLHKLGIIYRDIKLENILLDSN 165
Query: 121 MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQ 178
++DFGL++ F + + GTI Y+ P+ R G + D +S GVL+ +
Sbjct: 166 GHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK--LMRCLEIALL 236
+++G + G + + + + ++ + + ++ K + R L
Sbjct: 225 LLTGASPFTVDGEKNSQAEISR--------RILKSEPPYPQEMSALAKDLIQRLL----- 271
Query: 237 CVQENPNDRPSM 248
++P R
Sbjct: 272 --MKDPKKRLGC 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 4e-27
Identities = 42/183 (22%), Positives = 72/183 (39%), Gaps = 14/183 (7%)
Query: 6 GEVIAVKKLSKSSA---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G A+K L K + E NE + + L+++ D+ +V EY+
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ +L R I YL L +I+RDLK N+L+ +
Sbjct: 126 GEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+++DFG A+ K T + GT + PE Y+ D ++ GVL+ ++ +G
Sbjct: 180 IQVTDFGFAKRV-----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 183 KRL 185
Sbjct: 235 YPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.0 bits (243), Expect = 3e-24
Identities = 51/272 (18%), Positives = 97/272 (35%), Gaps = 41/272 (15%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERM--LVYEYMPN 62
E + VK L ++ K E+ + L+ N+I + D R LV+E++ N
Sbjct: 60 NEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDM 121
+ L + I + L Y + I+HRD+K N+++ E
Sbjct: 117 TDF----KQLYQTL--TDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHR 167
Query: 122 KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQII 180
K ++ D+GLA + V + + PE +Y D++S G +L +I
Sbjct: 168 KLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 181 SGKR--------LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLE 232
K L I + L + + K ++ + + R+S + R +
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284
Query: 233 -----------IALL--CVQENPNDRPSMLEV 251
+ L ++ + R + E
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 9e-23
Identities = 52/263 (19%), Positives = 98/263 (37%), Gaps = 24/263 (9%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPN 62
G +AVKKLS+ S + E+ L ++H N+I +L + Y+
Sbjct: 43 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ L + ++ L +I I +GL Y+ IHRDLK SN+ + ED +
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCE 159
Query: 123 PKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI DFGLAR E T V P Y+ D++S G ++ ++++G
Sbjct: 160 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 183 KRL--------SMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMR----- 229
+ L + + + + ++ S + +
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 275
Query: 230 -CLEIALLCVQENPNDRPSMLEV 251
+++ + + + R + +
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 9e-22
Identities = 66/308 (21%), Positives = 112/308 (36%), Gaps = 49/308 (15%)
Query: 6 GEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCI------DSEERMLVY 57
+A+KKLS+ + + E++L + H N+I +L + ++ LV
Sbjct: 42 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E M + D ++ +++ + G+ +L IIHRDLK SNI++
Sbjct: 102 ELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 152
Query: 118 GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
D KI DFGLAR + V T Y PE Y D++S G ++
Sbjct: 153 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 178 QIISGKRLSMLCGINENLS-ILEHAY----ELWKGGKGME------------------FV 214
+++ K L + + ++E E K + F
Sbjct: 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269
Query: 215 DSFLDDRNSSCKLMRCLEIALL--CVQENPNDRPSMLEVSSM----LKNETTNTNTPKKP 268
DS + KL LL + +P R S+ + + + P
Sbjct: 270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQ 329
Query: 269 AFSKQVDE 276
+ KQ+DE
Sbjct: 330 IYDKQLDE 337
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.7 bits (221), Expect = 4e-21
Identities = 50/291 (17%), Positives = 96/291 (32%), Gaps = 48/291 (16%)
Query: 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY--EYMPNK 63
+A+K + E ++E+ L ++ + + + ++L + PN
Sbjct: 38 NTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96
Query: 64 SLDCYLFDPIRRLILDWKKR-----------VHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+F+ + +L K+ I + + GL Y+ + R IIH D+K
Sbjct: 97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM--HRRCGIIHTDIKP 154
Query: 113 SNILL-GEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
N+L+ D + +A + + + T Y PE + +D++S
Sbjct: 155 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWS 214
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEH------------AYELWKGGKGMEFVDSFLD 219
L+ ++I+G L + +H +Y L G F +S
Sbjct: 215 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274
Query: 220 DRNSSCKLMRCLE-----------------IALL--CVQENPNDRPSMLEV 251
RN S LE L +Q +P R +
Sbjct: 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 2e-14
Identities = 29/185 (15%), Positives = 58/185 (31%), Gaps = 33/185 (17%)
Query: 1 GVLPCGEVIAVKKLSKSSA----------QGFEEFKNEVMLTAKLQHVNLIRVLGFCI-- 48
VK G F + +A+ + L ++ G +
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78
Query: 49 --DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTII 106
E ++ E + K L + +++ I + + I+
Sbjct: 79 VYAWEGNAVLMELIDAKELYRVRVENPDE----------VLDMILEEVAKFYHR---GIV 125
Query: 107 HRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166
H DL N+L+ + I DF + +E + E + + I ++R Y T+
Sbjct: 126 HGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR---EILERDVRNIITYFSRT--YRTE 179
Query: 167 SDVFS 171
D+ S
Sbjct: 180 KDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.78 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.06 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=342.50 Aligned_cols=230 Identities=23% Similarity=0.314 Sum_probs=183.4
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+|||||++|+|.+++. ....+++..
T Consensus 28 ~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~ 104 (271)
T d1nvra_ 28 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPD 104 (271)
T ss_dssp TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHH
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh---cCCCCCHHH
Confidence 579999999986543 3345678999999999999999999999999999999999999999999984 345699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..+............+||+.|+|||++.+..
T Consensus 105 ~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~ 181 (271)
T d1nvra_ 105 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSS
T ss_pred HHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCC
Confidence 9999999999999999999 9999999999999999999999999998765443333344567999999999998877
Q ss_pred C-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 Y-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
+ +.++|||||||++|+|++|+.||......... .. ......... ......+.++.+||.+||+.|
T Consensus 182 ~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~---~~~~~~~~~---------~~~~~~s~~~~~li~~~L~~d 247 (271)
T d1nvra_ 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YS---DWKEKKTYL---------NPWKKIDSAPLALLHKILVEN 247 (271)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HH---HHHTTCTTS---------TTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HH---HHhcCCCCC---------CccccCCHHHHHHHHHHcCCC
Confidence 5 57899999999999999999999644322211 11 111111100 011122347889999999999
Q ss_pred CCCCCCHHHHHH
Q 045452 242 PNDRPSMLEVSS 253 (303)
Q Consensus 242 p~~Rps~~~l~~ 253 (303)
|++|||++++++
T Consensus 248 P~~R~t~~eil~ 259 (271)
T d1nvra_ 248 PSARITIPDIKK 259 (271)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhHCcCHHHHhc
Confidence 999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=342.19 Aligned_cols=227 Identities=24% Similarity=0.367 Sum_probs=186.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.......+.+.+|+.++++++||||+++++++.+++.+|+|||||++|+|.+++. +..+++..+
T Consensus 43 ~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~----~~~l~~~~~ 118 (293)
T d1yhwa1 43 ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQI 118 (293)
T ss_dssp TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH----HSCCCHHHH
T ss_pred CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh----ccCCCHHHH
Confidence 6799999999976555566789999999999999999999999999999999999999999998873 346999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+.... .......||+.|+|||++.+..+
T Consensus 119 ~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~ 193 (293)
T d1yhwa1 119 AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193 (293)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCB
T ss_pred HHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCC
Confidence 999999999999999999 9999999999999999999999999998765332 22334579999999999999999
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|||||||++|+|++|..||..... ............. . ...+...+.++.+||.+||+.||+
T Consensus 194 ~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~-~-------~~~~~~~s~~~~~li~~~L~~dP~ 259 (293)
T d1yhwa1 194 GPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-E-------LQNPEKLSAIFRDFLNRCLDMDVE 259 (293)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-C-------CSSGGGSCHHHHHHHHHHTCSSTT
T ss_pred CchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC-C-------CCCcccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999953321 1111111111110 0 011122345788999999999999
Q ss_pred CCCCHHHHHH
Q 045452 244 DRPSMLEVSS 253 (303)
Q Consensus 244 ~Rps~~~l~~ 253 (303)
+|||+.++++
T Consensus 260 ~R~s~~eil~ 269 (293)
T d1yhwa1 260 KRGSAKELLQ 269 (293)
T ss_dssp TSCCHHHHTT
T ss_pred HCcCHHHHhc
Confidence 9999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=334.13 Aligned_cols=223 Identities=26% Similarity=0.374 Sum_probs=184.9
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||||++|+|.+++. ....+++
T Consensus 29 ~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~---~~~~l~e 105 (263)
T d2j4za1 29 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDE 105 (263)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCH
T ss_pred CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh---hcCCCCH
Confidence 57999999998643 23346778999999999999999999999999999999999999999999984 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++....... .....||+.|+|||++.+
T Consensus 106 ~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 106 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcC
Confidence 999999999999999999998 9999999999999999999999999997654332 233568999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|+.||...... ........... ..+...+.++.+||.+||+.
T Consensus 179 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEF-----------TFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC-----------CCCccCCHHHHHHHHHHccC
Confidence 99999999999999999999999999532211 11111111110 11122345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 045452 241 NPNDRPSMLEVSS 253 (303)
Q Consensus 241 dp~~Rps~~~l~~ 253 (303)
||++|||++++++
T Consensus 242 dp~~R~t~~eil~ 254 (263)
T d2j4za1 242 NPSQRPMLREVLE 254 (263)
T ss_dssp SGGGSCCHHHHHT
T ss_pred CHhHCcCHHHHHc
Confidence 9999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=338.56 Aligned_cols=229 Identities=21% Similarity=0.293 Sum_probs=186.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++|||||++|+|.+++.. ....+++..+
T Consensus 35 ~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~--~~~~l~e~~~ 112 (288)
T d2jfla1 35 ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQI 112 (288)
T ss_dssp TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--HTSCCCHHHH
T ss_pred CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh--cCCCCCHHHH
Confidence 57999999999776666778899999999999999999999999999999999999999999998743 2456999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc----
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---- 159 (303)
..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... ........||+.|+|||++.
T Consensus 113 ~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~ 187 (288)
T d2jfla1 113 QVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETS 187 (288)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCST
T ss_pred HHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhccc
Confidence 999999999999999999 999999999999999999999999998765432 12223457899999999884
Q ss_pred -cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcc
Q 045452 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 238 (303)
+..++.++|||||||++|+|++|..||....... .+. ........ . ...+...+.++.+||.+||
T Consensus 188 ~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~~~~~-~-------~~~~~~~s~~~~~li~~~L 253 (288)
T d2jfla1 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAKSEPP-T-------LAQPSRWSSNFKDFLKKCL 253 (288)
T ss_dssp TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHHSCCC-C-------CSSGGGSCHHHHHHHHHHS
T ss_pred CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHcCCCC-C-------CCccccCCHHHHHHHHHHc
Confidence 4557899999999999999999999996443222 111 11221110 0 1112223457889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 045452 239 QENPNDRPSMLEVSS 253 (303)
Q Consensus 239 ~~dp~~Rps~~~l~~ 253 (303)
+.||++|||++++++
T Consensus 254 ~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 254 EKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=336.03 Aligned_cols=237 Identities=28% Similarity=0.397 Sum_probs=180.9
Q ss_pred CEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 7 EVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
..||||+++.. .....+.|.+|+.++++++||||+++++++. ....++|||||++|+|.+++.. .+..+++..+.
T Consensus 31 ~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~ 107 (276)
T d1uwha_ 31 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLI 107 (276)
T ss_dssp SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHT--SCCCCCHHHHH
T ss_pred CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhh--ccCCCCHHHHH
Confidence 46999999644 4456788999999999999999999999875 4578999999999999999854 24569999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccC---
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG--- 161 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--- 161 (303)
.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++................||+.|+|||++.+.
T Consensus 108 ~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 184 (276)
T d1uwha_ 108 DIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184 (276)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSC
T ss_pred HHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCC
Confidence 99999999999999998 999999999999999999999999999776543333334446789999999998643
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|||++|+.||....... .+ ......+....... ..+...+.++.+||.+||..|
T Consensus 185 ~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~---~~~~~~~~~~p~~~-----~~~~~~~~~l~~li~~cl~~d 253 (276)
T d1uwha_ 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QI---IFMVGRGYLSPDLS-----KVRSNCPKAMKRLMAECLKKK 253 (276)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HH---HHHHHHTSCCCCGG-----GSCTTCCHHHHHHHHHHTCSS
T ss_pred CCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HH---HHHHhcCCCCCcch-----hccccchHHHHHHHHHHcCCC
Confidence 47889999999999999999999995432211 11 11111111111000 111122347889999999999
Q ss_pred CCCCCCHHHHHHhhccCCC
Q 045452 242 PNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~ 260 (303)
|++|||+.+|++.|+.+..
T Consensus 254 p~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 254 RDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHH
Confidence 9999999999999887654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=334.45 Aligned_cols=237 Identities=27% Similarity=0.469 Sum_probs=180.3
Q ss_pred CcCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 g~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
|++.+++.||||+++... ...+.|.+|+.++++++||||+++++++...+..++||||+++|+|.+++.. ....+++
T Consensus 24 ~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~ 100 (263)
T d1sm2a_ 24 GYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAA 100 (263)
T ss_dssp EEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCCCH
T ss_pred EEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc--cccCCCH
Confidence 356788899999996543 3457899999999999999999999999999999999999999999998854 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.+ ++||||||+||+++.++++||+|||+++.+...... ......|+..|+|||++.+
T Consensus 101 ~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 101 ETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSF 176 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcC
Confidence 999999999999999999998 999999999999999999999999999876543222 2233568999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|||+++..|+..... ...... ....+ ... ..+...+.++.+|+.+||+.
T Consensus 177 ~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~---~i~~~-~~~---------~~p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVE---DISTG-FRL---------YKPRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHH---HHHHT-CCC---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHH---HHHhc-CCC---------CCccccCHHHHHHHHHHccC
Confidence 9999999999999999999996544432211 111111 11111 111 11122235788999999999
Q ss_pred CCCCCCCHHHHHHhhccCC
Q 045452 241 NPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~ 259 (303)
||++|||+++|++.|+++.
T Consensus 242 ~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 242 RPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp SGGGSCCHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHH
Confidence 9999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-49 Score=335.56 Aligned_cols=236 Identities=29% Similarity=0.409 Sum_probs=191.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++... ...+++.+|+.++++++|||||++++++.+++..++|||||++|+|.+++... ....+++..+
T Consensus 40 ~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~ 117 (287)
T d1opja_ 40 KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVL 117 (287)
T ss_dssp GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHH
T ss_pred CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhc-cccchHHHHH
Confidence 468899999996543 35678999999999999999999999999999999999999999999998542 3456899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........ ......|+..|+|||.+.+..+
T Consensus 118 ~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~ 193 (287)
T d1opja_ 118 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKF 193 (287)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCC
Confidence 999999999999999998 999999999999999999999999999876543322 2223457889999999999999
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++|||||||++|+|++|..||...... .........+...+ .+...+.++.+||.+||+.||+
T Consensus 194 ~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~ 258 (287)
T d1opja_ 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRME---------RPEGCPEKVYELMRACWQWNPS 258 (287)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred CchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcCCCCC---------CCccchHHHHHHHHHHcCCCHh
Confidence 99999999999999999987776432211 11122222222111 1222345789999999999999
Q ss_pred CCCCHHHHHHhhccCCC
Q 045452 244 DRPSMLEVSSMLKNETT 260 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~~~ 260 (303)
+|||+.++++.|+....
T Consensus 259 ~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 259 DRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp GSCCHHHHHHHHHHTTS
T ss_pred HCcCHHHHHHHHHHHHH
Confidence 99999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=335.89 Aligned_cols=233 Identities=27% Similarity=0.327 Sum_probs=174.8
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--CCeeeEEEeeCCCCChhhhhcCcC-cccC
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI-RRLI 77 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-~~~~ 77 (303)
..+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+ +..+|+|||||++|+|.+++.... .+..
T Consensus 26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~ 105 (269)
T d2java1 26 KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 105 (269)
T ss_dssp TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCC
T ss_pred CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCC
Confidence 367999999998654 34456789999999999999999999999865 456899999999999999986432 2457
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~--~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
+++..++.++.||+.||+|||+.+ .++|+||||||+|||++.++.+||+|||++..+.... .......||+.|+||
T Consensus 106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~AP 183 (269)
T d2java1 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSP 183 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCH
Confidence 999999999999999999999865 2459999999999999999999999999998765432 122345789999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|++.+..++.++|||||||++|+|++|+.||...... ........+ .... .+...+.++.+||.
T Consensus 184 E~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~-~~~~---------~~~~~s~~l~~li~ 247 (269)
T d2java1 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREG-KFRR---------IPYRYSDELNEIIT 247 (269)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT-CCCC---------CCTTSCHHHHHHHH
T ss_pred HHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcC-CCCC---------CCcccCHHHHHHHH
Confidence 9999999999999999999999999999999533211 111111111 1111 11223347889999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 045452 236 LCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~ 253 (303)
+||+.||++|||+.++++
T Consensus 248 ~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 248 RMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHcCCChhHCcCHHHHHh
Confidence 999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=337.48 Aligned_cols=226 Identities=24% Similarity=0.287 Sum_probs=182.7
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..|+|||||++|+|.+++. ....+++
T Consensus 31 ~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~---~~~~l~e 107 (288)
T d1uu3a_ 31 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDE 107 (288)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCH
T ss_pred CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh---ccCCCCH
Confidence 57999999998643 23355789999999999999999999999999999999999999999999884 4567999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++..+.............||+.|+|||++.+
T Consensus 108 ~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 108 TCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence 999999999999999999999 99999999999999999999999999987764443444445679999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||...+. ............ . .+...+.++.+||.+||..
T Consensus 185 ~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~--~---------~p~~~s~~~~~li~~~L~~ 247 (288)
T d1uu3a_ 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLEY--D---------FPEKFFPKARDLVEKLLVL 247 (288)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCC--C---------CCTTCCHHHHHHHHTTSCS
T ss_pred CCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCCC--C---------CCccCCHHHHHHHHHHccC
Confidence 9999999999999999999999999964321 111112222111 1 1122334788999999999
Q ss_pred CCCCCCCHHHHH
Q 045452 241 NPNDRPSMLEVS 252 (303)
Q Consensus 241 dp~~Rps~~~l~ 252 (303)
||++|||++|++
T Consensus 248 dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 248 DATKRLGCEEME 259 (288)
T ss_dssp SGGGSTTSGGGT
T ss_pred CHhHCcCHHHHc
Confidence 999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=340.16 Aligned_cols=241 Identities=23% Similarity=0.296 Sum_probs=184.7
Q ss_pred CCCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 3 LPCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 l~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
..+|+.||+|+++.. .....+.+.+|+.++++++|||||+++++|.+..+.|+||||+++|+|.+++. +...+++.
T Consensus 28 ~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~---~~~~l~~~ 104 (322)
T d1s9ja_ 28 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104 (322)
T ss_dssp TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH---HHSSCCHH
T ss_pred CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh---hcCCCCHH
Confidence 367999999999754 34456789999999999999999999999999999999999999999999984 34569999
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 82 KRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
.+..++.||+.||.|||+ +| |+||||||+|||++.+|.+||+|||++..+... .....+||+.|+|||++.+
T Consensus 105 ~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 105 ILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcC
Confidence 999999999999999997 47 999999999999999999999999999866432 2234579999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHH----------HhhC----------CCc---ccccc--
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE----------LWKG----------GKG---MEFVD-- 215 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----------~~~~----------~~~---~~~~~-- 215 (303)
..++.++||||+||++|+|++|+.||................. .... ... .+...
T Consensus 178 ~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (322)
T d1s9ja_ 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257 (322)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhh
Confidence 9999999999999999999999999965432211000000000 0000 000 00000
Q ss_pred --ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 216 --SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 216 --~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...........+.++.+||.+||..||++|||++++++
T Consensus 258 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 258 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp HTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000011122457889999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=326.84 Aligned_cols=227 Identities=26% Similarity=0.370 Sum_probs=179.3
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||+|++... .....+.+.+|++++++++||||+++++++.. ...+++||||+++|+|.+++. ....
T Consensus 32 ~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~---~~~~ 108 (270)
T d1t4ha_ 32 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKV 108 (270)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHh---cccc
Confidence 57899999998643 44566789999999999999999999999875 346799999999999999984 3457
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+++..+..++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||++...... ......||+.|+|||
T Consensus 109 ~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE 183 (270)
T d1t4ha_ 109 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE 183 (270)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGG
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHH
Confidence 999999999999999999999865 3499999999999997 4789999999999754322 223457899999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
++.+ .++.++|||||||++|+|++|+.||...... .........+....... ...+.++.+||.+
T Consensus 184 ~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~--------~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 184 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD--------KVAIPEVKEIIEG 248 (270)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG--------GCCCHHHHHHHHH
T ss_pred HhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccC--------ccCCHHHHHHHHH
Confidence 9875 5899999999999999999999999533211 11112222221111111 1122368899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 045452 237 CVQENPNDRPSMLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~ 253 (303)
||++||++|||++|+++
T Consensus 249 ~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 249 CIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCCHhHCcCHHHHhC
Confidence 99999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=333.95 Aligned_cols=238 Identities=32% Similarity=0.468 Sum_probs=188.0
Q ss_pred CcCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 g~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
|++++++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||+++|+|.+++... ....+++
T Consensus 32 ~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~-~~~~l~~ 108 (272)
T d1qpca_ 32 GYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTI 108 (272)
T ss_dssp EEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH-HHHTCCH
T ss_pred EEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhc-CCCCCCH
Confidence 456788999999996543 34578999999999999999999999875 45779999999999999887542 3345899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ......|+..|+|||++.+
T Consensus 109 ~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 109 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccChHHHhC
Confidence 999999999999999999998 999999999999999999999999999876543222 2223467899999999998
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|||++|..|+...... .. .......+.... .+...+.++.+|+.+||+.
T Consensus 185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~-~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~ 249 (272)
T d1qpca_ 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PE-VIQNLERGYRMV---------RPDNCPEELYQLMRLCWKE 249 (272)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCS
T ss_pred CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HH-HHHHHHhcCCCC---------CcccChHHHHHHHHHHcCC
Confidence 88999999999999999999976654322111 11 111111111111 1122334788999999999
Q ss_pred CCCCCCCHHHHHHhhccCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~ 260 (303)
||++|||+++|++.|++.++
T Consensus 250 ~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 250 RPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-49 Score=343.20 Aligned_cols=237 Identities=21% Similarity=0.251 Sum_probs=192.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.......+.+.+|+.++++++||||+++++++.+++.+|+|||||+||+|.+++.. ....+++..+
T Consensus 52 ~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~--~~~~l~e~~~ 129 (352)
T d1koba_ 52 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEV 129 (352)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TTCCBCHHHH
T ss_pred CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh--cCCCCCHHHH
Confidence 57999999999877666677889999999999999999999999999999999999999999887743 3446999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC--CCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~--~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||+.| |+||||||+|||++ .++.+||+|||++..+.... ......|++.|+|||++.+.
T Consensus 130 ~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 203 (352)
T d1koba_ 130 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDRE 203 (352)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCC
Confidence 999999999999999999 99999999999998 57899999999998765432 23345689999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|..||...... ............ .........+.++.+||.+||+.|
T Consensus 204 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~d 270 (352)
T d1koba_ 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWE-------FDEDAFSSVSPEAKDFIKNLLQKE 270 (352)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCC-------CCSSTTTTSCHHHHHHHHTTSCSS
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999533211 111122222111 011111223347889999999999
Q ss_pred CCCCCCHHHHHH--hhccCCCC
Q 045452 242 PNDRPSMLEVSS--MLKNETTN 261 (303)
Q Consensus 242 p~~Rps~~~l~~--~L~~~~~~ 261 (303)
|.+|||+.++++ +|++....
T Consensus 271 p~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 271 PRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp GGGSCCHHHHHTSTTTSSCCTT
T ss_pred hhHCcCHHHHhcCHhhCCCcch
Confidence 999999999987 46654433
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=336.73 Aligned_cols=234 Identities=25% Similarity=0.365 Sum_probs=189.2
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
++..||||.++.. .....+.|.+|+.++++++|||||++++++.. +..++||||+++|+|.+++.. .+..+++..+
T Consensus 35 ~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~--~~~~l~~~~~ 111 (285)
T d1u59a_ 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNV 111 (285)
T ss_dssp CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT--CTTTSCHHHH
T ss_pred CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc--cccCCCHHHH
Confidence 4568999999754 45567889999999999999999999999864 568999999999999998743 3456999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCchhcccCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 162 (303)
..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+..... ........|+..|+|||++.+..
T Consensus 112 ~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (285)
T d1u59a_ 112 AELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188 (285)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC
Confidence 999999999999999998 99999999999999999999999999987654322 22223346789999999999899
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++|||||||++|||++ |+.||......+ .......+...+. +...+.++.+||.+||+.|
T Consensus 189 ~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~ 252 (285)
T d1u59a_ 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC---------PPECPPELYALMSDCWIYK 252 (285)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHTTCSS
T ss_pred CCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CCcCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 899996432211 1111222222221 2223357899999999999
Q ss_pred CCCCCCHHHHHHhhccCCC
Q 045452 242 PNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~~~ 260 (303)
|++|||+.+|.+.|+..+.
T Consensus 253 p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 253 WEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHH
Confidence 9999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=336.99 Aligned_cols=232 Identities=26% Similarity=0.377 Sum_probs=184.1
Q ss_pred CCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
+++.||||+++.. .....+.+.+|+.++++++|||||++++++.. +..++||||+++|+|.+++. ....+++..
T Consensus 33 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~---~~~~l~~~~ 108 (277)
T d1xbba_ 33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKN 108 (277)
T ss_dssp SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH---HCTTCCHHH
T ss_pred cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh---hccCCCHHH
Confidence 4678999999643 33456789999999999999999999999854 56789999999999999984 345699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc-cccceeeccccccCchhcccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK-ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 161 (303)
++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .......|++.|+|||.+.+.
T Consensus 109 ~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 109 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC
Confidence 9999999999999999998 999999999999999999999999999876543222 222335688999999999999
Q ss_pred CCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
.++.++|||||||++|||++ |+.||...... ........+..... +...+.++.+||.+||+.
T Consensus 186 ~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~~~---------p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGC---------PAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCS
T ss_pred CCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCCCCCC---------CcccCHHHHHHHHHHcCC
Confidence 99999999999999999997 89998533211 11122222222211 122335789999999999
Q ss_pred CCCCCCCHHHHHHhhccCC
Q 045452 241 NPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~ 259 (303)
||++|||+++|.+.|++.+
T Consensus 250 dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp STTTSCCHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHH
Confidence 9999999999999888743
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-49 Score=334.46 Aligned_cols=231 Identities=25% Similarity=0.415 Sum_probs=177.5
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||||.+... .....+.|.+|+.++++++|||||++++++.+++..++|||||++|+|.+++.. ....+++..+..+
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i 133 (299)
T d1jpaa_ 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGM 133 (299)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc--ccCCCCHHHHHHH
Confidence 6899998654 455667899999999999999999999999999999999999999999998854 3456899999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc---ccceeeccccccCchhcccCCC
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA---NTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+....... ......+++.|+|||.+.+..+
T Consensus 134 ~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 210 (299)
T d1jpaa_ 134 LRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210 (299)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCC
Confidence 999999999999998 9999999999999999999999999998765432221 1122357889999999999999
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|||||||++|||++ |..||......+ .. .....+... ..+...+.++.+|+.+||+.||
T Consensus 211 ~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~----~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~~P 274 (299)
T d1jpaa_ 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VI----NAIEQDYRL---------PPPMDCPSALHQLMLDCWQKDR 274 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSST
T ss_pred CcccccccchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC---------CCCccchHHHHHHHHHHcCCCH
Confidence 999999999999999998 899985432111 11 111111111 1122234578899999999999
Q ss_pred CCCCCHHHHHHhhccCC
Q 045452 243 NDRPSMLEVSSMLKNET 259 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~ 259 (303)
++|||+.+|++.|++..
T Consensus 275 ~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 275 NHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp TTSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHh
Confidence 99999999999988754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=329.90 Aligned_cols=234 Identities=26% Similarity=0.397 Sum_probs=190.7
Q ss_pred CcCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 g~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
|++++++.||||.++.... ..+.|++|+.++++++||||+++++++.+++..++||||+++|+|..++.. ....+++
T Consensus 23 ~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~--~~~~~~~ 99 (258)
T d1k2pa_ 23 GKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQT 99 (258)
T ss_dssp EEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS--GGGCCCH
T ss_pred EEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc--cccCCcH
Confidence 4567888999999975433 457899999999999999999999999999999999999999999988754 3556889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+++++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++..+...... ......++..|+|||.+.+
T Consensus 100 ~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 100 QQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY 175 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcC
Confidence 999999999999999999998 999999999999999999999999999766543222 2223568899999999999
Q ss_pred CCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
..++.++|||||||++|||++ |+.||...... + .......+.... .+...+.++.+||.+||+
T Consensus 176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~ 239 (258)
T d1k2pa_ 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQGLRLY---------RPHLASEKVYTIMYSCWH 239 (258)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHTTCCCC---------CCTTCCHHHHHHHHHTTC
T ss_pred CCCCcceeecccchhhHhHHhcCCCCCCCCCHH------H-HHHHHHhCCCCC---------CcccccHHHHHHHHHHcc
Confidence 999999999999999999998 78898533221 1 111122221111 112233578999999999
Q ss_pred CCCCCCCCHHHHHHhhcc
Q 045452 240 ENPNDRPSMLEVSSMLKN 257 (303)
Q Consensus 240 ~dp~~Rps~~~l~~~L~~ 257 (303)
.||++|||++++++.|.+
T Consensus 240 ~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 240 EKADERPTFKILLSNILD 257 (258)
T ss_dssp SSGGGSCCHHHHHHHHHC
T ss_pred CCHhHCcCHHHHHHHhhC
Confidence 999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-48 Score=339.34 Aligned_cols=234 Identities=21% Similarity=0.260 Sum_probs=190.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||++........+.+.+|+.++++++|||||++++++.+.+.+|+|||||+||+|.+++.. ....+++..+
T Consensus 49 ~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~l~e~~~ 126 (350)
T d1koaa2 49 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEA 126 (350)
T ss_dssp TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC--TTSCBCHHHH
T ss_pred CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh--hcCCCCHHHH
Confidence 57999999999877777778899999999999999999999999999999999999999999998853 2456999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC--CCCcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~--~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
..++.||+.||+|||++| ++||||||+|||++ .++.+||+|||++..+.... ......||+.|+|||++.+.
T Consensus 127 ~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~ 200 (350)
T d1koaa2 127 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGK 200 (350)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCC
Confidence 999999999999999999 99999999999996 46789999999998765432 22345789999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|..||...... .............. .......+.++.+||.+||..|
T Consensus 201 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~d 267 (350)
T d1koaa2 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNMD-------DSAFSGISEDGKDFIRKLLLAD 267 (350)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCSC-------CGGGGGCCHHHHHHHHHHCCSS
T ss_pred CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC-------cccccCCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999533211 11112222211110 0011122347889999999999
Q ss_pred CCCCCCHHHHHHh--hccC
Q 045452 242 PNDRPSMLEVSSM--LKNE 258 (303)
Q Consensus 242 p~~Rps~~~l~~~--L~~~ 258 (303)
|++|||++++++. +...
T Consensus 268 P~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 268 PNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp GGGSCCHHHHHHSTTTSCT
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999874 5543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-49 Score=336.25 Aligned_cols=228 Identities=21% Similarity=0.278 Sum_probs=169.4
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++.+|+|||||+||+|.+++. ....+++..
T Consensus 32 ~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~---~~~~l~e~~ 108 (307)
T d1a06a_ 32 RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERD 108 (307)
T ss_dssp TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCCHHH
T ss_pred CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh---cccCCCHHH
Confidence 579999999996543 2344678899999999999999999999999999999999999999999995 345699999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~---~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..++.||+.||+|||+.| ++||||||+||++. .++.+||+|||++....... .....+||+.|+|||++.
T Consensus 109 ~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~ 182 (307)
T d1a06a_ 109 ASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 182 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHT
T ss_pred HHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHc
Confidence 9999999999999999999 99999999999995 57899999999997654322 223457999999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|..||..... .............. ........+.++.+||.+||.
T Consensus 183 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~ 249 (307)
T d1a06a_ 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKAEYEF-------DSPYWDDISDSAKDFIRHLME 249 (307)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTTCCCC-------CTTTTTTSCHHHHHHHHHHSC
T ss_pred CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhccCCCC-------CCccccCCCHHHHHHHHHHcc
Confidence 99999999999999999999999999953221 11111222211110 011112233478899999999
Q ss_pred CCCCCCCCHHHHHH
Q 045452 240 ENPNDRPSMLEVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~~l~~ 253 (303)
+||++|||++++++
T Consensus 250 ~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 250 KDPEKRFTCEQALQ 263 (307)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCHhHCcCHHHHhc
Confidence 99999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=328.07 Aligned_cols=246 Identities=27% Similarity=0.427 Sum_probs=188.7
Q ss_pred CcCCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 1 GVLPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 g~l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
|++.+++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||+++|+|..++... ....+++
T Consensus 36 ~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~-~~~~l~~ 112 (285)
T d1fmka3 36 GTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-TGKYLRL 112 (285)
T ss_dssp EEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHH-HHTTCCH
T ss_pred EEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhc-ccccchH
Confidence 356677889999996543 34578999999999999999999999985 45689999999999998887542 2446999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++....... .......++..|+|||.+..
T Consensus 113 ~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 113 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhC
Confidence 999999999999999999998 99999999999999999999999999986643322 22223467999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|||++|..|+...... .........+.... .+...+.++.+||.+||+.
T Consensus 189 ~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------~~~~~~i~~~~~~~---------~~~~~~~~l~~li~~cl~~ 253 (285)
T d1fmka3 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYRMP---------CPPECPESLHDLMCQCWRK 253 (285)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCC---------CCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCCC---------CCcccCHHHHHHHHHHccc
Confidence 99999999999999999999977665433211 11111122121111 1222335789999999999
Q ss_pred CCCCCCCHHHHHHhhccCCCCCCCCCCC
Q 045452 241 NPNDRPSMLEVSSMLKNETTNTNTPKKP 268 (303)
Q Consensus 241 dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 268 (303)
||++|||+++|+++|++..+....+..|
T Consensus 254 dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 254 EPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 9999999999999999988766544443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=335.63 Aligned_cols=232 Identities=28% Similarity=0.413 Sum_probs=185.4
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCc----------
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR---------- 74 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 74 (303)
..||+|.+... .......+.+|+.+++++ +|||||++++++.+.+..++|||||++|+|.+++.....
T Consensus 68 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (325)
T d1rjba_ 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147 (325)
T ss_dssp EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred eEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhc
Confidence 46999998654 334456789999999998 899999999999999999999999999999999865321
Q ss_pred ----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccc
Q 045452 75 ----------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTE 144 (303)
Q Consensus 75 ----------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 144 (303)
...+++..++.++.||+.||+|||+++ |+||||||+||+++.++++||+|||+++............
T Consensus 148 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 224 (325)
T d1rjba_ 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224 (325)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEET
T ss_pred cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeec
Confidence 235889999999999999999999998 9999999999999999999999999998765544444444
Q ss_pred eeeccccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCC
Q 045452 145 QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNS 223 (303)
Q Consensus 145 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
...||+.|+|||++.+..++.++|||||||++|||++ |..||........ + ......+.... .+
T Consensus 225 ~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~---~---~~~~~~~~~~~---------~p 289 (325)
T d1rjba_ 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN---F---YKLIQNGFKMD---------QP 289 (325)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---H---HHHHHTTCCCC---------CC
T ss_pred cccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH---H---HHHHhcCCCCC---------CC
Confidence 5678999999999999999999999999999999998 8999864332211 1 12222221111 12
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhc
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSSMLK 256 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~ 256 (303)
...+.++.+||.+||+.||++|||+++|++.|.
T Consensus 290 ~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 290 FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 223457899999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-48 Score=329.37 Aligned_cols=228 Identities=29% Similarity=0.399 Sum_probs=183.4
Q ss_pred CCCCCEEEEEEccCCC---hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 3 LPCGEVIAVKKLSKSS---AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
..+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+|||||.+|+|..++. .+..++
T Consensus 37 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~---~~~~l~ 113 (309)
T d1u5ra_ 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQ 113 (309)
T ss_dssp TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---HTSCCC
T ss_pred CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH---hCCCCC
Confidence 3679999999986543 3445678999999999999999999999999999999999999998876653 356799
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... ....||+.|+|||++.
T Consensus 114 e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~ 184 (309)
T d1u5ra_ 114 EVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVIL 184 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHHHHh
Confidence 9999999999999999999999 999999999999999999999999999765332 2356899999999985
Q ss_pred c---CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 160 Q---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 160 ~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+ ..++.++|||||||++|+|++|..||.... .............. .. .+...+.++.+||.+
T Consensus 185 ~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~~~~-~~--------~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP-AL--------QSGHWSEYFRNFVDS 249 (309)
T ss_dssp TTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CC--------SCTTSCHHHHHHHHH
T ss_pred ccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCC-CC--------CCCCCCHHHHHHHHH
Confidence 4 357889999999999999999999995332 11222222222211 11 111223478899999
Q ss_pred cccCCCCCCCCHHHHHH--hhcc
Q 045452 237 CVQENPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 237 cl~~dp~~Rps~~~l~~--~L~~ 257 (303)
||+.||++|||++++++ ++.+
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HCcCChhHCcCHHHHHhCHHhcC
Confidence 99999999999999986 4543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=321.43 Aligned_cols=234 Identities=24% Similarity=0.390 Sum_probs=180.1
Q ss_pred CEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 7 EVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
..||||+++.. .......|.+|+.++++++|||||++++++.+.+..++||||+.++++.+++.. ....+++..+..
T Consensus 37 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~ 114 (283)
T d1mqba_ 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVG 114 (283)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHH
T ss_pred EEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc--ccccccHHHHHH
Confidence 47999999654 344566899999999999999999999999999999999999999999887743 345699999999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCchhcccCCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ........||..|+|||.+.+..++
T Consensus 115 i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (283)
T d1mqba_ 115 MLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191 (283)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC
T ss_pred HHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCC
Confidence 9999999999999998 99999999999999999999999999987644322 1222334578999999999999999
Q ss_pred CcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCC
Q 045452 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 244 (303)
.++|||||||++|||+++..|+...... .........+.... .+...+.++.+||.+||+.||++
T Consensus 192 ~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~ 256 (283)
T d1mqba_ 192 SASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFRLP---------TPMDCPSAIYQLMMQCWQQERAR 256 (283)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCCC---------CCTTCBHHHHHHHHHHTCSSTTT
T ss_pred CcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhccCCCC---------CchhhHHHHHHHHHHHCcCCHhH
Confidence 9999999999999999976665432211 11112222221111 12223357899999999999999
Q ss_pred CCCHHHHHHhhccCCC
Q 045452 245 RPSMLEVSSMLKNETT 260 (303)
Q Consensus 245 Rps~~~l~~~L~~~~~ 260 (303)
|||+.+|++.|+....
T Consensus 257 RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 257 RPKFADIVSILDKLIR 272 (283)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHhh
Confidence 9999999999987543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=327.43 Aligned_cols=228 Identities=22% Similarity=0.303 Sum_probs=183.5
Q ss_pred CCCCEEEEEEccCCC------hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS------AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+....|+|||||++|+|.+++. ....
T Consensus 33 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~---~~~~ 109 (293)
T d1jksa_ 33 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKES 109 (293)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc---cccc
Confidence 679999999985431 2346789999999999999999999999999999999999999999999984 3457
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEecccccccccccccccccceeecccccc
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~----~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+|++|||++..+.... ......+++.|+
T Consensus 110 l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~ 183 (293)
T d1jksa_ 110 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFV 183 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGC
T ss_pred cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCccc
Confidence 999999999999999999999999 99999999999998776 49999999997764322 223356899999
Q ss_pred CchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHH
Q 045452 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||++.+..++.++|||||||++|+|++|+.||...... ............ ..... +...+.++.+|
T Consensus 184 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~--~~~~~-----~~~~s~~~~~l 250 (293)
T d1jksa_ 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNYE--FEDEY-----FSNTSALAKDF 250 (293)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCCC--CCHHH-----HTTSCHHHHHH
T ss_pred CHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHhcCCC--CCchh-----cCCCCHHHHHH
Confidence 999999999999999999999999999999999633211 111111111110 00000 01123468899
Q ss_pred HHhcccCCCCCCCCHHHHHH
Q 045452 234 ALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 234 i~~cl~~dp~~Rps~~~l~~ 253 (303)
|.+||..||++|||++++++
T Consensus 251 i~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 251 IRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-46 Score=321.34 Aligned_cols=226 Identities=23% Similarity=0.318 Sum_probs=185.7
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..|+||||+.||+|..++. .+..+++
T Consensus 27 ~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~---~~~~~~~ 103 (316)
T d1fota_ 27 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPN 103 (316)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HTSSCCH
T ss_pred CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc---ccccccc
Confidence 67999999999643 23356788999999999999999999999999999999999999999988884 4566889
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++....... ....||+.|+|||++.+
T Consensus 104 ~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 104 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVST 175 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTT
T ss_pred cHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccccCHHHHcC
Confidence 999999999999999999998 9999999999999999999999999998764332 23578999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|+.||...+. .........+.. ..+...+.++.++|.+||..
T Consensus 176 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL-----------RFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhhh
Confidence 9999999999999999999999999954321 111112222211 11122234788999999999
Q ss_pred CCCCCC-----CHHHHHH--hhcc
Q 045452 241 NPNDRP-----SMLEVSS--MLKN 257 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~--~L~~ 257 (303)
||.+|+ |++++++ ++++
T Consensus 239 dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CHHhccccchhhHHHHHcCccccc
Confidence 999996 8999976 3544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=324.31 Aligned_cols=245 Identities=22% Similarity=0.226 Sum_probs=181.2
Q ss_pred CCCCEEEEEEccCCChh-----hHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCC
Q 045452 4 PCGEVIAVKKLSKSSAQ-----GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 78 (303)
.+|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+.++++..+.. .+..+
T Consensus 21 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~---~~~~l 97 (299)
T d1ua2a_ 21 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVL 97 (299)
T ss_dssp SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT---CCSSC
T ss_pred CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh---cccCC
Confidence 57999999999654322 23468899999999999999999999999999999999998887766652 45668
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhc
Q 045452 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 158 (303)
++..+..++.||+.||+|||++| ++||||||+|||++.++.+||+|||++........ .....+||+.|+|||++
T Consensus 98 ~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~ 172 (299)
T d1ua2a_ 98 TPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL 172 (299)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHH
Confidence 99999999999999999999999 99999999999999999999999999976654321 22235689999999988
Q ss_pred cc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc--------ccccccC-CC-----C
Q 045452 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF--------VDSFLDD-RN-----S 223 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-~~-----~ 223 (303)
.+ ..++.++|||||||++|+|++|..||......+ .+............... ....... .. .
T Consensus 173 ~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
T d1ua2a_ 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249 (299)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred ccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhc
Confidence 64 457899999999999999999999985433222 12211111110000000 0000000 00 0
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCC
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
...+.++.+||.+||+.||++|||++|+++ +|++..
T Consensus 250 ~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 112357889999999999999999999986 465543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=324.45 Aligned_cols=225 Identities=21% Similarity=0.252 Sum_probs=185.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+.+|+||||++||+|..++. ....+++
T Consensus 28 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~---~~~~~~e 104 (337)
T d1o6la_ 28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTE 104 (337)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCH
T ss_pred CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh---cccCCcH
Confidence 68999999999643 23356778899999999999999999999999999999999999999999884 4567899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+
T Consensus 105 ~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 105 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSS
T ss_pred HHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccC
Confidence 999999999999999999999 9999999999999999999999999998654322 22344679999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|+.||...+... + ........ . ..+...+.++.+||.+||++
T Consensus 180 ~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~--~~~i~~~~--~---------~~p~~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----L--FELILMEE--I---------RFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----H--HHHHHHCC--C---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----H--HHHHhcCC--C---------CCCccCCHHHHHHHHhhccC
Confidence 999999999999999999999999996433211 1 11111111 1 11222345788999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 045452 241 NPNDRPS-----MLEVSS 253 (303)
Q Consensus 241 dp~~Rps-----~~~l~~ 253 (303)
||++|++ ++++++
T Consensus 243 dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp STTTSTTCSTTTHHHHHT
T ss_pred CchhhcccccccHHHHHc
Confidence 9999995 777765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=321.36 Aligned_cols=237 Identities=28% Similarity=0.432 Sum_probs=188.9
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC---------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 73 (303)
.+++.||||+++.. .....+.+.+|+.++++++||||+++++++......+++|||+.+|+|.+++....
T Consensus 41 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~ 120 (301)
T d1lufa_ 41 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120 (301)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccc
Confidence 56789999999754 34456789999999999999999999999999999999999999999999885421
Q ss_pred ------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc
Q 045452 74 ------------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA 141 (303)
Q Consensus 74 ------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~ 141 (303)
....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++..+.......
T Consensus 121 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~ 197 (301)
T d1lufa_ 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197 (301)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred cccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCcccc
Confidence 1234789999999999999999999999 9999999999999999999999999998665444334
Q ss_pred ccceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCC-CCccccCCCccccHHHHHHHHhhCCCccccccccccC
Q 045452 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDD 220 (303)
Q Consensus 142 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......++..|+|||.+.+..++.++|||||||++|||++|. +||......+ .. .....+.....
T Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e---~~----~~v~~~~~~~~------- 263 (301)
T d1lufa_ 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---VI----YYVRDGNILAC------- 263 (301)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHTTCCCCC-------
T ss_pred ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH---HH----HHHHcCCCCCC-------
Confidence 444466889999999999999999999999999999999986 4554322111 11 11222222211
Q ss_pred CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 221 RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
+...+.++.+||.+||+.||++|||+.+|+++|++..
T Consensus 264 --p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 264 --PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1122347889999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-46 Score=321.47 Aligned_cols=222 Identities=20% Similarity=0.213 Sum_probs=184.1
Q ss_pred CCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|..++. ....+++
T Consensus 64 ~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~---~~~~l~e 140 (350)
T d1rdqe_ 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSE 140 (350)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCCCCH
T ss_pred CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHh---hcCCCCH
Confidence 57999999998643 22345778999999999999999999999999999999999999999999884 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..++.++.||+.||.|||+++ |+||||||+|||++.+|++||+|||++..+... .....||+.|+|||++.+
T Consensus 141 ~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcC
Confidence 999999999999999999999 999999999999999999999999999876532 223578999999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccC
Q 045452 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 240 (303)
..++.++|||||||++|+|++|..||.... ............. ..+...+.++.+||.+||..
T Consensus 213 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKV-----------RFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-----------CCCTTCCHHHHHHHHHHSCS
T ss_pred CCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCC-----------CCCccCCHHHHHHHHHHhhh
Confidence 999999999999999999999999995322 1111122222211 11112334788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 045452 241 NPNDRP-----SMLEVSS 253 (303)
Q Consensus 241 dp~~Rp-----s~~~l~~ 253 (303)
||.+|+ |++++++
T Consensus 276 dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHhccccccccHHHHHc
Confidence 999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=321.62 Aligned_cols=234 Identities=17% Similarity=0.223 Sum_probs=185.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.+|+.||||+++.... ....+.+|+.++++++||||+++++++.+.+.+|+|||||+||+|.+++.. .+..+++..+
T Consensus 28 ~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~--~~~~l~e~~~ 104 (321)
T d1tkia_ 28 SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREI 104 (321)
T ss_dssp TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHH
T ss_pred CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCCHHHH
Confidence 5799999999976543 345688999999999999999999999999999999999999999999854 2346899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC--CcEEEecccccccccccccccccceeeccccccCchhcccC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED--MKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~--~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 161 (303)
..++.||+.||+|||+.| |+||||||+|||++.+ +.+||+|||++...... .......+++.|+|||.+.+.
T Consensus 105 ~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~~~~~~~~t~~y~ape~~~~~ 178 (321)
T d1tkia_ 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC---CcccccccccccccchhccCC
Confidence 999999999999999999 9999999999999854 57999999999765432 223345789999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
.++.++|||||||++|+|++|..||...... ............. ..... ...+.++.+||.+||..|
T Consensus 179 ~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~--~~~~~-----~~~s~~~~~li~~~L~~d 245 (321)
T d1tkia_ 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF--DEEAF-----KEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC--CHHHH-----TTSCHHHHHHHHTTSCSS
T ss_pred CCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC--Chhhc-----cCCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999643221 1111122211110 00000 011346889999999999
Q ss_pred CCCCCCHHHHHH--hhccCC
Q 045452 242 PNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 242 p~~Rps~~~l~~--~L~~~~ 259 (303)
|++|||+.++++ ++.+..
T Consensus 246 p~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 246 RKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp GGGSCCHHHHHHSHHHHSCG
T ss_pred hhHCcCHHHHhcCHhhccCc
Confidence 999999999987 455433
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-46 Score=315.19 Aligned_cols=237 Identities=24% Similarity=0.327 Sum_probs=181.1
Q ss_pred CCCCCEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcc
Q 045452 3 LPCGEVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 l~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
..+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.... .+|+||||++|++|..++. ..
T Consensus 29 ~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~---~~ 105 (277)
T d1o6ya_ 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TE 105 (277)
T ss_dssp TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH---HH
T ss_pred CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc---cc
Confidence 367999999999654 3445678999999999999999999999998654 3789999999999998884 45
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccc-cccccceeeccccccC
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES-LKANTEQVVGTIGYIP 154 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~~~~y~a 154 (303)
..+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++++|||.+....... .........||+.|+|
T Consensus 106 ~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 182 (277)
T d1o6ya_ 106 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182 (277)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccC
Confidence 57999999999999999999999998 9999999999999999999999999986554322 1223334578999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||++.+..++.++|||||||++|+|++|+.||.... ................ .......+.++.++|
T Consensus 183 PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~~-------~~~~~~~s~~l~~li 249 (277)
T d1o6ya_ 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPP-------SARHEGLSADLDAVV 249 (277)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCG-------GGTSSSCCHHHHHHH
T ss_pred HHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCCC-------chhccCCCHHHHHHH
Confidence 999999999999999999999999999999995322 1222222222221111 011112234788999
Q ss_pred HhcccCCCCCCC-CHHHHHHhhccC
Q 045452 235 LLCVQENPNDRP-SMLEVSSMLKNE 258 (303)
Q Consensus 235 ~~cl~~dp~~Rp-s~~~l~~~L~~~ 258 (303)
.+||.+||++|| |++++++.|.+.
T Consensus 250 ~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 250 LKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHccCCHhHCHhHHHHHHHHHHHH
Confidence 999999999999 899998887653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=318.06 Aligned_cols=228 Identities=29% Similarity=0.426 Sum_probs=176.5
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe-CCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
.|+.||||+++... ..+.+.+|+.++++++||||+++++++.+ .+.+++||||+++|+|.+++... ....+++..+
T Consensus 29 ~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~ 105 (262)
T d1byga_ 29 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 105 (262)
T ss_dssp TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHH
T ss_pred CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc-CCCCCCHHHH
Confidence 47899999996543 45779999999999999999999999865 45689999999999999998542 2345899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||.|||+.+ ++||||||+||+++.++.+|++|||++...... .....++..|+|||.+.+..+
T Consensus 106 ~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~ 177 (262)
T d1byga_ 106 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF 177 (262)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCC
Confidence 999999999999999998 999999999999999999999999999765432 222356889999999998999
Q ss_pred CCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCC
Q 045452 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 242 (303)
+.++|||||||++|||++ |.+||....... .... ...+...+ .+...+.++.+||.+||..||
T Consensus 178 t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP 241 (262)
T d1byga_ 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMD---------APDGCPPAVYEVMKNCWHLDA 241 (262)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCCC---------CCTTCCHHHHHHHHHHTCSSG
T ss_pred ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCCC---------CCccCCHHHHHHHHHHcccCH
Confidence 999999999999999998 677765332221 1111 11122222 122233578999999999999
Q ss_pred CCCCCHHHHHHhhccCC
Q 045452 243 NDRPSMLEVSSMLKNET 259 (303)
Q Consensus 243 ~~Rps~~~l~~~L~~~~ 259 (303)
++|||+.++++.|++..
T Consensus 242 ~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 242 AMRPSFLQLREQLEHIK 258 (262)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHH
Confidence 99999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-46 Score=316.73 Aligned_cols=228 Identities=23% Similarity=0.304 Sum_probs=182.2
Q ss_pred CCCCEEEEEEccCCC---------hhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKSS---------AQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||||+++... ....+.+.+|+.++++++ ||||+++++++.+++..|+||||+++|+|.+++.
T Consensus 26 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~--- 102 (277)
T d1phka_ 26 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--- 102 (277)
T ss_dssp TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---
T ss_pred CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH---
Confidence 589999999986542 123356889999999996 9999999999999999999999999999999995
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeecccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~ 153 (303)
.+..+++..++.++.||+.||+|||++| ++||||||+||+++.++.+||+|||++..+.... ......||..|+
T Consensus 103 ~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~ 176 (277)
T d1phka_ 103 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 176 (277)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCC
Confidence 3557999999999999999999999999 9999999999999999999999999998765432 223356899999
Q ss_pred Cchhccc------CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 154 PPEYARQ------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 154 aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
|||.+.+ ..++.++||||+||++|+|++|+.||..... .........+.... ........+
T Consensus 177 ~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~i~~~~~~~-------~~~~~~~~s 243 (277)
T d1phka_ 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQF-------GSPEWDDYS 243 (277)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-------CTTTGGGSC
T ss_pred CHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHHHHhCCCCC-------CCcccccCC
Confidence 9998853 3467899999999999999999999963321 11111222221110 011111233
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.++.+||.+||.+||++|||++++++
T Consensus 244 ~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 57899999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=318.59 Aligned_cols=230 Identities=21% Similarity=0.337 Sum_probs=174.8
Q ss_pred CCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHH
Q 045452 6 GEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 84 (303)
+..||||.++.. .....+.+.+|+.++++++||||+++++++. .+..++||||+.+|+|.+++.. ....+++..++
T Consensus 35 ~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~ 111 (273)
T d1mp8a_ 35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 111 (273)
T ss_dssp CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHH
T ss_pred eEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHH
Confidence 457899998654 4455678999999999999999999999985 5678999999999999888743 34568999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCC
Q 045452 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..+.... ........|++.|+|||.+.+..++
T Consensus 112 ~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 112 LYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCC
Confidence 99999999999999999 9999999999999999999999999998765332 2222334678999999999999999
Q ss_pred CcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
.++|||||||++|||++ |.+||......+. .. . ...+.... .+...+.++.+||.+||..||+
T Consensus 188 ~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~---~-i~~~~~~~---------~~~~~~~~~~~li~~cl~~dp~ 251 (273)
T d1mp8a_ 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---R-IENGERLP---------MPPNCPPTLYSLMTKCWAYDPS 251 (273)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---H-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred CccccccchHHHHHHHhcCCCCCCCCCHHHH---HH---H-HHcCCCCC---------CCCCCCHHHHHHHHHHcCCCHh
Confidence 99999999999999998 7888854433221 11 1 11111111 1122335789999999999999
Q ss_pred CCCCHHHHHHhhccC
Q 045452 244 DRPSMLEVSSMLKNE 258 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~ 258 (303)
+|||+.+|++.|+..
T Consensus 252 ~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 252 RRPRFTELKAQLSTI 266 (273)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=319.40 Aligned_cols=238 Identities=28% Similarity=0.384 Sum_probs=178.9
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcC-------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPI------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------- 73 (303)
.+++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++... ...++|||||++|+|.+++....
T Consensus 41 ~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~ 120 (299)
T d1ywna1 41 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120 (299)
T ss_dssp SCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC--
T ss_pred cCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccc
Confidence 45689999999754 344566788888888877 789999999998765 46899999999999999986422
Q ss_pred ------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceee
Q 045452 74 ------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVV 147 (303)
Q Consensus 74 ------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...............
T Consensus 121 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 197 (299)
T d1ywna1 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197 (299)
T ss_dssp ---------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCC
T ss_pred cchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCcee
Confidence 1345889999999999999999999998 9999999999999999999999999998765544344444567
Q ss_pred ccccccCchhcccCCCCCcccchhhHHHHHHHHhCC-CCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHH
Q 045452 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCK 226 (303)
Q Consensus 148 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||+.|+|||++.+..++.++|||||||++|+|++|. .||....... .+. .....+.... .+...
T Consensus 198 gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---~~~---~~~~~~~~~~---------~~~~~ 262 (299)
T d1ywna1 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC---RRLKEGTRMR---------APDYT 262 (299)
T ss_dssp CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HHH---HHHHHTCCCC---------CCTTC
T ss_pred eCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHhcCCCCC---------CCccC
Confidence 899999999999999999999999999999999875 5664332221 111 1111111111 11222
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 227 LMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 227 ~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
+.++.++|.+||+.||++|||+.++++.|++..
T Consensus 263 ~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 263 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 347889999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=316.46 Aligned_cols=237 Identities=28% Similarity=0.386 Sum_probs=192.8
Q ss_pred CCCCEEEEEEccCCC-hhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC--------
Q 045452 4 PCGEVIAVKKLSKSS-AQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------- 73 (303)
.++..||||+++... ......+.+|+..+.++ +|||||++++++.++...++||||+.+|+|.+++....
T Consensus 43 ~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~ 122 (299)
T d1fgka_ 43 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122 (299)
T ss_dssp CCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------
T ss_pred cCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccccc
Confidence 345689999997654 34567888899999888 89999999999999999999999999999999996532
Q ss_pred -----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeec
Q 045452 74 -----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVG 148 (303)
Q Consensus 74 -----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 148 (303)
....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++................+
T Consensus 123 ~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp ------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred ccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCC
Confidence 1345899999999999999999999999 99999999999999999999999999987765544444445678
Q ss_pred cccccCchhcccCCCCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHH
Q 045452 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .........+..... +...+
T Consensus 200 ~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~~~---------p~~~~ 263 (299)
T d1fgka_ 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMDK---------PSNCT 263 (299)
T ss_dssp GGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCC---------CSSCC
T ss_pred ChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-------HHHHHHHHcCCCCCC---------Cccch
Confidence 999999999999999999999999999999998 6777743221 112222222222221 11223
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 228 MRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 228 ~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
.++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 264 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 264 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 47899999999999999999999999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=313.50 Aligned_cols=231 Identities=25% Similarity=0.340 Sum_probs=179.4
Q ss_pred CEEEEEEccCC---ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 7 EVIAVKKLSKS---SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 7 ~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
..||||+++.. .....+.|.+|+.++++++||||+++++++.+ ...++||||+++|++.+++.. ....+++..+
T Consensus 37 ~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~ 113 (273)
T d1u46a_ 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTL 113 (273)
T ss_dssp EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH--HGGGSCHHHH
T ss_pred EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhc--ccCCCCHHHH
Confidence 36899998654 33456789999999999999999999999965 577899999999999888753 3456999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccc-ccceeeccccccCchhcccCC
Q 045452 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKA-NTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 162 (303)
+.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++..+....... ......++..|+|||.+.+..
T Consensus 114 ~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 190 (273)
T d1u46a_ 114 SRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190 (273)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC
Confidence 999999999999999998 9999999999999999999999999998765443222 222345678999999999999
Q ss_pred CCCcccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCC
Q 045452 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 241 (303)
++.++||||||+++|||++ |..||.... ...........+...+ .+...+.++.+||.+||..|
T Consensus 191 ~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~~~~---------~~~~~~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERLP---------RPEDCPQDIYNVMVQCWAHK 255 (273)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCCC---------CCTTCCHHHHHHHHHHTCSS
T ss_pred CCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCCCCCC---------CcccccHHHHHHHHHHcCCC
Confidence 9999999999999999998 899985322 1111222222222211 11222347889999999999
Q ss_pred CCCCCCHHHHHHhhccC
Q 045452 242 PNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 242 p~~Rps~~~l~~~L~~~ 258 (303)
|++|||+.+|.+.|++.
T Consensus 256 p~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 256 PEDRPTFVALRDFLLEA 272 (273)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHhc
Confidence 99999999999998763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=322.75 Aligned_cols=229 Identities=24% Similarity=0.393 Sum_probs=178.8
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHHH
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 86 (303)
.||+|.++.. .....+.+.+|+.++++++|||||++++++.++ ..+++++++.+++|.+++.. ....+++..++.+
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i 116 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNW 116 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH--TSSSCCHHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc--cccCCCHHHHHHH
Confidence 5899988654 344677899999999999999999999999764 56788899999999887754 3556899999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcccCCCCCc
Q 045452 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+.............||..|+|||.+.+..++.+
T Consensus 117 ~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 193 (317)
T d1xkka_ 117 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193 (317)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChh
Confidence 999999999999998 99999999999999999999999999987654433333344568999999999999999999
Q ss_pred ccchhhHHHHHHHHh-CCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCCCC
Q 045452 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 245 (303)
+|||||||++|||+| |..||....... +... ...+... ..+...+.++.+|+.+||..||++|
T Consensus 194 sDvwS~Gvil~el~t~g~~p~~~~~~~~----~~~~---i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~R 257 (317)
T d1xkka_ 194 SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI---LEKGERL---------PQPPICTIDVYMIMVKCWMIDADSR 257 (317)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCGGG----HHHH---HHHTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhhHHHHHHHHHHCCCCCCCCCCHHH----HHHH---HHcCCCC---------CCCcccCHHHHHHHHHhCCCChhhC
Confidence 999999999999998 788875433222 1111 1111111 1122233578899999999999999
Q ss_pred CCHHHHHHhhccC
Q 045452 246 PSMLEVSSMLKNE 258 (303)
Q Consensus 246 ps~~~l~~~L~~~ 258 (303)
||+.+|++.|...
T Consensus 258 Ps~~eil~~l~~~ 270 (317)
T d1xkka_ 258 PKFRELIIEFSKM 270 (317)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHH
Confidence 9999999887664
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-45 Score=321.67 Aligned_cols=226 Identities=22% Similarity=0.243 Sum_probs=177.9
Q ss_pred CCCCEEEEEEccCCC---hhhHHHH---HHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEF---KNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||++.... ......+ ..++.+++.++||||+++++++.+.+..|+|||||+||+|.+++. ....
T Consensus 27 ~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~---~~~~ 103 (364)
T d1omwa3 27 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGV 103 (364)
T ss_dssp TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCS
T ss_pred CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH---hccc
Confidence 579999999985331 1122233 345777888899999999999999999999999999999999984 3566
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchh
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 157 (303)
+++..++.++.||+.||+|||+.| ++||||||+|||++.+|.+||+|||++..+.... .....||+.|+|||+
T Consensus 104 ~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~ 176 (364)
T d1omwa3 104 FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 176 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHH
Confidence 899999999999999999999999 9999999999999999999999999998765432 233568999999999
Q ss_pred cc-cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHh
Q 045452 158 AR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+. +..++.++|||||||++|+|++|+.||......... ....... .... ..+...+.++.+||.+
T Consensus 177 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~-~~~~---------~~~~~~s~~~~~li~~ 242 (364)
T d1omwa3 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL-TMAV---------ELPDSFSPELRSLLEG 242 (364)
T ss_dssp HSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSS-SCCC---------CCCSSSCHHHHHHHHH
T ss_pred hhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcc-cCCC---------CCCCCCCHHHHHHHHH
Confidence 86 456899999999999999999999999654433211 1111111 1111 1111233478899999
Q ss_pred cccCCCCCCCC-----HHHHHH
Q 045452 237 CVQENPNDRPS-----MLEVSS 253 (303)
Q Consensus 237 cl~~dp~~Rps-----~~~l~~ 253 (303)
||..||++||| ++++++
T Consensus 243 ~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 243 LLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HTCSSTTTSTTTSSSTHHHHHT
T ss_pred HcccCHHHhCCCcccCHHHHHc
Confidence 99999999999 688864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=320.09 Aligned_cols=230 Identities=20% Similarity=0.244 Sum_probs=178.0
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhc-CCCCcceeEEEEEEe----CCeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAK-LQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
..+|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.+ ...+|+|||||+||+|.+++... ....
T Consensus 34 ~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~-~~~~ 107 (335)
T d2ozaa1 34 KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQA 107 (335)
T ss_dssp TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC-SCCC
T ss_pred CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc-CCCC
Confidence 368999999999543 456789988765 489999999999875 35789999999999999999642 2346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccccccceeeccccccC
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
+++..++.++.||+.||+|||+.| |+||||||+|||++. .+.+||+|||++....... ......||+.|+|
T Consensus 108 l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~a 181 (335)
T d2ozaa1 108 FTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVA 181 (335)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCC
Confidence 999999999999999999999999 999999999999985 4679999999998665432 2234578999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||++.+..++.++|||||||++|+|++|+.||...........+. ...... ... .........+.++.+||
T Consensus 182 PE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~-~~~-----~~~~~~~~~s~~~~~li 252 (335)
T d2ozaa1 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMG-QYE-----FPNPEWSEVSEEVKMLI 252 (335)
T ss_dssp CCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC-SSS-----CCTTHHHHSCHHHHHHH
T ss_pred cHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcC-CCC-----CCCcccccCCHHHHHHH
Confidence 999999999999999999999999999999996544332211111 000000 000 00011112345789999
Q ss_pred HhcccCCCCCCCCHHHHHH
Q 045452 235 LLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~ 253 (303)
.+||+.||++|||+.++++
T Consensus 253 ~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 253 RNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHSCSSTTTSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHHc
Confidence 9999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=317.20 Aligned_cols=237 Identities=25% Similarity=0.374 Sum_probs=190.2
Q ss_pred CCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC--------
Q 045452 4 PCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------- 73 (303)
.+++.||||+++.. .......+.+|+.+++.+ +|||||++++++.+....+++||||++|+|.+++....
T Consensus 51 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~ 130 (311)
T d1t46a_ 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (311)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred CCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccc
Confidence 57789999999754 345667899999999999 79999999999999999999999999999999986422
Q ss_pred -------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccccee
Q 045452 74 -------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQV 146 (303)
Q Consensus 74 -------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 146 (303)
....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+|++|||.+..+............
T Consensus 131 ~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~ 207 (311)
T d1t46a_ 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (311)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeec
Confidence 2335889999999999999999999999 999999999999999999999999999877654434444446
Q ss_pred eccccccCchhcccCCCCCcccchhhHHHHHHHHhCC-CCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChH
Q 045452 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSC 225 (303)
Q Consensus 147 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.|++.|+|||.+.+..++.++|||||||++|+|+++. +||......+. +. .....+... ..+..
T Consensus 208 ~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---~~---~~i~~~~~~---------~~~~~ 272 (311)
T d1t46a_ 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FY---KMIKEGFRM---------LSPEH 272 (311)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---HH---HHHHHTCCC---------CCCTT
T ss_pred ccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHhcCCCC---------CCccc
Confidence 7899999999999999999999999999999999954 44433322211 11 111111111 11122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHhhccC
Q 045452 226 KLMRCLEIALLCVQENPNDRPSMLEVSSMLKNE 258 (303)
Q Consensus 226 ~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~ 258 (303)
.+.++.+||.+||+.||++|||+++|++.|++.
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 234788999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=316.16 Aligned_cols=234 Identities=25% Similarity=0.368 Sum_probs=185.8
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-CeeeEEEeeCCCCChhhhhcCcCcccCCCHHHHHH
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 85 (303)
.||||+++.. .....++|.+|++++++++||||+++++++... ...++|||||++|+|.+++.. .....++..++.
T Consensus 57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~--~~~~~~~~~~~~ 134 (311)
T d1r0pa_ 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIG 134 (311)
T ss_dssp EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC--TTCCCBHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc--ccccchHHHHHH
Confidence 6899999743 556678899999999999999999999998764 588999999999999998864 344577889999
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccc--cccceeeccccccCchhcccCCC
Q 045452 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLK--ANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 86 ~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 163 (303)
++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++......... .......|+..|+|||.+....+
T Consensus 135 i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 211 (311)
T d1r0pa_ 135 FGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211 (311)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC
T ss_pred HHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCC
Confidence 9999999999999999 999999999999999999999999999876543221 12223467899999999999999
Q ss_pred CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhcccCCCC
Q 045452 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 243 (303)
+.++||||||+++|||++|..||........ ... .... +.... .+...+.++.+||.+||+.||+
T Consensus 212 ~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~---~i~~-g~~~~---------~p~~~~~~l~~li~~cl~~dP~ 276 (311)
T d1r0pa_ 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITV---YLLQ-GRRLL---------QPEYCPDPLYEVMLKCWHPKAE 276 (311)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHT-TCCCC---------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred CChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHH---HHHc-CCCCC---------CcccCcHHHHHHHHHHcCCCHh
Confidence 9999999999999999998888754322111 111 1111 11111 1112234788999999999999
Q ss_pred CCCCHHHHHHhhccCCCC
Q 045452 244 DRPSMLEVSSMLKNETTN 261 (303)
Q Consensus 244 ~Rps~~~l~~~L~~~~~~ 261 (303)
+|||+.||++.|+....+
T Consensus 277 ~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 277 MRPSFSELVSRISAIFST 294 (311)
T ss_dssp GSCCHHHHHHHHHHHHHT
T ss_pred HCcCHHHHHHHHHHHHHh
Confidence 999999999999987654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=311.02 Aligned_cols=237 Identities=26% Similarity=0.373 Sum_probs=191.3
Q ss_pred CCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcC-------ccc
Q 045452 5 CGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------RRL 76 (303)
Q Consensus 5 ~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~ 76 (303)
+++.||||+++.. .......+.+|+.++++++||||+++++++...+..++||||+.+|+|.+++.... ...
T Consensus 49 ~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~ 128 (308)
T d1p4oa_ 49 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128 (308)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccC
Confidence 4678999999754 44556678999999999999999999999999999999999999999999885421 123
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCch
Q 045452 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
.+++..+..++.+++.||.|||+.+ |+||||||+|||++.++++||+|||+++.+.............+++.|+|||
T Consensus 129 ~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 129 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence 4688999999999999999999998 9999999999999999999999999998776554444445567899999999
Q ss_pred hcccCCCCCcccchhhHHHHHHHHhCC-CCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHH
Q 045452 157 YARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|||||||++|||++|. .||.... ......... .+..... +...+..+.+||.
T Consensus 206 ~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~~i~-~~~~~~~---------p~~~~~~l~~li~ 269 (308)
T d1p4oa_ 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVM-EGGLLDK---------PDNCPDMLFELMR 269 (308)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHHH-TTCCCCC---------CTTCCHHHHHHHH
T ss_pred HHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHHHHH-hCCCCCC---------cccchHHHHHHHH
Confidence 999999999999999999999999985 5553221 111111111 2221111 1122347899999
Q ss_pred hcccCCCCCCCCHHHHHHhhccCCC
Q 045452 236 LCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 236 ~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
+||+.||++|||+++|++.|++...
T Consensus 270 ~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 270 MCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHcCCChhHCcCHHHHHHHHHHhcC
Confidence 9999999999999999999998765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=311.86 Aligned_cols=247 Identities=21% Similarity=0.237 Sum_probs=181.5
Q ss_pred CCCCCEEEEEEccCCCh--hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKSSA--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.++...|+||||+.++.+ .++.. .....+++
T Consensus 24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~-~~~~~-~~~~~l~e 101 (298)
T d1gz8a_ 24 KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFMDA-SALTGIPL 101 (298)
T ss_dssp TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH-HHHHH-TTTTCCCH
T ss_pred CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh-hhhhh-hcccCCCH
Confidence 36799999999965432 3457889999999999999999999999999999999999976544 44322 23556999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||.+....... .......|++.|+|||.+..
T Consensus 102 ~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 102 PLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhcc
Confidence 999999999999999999999 9999999999999999999999999997654322 22334578999999998766
Q ss_pred CC-CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCc---ccc------ccccccCC------CCh
Q 045452 161 GV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---MEF------VDSFLDDR------NSS 224 (303)
Q Consensus 161 ~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~~~~~~~~------~~~ 224 (303)
.. ++.++|||||||++|+|++|+.||...+.. ............... ... ........ ...
T Consensus 177 ~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T d1gz8a_ 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253 (298)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHST
T ss_pred ccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhcc
Confidence 55 578999999999999999999999643221 111111111111000 000 00000000 001
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
..+.++.+||.+||..||++|||+.++++. |++..
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 123478899999999999999999999873 65553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=318.24 Aligned_cols=225 Identities=24% Similarity=0.287 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccCCC---hhhHHHHHHHHHHHh-cCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 4 PCGEVIAVKKLSKSS---AQGFEEFKNEVMLTA-KLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
.+|+.||||+++... ....+.+..|..++. .++||||+++++++.+++..|+||||+++|+|.+++. ....++
T Consensus 25 ~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~---~~~~~~ 101 (320)
T d1xjda_ 25 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD 101 (320)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh---ccCCCC
Confidence 579999999996432 234556667777665 6899999999999999999999999999999999984 455689
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+++ ++||||||+|||++.++++||+|||++....... .......||+.|+|||++.
T Consensus 102 e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 176 (320)
T d1xjda_ 102 LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILL 176 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999997654332 2233357899999999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhccc
Q 045452 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 239 (303)
+..++.++|||||||++|+|++|+.||....... +. ........ ..+...+.++.+||.+||.
T Consensus 177 ~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~--~~i~~~~~-----------~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LF--HSIRMDNP-----------FYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HH--HHHHHCCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----HH--HHHHcCCC-----------CCCccCCHHHHHHHHHhcc
Confidence 9999999999999999999999999996432111 11 11111110 1111223478899999999
Q ss_pred CCCCCCCCHH-HHHH
Q 045452 240 ENPNDRPSML-EVSS 253 (303)
Q Consensus 240 ~dp~~Rps~~-~l~~ 253 (303)
.||++|||+. ++++
T Consensus 240 ~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQ 254 (320)
T ss_dssp SSGGGSBTTBSCGGG
T ss_pred cCCCCCcCHHHHHHh
Confidence 9999999996 6754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=310.97 Aligned_cols=231 Identities=29% Similarity=0.408 Sum_probs=180.6
Q ss_pred EEEEEEccCC-ChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCc-------------
Q 045452 8 VIAVKKLSKS-SAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP------------- 72 (303)
Q Consensus 8 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------- 72 (303)
.||||.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 4788887543 344567899999999999 7999999999999999999999999999999998653
Q ss_pred CcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccc
Q 045452 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 73 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
.....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ......|+..|
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y 192 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRW 192 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTT
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcc
Confidence 23467899999999999999999999998 9999999999999999999999999987554322 12234579999
Q ss_pred cCchhcccCCCCCcccchhhHHHHHHHHhCCC-CccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKR-LSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++|||||||++|||++|.. ||.... ... .......+...+ .+...+.++.
T Consensus 193 ~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~-~~~~i~~~~~~~---------~~~~~~~~~~ 256 (309)
T d1fvra_ 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAE-LYEKLPQGYRLE---------KPLNCDDEVY 256 (309)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHH-HHHHGGGTCCCC---------CCTTBCHHHH
T ss_pred cchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHH-HHHHHHhcCCCC---------CCccCCHHHH
Confidence 99999999999999999999999999999765 553221 111 111111111111 1222335789
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
+||.+||+.||++|||+++|++.|++...
T Consensus 257 ~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 257 DLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999888653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=310.68 Aligned_cols=246 Identities=22% Similarity=0.238 Sum_probs=179.0
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
+|+.||||+++.... .......|+..+.+++||||+++++++.+.+ ..++||||+++|+|.++++ ...+++
T Consensus 25 ~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~l~~ 99 (303)
T d1vjya_ 25 RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTV 99 (303)
T ss_dssp TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH----HCCBCH
T ss_pred CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHh----cCCCCH
Confidence 588999999964422 2222334556666789999999999998654 5799999999999999994 345899
Q ss_pred HHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc--ccccceeecccccc
Q 045452 81 KKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVVGTIGYI 153 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~-----~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~~~~y~ 153 (303)
..++.++.+++.||+|+|.. +.++|+||||||+|||++.++.+||+|||++........ ........||+.|+
T Consensus 100 ~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~ 179 (303)
T d1vjya_ 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcC
Confidence 99999999999999999974 223499999999999999999999999999987654322 22333467899999
Q ss_pred CchhcccCC------CCCcccchhhHHHHHHHHhCCCCccccCCCcc--------ccHHHHHHHHhhC-CCccccccccc
Q 045452 154 PPEYARQGV------YSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--------LSILEHAYELWKG-GKGMEFVDSFL 218 (303)
Q Consensus 154 aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~ 218 (303)
|||++.+.. ++.++|||||||++|||++|..||........ ............. ...+.+.
T Consensus 180 aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~---- 255 (303)
T d1vjya_ 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP---- 255 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC----
T ss_pred ChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCC----
Confidence 999987653 46689999999999999999988754332211 0111111121111 1111111
Q ss_pred cCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHhhccCC
Q 045452 219 DDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSMLKNET 259 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~L~~~~ 259 (303)
...........+.+|+.+||+.||++|||+.+|++.|++..
T Consensus 256 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11112234456889999999999999999999999988654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-44 Score=307.18 Aligned_cols=241 Identities=19% Similarity=0.266 Sum_probs=180.4
Q ss_pred cCCCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 2 VLPCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
+.++|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+++|+++.++.+..+.. ....++
T Consensus 22 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~---~~~~l~ 98 (286)
T d1ob3a_ 22 QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLE 98 (286)
T ss_dssp EETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT---STTCCC
T ss_pred EeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHh---hcCCcc
Confidence 35689999999996553 2345789999999999999999999999999999999999998776666653 356799
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+....... .......+++.|+|||.+.
T Consensus 99 ~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~ 173 (286)
T d1ob3a_ 99 SVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLM 173 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHT
T ss_pred hhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--cccceecccchhhhHHHHh
Confidence 9999999999999999999998 9999999999999999999999999998765332 2223346789999999886
Q ss_pred cC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccc---------c------ccccccCCCC
Q 045452 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGME---------F------VDSFLDDRNS 223 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~------~~~~~~~~~~ 223 (303)
+. .++.++|||||||++|+|++|+.||......+ ................ . ..........
T Consensus 174 ~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T d1ob3a_ 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250 (286)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhc
Confidence 54 57899999999999999999999996432211 1122111111100000 0 0000001111
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
...+.++.+||.+||+.||++|||++|+++
T Consensus 251 ~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 251 KGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222357889999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=301.70 Aligned_cols=218 Identities=22% Similarity=0.335 Sum_probs=173.7
Q ss_pred CCCCCEEEEEEccCCCh------hhHHHHHHHHHHHhcCC--CCcceeEEEEEEeCCeeeEEEeeCCC-CChhhhhcCcC
Q 045452 3 LPCGEVIAVKKLSKSSA------QGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPN-KSLDCYLFDPI 73 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~ 73 (303)
..+|+.||||+++.... ....++.+|+.++++++ ||||+++++++.+.+..++||||+.+ +++.+++.
T Consensus 26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~--- 102 (273)
T d1xwsa_ 26 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--- 102 (273)
T ss_dssp TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---
T ss_pred CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh---
Confidence 36899999999864311 12234668999999985 89999999999999999999999976 56767773
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEecccccccccccccccccceeeccccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLKANTEQVVGTIGY 152 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y 152 (303)
.+..+++..++.++.||+.||+|||+.| |+||||||+|||++. ++.+||+|||++....... .....||+.|
T Consensus 103 ~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y 175 (273)
T d1xwsa_ 103 ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 175 (273)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCc
Confidence 3567999999999999999999999999 999999999999985 4789999999997654322 2335789999
Q ss_pred cCchhcccCCC-CCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 153 IPPEYARQGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||++.+..+ +.++|||||||++|+|++|+.||.... ........ . +...+.++.
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~~-------~----~~~~s~~~~ 232 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF-------F----RQRVSSECQ 232 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC-------C----SSCCCHHHH
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcccC-------C----CCCCCHHHH
Confidence 99999877654 567899999999999999999995321 11111110 1 111234788
Q ss_pred HHHHhcccCCCCCCCCHHHHHH
Q 045452 232 EIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~ 253 (303)
+||.+||..||++|||++++++
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=305.24 Aligned_cols=239 Identities=23% Similarity=0.274 Sum_probs=174.1
Q ss_pred CCCEEEEEEccCC--ChhhHHHHHHHHHHHhcC---CCCcceeEEEEEEe-----CCeeeEEEeeCCCCChhhhhcCcCc
Q 045452 5 CGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKL---QHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 5 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~ 74 (303)
+++.||||+++.. .......+.+|+.+++.| +||||+++++++.. ....+++|||+.++++..... ..
T Consensus 32 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--~~ 109 (305)
T d1blxa_ 32 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VP 109 (305)
T ss_dssp TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH--SC
T ss_pred CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh--cc
Confidence 4678999998643 222233456677776665 89999999999863 246899999998876654432 24
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccC
Q 045452 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~a 154 (303)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .......||+.|+|
T Consensus 110 ~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~A 183 (305)
T d1blxa_ 110 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRA 183 (305)
T ss_dssp TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcC
Confidence 556899999999999999999999999 999999999999999999999999998754432 22344678999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcccc------ccc-------cccCC
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEF------VDS-------FLDDR 221 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~-------~~~~~ 221 (303)
||++.+..++.++||||+||++|+|++|+.||......+. +............... ... .....
T Consensus 184 PE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (305)
T d1blxa_ 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260 (305)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred cchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence 9999999999999999999999999999999964332211 1111111110000000 000 00001
Q ss_pred CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 222 NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
.....+..+.+||.+||+.||++|||+.|+++.
T Consensus 261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 112223568899999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=304.75 Aligned_cols=246 Identities=20% Similarity=0.248 Sum_probs=176.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC------CeeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
.+|+.||||+++..... ..+|+.++++++|+||+++++++... .+.++|||||+++.+..+.........
T Consensus 43 ~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~ 118 (350)
T d1q5ka_ 43 DSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118 (350)
T ss_dssp TTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCC
T ss_pred CCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCC
Confidence 57999999999654322 34699999999999999999998643 247899999976644333322234567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 156 (303)
+++..++.++.||+.||+|||+.| |+||||||+|||++.++ .+||+|||++..+.... ......|+..|+|||
T Consensus 119 l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 192 (350)
T d1q5ka_ 119 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPE 192 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChH
Confidence 999999999999999999999988 99999999999999775 89999999997764332 222356899999999
Q ss_pred hccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH--------HHHHhhCC----CccccccccccCCCC
Q 045452 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGG----KGMEFVDSFLDDRNS 223 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~----~~~~~~~~~~~~~~~ 223 (303)
.+.+ ..++.++||||+||++|+|++|+.||......+....+.. ........ ...............
T Consensus 193 ~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (350)
T d1q5ka_ 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272 (350)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSC
T ss_pred HhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcc
Confidence 8764 5689999999999999999999999964432221111100 00000000 000000000011112
Q ss_pred hHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCC
Q 045452 224 SCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNET 259 (303)
Q Consensus 224 ~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~ 259 (303)
...+.++.+||.+||..||++|||+.|+++ +|++..
T Consensus 273 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 223457889999999999999999999986 455543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=299.02 Aligned_cols=242 Identities=24% Similarity=0.276 Sum_probs=180.8
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC------eeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||+++.. .....+.+.+|+.++++++|||||+++++|...+ .+|+||||+ +.+|..++ ..
T Consensus 41 ~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~----~~ 115 (346)
T d1cm8a_ 41 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KH 115 (346)
T ss_dssp TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH----HH
T ss_pred CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH----Hh
Confidence 57999999999754 3345678899999999999999999999997654 579999999 66776665 34
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||.+....... ....|++.|+||
T Consensus 116 ~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aP 187 (346)
T d1cm8a_ 116 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAP 187 (346)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCT
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCcc-----ccccccccccCH
Confidence 56999999999999999999999999 9999999999999999999999999998664332 235689999999
Q ss_pred hhccc-CCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHH-----HHhhCCC----------cccccccccc
Q 045452 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGK----------GMEFVDSFLD 219 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~----------~~~~~~~~~~ 219 (303)
|.+.+ ..++.++||||+||++|+|++|..||................ ..+.... ..+.......
T Consensus 188 E~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (346)
T d1cm8a_ 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 267 (346)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG
T ss_pred HHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH
Confidence 98865 457899999999999999999999996543221111111000 0000000 0000000000
Q ss_pred CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 220 DRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
......+.++.+||.+||..||++|||+.++++. |++..
T Consensus 268 -~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 268 -SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp -GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred -HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0111123467899999999999999999999974 66544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=297.63 Aligned_cols=247 Identities=21% Similarity=0.241 Sum_probs=180.6
Q ss_pred CCCCCEEEEEEccCC-ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCC----eeeEEEeeCCCCChhhhhcCcCcccC
Q 045452 3 LPCGEVIAVKKLSKS-SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 3 l~~g~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~ 77 (303)
..+|+.||||+++.. .....+.+++|+.++++++||||+++++++.... ..+++++++.+|+|.+++. ...
T Consensus 30 ~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~----~~~ 105 (345)
T d1pmea_ 30 NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK----TQH 105 (345)
T ss_dssp TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHH----HCC
T ss_pred CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhh----cCC
Confidence 368999999999654 3445678899999999999999999999997653 2345555667999999984 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc-ccccceeeccccccCch
Q 045452 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-KANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE 156 (303)
+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++........ ........|++.|+|||
T Consensus 106 l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 106 LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHH
Confidence 999999999999999999999999 99999999999999999999999999976543322 22234467899999999
Q ss_pred hc-ccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc--------c---cccccccCC---
Q 045452 157 YA-RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM--------E---FVDSFLDDR--- 221 (303)
Q Consensus 157 ~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~--- 221 (303)
++ .+..++.++||||+||++|+|++|+.||......+.. ............. . .........
T Consensus 183 ~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (345)
T d1pmea_ 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP 259 (345)
T ss_dssp GTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred HhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCC
Confidence 87 4556788999999999999999999999544321111 1111100000000 0 000000000
Q ss_pred ---CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hccCC
Q 045452 222 ---NSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKNET 259 (303)
Q Consensus 222 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~~~ 259 (303)
.....+.++.+||.+||..||++|||++++++. |+...
T Consensus 260 ~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 260 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 001112368899999999999999999999874 55443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=298.46 Aligned_cols=241 Identities=20% Similarity=0.266 Sum_probs=175.1
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe--------CCeeeEEEeeCCCCChhhhhcCcC
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--------SEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~ 73 (303)
.+|+.||||++... .......+.+|+.++++++|+||+++++++.. ....+++|||+.++.+.... .
T Consensus 33 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~---~ 109 (318)
T d3blha1 33 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---N 109 (318)
T ss_dssp TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT---C
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh---h
Confidence 68999999998543 23345778899999999999999999999855 34689999999877665444 2
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccc--ccccceeecccc
Q 045452 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--KANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~~~~ 151 (303)
....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+|++|||++..+..... ........||+.
T Consensus 110 ~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~ 186 (318)
T d3blha1 110 VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186 (318)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGG
T ss_pred cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHH
Confidence 3556899999999999999999999999 99999999999999999999999999976653322 122233568999
Q ss_pred ccCchhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccc------------cc
Q 045452 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDS------------FL 218 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~ 218 (303)
|+|||++.+. .++.++||||+||++|+|++|+.||......... ....... +....+.... ..
T Consensus 187 Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T d3blha1 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLC-GSITPEVWPNVDNYELYEKLELVK 262 (318)
T ss_dssp GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH-CCCCTTTSTTCCCC-------CCS
T ss_pred HhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhc-CCCChhhccccchhhhhhhhcccc
Confidence 9999988655 6899999999999999999999999543221111 1111111 1110000000 00
Q ss_pred cCCCCh-------HHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 219 DDRNSS-------CKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 219 ~~~~~~-------~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
...... .....+.+||.+||..||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 263 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 112356789999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=299.16 Aligned_cols=229 Identities=21% Similarity=0.278 Sum_probs=182.3
Q ss_pred CCCEEEEEEccCCC----hhhHHHHHHHHHHHhcCCC-CcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCC
Q 045452 5 CGEVIAVKKLSKSS----AQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 5 ~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 79 (303)
+|+.||||.++... ....+.+.+|+.++++++| |||+++++++.+....+++|||+.+|+|.+++. ....++
T Consensus 51 ~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~---~~~~~~ 127 (322)
T d1vzoa_ 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFT 127 (322)
T ss_dssp TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH---HHSCCC
T ss_pred CCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHH---hccccc
Confidence 68999999986432 2345678899999999966 899999999999999999999999999999984 455678
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++..+...... ......|++.|+|||.+.
T Consensus 128 e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~ 203 (322)
T d1vzoa_ 128 EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVR 203 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhh
Confidence 9999999999999999999998 999999999999999999999999999876543322 223356899999999886
Q ss_pred cC--CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHHHhc
Q 045452 160 QG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 237 (303)
+. .++.++|||||||++|+|++|..||...........+......... ..+...+.++.+||.+|
T Consensus 204 ~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-------------~~~~~~s~~~~~li~~~ 270 (322)
T d1vzoa_ 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-------------PYPQEMSALAKDLIQRL 270 (322)
T ss_dssp TCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-------------CCCTTSCHHHHHHHHHH
T ss_pred cCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-------------CCcccCCHHHHHHHHHH
Confidence 54 4678999999999999999999999766554443333322211111 11122345788999999
Q ss_pred ccCCCCCCCC-----HHHHHH
Q 045452 238 VQENPNDRPS-----MLEVSS 253 (303)
Q Consensus 238 l~~dp~~Rps-----~~~l~~ 253 (303)
|.+||++||| ++|+++
T Consensus 271 l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 271 LMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TCSSGGGSTTSSTTTHHHHHT
T ss_pred cccCHHHcCCCCcccHHHHHc
Confidence 9999999995 778775
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=291.87 Aligned_cols=245 Identities=20% Similarity=0.224 Sum_probs=186.0
Q ss_pred CCCCCEEEEEEccCCC--hhhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 3 LPCGEVIAVKKLSKSS--AQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
..+|+.||||+++... ....+++.+|+.+++.++||||+++++++.+....+++++++.+++|..++. ....+++
T Consensus 24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~---~~~~~~~ 100 (292)
T d1unla_ 24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDP 100 (292)
T ss_dssp TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH---TTTCCCH
T ss_pred CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc---cccccch
Confidence 3689999999986443 3456789999999999999999999999999999999999999998887774 4556899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCchhccc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+......... .....++..|.|||.+.+
T Consensus 101 ~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 101 EIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTT
T ss_pred hHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhcc
Confidence 999999999999999999998 999999999999999999999999999876543221 222346788999998876
Q ss_pred CC-CCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc---------------ccccccccCCCCh
Q 045452 161 GV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM---------------EFVDSFLDDRNSS 224 (303)
Q Consensus 161 ~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~ 224 (303)
.. ++.++|||||||++|+|++|+.||....... ................ .............
T Consensus 176 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (292)
T d1unla_ 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTST
T ss_pred CCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccc
Confidence 54 6899999999999999999999975433221 1122211111111000 0000001111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhcc
Q 045452 225 CKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKN 257 (303)
Q Consensus 225 ~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~ 257 (303)
..+..+.+||.+||+.||++|||++|+++ +|++
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 23457889999999999999999999986 4544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-41 Score=291.37 Aligned_cols=235 Identities=19% Similarity=0.227 Sum_probs=175.9
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhcCcCcccCCCH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 80 (303)
.+|+.||||+++... .+++.+|+.+++.+ .||||+++++++... ...++||||+.+++|..+. ..+++
T Consensus 58 ~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~------~~l~e 128 (328)
T d3bqca1 58 TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTD 128 (328)
T ss_dssp TTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT------TSCCH
T ss_pred CCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh------cCCCH
Confidence 679999999996543 46788999999999 599999999999754 5689999999999986664 24899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEecccccccccccccccccceeeccccccCchhcc
Q 045452 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLKANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 159 (303)
..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++....... ......+|..|+|||.+.
T Consensus 129 ~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~ 202 (328)
T d3bqca1 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLV 202 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCccccc
Confidence 999999999999999999999 99999999999998655 69999999997664332 223356899999999876
Q ss_pred cC-CCCCcccchhhHHHHHHHHhCCCCccccCCCcccc-HHHH---------HHHHhhCCCccc-----------ccccc
Q 045452 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-ILEH---------AYELWKGGKGME-----------FVDSF 217 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~---------~~~~~~~~~~~~-----------~~~~~ 217 (303)
+. .++.++||||+||++|+|++|..||.......... .... ............ .....
T Consensus 203 ~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (328)
T d3bqca1 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282 (328)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGG
T ss_pred CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhc
Confidence 65 47999999999999999999999986543321110 0000 000000000000 00111
Q ss_pred ccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 045452 218 LDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS 253 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~ 253 (303)
.........+.++.+||.+||..||++|||++++++
T Consensus 283 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122233457889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-41 Score=288.59 Aligned_cols=244 Identities=16% Similarity=0.140 Sum_probs=187.9
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCC-CcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
..+|+.||||+++.... ...+.+|++.++.++| +|++.+++++..+...++||||+ +++|.+++.. .+..++..
T Consensus 27 ~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~--~~~~~~~~ 101 (293)
T d1csna_ 27 LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVK 101 (293)
T ss_dssp TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHH
T ss_pred CCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh--hccchhhH
Confidence 35799999999855432 2356788999999955 89999999999999999999999 7899888753 34468999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-----CCcEEEecccccccccccccc-----cccceeecccc
Q 045452 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-----DMKPKISDFGLARIFAKESLK-----ANTEQVVGTIG 151 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~-----~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~ 151 (303)
.+..++.|++.||+|||+.| ++||||||+||+++. ++.+||+|||+++.+...... .......||+.
T Consensus 102 ~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~ 178 (293)
T d1csna_ 102 TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178 (293)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchh
Confidence 99999999999999999999 999999999999974 578999999999876433211 12334579999
Q ss_pred ccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHH
Q 045452 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|+|||.+.+..++.++|||||||++|+|++|..||.........................++ .... +.++.
T Consensus 179 y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l-----~~~~----p~~l~ 249 (293)
T d1csna_ 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-----CAGF----PEEFY 249 (293)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-----TTTS----CHHHH
T ss_pred hcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh-----cCCC----CHHHH
Confidence 99999999999999999999999999999999999755444333333222221111111111 1111 24688
Q ss_pred HHHHhcccCCCCCCCCHHHHHHhhccCCCCCC
Q 045452 232 EIALLCVQENPNDRPSMLEVSSMLKNETTNTN 263 (303)
Q Consensus 232 ~li~~cl~~dp~~Rps~~~l~~~L~~~~~~~~ 263 (303)
+++..|+..+|++||+++.+.+.|++......
T Consensus 250 ~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 250 KYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 99999999999999999999888877654443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=289.79 Aligned_cols=240 Identities=18% Similarity=0.161 Sum_probs=178.0
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCc-ceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 82 (303)
.+|+.||||++..... .+++..|+++++.++|++ |+.+..++.+....++||||+ ++++...+.. ....+++..
T Consensus 30 ~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~--~~~~~~~~~ 104 (299)
T d1ckia_ 30 AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKT 104 (299)
T ss_dssp TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHH
T ss_pred CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh--ccCCCcHHH
Confidence 5789999999865432 235778999999997766 455566667788899999999 5566555532 345689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEecccccccccccccc-----cccceeeccccccC
Q 045452 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLK-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~---~~~~kl~df~~~~~~~~~~~~-----~~~~~~~~~~~y~a 154 (303)
+..++.|++.||+|||++| |+||||||+|||++. +..++++|||++..+...... .......||+.|+|
T Consensus 105 ~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 181 (299)
T d1ckia_ 105 VLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCC
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccC
Confidence 9999999999999999999 999999999999864 456999999999876543221 22234579999999
Q ss_pred chhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCccccccccccCCCChHHHHHHHHHH
Q 045452 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGMEFVDSFLDDRNSSCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|||||||++|+|++|..||.......................... ... ..+.++.++|
T Consensus 182 PE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~----~~p~~~~~li 252 (299)
T d1ckia_ 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LCK----GYPSEFATYL 252 (299)
T ss_dssp HHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH-----HTT----TSCHHHHHHH
T ss_pred HHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH-----hcc----CCCHHHHHHH
Confidence 9999999999999999999999999999999976554443333322222111111000 011 1124688999
Q ss_pred HhcccCCCCCCCCHHHHHHhhccCCC
Q 045452 235 LLCVQENPNDRPSMLEVSSMLKNETT 260 (303)
Q Consensus 235 ~~cl~~dp~~Rps~~~l~~~L~~~~~ 260 (303)
.+||+.||++||++.++.+.|++...
T Consensus 253 ~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 253 NFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999888887543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=298.61 Aligned_cols=246 Identities=24% Similarity=0.285 Sum_probs=178.9
Q ss_pred CCCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEeC-----CeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 3 LPCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 l~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
..+|+.||||+++.. .....+++.+|+.++++++||||+++++++... ...+++++++.+|+|.+++. .
T Consensus 40 ~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~----~ 115 (348)
T d2gfsa1 40 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----C 115 (348)
T ss_dssp TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT----T
T ss_pred CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc----c
Confidence 468999999999754 334556788999999999999999999998643 34466777788999999883 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||.+...... .....|+..|+||
T Consensus 116 ~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~ap 187 (348)
T d2gfsa1 116 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187 (348)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCH
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc-----cccccccccccCc
Confidence 45999999999999999999999999 999999999999999999999999998654322 2335689999999
Q ss_pred hhcccC-CCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHHHHHhhCCCcc-------------------cccc
Q 045452 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGM-------------------EFVD 215 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~ 215 (303)
|.+.+. .++.++|||||||++|+|++|+.||...........+. ... +.... ....
T Consensus 188 E~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (348)
T d2gfsa1 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLV-GTPGAELLKKISSESARNYIQSLTQMPK 263 (348)
T ss_dssp HHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHH-CCCCHHHHTTCCCHHHHHHHTTSCCCCC
T ss_pred hhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhc-CCCChHHhhhccchhhhhhhhhcccCCC
Confidence 987665 46889999999999999999999996433221111111 100 00000 0000
Q ss_pred ccccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH--hhccCCCCCCCC
Q 045452 216 SFLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSS--MLKNETTNTNTP 265 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~--~L~~~~~~~~~~ 265 (303)
..... .....+.++.+||.+||..||++|||++|+++ ++++...+...+
T Consensus 264 ~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~ 314 (348)
T d2gfsa1 264 MNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314 (348)
T ss_dssp CCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred cchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence 00000 00112346789999999999999999999997 577655443333
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=294.42 Aligned_cols=239 Identities=23% Similarity=0.251 Sum_probs=171.3
Q ss_pred CCCCEEEEEEccCC--ChhhHHHHHHHHHHHhcCCCCcceeEEEEEEe------CCeeeEEEeeCCCCChhhhhcCcCcc
Q 045452 4 PCGEVIAVKKLSKS--SAQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~ 75 (303)
.+|+.||||+++.. .....+++.+|+.++++++||||+++++++.. ..++|+|||||.++.+ ..+.
T Consensus 40 ~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~----- 113 (355)
T d2b1pa1 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQ----- 113 (355)
T ss_dssp TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHT-----
T ss_pred CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhh-----
Confidence 57999999999754 34455678999999999999999999999964 3678999999976554 4442
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEecccccccccccccccccceeeccccccCc
Q 045452 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 155 (303)
..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||++...... .......+|+.|+||
T Consensus 114 ~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~---~~~~~~~~t~~y~aP 187 (355)
T d2b1pa1 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 187 (355)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc---cccccccccccccCh
Confidence 34889999999999999999999999 999999999999999999999999998765432 222334689999999
Q ss_pred hhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHH----------------HHHHhhCCC---cc---cc
Q 045452 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELWKGGK---GM---EF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~---~~---~~ 213 (303)
|++.+..++.++||||+||++|+|++|+.||...........+.. ......... .. ..
T Consensus 188 E~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (355)
T d2b1pa1 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267 (355)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccc
Confidence 999999999999999999999999999999964331111111100 000000000 00 00
Q ss_pred ccccccC---CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh
Q 045452 214 VDSFLDD---RNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM 254 (303)
Q Consensus 214 ~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~ 254 (303)
....... ......+.++.+||.+||..||++|||++|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0112235678999999999999999999999854
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-36 Score=260.94 Aligned_cols=245 Identities=18% Similarity=0.161 Sum_probs=172.3
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-----------CCcceeEEEEEEeC--CeeeEEEeeCCCCChhhhhc
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-----------HVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~ 70 (303)
.+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++... ...++++.++..+.......
T Consensus 36 ~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (362)
T d1q8ya_ 36 VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114 (362)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHH
T ss_pred CCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccc
Confidence 68999999999654 334567788888888774 57899999988643 45667777765554333332
Q ss_pred CcCcccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCc------EEEeccccccccccccccccc
Q 045452 71 DPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMK------PKISDFGLARIFAKESLKANT 143 (303)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~H~dl~p~nil~~~~~~------~kl~df~~~~~~~~~~~~~~~ 143 (303)
.......+++..++.++.||+.||+|||+ .| |+||||||+|||++.++. ++++|||.+...... .
T Consensus 115 ~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~ 186 (362)
T d1q8ya_ 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----Y 186 (362)
T ss_dssp HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----C
T ss_pred ccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----c
Confidence 33345678999999999999999999997 77 999999999999986654 999999998754322 2
Q ss_pred ceeeccccccCchhcccCCCCCcccchhhHHHHHHHHhCCCCccccCCCccccHHHHH---HHHhhC-------------
Q 045452 144 EQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA---YELWKG------------- 207 (303)
Q Consensus 144 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~------------- 207 (303)
....|++.|+|||++.+..++.++|+||+||++++|++|+.||............... ......
T Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~ 266 (362)
T d1q8ya_ 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266 (362)
T ss_dssp CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHH
T ss_pred ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccc
Confidence 3356899999999999999999999999999999999999999654432222111111 111000
Q ss_pred -----CCccccccc----------cccCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHh--hcc
Q 045452 208 -----GKGMEFVDS----------FLDDRNSSCKLMRCLEIALLCVQENPNDRPSMLEVSSM--LKN 257 (303)
Q Consensus 208 -----~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~l~~~--L~~ 257 (303)
......... ..........+.++.+||.+||+.||.+|||++|+++. +++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 267 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred cccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCC
Confidence 000000000 01122345566789999999999999999999999863 554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.78 E-value=6.4e-20 Score=144.68 Aligned_cols=152 Identities=19% Similarity=0.159 Sum_probs=103.3
Q ss_pred cCCCCCEEEEEEccCCCh------------------hhHHHHHHHHHHHhcCCCCcceeEEEEEEeCCeeeEEEeeCCCC
Q 045452 2 VLPCGEVIAVKKLSKSSA------------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63 (303)
Q Consensus 2 ~l~~g~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 63 (303)
+.++|+.||||+++.... ........|...+.++.|.+++..+++. ..+++|||+++.
T Consensus 20 ~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~ 95 (191)
T d1zara2 20 YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK 95 (191)
T ss_dssp EETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCE
T ss_pred ECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccc
Confidence 457899999998753211 1123345688899999999999988764 247999999876
Q ss_pred ChhhhhcCcCcccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeccccccccccccccccc
Q 045452 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLKANT 143 (303)
Q Consensus 64 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~H~dl~p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 143 (303)
.+.. ++......++.|++.++++||+.| ++||||||+|||++++ .++|+|||.+............
T Consensus 96 ~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l 161 (191)
T d1zara2 96 ELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREIL 161 (191)
T ss_dssp EGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHH
T ss_pred cccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHH
Confidence 5533 223345678999999999999999 9999999999999865 5899999998765422111000
Q ss_pred ceeeccccccCchhcccCCCCCcccchhhHHHH
Q 045452 144 EQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176 (303)
Q Consensus 144 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 176 (303)
. .... .-.+.+ .+.|..++|+||+.--+
T Consensus 162 ~---rd~~-~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 162 E---RDVR-NIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp H---HHHH-HHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred H---HHHH-HHHHHH-cCCCCCcccHHHHHHHH
Confidence 0 0000 001111 35567889999976433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.62 E-value=4.6e-08 Score=79.30 Aligned_cols=120 Identities=18% Similarity=0.112 Sum_probs=83.0
Q ss_pred CCCEEEEEEccCCChhhHHHHHHHHHHHhcCC-CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHHHH
Q 045452 5 CGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 83 (303)
+++.+++|+...........+.+|...++.+. +--+.+++.+...++..++||++++|.++...... ....
T Consensus 36 ~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--------~~~~ 107 (263)
T d1j7la_ 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSP 107 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT--------CSCH
T ss_pred CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc--------cccH
Confidence 56677888876554334445677888877773 44467888888888899999999999887554421 1112
Q ss_pred HHHHHHHHHHHHHHHhcC--------------------------------------------------------CCCeee
Q 045452 84 VHIIEGITQGLLYLQEYS--------------------------------------------------------RLTIIH 107 (303)
Q Consensus 84 ~~~~~~i~~~l~~lh~~~--------------------------------------------------------~~~i~H 107 (303)
..++.+++..++.||+.. ...++|
T Consensus 108 ~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~H 187 (263)
T d1j7la_ 108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH 187 (263)
T ss_dssp HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEE
Confidence 334555556666666321 123789
Q ss_pred cCCCCCcEEECCCCcEEEecccccc
Q 045452 108 RDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 108 ~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
+|+.|.||++++++.+.|+||+.+.
T Consensus 188 gD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 188 GDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCTTSEEEETTEEEEECCCTTCE
T ss_pred eeccCcceeecCCceEEEeechhcc
Confidence 9999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=9.2e-06 Score=64.87 Aligned_cols=115 Identities=18% Similarity=0.169 Sum_probs=75.4
Q ss_pred CCCCEEEEEEccCCChhhHHHHHHHHHHHhcCC--CCcceeEEEEEEeCCeeeEEEeeCCCCChhhhhcCcCcccCCCHH
Q 045452 4 PCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 81 (303)
++|..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++||++++|.++.... ...
T Consensus 33 ~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--------~~~- 100 (255)
T d1nd4a_ 33 QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--------LAP- 100 (255)
T ss_dssp TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--------CCH-
T ss_pred CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--------ccH-
Confidence 5677889998755433 23566777777663 234677888888888899999999887664321 111
Q ss_pred HHHHHHHHHHHHHHHHHhc-------------------------------------------------------CCCCee
Q 045452 82 KRVHIIEGITQGLLYLQEY-------------------------------------------------------SRLTII 106 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~lh~~-------------------------------------------------------~~~~i~ 106 (303)
...+.+++..|+.||.. ....++
T Consensus 101 --~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~li 178 (255)
T d1nd4a_ 101 --AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT 178 (255)
T ss_dssp --HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEE
T ss_pred --HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEE
Confidence 11122333333344421 112379
Q ss_pred ecCCCCCcEEECCCCcEEEecccccc
Q 045452 107 HRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 107 H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
|+|+.|.||+++.++.+.|+||+.+.
T Consensus 179 HgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 179 HGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eCCCCCcceEEeCCceEEEEEchhcc
Confidence 99999999999987667899998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.44 E-value=0.00023 Score=58.79 Aligned_cols=62 Identities=8% Similarity=-0.000 Sum_probs=39.3
Q ss_pred CCCCCEEEEEEccCCChhhHHHHHHHHHHHhcCCCCcc--eeEE-----EEEEeCCeeeEEEeeCCCCCh
Q 045452 3 LPCGEVIAVKKLSKSSAQGFEEFKNEVMLTAKLQHVNL--IRVL-----GFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 3 l~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~sL 65 (303)
+++|+.|++|+.++.. ...+++..|...+..|...++ +..+ ..+......+.+++++.|..+
T Consensus 43 ~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 43 DEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 5789999999986542 234667778888877732222 1111 122345677889999876543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.42 E-value=0.00022 Score=60.66 Aligned_cols=28 Identities=36% Similarity=0.461 Sum_probs=24.7
Q ss_pred CeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 104 TIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 104 ~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
.++|||++|.|||+++++ ++|+||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 489999999999998765 8999998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.96 E-value=0.00063 Score=57.69 Aligned_cols=54 Identities=13% Similarity=0.166 Sum_probs=35.4
Q ss_pred CCEEEEEEccCCChhhHHHHHHHHHHHhcC-CCCcceeEEEEEEeCCeeeEEEeeCCCCCh
Q 045452 6 GEVIAVKKLSKSSAQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 6 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 65 (303)
.+.|++++.. ... ..-...+|..+++.+ ++.-..++++++.+ .+|++|++|.++
T Consensus 74 ~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 4567777764 222 223455788888887 44444678888743 689999987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.06 E-value=0.0072 Score=49.05 Aligned_cols=31 Identities=29% Similarity=0.340 Sum_probs=27.2
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEecccccc
Q 045452 102 RLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 102 ~~~i~H~dl~p~nil~~~~~~~kl~df~~~~ 132 (303)
..+++|+|+.++|++++++...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3559999999999999988878999999874
|